0.3289425.9328472.html.plaintext.txt	0	new pathogenic mutation app gene inumv increase relative proportion abetanumnum new pathogenic mutation app gene inumv increase relative proportion betanumnum christopher b
0.3289425.9328472.html.plaintext.txt	1	mehtanumnum richard crooknumnum jordi perez turnumnum guy priharnumnum eric pfeiffernum neill graff radfordnum paul hindernum debra yagernum brenda zenknum lawrence m
0.3289425.9328472.html.plaintext.txt	2	refolonum cristian mihail pradanum steven g
0.3289425.9328472.html.plaintext.txt	3	younkinnum mike huttonnumnum john hardynumnum
0.3289425.9328472.html.plaintext.txt	4	nummayo clinic jacksonville num san pablo road jacksonville fl num usa numdepartment neuroscience case western reserve university cleveland oh num usa numsuncoast gerontology center laboratory department psychiatry pharmacology neurology biochemistry university south florida tampa fl num usa
0.3289425.9328472.html.plaintext.txt	5	received june num num revised accepted august num num
0.3289425.9328472.html.plaintext.txt	6	report novel mutation amyloid precursor protein gene app inumv probably lead familial early onset alzheimers disease onset age mid nums
0.3289425.9328472.html.plaintext.txt	7	cell transfected cdna bearing mutation produce abetanum numnum transfected wild type app effect additive previously reported app vnumi mutation thus providing novel approach increasing abetanum numnum model system
0.3289425.9328472.html.plaintext.txt	8	mutation amyloid precursor protein app cause early onset familial alzheimers disease fad previously identified num
0.3289425.9328472.html.plaintext.txt	9	lead solely ad reported two site codon num double mutation codon numnum kmnumnumnl review see ref
0.3289425.9328472.html.plaintext.txt	10	mutation presenilin mutation also lead fad common feature increase concentration abeta ending abetanumnum num num
0.3289425.9328472.html.plaintext.txt	11	report identification novel mutation app associated alzheimer phenotype show result increased extracellular concentration abetanumnum
0.3289425.9328472.html.plaintext.txt	12	report identification new mutation app gene inumv demonstrate mutation also increase relative concentration abetanum numnum transfected cell plasma providing additional support hypothesis alteration abeta concentration critical early feature development ad
0.3289425.9328472.html.plaintext.txt	13	demonstrate additive increase relative concentration abetanum numnum cell transfected construct containing inumv vnumi mutation
0.3289425.9328472.html.plaintext.txt	14	finding provides novel approach increasing abetanum numnum concentration model system
0.3289425.9328472.html.plaintext.txt	15	family ad caused app mutation disease onset age num num year typically onset age mid nums
0.3289425.9328472.html.plaintext.txt	16	context family report mean documented onset age num year candidate app mutation
0.3289425.9328472.html.plaintext.txt	17	sequencing revealed mutation changing predicted amino acid codon num isoleucine valine
0.3289425.9328472.html.plaintext.txt	18	mutation likely pathogenic due proximity previously identified vnumi mutation previously observed hundred normal sample others previously sequenced
0.3289425.9328472.html.plaintext.txt	19	living affected family member wish sampled precluded segregation analysis mutation
0.3289425.9328472.html.plaintext.txt	20	common feature early onset fad linked mutation increase concentration abeta ending abetanumnum
0.3289425.9328472.html.plaintext.txt	21	determine whether inumv mutation also affected extracellular concentration abetanum numnum performed transient transfection analysis cho human embryonic kidney hek num cell
0.3289425.9328472.html.plaintext.txt	22	result obtained representative experiment shown table num
0.3289425.9328472.html.plaintext.txt	23	relative wild type vector control inumv mutant cdna caused num num increase proportion abetanum numnum cell line examined
0.3289425.9328472.html.plaintext.txt	24	increase similar effect vnumi mutation analyzed parallel series experiment reported previously num num
0.3289425.9328472.html.plaintext.txt	25	importantly increase absolute concentration abetanum numnum produced inumv transfected cell observed even absolute concentration abetanum num essentially identical
0.3289425.9328472.html.plaintext.txt	26	order increase n number statistical analysis account variance transfection efficiency experiment focused subsequent analysis ratio abetanum numnum abetanum num previously shown elevated invariably app vnumi presenilin mutation num num
0.3289425.9328472.html.plaintext.txt	27	ratio obtained three additional independent transient transfections hek num cho cell combined ratio obtained experiment table num produce figure num
0.3289425.9328472.html.plaintext.txt	28	result demonstrate num fold increase ratio abetanum numnum abetanum num compared wild type control p num
0.3289425.9328472.html.plaintext.txt	29	table num effect app mutation abeta concentration num cell cho cell abetanum num
0.3289425.9328472.html.plaintext.txt	30	control plasma n num num
0.3289425.9328472.html.plaintext.txt	31	data point mean two well analyzed duplicate expressed pm plus minus standard deviation
0.3289425.9328472.html.plaintext.txt	32	plasma concentration reported pm plus minus se
0.3289425.9328472.html.plaintext.txt	33	data show inumv vnumi mutation increase proportion abetanum numnum double mutant inumvvnumi increase proportion abetanum numnum mutant individually
0.3289425.9328472.html.plaintext.txt	34	ratio show abetanum numnumabetanum num percentage
0.3289425.9328472.html.plaintext.txt	35	effect inumv ratio abetanum numnumabnum num compiled four independent experiment
0.3289425.9328472.html.plaintext.txt	36	ratio represents abetanum numnumabetanum num expressed percentage
0.3289425.9328472.html.plaintext.txt	37	previously reported elevation plasma abetanumnum concentration patient fad linked mutation num
0.3289425.9328472.html.plaintext.txt	38	availability single living identified carrier inumv mutation precluded depth analysis plasma abeta concentration kindred
0.3289425.9328472.html.plaintext.txt	39	increase absolute concentration abetanumnum however observed plasma patient compared average concentration five non demented control subject analyzed parallel table num
0.3289425.9328472.html.plaintext.txt	40	fact individual highest concentration abetanumnum series despite second lowest concentration abetanum num
0.3289425.9328472.html.plaintext.txt	41	thus mutation cause clear increase absolute concentration abetanumnum vivo
0.3289425.9328472.html.plaintext.txt	42	thus mutation adjacent residue app inumv vnumi result similar increase relative concentration abetanum numnum
0.3289425.9328472.html.plaintext.txt	43	due proximity mutation nature amino acid change interested exploring effect combination mutation abetanum phenotype
0.3289425.9328472.html.plaintext.txt	44	address question constructed cdna containing inumv vnumi mutation pcdnanum vector
0.3289425.9328472.html.plaintext.txt	45	analysis cell transiently transfected artificial double mutant construct demonstrated increase ratio abetanum numnum abetanum num compared individual mutation either separately p num
0.3289425.9328472.html.plaintext.txt	46	feature may useful designing construct maximize abetanum numnum concentration modeling disease process
0.3289425.9328472.html.plaintext.txt	47	conclusion result reported extend site pathogenic app mutation observed five
0.3289425.9328472.html.plaintext.txt	48	importantly pathogenic mutation continue follow established pattern increase extracellular concentration abetanum numnum
0.3289425.9328472.html.plaintext.txt	49	thus result provide support hypothesis alteration concentration abeta play early critical role pathogenesis ad
0.3289425.9328472.html.plaintext.txt	50	material method family ascertainment clinical feature
0.3289425.9328472.html.plaintext.txt	51	family identified telephone call professional caregiver research laboratory detailing case family history
0.3289425.9328472.html.plaintext.txt	52	proband num year old right handed woman
0.3289425.9328472.html.plaintext.txt	53	slowly progressive cognitive difficulty num year period
0.3289425.9328472.html.plaintext.txt	54	history significant head injury rarely drank alcohol
0.3289425.9328472.html.plaintext.txt	55	examination proband preserved social grace mini mental test score num num num impaired knowledge current event anomia scoring numnum boston naming test num
0.3289425.9328472.html.plaintext.txt	56	neurological examination otherwise normal
0.3289425.9328472.html.plaintext.txt	57	scored numnum dementia rating scale num difficulty visual spatial task num
0.3289425.9328472.html.plaintext.txt	58	language fluent made semantic substitution circumlocution
0.3289425.9328472.html.plaintext.txt	59	scored numnum multilingual aphasia examination token test num
0.3289425.9328472.html.plaintext.txt	60	comprehension command impaired repetition phrase intact
0.3289425.9328472.html.plaintext.txt	61	recognition memory test num scored numth percentile
0.3289425.9328472.html.plaintext.txt	62	mri scan showed diffuse cortical atrophy prominent left anterior temporal lobe
0.3289425.9328472.html.plaintext.txt	63	diagnosis probable ad num
0.3289425.9328472.html.plaintext.txt	64	father died heart disease age num year
0.3289425.9328472.html.plaintext.txt	65	mother died probable ad early nums cognitive problem early nums
0.3289425.9328472.html.plaintext.txt	66	sister sibling age num year progressive memory difficulty num year period
0.3289425.9328472.html.plaintext.txt	67	maternal grandmother also probable ad uncertain age onset death
0.3289425.9328472.html.plaintext.txt	68	clinical feature age onset slow progression disease preservation social grace reminiscent first family fnum inumv discovered num indeed similarity pronounced exon num app gene sequenced immediately
0.3289425.9328472.html.plaintext.txt	69	exon num app gene sequenced previously described except pharmacia alf automated sequencer used
0.3289425.9328472.html.plaintext.txt	70	dna sequencing revealed heterozygote g transversion codon num changing predicted amino acid sequence isoleucine atc valine gtc
0.3289425.9328472.html.plaintext.txt	71	resequencing opposite orientation revealed corresponding change
0.3289425.9328472.html.plaintext.txt	72	change destroys saunumai enzyme cut site
0.3289425.9328472.html.plaintext.txt	73	pcr amplification exon num flanking intronic primer numinf num cctcatccaaatgtccc num numinr num ggtaagttgcaatgaat num followed restriction digestion saunumai give two fragment num num bp normal individual carrier mutation additional fragment num bp corresponds uncut pcr product observed
0.3289425.9328472.html.plaintext.txt	74	screening change proband confirmed alteration failed find change num normal
0.3289425.9328472.html.plaintext.txt	75	addition exon app gene sequenced group order num time without finding change except case ad segregating autosomal dominant disorder onset age nums
0.3289425.9328472.html.plaintext.txt	76	mutagenesis transfection abeta assay
0.3289425.9328472.html.plaintext.txt	77	transformer mutagenesis system clontech used convert wild type appnum sequence mutant
0.3289425.9328472.html.plaintext.txt	78	evaluate effect mutant app cdna abeta concentration employed transient transfection paradigm coupled well characterized bannumbanum bannumbcnum sandwich elisa system determine extracellular concentration abetanum num abetanum numnum respectively table num
0.3289425.9328472.html.plaintext.txt	79	cell transfected pcdnanum vector alone pcdnanum containing appnum wild type appnum inumv appnum vnumi appnum inumvvnumi using dotap boehringer mannheim num cell lipofectamine gibco brl laboratory chinese hamster ovary cho cell dna concentration previously determined yield maximal transfection efficiency cell type data shown
0.3289425.9328472.html.plaintext.txt	80	num h post transfection medium changed growth medium
0.3289425.9328472.html.plaintext.txt	81	fresh medium conditioned num num h facilitate measurement abeta sandwich elisa
0.3289425.9328472.html.plaintext.txt	82	due variation transfection efficiency focused analysis ratio abetanum numnumto abetanum num
0.3289425.9328472.html.plaintext.txt	83	absolute concentration abetanum num abetanum numnum representative experiment provided comparison
0.3289425.9328472.html.plaintext.txt	84	analysis plasma abeta concentration performed essentially described previously num except bannum capture replaced bntnumraised abetanum num determination abeta ending abetanumnum num
0.3289425.9328472.html.plaintext.txt	85	change obviates need pre clearance non specific iggnumkappa
0.3289425.9328472.html.plaintext.txt	86	num evidence abetanum real culprit alzheimers disease
0.3289425.9328472.html.plaintext.txt	87	num secreted amyloid beta protein similar senile plaque alzheimers disease increased vivo presenilin num num app mutation linked familial alzheimers disease
0.3289425.9328472.html.plaintext.txt	88	increased amyloid betanumnum brain mouse expressing mutant presenilin num
0.3289425.9328472.html.plaintext.txt	89	num familial alzheimers disease linked presenilin num variant elevate abetanum numnum num ratio vitro vivo
0.3289425.9328472.html.plaintext.txt	90	num mutant presenilins alzheimers disease increase production num residue amyloid beta protein transfected cell transgenic mouse
0.3289425.9328472.html.plaintext.txt	91	presenilin num mutation nnumi linked familial alzheimer disease volga german family increase secretion amyloid beta protein ending numnd numrd residue
0.3289425.9328472.html.plaintext.txt	92	num increased percentage long amyloid beta protein secreted familial amyloid beta protein betaappnum mutant
0.3289425.9328472.html.plaintext.txt	93	num mini mental state practical method grading cognitive state patient clinician
0.3289425.9328472.html.plaintext.txt	94	lea febiger philadelphia pa
0.3289425.9328472.html.plaintext.txt	95	psychological assessment resource odessa
0.3289425.9328472.html.plaintext.txt	96	num weschler memory scale revised
0.3289425.9328472.html.plaintext.txt	97	psychological corporation new york
0.3289425.9328472.html.plaintext.txt	98	num multilingual aphasia examination
0.3289425.9328472.html.plaintext.txt	99	num recognition memory test
0.3289425.9328472.html.plaintext.txt	100	num clinical diagnosis alzheimers disease report nincds adrda work group auspex department health human service task force alzheimers disease
0.3289425.9328472.html.plaintext.txt	101	num clinical comparison alzheimers disease pedigree codon num val ile mutation amyloid precursor protein gene
0.3289425.9328472.html.plaintext.txt	102	num long amyloid b protein secreted wild type human neuroblastoma imrnum cell
0.3289425.9328472.html.plaintext.txt	103	correspondence addressed mayo clinic jacksonville num san pablo road jacksonville fl num usa
0.3289425.9328472.html.plaintext.txt	104	tel num num num num fax num num num num email hardymayo
0.3289425.9328472.html.plaintext.txt	105	edu page maintained oup admin
0.3289425.9328472.html.plaintext.txt	106	last updated sat oct num numnumnum bst num
0.3289425.9328472.html.plaintext.txt	107	part oup journal world wide web service
0.3289425.9328472.html.plaintext.txt	108	copyright oxford university press num
0.3291776.12119298.html.plaintext.txt	0	presenilin num mutation activate num secretase reciprocally inhibit secretase cleavage amyloid precursor protein app snum cleavage notch fusheng chen yongjun gu hiroshi hasegawa xueying ruan shigeki arawaka paul fraser david westaway howard mount peter st george hyslop
0.3291776.12119298.html.plaintext.txt	1	centre research neurodegenerative disease department medicine medical biophysics laboratory medicine pathobiology university toronto toronto ontario mnums numhnum canada department medicine division neurology university health network toronto ontario mnums numhnum canada
0.3291776.12119298.html.plaintext.txt	2	received publication may num num revised form july num num
0.3291776.12119298.html.plaintext.txt	3	amyloid precursor protein appnum undergoes series proteolytic processing event fig
0.3291776.12119298.html.plaintext.txt	4	one processing event mediated sequentially first secretase secretase generates several proteolytic fragment including num num amino acid fragment termed number c terminal fragment ctfs contain cytoplasmic tail app
0.3291776.12119298.html.plaintext.txt	5	ctfs variously termed stub stub app intracellular domain aicd
0.3291776.12119298.html.plaintext.txt	6	detailed analysis product revealed cleavage event give rise c terminus occur residue num num secretase stub fig
0.3291776.12119298.html.plaintext.txt	7	however give rise predominant stable ctfs n terminus residue num num num located num num residue inside cytoplasmic membrane boundary num num
0.3291776.12119298.html.plaintext.txt	8	latter cleavage event snum cleavage notch occur approximately position relative inner surface membrane
0.3291776.12119298.html.plaintext.txt	9	within num num residue surface fig
0.3291776.12119298.html.plaintext.txt	10	beyreuther colleague num referred cleavage residue num num secretase cleavage cleavage residue num num cleavage
0.3291776.12119298.html.plaintext.txt	11	sake clarity retain terminology
0.3291776.12119298.html.plaintext.txt	12	view larger version numk fig
0.3291776.12119298.html.plaintext.txt	13	schematic diagram app notch cleavage pathway
0.3291776.12119298.html.plaintext.txt	14	site num num secretase cleavage app indicated arrow upper panel
0.3291776.12119298.html.plaintext.txt	15	stub peptide depicted horizontal bar
0.3291776.12119298.html.plaintext.txt	16	number near amino acid sequence app top panel notch codon number number parenthesis next app codon number correspond amino acid numbering cnum app secretase product
0.3291776.12119298.html.plaintext.txt	17	transmembrane domain depicted blue box
0.3291776.12119298.html.plaintext.txt	18	tace tumor necrosis factor converting enzyme
0.3291776.12119298.html.plaintext.txt	19	cell culture transfection human embryonic kidney num heknum cell line stably transfected wild type psnum various mutant psnums including lnumv gnuma exon num missplicing mutation exon num dnuma
0.3291776.12119298.html.plaintext.txt	20	certain cell line also stably expressed appnum swedish mutant
0.3291776.12119298.html.plaintext.txt	21	experiment cell transiently transfected cdna encoding membrane bound notch protein myc tagged notche cloned pcsnum vector num num
0.3291776.12119298.html.plaintext.txt	22	examine ability app mutant increase decrease production cell co transfected cdna encoding wild type mutant form c terminal num amino acid app corresponding product secretase cleavage fl app fused artificial signal peptide ensure correct orientation cloned pcepnum vector num
0.3291776.12119298.html.plaintext.txt	23	cell line maintained num fetal bovine serum dulbeccos modified eagle medium num microgml zeocin invitrogen orand num microgml blasticidin invitrogen orand num microgml gnum invitrogen
0.3291776.12119298.html.plaintext.txt	24	generation stub cell free assay system generation stub performed cell free assay system described previously num num
0.3291776.12119298.html.plaintext.txt	25	heknum cell resuspended num mm hepes ph num
0.3291776.12119298.html.plaintext.txt	26	num m sucrose plus protease inhibitor homogenized postnuclear supernatant prepared described num
0.3291776.12119298.html.plaintext.txt	27	microsomal membrane pelleted postnuclear supernatant centrifugation numnum x g num h num degree c detergent solubilized purified high molecular weight psnum complex see washed assay buffer resuspended assay buffer ph num
0.3291776.12119298.html.plaintext.txt	28	num mm mgclnum num mm sodium citrate containing protease inhibitor incubated num degree c indicated time generate stub
0.3291776.12119298.html.plaintext.txt	29	control sample kept ice
0.3291776.12119298.html.plaintext.txt	30	end assay microsomal membrane sample either used western blotting separated pellet supernatant fraction ultracentrifugation num h numnum x g num degree c
0.3291776.12119298.html.plaintext.txt	31	purified psnum complex prepared sd page adding num x sample buffer
0.3291776.12119298.html.plaintext.txt	32	western blot immunoprecipitation purified detergent solubilized high molecular weight psnum complex crude microsomal membrane preparation lysed adding num nonidet p num tris buffered saline
0.3291776.12119298.html.plaintext.txt	33	protein assay equal amount total protein sample dissolved sd sample buffer separated sd page transferred nitrocellulose membrane
0.3291776.12119298.html.plaintext.txt	34	target protein visualized enhanced chemiluminescence amersham bioscience antibody c terminus app app c terminal polyclonal antibody sigma psnum ntf antibody num gift dr
0.3291776.12119298.html.plaintext.txt	35	gandy num num gift dr
0.3291776.12119298.html.plaintext.txt	36	checler numenum numgnum signet laboratory inc
0.3291776.12119298.html.plaintext.txt	37	necessary nitrocellulose membrane stripped reuse
0.3291776.12119298.html.plaintext.txt	38	immunoprecipitation reaction lysates generated vitro cell free preparation conditioned medium secreted intact cell performed described previously num using antibody numenum numgnum num num
0.3291776.12119298.html.plaintext.txt	39	detection electrophoretic separation anum anum bicinetris sd page system employed described num
0.3291776.12119298.html.plaintext.txt	40	metabolic labeling quantification nicd aicd pulse chase experiment cell metabolically labeled numsmethioninecysteine icn pharmaceutical num min chased num h maximum nicd formation occurred num h num num num
0.3291776.12119298.html.plaintext.txt	41	cell lysates subjected immunoprecipitation antibody myc epitope fused c terminus notche
0.3291776.12119298.html.plaintext.txt	42	intensity autoradiographic band ecl signal notch app ctfs including stubaicd fl app measured densitometry andor phosphorimager analysis
0.3291776.12119298.html.plaintext.txt	43	ratio stub cnum app fl app nicd total notch protein nicd notche calculated cell line
0.3291776.12119298.html.plaintext.txt	44	permit comparison across different replication normalized ratio cell expressing wild type psnum set num
0.3291776.12119298.html.plaintext.txt	45	pairwise comparison made using student test independent group preplanned comparison stub nicd generation normalized production cell expressing psnum wt
0.3291776.12119298.html.plaintext.txt	46	presenilin num complex purification microsomal membrane see lysed num detergent containing immunoprecipitation buffer num mm hepes ph num
0.3291776.12119298.html.plaintext.txt	47	num num mm nacl num mm edta plus mixture protease inhibitor sigma
0.3291776.12119298.html.plaintext.txt	48	lysates centrifuged numnum rpm tla num
0.3291776.12119298.html.plaintext.txt	49	num rotor num h supernatant immunoprecipitated anti psnum n terminal antibody described num
0.3291776.12119298.html.plaintext.txt	50	mass spectrometric analysis app c terminal stub product cleavage immunoprecipitated supernatant fraction either crude microsomal membrane preparation purified psnum complex using anti app ctf monoclonal antibody cnumnum
0.3291776.12119298.html.plaintext.txt	51	captured c terminal app stub eluted bead num microl num trifluoroacetic acidnum acetonitrile
0.3291776.12119298.html.plaintext.txt	52	prepare sample matrix solution num microl immunoprecipitated stub sample mixed num microl saturated cyano num hydroxycinnamic acid solution num
0.3291776.12119298.html.plaintext.txt	53	num trifluoroacetic acidacetonitrile
0.3291776.12119298.html.plaintext.txt	54	sample matrix solution applied sample plate dried ambient temperature prior mass spectrometric analysis
0.3291776.12119298.html.plaintext.txt	55	matrix assisted laser desorptionionization mass spectrometric maldi m analysis performed voyager de str mass spectrometer
0.3291776.12119298.html.plaintext.txt	56	protein assay protein concentration determined using bca protein assay reagent according manufacturer instruction
0.3291776.12119298.html.plaintext.txt	57	generation app c terminal stub microsomal membrane purified psnum complex incubation microsomal membrane fraction derived either native heknum cell heknum cell expressing appswedish generated num kda app c terminal fragment migrated major app c terminal fragment
0.3291776.12119298.html.plaintext.txt	58	stub stub arising secretase secretase cleavage fl app fig
0.3291776.12119298.html.plaintext.txt	59	similar result observed microsomal membrane fraction generated fibroblast psnum wild type mouse
0.3291776.12119298.html.plaintext.txt	60	contrast microsomal membrane fraction fibroblast psnum mouse heknum cell stably expressing loss function psnum dnuma mutant showed significant inhibition production num kda c terminal fragment app fig
0.3291776.12119298.html.plaintext.txt	61	similarly significant inhibition production num kda c terminal fragment app microsomal membrane extracted heknum cell line expressing appswedish resulting microsomal membrane incubated compound e well documented secretase inhibitor production num fig
0.3291776.12119298.html.plaintext.txt	62	detergent solubilized immuno purified high molecular weight presenilin complex contained cnum app psnum ntf psnum ctf nicastrin investigated assay condition num kda app c terminal band also produced fig
0.3291776.12119298.html.plaintext.txt	63	generation num kda fragment highly sensitive detergent used
0.3291776.12119298.html.plaintext.txt	64	thus chapso permitted robust production fragment whereas detergent digitonin dodecylmaltoside supported cleavage event le efficiently data shown
0.3291776.12119298.html.plaintext.txt	65	triton x num nonidet p num disassemble psnum complex resulted c terminal app stub generation data shown
0.3291776.12119298.html.plaintext.txt	66	data taken together imply num kda fragment authentic presenilin dependent proteolytic cleavage product
0.3291776.12119298.html.plaintext.txt	67	view larger version numk fig
0.3291776.12119298.html.plaintext.txt	68	generation c terminal app fragment
0.3291776.12119298.html.plaintext.txt	69	c terminal stub generation microsomal membrane left panel purified psnum complex right panel
0.3291776.12119298.html.plaintext.txt	70	microsomal membrane stable heknum cell expressing appswedish appswe purified psnum complex stable heknum cell expressing cnum app incubated num degree c num min num h
0.3291776.12119298.html.plaintext.txt	71	num kda stub migrating major app ctfs stub stub generated cleavage stub detected western blot anti app ctf antibody
0.3291776.12119298.html.plaintext.txt	72	variation stub density reflects difference stub abundance cell used prepare psnum complex overexpressed cnum app
0.3291776.12119298.html.plaintext.txt	73	shown b cleavage dependent presence functional presenilin
0.3291776.12119298.html.plaintext.txt	74	stub inhibited microsomal membrane fibroblast psnum mouse dnuma mutant psnum transfected heknum cell microsomal membrane preparation treated secretase activity inhibitor compound e
0.3291776.12119298.html.plaintext.txt	75	mass spectrometric identification c terminal app stub establish identity num kda c terminal app band generated microsomal membrane preparation immuno purified psnum complex soluble c terminal app fragment immunoprecipitated reaction supernatant using cnumnum
0.3291776.12119298.html.plaintext.txt	76	num anti app ctf monoclonal antibody immunoprecipitation product subjected maldi m analysis fig
0.3291776.12119298.html.plaintext.txt	77	agreement previous data three major c terminal product stub beginning residue num stubnum num calculated mass num
0.3291776.12119298.html.plaintext.txt	78	num stub beginning residue num stubnum num calculated mass num
0.3291776.12119298.html.plaintext.txt	79	num stub beginning residue num stubnum num calculated mass num
0.3291776.12119298.html.plaintext.txt	80	c terminal app stub beginning residue num num num identified fig
0.3291776.12119298.html.plaintext.txt	81	view larger version numk fig
0.3291776.12119298.html.plaintext.txt	82	maldi m spectrum c terminal app product supernatant microsomal membrane preparation left right panel immuno purified high molecular weight detergent soluble psnum complex center panel
0.3291776.12119298.html.plaintext.txt	83	peak corresponding predicted molecular mass stubnum num stubnum num stubnum num detected principal component num kda band generated microsomal membrane psnum complex
0.3291776.12119298.html.plaintext.txt	84	fragment beginning position num num representing counterpart detected
0.3291776.12119298.html.plaintext.txt	85	microsomal membrane expressing mutant psnum right panel fragment similar mass wild type psnum membrane purified complex
0.3291776.12119298.html.plaintext.txt	86	psnum fad mutation enhance anum inhibit stub explore effect psnum mutation app notch processing compared production app stub nicd fragment heknum cell stably expressing either wild type psnum one three different psnum missense mutation associated fad
0.3291776.12119298.html.plaintext.txt	87	analysis conditioned medium cultured cell line fig
0.3291776.12119298.html.plaintext.txt	88	numa upper panel table revealed pathogenic psnum mutation produced increased amount anum compared either mock transfected cell cell expressing wild type psnum normalized value psnum wt num
0.3291776.12119298.html.plaintext.txt	89	num plus minus num psnum lnumv num
0.3291776.12119298.html.plaintext.txt	90	anum production also increased supernatant microsomal preparation mutant psnum cell psnum wt num
0.3291776.12119298.html.plaintext.txt	91	agreement prior data anum level statistically increased psnum mutant cell either conditioned medium psnum wt num
0.3291776.12119298.html.plaintext.txt	92	num p significant cell free preparation psnum wt num
0.3291776.12119298.html.plaintext.txt	93	intuitive expectation increased secretase activity induced mutation would accompanied increased level n terminal c terminal stub cleavage product
0.3291776.12119298.html.plaintext.txt	94	fact microsomal membrane preparation containing mutant psnum produced lower amount num kda stub regardless whether production stub assessed microsomal membrane fig
0.3291776.12119298.html.plaintext.txt	95	numb table supernatant membrane pelleted shown
0.3291776.12119298.html.plaintext.txt	96	difference cleavage microsomal membrane preparation cell line expressing mutant psnum statistically significant compared similar preparation mock transfected psnum wild type transfected control psnum lnumv num
0.3291776.12119298.html.plaintext.txt	97	furthermore despite increased production anum maldi m analysis c terminal app fragment revealed presence stub beginning position num num num fig
0.3291776.12119298.html.plaintext.txt	98	decrease generation stub due difference expression full length app maturation processing app steady state level secretase generated c terminal stub app direct substrate secretase secretase cleavage
0.3291776.12119298.html.plaintext.txt	99	view larger version numk fig
0.3291776.12119298.html.plaintext.txt	100	psnum mutation inhibit generation stub enhance production abnum stably transfected heknum cell
0.3291776.12119298.html.plaintext.txt	101	immunoprecipitation western blot secreted anum anum heknum cell line double expressing appswedish either psnum lnumv psnum gnuma
0.3291776.12119298.html.plaintext.txt	102	anum level conditioned medium top panel psnum mutant cell line increased num num fold
0.3291776.12119298.html.plaintext.txt	103	num num fold observed microsomal membrane preparation bottom panel
0.3291776.12119298.html.plaintext.txt	104	anum level statistically different
0.3291776.12119298.html.plaintext.txt	105	b stub formation inhibited psnum mutation lnumv gnuma exon num
0.3291776.12119298.html.plaintext.txt	106	decrease stub generation correlate difference fl app ctf app level
0.3291776.12119298.html.plaintext.txt	107	n three independent replication
0.3291776.12119298.html.plaintext.txt	108	view table table effect fad associated psnum mutation production stub nicd production stub nicd vitro analyzed stably expressing psnum wt p fad lnumv gnuma exon num mutation described experimental procedure
0.3291776.12119298.html.plaintext.txt	109	represent result three independent experiment
0.3291776.12119298.html.plaintext.txt	110	ratio stub ctf app fl app nicd total notch protein nicd notch de value level normalized relative cell expressing wild type psnum set num
0.3291776.12119298.html.plaintext.txt	111	p value indicated significance two tailed student test relative wild type psnum
0.3291776.12119298.html.plaintext.txt	112	psnum fad mutation reduce generation nicd site cleavage within transmembrane domain app similar site snum cleavage notch
0.3291776.12119298.html.plaintext.txt	113	however study using isocoumarin inhibitor num analysis effect specific psnum mutation revealed biological function p protein generation nicd separated num num
0.3291776.12119298.html.plaintext.txt	114	compare snum cleavage notch cleavage app next investigated effect fad mutation snum cleavage notch
0.3291776.12119298.html.plaintext.txt	115	stable heknum cell line expressing either wild type mutant psnum transiently transfected notche num num
0.3291776.12119298.html.plaintext.txt	116	notche encodes membrane tethered notch tagged c terminus c myc substrate presenilin dependent cleavage snum site num
0.3291776.12119298.html.plaintext.txt	117	nicd formation followed pulse chase experiment
0.3291776.12119298.html.plaintext.txt	118	contrast cell expressing wild type psnum expressing mutant psnum showed significant reduction nicd formation half amount wild type cell psnum lnumv num
0.3291776.12119298.html.plaintext.txt	119	view larger version numk fig
0.3291776.12119298.html.plaintext.txt	120	psnum mutation inhibit generation nicd
0.3291776.12119298.html.plaintext.txt	121	heknum cell line stably expressing wild type psnum psnum mutation proven enhance anum production transiently transfected notche cdna
0.3291776.12119298.html.plaintext.txt	122	nicd formation assessed pulse chase experiment incubation num h incubation num degree c
0.3291776.12119298.html.plaintext.txt	123	nicd generation cell expressing psnum mutation significantly inhibited
0.3291776.12119298.html.plaintext.txt	124	n three independent replication
0.3291776.12119298.html.plaintext.txt	125	cnum app mutation alter anum production alter stub generation data demonstrated although fad mutation psnum increase anum secretion inhibit stub generation
0.3291776.12119298.html.plaintext.txt	126	determine whether mutation substrate cleavage
0.3291776.12119298.html.plaintext.txt	127	cnumcnum app might also effect heknum cell transfected wild type cnum app inumf mutant cnum app increase anum num vnumf mutant cnum app decrease anum num
0.3291776.12119298.html.plaintext.txt	128	equivalent amount total membrane cell line incubated assay system described
0.3291776.12119298.html.plaintext.txt	129	agreement similar result published preparation manuscript num amount stub generated cell line essentially equivalent suggesting cnum mutation affect generation stub fig
0.3291776.12119298.html.plaintext.txt	130	num although significantly alter production anum
0.3291776.12119298.html.plaintext.txt	131	data reveal three pathogenic psnum mutation tested differentially affect several presenilin dependent activity
0.3291776.12119298.html.plaintext.txt	132	three mutation different domain psnum cause increase activity secretase producing anum whereas simultaneously inhibiting cleavage app snum cleavage notch
0.3291776.12119298.html.plaintext.txt	133	differential effect psnum mutation provides insight complex regulated intramembranous proteolysis type num membrane protein app notch
0.3291776.12119298.html.plaintext.txt	134	first data support growing body evidence suggests cleavage app snum cleavage notch likely similar identical proteolytic processing event num num
0.3291776.12119298.html.plaintext.txt	135	single difference noted date snum cleavage snum cleavage notch sequence dependent whereas cleavage app num num
0.3291776.12119298.html.plaintext.txt	136	second data show increase num cleavage app accompanied decrease snum cleavage activity
0.3291776.12119298.html.plaintext.txt	137	conclusion entirely compatible prior data suggest fad pathogenic mutation loss function effect snum cleavage notch examined vivo c
0.3291776.12119298.html.plaintext.txt	138	elegans biochemically vitro num num num
0.3291776.12119298.html.plaintext.txt	139	reduction snum cleavage notch modest provides explanation fad associated mutation psnum clinical evidence embryonic defect human usually heterozygous psnum mutation transgene encoding fad linked psnum mutant able rescue notch phenotype psnum mouse num
0.3291776.12119298.html.plaintext.txt	140	however aware one case compound heterozygote mutation psnum mnumvsnumt affected proband several minor congenital malformation num
0.3291776.12119298.html.plaintext.txt	141	data also accord previously published data indicating c
0.3291776.12119298.html.plaintext.txt	142	elegans sel num cnums loss function mutant expressed mammalian cell human psnum cnums homologue reduced processing notch increased anum production num num
0.3291776.12119298.html.plaintext.txt	143	finally reciprocal relationship num secretase secretasesnum cleavage suggests molecular event leading production peptide probably complex single proteolytic cleavage
0.3291776.12119298.html.plaintext.txt	144	seems likely secretase snum cleavage function presenilin dependent
0.3291776.12119298.html.plaintext.txt	145	however remains unclear whether secretase cleavage necessary generation order cleavage event occur
0.3291776.12119298.html.plaintext.txt	146	fact authentic stub containing residue num num never observed taken support view cleavage may initial necessary cleavage followed carboxyl exopeptidase degradation back residue num
0.3291776.12119298.html.plaintext.txt	147	however data suggest two activity likely separate event
0.3291776.12119298.html.plaintext.txt	148	indeed parsimonious explanation data two pathway physiological pathway mediating snum cleavage generate signal transduction molecule aicd nicd default pathway generates anum
0.3291776.12119298.html.plaintext.txt	149	functionally distinct pathway however could still subserved catalytic machinery
0.3291776.12119298.html.plaintext.txt	150	thus absence presenilin complex neither pathway would active
0.3291776.12119298.html.plaintext.txt	151	however functional modulation presenilin complex instance missense mutation post translational modification presenilins component presenilin complex e
0.3291776.12119298.html.plaintext.txt	152	glycosylation nicastrin might alter relative balance cleavage pathway
0.3291776.12119298.html.plaintext.txt	153	course preclude alternate possibility distinct structural component involved two pathway
0.3291776.12119298.html.plaintext.txt	154	data agreement previously published data show although many missense mutation substrate secretase cleavage cnum app alter production modulate cleavage num num
0.3291776.12119298.html.plaintext.txt	155	observation compatible hypothesis num molecular mechanism substratecatalysis interaction generation stubnicd production different num psnum mutation might primarily affect regulatory function rather directly execute catalytic cleavage
0.3291776.12119298.html.plaintext.txt	156	ying yang mass spectrometry lab university toronto help mass spectrometric analysis
0.3291776.12119298.html.plaintext.txt	157	work supported grant canadian institute health research canadian genetic disease network alzheimer society ontario howard hughes medical institute scottish rite charitable foundation
0.3291776.12119298.html.plaintext.txt	158	cost publication article defrayed part payment page charge
0.3291776.12119298.html.plaintext.txt	159	article must therefore hereby marked advertisement accordance num u
0.3291776.12119298.html.plaintext.txt	160	section num solely indicate fact
0.3291776.12119298.html.plaintext.txt	161	correspondence addressed centre research neurodegenerative disease university toronto num queen park crescent w
0.3291776.12119298.html.plaintext.txt	162	tanz neuroscience building toronto mnums numhnum canada
0.3291776.12119298.html.plaintext.txt	163	num num num fax num num num e mail p
0.3291776.12119298.html.plaintext.txt	164	published jbc paper press july num num doi num
0.3291776.12119298.html.plaintext.txt	165	abbreviation used app amyloid precursor protein fl app full length amyloid precursor protein p presenilin fad familial alzheimer disease aicd app intracellular domain nicd notch intracellular domain ctf c terminal fragment maldi m matrix assisted laser desorptionionization mass spectrometry chapso num num cholamidopropyldimethylammonio num hydroxy num propanesulfonic acid bicine nn bisnum hydroxyethylglycine
0.3291776.12119298.html.plaintext.txt	166	copyright num american society biochemistry molecular biology inc
0.32985634.11331298.html.plaintext.txt	0	negative regulation sapkjnk signaling pathway presenilin num jin woo kima tong shin changa ji eun leea sung ho huha seung woo yeonb wan seok yangc cheol o
0.32985634.11331298.html.plaintext.txt	1	joec inhee mook jungb rudolph e
0.32985634.11331298.html.plaintext.txt	2	tanzid tae wan kimd eui ju choia national creative research initiative center cell death graduate school biotechnology korea university seoul num num korea b brain disease research center ajou university school medicine suwon kyongki korea c department biological science korea advanced institute science technology taejon num num korea d genetics aging research unit department neurology massachusetts general hospital harvard medical school charlestown massachusetts num
0.32985634.11331298.html.plaintext.txt	3	correspondence eui ju choi national creative research initiative center cell death graduate school biotechnology korea university seoul num num korea
0.32985634.11331298.html.plaintext.txt	4	telnum num num num faxnum num num num e mailejchoiatmail
0.32985634.11331298.html.plaintext.txt	5	presenilin num psnum play pivotal role notch signaling intracellular metabolism amyloid s protein
0.32985634.11331298.html.plaintext.txt	6	understand intracellular signaling event downstream psnum investigated study action psnum mitogen activated protein kinase pathway
0.32985634.11331298.html.plaintext.txt	7	overexpressed psnum suppressed stress induced stimulation stress activated protein kinase sapkc jun nhnum terminal kinase jnk human embryonic kidney num cell
0.32985634.11331298.html.plaintext.txt	8	interestingly two functionally inactive psnum mutant psnumdnuma psnumdnuma failed inhibit uv stimulated sapkjnk
0.32985634.11331298.html.plaintext.txt	9	furthermore hnumonum uv stimulated sapk activity higher mouse embryonic fibroblast mef cell psnum null mouse mef cell p mouse
0.32985634.11331298.html.plaintext.txt	10	mefpsnum cell sensitive hnumonum induced apoptosis mefpsnum cell
0.32985634.11331298.html.plaintext.txt	11	ectopic expression psnum mefpsnum cell suppressed hnumonum stimulated sapkjnk activity apoptotic cell death
0.32985634.11331298.html.plaintext.txt	12	together data suggest psnum inhibits stress activated signaling suppressing sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	13	key word apoptosis c jun nhnum terminal kinase presenilin num secretase stress activated protein kinase
0.32985634.11331298.html.plaintext.txt	14	alzheimers disease adnum progressive fatal neurodegenerative disorder characterized loss neuron brain region involved learning memory
0.32985634.11331298.html.plaintext.txt	15	one early event development ad accumulation amyloid s peptide as cerebral cortex
0.32985634.11331298.html.plaintext.txt	16	assnum num produced amyloid s protein precursor app s secretase secrease mediated processing selkoe num
0.32985634.11331298.html.plaintext.txt	17	case early onset familial ad fad caused mutation gene encoding presenilin num psnum sherrington et al
0.32985634.11331298.html.plaintext.txt	18	num presenilin num psnum levy lahad et al
0.32985634.11331298.html.plaintext.txt	19	presenilins appear required processing app as secretase activation de strooper et al
0.32985634.11331298.html.plaintext.txt	20	psnum membrane protein contains eight putative transmembrane domain primarily localized intracellular membrane including endoplasmic reticulum golgi apparatus cook et al
0.32985634.11331298.html.plaintext.txt	21	presenilins homologous two caenorhabitis elegans gene product sel num hopnum facilitate notchlin num signaling artavanis tsakonas et al
0.32985634.11331298.html.plaintext.txt	22	indeed psnum play pivotal role notch signaling regulation notch processing secretase activation levitan greenwald num li greenwald num chan jan num de strooper et al
0.32985634.11331298.html.plaintext.txt	23	notch signaling appears associated regulatory mechanism variety cellular event including cell fate control embryonic development differentiation cell growth apoptosis artavanis tsakonas et al
0.32985634.11331298.html.plaintext.txt	24	mitogen activated protein kinase mapk pathway one major signaling pathway transmit intracellular signal initiated extracellular stimulus nucleus
0.32985634.11331298.html.plaintext.txt	25	mapk pathway regulates variety cellular function including cell proliferation differentiation death minden karin num ip davis num schaeffer weber num
0.32985634.11331298.html.plaintext.txt	26	mapk pathway includes three distinct component mapks mapk kinase mapkks mapkk kinase mapkkks
0.32985634.11331298.html.plaintext.txt	27	mapkkks phosphorylate activate mapkks turn phosphorylate activate mapks
0.32985634.11331298.html.plaintext.txt	28	activated mapks phosphorylate various protein include transcription factor thereby regulating gene expression cellular function
0.32985634.11331298.html.plaintext.txt	29	family mammalian mapks includes three subfamily extracellular signal regulated kinase erk stress activated protein kinase sapkc jun nhnum terminal kinase jnk pnum mapk boulton et al
0.32985634.11331298.html.plaintext.txt	30	num cobb goldsmith num kyriakis avruch num su karin num fanger et al
0.32985634.11331298.html.plaintext.txt	31	erk pathway consists erk upstream kinase include mapkerk kinase num raf num schaeffer weber num
0.32985634.11331298.html.plaintext.txt	32	pathway often stimulated mitogenic stimulus
0.32985634.11331298.html.plaintext.txt	33	pnum mapk pathway consists pnum mapk upstream kinase include mapkks mkknum mkknum mapkkk asknum taknum schaeffer weber num
0.32985634.11331298.html.plaintext.txt	34	sapkjnk pathway consists sapkjnk upstream kinase include mapkks seknumjnkknummkknum mkknum mapkkks mekknum asknum taknum minden karin num ip davis num
0.32985634.11331298.html.plaintext.txt	35	like pnum pathway sapkjnk pathway activated variety cellular stress include genotoxic stress free radical heat shock osmotic shock ischemia proinflammatory cytokine tumor necrosis factor interleukin numss minden karin num ip davis num
0.32985634.11331298.html.plaintext.txt	36	activated sapkjnk phosphorylate activate c jun transcription factor including atf num elk num gupta et al
0.32985634.11331298.html.plaintext.txt	37	although physiological role sapkjnk fully understood sapkjnk shown involved cellular mechanism apoptotic cell death certain condition minden karin num ip davis num
0.32985634.11331298.html.plaintext.txt	38	particular series study using mouse demonstrated pivotal role sapkjnk apoptotic cell death excitotoxic neuronal death yang et al
0.32985634.11331298.html.plaintext.txt	39	better understand intracellular signaling downstream psnum investigated whether psnum could modulate mapk signaling pathway
0.32985634.11331298.html.plaintext.txt	40	report study psnum inhibits sapkjnk pathway psnum induced suppression sapkjnk pathway requires functionally active psnum
0.32985634.11331298.html.plaintext.txt	41	finding suggest psnum inhibits stress activated signaling suppressing sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	42	plasmid cdna clone encoding wild type psnum mutant inserted pcdnanum flag vector described kovacs et al
0.32985634.11331298.html.plaintext.txt	43	woodgett ontario cancer institute toronto canada pcdnanum sapkss hemagglutinin ha pcepnum ha erknum m
0.32985634.11331298.html.plaintext.txt	44	cobb university texas southwestern medical center dallas tx pcdnanum pnum flag r
0.32985634.11331298.html.plaintext.txt	45	ulevitch scripps research institute la jolla ca pebg seknum l
0.32985634.11331298.html.plaintext.txt	46	zou harvard medicaal school boston ma pcdnanum ha mekknum g
0.32985634.11331298.html.plaintext.txt	47	johnson university colorado denver co pcdnanum mekknum pexv racnumvnum
0.32985634.11331298.html.plaintext.txt	48	hall university college london london uk described previously shim et al
0.32985634.11331298.html.plaintext.txt	49	cell culture dna transfection human embryonic kidney hek num cell bnum rat neuroblastoma cell mouse embryonic fibroblast mefs wild type psnum null mouse shen et al
0.32985634.11331298.html.plaintext.txt	50	num grown dme gibco brl supplemented num fetal bovine serum
0.32985634.11331298.html.plaintext.txt	51	mefpsnum mefpsnum cell j
0.32985634.11331298.html.plaintext.txt	52	shen brigham woman hospital harvard medical school boston ma passage three six used passage experiment
0.32985634.11331298.html.plaintext.txt	53	cultured cell transfected calcium phosphate method lipofectamine gibco brl
0.32985634.11331298.html.plaintext.txt	54	establish cell stably expressed ectopic psnum bnum cell transfected pcdnanum empty vector pcdnanum psnum
0.32985634.11331298.html.plaintext.txt	55	num h transfection cell maintained complete medium containing num microgml gnum select neomycin resistant cell
0.32985634.11331298.html.plaintext.txt	56	expression ectopic psnum neomycin resistant cell analyzed immunoblot using anti psnum antibody
0.32985634.11331298.html.plaintext.txt	57	apoptosis assay proper treatment cultured cell fixed num ethanol ice num h stained num microgml propidium iodide
0.32985634.11331298.html.plaintext.txt	58	propidium iodide stained cell analyzed flow cytometry facscalibur becton dickinson
0.32985634.11331298.html.plaintext.txt	59	alternatively cell transfected indicated vector construct plus pegfp
0.32985634.11331298.html.plaintext.txt	60	num h transfection cell treated indicated apoptotic stimulus
0.32985634.11331298.html.plaintext.txt	61	cell fixed num formaldehyde num min stained num microgml dapi num min
0.32985634.11331298.html.plaintext.txt	62	dapi stained nucleus examined apoptotic morphology zeiss axiovert fluorescence microscope
0.32985634.11331298.html.plaintext.txt	63	green fluorescent protein gfp expressing cell scored apoptotic nucleus
0.32985634.11331298.html.plaintext.txt	64	num cell counted experiment data three independent experiment analyzed
0.32985634.11331298.html.plaintext.txt	65	immune complex kinase assay cultured cell lysed lysis buffer cell lysates subjected immunoprecipitation using appropriate antibody park et al
0.32985634.11331298.html.plaintext.txt	66	resultant immunopellets assayed activity indicated protein kinase park et al
0.32985634.11331298.html.plaintext.txt	67	gst c jun num num used substrate sapkjnk gst atfnum num num pnum myelin basic protein erknum gst sapkssknumr seknum gst seknumknumr mekknum
0.32985634.11331298.html.plaintext.txt	68	phosphorylated protein resolved sd page num polyacrylamide gel analyzed fuji ba num phosphorimager
0.32985634.11331298.html.plaintext.txt	69	cell lysates also subjected immunoblot analysis using indicated antibody
0.32985634.11331298.html.plaintext.txt	70	band immunoblot visualized using enhanced chemiluminescence system amersham pharmacia biotech
0.32985634.11331298.html.plaintext.txt	71	psnum suppresses sapkjnk pathway investigate whether psnum might modulate function sapkjnk pathway transfected heknum cell sapkssjnknum psnum construct fig num
0.32985634.11331298.html.plaintext.txt	72	exposure transfected cell num jmnum uv light resulted stimulation sapk activity
0.32985634.11331298.html.plaintext.txt	73	interestingly ectopically expressed psnum suppressed uv stimulated sapk activity
0.32985634.11331298.html.plaintext.txt	74	similarly ectopic psnum suppressed sapk activity stimulated sorbitol fig num stress including anisomycin data shown
0.32985634.11331298.html.plaintext.txt	75	psnum also inhibited pnum mapk activity stimulated uv light whereas affect pma induced stimulation erknum activity fig num b
0.32985634.11331298.html.plaintext.txt	76	following experiment looked mechanism psnum inhibited sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	77	view larger version numk figure num
0.32985634.11331298.html.plaintext.txt	78	psnum suppresses sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	79	overexpressed psnum inhibited stress stimulated sapkjnk activity heknum cell
0.32985634.11331298.html.plaintext.txt	80	b effect psnum pnum erknum activity
0.32985634.11331298.html.plaintext.txt	81	b heknum cell num mm dish transiently transfected psnum construct num microg along ha sapkss num microg ha pnum num microg ha erknum num microg construct indicated
0.32985634.11331298.html.plaintext.txt	82	num h transfection cell exposed uv light num jmnum sorbitol num
0.32985634.11331298.html.plaintext.txt	83	num m tpa num nm incubated num min
0.32985634.11331298.html.plaintext.txt	84	cell lysates examined indicated protein kinase activity immune complex kinase assay
0.32985634.11331298.html.plaintext.txt	85	protein phoshorylation quantified using phosphorimager
0.32985634.11331298.html.plaintext.txt	86	ib immunoblot analysis transfected cell indicated antibody
0.32985634.11331298.html.plaintext.txt	87	sapkjnk pathway composed sapkjnk upstream kinase include seknum mekknum minden karin num ip davis num
0.32985634.11331298.html.plaintext.txt	88	activated mekknum phosphorylate activate seknum phosphorylates activates sapkjnk
0.32985634.11331298.html.plaintext.txt	89	better understand psnum suppressed sapk activity cell examined possible action psnum seknum mekknum
0.32985634.11331298.html.plaintext.txt	90	ectopic psnum inhibited uv stimulated seknum mekknum activity transfected heknum cell fig numa fig b
0.32985634.11331298.html.plaintext.txt	91	overexpressed psnum however failed inhibit sapk activity stimulated coexpression constitutively active form mekknum mekknum fig num c
0.32985634.11331298.html.plaintext.txt	92	result suggest psnum might suppress sapkjnk pathway acting site site upstream mekknum
0.32985634.11331298.html.plaintext.txt	93	racnum member small gtp binding protein rho family shown act upstream mekknum stimulate sapkjnk pathway coso et al
0.32985634.11331298.html.plaintext.txt	94	overexpression racnumvnum constitutively active mutant racnum induced sapk stimulation transfected heknum cell fig num d psnum repress racnumvnum induced sapk stimulation
0.32985634.11331298.html.plaintext.txt	95	suggests psnum may inhibit sapkjnk pathway acting site upstream racnum pathway independent racnum mediated signaling
0.32985634.11331298.html.plaintext.txt	96	view larger version numk figure num
0.32985634.11331298.html.plaintext.txt	97	psnum inhibits uv stimulated activity seknum mekknum
0.32985634.11331298.html.plaintext.txt	98	psnum inhibits seknum activity
0.32985634.11331298.html.plaintext.txt	99	b psnum inhibits mekknum activity
0.32985634.11331298.html.plaintext.txt	100	b heknum cell num mm dish transfected pcdnanum psnum flag num microg pebg seknum num microg pcdnanum ha mekknum num microg indicated
0.32985634.11331298.html.plaintext.txt	101	num h transfection cell exposed num jmnum uv light incubated num min lysed
0.32985634.11331298.html.plaintext.txt	102	measuring gst seknum activity gst seknum isolated cell lysates using glutathione agarose bead assayed phosphorylation gst sapkssknumr
0.32985634.11331298.html.plaintext.txt	103	measuring ha mekknum activity cell lysates subjected immunoprecipitation using anti ha antibody
0.32985634.11331298.html.plaintext.txt	104	immunopellets assayed mekknum activity immune complex kinase assay
0.32985634.11331298.html.plaintext.txt	105	c psnum affect mekknum stimulated sapk activity
0.32985634.11331298.html.plaintext.txt	106	heknum cell num mm dish cotransfected pcdnanum psnum flag num microg pcdnanum seknumknumr num microg pcdnanum mekknum flag num microg along pcdnanum ha sapkss num microg indicated
0.32985634.11331298.html.plaintext.txt	107	d psnum change racnum stimulated sapk activity
0.32985634.11331298.html.plaintext.txt	108	heknum cell num mm dish cotransfected pcdnanum psnum flag num microg pcdnanum racnumvnum num microg along pcdnanum ha sapkss num microg
0.32985634.11331298.html.plaintext.txt	109	c d transfected cell lysed num h transfection
0.32985634.11331298.html.plaintext.txt	110	sapk activity cell lysates measured immune complex kinase assay using mouse anti ha antibody
0.32985634.11331298.html.plaintext.txt	111	ib immunoblot analysis transfected cell indicated antibody
0.32985634.11331298.html.plaintext.txt	112	psnum induced suppression sapkjnk pathway requires functionally active psnum following experiment examined effect several fad linked psnum mutant sapk pathway
0.32985634.11331298.html.plaintext.txt	113	fad linked psnum mutant mnumv cnumy lnumv inhibited uv stimulated sapk activity cotransfected heknum cell wild type psnum fig num
0.32985634.11331298.html.plaintext.txt	114	contrast biologically inactive transmembrane aspartate mutant psnum dnuma dnuma could inhibit uv induced sapk stimulation fig num b
0.32985634.11331298.html.plaintext.txt	115	two aspartic acid residue dnum dnum psnum essential psnum endoproteolysis secretase activation wolfe et al
0.32985634.11331298.html.plaintext.txt	116	uv induced sapk stimulation also repressed overexpression psnumexnum fig num b
0.32985634.11331298.html.plaintext.txt	117	psnumexnum functional psnum mutant lacking exon num amino acid num num contains endoproteolytic site mnum thinakaran et al
0.32985634.11331298.html.plaintext.txt	118	thus psnumexnum undergo endoproteolysis competent secretase activation li et al
0.32985634.11331298.html.plaintext.txt	119	data therefore suggest secretase activation may important psnum suppress sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	120	view larger version numk figure num
0.32985634.11331298.html.plaintext.txt	121	effect psnum mutant sapkjnk
0.32985634.11331298.html.plaintext.txt	122	effect fad linked psnum variant uv stimulated sapk activity
0.32985634.11331298.html.plaintext.txt	123	heknum cell num mm dish cotransfected pcdnanum ha sapkss num microg pcdnanum flag vector num microg expressing psnum variant wild type mnumv cnumy lnumv indicated
0.32985634.11331298.html.plaintext.txt	124	num h transfection cell exposed uv light num jmnum incubated num min
0.32985634.11331298.html.plaintext.txt	125	cell lysates examined sapk activity immune complex kinase assay using mouse anti ha antibody
0.32985634.11331298.html.plaintext.txt	126	b effect endoproteolysis mutant psnum uv stimulated sapk activity
0.32985634.11331298.html.plaintext.txt	127	heknum cell num mm dish cotransfected pcdnanum ha sapkss num microg pcdnanum flag vector num microg expressing psnum variant wild type dnuma dnuma exnum indicated
0.32985634.11331298.html.plaintext.txt	128	transfected cell exposed uv light num jmnum sapk activity cell lysates measured immune complex kinase assay using mouse anti ha antibody
0.32985634.11331298.html.plaintext.txt	129	ib immunoblot analysis transfected cell anti ha anti flag antibody
0.32985634.11331298.html.plaintext.txt	130	ctf cooh terminal fragment psnum psnum endoproteolysis
0.32985634.11331298.html.plaintext.txt	131	psnum protects neuroblastoma bnum cell apoptosis mediated sapkjnk activation next stably transfected rat neuroblastoma bnum cell psnum bnum psnum cell empty vector bnum neo cell
0.32985634.11331298.html.plaintext.txt	132	investigated inhibitory effect psnum sapkjnk
0.32985634.11331298.html.plaintext.txt	133	immunoblot data confirmed expression psnum bnum psnum cell bnum neo control cell fig num
0.32985634.11331298.html.plaintext.txt	134	exposure bnum neo control cell uv light hnumonum resulted stimulation endogenous sapkjnk whereas uv hnumonum induced stimulation sapkjnk activity repressed bnum psnum cell fig num b
0.32985634.11331298.html.plaintext.txt	135	stably expressed ectopic psnum also inhibited hnumonum induced stimulation endogenous seknum mekknum bnum psnum cell fig num c
0.32985634.11331298.html.plaintext.txt	136	view larger version numk figure num
0.32985634.11331298.html.plaintext.txt	137	overexpressed psnum inhibits stress induced stimulation sapkjnk pathway bnum rat neuroblastoma cell
0.32985634.11331298.html.plaintext.txt	138	establishment bnum cell stably expressing psnum
0.32985634.11331298.html.plaintext.txt	139	bnum cell transfected pcdnanum psnum pcdnanum empty vector expression psnum isolated clone examined immunoblot analysis mouse anti psnum monoclonal antibody
0.32985634.11331298.html.plaintext.txt	140	fl full length ntf nhnum terminal fragment psnum psnum endoproteolysis
0.32985634.11331298.html.plaintext.txt	141	b overexpressed psnum inhibits uv hnumonum stimulated activity endogenous sapkjnk bnum cell
0.32985634.11331298.html.plaintext.txt	142	either bnum neo bnum psnum cell exposed uv light num jmnum hnumonum num microm num hr
0.32985634.11331298.html.plaintext.txt	143	cell lysates subjected immunoprecipitation using mouse anti sapkjnknum antibody
0.32985634.11331298.html.plaintext.txt	144	resultant immunopellets examined sapkjnknum activity immune complex kinase assay
0.32985634.11331298.html.plaintext.txt	145	c overexpressed psnum inhibits hnumonum induced stimulation endogenous seknum mekknum
0.32985634.11331298.html.plaintext.txt	146	bnum neo bnum psnum cell exposed num microm hnumonum num h
0.32985634.11331298.html.plaintext.txt	147	enzymatic activity seknum mekknum bnum neo bnum psnum cell examined immune complex kinase assay using anti seknum anti mekknum antibody
0.32985634.11331298.html.plaintext.txt	148	sapkjnk shown mediate stress induced apoptotic cell death certain condition xia et al
0.32985634.11331298.html.plaintext.txt	149	num minden karin num ip davis num
0.32985634.11331298.html.plaintext.txt	150	examined whether psnum could modulate sapk involved apoptotic cell death bnum cell fig num
0.32985634.11331298.html.plaintext.txt	151	exposure bnum cell hnumonum resulted increase apoptosis fig num
0.32985634.11331298.html.plaintext.txt	152	hnumonum induced apoptotic cell death markedly reduced cell transfected seknumknumr dominant negative form seknum
0.32985634.11331298.html.plaintext.txt	153	apoptosis induced mekknum overexpression also repressed bnum cell transfected seknumknumr fig num b
0.32985634.11331298.html.plaintext.txt	154	result suggest sapkjnk signaling cascade involved mechanism hnumonum mekknum induced apoptosis bnum cell
0.32985634.11331298.html.plaintext.txt	155	overexpressed psnum prevented apoptotic cell death induced hnumonum fig num mekknum fig num b
0.32985634.11331298.html.plaintext.txt	156	data suggest psnum might prevent hnumonum induced apoptotic cell death inhibiting sapkjnk pathway inhibition occurs site upstream mekknum sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	157	data also show psnumexnum retains ability secretase activation li et al
0.32985634.11331298.html.plaintext.txt	158	num suppressed sapkjnk pathway fig num also inhibited hnumonum induced apoptotic cell death fig num
0.32985634.11331298.html.plaintext.txt	159	contrast psnumdnuma lack ability secretase activation wolfe et al
0.32985634.11331298.html.plaintext.txt	160	num could suppress sapk pathway fig num failed block hnumonum induced apoptotic cell death
0.32985634.11331298.html.plaintext.txt	161	view larger version numk figure num
0.32985634.11331298.html.plaintext.txt	162	psnum suppresses hnumonum induced apoptotic cell death bnum cell
0.32985634.11331298.html.plaintext.txt	163	bnum cell num mm dish transfected pegfp num
0.32985634.11331298.html.plaintext.txt	164	num microg along pcdnanum flag expressing psnum variant wild type dnuma exnum num microg pcdnanum ha seknumknuma num
0.32985634.11331298.html.plaintext.txt	165	indicated num h transfection cell exposed hnumonum num
0.32985634.11331298.html.plaintext.txt	166	cell fixed num formaldehyde stained dapi num microgml num min
0.32985634.11331298.html.plaintext.txt	167	gfp expressing cell counted apoptotic nucleus
0.32985634.11331298.html.plaintext.txt	168	num cell counted experiment
0.32985634.11331298.html.plaintext.txt	169	data represent result three independent experiment
0.32985634.11331298.html.plaintext.txt	170	elevated sapkjnk activity cell psnum null mouse next examined hnumonum induced jnknumsapk stimulation mef cell psnum psnum mouse shen et al
0.32985634.11331298.html.plaintext.txt	171	interestingly endogenous jnknumsapk activity basal state hnumonum stimulated state higher mefpsnum cell mefpsnum cell fig num
0.32985634.11331298.html.plaintext.txt	172	ectopic expression psnum mefpsnum cell resulted decrease hnumonum stimulated sapkjnk activity fig num b
0.32985634.11331298.html.plaintext.txt	173	also examined hnumonum induced apoptotic cell death mefpsnum mefpsnum cell
0.32985634.11331298.html.plaintext.txt	174	mefpsnum cell sensitive hnumonum induced apoptosis mefpsnum cell fig num c
0.32985634.11331298.html.plaintext.txt	175	furthermore overexpressed psnum converted mefpsnum cell resistant hnumonum induced apoptosis fig num d
0.32985634.11331298.html.plaintext.txt	176	hand biologically inactive psnumdnuma failed suppress sapk pathway fig num lower hnumonum induced apoptotic cell death mefpsnum cell
0.32985634.11331298.html.plaintext.txt	177	together data strongly suggest psnum function negative regulator sapkjnk pathway psnum suppresses hnumonum induced apoptosis inhibiting sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	178	view larger version numk figure num
0.32985634.11331298.html.plaintext.txt	179	sapkjnk activity hnumonum induced apoptotic cell death higher mefpsnum cell mefpsnum cell
0.32985634.11331298.html.plaintext.txt	180	sapkjnk activity mef cell psnum psnum mouse
0.32985634.11331298.html.plaintext.txt	181	mefpsnum mefpsnum cell exposed num microm hnumonum num h
0.32985634.11331298.html.plaintext.txt	182	cell lysates subjected immunoprecipitation using anti sapkjnknum antibody
0.32985634.11331298.html.plaintext.txt	183	resultant immunopellets examined sapkjnknum activity immune complex kinase assay
0.32985634.11331298.html.plaintext.txt	184	b overexpression psnum result decrease hnumonum stimulated sapkjnk activity mefpsnum cell
0.32985634.11331298.html.plaintext.txt	185	mef cell psnum mouse transiently transfected pcdnanum ha sapkss num microg pcdnanum psnum flag num microg indicated
0.32985634.11331298.html.plaintext.txt	186	num h transfection cell exposed num microm hnumonum num h examined sapkjnk activity immune complex kinase assay using anti ha antibody
0.32985634.11331298.html.plaintext.txt	187	c hnumonum induced apoptotic cell death mefpsnum mefpsnum cell
0.32985634.11331298.html.plaintext.txt	188	mefpsnum mefpsnum cell exposed num microm hnumonum num h fixed num ethanol stained num microgml propidium iodide
0.32985634.11331298.html.plaintext.txt	189	percentage apoptotic cell sub gnum dna content determined measuring fluorescence propidium iodide stained cell using facscan
0.32985634.11331298.html.plaintext.txt	190	d overexpressed psnum suppresses hnumonum induced apoptosis mefpsnum cell
0.32985634.11331298.html.plaintext.txt	191	mefpsnum cell transfected plasmid expressing indicated protein along pegfp
0.32985634.11331298.html.plaintext.txt	192	num h transfection cell exposed num microm hnumonum num h stained dapi
0.32985634.11331298.html.plaintext.txt	193	gfp positive cell scored dapi stained apoptotic nucleus zeiss axiovert fluorescence microscope
0.32985634.11331298.html.plaintext.txt	194	study demonstrate psnum inhibits sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	195	ectopically expressed psnum blocked stress induced stimulation sapkjnk upstream kinase including seknum mekknum
0.32985634.11331298.html.plaintext.txt	196	fad linked psnum mutant mnumv cnumy lnumv also able inhibit sapk stimulation
0.32985634.11331298.html.plaintext.txt	197	interestingly biologically inactive psnum mutant dnuma dnuma shown lack secretase activation psnum endoproteolysis wolfe et al
0.32985634.11331298.html.plaintext.txt	198	num failed inhibit sapk stimulation
0.32985634.11331298.html.plaintext.txt	199	furthermore psnumexnum lack endoproteolysis site competent activation secretase activity li et al
0.32985634.11331298.html.plaintext.txt	200	num retained inhibitory effect sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	201	data suggest secretase activation rather psnum endoproteolysis required psnum induced inhibition sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	202	secretase two major substrate app notch de strooper et al
0.32985634.11331298.html.plaintext.txt	203	cleavage app notch secretase produce as intracellular domain notch notch ic respectively
0.32985634.11331298.html.plaintext.txt	204	assnum num inhibit sapkjnk activity data shown
0.32985634.11331298.html.plaintext.txt	205	comparison preliminary data showed overexpression notch intracellular domain active form intracellular notch resulted suppression sapkjnk activation data shown
0.32985634.11331298.html.plaintext.txt	206	finding imply psnum mediated cleavage notch might involved mechanism psnum induced suppression sapk pathway
0.32985634.11331298.html.plaintext.txt	207	regard notch previously proposed play role regulation sapkjnk pathway ordentlich et al
0.32985634.11331298.html.plaintext.txt	208	several line evidence suggest presenilins involved apoptosis kim tanzi num kim et al
0.32985634.11331298.html.plaintext.txt	209	overexpression psnum shown potentiate apoptosis pcnum cell induced ngf withdrawal neurotoxic assnum num wolozin et al
0.32985634.11331298.html.plaintext.txt	210	another study showed algnum truncated form murine psnum reduced cell receptor fa induced apoptosis mouse cell hybridoma vito et al
0.32985634.11331298.html.plaintext.txt	211	study using psnum null mouse demonstrated psnum involved neuronal survival shen et al
0.32985634.11331298.html.plaintext.txt	212	study show ectopic psnum suppressed hnumonum induced apoptosis bnum neuroblastoma cell
0.32985634.11331298.html.plaintext.txt	213	moreover deficiency psnum caused elevation hnumonum induced apoptosis mef cell psnum null mouse compared mef cell psnum wild type mouse
0.32985634.11331298.html.plaintext.txt	214	hnumonum induced apoptosis blocked overexpression seknumknumr suggesting sapkjnk pathway involved mechanism hnumonum induced apoptosis
0.32985634.11331298.html.plaintext.txt	215	thus finding suggest psnum inhibiting sapk pathway protect cell stress induced apoptotic cell death
0.32985634.11331298.html.plaintext.txt	216	precise mechanism psnum inhibits sapkjnk pathway however need studied
0.32985634.11331298.html.plaintext.txt	217	chang contributed equally work considered co first author
0.32985634.11331298.html.plaintext.txt	218	kims present address taub institute research alzheimers disease aging brain department pathology college physician surgeon columbia university new york ny num
0.32985634.11331298.html.plaintext.txt	219	num abbreviation used paper as amyloid s peptide ad alzheimers disease app amyloid s protein precursor erk extracellular signal regulated kinase fad familial ad ha hemagglutinin hek human embryonic kidney jnk c jun n terminal kinase mapk mitogen activated protein kinase mapkk mapk kinase mapkkk mapkk kinase mef mouse embryonic fibroblast psnum psnum presenilins num num sapk stress activated protein kinase
0.32985634.11331298.html.plaintext.txt	220	davis university massachusetts worcester ma j
0.32985634.11331298.html.plaintext.txt	221	hall providing jnknum sapkss mekknum seknum erknum pnum racnumvnum cdna clone respectively dr
0.32985634.11331298.html.plaintext.txt	222	shen mefpsnum mefpsnum cell dr
0.32985634.11331298.html.plaintext.txt	223	hoschek critical reading manuscript
0.32985634.11331298.html.plaintext.txt	224	work supported creative research initiative program korean ministry science technology e
0.32985634.11331298.html.plaintext.txt	225	submitted num november num revised num march num accepted num march num
0.32985634.11331298.html.plaintext.txt	226	notch signaling cell fate control signal integration development
0.32985634.11331298.html.plaintext.txt	227	science numnum numabstractfree full text
0.32985634.11331298.html.plaintext.txt	228	numnum numfree full text
0.32985634.11331298.html.plaintext.txt	229	expression analysis presenilin num human neuronal system localization cell body dendrite
0.32985634.11331298.html.plaintext.txt	230	usa numnum numabstractfree full text
0.32985634.11331298.html.plaintext.txt	231	phosphorylation subcellular localization membrane orientation alzheimers disease associated presenilins
0.32985634.11331298.html.plaintext.txt	232	numnum numabstractfree full text
0.32985634.11331298.html.plaintext.txt	233	defective cell differentiation absence jnknum
0.32985634.11331298.html.plaintext.txt	234	science numnum numabstractfree full text
0.32985634.11331298.html.plaintext.txt	235	alternative cleavage alzheimer associated presenilins apoptosis caspase num family protease
0.32985634.11331298.html.plaintext.txt	236	numnum numabstractfree full text
0.32985634.11331298.html.plaintext.txt	237	hop num caenorhabditis elegans presenilin appears functionally redundant sel num presenilin facilitate lin num glp num signaling
0.32985634.11331298.html.plaintext.txt	238	numnum numabstractfree full text
0.32985634.11331298.html.plaintext.txt	239	notch inhibition enum support existence novel signaling pathway
0.32985634.11331298.html.plaintext.txt	240	biol numnum numabstractfree full text
0.32985634.11331298.html.plaintext.txt	241	selenite inhibits c jun n terminal kinasestress activated protein kinase jnksapk thiol redox mechanism
0.32985634.11331298.html.plaintext.txt	242	chem numnum numabstractfree full text
0.32985634.11331298.html.plaintext.txt	243	evidence physical interaction presenilin notch
0.32985634.11331298.html.plaintext.txt	244	numnum numabstractfree full text
0.32985634.11331298.html.plaintext.txt	245	mitogen activated protein kinase specific message ubiquitous messenger
0.32985634.11331298.html.plaintext.txt	246	biol numnum numfree full text
0.32985634.11331298.html.plaintext.txt	247	rb protein regulates stress activated signal inhibiting c jun n terminal kinasestress activated protein kinase
0.32985634.11331298.html.plaintext.txt	248	chem numnum numabstractfree full text
0.32985634.11331298.html.plaintext.txt	249	requirement jnk stress induced activation cytochrome c mediated death pathway
0.32985634.11331298.html.plaintext.txt	250	science numnum numabstractfree full text
0.32985634.11331298.html.plaintext.txt	251	interfering apoptosis canum binding protein alg num alzheimers disease gene alg num
0.32985634.11331298.html.plaintext.txt	252	opposing effect erk jnk pnum map kinase apoptosis
0.32985634.11331298.html.plaintext.txt	253	science numnum numabstract
0.32985634.11331298.html.plaintext.txt	254	differential targeting map kinase ets domain transcription factor elk num
0.32985634.11331298.html.plaintext.txt	255	numnum numabstractfree full text
0.3369568.15123598.html.plaintext.txt	0	presenilin protein component multiple membrane bound complex different biological activity yongjun gu nobuo sanjo fusheng chen hiroshi hasegawa agnes petit xueying ruan wenping li cortney shier toshitaka kawarai gerold schmitt ulms david westaway peter st george hyslop paul e
0.3369568.15123598.html.plaintext.txt	1	centre research neurodegenerative disease department medicine laboratory medicine pathobiology medical biophysics university toronto num queen park crescent west toronto ontario mnums numhnum canada department medicine division neurology toronto western hospital toronto ontario mnums numhnum canada
0.3369568.15123598.html.plaintext.txt	2	received publication february num num revised form april num num
0.3369568.15123598.html.plaintext.txt	3	cell culture sample preparation human embryonic kidney hek num cell cultured dulbeccos modified eagle medium plus num fetal bovine serum supplemented num microgml gnum cell stably expressing app cnum appnum swedish mutant psnumenum andor num microgml zeocin cell stably expressing wild type psnum mutant dnuma presenilin num described previously num num num num
0.3369568.15123598.html.plaintext.txt	4	cell harvested homogenized buffer containing num mm hepes ph num
0.3369568.15123598.html.plaintext.txt	5	num num mm nacl num glycerol complete protease inhibitor mixture roche applied science
0.3369568.15123598.html.plaintext.txt	6	postnuclear supernatant collected centrifugation cell homogenate num x g num min num
0.3369568.15123598.html.plaintext.txt	7	membranous fraction pelleted centrifugation numnum x g num h
0.3369568.15123598.html.plaintext.txt	8	two dimensional gel electrophoresis western blotting first dimensional blue native bn polyacrylamide gel electrophoresis performed essentially described previously num
0.3369568.15123598.html.plaintext.txt	9	brief microsomal membrane prepared described solubilized ice cold bn lysis buffer containing num wv detergent either digitonin chapso num mm num aminocaproic acid num mm bi tris ph num
0.3369568.15123598.html.plaintext.txt	10	num plus complete protease inhibitor mixture roche applied science
0.3369568.15123598.html.plaintext.txt	11	lysate num microl centrifuged numnum x g num min supernatant adjusted num
0.3369568.15123598.html.plaintext.txt	12	num volume bn sample buffer containing num
0.3369568.15123598.html.plaintext.txt	13	num wv coomassie brilliant blue g num num mm num aminocaproic acid num mm bi tris ph num
0.3369568.15123598.html.plaintext.txt	14	num num glycerol num detergent
0.3369568.15123598.html.plaintext.txt	15	sample separated num num blue native polyacrylamide gel poured num day analysis described previously num
0.3369568.15123598.html.plaintext.txt	16	marker protein used bn page thyroglobulin num kda apoferritin num kda amylase num kda bovine serum albumin num kda sigma
0.3369568.15123598.html.plaintext.txt	17	second dimensional sd page blue native gel destained num acetic acidnum methanol
0.3369568.15123598.html.plaintext.txt	18	thorough washing num methanol individual lane excised equilibrated num min two dimensional numd sample buffer num mm tris hcl ph num
0.3369568.15123598.html.plaintext.txt	19	num num m urea num sd num glycerol num dithiothreitol bromphenol blue
0.3369568.15123598.html.plaintext.txt	20	gel strip loaded onto nu page bi tris num num precast numd gel invitrogen sd page
0.3369568.15123598.html.plaintext.txt	21	western blotting resolved protein transferred nitrocellulose membrane
0.3369568.15123598.html.plaintext.txt	22	target protein visualized enhanced chemiluminescence ecl amersham bioscience
0.3369568.15123598.html.plaintext.txt	23	primary antibody mouse monoclonal anti nicastrin clone num bd transduction laboratory rabbit polyclonal anti nicastrin pai num affinity bioreagents rabbit anti aph num n terminal antibody onumcnum num rabbit polyclonal antibody pen num gift c
0.3369568.15123598.html.plaintext.txt	24	haass mouse monoclonal anti psnum n terminal antibody ntnum gift p
0.3369568.15123598.html.plaintext.txt	25	mathews rabbit polyclonal antibody psnum ntf abnum gift
0.3369568.15123598.html.plaintext.txt	26	intensity profile western blotting signal plotted using nih image software rsb
0.3369568.15123598.html.plaintext.txt	27	glycerol velocity gradient heknum cell stably expressing app cnum washed num degree c cold pb resuspended num mm hepes ph num
0.3369568.15123598.html.plaintext.txt	28	num m sucrose plus protease inhibitor homogenized postnuclear supernatant prepared described previously num
0.3369568.15123598.html.plaintext.txt	29	microsomal membrane pelleted postnuclear supernatant centrifugation numnum x g num h num degree c lysised num chapso num mm tris hcl ph num
0.3369568.15123598.html.plaintext.txt	30	num num mm edta num mm nacl plus protease inhibitor
0.3369568.15123598.html.plaintext.txt	31	lysates re centrifuged numnum x g num min supernatant used glycerol gradient centrifugation fractionation experiment described previously num
0.3369568.15123598.html.plaintext.txt	32	brief num ml total protein extract applied top num
0.3369568.15123598.html.plaintext.txt	33	num ml num num wv linear glycerol gradient containing num mm hepes ph num
0.3369568.15123598.html.plaintext.txt	34	gradient centrifuged num h numnum rpm num degree c using beckman swnum rotor collected num
0.3369568.15123598.html.plaintext.txt	35	num ml fraction top centrifugation tube
0.3369568.15123598.html.plaintext.txt	36	cell free secretase assay chapso solubilized membrane resolved glycerol velocity gradient fractionation precleared preimmune serum linked bead incubated overnight num degree c antibody psnum n terminus antibody num cross linked protein sepharose dimethylpimelimidate sigma
0.3369568.15123598.html.plaintext.txt	37	immunopurified high molecular weight psnum complex washed assay buffer resuspended num
0.3369568.15123598.html.plaintext.txt	38	num detergent chapso digitonin containing assay buffer ph num
0.3369568.15123598.html.plaintext.txt	39	num mm mgclnum num mm sodium citrate containing protease inhibitor incubated num degree c num h generate stub
0.3369568.15123598.html.plaintext.txt	40	control sample kept ice
0.3369568.15123598.html.plaintext.txt	41	end assay sample resuspended sd sample buffer num sd num mm tris num glycerol num
0.3369568.15123598.html.plaintext.txt	42	num used western blotting measure appearance stub described previously num
0.3369568.15123598.html.plaintext.txt	43	view larger version numk fig
0.3369568.15123598.html.plaintext.txt	44	mouse cerebellar glial cell anum investigated confocal microscopy prepared fixed co stained anti aph num red anti nicastrin green anti psnum blue antibody described experimental procedure top row
0.3369568.15123598.html.plaintext.txt	45	two component showed partial overlap bottom row three component showed modest overlap b
0.3369568.15123598.html.plaintext.txt	46	begin address issue undertook detailed numd gel electrophoresis study using bn gel electrophoresis first dimension followed standard sd page gel electrophoresis second dimension
0.3369568.15123598.html.plaintext.txt	47	initial cell lysates heknum cell expressing appswedish prepared using num chapso solubilizing detergent least two distinct psnum immunoreactive spot identified num num kda together smear pattern even higher mass fig
0.3369568.15123598.html.plaintext.txt	48	num num kda complex contained maturely glycosylated nicastrin aph num pen num psnum ntf psnum ctf
0.3369568.15123598.html.plaintext.txt	49	however num kda complex contained app ctfs
0.3369568.15123598.html.plaintext.txt	50	observation unlikely simply represent idiosyncrasy gel electrophoresis methodology broad distribution complex ranging num num kda also seen lysates resolved glycerol velocity gradient fig
0.3369568.15123598.html.plaintext.txt	51	resolution individual complex le robust unidimensional glycerol velocity gradient glycerol velocity gradient resolve protein according relative buoyancy rather charge mass gel electrophoretic separation predicted mass measurement identical numd gel study velocity gradient
0.3369568.15123598.html.plaintext.txt	52	nevertheless general agreement result numd gel immature nicastrin one two peak aph num enriched lower molecular weight fraction num num kda fig
0.3369568.15123598.html.plaintext.txt	53	hand psnum pen num maturely glycosylated nicastrin enriched higher molecular weight fraction num num kda secondary peak aph num num kda fig
0.3369568.15123598.html.plaintext.txt	54	view larger version numk fig
0.3369568.15123598.html.plaintext.txt	55	two dimensional gel electrophoresis presenilin complex heknum cell expressing appswedish solubilized num chapso left num digitonin right reveal presence several distinct complex
0.3369568.15123598.html.plaintext.txt	56	chapso support secretase activity cell free assay least two heteromeric complex num num kda containing psnum nicastrin nct aph num pen num
0.3369568.15123598.html.plaintext.txt	57	digitonin support secretase activity cell free assay abundance num kda complex dramatically reduced
0.3369568.15123598.html.plaintext.txt	58	view larger version numk fig
0.3369568.15123598.html.plaintext.txt	59	glycerol velocity gradient analysis membrane preparation containing presenilin complex solubilized num chapso left num digitonin right
0.3369568.15123598.html.plaintext.txt	60	study confirm existence low molecular mass num kda complex enriched aph num immature nicastrin lane num num one higher molecular weight complex num num kda containing psnum varying amount mature nicastrin nct aph num pen num lane num num
0.3369568.15123598.html.plaintext.txt	61	like numd gel study num kda complex lane num num essentially absent membrane solubilized num digitonin
0.3369568.15123598.html.plaintext.txt	62	b cell free secretase assay performed pooled fraction chapso glycerol velocity gradient leftnum digitonin glycerol velocity gradient right
0.3369568.15123598.html.plaintext.txt	63	compared control fraction incubated num degree c top left stub actively generated chapso solubilized fraction num num num num num num num num incubated num degree c num h middle left highest specific activity relative starting amount psnum fraction num num num num lower left
0.3369568.15123598.html.plaintext.txt	64	psnum complex digitonin solubilized fraction failed co immunoprecipitate app ctfs consequently failed generate stub right
0.3369568.15123598.html.plaintext.txt	65	failure generate stub digitonin solubilized psnum complex could reversed adding additional exogenous app ctfs see fig
0.3369568.15123598.html.plaintext.txt	66	numd addition digitonin chapso solubilized psnum complex docked substrate also resulted loss secretase activity data shown arguing digitonin alters conformation andor componentry psnum complex rendering non functional
0.3369568.15123598.html.plaintext.txt	67	c histogram specific secretase activity pooled fraction glycerol velocity gradient
0.3369568.15123598.html.plaintext.txt	68	secretase activity calculated quantity stub producedquantity stub produced plus residual app ctfs relative amount psnum fraction
0.3369568.15123598.html.plaintext.txt	69	pooled fraction containing protein molecular mass le num kda fraction num num num num le secretase activity fraction protein molecular mass greater num kda fraction num num
0.3369568.15123598.html.plaintext.txt	70	d addition exogenous substrate app cnum resulted robust generation stub chapso solubilized psnum complex chp incubated num degree c failed induce stub production num degree c negative control digitonin solubilized membrane dig temperature
0.3369568.15123598.html.plaintext.txt	71	result argues absence stub generation digitonin solubilized psnum complex b right caused failure digitonin solubilized psnum complex dock secretase substrate
0.3369568.15123598.html.plaintext.txt	72	num kda aph num nicastrin complex unlikely subserve catalytic activity present psnum cell support secretase activity
0.3369568.15123598.html.plaintext.txt	73	experiment alone possible conclude higher mass complex associated functional secretase activity
0.3369568.15123598.html.plaintext.txt	74	attempt measure activity specific complex isolated numd gel successful presumably low abundance properly folded complex recovered
0.3369568.15123598.html.plaintext.txt	75	circumvent problem elected use three complementary strategy might taken together indirectly infer complex necessary functional activity
0.3369568.15123598.html.plaintext.txt	76	three approach num direct ascertainment functional secretase activity glycerol velocity gradient fraction num analysis differential effect detergent secretase activity complex composition complex size num analysis differential effect psnum mutation secretase activity complex composition complex size
0.3369568.15123598.html.plaintext.txt	77	estimate secretase activity complex used cell free assay num investigate generation stub anti psnum immunopurified membrane solubilized num chapso resolved size glycerol velocity gradient
0.3369568.15123598.html.plaintext.txt	78	highest specific secretase activity relative amount psnum ntf fraction found higher mass fraction num kda glycerol velocity gradient specific activity num
0.3369568.15123598.html.plaintext.txt	79	num fraction num num num num respectively compared num
0.3369568.15123598.html.plaintext.txt	80	num fraction num num num num respectively p num
0.3369568.15123598.html.plaintext.txt	81	previous vitro study shown chapso optimum detergent preserving secretase activity cell free membrane preparation secretase activity significantly reduced digitonin completely abolished triton x num n octyl glucoside many detergent num num
0.3369568.15123598.html.plaintext.txt	82	glycerol velocity numd gel electrophoretic experiment repeated using digitonin significant num fold reduction abundance high molecular weight presenilin complex numd gel electrophoreses fig
0.3369568.15123598.html.plaintext.txt	83	num right glycerol velocity fractionation experiment fig
0.3369568.15123598.html.plaintext.txt	84	furthermore fraction contain little co immunoprecipitating app ctfs failed generate significant quantity stub cell free secretase assay fig
0.3369568.15123598.html.plaintext.txt	85	confirm absence secretase activity digitonin solubilized fraction caused failure docking cleavage app ctfs digitonin solubilized complex opposed artifact simple degradation app ctfs assay performed two additional experiment
0.3369568.15123598.html.plaintext.txt	86	first immunopurified chapso solubilized psnum complex split product two aliquot
0.3369568.15123598.html.plaintext.txt	87	one aliquot submitted directly secretase assay whereas digitonin added aliquot final concentration num
0.3369568.15123598.html.plaintext.txt	88	num submitted secretase assay
0.3369568.15123598.html.plaintext.txt	89	stub generated aliquot containing digitonin data shown
0.3369568.15123598.html.plaintext.txt	90	second experiment simply added additional purified app cnum chapso solubilized digitonin solubilized psnum complex fig
0.3369568.15123598.html.plaintext.txt	91	despite abundant presence substrate digitonin solubilized psnum complex failed generate stub fig
0.3369568.15123598.html.plaintext.txt	92	taken together experiment suggest digitonin solubilized psnum complex undergone either conformational shift andor lost substrated adaptor protein
0.3369568.15123598.html.plaintext.txt	93	presenilin complex solubilized num triton x num num n octyl glucoside neither support secretase activity high molecular weight presenilin complex specie essentially abolished monomeric specie found data shown
0.3369568.15123598.html.plaintext.txt	94	functional secretase activity also modulated selected mutation presenilin protein
0.3369568.15123598.html.plaintext.txt	95	particular mutation either two aspartyl residue within membrane embedded hydrophobic domain psnum dnuma psnum dnuma associated loss proteolytic activity num num
0.3369568.15123598.html.plaintext.txt	96	therefore investigated structure relative abundance presenilin complex isolated cell overexpressing either wild type psnum psnum dnuma loss function mutant
0.3369568.15123598.html.plaintext.txt	97	shown previously psnum dnuma mutation cause reduction abundance higher mw specie glycerol velocity gradient fractionation num
0.3369568.15123598.html.plaintext.txt	98	also shown reduction caused simple failure endoproteolytic cleavage psnum num
0.3369568.15123598.html.plaintext.txt	99	thus high molecular weight complex comparable size wild type psnum ntfctfs observed cell expressing holoprotein psnum exon num deletion mutant cause increased num secretase activity impaired psnum endoproteolysis num
0.3369568.15123598.html.plaintext.txt	100	agreement prior observation current numd gel analysis psnum dnuma mutation associated altered distribution complex component fig
0.3369568.15123598.html.plaintext.txt	101	thus num kda complex absent digitonin solubilized lysates psnum dnuma expressing cell displayed num kda complex monomeric band nicastrin num kda psnum dnuma holoprotein num kda observed fig numa right
0.3369568.15123598.html.plaintext.txt	102	similar le profound change relative abundance num num kda complex also apparent chapso solubilization fig
0.3369568.15123598.html.plaintext.txt	103	thus cell expressing wild type psnum fig
0.3369568.15123598.html.plaintext.txt	104	num b left c f greater abundance num kda complex relative num kda complex num kdanum kda ratio num
0.3369568.15123598.html.plaintext.txt	105	however psnum dnuma overexpressing cell fig
0.3369568.15123598.html.plaintext.txt	106	num b right c f significant loss num kda complex corresponding overabundance num kda complex num kdanum kda ratio num
0.3369568.15123598.html.plaintext.txt	107	view larger version numk fig
0.3369568.15123598.html.plaintext.txt	108	loss function psnum dnuma mutant alters abundance size distribution psnum complex
0.3369568.15123598.html.plaintext.txt	109	numd gel analysis digitonin solubilized membrane preparation heknum cell overexpressing wild type psnum left psnum dnuma mutant right
0.3369568.15123598.html.plaintext.txt	110	psnum dnuma cell show accumulation num kda complex loss num kda complex num kda nicastrinaph num complex
0.3369568.15123598.html.plaintext.txt	111	b numd gel analysis chapso solubilized membrane preparation heknum cell overexpressing wild type psnum left psnum dnuma mutant right
0.3369568.15123598.html.plaintext.txt	112	wild type psnum cell show equal greater abundance num kda complex compared num kda complex
0.3369568.15123598.html.plaintext.txt	113	contrast psnumdnuma mutant cell show greater abundance num kda complex relative loss num kda complex
0.3369568.15123598.html.plaintext.txt	114	c f confirm result direct visual interpretation intensity profile western blotting signal plotted using nih image software solid line wild type psnum dotted line psnum dnuma
0.3369568.15123598.html.plaintext.txt	115	peak height computed num num kda complex data used compare effect detergent psnum mutation using num kdanum kda peak height ratio
0.3369568.15123598.html.plaintext.txt	116	wild type psnum expressing cell num kda complex predominated whereas psnum dnuma mutant cell num kda complex predominated p num
0.3369568.15123598.html.plaintext.txt	117	two potential explanation result
0.3369568.15123598.html.plaintext.txt	118	first straightforward explanation complex reflect evolution presenilin complex assembled
0.3369568.15123598.html.plaintext.txt	119	lower mass num num kda complex might represent initial intermediary complex whereas low abundance high mass complex num kda could represent functional complex contain either additional component contain four known component higher order stoichiometry e
0.3369568.15123598.html.plaintext.txt	120	direct experiment analyzing composition complex required resolve possibility
0.3369568.15123598.html.plaintext.txt	121	however two caveat hypothesis
0.3369568.15123598.html.plaintext.txt	122	first small measurable amount num kda complex still present chapso lysates psnum dnuma cell although complex considerably reduced abundance relative num kda complex
0.3369568.15123598.html.plaintext.txt	123	completely negate hypothesis num kda complex functional conform substantial proportion psnum dnuma molecule clearly aberrant conformational num kda state chapso nearly psnum dnuma molecule num kda complex digitonin
0.3369568.15123598.html.plaintext.txt	124	result probable psnum dnuma molecule num kda complex chapso entirely normal conform
0.3369568.15123598.html.plaintext.txt	125	second caveat concerning postulated hierarchy complex arises observation psnum dnuma expressing cell assemble robust nicastrin aph num num kda complex
0.3369568.15123598.html.plaintext.txt	126	could argued num kda nicastrinaph num complex precursor complex postulated represents downstream catabolic product num num kda complex
0.3369568.15123598.html.plaintext.txt	127	stable presence num kda complex psnum cell make hypothesis unlikely
0.3369568.15123598.html.plaintext.txt	128	alternate explanation disappearance num kda complex psnum dnuma cell psnum cell num kda complex could dual role
0.3369568.15123598.html.plaintext.txt	129	complex could involved presenting new nicastrin molecule num kda complex involved recovering re presenting used nicastrin molecule back num kda complex
0.3369568.15123598.html.plaintext.txt	130	conceivable presence psnum dnuma mutant available aph num might become locked psnum dnuma mutant num kda complex fails mature thereby causing disappearance num kda nicastrin aph num complex
0.3369568.15123598.html.plaintext.txt	131	second observation note result fact c terminal fragment app arising secretase cleavage app holoprotein substrate presenilin dependent secretase cleavage uniformly present presenilin complex see fig
0.3369568.15123598.html.plaintext.txt	132	fact app c terminal stub abundant complex associated functional secretase activity
0.3369568.15123598.html.plaintext.txt	133	increase apparent molecular mass non functional complex functional complex accounted simple addition one molecule c terminal app stub per complex although exclude possibility multiple app stub docked onto functional complex
0.3369568.15123598.html.plaintext.txt	134	however differential presence app ctfs raise intriguing plausible possibility detergent mutant associated loss secretase activity either num altered conformation andor complex stoichiometry way precludes efficient docking substrate num perturbed binding adapter molecule might required allow substrate docking
0.3369568.15123598.html.plaintext.txt	135	keeping hypothesis recent cross competition assay different class secretase inhibitor supported notion substrate binding catalytic site secretase may physically separate correct conformational shift required bring bound substrate catalytic site num
0.3369568.15123598.html.plaintext.txt	136	conclusion experiment suggest maturation functional deployment presenilin protein complex previously thought
0.3369568.15123598.html.plaintext.txt	137	data raise possibility additional component may exist high molecular mass functional complex
0.3369568.15123598.html.plaintext.txt	138	result also require detailed assessment whether substrate undergo presenilin dependent proteolysis dependent set presenilin complex whether specialized complex subserving cleavage specific protein
0.3369568.15123598.html.plaintext.txt	139	instance conceivable complex may differ componentry according subcellular distribution e
0.3369568.15123598.html.plaintext.txt	140	lipid rich raft domain plasma membrane endosomal lysosomal pathway autophagic vacuole num num
0.3369568.15123598.html.plaintext.txt	141	case site specific composition complex might confer either substrate specificity preferred proteolytic cleavage site within transmembrane domain might therefore potentially exploited therapeutically
0.3369568.15123598.html.plaintext.txt	142	footnote work supported grant canadian institute health research howard hughes medical institute alzheimer society ontario scottish rite charitable foundation canada
0.3369568.15123598.html.plaintext.txt	143	cost publication article defrayed part payment page charge
0.3369568.15123598.html.plaintext.txt	144	article must therefore hereby marked advertisement accordance num u
0.3369568.15123598.html.plaintext.txt	145	section num solely indicate fact
0.3369568.15123598.html.plaintext.txt	146	author contributed equally work
0.3369568.15123598.html.plaintext.txt	147	correspondence addressed p
0.3369568.15123598.html.plaintext.txt	148	centre research neurodegenerative disease tanz neuroscience bldg university toronto num queen park crescent west toronto ontario mnums numhnum canada
0.3369568.15123598.html.plaintext.txt	149	num num num fax num num num e mail p
0.3369568.15123598.html.plaintext.txt	150	num abbreviation used pb phosphate buffered saline bn blue native chapso num num cholamidopropyldimethylammonio num hydroxy num propanesulfonic acid numd two dimensional hek human embryonic kidney aph num anterior pharynx defective num pen num presenilin enhancer num psnum presenilin num app amyloid precursor protein ntf n terminal fragment ctf c terminal fragment bi tris num bisnum hydroxyethylamino num hydroxymethylpropane numnum diol
0.33924845.15583026.html.plaintext.txt	0	rockefeller university press num num num
0.33924845.15583026.html.plaintext.txt	1	num jcb volume num number num num num article abstract pdf full text alert article cited citation map service alert new content jcb download citation manager google scholar article kaether c
0.33924845.15583026.html.plaintext.txt	2	article citing article pubmed pubmed citation article kaether c
0.33924845.15583026.html.plaintext.txt	3	lipid boundary separate app secretase limit amyloid s peptide generation christoph kaether christian haass
0.33924845.15583026.html.plaintext.txt	4	adolf butenandt institute department biochemistry laboratory alzheimers parkinson disease research ludwig maximilians university num munchen germany
0.33924845.15583026.html.plaintext.txt	5	correspondence christian haass chaassatmed
0.33924845.15583026.html.plaintext.txt	6	abstract million patient suffer alzheimers disease intensive effort find cure devastating disorder center protease release deadly amyloid s peptide precursor
0.33924845.15583026.html.plaintext.txt	7	cutting procedure thought cholesterol dependent strategy lower cholesterol therapeutic treatment intensive investigation
0.33924845.15583026.html.plaintext.txt	8	recent finding suggest complete proteolytic machinery required amyloid s peptide generation located within lipid raft
0.33924845.15583026.html.plaintext.txt	9	data dotti colleague abad rodriguez et al
0.33924845.15583026.html.plaintext.txt	10	num issue suggest raft isolate cutting machinery away deadly substrate
0.33924845.15583026.html.plaintext.txt	11	finding describe novel mechanism controlling proteolytic activity building lipid boundary protease substrate
0.33924845.15583026.html.plaintext.txt	12	abbreviation used paper as amyloid s peptide ad alzheimers disease app s amyloid precursor protein
0.33924845.15583026.html.plaintext.txt	13	developed country human live longer longer
0.33924845.15583026.html.plaintext.txt	14	although wish enjoy increased longevity longer life unfortunately associated dramatic increase risk alzheimers disease ad
0.33924845.15583026.html.plaintext.txt	15	widely recognized year numerous scientist studied cellular mechanism causing ad goal finally identifying target treatment
0.33924845.15583026.html.plaintext.txt	16	indeed likely gene directly involved generation deadly amyloid s peptide as form disease defining amyloid plaque identified haass num
0.33924845.15583026.html.plaintext.txt	17	currently clear as generated proteolytic processing s amyloid precursor protein app two amyloidogenic secretase s secretase involved fig
0.33924845.15583026.html.plaintext.txt	18	s secretase s site app cleaving enzyme bace typical aspartyl protease
0.33924845.15583026.html.plaintext.txt	19	secretase however unusual aspartyl protease complex composed four individual protein presenilin nicastrin aph num pen num presenilin carrying protease active site haass num
0.33924845.15583026.html.plaintext.txt	20	secretase uncommon molecular composition also proteolytic activity since able cleave substrate within membrane fig
0.33924845.15583026.html.plaintext.txt	21	prerequisite intramembrane cut release ectodomain app via cleavage bace secretase
0.33924845.15583026.html.plaintext.txt	22	removal ectodomain bace result production as following secretase cleavage whereas ectodomain cleavage secretase nonamyloidogenic since cut within as domain fig
0.33924845.15583026.html.plaintext.txt	23	view larger version numk figure num
0.33924845.15583026.html.plaintext.txt	24	processing app secretase
0.33924845.15583026.html.plaintext.txt	25	secretase cleavage occurs within as domain prevents amyloidogenesis
0.33924845.15583026.html.plaintext.txt	26	however small peptide pnum generated subsequent cleavage cnum fragment secretase
0.33924845.15583026.html.plaintext.txt	27	besides pnum large ectodomain apps secreted
0.33924845.15583026.html.plaintext.txt	28	shorter apps specie secreted upon cleavage bace apps s
0.33924845.15583026.html.plaintext.txt	29	resulting cnum fragment cleaved secretase produce as
0.33924845.15583026.html.plaintext.txt	30	secretase cut release app intracellular domain aicd may involved nuclear signaling
0.33924845.15583026.html.plaintext.txt	31	amyloidogenesis known dependent cholesterol level simon et al
0.33924845.15583026.html.plaintext.txt	32	num moreover seems direct relevance ad since high cholesterol correlated increased risk disease kuo et al
0.33924845.15583026.html.plaintext.txt	33	addition apolipoprotein num allele known major genetic risk factor ad corder et al
0.33924845.15583026.html.plaintext.txt	34	cellular level as generation found occur special cholesterol rich membrane subdomains called drms detergent resistant membrane lowering cholesterol level treatment cholesterol synthesis inhibitor statin resulted strong decrease as production simon et al
0.33924845.15583026.html.plaintext.txt	35	likely due part increase nonamyloidogenic cleavage secretase kojro et al
0.33924845.15583026.html.plaintext.txt	36	animal model statin treatment also associated significant drop as load fassbender et al
0.33924845.15583026.html.plaintext.txt	37	furthermore clear correlation cholesteryl ester level as generation reported cultured cell puglielli et al
0.33924845.15583026.html.plaintext.txt	38	recently demonstrated inhibition enzyme regulates conversion free cholesterol cholesteryl ester lead dramatic lowering ad pathology animal model also associated reversion cognitive deficit hutter paier et al
0.33924845.15583026.html.plaintext.txt	39	surprisingly effort way use cholesterol lowering drug patient decrease as production
0.33924845.15583026.html.plaintext.txt	40	indeed preliminary epidemiological study small clinical trial suggest lowering cholesterol level may reduce risk ad wolozin et al
0.33924845.15583026.html.plaintext.txt	41	strong cholesterol dependency as generation suggested secretase might located within drms may regulate processing app
0.33924845.15583026.html.plaintext.txt	42	num demonstrated antibody cross linking induced bace app copatch within cholesterol rich microdomains resulted increased as production
0.33924845.15583026.html.plaintext.txt	43	proposed localization secretase supported recent finding two different laboratory
0.33924845.15583026.html.plaintext.txt	44	num report able identify endogenous bace within drms primary hippocampal neuron
0.33924845.15583026.html.plaintext.txt	45	num recently demonstrated completely assembled biologically active secretase complex consisting presenilin fragment aph num mature nicastrin pen num resides within drms
0.33924845.15583026.html.plaintext.txt	46	moreover secretase found syntaxin num syntaxin num vampnum positive vesicle demonstrating secretase accumulates drms late golgi endosomes vetrivel et al
0.33924845.15583026.html.plaintext.txt	47	num exactly bace thought biologically active haass et al
0.33924845.15583026.html.plaintext.txt	48	similarly monomeric oligomeric as concentrated drms brain mouse model ad lee et al
0.33924845.15583026.html.plaintext.txt	49	thus appears complete as generating proteolytic machinery coexists within drms vesicle
0.33924845.15583026.html.plaintext.txt	50	issue researcher provide novel unexpected explanation secretase localized cholesterol rich membrane domain
0.33924845.15583026.html.plaintext.txt	51	present data suggesting drm association bace restricts access app demonstrate accumulates detergent sensitive membrane domain outside drms see fig
0.33924845.15583026.html.plaintext.txt	52	may indicate aberrant access app drms hence aberrant as production ad may indicate even physiological condition app molecule come close contact drms
0.33924845.15583026.html.plaintext.txt	53	latter seems likely since as physiologically normal product produced brain ad patient haass num
0.33924845.15583026.html.plaintext.txt	54	finding also demonstrate completely novel cellular mechanism controlling protease activity
0.33924845.15583026.html.plaintext.txt	55	cell undergo major effort prevent protease contacting protein destined digested
0.33924845.15583026.html.plaintext.txt	56	accomplished numerous mechanism including synthesis inactive proforms activated appropriate site tagging protease substrate ubiquitin sequestering protease membrane surrounded environment endosomeslysosomes hiding active site protease within narrow tunnel proteasomes
0.33924845.15583026.html.plaintext.txt	57	num add yet another control mechanism
0.33924845.15583026.html.plaintext.txt	58	show lipid build invisible boundary corralling secretase complex bace away substrate app
0.33924845.15583026.html.plaintext.txt	59	certainly mechanism evolve protect u ad
0.33924845.15583026.html.plaintext.txt	60	secretase concentrate within drms probable explanation secretase involved several signaling pathway including notch signaling selkoe kopan num haass num concentrating proteolytic machinery small membrane domain facilitates process
0.33924845.15583026.html.plaintext.txt	61	would however imply physiological substrate notch others must gain access drms observation yet made
0.33924845.15583026.html.plaintext.txt	62	view larger version numk figure num
0.33924845.15583026.html.plaintext.txt	63	model describing effect cholesterol reduction as generation
0.33924845.15583026.html.plaintext.txt	64	however one obvious discrepancy result current study earlier one must addressed
0.33924845.15583026.html.plaintext.txt	65	num demonstrate upon moderate lowering cholesterol as generation surprisingly increased whereas large body previously published data see clearly demonstrated reduced as generation upon cholesterol reduction
0.33924845.15583026.html.plaintext.txt	66	could case mean previous approach simply wrong truth may found side
0.33924845.15583026.html.plaintext.txt	67	finding dotti colleague abad rodriguez et al
0.33924845.15583026.html.plaintext.txt	68	num indeed apparent disagreement study showing lowering cholesterol inhibits amyloidogenesis cultured cell animal model simon et al
0.33924845.15583026.html.plaintext.txt	69	however study cholesterol always strongly depleted cell used overexpressed app
0.33924845.15583026.html.plaintext.txt	70	contrast current study investigated neuron cell affected deadly activity as
0.33924845.15583026.html.plaintext.txt	71	moderate reduction cholesterol led increased as level whereas strong cholesterol reduction resulted significant drop as generation fig
0.33924845.15583026.html.plaintext.txt	72	num similar observed simon et al
0.33924845.15583026.html.plaintext.txt	73	thus effect cholesterol reduction dose dependent two apparently independent cellular mechanism affected
0.33924845.15583026.html.plaintext.txt	74	moderate reduction cholesterol cause disorganization drms allowing bace contact app resulting enhanced as generation fig
0.33924845.15583026.html.plaintext.txt	75	strong reduction cholesterol inhibits bace secretase activity result dramatic drop as generation even though bace secretase contact app directly fig
0.33924845.15583026.html.plaintext.txt	76	clear contrast model ehehalt et al
0.33924845.15583026.html.plaintext.txt	77	reported bace cleavage app occurs within lipid drms ehehalt et al
0.33924845.15583026.html.plaintext.txt	78	num discrepancy might due fact overexpressed fraction app may mislocalized drms cleaved bace observation also made abad rodriguez et al
0.33924845.15583026.html.plaintext.txt	79	work needed settle controversy since effect lowering brain cholesterol production endogenous as mouse neuron human brain directly demonstrated
0.33924845.15583026.html.plaintext.txt	80	although current finding raise interesting question necessarily challenge cholesterol lowering tactic ad therapyprevention since animal study date clear favor strategy fassbender et al
0.33924845.15583026.html.plaintext.txt	81	moreover cholesterol lowering drug taken numerous patient enormous beneficial effect cardiovascular disorder side effect concerning as generation dementia reported
0.33924845.15583026.html.plaintext.txt	82	cholesterol dependent processing app provides striking example disease based research dramatically advance basic knowledge cell biology vice versa
0.33924845.15583026.html.plaintext.txt	83	would thought num year ago drms might contain regulate deadly machinery responsible abundant human neurodegenerative disorder machinery might function via novel totally unexpected mechanism intramembrane proteolysis
0.33924845.15583026.html.plaintext.txt	84	submitted num october numaccepted num november num
0.33924845.15583026.html.plaintext.txt	85	neuronal membrane cholesterol loss enhances amyloid peptide generation
0.33924845.15583026.html.plaintext.txt	86	gene dose apolipoprotein e type num allele risk alzheimers disease late onset family
0.33924845.15583026.html.plaintext.txt	87	amyloidogenic processing alzheimer beta amyloid precursor protein depends lipid raft
0.33924845.15583026.html.plaintext.txt	88	simvastatin strongly reduces level alzheimers disease beta amyloid peptide abeta num abeta num vitro vivo
0.33924845.15583026.html.plaintext.txt	89	take five bace secretase quartet conduct alzheimers amyloid s peptide generation
0.33924845.15583026.html.plaintext.txt	90	swedish mutation cause early onset alzheimers disease beta secretase cleavage within secretory pathway
0.33924845.15583026.html.plaintext.txt	91	acat inhibitor cp numnum markedly reduces amyloid pathology mouse model alzheimers disease
0.33924845.15583026.html.plaintext.txt	92	dimeric amyloid beta protein rapidly accumulates lipid raft followed apolipoprotein e phosphorylated tau accumulation tgnum mouse model alzheimers disease
0.33924845.15583026.html.plaintext.txt	93	low cholesterol stimulates nonamyloidogenic pathway effect alpha secretase adam num
0.33924845.15583026.html.plaintext.txt	94	elevated low density lipoprotein alzheimers disease correlate brain abeta num num level
0.33924845.15583026.html.plaintext.txt	95	detergent insoluble membrane compartment contains beta vivo
0.33924845.15583026.html.plaintext.txt	96	acyl coenzyme cholesterol acyltransferase modulates generation amyloid beta peptide
0.33924845.15583026.html.plaintext.txt	97	notch presenilin regulated intramembrane proteolysis link development degeneration
0.33924845.15583026.html.plaintext.txt	98	cholesterol depletion inhibits generation beta amyloid hippocampal neuron
0.33924845.15583026.html.plaintext.txt	99	cholesterol alzheimers disease link neurology
0.33924845.15583026.html.plaintext.txt	100	treatment simvastatin normocholesterolemic patient alzheimers disease num week randomized placebo controlled double blind trial
0.33924845.15583026.html.plaintext.txt	101	beta secretase cleavage alzheimers amyloid precursor protein transmembrane aspartic protease bace
0.33924845.15583026.html.plaintext.txt	102	association gamma secretase lipid raft post golgi endosome membrane
0.33924845.15583026.html.plaintext.txt	103	phosphorylation regulates intracellular trafficking beta secretase
0.33924845.15583026.html.plaintext.txt	104	decreased prevalence alzheimer disease associated num hydroxy num methylglutaryl coenzyme reductase inhibitor
0.33924845.15583026.html.plaintext.txt	105	article abstract pdf full text alert article cited citation map service alert new content jcb download citation manager google scholar article kaether c
0.33924845.15583026.html.plaintext.txt	106	article citing article pubmed pubmed citation article kaether c
0.33924845.15583026.html.plaintext.txt	107	home help feedback subscription archive search table content
0.33943188.11502763.html.plaintext.txt	0	rockefeller university press num numnumnumnum num
0.33943188.11502763.html.plaintext.txt	1	num journal cell biology volume num number num august num num num num article
0.33943188.11502763.html.plaintext.txt	2	discrepancy presenilin subcellular localization secretase processing amyloid precursor protein philippe cupersnum mustapha bentahirnum katleen craessaertsnum isabelle orlansnum hugo vanderstichelenum paul saftignum bart de stroopernum wim annaertnum
0.33943188.11502763.html.plaintext.txt	3	num center human genetics neuronal cell biology group flanders interuniversity institute biotechnology catholic university leuven b num leuven belgium num department biochemistry num university gottingen d num gottingen germany num innogenetics nv b num gent belgium
0.33943188.11502763.html.plaintext.txt	4	address correspondence wim annaert bart de strooper center human genetics neuronal cell biology group herestraat num b num leuven belgium
0.33943188.11502763.html.plaintext.txt	5	key word presenilin num amyloid peptide secretase er retention app processing
0.33943188.11502763.html.plaintext.txt	6	several line evidence led hypothesis p secretase
0.33943188.11502763.html.plaintext.txt	7	first secretase cleavage app notch inactivated partially psnum deficient cell completely psnumpsnum double deficient cell de strooper et al
0.33943188.11502763.html.plaintext.txt	8	num struhl greenwald num herreman et al
0.33943188.11502763.html.plaintext.txt	9	moreover mutagenesis one two aspartyl residue located transmembrane domain num num result dominant negative like effect secretase cleavage suggesting aspartates contribute active site p wolfe et al
0.33943188.11502763.html.plaintext.txt	10	similarity prepilin peptidase taken evidence p protease steiner et al
0.33943188.11502763.html.plaintext.txt	11	however strongest argument favor idea come observation several compound inhibit secretase bind specifically p esler et al
0.33943188.11502763.html.plaintext.txt	12	nevertheless direct proof p hydrolyze peptide bound still lacking
0.33943188.11502763.html.plaintext.txt	13	remarkably notch app apparently first need proteolytical trimming extracellular domain tace s secretase respectively become substrate p secretase de strooper et al
0.33943188.11502763.html.plaintext.txt	14	num struhl adachi num
0.33943188.11502763.html.plaintext.txt	15	protease located downstream biosynthetic pathway therefore notch app first leave er become substrate p secretase
0.33943188.11502763.html.plaintext.txt	16	despite significant advance understanding secretase processing remains unclear app cleavage s secretase becomes exposed p
0.33943188.11502763.html.plaintext.txt	17	moreover as appears produced mainly endosomal compartment koo squazzo num hartmann et al
0.33943188.11502763.html.plaintext.txt	18	num whereas p abundantly present er intermediate compartment walter et al
0.33943188.11502763.html.plaintext.txt	19	problem summarized spatial paradox annaert de strooper num tackle problem analyzing processing series app trafficking mutant primary cortical neuron derived psnum psnum mouse
0.33943188.11502763.html.plaintext.txt	20	analyzed consequence restricting app trafficking certain subcellular compartment generation total as assnum
0.33943188.11502763.html.plaintext.txt	21	construct tested app deleted cytosolic tail app ct b app double lysine er retention motif cytoplasmic tail app kk c app cytoplasmic tail ldl receptor app ldl d app truncated s secretase cleavage site app cnum e app cnum double lysine kk motif
0.33943188.11502763.html.plaintext.txt	22	app ct poorly reinternalized stay longer time cell surface tienari et al
0.33943188.11502763.html.plaintext.txt	23	kk motif act er retrieval signal jackson et al
0.33943188.11502763.html.plaintext.txt	24	num therefore app kk colocalizes abundantly endogenous psnum peraus et al
0.33943188.11502763.html.plaintext.txt	25	app ldl recycles endosomal system cell surface annaert et al
0.33943188.11502763.html.plaintext.txt	26	app cnum direct substrate secretase addition kk er retention motif app cnum kk anticipated creating excellent substrate psnum secretase
0.33943188.11502763.html.plaintext.txt	27	overall data confirm spatial paradox p secretase hypothesis provide evidence transfer app cnum compartment downstream er needed addition processed psnum obtain secretase activity primary culture neuron
0.33943188.11502763.html.plaintext.txt	28	view larger version numk figure num
0.33943188.11502763.html.plaintext.txt	29	app schematically represented app wt
0.33943188.11502763.html.plaintext.txt	30	different relevant proteolytic fragment indicated top
0.33943188.11502763.html.plaintext.txt	31	ectodomain detected pabnum amyloid peptide region num num detected pab bnum region num num mab numdnum region num num detected mabnumgnum last num amino acid cooh terminal cytoplasmic tail detected pab bnumnum pab num
0.33943188.11502763.html.plaintext.txt	32	s secretase cleavage site indicated
0.33943188.11502763.html.plaintext.txt	33	app cnum construct supplementary asp ala residue da added obtain cleavage signal peptidase s secretase site see lichtenthaler et al
0.33943188.11502763.html.plaintext.txt	34	detail see material method
0.33943188.11502763.html.plaintext.txt	35	view larger version numk figure num
0.33943188.11502763.html.plaintext.txt	36	processing app trafficking mutant psnum psnum neuron
0.33943188.11502763.html.plaintext.txt	37	psnum psnum primary neuronal culture transduced psfv bearing app wt app ct app kk app ldl described metabolically labeled numsmethionine num h num degree c
0.33943188.11502763.html.plaintext.txt	38	cell extract two top panel culture medium two bottom panel immunoprecipitated using appropriate antibody analyzed num num num nupage gel
0.33943188.11502763.html.plaintext.txt	39	position various app fragment indicated
0.33943188.11502763.html.plaintext.txt	40	note app ct holo form cooh terminal s fragment migrate faster cytoplasmic domain deleted whereas app ldl fragment migrates slower due large ldl receptor cytoplasmic domain
0.33943188.11502763.html.plaintext.txt	41	cooh terminal stub detected antibody bnum react fragment
0.33943188.11502763.html.plaintext.txt	42	b app fragment three independent experiment quantified using phosphorimaging normalized level expression app holo form de strooper et al
0.33943188.11502763.html.plaintext.txt	43	data obtained psnum neuron compared data obtained psnum neuron
0.33943188.11502763.html.plaintext.txt	44	show relative effect absence psnum app fragment separately
0.33943188.11502763.html.plaintext.txt	45	since app ct processed s secretase limited extent result displayed fig
0.33943188.11502763.html.plaintext.txt	46	num significant conclusion regarding level secretase processing construct
0.33943188.11502763.html.plaintext.txt	47	c secretion assnum analyzed elisa
0.33943188.11502763.html.plaintext.txt	48	result normalized level secreted psnum neuron transfected app wt
0.33943188.11502763.html.plaintext.txt	49	dark bar light bar represent data obtained psnum psnum neuron respectively
0.33943188.11502763.html.plaintext.txt	50	view larger version numk figure num
0.33943188.11502763.html.plaintext.txt	51	secretion pnum psnum neuron expressing app ct
0.33943188.11502763.html.plaintext.txt	52	neuron transduced metabolically labeled
0.33943188.11502763.html.plaintext.txt	53	cell extract top culture medium bottom immunoprecipitated using pabnum holo app mabnumgnum apps asspnum
0.33943188.11502763.html.plaintext.txt	54	intermediate band running as pnum cell transduced app wt corresponds truncated as generated s secretase cleavage glunum position creemers et al
0.33943188.11502763.html.plaintext.txt	55	reduction s cleaved app ctf app ct transduced wild type neuron accompanied num decrease secretion total as assnum fig
0.33943188.11502763.html.plaintext.txt	56	moreover relative accumulation s cleaved app ctf psnum neuron observed
0.33943188.11502763.html.plaintext.txt	57	explained predominant secretase cleavage app ct near plasma membrane reflected increased secretion apps cleaved secretase site concomitant fivefold increase pnum secretion fig
0.33943188.11502763.html.plaintext.txt	58	interestingly secretion pnum dramatically inhibited absence psnum fig
0.33943188.11502763.html.plaintext.txt	59	num bottom indicating stub generated near cell surface still substrate psnum dependent secretase processing
0.33943188.11502763.html.plaintext.txt	60	therefore data app ct app ldl clearly demonstrate psnum needed normal secretase processing late golgi region cell surface endosomal compartment
0.33943188.11502763.html.plaintext.txt	61	contrast mutant level apps cooh terminal s stub generated app kk low confirming low s secretase activity er fig
0.33943188.11502763.html.plaintext.txt	62	accordingly total as fig
0.33943188.11502763.html.plaintext.txt	63	num c secretion also strongly reduced num
0.33943188.11502763.html.plaintext.txt	64	however overexpressed psnum neuron secretion as peptide inhibited extent observed peptide derived app wt fig
0.33943188.11502763.html.plaintext.txt	65	circumvent need preactivation app kk s secretase generated app cnum kk corresponding app truncated s secretase site lichtenthaler et al
0.33943188.11502763.html.plaintext.txt	66	num containing kk er retention motif
0.33943188.11502763.html.plaintext.txt	67	expressed neuron app cnum kk migrated apparent molecular weight num kd s stub coming app wt app cnum without kk motif fig
0.33943188.11502763.html.plaintext.txt	68	app cnum like app wt processed secretase reflected generation appctf fig
0.33943188.11502763.html.plaintext.txt	69	app cnum kk contrast either processed processed little s secretase confirming specific retention app cnum kk er ci golgi region
0.33943188.11502763.html.plaintext.txt	70	line prediction app cnum require s secretase cleavage become substrate secretase estimated sevenfold increase total as secretion fig
0.33943188.11502763.html.plaintext.txt	71	effect also observed assnum detected elisa fig
0.33943188.11502763.html.plaintext.txt	72	secretase cleavage app cnum strongly inhibited absence psnum fig
0.33943188.11502763.html.plaintext.txt	73	surprisingly however observation app cnum kk also expected substrate psnum secretase retained er turned yield little as peptide fig
0.33943188.11502763.html.plaintext.txt	74	unlikely kk motif directly interfered recognition cnum secretase complex since cytoplasmic tail app removed without affecting secretase cleavage fig
0.33943188.11502763.html.plaintext.txt	75	moreover cnumkk becomes substrate secretase condition specified
0.33943188.11502763.html.plaintext.txt	76	alternatively low as secretion neuron expressing app cnum kk might explained intracellular retention newly formed as peptide
0.33943188.11502763.html.plaintext.txt	77	could ruled increased amount as could immunoprecipitated cell extract result shown see fig
0.33943188.11502763.html.plaintext.txt	78	view larger version numk figure num
0.33943188.11502763.html.plaintext.txt	79	secretase processing app cnum trafficking mutant psnum psnum neuron
0.33943188.11502763.html.plaintext.txt	80	cell extract top culture medium bottom neuron expressing app wt app cnum app cnum kk immunoprecipitated using antibody bnumnum app cooh terminal domain top bnum amyloid region
0.33943188.11502763.html.plaintext.txt	81	arrow gel indicate position various app fragment
0.33943188.11502763.html.plaintext.txt	82	notice striking absence as generation app cnum kk
0.33943188.11502763.html.plaintext.txt	83	num kd stub seen app cnum app cnum kk psnum independent probably physiologically relevant since never observed app wt
0.33943188.11502763.html.plaintext.txt	84	b assnum level measured elisa fig
0.33943188.11502763.html.plaintext.txt	85	result expressed relatively obtained psnum neuron transfected app wt
0.33943188.11502763.html.plaintext.txt	86	n nonsignificant value detection limit
0.33943188.11502763.html.plaintext.txt	87	c as fragment quantified using phosphorimaging normalized level expression app holo form n num mean plus minus sem
0.33943188.11502763.html.plaintext.txt	88	data obtained psnum neuron compared data obtained psnum neuron
0.33943188.11502763.html.plaintext.txt	89	show relative effect absence psnum as production app wt app cnum
0.33943188.11502763.html.plaintext.txt	90	as signal obtained app cnum kk detection limit
0.33943188.11502763.html.plaintext.txt	91	view larger version numk figure num
0.33943188.11502763.html.plaintext.txt	92	bfa treatment partially restores secretase processing app cnum kk
0.33943188.11502763.html.plaintext.txt	93	neuron transduced sfv app cnum app cnum kk treated without num microm bfa num h
0.33943188.11502763.html.plaintext.txt	94	culture medium cell extract immunoprecipitated using antibody bnum separated num nupage gel
0.33943188.11502763.html.plaintext.txt	95	detection secreted intracellular as done western blotting using wnum num mab raised nhnum terminus as sequence ida et al
0.33943188.11502763.html.plaintext.txt	96	neuron transduced sfv app cnum kk treated bfa
0.33943188.11502763.html.plaintext.txt	97	cell extract sequentially immunoprecipitated using antibody fcanum specific as peptide ending residue num fcanum specific as peptide ending residue num barelli et al
0.33943188.11502763.html.plaintext.txt	98	num separated num nupage gel
0.33943188.11502763.html.plaintext.txt	99	blotting as peptide revealed using wo num mab
0.33943188.11502763.html.plaintext.txt	100	using confocal scanning microscopy confirmed app cnum kk effectively retained er demonstrated colocalization er marker protein bip fig
0.33943188.11502763.html.plaintext.txt	101	num c limited extent intermediate compartment marker ergic num fig
0.33943188.11502763.html.plaintext.txt	102	importantly app cnum kk colocalized abundantly psnum fig
0.33943188.11502763.html.plaintext.txt	103	num d f indicating simple presence psnum sufficient secretase processing occur
0.33943188.11502763.html.plaintext.txt	104	respect important note demonstrated previously psnum er already processed towards nhnum cooh terminal fragment annaert et al
0.33943188.11502763.html.plaintext.txt	105	next investigated subcellular localization app cnum primary cortical neuron
0.33943188.11502763.html.plaintext.txt	106	app cnum clearly distributed er fig
0.33943188.11502763.html.plaintext.txt	107	num c deduced complete lack colocalization bip
0.33943188.11502763.html.plaintext.txt	108	similarly little colocalization observed ergic num marking intermediate compartment arrowhead fig
0.33943188.11502763.html.plaintext.txt	109	num d f including horizontal section arrow
0.33943188.11502763.html.plaintext.txt	110	surprisingly however observation app cnum immunoreactivity also essentially distribute golgi apparatus demonstrated gmnum staining fig
0.33943188.11502763.html.plaintext.txt	111	finally despite app cnum good secretase substrate fig
0.33943188.11502763.html.plaintext.txt	112	num fragment colocalize psnum arrowhead vertical section fig
0.33943188.11502763.html.plaintext.txt	113	clear contrast colocalization psnum inactive secretase substrate app cnum kk see also fig
0.33943188.11502763.html.plaintext.txt	114	view larger version numk figure num
0.33943188.11502763.html.plaintext.txt	115	app cnum kk colocalizes psnum endoplasmic reticulum
0.33943188.11502763.html.plaintext.txt	116	hippocampal neuron transduced sfv app cnum kk fixed num h postinfection stained antibody app pab num d g mab numdnum bip b psnum e ergic num h
0.33943188.11502763.html.plaintext.txt	117	c f represent merged picture
0.33943188.11502763.html.plaintext.txt	118	app cnum kk abundantly colocalized er marker protein bip psnum
0.33943188.11502763.html.plaintext.txt	119	little colocalization observed ergic num resident protein intermediate compartment
0.33943188.11502763.html.plaintext.txt	120	detection primary antibody done alexa num alexa num conjugated goat anti mouse goat anti rabbit secondary antibody numnumnum diluted
0.33943188.11502763.html.plaintext.txt	121	view larger version numk figure num
0.33943188.11502763.html.plaintext.txt	122	app cnum colocalize psnum essentially present bip ergic num gmnum negative compartment
0.33943188.11502763.html.plaintext.txt	123	sfv app cnum transduced hippocampal neuron fixed subcellular localization app cnum g pab num d j mab numdnum compared established marker protein er bip b intermediate compartment ergic num e golgi apparatus gmnum h finally psnum k
0.33943188.11502763.html.plaintext.txt	124	c f l show merged picture
0.33943188.11502763.html.plaintext.txt	125	d f j l arrow point position corresponding vertical section
0.33943188.11502763.html.plaintext.txt	126	immunodetection done fig
0.33943188.11502763.html.plaintext.txt	127	app cnum immunoreactivity mainly concentrated discrete spot colocalize er c bip arrowhead l psnum golgi region merged panel
0.33943188.11502763.html.plaintext.txt	128	occasionally minor colocalization ergic num could observed arrowhead d f
0.33943188.11502763.html.plaintext.txt	129	test hypothesis component downstream subcellular compartment needed process app cnum kk er treated neuron expressing app cnum app cnum kk brefeldin bfa drug cause rapid redistribution golgi apparatus er lippincott schwartz et al
0.33943188.11502763.html.plaintext.txt	130	treatment resulted drastic reduction app cnum derived as secretion whereas difference observed case app cnum kk fig
0.33943188.11502763.html.plaintext.txt	131	however addition bfa resulted strong increase intracellular as generated app cnum kk towards level indistinguishable obtained bfa treated app cnum transduced cell
0.33943188.11502763.html.plaintext.txt	132	suggests unknown factor required secretase activity redistributed golgi region er appears sufficient partially restore as production app cnum kk
0.33943188.11502763.html.plaintext.txt	133	suggested as generated endoplasmic reticulum consists mainly as ending residue num chyung et al
0.33943188.11502763.html.plaintext.txt	134	remarkably although detect little intracellular as experimental condition fig
0.33943188.11502763.html.plaintext.txt	135	num b treatment bfa induces generation as peptide ending residue num well residue num fig
0.33943188.11502763.html.plaintext.txt	136	app ldl expression selectively increased assnum secretion predicted preferential localization endosomes koo squazzo num peraus et al
0.33943188.11502763.html.plaintext.txt	137	absence psnum as generation app ldl strongly decreased demonstrating secretase processing app endosomes depends psnum
0.33943188.11502763.html.plaintext.txt	138	noted able detect endogenous psnum immunoreactivity cell surface endosomes neuronal cell used current study annaert et al
0.33943188.11502763.html.plaintext.txt	139	next investigated whether could increase secretase processing app er intermediate compartment contain bulk psnum immunoreactivity neuron
0.33943188.11502763.html.plaintext.txt	140	although several author provided evidence er production site peptide particular assnum chyung et al
0.33943188.11502763.html.plaintext.txt	141	num others able confirm observation annaert et al
0.33943188.11502763.html.plaintext.txt	142	num severe decrease assnum assnum secretion observed app retained er mean double lysine retention motif app kk
0.33943188.11502763.html.plaintext.txt	143	since retention app er implies cleavage s secretase residing tgn cell surface endosomes becomes strongly compromised since proteolytic trimming app ectodomain prerequisite secretase processing struhl adachi num seems logical app kk mutation result strongly decreased secretase cleavage inhibition as generation
0.33943188.11502763.html.plaintext.txt	144	consequence difficult interpret data obtained app kk regard secretase sensitivity
0.33943188.11502763.html.plaintext.txt	145	therefore generated app cnum construct direct substrate secretase lichtenthaler et al
0.33943188.11502763.html.plaintext.txt	146	num added double lysine er retention motif
0.33943188.11502763.html.plaintext.txt	147	num construct indeed retained er codistributes abundantly psnum
0.33943188.11502763.html.plaintext.txt	148	although expected increased as production significant amount as could precipitated wild type neuron fig
0.33943188.11502763.html.plaintext.txt	149	result even significant neuron expressing app cnum secreted seven time total as specifically assnum expressing app wt
0.33943188.11502763.html.plaintext.txt	150	possibility as generated app cnum kk retained cell ruled since significant accumulation cell associated as could demonstrated fig
0.33943188.11502763.html.plaintext.txt	151	num lane num b lane num numthe possibility kk motif directly interfered secretase cleavage ruled two observation
0.33943188.11502763.html.plaintext.txt	152	first clear result app ct cytoplasmic domain app involved processing app secretase
0.33943188.11502763.html.plaintext.txt	153	second treatment cell culture bfa could restore processing cnum kk clearly demonstrating inhibitory effect kk mutation trans ci phenomenon fig
0.33943188.11502763.html.plaintext.txt	154	pointed psnum er already proteolytically processed presenilinase present psnum ctf psnum ntf annaert et al
0.33943188.11502763.html.plaintext.txt	155	num thus putative active conformation
0.33943188.11502763.html.plaintext.txt	156	follows data simple colocalization substrate app cnum kk putative protease psnum sufficient proteolytic cleavage
0.33943188.11502763.html.plaintext.txt	157	conclude as production including assnum occur directly er requires least one factor derived post er compartment
0.33943188.11502763.html.plaintext.txt	158	conclusion corroborated two important piece evidence current work
0.33943188.11502763.html.plaintext.txt	159	first app cnum good substrate secretase mainly localized psnum bip ergicnum negative subcellular compartment fig
0.33943188.11502763.html.plaintext.txt	160	although characterization compartment requires experimentation result suggests least proteolytic cleavage app cnum substrate occurs non er compartment
0.33943188.11502763.html.plaintext.txt	161	second important argument come experiment using bfa
0.33943188.11502763.html.plaintext.txt	162	bfa drug cause redistribution post er compartment er lippincott schwartz et al
0.33943188.11502763.html.plaintext.txt	163	treatment drug sufficient restore partially secretase processing app cnum kk proving least one non er component needed activate secretase er fig
0.33943188.11502763.html.plaintext.txt	164	bfa treatment result secretase processing app position assnum something could possibly anticipated based current knowledge chyung et al
0.33943188.11502763.html.plaintext.txt	165	surprisingly however cleavage position assnum also observed fig
0.33943188.11502763.html.plaintext.txt	166	num b believed occur mainly late compartment secretory endosomal limb subcellular trafficking pathway koo squazzo num hartmann et al
0.33943188.11502763.html.plaintext.txt	167	summarizing data indicate efficient secretase cleavage app occur compartment contain little psnum little secretase activity observed compartment abundant maturated psnum residing
0.33943188.11502763.html.plaintext.txt	168	surprising result since data currently available imply psnum closely involved secretase type enzymatic activity de strooper et al
0.33943188.11502763.html.plaintext.txt	169	num num struhl greenwald num wolfe et al
0.33943188.11502763.html.plaintext.txt	170	spatial paradox psnum localization secretase activity explained two hypothesis minute amount psnum post ci golgi compartment active enzyme
0.33943188.11502763.html.plaintext.txt	171	implies addition activation presenilinase additional protein compartment needed make psnum enzymatically active b psnum actually secretase act probably concert protein er intermediate compartment dispatch app secretase subcellular compartment cleavage occur
0.33943188.11502763.html.plaintext.txt	172	hypothesis bfa treatment result relocalization catalytic subunit secretase er
0.33943188.11502763.html.plaintext.txt	173	support first hypothesis evidence presence minute amount psnum compartment er provided
0.33943188.11502763.html.plaintext.txt	174	study specificity antibody used questioned dewji singer num polarized cell type like mdck cell georgakopoulos et al
0.33943188.11502763.html.plaintext.txt	175	num specialized cell membrane like growth cone lamellipodia schwarzman et al
0.33943188.11502763.html.plaintext.txt	176	num psnum seems located near cell surface
0.33943188.11502763.html.plaintext.txt	177	num provided evidence psnum travel complex notch cell surface albeit conclusion based single type experimental approach
0.33943188.11502763.html.plaintext.txt	178	furthermore hypothesis p travel together substrate er cell surface becomes activated probably tenable one take account relative amount psnum substrate extremely low thinakaran et al
0.33943188.11502763.html.plaintext.txt	179	psnum need accompany every substrate cleave er cell surface becomes given limited amount p available cell type difficult understand strong overexpression app saturate system lead inefficient secretase processing
0.33943188.11502763.html.plaintext.txt	180	although remains impossible exclude minute amount psnum endosomes cell surface active enzyme clear hypothesis raise several new question need addressed
0.33943188.11502763.html.plaintext.txt	181	addition function inactive pool psnum er also remains explained
0.33943188.11502763.html.plaintext.txt	182	bfa experiment follows least one component non er compartment needed obtain activated psnum
0.33943188.11502763.html.plaintext.txt	183	component elusive protease called presenilinase responsible p maturation probably nicastrin since protein present er yu et al
0.33943188.11502763.html.plaintext.txt	184	second hypothesis psnum needed correct trafficking secretase substrate find theoretical support analogy sterol regulatory element binding protein srebp screb cleavage activating protein scap complex regulation proteolytical cleavage srebp brown et al
0.33943188.11502763.html.plaintext.txt	185	scap like psnum er resident multitransmembrane domain containing protein regulates trafficking membrane bound transcription factor srebp post er compartment
0.33943188.11502763.html.plaintext.txt	186	upon cholesterol depletion srebp travel ci golgi site num protease cleaves srebp luminal domain
0.33943188.11502763.html.plaintext.txt	187	remaining nhnum terminal membrane bound fragment becomes substrate site num protease cleaves transmembrane domain srebp rawson et al
0.33943188.11502763.html.plaintext.txt	188	coupling vesicular protein transport proteolysis provides stringent control activation system could envisaged psnum like scap provides similar control app notch processing
0.33943188.11502763.html.plaintext.txt	189	however pointed case srebp processing scap regulates luminal cleavage site num intramembraneous cleavage occurs default
0.33943188.11502763.html.plaintext.txt	190	case psnum role limited regulation intramembraneous secretase cleavage de strooper et al
0.33943188.11502763.html.plaintext.txt	191	conclusion data indicate complex relationship app trafficking processing secretase
0.33943188.11502763.html.plaintext.txt	192	moreover directly question exact role psnum secretase processing demonstrate least one cofactor first hypothesis protease second hypothesis located compartment downstream er
0.33943188.11502763.html.plaintext.txt	193	future reconstitution secretase processing app mixing extract purified er fraction post er compartment allow u define molecular level highly intriguing proteolytic system
0.33943188.11502763.html.plaintext.txt	194	semliki forest virus sfv construct following modification made cdna coding human appnum fig
0.33943188.11502763.html.plaintext.txt	195	num deletion last num amino acid cytoplasmic tail app ct described tienari et al
0.33943188.11502763.html.plaintext.txt	196	num b addition di lysine motif qm mutated kk app kk site directed mutagenesis stratagene c exchange cytoplasmic domain ldl receptor app ldl d full deletion app ectodomain aspnum amino acid amyloid peptide region s secretase site
0.33943188.11502763.html.plaintext.txt	197	additional aspala da cloned site directed mutagenesis stratagene last amino acid signal sequence ala first as region lichtenthaler et al
0.33943188.11502763.html.plaintext.txt	198	site directed mutagenesis used add di lysine motif app cnum kk
0.33943188.11502763.html.plaintext.txt	199	recombinant sfv containing app mutant generated described previously de strooper et al
0.33943188.11502763.html.plaintext.txt	200	transduction metabolic labeling neuronal cell culture recombinant sfv diluted num fold neurobasal medium added culture dish
0.33943188.11502763.html.plaintext.txt	201	num h incubation num degree c fresh neurobasal medium added
0.33943188.11502763.html.plaintext.txt	202	num h cell metabolically labeled methionine free mem gibco brl supplemented bnum num microciml numsmethionine icn biomedicals
0.33943188.11502763.html.plaintext.txt	203	num microm bfa epicentre added indicated
0.33943188.11502763.html.plaintext.txt	204	num h conditioned medium cell recovered
0.33943188.11502763.html.plaintext.txt	205	cell lysed ip buffer num mm tris hcl ph num
0.33943188.11502763.html.plaintext.txt	206	num num mm nacl num triton x num num sodium deoxycholate num
0.33943188.11502763.html.plaintext.txt	207	num sd cleared centrifugation
0.33943188.11502763.html.plaintext.txt	208	labeled protein immunoprecipitated using num microl protein g sepharose specific antibody indicated fig
0.33943188.11502763.html.plaintext.txt	209	immunoprecipitates finally solubilized num microl nu page sample buffer invitrogen electrophoresed num num num acrylamide nupage bi tris gel reducing condition me running buffer invitrogen
0.33943188.11502763.html.plaintext.txt	210	result analyzed using phosphorimager molecular dynamic imagquantnum
0.33943188.11502763.html.plaintext.txt	211	data normalized value obtained corresponding app holoform normalize variation culture dish
0.33943188.11502763.html.plaintext.txt	212	following antibody used fig
0.33943188.11502763.html.plaintext.txt	213	rabbit pab bnum recognizes first num amino acid as bnum last num amino acid app cooh terminal domain de strooper et al
0.33943188.11502763.html.plaintext.txt	214	num goat pab num app ectodomain provided dr
0.33943188.11502763.html.plaintext.txt	215	west chester pa mab numgnum senetek amino acid num num as mab wnum num nhnum terminal region as provided dr
0.33943188.11502763.html.plaintext.txt	216	tobias hartmann konrad beyreuther university heidelberg heidelberg germany ida et al
0.33943188.11502763.html.plaintext.txt	217	antibody fcanum fcanum specifically precipitate as peptide ending residue num num num num provided dr
0.33943188.11502763.html.plaintext.txt	218	checler institut de pharmacologie moleculaire et cellulaire valbonne france barelli et al
0.33943188.11502763.html.plaintext.txt	219	quantification assnum peptide elisa level assnum conditioned medium cell lysates quantified sandwich elisa test de strooper et al
0.33943188.11502763.html.plaintext.txt	220	num according published protocol vanderstichele et al
0.33943188.11502763.html.plaintext.txt	221	brief sample dried speed vacuum savant resuspended num microl sample diluent incubated num well elisa plate precoated mab numdnum as
0.33943188.11502763.html.plaintext.txt	222	washing sample incubated biotin labeled anti assnum antibody mab numfnum recognizes final two amino acid assnum sequence followed streptavidine hrp
0.33943188.11502763.html.plaintext.txt	223	adding hrp substrate sample measured spectrophotometrically using victornum wallac num nm filter
0.33943188.11502763.html.plaintext.txt	224	assnum concentration sample calculated based assnum standard sigmoid curve equation using prism num
0.33943188.11502763.html.plaintext.txt	225	confocal microscopy hippocampal neuron grown poly l lysine coated glass coverslips presence glial feeder layer goslin banker num de strooper et al
0.33943188.11502763.html.plaintext.txt	226	num transduced sfv app cnum cnumkk
0.33943188.11502763.html.plaintext.txt	227	num h transduction cycloheximide num microgml added block protein synthesis
0.33943188.11502763.html.plaintext.txt	228	num h neuron fixed num mm phosphate buffer containing num paraformaldehyde ph num
0.33943188.11502763.html.plaintext.txt	229	num num sucrose permeabilized ice cold methanol acetone immunostained annaert et al
0.33943188.11502763.html.plaintext.txt	230	recombinant app cnum detected pab num gift dr
0.33943188.11502763.html.plaintext.txt	231	haass university munchen germany mab numdnum gift dr
0.33943188.11502763.html.plaintext.txt	232	seubert elan pharmaceutical san francisco ca
0.33943188.11502763.html.plaintext.txt	233	mabs bip purchased sigma
0.33943188.11502763.html.plaintext.txt	234	num used detect endogenous psnum annaert et al
0.33943188.11502763.html.plaintext.txt	235	intermediate compartment golgi region identified using anti ergic num provided dr
0.33943188.11502763.html.plaintext.txt	236	saraste university bergen norway anti gmnum transduction laboratory respectively
0.33943188.11502763.html.plaintext.txt	237	alexa num alexa num conjugated secondary antibody molecular probe
0.33943188.11502763.html.plaintext.txt	238	biorad mrcnum confocal microscope adobe photoshop num
0.33943188.11502763.html.plaintext.txt	239	num used final processing annaert et al
0.33943188.11502763.html.plaintext.txt	240	footnote abbreviation used paper as amyloid peptide app amyloid precursor protein bfa brefeldin ctf cooh terminal fragment kk dilysine pab polyclonal antibody p presenilin scap screb cleavage activating protein sfv semliki forest virus screb sterol regulatory element binding protein
0.33943188.11502763.html.plaintext.txt	241	acknowledgment author acknowledge dr
0.33943188.11502763.html.plaintext.txt	242	seubert elan pharmaceutical dr
0.33943188.11502763.html.plaintext.txt	243	hartmann university heidelberg germany dr
0.33943188.11502763.html.plaintext.txt	244	haass university munchen germany dr
0.33943188.11502763.html.plaintext.txt	245	savage cephalon west chester pa dr
0.33943188.11502763.html.plaintext.txt	246	saraste university bergen bergen norway providing u valuable antibody
0.33943188.11502763.html.plaintext.txt	247	tienari embl heidelberg germany providing u app ct construct
0.33943188.11502763.html.plaintext.txt	248	work financially supported f
0.33943188.11502763.html.plaintext.txt	249	leuven flanders interuniversity institute biotechnology bayer alzheimer disease research network barn
0.33943188.11502763.html.plaintext.txt	250	annaert holder fonds voor wetenschappelijik onderzoek postdoctoral fellowship
0.33943188.11502763.html.plaintext.txt	251	submitted num april numrevised num june numaccepted num july num
0.33943188.11502763.html.plaintext.txt	252	presenilins molecular switch proteolysis signal transduction
0.33943188.11502763.html.plaintext.txt	253	presenilin num control secretase processing amyloid precursor protein pre golgi compartment hippocampal neuron
0.33943188.11502763.html.plaintext.txt	254	characterization new polyclonal antibody specific num num amino acid long amyloid s peptide use examine cell biology presenilins immunohistochemistry sporadic alzheimers disease cerebral amyloid angiopathy case
0.33943188.11502763.html.plaintext.txt	255	novel proteolytic cleavage involved notch signaling role disintegrin metalloprotease tace
0.33943188.11502763.html.plaintext.txt	256	regulated intramembrane proteolysis control mechanism conserved bacteria human
0.33943188.11502763.html.plaintext.txt	257	evidence tumor necrosis factor converting enzyme involved regulated secretase cleavage alzheimer amyloid protein precursor
0.33943188.11502763.html.plaintext.txt	258	novel s secretase cleavage s amyloid precursor protein endoplasmic reticulumintermediate compartment ntnumn cell
0.33943188.11502763.html.plaintext.txt	259	alzheimers ssnum num generated endoplasmic reticulumintermediate compartment ntnumn cell
0.33943188.11502763.html.plaintext.txt	260	processing s secretase bace furin member proprotein convertase family
0.33943188.11502763.html.plaintext.txt	261	alzheimers disease associated presenilin num neuronal cell evidence localization endoplasmic reticulum golgi intermediate compartment
0.33943188.11502763.html.plaintext.txt	262	production intracellular amyloid containing fragment hippocampal neuron expressing human amyloid precursor protein protection amyloidogenesis subtle amino acid substitution rodent sequence
0.33943188.11502763.html.plaintext.txt	263	deficiency presenilin num inhibits normal cleavage amyloid precursor protein
0.33943188.11502763.html.plaintext.txt	264	presenilin num dependent secretase like protease mediates release notch intracellular domain
0.33943188.11502763.html.plaintext.txt	265	cell surface expression alzheimer disease related presenilin protein
0.33943188.11502763.html.plaintext.txt	266	transition state analogue inhibitor secretase bind directly presenilin num
0.33943188.11502763.html.plaintext.txt	267	signal mediated retrieval membrane protein golgi er yeast
0.33943188.11502763.html.plaintext.txt	268	presenilin num form complex cadherincatenin cell cell adhesion system recruited intercellular synaptic contact
0.33943188.11502763.html.plaintext.txt	269	rat hippocampal neuron low density culture
0.33943188.11502763.html.plaintext.txt	270	distinct site intracellular production alzheimers disease ssnumnum amyloid peptide
0.33943188.11502763.html.plaintext.txt	271	total inactivation secretase activity presenilin deficient embryonic stem cell
0.33943188.11502763.html.plaintext.txt	272	analysis heterogeneous anum peptide human cerebrospinal fluid blood newly developed sensitive western blot assay
0.33943188.11502763.html.plaintext.txt	273	subcellular compartment molecular subdomain s amyloid precursor protein relevant abeta num promoting effect alzheimer mutant presenilin num
0.33943188.11502763.html.plaintext.txt	274	retrieval transmembrane protein endoplasmic reticulum
0.33943188.11502763.html.plaintext.txt	275	subcellular localization presenilins association unique membrane pool cultured cell
0.33943188.11502763.html.plaintext.txt	276	membrane anchored metalloprotease mdcnum secretase activity responsible processing amyloid precursor protein
0.33943188.11502763.html.plaintext.txt	277	evidence production release amyloid s protein involves endocytic pathway
0.33943188.11502763.html.plaintext.txt	278	constitutive regulated secretase cleavage alzheimers amyloid precursor protein disintegrin metalloprotease
0.33943188.11502763.html.plaintext.txt	279	photoactivated secretase inhibitor directed active site covalently label presenilin num
0.33943188.11502763.html.plaintext.txt	280	novel substrate analyzing alzheimers disease secretase
0.33943188.11502763.html.plaintext.txt	281	rapid redistribution golgi protein er cell treated brefeldin evidence membrane cycling golgi er
0.33943188.11502763.html.plaintext.txt	282	retention alzheimers amyloid precursor protein fragment cnum endoplasmic reticulum prevents formation amyloid s peptide
0.33943188.11502763.html.plaintext.txt	283	ligand induced extracellular cleavage regulates secretase like proteolytic activation notchnum
0.33943188.11502763.html.plaintext.txt	284	effect psnum deficiency membrane protein trafficking neuron
0.33943188.11502763.html.plaintext.txt	285	sterol regulate cycling srebp cleavage activating protein scap endoplasmic reticulum golgi
0.33943188.11502763.html.plaintext.txt	286	late compartment amyloid precursor protein transport synumy cell involved s amyloid secretion
0.33943188.11502763.html.plaintext.txt	287	mutagenesis identifies new signal s amyloid precursor protein endocytosis turnover generation secreted fragment including assnum
0.33943188.11502763.html.plaintext.txt	288	complementation cloning snump gene encoding putative metalloprotease required intramembrane cleavage srebps
0.33943188.11502763.html.plaintext.txt	289	cell surface presenilin num participates secretase like proteolysis notch
0.33943188.11502763.html.plaintext.txt	290	endogenous presenilin num redistributes surface lamellipodia upon adhesion jurkat cell collagen matrix
0.33943188.11502763.html.plaintext.txt	291	presenilin num num molecular target secretase inhibitor
0.33943188.11502763.html.plaintext.txt	292	translating cell biology therapeutic advance alzheimers disease
0.33943188.11502763.html.plaintext.txt	293	s amyloid precursor protein cleavage membrane bound protease
0.33943188.11502763.html.plaintext.txt	294	proteolytic release nuclear translocation notch num induced presenilin num impaired pathogenic presenilin num mutation
0.33943188.11502763.html.plaintext.txt	295	loss function mutation presenilin num interferes amyloid s peptide production notch signaling
0.33943188.11502763.html.plaintext.txt	296	glycine num required presenilin num function conserved bacterial polytopic aspartyl protease
0.33943188.11502763.html.plaintext.txt	297	requirement presenilin dependent cleavage notch transmembrane protein
0.33943188.11502763.html.plaintext.txt	298	presenilin required activity nuclear access notch drosophila
0.33943188.11502763.html.plaintext.txt	299	stable association presenilin derivative absence presenilin interaction app
0.33943188.11502763.html.plaintext.txt	300	s amyloid domain essential axonal sorting amyloid precursor protein
0.33943188.11502763.html.plaintext.txt	301	intracellular secreted alzheimer s amyloid specie generated distinct mechanism cultured hippocampal neuron
0.33943188.11502763.html.plaintext.txt	302	standardization measurement s amyloidnum num cerebrospinal fluid plasma
0.33943188.11502763.html.plaintext.txt	303	s secretase cleavage alzheimers amyloid precursor protein transmembrane aspartic protease bace
0.33943188.11502763.html.plaintext.txt	304	alzheimers disease associated presenilins differentially phosphorylated protein located predominantly within endoplasmic reticulum
0.33943188.11502763.html.plaintext.txt	305	intracellular generation accumulation amyloid s peptide terminating amino acid num
0.33943188.11502763.html.plaintext.txt	306	two transmembrane aspartates presenilin num required presenelin endoproteolysis secretase activity
0.33943188.11502763.html.plaintext.txt	307	nicastrin modulates presenilin mediated notchglp num signal transduction ssapp processing
0.33943188.11502763.html.plaintext.txt	308	presenilins required secretase cleavage s app transmembrane cleavage notch num
0.34432584.9115271.html.plaintext.txt	0	evidence six transmembrane domain structure presenilin num
0.34432584.9115271.html.plaintext.txt	1	received publication february num num revised form march num num
0.34432584.9115271.html.plaintext.txt	2	sylvain lehmann roberto chiesa david
0.34432584.9115271.html.plaintext.txt	3	mutation gene encoding presenilin num presenilin num account majority case early onset familial alzheimers disease
0.34432584.9115271.html.plaintext.txt	4	presenilins localized endoplasmic reticulum golgi multiple hydrophobic segment polypeptide chain span lipid bilayer unclear
0.34432584.9115271.html.plaintext.txt	5	address question constructed series chimeric molecule topologically neutral reporter protein c terminal fragment prolactin containing three artificial glycosylation site fused presenilin num following num potential transmembrane domain identified hydrophobicity plot
0.34432584.9115271.html.plaintext.txt	6	expressed chimera translation reticulocyte lysate containing canine pancreatic microsome synthesis transfected co cell
0.34432584.9115271.html.plaintext.txt	7	based utilization glycosylation site sensitivity reporter protease digestion provide evidence presenilin num six transmembrane segment n c terminus cytoplasm
0.34432584.9115271.html.plaintext.txt	8	model provides important clue potential function different part presenilin molecule might relate pathogenesis alzheimers disease
0.34432584.9115271.html.plaintext.txt	9	alzheimers disease adnum debilitating neurodegenerative disorder characterized dementia neuronal loss accumulation brain extracellular amyloid plaque intraneuronal neurofibrillary tangle num
0.34432584.9115271.html.plaintext.txt	10	familial form ad linked mutation three different gene encoding amyloid precursor protein app presenilin num psnum presenilin num psnum chromosome num num num respectively num num
0.34432584.9115271.html.plaintext.txt	11	num case early onset familial ad attributable mutation presenilin gene
0.34432584.9115271.html.plaintext.txt	12	mutation described include num different amino acid substitution well frame deletion exon num reviewed ref
0.34432584.9115271.html.plaintext.txt	13	psnum psnum polypeptide num num amino acid respectively multiple hydrophobic segment num num num
0.34432584.9115271.html.plaintext.txt	14	protein expressed number tissue addition brain encoded several alternatively spliced mrna num num num
0.34432584.9115271.html.plaintext.txt	15	presenilins exhibit significant homology protein caenorhabditis elegans called sel num based genetic evidence modulates signaling lin numnotch pathway num
0.34432584.9115271.html.plaintext.txt	16	show weaker homology spe num membrane protein c
0.34432584.9115271.html.plaintext.txt	17	immunofluorescence localization study transfected cell indicate protein present steady state primarily er perhaps golgi also probably plasma membrane num
0.34432584.9115271.html.plaintext.txt	18	neuronal cell line psnum expressed using viral vector localized cell body dendrite num
0.34432584.9115271.html.plaintext.txt	19	recent evidence indicates psnum proteolytically cleaved amino acid num num transfected cell well brain tissue although significance cleavage unclear num
0.34432584.9115271.html.plaintext.txt	20	report recombinant form psnum positively regulate apoptosis lymphocyte pcnum cell whether endogenous protein normally function way unclear num num
0.34432584.9115271.html.plaintext.txt	21	taken together none available evidence clearly identifies physiological role presenilins
0.34432584.9115271.html.plaintext.txt	22	however analysis patient fibroblast transfected cell transgenic mouse co express psnum app indicate pathogenic mutation presenilin protein enhance production amyloidgenic anum fragment num
0.34432584.9115271.html.plaintext.txt	23	determination membrane topology presenilins word defining part polypeptide chain traverse lipid bilayer enormous importance understanding function protein role ad
0.34432584.9115271.html.plaintext.txt	24	several reason
0.34432584.9115271.html.plaintext.txt	25	first knowing domain polypeptide lie cytoplasm lumen er golgi dictate hypothesis function domain
0.34432584.9115271.html.plaintext.txt	26	second experimental attempt identify cytoplasmic protein interact presenilins using screening procedure yeast two hybrid system interaction cloning require knowledge segment polypeptide chain lie cytoplasm
0.34432584.9115271.html.plaintext.txt	27	third membrane topology presenilins correlated position pathogenic mutation providing clue mutation alter function protein
0.34432584.9115271.html.plaintext.txt	28	finally knowledge membrane topology presenilins allow detailed comparison possible homologues possible simply basis hydrophobicity plot
0.34432584.9115271.html.plaintext.txt	29	report analysis membrane topology psnum using vitro vivo expression system
0.34432584.9115271.html.plaintext.txt	30	result suggest protein span membrane six time n c terminus located cytoplasm
0.34432584.9115271.html.plaintext.txt	31	model stand marked contrast one originally proposed basis hydrophobicity plot hypothesized either seven nine transmembrane domain psnum psnum num num num num
0.34432584.9115271.html.plaintext.txt	32	conclusion consistent significantly extend recent report suggesting psnum posse either six eight transmembrane segment num differ second study proposing eight transmembrane topology presenilin homologue sel num num
0.34432584.9115271.html.plaintext.txt	33	psnum segment hr prl chimera generated pcr using template psnum cdna derived rna splice variant lacking exon num encodes sequence vsrq provided dr
0.34432584.9115271.html.plaintext.txt	34	num primer gatcaggaattcatgacagagttacctgcaccg
0.34432584.9115271.html.plaintext.txt	35	num primer consisted sequence gactagggtaaccaa followed complement sequence encoding following amino acid num num hrnum prl num num hrnum prl num num hrnum prl num num hrnum prl num num hrnum prl num num hrnum prl num num hrnum prl num num hrnum prl num num hrnum prl num num hrnum prl
0.34432584.9115271.html.plaintext.txt	36	reporter segment chimera generated amplification num c terminal amino acid bovine prolactin using template pbpnum american type culture collection
0.34432584.9115271.html.plaintext.txt	37	num primer gatcaggaattcgatcttggttaccatggccctcaacagctgccat
0.34432584.9115271.html.plaintext.txt	38	num primer encoded three consensus site n glycosylation ha tag sequence ctgctatctagactatgcgtaatctggaacatcgtatgggtacatagttccgttcatggatccgttagtgcagttgttgttgtagatgat
0.34432584.9115271.html.plaintext.txt	39	psnum fragment digested ecori bsteii reporter fragment bsteii xbai
0.34432584.9115271.html.plaintext.txt	40	fragment ligated ecori xbai digested pcdnanum invitrogen
0.34432584.9115271.html.plaintext.txt	41	construct sequenced entirety
0.34432584.9115271.html.plaintext.txt	42	vitro transcription translation
0.34432584.9115271.html.plaintext.txt	43	plasmid linearized xbai capped mrna synthesized tnum rna polymerase using kit ambion
0.34432584.9115271.html.plaintext.txt	44	rabbit reticulocyte lysate canine pancreatic microsome obtained promega used translate mrna presence numsmethionine described manufacturer
0.34432584.9115271.html.plaintext.txt	45	proteinase k treatment translation reaction performed final concentration num microgml num h ice presence absence num
0.34432584.9115271.html.plaintext.txt	46	num triton x num followed inactivation protease num mm phenylmethylsulfonyl fluoride
0.34432584.9115271.html.plaintext.txt	47	num microl translation reaction added num microl lysis buffer num mm nacl num mm tris ph num
0.34432584.9115271.html.plaintext.txt	48	num sd supplemented protease inhibitor pepstatin leupeptin num microgml phenylmethylsulfonyl fluoride num
0.34432584.9115271.html.plaintext.txt	49	num min num degree c num microl dilution buffer num mm nacl num
0.34432584.9115271.html.plaintext.txt	50	num triton x num containing protease inhibitor added sample precleared protein sepharose bead
0.34432584.9115271.html.plaintext.txt	51	supernatant incubated one following rabbit antibody anti ha babco anti bovine prolactin dr
0.34432584.9115271.html.plaintext.txt	52	parlow anti psnum prepared dr
0.34432584.9115271.html.plaintext.txt	53	jeanne nerbonne synthetic peptide encompassing residue num num
0.34432584.9115271.html.plaintext.txt	54	immunocomplexes collected protein sepharose bead analyzed sd page autoradiography
0.34432584.9115271.html.plaintext.txt	55	sample heated num degree c num min prior sd page since boiling result aggregation psnum protein num
0.34432584.9115271.html.plaintext.txt	56	co num cell grown dulbeccos modified eagle medium containing num fetal calf serum num mm pyruvate penicillinstreptomycin atmosphere num cnum num air
0.34432584.9115271.html.plaintext.txt	57	cell transfected lipofectamine life technology inc
0.34432584.9115271.html.plaintext.txt	58	according manufacturer direction num h later labeled num h numsmethionine
0.34432584.9115271.html.plaintext.txt	59	labeled culture extracted lysis buffer psnum prl protein immunoprecipitated anti ha antibody described
0.34432584.9115271.html.plaintext.txt	60	protease digestion experiment labeled cell collected phosphate buffered saline gently homogenized passage eight time num
0.34432584.9115271.html.plaintext.txt	61	num mm diameter plastic tubing attached end num gauge needle syringe
0.34432584.9115271.html.plaintext.txt	62	centrifugation num x g num min postnuclear supernatant treated proteinase k presence absence triton x num protein immunoprecipitated described
0.34432584.9115271.html.plaintext.txt	63	addition lysis dilution buffer described reticulocyte lysate treated num
0.34432584.9115271.html.plaintext.txt	64	num unitml n glycosidase f boehringer mannheim num h num degree c
0.34432584.9115271.html.plaintext.txt	65	protein precipitated num volume methanol analyzed sd page autoradiography
0.34432584.9115271.html.plaintext.txt	66	diluted lysates co cell treated num
0.34432584.9115271.html.plaintext.txt	67	num unitml enzyme num h num degree c prior immunoprecipitation
0.34432584.9115271.html.plaintext.txt	68	hydrophobicity plot identify num segment least num amino acid sequence psnum could potentially span membrane fig
0.34432584.9115271.html.plaintext.txt	69	constructed chimera prolactin reporter fused hydrophobic region fig
0.34432584.9115271.html.plaintext.txt	70	reporter c terminal fragment bovine prolactin residue num num onto appended three consensus site n glycosylation well ha tag protein recognized anti ha well anti prolactin antibody
0.34432584.9115271.html.plaintext.txt	71	number study utilized portion prolactin reporter since lack signal might influence membrane orientation adjacent polypeptide num num
0.34432584.9115271.html.plaintext.txt	72	fusion protein synthesized membrane attached ribosome reporter glycosylated protected protease applied cytoplasmic surface resides lumen er topologically equivalent extracellular space
0.34432584.9115271.html.plaintext.txt	73	two technique combined tagging protein artificial glycosylation site fusing reporter molecule recognized antibody binding enzymatic activity used individually map topology number membrane protein num num
0.34432584.9115271.html.plaintext.txt	74	recognize although technique provide evidence support specific model membrane topology always possible experimental modification polypeptide chain may perturb interaction lipid bilayer
0.34432584.9115271.html.plaintext.txt	75	hydrophobicity plot psnum schematic illustration fusion construct
0.34432584.9115271.html.plaintext.txt	76	panel hydrophobicity plot human psnum
0.34432584.9115271.html.plaintext.txt	77	method kyte doolittle num used window size num residue
0.34432584.9115271.html.plaintext.txt	78	amino acid position bounding num hydrophobic region hr follows hrnum num num hrnum num num hrnum num num hrnum num num hrnum num num hrnum num num hrnum num num hrnum num num hrnum num num hrnum num num
0.34432584.9115271.html.plaintext.txt	79	numbering based rna splice variant lack exon num encoding sequence vrsq ref
0.34432584.9115271.html.plaintext.txt	80	panel b psnum prolactin fusion protein
0.34432584.9115271.html.plaintext.txt	81	prolactin prl reporter fused following residue psnum hrnum num hrnum num hrnum num hrnum num hrnum num hrnum num hrnum num hrnum num hrnum num hrnum num
0.34432584.9115271.html.plaintext.txt	82	fusion point construct positioned c terminal possible minimize effect reporter topology adjacent hydrophobic region
0.34432584.9115271.html.plaintext.txt	83	nctngsngt three artificial glycosylation site ha hemagglutinin tag engineered c terminus prolactin reporter
0.34432584.9115271.html.plaintext.txt	84	view larger version image numk gif file
0.34432584.9115271.html.plaintext.txt	85	first translated synthetic mrna encoding psnum prolactin chimera reticulocyte lysate system
0.34432584.9115271.html.plaintext.txt	86	absence canine pancreatic microsome protein ranging size num num kda recovered immunoprecipitation anti ha antibody corresponding unglycosylated fusion protein fig
0.34432584.9115271.html.plaintext.txt	87	translation performed presence microsome hrnum prl hrnum prl hrnum prl construct yielded additional product slightly higher molecular weight fig
0.34432584.9115271.html.plaintext.txt	88	larger product represent glycosylated form protein since eliminated sample treated n glycosidase f fig
0.34432584.9115271.html.plaintext.txt	89	observed others num num glycosylation vitro system inefficient resulting presence unglycosylated protein even translation performed microsome fig
0.34432584.9115271.html.plaintext.txt	90	noted psnum prl fusion protein often migrated closely spaced doublet sd page see fig
0.34432584.9115271.html.plaintext.txt	91	numb lane num num phenomenon observed full length psnum synthesized vitro transfected cell likely result uncharacterized posttranslational modification num num num
0.34432584.9115271.html.plaintext.txt	92	vitro translation psnum prolactin chimera
0.34432584.9115271.html.plaintext.txt	93	panel mrna encoding hr prl construct shown fig
0.34432584.9115271.html.plaintext.txt	94	numb translated reticulocyte lysate absence lane num presence lane num num num canine pancreatic microsome
0.34432584.9115271.html.plaintext.txt	95	sample left untreated lane num num digested proteinase k absence lane num presence lane num triton x num
0.34432584.9115271.html.plaintext.txt	96	sample immunoprecipitated anti ha antibody
0.34432584.9115271.html.plaintext.txt	97	unglycosylated fusion protein indicated filled arrowhead glycosylated form open arrowhead protease protected fragment asterisk
0.34432584.9115271.html.plaintext.txt	98	protease protected fragment like intact fusion protein sometimes migrated doublet unknown posttranslational modification described text see lane num hrnum
0.34432584.9115271.html.plaintext.txt	99	molecular mass marker kilodaltons
0.34432584.9115271.html.plaintext.txt	100	panel b mrna encoding hrnum prl hrnum prl hrnum prl translated reticulocyte lysate absence lane num num presence lane num num canine pancreatic microsome
0.34432584.9115271.html.plaintext.txt	101	sample left untreated lane num num digested n glycosidase f remove n linked sugar lane num num
0.34432584.9115271.html.plaintext.txt	102	protein analyzed without immunoprecipitation avoid distortion gel band immunoglobulin
0.34432584.9115271.html.plaintext.txt	103	arrowhead mark position glycosylated form fusion protein
0.34432584.9115271.html.plaintext.txt	104	similar analysis num chimera showed glycosylated shown
0.34432584.9115271.html.plaintext.txt	105	view larger version image numk gif file
0.34432584.9115271.html.plaintext.txt	106	hrnum prl hrnum prl hrnum prl also three chimera produced protected fragment reactive anti ha antibody treatment microsome containing translation mixture proteinase k fig
0.34432584.9115271.html.plaintext.txt	107	protected fragment glycosylated shown migrated approximately num kda lower corresponding intact glycosylated protein fig
0.34432584.9115271.html.plaintext.txt	108	fragment eliminated microsome permeabilized triton x num prior protease digestion fig
0.34432584.9115271.html.plaintext.txt	109	numa lane num demonstrating represent intrinsically protease resistant portion molecule
0.34432584.9115271.html.plaintext.txt	110	protected fragment could immunoprecipitated anti prolactin well anti ha antibody antibody n terminus psnum fig
0.34432584.9115271.html.plaintext.txt	111	num lane num num indicating n terminus protease accessible therefore cytoplasmic
0.34432584.9115271.html.plaintext.txt	112	based num kda reduction molecular size infer proteinase k remove approximately num amino acid n terminus hrnum hrnum hrnum prl point near beginning hrnum cytoplasmic loop transmembrane hydrophobic segment resistant cleavage probably short num amino acid therefore closely apposed lipid bilayer num
0.34432584.9115271.html.plaintext.txt	113	antibody reactivity protease protected fragment generated vitro translation
0.34432584.9115271.html.plaintext.txt	114	mrna encoding hrnum prl hrnum prl hrnum prl translated reticulocyte lysate presence canine pancreatic microsome left untreated lane num num digested proteinase k lane num num
0.34432584.9115271.html.plaintext.txt	115	sample immunoprecipitated either anti prolactin antibody lane num num antibody raised psnum residue num num lane num num
0.34432584.9115271.html.plaintext.txt	116	view larger version image numk gif file
0.34432584.9115271.html.plaintext.txt	117	confirm vitro translation result intact cell expressed psnum prl fusion protein co cell
0.34432584.9115271.html.plaintext.txt	118	observed hrnum hrnum hrnum prl glycosylated indicated reduction molecular weight protein upon treatment n glycosidase f fig
0.34432584.9115271.html.plaintext.txt	119	contrast situation reticulocyte lysate glycosylation chimera co cell essentially quantitative making unlikely protein heterogeneous respect localization reporter
0.34432584.9115271.html.plaintext.txt	120	three fusion protein also produce protected fragment num kda smaller intact protein following proteinase k digestion postnuclear supernatant derived transfected cell fig
0.34432584.9115271.html.plaintext.txt	121	numb seven fusion protein yield protected fragment data shown
0.34432584.9115271.html.plaintext.txt	122	result similar shown fig
0.34432584.9115271.html.plaintext.txt	123	num also obtained transfected chinese hamster ovary cell shown
0.34432584.9115271.html.plaintext.txt	124	expression psnum prl fusion protein co cell
0.34432584.9115271.html.plaintext.txt	125	panel fusion protein immunoprecipitated anti ha antibody metabolically labeled co cell transiently transfected plasmid encoding hrnum hrnum prl
0.34432584.9115271.html.plaintext.txt	126	prior immunoprecipitation cell lysates either left untreated lane digested n glycosidase f lane
0.34432584.9115271.html.plaintext.txt	127	panel b postnuclear supernatant prepared metabolically labeled co cell expressing hrnum hrnum hrnum prl either left untreated lane num digested proteinase k absence lane num presence triton x num lane num
0.34432584.9115271.html.plaintext.txt	128	fusion protein immunoprecipitated anti ha antibody
0.34432584.9115271.html.plaintext.txt	129	arrowhead mark position protease protected fragment
0.34432584.9115271.html.plaintext.txt	130	view larger version image numk gif file
0.34432584.9115271.html.plaintext.txt	131	taken together result glycosylation site utilization protease protection vitro cell suggest model psnum topology shown fig
0.34432584.9115271.html.plaintext.txt	132	hrnum hrnum hrnum span membrane cytoplasmic lumenal side hrnum hrnum hrnum lumenal cytoplasmic side
0.34432584.9115271.html.plaintext.txt	133	n c terminus cytoplasmic
0.34432584.9115271.html.plaintext.txt	134	hrnum hrnum constitute transmembrane domain although analysis address issue whether segment associate closely lipid bilayer manner reentrant loop described channel protein num num num
0.34432584.9115271.html.plaintext.txt	135	model place two consensus site n linked glycosylation asparagine residue num num cytoplasm consistent fact full length psnum expressed cell vitro translation glycosylated num num num
0.34432584.9115271.html.plaintext.txt	136	given high degree homology psnum psnum would predict psnum membrane topology shown fig
0.34432584.9115271.html.plaintext.txt	137	although data support six transmembrane domain structure psnum course possible membrane topology native protein different one inferred based property psnum prolactin fusion
0.34432584.9115271.html.plaintext.txt	138	however fusion reporter segment introduction ectopic glycosylation site found disturb topology number membrane protein num num
0.34432584.9115271.html.plaintext.txt	139	model membrane topology psnum
0.34432584.9115271.html.plaintext.txt	140	although data indicate hrnum hrnum span membrane one hydrophobic segment may associate closely lipid bilayer
0.34432584.9115271.html.plaintext.txt	141	view larger version image numk gif file
0.34432584.9115271.html.plaintext.txt	142	result consistent doan et al
0.34432584.9115271.html.plaintext.txt	143	num concluded psnum either six eight transmembrane domain data distinguish two possibility n terminus c terminus part loop region residue num num cytoplasm
0.34432584.9115271.html.plaintext.txt	144	however result differ li greenwald num proposed model c
0.34432584.9115271.html.plaintext.txt	145	elegans psnum homologue sel num eight transmembrane segment including hrnum hrnum hr num hr num
0.34432584.9115271.html.plaintext.txt	146	think unlikely theoretical ground hrnum psnum span membrane since short num amino acid marginally hydrophobic see fig
0.34432584.9115271.html.plaintext.txt	147	identification hrnum hrnum transmembrane segment sel num inferred indirectly enzymatic activity pair galactosidase fusion hrnum deleted possible deletion modified membrane topology protein altered activity galactosidase reporter
0.34432584.9115271.html.plaintext.txt	148	also conceivable membrane topology psnum sel num different
0.34432584.9115271.html.plaintext.txt	149	model topology psnum important implication function protein role ad
0.34432584.9115271.html.plaintext.txt	150	find polypeptide chain psnum cytoplasmic including n terminal region long c terminal tail encompassing hrnum hrnum
0.34432584.9115271.html.plaintext.txt	151	segment may therefore important interaction cytoplasmic protein
0.34432584.9115271.html.plaintext.txt	152	much cytoplasmic region hrnum c terminus exclusive segment hrnum hrnum highly conserved presenilins sel num suggesting essential function domain
0.34432584.9115271.html.plaintext.txt	153	number pathogenic mutation found end hrnum end hrnum reviewed ref
0.34432584.9115271.html.plaintext.txt	154	num one might speculate alter association psnum molecule cytoplasm
0.34432584.9115271.html.plaintext.txt	155	since little polypeptide chain protrudes er lumen direct interaction psnum lumenal protein seems unlikely although association er membrane protein possible
0.34432584.9115271.html.plaintext.txt	156	psnum bind app possibility suggested enhanced production num fragment cell expressing mutant psnum num num interaction would likely occur transiently transit app er golgi would probably involve either transmembrane region short cytoplasmic tail app
0.34432584.9115271.html.plaintext.txt	157	topology model proposed make unlikely psnum function conventional g protein coupled receptor consistent role psnum process vesicle docking budding membrane cytoskeletal interaction ion solute transport
0.34432584.9115271.html.plaintext.txt	158	recently described endoproteolytic cleavage psnum num predicted occur following hrnum would expected generate c terminal fragment lack transmembrane segment
0.34432584.9115271.html.plaintext.txt	159	whether fragment soluble would depend tightly hrnum hrnum associated lipid bilayer diffusible could serve transmit signal region cell
0.34432584.9115271.html.plaintext.txt	160	knowing membrane topology psnum facilitate attempt isolate interacting molecule provide starting point investigation biological activity normal mutant form protein
0.34432584.9115271.html.plaintext.txt	161	thank alison goate psnum cdna jeanne nerbonne athena guo
0.34432584.9115271.html.plaintext.txt	162	parlow antibody jane wu advice automated dna sequencing brendan walsh dung le technical assistance
0.34432584.9115271.html.plaintext.txt	163	also acknowledge maurine linder carl romano member harris laboratory comment manuscript
0.34432584.9115271.html.plaintext.txt	164	ed num research advance alzheimers disease related disorder john wiley son chichester united kingdom levy lahad e
0.34432584.9115271.html.plaintext.txt	165	num science num num num medline order article via infotrieve busfield f
0.34432584.9115271.html.plaintext.txt	166	num pathobiology alzheimers disease goate
0.34432584.9115271.html.plaintext.txt	167	num num academic press san diego ca rogaev e
0.34432584.9115271.html.plaintext.txt	168	num nature num num num crossrefmedline order article via infotrieve sherrington r
0.34432584.9115271.html.plaintext.txt	169	num nature num num num crossrefmedline order article via infotrieve haass c
0.34432584.9115271.html.plaintext.txt	170	num num num medline order article via infotrieve cruts m
0.34432584.9115271.html.plaintext.txt	171	num num num abstract alzheimers disease collaborative group num nat
0.34432584.9115271.html.plaintext.txt	172	num num num medline order article via infotrieve levitan d
0.34432584.9115271.html.plaintext.txt	173	num nature num num num crossrefmedline order article via infotrieve lhernault
0.34432584.9115271.html.plaintext.txt	174	num num num abstract kovacs d
0.34432584.9115271.html.plaintext.txt	175	num num num medline order article via infotrieve cook d
0.34432584.9115271.html.plaintext.txt	176	num num num abstractfree full text thinakaran g
0.34432584.9115271.html.plaintext.txt	177	num neuron num num num medline order article via infotrieve wolozin b
0.34432584.9115271.html.plaintext.txt	178	num science num num num abstractfree full text vito p
0.34432584.9115271.html.plaintext.txt	179	num science num num num abstract citron m
0.34432584.9115271.html.plaintext.txt	180	num num num medline order article via infotrieve borchelt d
0.34432584.9115271.html.plaintext.txt	181	num neuron num num num scheuner d
0.34432584.9115271.html.plaintext.txt	182	num num num medline order article via infotrieve duff k
0.34432584.9115271.html.plaintext.txt	183	num nature num num num crossrefmedline order article via infotrieve slunt h
0.34432584.9115271.html.plaintext.txt	184	num neuron num num num medline order article via infotrieve li x
0.34432584.9115271.html.plaintext.txt	185	num neuron num num num medline order article via infotrieve yamamoto
0.34432584.9115271.html.plaintext.txt	186	num num num crossrefmedline order article via infotrieve rothman r
0.34432584.9115271.html.plaintext.txt	187	num num num abstractfree full text bennett j
0.34432584.9115271.html.plaintext.txt	188	num neuron num num num medline order article via infotrieve chavez r
0.34432584.9115271.html.plaintext.txt	189	num num num abstract hollmann m
0.34432584.9115271.html.plaintext.txt	190	num neuron num num num medline order article via infotrieve hennessey e
0.34432584.9115271.html.plaintext.txt	191	num num num crossref selkoe d
0.34432584.9115271.html.plaintext.txt	192	num neuron num num num medline order article via infotrieve kyte j
0.34432584.9115271.html.plaintext.txt	193	num num num medline order article via infotrieve num american society biochemistry molecular biology inc
0.34448025.16033878.html.plaintext.txt	0	large meta analysis establishes ace insertion deletion polymorphism marker alzheimers disease donald j
0.34448025.16033878.html.plaintext.txt	1	lehmannnum mario cortina borjanum donald r
0.34448025.16033878.html.plaintext.txt	2	david smithnum kristel sleegersnum jonathan
0.34448025.16033878.html.plaintext.txt	3	num oxford project investigate memory ageing optimum department pharmacology university oxford oxford united kingdom num centre paediatric epidemiology biostatistics institute child health university college london london united kingdom num department epidemiology biostatistics erasmus mc rotterdam netherlands num center genomics bioinformatics karolinska institute stockholm sweden num care elderly department clinical science north bristol university bristol frenchay hospital bristol united kingdom
0.34448025.16033878.html.plaintext.txt	4	lehmann university department pharmacology mansfield road oxford oxnum numqt united kingdom e mail donald
0.34448025.16033878.html.plaintext.txt	5	received publication january num num
0.34448025.16033878.html.plaintext.txt	6	accepted publication march num num
0.34448025.16033878.html.plaintext.txt	7	alzheimer disease heterogeneity meta analysis
0.34448025.16033878.html.plaintext.txt	8	abbreviation ace angiotensin converting enzyme protein ace angiotensin converting enzyme gene apoenum apolipoprotein e num allele
0.34448025.16033878.html.plaintext.txt	9	since potential association examined num sample num num table num around world
0.34448025.16033878.html.plaintext.txt	10	several study replicated report increased risk positive contradicted many found association alzheimers disease
0.34448025.16033878.html.plaintext.txt	11	one study suggested effect age association num another proposed influence gender num
0.34448025.16033878.html.plaintext.txt	12	association onset age alzheimers disease also proposed num
0.34448025.16033878.html.plaintext.txt	13	cohort used meta analysis ace insertion deletion polymorphism alzheimers disease
0.34448025.16033878.html.plaintext.txt	14	association recently studied longitudinal observational cohort oxford project investigate memory ageing optimum rotterdam study num
0.34448025.16033878.html.plaintext.txt	15	group found suggestion gender difference result consistent previous report num
0.34448025.16033878.html.plaintext.txt	16	therefore undertook meta analysis study association ace indel alzheimers disease stratified gender age ethnic group apolipoprotein e num allele apoenum carrier status using mainly primary data supplied author
0.34448025.16033878.html.plaintext.txt	17	although three previous meta analysis ace study reported num num subsequent study made data available
0.34448025.16033878.html.plaintext.txt	18	compared even latest meta analysis num num sample eight study available u num num num study oxford project investigate memory ageing
0.34448025.16033878.html.plaintext.txt	19	addition previous meta analysis based published data largely unstratified thus limited interpretation allowed
0.34448025.16033878.html.plaintext.txt	20	using primary data able explore deeply searching source heterogeneity
0.34448025.16033878.html.plaintext.txt	21	two previous stratified meta analysis alzheimers disease gene num num based primary data deepened understanding
0.34448025.16033878.html.plaintext.txt	22	num stressed need examine source heterogeneity meta analysis case control study
0.34448025.16033878.html.plaintext.txt	23	therefore divided analysis two phase first broad overall analysis second detailed examination source heterogeneity
0.34448025.16033878.html.plaintext.txt	24	aimed discover whether ace indel associated alzheimers disease nature association
0.34448025.16033878.html.plaintext.txt	25	phase num examination heterogeneity examined six possible source heterogeneity
0.34448025.16033878.html.plaintext.txt	26	performed analysis stratified age gender apoenum status
0.34448025.16033878.html.plaintext.txt	27	age stratification num year num num year num year divided sample two group according age case defined example onset first group examination death second group
0.34448025.16033878.html.plaintext.txt	28	also conducted analysis restricted control diagnosis probable definite alzheimers disease according criterion consortium establish registry alzheimers disease cerad num national institute neurological communicative disorder stroke alzheimers disease related disorder association nincds adrda num num full sample two part sample
0.34448025.16033878.html.plaintext.txt	29	separate analysis excluded eight sample hardy weinberg analysis genotyping method compatible mistyping
0.34448025.16033878.html.plaintext.txt	30	underreporting heterozygote may occur unless either num percent dimethyl sulfoxide included polymerase chain reaction num dd genotype confirmed insertion specific second amplification num
0.34448025.16033878.html.plaintext.txt	31	analysis sample placed possible num num sample one three ethnic group north european num sample south caucasian num sample defined mediterranean middle east east asian four sample china japan
0.34448025.16033878.html.plaintext.txt	32	data analysis statistical method three method commonly used produce odds ratio genetic association study method num allelic
0.34448025.16033878.html.plaintext.txt	33	case method num comparing genotype one turn e
0.34448025.16033878.html.plaintext.txt	34	di method num comparing genotype turn two combined
0.34448025.16033878.html.plaintext.txt	35	three method subject bias degree bias depending imperfectly model fit reality
0.34448025.16033878.html.plaintext.txt	36	instance method num best suited testing codominant model allelic dose effect e
0.34448025.16033878.html.plaintext.txt	37	method num hand may used test either dominantd recessive d dominanti recessive model
0.34448025.16033878.html.plaintext.txt	38	chose follow hypothesis generating study num using method num partly preliminary examination subsequent study shown evidence codominance
0.34448025.16033878.html.plaintext.txt	39	also used method num num examine heterosis heterozygote greater lesser risk either homozygote
0.34448025.16033878.html.plaintext.txt	40	main approach method num give estimate risk associated genotype compared rest population
0.34448025.16033878.html.plaintext.txt	41	pooled odds ratio calculated three time fixed effect method mantel haenszel num random effect method dersimonian laird num bayesian random effect method warn et al
0.34448025.16033878.html.plaintext.txt	42	however result three method similar first two shown table num
0.34448025.16033878.html.plaintext.txt	43	method meta analysis permit accumulation result across independent study even number subject ratio case control varies considerably cohort sleegers et al
0.34448025.16033878.html.plaintext.txt	44	heterogeneity test method armitage num
0.34448025.16033878.html.plaintext.txt	45	logistic regression analysis used compare odds ratio among ethnic group
0.34448025.16033878.html.plaintext.txt	46	funnel plot num cumulative meta analysis num used investigate bias
0.34448025.16033878.html.plaintext.txt	47	analysis performed using r num package rmeta thomas lumley httpwww
0.34448025.16033878.html.plaintext.txt	48	orgsrccontribdescriptionsrmeta
0.34448025.16033878.html.plaintext.txt	49	test significance two sided
0.34448025.16033878.html.plaintext.txt	50	bonferroni correction factor num applied p value genotype
0.34448025.16033878.html.plaintext.txt	51	odds ratio alzheimers disease ace genotype versus two meta analysis
0.34448025.16033878.html.plaintext.txt	52	view larger version numk figure num
0.34448025.16033878.html.plaintext.txt	53	funnel plot angiotensin converting enzyme gene ace study d homozygote versus di ii p num
0.34448025.16033878.html.plaintext.txt	54	num b homozygote versus di dd p num
0.34448025.16033878.html.plaintext.txt	55	d represents deletion allele represents insertion allele
0.34448025.16033878.html.plaintext.txt	56	horizontal line num confidence interval dashed vertical line summary log odds ratio
0.34448025.16033878.html.plaintext.txt	57	view larger version numk figure num
0.34448025.16033878.html.plaintext.txt	58	cumulative meta analysis odds ratio alzheimers disease aced homozygote versus positive
0.34448025.16033878.html.plaintext.txt	59	d represents deletion allele represents insertion allele
0.34448025.16033878.html.plaintext.txt	60	horizontal line num confidence interval vertical dotted line summary odds ratio
0.34448025.16033878.html.plaintext.txt	61	optimum oxford project investigate memory ageing ace angiotensin converting enzyme gene
0.34448025.16033878.html.plaintext.txt	62	additional study information given table num
0.34448025.16033878.html.plaintext.txt	63	risk alzheimers disease genotype
0.34448025.16033878.html.plaintext.txt	64	odds ratio genotype versus two shown figure num num num summarized table num
0.34448025.16033878.html.plaintext.txt	65	d homozygote reduced risk alzheimers disease overall odds ratio num
0.34448025.16033878.html.plaintext.txt	66	num num percent confidence interval num
0.34448025.16033878.html.plaintext.txt	67	num method dersimonian laird num
0.34448025.16033878.html.plaintext.txt	68	heterozygote increased risk alzheimers disease overall odds ratio num
0.34448025.16033878.html.plaintext.txt	69	num num percent confidence interval num
0.34448025.16033878.html.plaintext.txt	70	odds ratio alzheimers disease homozygote versus d positive differ significantly num
0.34448025.16033878.html.plaintext.txt	71	two three result heterogeneous
0.34448025.16033878.html.plaintext.txt	72	view larger version numk figure num
0.34448025.16033878.html.plaintext.txt	73	odds ratio alzheimers disease aced homozygote versus positive
0.34448025.16033878.html.plaintext.txt	74	d represents deletion allele represents insertion allele
0.34448025.16033878.html.plaintext.txt	75	horizontal line num confidence interval
0.34448025.16033878.html.plaintext.txt	76	optimum oxford project investigate memory ageing ace angiotensin converting enzyme gene
0.34448025.16033878.html.plaintext.txt	77	additional study information given table num
0.34448025.16033878.html.plaintext.txt	78	view larger version numk figure num
0.34448025.16033878.html.plaintext.txt	79	odds ratio alzheimers disease ace heterozygote versus homozygote
0.34448025.16033878.html.plaintext.txt	80	horizontal line num confidence interval
0.34448025.16033878.html.plaintext.txt	81	optimum oxford project investigate memory ageing ace angiotensin converting enzyme gene
0.34448025.16033878.html.plaintext.txt	82	additional study information given table num
0.34448025.16033878.html.plaintext.txt	83	view larger version numk figure num
0.34448025.16033878.html.plaintext.txt	84	odds ratio alzheimers disease acei homozygote versus d positive
0.34448025.16033878.html.plaintext.txt	85	d represents deletion allele represents insertion allele
0.34448025.16033878.html.plaintext.txt	86	horizontal line num confidence interval
0.34448025.16033878.html.plaintext.txt	87	optimum oxford project investigate memory ageing ace angiotensin converting enzyme gene
0.34448025.16033878.html.plaintext.txt	88	additional study information given table num
0.34448025.16033878.html.plaintext.txt	89	onset age alzheimers disease
0.34448025.16033878.html.plaintext.txt	90	onset age data available num sample comprising numnum case alzheimers disease
0.34448025.16033878.html.plaintext.txt	91	stratified analysis linear regression analysis performed data also subset num north european sample comprising numnum case alzheimers disease
0.34448025.16033878.html.plaintext.txt	92	effect acei carrier status onset age alzheimers disease surprisingly modest effect apoenum carrier status onset age seen data shown
0.34448025.16033878.html.plaintext.txt	93	phase num examination heterogeneity examined six potential source heterogeneity age gender race apoenum status misdiagnosis mistyping
0.34448025.16033878.html.plaintext.txt	94	stratification gender apoenum status
0.34448025.16033878.html.plaintext.txt	95	significant effect seen gender apoenum status association alzheimers disease stratification either two factor remove heterogeneity data shown
0.34448025.16033878.html.plaintext.txt	96	calculated odds ratio alzheimers disease aced homozygote versus positive stratified age num year num num year num year
0.34448025.16033878.html.plaintext.txt	97	rather little effect age seen association d homozygote alzheimers disease data shown reduction heterogeneity stratification age
0.34448025.16033878.html.plaintext.txt	98	repeated overall analysis three genotype restricting data num sample could limited rigorous diagnosis probable definite alzheimers disease according criterion consortium establish registry alzheimers disease num national institute neurological communicative disorder stroke alzheimers disease related disorder association num
0.34448025.16033878.html.plaintext.txt	99	odds ratio similar shown table num significant odds ratio method dersimonian laird num num
0.34448025.16033878.html.plaintext.txt	100	num heterozygote nonsignificant odds ratio num
0.34448025.16033878.html.plaintext.txt	101	heterogeneity remained d homozygote p num
0.34448025.16033878.html.plaintext.txt	102	num longer significant p num
0.34448025.16033878.html.plaintext.txt	103	num instance hardy weinberg disequilibrium individual study four six group pooled case control analyzed race table num
0.34448025.16033878.html.plaintext.txt	104	therefore excluded eight sample mistyping considered possible underreporting heterozygote taking account genotyping method hardy weinberg analysis
0.34448025.16033878.html.plaintext.txt	105	repeated overall analysis remaining num sample
0.34448025.16033878.html.plaintext.txt	106	odds ratio similar table num significant odds ratio num
0.34448025.16033878.html.plaintext.txt	107	num heterozygote nonsignificant odds ratio num
0.34448025.16033878.html.plaintext.txt	108	heterogeneity remained homozygote p num
0.34448025.16033878.html.plaintext.txt	109	num longer significant d homozygote p num
0.34448025.16033878.html.plaintext.txt	110	odds ratio alzheimers disease ace genotype meta analysis ethnic group
0.34448025.16033878.html.plaintext.txt	111	sample divided three ethnic group possible north european num sample south caucasian mediterranean middle eastern num sample east asian chinese japanese four sample
0.34448025.16033878.html.plaintext.txt	112	removed nearly heterogeneity table num
0.34448025.16033878.html.plaintext.txt	113	table num show clear difference among three ethnic group
0.34448025.16033878.html.plaintext.txt	114	overlap whatsoever allelic frequency among three group
0.34448025.16033878.html.plaintext.txt	115	north european east asian differed odds ratio d homozygote versus positive p num
0.34448025.16033878.html.plaintext.txt	116	num homozygote versus d positive p num
0.34448025.16033878.html.plaintext.txt	117	south caucasian also differed east asian odds ratio d homozygote versus positive p num
0.34448025.16033878.html.plaintext.txt	118	d homozygote reduced risk group particularly east asian
0.34448025.16033878.html.plaintext.txt	119	heterozygote increased risk north european
0.34448025.16033878.html.plaintext.txt	120	homozygote higher risk east asian except bayesian analysis
0.34448025.16033878.html.plaintext.txt	121	examined heterosis heterozygote greater risk north european comparing di dd ii turn
0.34448025.16033878.html.plaintext.txt	122	found heterozygote higher risk d homozygote odds ratio num
0.34448025.16033878.html.plaintext.txt	123	num num percent confidence interval num
0.34448025.16033878.html.plaintext.txt	124	num significantly higher homozygote odds ratio num
0.34448025.16033878.html.plaintext.txt	125	num num percent confidence interval num
0.34448025.16033878.html.plaintext.txt	126	aced homozygote reduced risk alzheimers disease table num three main ethnic group examined table num
0.34448025.16033878.html.plaintext.txt	127	homozygote neutral regard alzheimers disease risk table num except east asian homozygote may higher risk table num
0.34448025.16033878.html.plaintext.txt	128	heterozygote increased risk alzheimers disease overall table num mainly north european table num
0.34448025.16033878.html.plaintext.txt	129	example heterosis discussed
0.34448025.16033878.html.plaintext.txt	130	similar result achieved three method fixed effect random effect bayesian random effect refer material method table num
0.34448025.16033878.html.plaintext.txt	131	genotypic comparison made refer material method showed allelic dose effect except east asian table num thus allelic comparison would proved le informative
0.34448025.16033878.html.plaintext.txt	132	finding odds ratio close num even though significantly different num table num num suggest either linkage disequilibrium true risk factor confounding hidden interaction
0.34448025.16033878.html.plaintext.txt	133	second possibility discussed
0.34448025.16033878.html.plaintext.txt	134	regarding former kehoe et al
0.34448025.16033878.html.plaintext.txt	135	num study ace haplotype gave evidence indel may actual risk factor rather linkage disequilibrium nearby functional polymorphism true risk factor
0.34448025.16033878.html.plaintext.txt	136	ace haplotype analysis also proved value phenotype enzyme level num insulin level myocardial infarction obesity num
0.34448025.16033878.html.plaintext.txt	137	future alzheimers disease study may better examine polymorphism regulatory region rather indel
0.34448025.16033878.html.plaintext.txt	138	overall result consistent kehoe et al
0.34448025.16033878.html.plaintext.txt	139	num num also recent meta analysis kehoe et al
0.34448025.16033878.html.plaintext.txt	140	num num elkins et al
0.34448025.16033878.html.plaintext.txt	141	latter report num also suggested age difference however although actual age available mean cohort age take account different way defining case age refer material method strongly confounding factor
0.34448025.16033878.html.plaintext.txt	142	latter problem exclude possibility association might stronger younger case example aged le num year onset le num year death
0.34448025.16033878.html.plaintext.txt	143	heterogeneity overall result showed heterogeneity table num
0.34448025.16033878.html.plaintext.txt	144	heterogeneity may due difference sample selection e
0.34448025.16033878.html.plaintext.txt	145	age gender diagnosis method e
0.34448025.16033878.html.plaintext.txt	146	genotyping may due real difference population e
0.34448025.16033878.html.plaintext.txt	147	race interaction risk factor e
0.34448025.16033878.html.plaintext.txt	148	examined potential source heterogeneity
0.34448025.16033878.html.plaintext.txt	149	found little effect age gender apoenum status thus confounding initial hypothesis
0.34448025.16033878.html.plaintext.txt	150	diagnostic genotyping difference contributed heterogeneity
0.34448025.16033878.html.plaintext.txt	151	former mainly due diagnosis possible alzheimers disease reported poor record confirmation autopsy num
0.34448025.16033878.html.plaintext.txt	152	latter largely due certain genotyping method may lead underreporting heterozygote num num shown hardy weinberg analysis
0.34448025.16033878.html.plaintext.txt	153	however greatest source heterogeneity ethnic difference
0.34448025.16033878.html.plaintext.txt	154	ethnic stratification removed nearly heterogeneity table num
0.34448025.16033878.html.plaintext.txt	155	clear contrast among three ethnic group examined north european south caucasian east asian allelic frequency odds ratio table num
0.34448025.16033878.html.plaintext.txt	156	latter might due difference linkage disequilibrium true risk polymorphism see
0.34448025.16033878.html.plaintext.txt	157	ethnic difference previously pointed panza et al
0.34448025.16033878.html.plaintext.txt	158	contrast highlight danger combining ethnic group within single cohort even north south european indicated panza et al
0.34448025.16033878.html.plaintext.txt	159	unfortunately one cohort african origin united state num
0.34448025.16033878.html.plaintext.txt	160	thus conclusion could drawn african
0.34448025.16033878.html.plaintext.txt	161	heterosis deviation hardy weinberg equilibrium common study ace indel previously pointed bus et al
0.34448025.16033878.html.plaintext.txt	162	may due either mistyping heterosis
0.34448025.16033878.html.plaintext.txt	163	several case disequilibrium indeed compatible mistyping
0.34448025.16033878.html.plaintext.txt	164	example disequilibrium north european however excess heterozygote alzheimers disease requires another explanation
0.34448025.16033878.html.plaintext.txt	165	believe explanation heterosis
0.34448025.16033878.html.plaintext.txt	166	heterosis occurs heterozygote show either greater lesser association given trait either group homozygote
0.34448025.16033878.html.plaintext.txt	167	case north european excess heterozygote alzheimers disease association heterozygote alzheimers disease found
0.34448025.16033878.html.plaintext.txt	168	coming macmurray num suggested three explanation heterosis second applied
0.34448025.16033878.html.plaintext.txt	169	proposes heterosis may follow inadvertent combination two unlike subset due hidden interaction another unknown risk factor
0.34448025.16033878.html.plaintext.txt	170	test proposal constructed mathematical model two equal subset based median split unknown factor x table num
0.34448025.16033878.html.plaintext.txt	171	model illustrates although heterozygote may intermediate odds ratio subset emerge highest odds ratio subset combined
0.34448025.16033878.html.plaintext.txt	172	overall result illustrative model table num close present meta analysis table num
0.34448025.16033878.html.plaintext.txt	173	stress however heterosis found north european
0.34448025.16033878.html.plaintext.txt	174	moreover although heterozygote greater risk d homozygote odds ratio num
0.34448025.16033878.html.plaintext.txt	175	num num percent confidence interval num
0.34448025.16033878.html.plaintext.txt	176	num significantly higher risk homozygote odds ratio num
0.34448025.16033878.html.plaintext.txt	177	num num percent confidence interval num
0.34448025.16033878.html.plaintext.txt	178	thus partial heterosis better describes case
0.34448025.16033878.html.plaintext.txt	179	model show heterosis may follow combination two unlike subset
0.34448025.16033878.html.plaintext.txt	180	hidden interaction partial heterosis north european suggests interaction another risk factor alzheimers disease another potential source heterogeneity
0.34448025.16033878.html.plaintext.txt	181	candidate include cardiovascular risk factor since many also contribute alzheimers disease risk since ace indel associated cardiovascular risk num num
0.34448025.16033878.html.plaintext.txt	182	biologic background full discussion biologic basis association outside scope mainly analytical study
0.34448025.16033878.html.plaintext.txt	183	however note association ace indel nearby polymorphism various phenotype including cardiovascular risk num num num
0.34448025.16033878.html.plaintext.txt	184	addition ace protein level raised certain brain region alzheimers disease num num enzyme reported modify s amyloid aggregation num ace inhibitor reported maintain memory aged rat num human patient num brain penetrating ace inhibitor associated reduced incidence alzheimers disease elderly hypertensive patient num le cognitive decline case mild moderate alzheimers disease num
0.34448025.16033878.html.plaintext.txt	185	num recently provided evidence magnetic resonance imaging increased atrophy hippocampus amygdala nondemented woman homozygous acei allele together modest significant increase risk alzheimers disease independent vascular factor
0.34448025.16033878.html.plaintext.txt	186	d allele associated raised plasma level ace num association thought due linkage disequilibrium nearby polymorphism num num
0.34448025.16033878.html.plaintext.txt	187	apparent conflict benefit ace inhibitor therapy association indel alzheimers disease risk pathology plasma level ace
0.34448025.16033878.html.plaintext.txt	188	however influence ace polymorphism brain level enzyme yet known assumed reflect level plasma
0.34448025.16033878.html.plaintext.txt	189	subject warrant fuller discussion possible
0.34448025.16033878.html.plaintext.txt	190	detailed discussion given kehoe num although need reconsidered perhaps revised light interacting factor factor may emerge future study
0.34448025.16033878.html.plaintext.txt	191	limitation meta analysis lack information author limitation obtained full data num percent subject
0.34448025.16033878.html.plaintext.txt	192	quality diagnosis genotyping varied among study overall result changed question taken account
0.34448025.16033878.html.plaintext.txt	193	considerable heterogeneity initial result
0.34448025.16033878.html.plaintext.txt	194	however found main source heterogeneity able remove
0.34448025.16033878.html.plaintext.txt	195	since cardiovascular factor strong candidate potential interaction ace variant lack data available u factor limitation hope overcome future study
0.34448025.16033878.html.plaintext.txt	196	cardiovascular factor might also influenced result selective mortality
0.34448025.16033878.html.plaintext.txt	197	however d homozygote slightly increased risk cardiovascular complication num num num little evidence association reduced life span num num
0.34448025.16033878.html.plaintext.txt	198	thus influence selective mortality likely small enough provide alternative explanation finding
0.34448025.16033878.html.plaintext.txt	199	conclusion suggest large study established ace indel marker alzheimers disease risk since found evidence bias found removed main source heterogeneity excluded various potential interaction significant result remained three ethnic group examined
0.34448025.16033878.html.plaintext.txt	200	indel however probably linkage disequilibrium true risk polymorphism num
0.34448025.16033878.html.plaintext.txt	201	marked contrast among three ethnic group studied table num
0.34448025.16033878.html.plaintext.txt	202	also found evidence interaction another risk factor north european
0.34448025.16033878.html.plaintext.txt	203	potential interaction factor age gender apoenum status examined particularly interaction cardiovascular risk factor
0.34448025.16033878.html.plaintext.txt	204	acknowledgment financial support received bristol myers squibb phytopharm plc medical research council norman collisson foundation takayama foundation
0.34448025.16033878.html.plaintext.txt	205	kehoe supported gestetner foundation fellowship
0.34448025.16033878.html.plaintext.txt	206	author thank group undertaken acealzheimers disease association study thereby providing data analysis
0.34448025.16033878.html.plaintext.txt	207	especially thank author generously responded request primary data dr
0.34448025.16033878.html.plaintext.txt	208	author particularly grateful dr
0.34448025.16033878.html.plaintext.txt	209	finkh colleague highlighting issue hardy weinberg disequilibrium ace study num dr
0.34448025.16033878.html.plaintext.txt	210	capurso colleague num num pointing ethnic difference ace indel frequency
0.34448025.16033878.html.plaintext.txt	211	author also warmly thank dr
0.34448025.16033878.html.plaintext.txt	212	pembrey advice genetics dr
0.34448025.16033878.html.plaintext.txt	213	marchini advice statistic c
0.34448025.16033878.html.plaintext.txt	214	aldridge administrative support m
0.34448025.16033878.html.plaintext.txt	215	lehmann help mathematical calculation dr
0.34448025.16033878.html.plaintext.txt	216	conflict interest none declared
0.34448025.16033878.html.plaintext.txt	217	note added proof two association study published since submission article kolsch et al
0.34448025.16033878.html.plaintext.txt	218	neurosci lett numnumnum num zhang et al
0.34448025.16033878.html.plaintext.txt	219	dement geriatr cogn disord numnumnum num
0.3493169.9384602.html.plaintext.txt	0	estimation genetic contribution presenilin num num mutation population based study presenile alzheimer disease estimation genetic contribution presenilin num num mutation population based study presenile alzheimer disease marc crutsnum cornelia m
0.3493169.9384602.html.plaintext.txt	1	van duijnnum hubert backhovensnum marleen van den broecknum anita wehnertnum sally serneelsnum robin sherringtonnum michael huttonnum john hardynum peter h
0.3493169.9384602.html.plaintext.txt	2	st george hyslopnum albert hofmannum christine van broeckhovennum
0.3493169.9384602.html.plaintext.txt	3	numlaboratory neurogenetics flanders interuniversity institute biotechnology vib born bunge foundation bb university antwerp uia department biochemistry antwerpen belgium numdepartment epidemiology biostatistics erasmus university rotterdam netherlands numcentre research neurodegenerative disease department medicine medical biophysics university toronto toronto canada numneurogenetics laboratory mayo clinic jacksonville fl usa
0.3493169.9384602.html.plaintext.txt	4	received august num num revised accepted october num num
0.3493169.9384602.html.plaintext.txt	5	two closely related gene presenilins p located chromosome numqnum
0.3493169.9384602.html.plaintext.txt	6	num identified autosomal dominant alzheimer disease ad onset age num year presenile ad
0.3493169.9384602.html.plaintext.txt	7	performed systematic mutation analysis coding num non coding exon p num p num population based epidemiological series num unrelated familial sporadic presenile ad case
0.3493169.9384602.html.plaintext.txt	8	familial case included num patient autosomal dominant ad family sampled linkage analysis study
0.3493169.9384602.html.plaintext.txt	9	patient mutation amyloid precursor protein gene app previously excluded
0.3493169.9384602.html.plaintext.txt	10	four different p num missense mutation identified six familial case two autosomal dominant case
0.3493169.9384602.html.plaintext.txt	11	three mutation resulted onset age num year one segregating autosomal dominant family mean onset age num year range num num year
0.3493169.9384602.html.plaintext.txt	12	one p num mutation identified sporadic case onset age num year
0.3493169.9384602.html.plaintext.txt	13	mutation data provided estimate p num p num mutation frequency presenile ad num num respectively
0.3493169.9384602.html.plaintext.txt	14	family history accounted mutation frequency p num num familial case num autosomal dominant case
0.3493169.9384602.html.plaintext.txt	15	polymorphism detected promoter num non coding region p num intronic exonic sequence p num useful genetic association study
0.3493169.9384602.html.plaintext.txt	16	alzheimer disease ad common cause senile dementia fourth leading cause death western society
0.3493169.9384602.html.plaintext.txt	17	ad neurodegenerative disorder central nervous system characterized progressive loss memory intellectual functioning due appearance brain two major lesion senile plaque neurofibrillary tangle
0.3493169.9384602.html.plaintext.txt	18	exact biochemical pathway leading neurodegeneration still unknown
0.3493169.9384602.html.plaintext.txt	19	ad case first symptom memory dysfunction behavior change become apparent age num year late onset senile ad however many case disease start earlier life early onset presenile ad
0.3493169.9384602.html.plaintext.txt	20	indication disease presenile ad case different observed senile ad case apart severe pathology rapid clinical progression
0.3493169.9384602.html.plaintext.txt	21	senile presenile ad genetic etiology however genetic case frequent among presenile ad case review see num
0.3493169.9384602.html.plaintext.txt	22	also several ad family documented segregate presenile ad autosomal dominant manner
0.3493169.9384602.html.plaintext.txt	23	family positional cloning approach employed identify ad gene review see num
0.3493169.9384602.html.plaintext.txt	24	date three ad gene known mutated lead presenile ad amyloid precursor protein gene app chromosome num numqnum
0.3493169.9384602.html.plaintext.txt	25	num num presenilin num gene p num chromosome num numqnum
0.3493169.9384602.html.plaintext.txt	26	numnum presenilin num gene p num chromosome num numqnum
0.3493169.9384602.html.plaintext.txt	27	although normal function amyloid precursor protein app unknown mutation demonstrated alter endoproteolysis app num amino acid long form amyloid beta abetanum produced num
0.3493169.9384602.html.plaintext.txt	28	rapid deposition abetanum ad brain early morphological event ad pathology
0.3493169.9384602.html.plaintext.txt	29	also normal pathological function presenilin protein p num p num unknown review see num
0.3493169.9384602.html.plaintext.txt	30	since constitute integral membrane protein six eight transmembrane domain tm one large hydrophilic loop hl num num similar function p num p num predicted
0.3493169.9384602.html.plaintext.txt	31	remarkably mutation p num p num also produce abetanum suggesting p mutation app mutation lead ad pathology common biochemical pathway
0.3493169.9384602.html.plaintext.txt	32	app seven different mutation identified autosomal dominant family presenile ad ad related phenotype num
0.3493169.9384602.html.plaintext.txt	33	mutation occur exon num num encoding abeta proteolysis product app
0.3493169.9384602.html.plaintext.txt	34	however extensive mutation analysis shown mutation app rare since segregate num presenile ad family num
0.3493169.9384602.html.plaintext.txt	35	since p gene identified recently review see num extensive mutation analysis yet performed
0.3493169.9384602.html.plaintext.txt	36	however initial estimate based linkage analysis study suggested num presenile ad family linked chromosome num num
0.3493169.9384602.html.plaintext.txt	37	later mutation p num found chromosome num linked ad family num num num
0.3493169.9384602.html.plaintext.txt	38	date num different missense mutation one frame splice site mutation p num reported num family world wide num
0.3493169.9384602.html.plaintext.txt	39	mutation screening p num presenile ad family selected basis linkage chromosome num indicated p num mutation contribute le num num initially estimated num num
0.3493169.9384602.html.plaintext.txt	40	possible explanation lower mutation frequency p num may initial mutation data biased towards finding p num mutation since family analyzed included genome wide search ad gene known linked chromosome num
0.3493169.9384602.html.plaintext.txt	41	one mutation reported proven non familial ad case num however mutation study sporadic ad case performed
0.3493169.9384602.html.plaintext.txt	42	initial linkage study indicated p num mutation far le frequent p num mutation num
0.3493169.9384602.html.plaintext.txt	43	apart one p num mutation identified chromosome num linked group volga german ad family one p num mutation identified date num num
0.3493169.9384602.html.plaintext.txt	44	however contrast p num family onset age p num family highly variable usually later life num
0.3493169.9384602.html.plaintext.txt	45	therefore excluded p num family may missed since presenile ad family earlier onset age likely ascertained linkage analysis study since clear inheritance pattern
0.3493169.9384602.html.plaintext.txt	46	date mutation report p num non familial presenile ad case published however p num le intensively investigated mutation p num
0.3493169.9384602.html.plaintext.txt	47	study aimed evaluating genetic contribution p num p num mutation presenile ad autosomal dominant familial sporadic case
0.3493169.9384602.html.plaintext.txt	48	overcome several bias mentioned used unique sample num unrelated familial sporadic presenile ad case ascertained population based manner netherlands num num
0.3493169.9384602.html.plaintext.txt	49	sample contained num autosomal dominant num familial num sporadic presenile ad case
0.3493169.9384602.html.plaintext.txt	50	num year range num num year lower num year num case lower num year num case
0.3493169.9384602.html.plaintext.txt	51	autosomal dominant ad family probands onset age num year however four family mean onset age num year
0.3493169.9384602.html.plaintext.txt	52	addition analyzed family num autosomal dominant presenile ad case included population based study num
0.3493169.9384602.html.plaintext.txt	53	case mutation exon num num app gene previously excluded num num one family shown linked chromosome num num
0.3493169.9384602.html.plaintext.txt	54	intronic pcr primer flanking coding num non coding exon p num p num p num p num exon primer sequence size bp exon primer sequence size bp numa snumexnuma num ttctccccgcaatcgtttctccag num num p numexnum num tgttagcagcggtgtttg num snumexnuma num gcccatgtccgcggtgccttcc p numexnum num tctgctcggagggatggac numb snumexnumb num aggaggggcggcccgtttctcg num num p numexnum num cagggccagggggaggaa num snumexnumb num agcctctgccaccaccgnaggatc p numexnum num aaaagcaggttgggagtcac num snumexnum num tggatgacctggtgaaatcctatt num num p numexnum num gtcctccactgcctttgtctcac num snumexnum num cagaaaacaaagcctcttgaggtt p numexnum num cttcccttctccctcccgcatcag num snumexnum num acaaagttctgtttttctttccc num num numps numxnum aaaaatccgtgcattacat num snumexnum num cagcatttctcagaggtgagg numps numxnum gctggttgtgagctgcaggtacagtg num snumexnum num cgttaccttgattctgctga num num p num exnum num agcctcgaggagcagtcag num snumexnum num gacatgctgtaaagaaaagcc p num exnum num gcagacggagagaagcgt num snumexnum num gattggtgagttggggaaaagtg num num numps numxnum ggtatcagtctcaggatcatggg num snumexnum num atacccaaccataagaagaacagg numps numxnum tggggaagactggagctcgatg num snumexnum num ggttgtgggacctgttaatt num num p num exnum num gtaaagagggccaggttggg num snumexnum num ttaattctgaaagacagaccc p num exnum num gtgcagcactggggacgattt num snumexnum num ggagccatcacattattctaaa num num numps numxnum gggcaggctcttcttcaggg num snumexnum num aacaaattatcagtcttgggttt numps numxnum gaaagccacggccaggaag num snumexnum num ttacaagtttagcccatacatttt num num p numexnum num accgcctgagacgtgaacctt num snumexnum num tcaagttcccgataaattctac p numexnum num tccctctgcccctcctgaact num snumexnum num tgtgtgtccagtgcttacctg num num numps numxnum ctctgaccagctgttgtttc num snumexnum num tgttagcttataacagtgaccctg numps numxnum agcctccaccctctgtct num snumexnum num ccagctagttacaatgacagc num num numps numxnum ttccattctgtgcacgcctc num snumexnum num tcaaaaaggttgataatgtagct numps numxnum acctgcccccaccacaatg num snumexnum num ggttgagtagggcagtgata num num p numexnum num acaccagggatcaccacgctcac num snumexnum num ttaaagggactgtgtaatcaaag p numexnum num tgcctcctcctcaccaagtaaaca num snumexnum num gtctttcccatcttctccac num snumexnum num gggattctaaccgcaaatat
0.3493169.9384602.html.plaintext.txt	55	missense mutation detected p num p num gene exon location mutation family onset age year family historya restriction site change p num num numc alanumval num num ad acii bbei ban ehei haeii hinpnumi hhai hspnumi kasi nari nlaiv num num f num num f num numa g tyrnumcys num num ad cspnumi rsai num numc alanumval num num f bgli bspnumi mwoi num numa g glunumgly num num f p num num numg argnumhis num num acii aad autosomal dominant f familial sporadic
0.3493169.9384602.html.plaintext.txt	56	nucleotide position relative translation start site p num p num cdna
0.3493169.9384602.html.plaintext.txt	57	restriction enzyme used study test presence mutation denoted bold fig
0.3493169.9384602.html.plaintext.txt	58	pedigree family p num mutation depicted figure num
0.3493169.9384602.html.plaintext.txt	59	polymorphism detected p num p num gene exon location codon allele frequency restriction site change p num numa numc num
0.3493169.9384602.html.plaintext.txt	60	num hgai hspnumi sfani numb numc num
0.3493169.9384602.html.plaintext.txt	61	num alwnumi p num num numc alanum num
0.3493169.9384602.html.plaintext.txt	62	num ddei num numc asnnum n
0.3493169.9384602.html.plaintext.txt	63	num ncoi nlaiii styi num numc hisnum num
0.3493169.9384602.html.plaintext.txt	64	num bbrpi bsaai econumi maeii nlaiii nspi taii num numg thrnum n
0.3493169.9384602.html.plaintext.txt	65	bsshii bstui cagnumi hinpi tspri num numa g num
0.3493169.9384602.html.plaintext.txt	66	num alui bstnumi bstfnumi cviji mspanumi pvuii nucleotide position exonic polymorphism relative translation start site p num p num cdna
0.3493169.9384602.html.plaintext.txt	67	nucleotide position intronic polymorphism relative start end intron
0.3493169.9384602.html.plaintext.txt	68	allele frequency determined num control individual using restriction enzyme denoted bold fig
0.3493169.9384602.html.plaintext.txt	69	result mutation analysis p num p num
0.3493169.9384602.html.plaintext.txt	70	previously complete genomic structure p num p num determined identifying num coding exon gene num num
0.3493169.9384602.html.plaintext.txt	71	order avoid confusion used exon numbering num num p num study introduced clark et al
0.3493169.9384602.html.plaintext.txt	72	intronic primer pair designed allowing pcr amplification num coding exon p num p num table num
0.3493169.9384602.html.plaintext.txt	73	num ad patient examined mutation p num p num sscp analysis pcr cycle sequencing
0.3493169.9384602.html.plaintext.txt	74	p num identified four missense mutation exon num num num num respectively one intronic polymorphism intron num table num num fig
0.3493169.9384602.html.plaintext.txt	75	alanumval mutation identified three patient num num num table num
0.3493169.9384602.html.plaintext.txt	76	test whether mutation three patient ancestral origin genotyped three simple tandem repeat str marker flanking p num num num
0.3493169.9384602.html.plaintext.txt	77	dnumsnum dnumsnum dnumsnum patient shared one common allele allele frequency calculated among case respectively num
0.3493169.9384602.html.plaintext.txt	78	data suggested three patient carrying alanumval mutation might related although closely since genealogy study indicated familial relationship
0.3493169.9384602.html.plaintext.txt	79	three mutation occurred none mutation present num control individual
0.3493169.9384602.html.plaintext.txt	80	polymorphism observed intron num identical reported wragg et al
0.3493169.9384602.html.plaintext.txt	81	num allele frequency determined primer mismatch pcr assay described author table num
0.3493169.9384602.html.plaintext.txt	82	since sscp pattern intron num polymorphism could masked presence mutation sequenced exon num case
0.3493169.9384602.html.plaintext.txt	83	restriction enzyme analysis mutation polymorphism p num p num
0.3493169.9384602.html.plaintext.txt	84	pcr amplified exon digested restriction enzyme indicated
0.3493169.9384602.html.plaintext.txt	85	missense mutation p num p num
0.3493169.9384602.html.plaintext.txt	86	b polymorphism p num p num
0.3493169.9384602.html.plaintext.txt	87	one patient missense mutation p num detected resulting arg substitution codon num exon num table num fig
0.3493169.9384602.html.plaintext.txt	88	restriction digestion analysis showed mutation absent patient control
0.3493169.9384602.html.plaintext.txt	89	addition sscp sequence analysis exon num identified two different polymorphism intron num codon hisnum respectively table num
0.3493169.9384602.html.plaintext.txt	90	also sscp pattern observed exon num num num num due polymorphism since nucleotide change involved intronic variation exonic silent mutation table num fig
0.3493169.9384602.html.plaintext.txt	91	polymorphism exon num thrnum seen one patient represents rare polymorphism
0.3493169.9384602.html.plaintext.txt	92	also polymorphism exon num sernum rare since seen two patient
0.3493169.9384602.html.plaintext.txt	93	allele frequency frequent polymorphism estimated num control individual restriction enzyme digestion table num
0.3493169.9384602.html.plaintext.txt	94	comparison allele distribution num control individual showed two exon num polymorphism linkage disequilibrium
0.3493169.9384602.html.plaintext.txt	95	also two exon num polymorphism linkage disequilibrium
0.3493169.9384602.html.plaintext.txt	96	demonstrated p num polymorphism exon num alanum num hisnum intron num show mendelian inheritance
0.3493169.9384602.html.plaintext.txt	97	complete mutation analysis p num p num developed flanking primer three exon located num untranslated region num utr p num numbered exon numa numb num two num utr p num num num
0.3493169.9384602.html.plaintext.txt	98	sscp analysis followed pcr cycle sequencing revealed two polymorphism num utr p num mutation table num
0.3493169.9384602.html.plaintext.txt	99	allele frequency polymorphism estimated sscp analysis exon numa restriction digestion exon numb table num fig
0.3493169.9384602.html.plaintext.txt	100	mendelian inheritance polymorphism demonstrated
0.3493169.9384602.html.plaintext.txt	101	mutation polymorphism detected num utr p num
0.3493169.9384602.html.plaintext.txt	102	although sscp analysis p num p num negative eight num autosomal dominant probands included sample could rule mutation may missed since sensitivity sscp num
0.3493169.9384602.html.plaintext.txt	103	therefore performed mutation analysis p num p num cdna synthesized rna isolated cultured lymphoblast patient escapee
0.3493169.9384602.html.plaintext.txt	104	alanumval tyrnumcys mutation p num detected
0.3493169.9384602.html.plaintext.txt	105	six p num mutation occurred patient positive family history presenile ad p num mutation observed sporadic case table num
0.3493169.9384602.html.plaintext.txt	106	two p num mutation present autosomal dominant case num num four p num mutation detected familial case num num num num fig
0.3493169.9384602.html.plaintext.txt	107	latter family inheritance pattern consistent autosomal dominant transmission fig
0.3493169.9384602.html.plaintext.txt	108	num however family selected linkage study since fulfil rigid criterion autosomal dominant ad num num num showed bilineal transmission ad num num
0.3493169.9384602.html.plaintext.txt	109	family num additional family member available p num mutation alanumval shown present risk individual
0.3493169.9384602.html.plaintext.txt	110	pedigree family autosomal dominant ad case familial case p num mutation observed
0.3493169.9384602.html.plaintext.txt	111	probands included mutation analysis except family num iii num num v num
0.3493169.9384602.html.plaintext.txt	112	family num num num num included previous linkage study num
0.3493169.9384602.html.plaintext.txt	113	symbol circle depict female square depict male open symbol unaffected individual filled symbol ad patient partly filled symbol patient diagnosed cva
0.3493169.9384602.html.plaintext.txt	114	roman number left pedigree denote generation
0.3493169.9384602.html.plaintext.txt	115	number patient symbol denote age onset age death dagger
0.3493169.9384602.html.plaintext.txt	116	patient autopsy confirmation ad indicated asterisk
0.3493169.9384602.html.plaintext.txt	117	autosomal dominant family num num co segregation mutation presenile ad confirmed restriction enzyme digestion table num fig
0.3493169.9384602.html.plaintext.txt	118	previously used informative family num autosomal dominant case included among num case genetic linkage study num
0.3493169.9384602.html.plaintext.txt	119	family num mean onset age num year linked dnumsnum located chromosome numqnum
0.3493169.9384602.html.plaintext.txt	120	num zero recombination num
0.3493169.9384602.html.plaintext.txt	121	family num informative chromosome num str marker used
0.3493169.9384602.html.plaintext.txt	122	mutation analysis num coding exon well num non coding exon p num p num sscp analysis pcr cycle sequencing identified four different missense mutation p num six patient alanumval tyrnumcys alanumval glunumgly one missense mutation p num one patient argnumhis among num unrelated presenile ad case study
0.3493169.9384602.html.plaintext.txt	123	one mutation num num novel mutation absent num control individual
0.3493169.9384602.html.plaintext.txt	124	based mutation data calculated mutation frequency num p num num p num presenile ad
0.3493169.9384602.html.plaintext.txt	125	since p num mutation occurred familial case
0.3493169.9384602.html.plaintext.txt	126	case least one first degree relative ad mutation frequency estimated num six num case familial presenile ad case
0.3493169.9384602.html.plaintext.txt	127	among familial case study num case belonging family fulfilling rigid criterion autosomal dominant ad
0.3493169.9384602.html.plaintext.txt	128	three patient two generation clinical diagnosis ad least two case num
0.3493169.9384602.html.plaintext.txt	129	two autosomal dominant family p num mutation found resulting mutation frequency num two num case autosomal dominant presenile ad
0.3493169.9384602.html.plaintext.txt	130	since mutation screening p num p num performed sscp analysis exclude estimate mutation frequency p num p num underestimate sensitivity sscp num num
0.3493169.9384602.html.plaintext.txt	131	however systematically analyzed pcr amplified exon p num p num together positive control known mutation presence absence glycerol denaturant
0.3493169.9384602.html.plaintext.txt	132	mutation p num p num may also masked polymorphism exonic flanking intronic sequence
0.3493169.9384602.html.plaintext.txt	133	polymorphic sscp pattern observed sequenced pcr product five num case showing homozygous heterozygous sscp pattern
0.3493169.9384602.html.plaintext.txt	134	case underlying polymorphism detected confirmed restriction enzyme digestion amplified product
0.3493169.9384602.html.plaintext.txt	135	efficiency mutation analysis strategy demonstrated detection mutation exon num p num one patient unique sscp pattern different polymorphic sscp pattern observed exon num
0.3493169.9384602.html.plaintext.txt	136	also sequence analysis polymorphic pcr product exon num p num identified mutation
0.3493169.9384602.html.plaintext.txt	137	onset age p num mutation case varied num num year three mutation alanumval alanumval glunumgly onset age num year table num
0.3493169.9384602.html.plaintext.txt	138	p num mutation reported far onset age num num year num
0.3493169.9384602.html.plaintext.txt	139	however majority mutation located exon num num coding part tm ii large hl tm vi num
0.3493169.9384602.html.plaintext.txt	140	mutation predicted interfere alpha helical structure tm ii proteolytic processing p num occurring hl vi num
0.3493169.9384602.html.plaintext.txt	141	p num mutation identified study located n terminal region alanumval exon num tm v alanumval exon num middle part hl vi glunumgly exon num
0.3493169.9384602.html.plaintext.txt	142	likely mutation milder effect p num functioning possibly amino acid change semi conserved alanumval alanumval located functionally le important region glunumgly
0.3493169.9384602.html.plaintext.txt	143	glunum mutation located region p num le conserved p num p specie num
0.3493169.9384602.html.plaintext.txt	144	also co segregation glunumgly mutation ad could demonstrated since relative family num available
0.3493169.9384602.html.plaintext.txt	145	high variability onset age observed p num family num segregating alanumval mutation mean onset age family num year ranging num num year
0.3493169.9384602.html.plaintext.txt	146	one mutation carrier disease yet fully penetrant age num year
0.3493169.9384602.html.plaintext.txt	147	possibly onset age family modulated genetic andor environmental factor
0.3493169.9384602.html.plaintext.txt	148	respect important note non penetrant case apoe epsilonnumepsilonnum genotype may delayed onset age num
0.3493169.9384602.html.plaintext.txt	149	however apoe study larger sample p num case family needed conclude apoe genotype modulates expression p num mutation
0.3493169.9384602.html.plaintext.txt	150	also effect apoe genotype onset age observed chromosome num linked ad family p num mutation leading early onset age severe phenotype num
0.3493169.9384602.html.plaintext.txt	151	another possibility p num linked phenotype modulated polymorphism p num mutation p num p num act together express disease phenotype digenic effect
0.3493169.9384602.html.plaintext.txt	152	however sscp analysis well rt pcr analysis p num cdna detect sequence alteration p num
0.3493169.9384602.html.plaintext.txt	153	family num also particular interest since family several patient identified cerebrovascular accident cva fig
0.3493169.9384602.html.plaintext.txt	154	however none carried p num mutation indicating cva family related presenile ad
0.3493169.9384602.html.plaintext.txt	155	contrast previous three p num mutation tyrnumcys mutation exon num corresponding hl detected chromosome num linked family num mean onset age num year range num num year num
0.3493169.9384602.html.plaintext.txt	156	latter provides evidence earlier mutation study may indeed biased towards finding p num mutation resulting earlier onset age severe phenotype
0.3493169.9384602.html.plaintext.txt	157	one p num mutation argnumhis observed sporadic ad case onset age num year
0.3493169.9384602.html.plaintext.txt	158	two published p num mutation identified autosomal dominant family presenile ad tm ii tm v p num num num
0.3493169.9384602.html.plaintext.txt	159	mutated argnum codon conserved human p num p mammalian specie located region n terminal domain generally conserved p num p num caenorhabditis elegans homolog sel num num
0.3493169.9384602.html.plaintext.txt	160	also mutation conserved amino acid substitution
0.3493169.9384602.html.plaintext.txt	161	therefore excluded p num mutation rare polymorphism related ad pathogenesis since patient also apoe epsilonnumepsilonnum genotype may increased risk developing ad num
0.3493169.9384602.html.plaintext.txt	162	conclusion mutation data showed p num p num mutation rare genetic cause presenile ad general
0.3493169.9384602.html.plaintext.txt	163	also frequency p num mutation autosomal dominant ad family num le frequent initially estimated
0.3493169.9384602.html.plaintext.txt	164	mutation identified exon num num app case num suggesting ad gene must exist
0.3493169.9384602.html.plaintext.txt	165	possible fraction case may attributed presence apoe epsilonnum allele
0.3493169.9384602.html.plaintext.txt	166	previous study population based sample demonstrated risk developing presenile ad significantly increased apoe epsilonnum homozygote independent family history apoe epsilonnum heterozygote family history positive num
0.3493169.9384602.html.plaintext.txt	167	sample num case num apoe epsilonnum homozygote num familial apoe epsilonnum heterozygote
0.3493169.9384602.html.plaintext.txt	168	contrast previous report num observed several p num mutation leading ad onset age num year
0.3493169.9384602.html.plaintext.txt	169	also one p num mutation identified autosomal dominant family mean onset age num year range num num year
0.3493169.9384602.html.plaintext.txt	170	identification p num mutation predicts p num mutation even milder effect p num functioning may present senile ad
0.3493169.9384602.html.plaintext.txt	171	particular importance since genetic association intronic p num polymorphism senile ad reported num although association could replicated study
0.3493169.9384602.html.plaintext.txt	172	possibly association result functionally relevant sequence variation elsewhere p num gene
0.3493169.9384602.html.plaintext.txt	173	preliminary data obtained sequence analysis failed demonstrate sequence variation coding region p num num
0.3493169.9384602.html.plaintext.txt	174	however promoter num non coding region p num examined since sequence became available recently
0.3493169.9384602.html.plaintext.txt	175	respect identification u two polymorphism num non coding region p num interest since polymorphism may used genetic association study test whether p num also susceptibility gene senile andor presenile ad
0.3493169.9384602.html.plaintext.txt	176	also intronic exonic polymorphism identified p num useful test role gene ad analysis yet performed
0.3493169.9384602.html.plaintext.txt	177	material method subject
0.3493169.9384602.html.plaintext.txt	178	patient clinical diagnosis ad onset age num year made period january num july num living metropolitan rotterdam four northern province ascertained num
0.3493169.9384602.html.plaintext.txt	179	clinical diagnosis ad independently confirmed two neurologist using standardized protocol according nincds adrda criterion ad num
0.3493169.9384602.html.plaintext.txt	180	total num patient participated study num
0.3493169.9384602.html.plaintext.txt	181	onset age defined age memory problem behavior change first noted
0.3493169.9384602.html.plaintext.txt	182	case considered familial least one first degree relative suffered dementia
0.3493169.9384602.html.plaintext.txt	183	percentage familial case total sample presenile ad patient num num num
0.3493169.9384602.html.plaintext.txt	184	familial case pedigree considered segregate autosomal dominant ad least three patient dementia reported two generation least two patient detailed medical record clinical diagnosis ad num num
0.3493169.9384602.html.plaintext.txt	185	blood sample drawn num randomly selected ad patient num detailed data family history disease collected num
0.3493169.9384602.html.plaintext.txt	186	affected unaffected relative num family visited home blood drawn
0.3493169.9384602.html.plaintext.txt	187	relative assessed family history disease risk factor ad memory performance num
0.3493169.9384602.html.plaintext.txt	188	blood sample obtained num control individual matched age within num year place residence
0.3493169.9384602.html.plaintext.txt	189	control drawn randomly population register municipality patient num
0.3493169.9384602.html.plaintext.txt	190	cognitive status control individual tested none showed symptom dementia time study
0.3493169.9384602.html.plaintext.txt	191	leukocyte collected total blood patient relative permanent lymphoblast cell line obtained transformation using ebstein barr virus
0.3493169.9384602.html.plaintext.txt	192	dna extracted total blood cultured lymphoblast using standard phenolchloroform dna extraction procedure
0.3493169.9384602.html.plaintext.txt	193	initial genetic analysis num case included nine autosomal dominant case
0.3493169.9384602.html.plaintext.txt	194	however recently risk individual num v num fig
0.3493169.9384602.html.plaintext.txt	195	num diagnosed probable ad included study bringing total number case num
0.3493169.9384602.html.plaintext.txt	196	mutation analysis exon num num app excluded presence app mutation case num
0.3493169.9384602.html.plaintext.txt	197	informative family num autosomal dominant case used linkage analysis study chromosome num num num marker num
0.3493169.9384602.html.plaintext.txt	198	family num mean onset age num year conclusively linked chromosome num two others excluded
0.3493169.9384602.html.plaintext.txt	199	result informative
0.3493169.9384602.html.plaintext.txt	200	since linkage analysis study performed presenile ad locus chromosome num identified family analyzed linkage chromosome num marker
0.3493169.9384602.html.plaintext.txt	201	polymerase chain reaction pcr analysis
0.3493169.9384602.html.plaintext.txt	202	num ng dna amplified num microl reaction mixture containing num pmol primer num
0.3493169.9384602.html.plaintext.txt	203	num u taq dna polymerase gibco brl gaithersburg md num
0.3493169.9384602.html.plaintext.txt	204	num mm mgclnum num mm tris hcl ph num
0.3493169.9384602.html.plaintext.txt	205	pcr amplification consisted num cycle num num degree c num empirically defined optimal annealing temperature num num degree c
0.3493169.9384602.html.plaintext.txt	206	pcr sscp analysis intronic pcr primer used amplify exon flanking intronic sequence p num p num table num
0.3493169.9384602.html.plaintext.txt	207	pcr amplification product heat denatured cooled ice separated using two different electrophoresis system
0.3493169.9384602.html.plaintext.txt	208	coding exon p num analyzed num x hydrolink mde gel j
0.3493169.9384602.html.plaintext.txt	209	baker phillipsburg without num glycerol
0.3493169.9384602.html.plaintext.txt	210	electrophoresis num h num v num degree c glycerol room temperature without glycerol
0.3493169.9384602.html.plaintext.txt	211	sscpheteroduplex pattern visualized using silver staining
0.3493169.9384602.html.plaintext.txt	212	alternatively non coding exon p num exon p num analyzed multiphorii electrophoresis system pharmacia biotech uppsala sweden using excellgel precast polyacrylamide gel num x hydrolink mde gel containing num glycerol
0.3493169.9384602.html.plaintext.txt	213	electrophoresis num v num num h depending product size sscp pattern visualized using silver staining
0.3493169.9384602.html.plaintext.txt	214	sscp analysis exon num num num p num performed presence positive control sample ilenumthr metnumleu hisnumarg alanumglu leunumval glynumala cysnumtyr mutation num num
0.3493169.9384602.html.plaintext.txt	215	aberrant sscp pattern observed sequence fragment determined using cycle sequencing
0.3493169.9384602.html.plaintext.txt	216	pcr amplification product pretreated num u exonuclease num u shrimp alkaline phosphatase remove excess pcr primer nucleotide
0.3493169.9384602.html.plaintext.txt	217	pcr amplification product num microl used template cycle sequencing reaction using abi prism dye terminator cycle sequencing core kit applied biosystems foster city ca according supplier protocol using primer pcr amplification
0.3493169.9384602.html.plaintext.txt	218	sequence analyzed abi numa automated dna sequencer
0.3493169.9384602.html.plaintext.txt	219	sequence variation p num p num analyzed restriction enzyme digestion amplified product involved creation abolition restriction enzyme recognition site
0.3493169.9384602.html.plaintext.txt	220	also intron num polymorphism p num analyzed bamhi digestion described num
0.3493169.9384602.html.plaintext.txt	221	genomic pcr amplification product digested num h using num u corresponding restriction enzyme table num num appropriate reaction temperature
0.3493169.9384602.html.plaintext.txt	222	restriction fragment separated num
0.3493169.9384602.html.plaintext.txt	223	num num agarose gel depending allele size visualized uv transilluminator etbr staining
0.3493169.9384602.html.plaintext.txt	224	apoe genotype scored pcr amplification genomic dna using published primer num standard pcr num cycle
0.3493169.9384602.html.plaintext.txt	225	digestion num u hhai num h num degree c allele separated excellgel precast polyacrylamide gel described visualized using silver staining
0.3493169.9384602.html.plaintext.txt	226	strs dnumsnum dnumsnum dnumsnum amplified standard pcr using published primer set one fluorescently labeled
0.3493169.9384602.html.plaintext.txt	227	allele separated num polyacrylamide gel containing num m urea analyzed abi numa automated dna sequencer using genescan num software applied biosystems
0.3493169.9384602.html.plaintext.txt	228	num segregation missense mutation amyloid precursor protein gene familial alzheimers disease
0.3493169.9384602.html.plaintext.txt	229	num cloning gene bearing mi sense mutation early onset familial alzheimers disease
0.3493169.9384602.html.plaintext.txt	230	num candidate gene chromosome num familial alzheimers disease locus
0.3493169.9384602.html.plaintext.txt	231	num familial alzheimers disease kindred missense mutation gene chromosome num related alzheimers disease type num gene
0.3493169.9384602.html.plaintext.txt	232	num amyloid presenilins alzheimer disease
0.3493169.9384602.html.plaintext.txt	233	num presenilin gene new gene family involved alzheimer disease pathology
0.3493169.9384602.html.plaintext.txt	234	num protein topology presenilin num
0.3493169.9384602.html.plaintext.txt	235	num evidence six transmembrane domain structure presenilin num
0.3493169.9384602.html.plaintext.txt	236	num genetic linkage evidence familial alzheimers disease locus chromosome num
0.3493169.9384602.html.plaintext.txt	237	num alzheimers disease collaborative group clarkr
0.3493169.9384602.html.plaintext.txt	238	num structure presenilin num snum gene identification six novel mutation early onset ad family
0.3493169.9384602.html.plaintext.txt	239	num molecular genetic analysis familial early onset alzheimers disease linked chromosome numqnum
0.3493169.9384602.html.plaintext.txt	240	num presenilin mutation alzheimers disease
0.3493169.9384602.html.plaintext.txt	241	num mutation presenilin num gene family early onset alzheimers disease
0.3493169.9384602.html.plaintext.txt	242	num complete analysis presenilin num gene family early onset alzheimers disease
0.3493169.9384602.html.plaintext.txt	243	num sequence analysis presenilin num gene mutation japanese alzheimers disease patient
0.3493169.9384602.html.plaintext.txt	244	num alzheimers disease associated mutation presenilin num rare variably penetrant
0.3493169.9384602.html.plaintext.txt	245	num history dementia parkinson disease numst degree relative patient alzheimers disease
0.3493169.9384602.html.plaintext.txt	246	num amyloid precursor protein gene mutation early onset alzheimers disease
0.3493169.9384602.html.plaintext.txt	247	num population based study familial alzheimers disease linkage chromosome num num num
0.3493169.9384602.html.plaintext.txt	248	num analysis num sequence genomic structure alternative splicing presenilin num gene psennum associated early onset alzheimers disease
0.3493169.9384602.html.plaintext.txt	249	num structure alternative splicing presenilin num gene
0.3493169.9384602.html.plaintext.txt	250	num molecular genetic analysis familial early onset alzheimers disease linked chromosome numqnum
0.3493169.9384602.html.plaintext.txt	251	num genetic association study presenilin num early onset alzheimers disease
0.3493169.9384602.html.plaintext.txt	252	num genetic association intronic polymorphism presenilin num gene late onset alzheimers disease
0.3493169.9384602.html.plaintext.txt	253	num genomic structure expression stmnum chromosome num familial alzheimers disease gene
0.3493169.9384602.html.plaintext.txt	254	num missense mutation snumpsnum gene german early onset alzheimers disease patient
0.3493169.9384602.html.plaintext.txt	255	num sensitive pcr sscp hum
0.3493169.9384602.html.plaintext.txt	256	num presenilins alzheimer disease
0.3493169.9384602.html.plaintext.txt	257	num gene dose apolipoprotein e type num allele risk alzheimers disease late onset family
0.3493169.9384602.html.plaintext.txt	258	num apoe genotype modulate age onset family chromosome num encoded alzheimers disease
0.3493169.9384602.html.plaintext.txt	259	num facilitation lin num mediated signalling sel num caenorhabditis elegans snum alzheimers disease gene
0.3493169.9384602.html.plaintext.txt	260	num apolipoprotein enum allele population based study early onset alzheimers disease
0.3493169.9384602.html.plaintext.txt	261	num clinical diagnosis alzheimers disease report nincds adrda work group auspex department health human service task force alzheimers disease
0.3493169.9384602.html.plaintext.txt	262	num apolipoprotein e genotyping one stage pcr
0.3493169.9384602.html.plaintext.txt	263	correspondence addressed
0.3493169.9384602.html.plaintext.txt	264	tel num num num fax num num num email cvbroeckuia
0.35055456.9285791.html.plaintext.txt	0	altered metabolism familial alzheimers disease linked amyloid precursor protein variant yeast artificial chromosome transgenic mouse altered metabolism familial alzheimers disease linked amyloid precursor protein variant yeast artificial chromosome transgenic mouse bruce
0.35055456.9285791.html.plaintext.txt	1	younkinnum greg holtznum steven l
0.35055456.9285791.html.plaintext.txt	2	department genetics case western reserve university num euclid avenue cleveland oh num usa numdevelopmental genetics laboratory department gynecology obstetrics physiology numneuropathology laboratory department pathology john hopkins university school medicine baltimore md num usa nummayo clinic jacksonville jacksonville fl num usa numsibia neuroscience inc
0.35055456.9285791.html.plaintext.txt	3	received april num num revised accepted june num num
0.35055456.9285791.html.plaintext.txt	4	missense mutation beta amyloid precursor protein gene app co segregate small subset autosomal dominant familial alzheimers disease fad case wherein deposition num num amino acid beta amyloid abeta peptide neurodegeneration principal neuropathological hallmark
0.35055456.9285791.html.plaintext.txt	5	accurately examine effect missense mutation app metabolism abeta production vivo introduced yeast artificial chromosome yacs containing entire num kbp human app gene encoding app harboring either asparagine lysine leucine methionine fad substitution codon num num appknumnmnuml isoleucine valine fad substitution codon num appvnumi combination substitution transgenic mouse
0.35055456.9285791.html.plaintext.txt	6	demonstrate relative yac transgenic mouse expressing wild type app high level abeta peptide detected brain yac transgenic mouse expressing human appknumnmnuml associated concomitant diminution level alpha secretase generated soluble app derivative
0.35055456.9285791.html.plaintext.txt	7	moreover level longer abeta peptide specie terminating amino acid numnum elevated yac transgenic mouse expressing human appvnumi
0.35055456.9285791.html.plaintext.txt	8	mouse prove valuable detailed analysis vivo effect app fad mutation variety tissue throughout aging testing therapeutic agent specifically alter app metabolism abeta production
0.35055456.9285791.html.plaintext.txt	9	alzheimers disease ad common cause dementia elderly major source disability death
0.35055456.9285791.html.plaintext.txt	10	genetic investigation identified several etiology ad reviewed num including dosage imbalance chromosome num occurs syndrome d mutation beta amyloid precursor protein gene app chromosome num presenilin num gene chromosome num presenilin num gene chromosome num autosomal dominant early onset familial ad fad inheritance apolipoprotein enum allele chromosome num genetic risk factor late onset fad sporadic ad
0.35055456.9285791.html.plaintext.txt	11	principal cytological hallmark ad case parenchymal deposit beta amyloid abeta num num amino acid peptide derived app num
0.35055456.9285791.html.plaintext.txt	12	app gene encompasses num exon num kbp dna give rise least four tissue specific alternatively spliced transcript encode protein num num num num amino acid num num
0.35055456.9285791.html.plaintext.txt	13	app type integral membrane glycoprotein unknown function matures constitutive secretory pathway processed several pathway including cleavage alpha secretase position num abeta resulting secretion app ectodomain thus precluding abeta formation degradation endosomal lysosomal pathway cleavage beta gamma secretase n c terminus abeta respectively resulting production secretion abeta peptide reviewed num
0.35055456.9285791.html.plaintext.txt	14	missense mutation app occur small subset num individual early onset fad
0.35055456.9285791.html.plaintext.txt	15	two large related fad pedigree sweden num double mutation codon num num app num result substitution lysine asparagine methionine leucine appknumnmnuml
0.35055456.9285791.html.plaintext.txt	16	num fad pedigree num num mutation within transmembrane domain lead substitution either isoleucine phenylalanine glycine valine residue num app num appvnumi appvnumf appvnumg
0.35055456.9285791.html.plaintext.txt	17	introduction mutation app yacs e cell
0.35055456.9285791.html.plaintext.txt	18	mutation m introduced vitro given dna sequence contained yac trpi uranum arm cloned plasmid pnum num contains yeast leunum cyhnum gene
0.35055456.9285791.html.plaintext.txt	19	cutting plasmid dna unique site r one side mutation well introduction linear molecule yeast containing yac selection leu transformants result targeted integration plasmid corresponding genomic sequence yac
0.35055456.9285791.html.plaintext.txt	20	b subsequent selection cyhr transformants result excision plasmid generation wt mutated sequence
0.35055456.9285791.html.plaintext.txt	21	c high molecular weight dna yeast strain containing app yac four representative e transformants see table num digested hindiii transferred nylon membrane hybridized human alu repetitive element num
0.35055456.9285791.html.plaintext.txt	22	right shown size molecular weight marker kbp
0.35055456.9285791.html.plaintext.txt	23	d cytoplasmic rna e transformants subjected rt pcr analysis appropriate mouse mapp human happ plasmid cdna control num
0.35055456.9285791.html.plaintext.txt	24	right shown size expected human num bp mouse num bp product
0.35055456.9285791.html.plaintext.txt	25	study transfected cell provided enormous insight mechanism whereby fad mutation affect app processing abeta production
0.35055456.9285791.html.plaintext.txt	26	example cell expressing appknumnmnuml secrete higher level abeta containing peptide compared cell expressing wild type wt app num num concomitantly alpha secretase generated soluble app derivative diminished num
0.35055456.9285791.html.plaintext.txt	27	addition cell expressing appnum substitution specifically secrete elevated level longer abeta peptide num extending residue num andor num abetanum numnum
0.35055456.9285791.html.plaintext.txt	28	evidence abetanum numnum highly pathogenic abeta specie derives biophysical study showing highly fibrillogenic nature peptide immunocytochemical study brain ad d individual demonstrating abetanum numnum peptide deposited relatively early disease num num
0.35055456.9285791.html.plaintext.txt	29	numerous standard transgenic mouse generated express various wt mutant app cdna gene fragment variety promoter reviewed num see also num num
0.35055456.9285791.html.plaintext.txt	30	although study revealed app transgenic mouse develop age related abeta deposit specifically accurately examined effect regulated expression appknumnmnuml appvnumi metabolism app abeta vivo
0.35055456.9285791.html.plaintext.txt	31	contrast effort designed introduce entire num kbp human app gene harboring fad mutation germline transgenic mouse thus allowing proper spatial temporal expression mutant app appropriate splice donor acceptor site needed generate entire spectrum alternatively spliced app transcript encoded protein
0.35055456.9285791.html.plaintext.txt	32	num kbp yeast artificial chromosome yac containing app gene mutagenized using homologous recombination strategy yeast introduced mouse embryonic stem e cell lipid mediated transfection finally transferred mouse germline
0.35055456.9285791.html.plaintext.txt	33	brain peripheral tissue mutant app yac transgenic mouse high level human app mrna protein expressed manner mirror spatial temporal expression pattern endogenous mouse app gene product
0.35055456.9285791.html.plaintext.txt	34	furthermore elevated level abeta peptide detected brain yac transgenic mouse expressing human appknumnmnuml concomitant decrease level soluble alpha secretase generated app derivative compared mouse expressing similar level wt app
0.35055456.9285791.html.plaintext.txt	35	finally demonstrate elevated level longer abeta peptide detected yac transgenic mouse expressing human appvnumi
0.35055456.9285791.html.plaintext.txt	36	result mutagenesis app yacs
0.35055456.9285791.html.plaintext.txt	37	appknumnmnuml appvnumi fad mutation introduced yac containing entire wt num kb human app gene num kbp flanking sequence multiple neomycin resistance expression cassette yac vector arm homologous recombination yeast num
0.35055456.9285791.html.plaintext.txt	38	briefly genomic sequence containing app exon num num mutagenized subcloned screening app yac genomic sub library exon specific pcr product
0.35055456.9285791.html.plaintext.txt	39	mutation exon num appknumnmnuml num appvnumi introduced respective genomic fragment using pcr based mutagenesis strategy subcloned yeast vector pnum
0.35055456.9285791.html.plaintext.txt	40	pnum contains yeast leunum gene permit growth absence leucine cyhnum gene confers sensitivity cycloheximide num
0.35055456.9285791.html.plaintext.txt	41	finally two step gene replacement performed yeast introduce mutated app genomic sequence num kbp app yac fig
0.35055456.9285791.html.plaintext.txt	42	yacs containing mutated app genomic sequence identified restriction digestion sequencing exon specific pcr product integrity mutant yacs confirmed restriction digestion southern analysis pulsed field gel electrophoresis yeast genomic dna data shown
0.35055456.9285791.html.plaintext.txt	43	intact yacs identified containing appknumnmnuml appvnumi fad mutation separately mutation together
0.35055456.9285791.html.plaintext.txt	44	mutant app yac e clone colonya mutation expressionb alu profilec copy
0.35055456.9285791.html.plaintext.txt	45	num knumnmnuml vnumi nd num num jnum
0.35055456.9285791.html.plaintext.txt	46	num knumnmnuml vnumi num num jnum
0.35055456.9285791.html.plaintext.txt	47	num knumnmnuml vnumi num jnum
0.35055456.9285791.html.plaintext.txt	48	num knumnmnuml vnumi num yes rnum
0.35055456.9285791.html.plaintext.txt	49	num knumnmnuml vnumi num num yes rnum
0.35055456.9285791.html.plaintext.txt	50	num knumnmnuml num num yes rnum
0.35055456.9285791.html.plaintext.txt	51	num knumnmnuml vnumi num num aan additional num jnum eight rnum e clone contained majority mutant app yac injected mouse blastocyst
0.35055456.9285791.html.plaintext.txt	52	brelative amount app mrna determined rt pcr num
0.35055456.9285791.html.plaintext.txt	53	cintactness alu repetitive element profile determined southern blot analysis num
0.35055456.9285791.html.plaintext.txt	54	dcopy number determined southern blot analysis app exon num probe recognizes mouse human app
0.35055456.9285791.html.plaintext.txt	55	egenerated previous study num
0.35055456.9285791.html.plaintext.txt	56	introduction mutated app yacs e cell mouse
0.35055456.9285791.html.plaintext.txt	57	result transfection study mutant app yacs presented table num
0.35055456.9285791.html.plaintext.txt	58	purified concentrated mutated app yac dna introduced jnum rnum e cell lipid mediated transfection suspension culture generating num num gnumr line respectively
0.35055456.9285791.html.plaintext.txt	59	twenty one jnum num rnum line positive majority yac pcr including app promoter exon num exon num exon num alu repetitive elementpcr data shown
0.35055456.9285791.html.plaintext.txt	60	copy number integrity app yacs resulting e line table num determined extensive restriction analysis hybridization app data shown human alu probe fig
0.35055456.9285791.html.plaintext.txt	61	integration yacs containing mutated app sequence confirmed pcr restriction analysis
0.35055456.9285791.html.plaintext.txt	62	expression human app mrna determined reverse transcription pcr rt pcr analysis fig
0.35055456.9285791.html.plaintext.txt	63	num d degenerate primer span first six exon mousehuman app mrna num
0.35055456.9285791.html.plaintext.txt	64	several line subsequently introduced mouse blastocyst numerous chimera ranging num num e cell contribution generated
0.35055456.9285791.html.plaintext.txt	65	date five separate line transmitted e dna germline
0.35055456.9285791.html.plaintext.txt	66	app expression mutant yac transgenic mouse
0.35055456.9285791.html.plaintext.txt	67	expression human app examined several mutant app yac transgenic mouse including line jnum
0.35055456.9285791.html.plaintext.txt	68	num contains appknumnmnuml appvnumi mutation line rnum
0.35055456.9285791.html.plaintext.txt	69	num contains appknumnmnuml mutation
0.35055456.9285791.html.plaintext.txt	70	rt pcr analysis degenerate primer span first six exon mousehuman app mrna num revealed jnum
0.35055456.9285791.html.plaintext.txt	71	num line containing single copy mutant app yac expressed human app mrna level similar endogenous mouse app mrna brain fig
0.35055456.9285791.html.plaintext.txt	72	num lane num peripheral tissue fig num lane num num num line rnum
0.35055456.9285791.html.plaintext.txt	73	num containing num num copy mutant app yac expressed human app mrna level num num fold endogenous app mrna tissue examined fig
0.35055456.9285791.html.plaintext.txt	74	additional rt pcr experiment num degenerate primer flank common alternatively spliced app exon num num demonstrated level transcript encode human app num num num selected tissue paralleled level alternatively spliced mouse app transcript transgenic line examined data shown
0.35055456.9285791.html.plaintext.txt	75	app processing mutant yac transgenic mouse
0.35055456.9285791.html.plaintext.txt	76	expression human app related derivative brain mutant app yac transgenic mouse examined western blot analysis
0.35055456.9285791.html.plaintext.txt	77	demonstrate membrane fraction brain line jnum
0.35055456.9285791.html.plaintext.txt	78	num accumulation full length mutant human app recognized antibody ct num specific terminal num amino acid mouse human app fig
0.35055456.9285791.html.plaintext.txt	79	num lane num essentially indistinguishable level wt human app num yac transgenic line pynum
0.35055456.9285791.html.plaintext.txt	80	num kda fragment likely represents beta secretase generated c terminal peptide extending n terminus abeta end app cytoplasmic tail slightly elevated membrane fraction jnum
0.35055456.9285791.html.plaintext.txt	81	num b lane num relative brain animal expressing wt human app fig
0.35055456.9285791.html.plaintext.txt	82	num b lane num whereas num kda fragment likely represents alpha secretase generated c terminal fragment remains unchanged
0.35055456.9285791.html.plaintext.txt	83	analysis app mrna expression mutant app yac transgenic mouse
0.35055456.9285791.html.plaintext.txt	84	total rna brain lane num num kidney lane num num testis lane num num heart lane num num num month old control mouse ctl mouse line jnum
0.35055456.9285791.html.plaintext.txt	85	num containing appknumnmnum appvnumi mutation mouse line rnum
0.35055456.9285791.html.plaintext.txt	86	num containing appknumnmnum mutation subjected rt pcr analysis appropriate mouse mapp human happ template control lane num num
0.35055456.9285791.html.plaintext.txt	87	sense primer nump labeled experiment gel dried band quantitated phosphorimaging technology
0.35055456.9285791.html.plaintext.txt	88	num produce roughly equivalent amount mouse human app mrna brain line rnum
0.35055456.9285791.html.plaintext.txt	89	num produce num fold higher level human app mrna relative mouse app mrna
0.35055456.9285791.html.plaintext.txt	90	right shown size expected human num bp mouse num bp product
0.35055456.9285791.html.plaintext.txt	91	soluble cell associated app derived molecule app yac transgenic mouse brain
0.35055456.9285791.html.plaintext.txt	92	soluble snum fraction cell associated pnum fraction protein extract brain num month old control ctl lane num wild type wt line pynum
0.35055456.9285791.html.plaintext.txt	93	num containing appknumnmnum appvnumi mutation line rnum
0.35055456.9285791.html.plaintext.txt	94	num containing appknumnmnum mutation lane num num app yac transgenic mouse num subjected western blot analysis numnum
0.35055456.9285791.html.plaintext.txt	95	pnum extract subjected sd page tris tricine page b visualized antibody ct num recognizing c terminal num amino acid mouse human app snum extract c subjected sd page visualized antibody pnum num recognizing epitope n terminus human app
0.35055456.9285791.html.plaintext.txt	96	right shown approximate size kda
0.35055456.9285791.html.plaintext.txt	97	data consistent earlier demonstration cultured cell expressing appknumnmnuml accumulate elevated level c terminal num
0.35055456.9285791.html.plaintext.txt	98	num kda fragment generated following cleavage beta secretase num
0.35055456.9285791.html.plaintext.txt	99	reinforcing view also document amount beta secretase generated fragment accumulates high level line rnum
0.35055456.9285791.html.plaintext.txt	100	num mouse overexpressing high level human appknumnmnuml fig
0.35055456.9285791.html.plaintext.txt	101	interestingly steady state level full length human app line rnum
0.35055456.9285791.html.plaintext.txt	102	num lane num num fold higher endogenous app fig
0.35055456.9285791.html.plaintext.txt	103	num lane num finding parallel rt pcr study shown figure num
0.35055456.9285791.html.plaintext.txt	104	analysis soluble app derivative apps brain mutant app line jnum
0.35055456.9285791.html.plaintext.txt	105	num c lane num wt app line pynum
0.35055456.9285791.html.plaintext.txt	106	num c lane num using antibody specific epitope n terminus human app failed reveal significant difference total apps line
0.35055456.9285791.html.plaintext.txt	107	however commensurate elevation beta secretase generated c terminal fragment brain line rnum
0.35055456.9285791.html.plaintext.txt	108	num observed elevated level accumulated apps fig
0.35055456.9285791.html.plaintext.txt	109	extended analysis examine level alpha secretase generated soluble derivative line jnum
0.35055456.9285791.html.plaintext.txt	110	num expressing essentially identical level mutant wt human app respectively
0.35055456.9285791.html.plaintext.txt	111	western blot analysis soluble fraction snum brain revealed num decrease steady state level alpha secretase generated human apps derivative jnum
0.35055456.9285791.html.plaintext.txt	112	num despite demonstration total level apps appeared unchanged mutant wt transgenic line fig
0.35055456.9285791.html.plaintext.txt	113	level alpha secretase cleaved app mutant app yac transgenic mouse brain
0.35055456.9285791.html.plaintext.txt	114	soluble snum fraction extract brain num month old control ctl lane num num wild type wt line pynum
0.35055456.9285791.html.plaintext.txt	115	num lane num num mutant line jnum
0.35055456.9285791.html.plaintext.txt	116	num containing appknumnmnum appvnumi mutation lane num num app yac transgenic mouse num alpha secretase cleaved app standard lane num num subjected western blot analysis
0.35055456.9285791.html.plaintext.txt	117	parallel blot visualized antibody numenum recognizing alpha secretase cleaved human app num horseradish peroxidase tagged antibody data shown full length app
0.35055456.9285791.html.plaintext.txt	118	blot quantified numi labeled protein revealed num num reduction alpha secretase cleaved product mutant line jnum
0.35055456.9285791.html.plaintext.txt	119	num relative wt normalized full length app signal
0.35055456.9285791.html.plaintext.txt	120	right shown approximate size molecular weight marker kda
0.35055456.9285791.html.plaintext.txt	121	although decreased alpha secretase processing mutantappknumnmnuml appears surprising data fully consistent earlier cellular transfection study documented one effect appknumnmnuml mutation enhance cleavage beta secretase site golgi compartment num
0.35055456.9285791.html.plaintext.txt	122	result fraction app molecule would normally cleared alpha secretase plasma membrane would effectively disabled prior action beta secretase
0.35055456.9285791.html.plaintext.txt	123	hence medium cell expressing appknumnmnuml level alpha secretase derivative considerably diminished relative medium cell expressing similar level wt app
0.35055456.9285791.html.plaintext.txt	124	abeta production mutant app yac transgenic mouse
0.35055456.9285791.html.plaintext.txt	125	level abeta quantified using sandwich enzyme linked immunosorbent assay elisa num
0.35055456.9285791.html.plaintext.txt	126	analysis brain homogenate demonstrated increase amount total soluble abeta proportion longer abetanum numnum mutant app jnum
0.35055456.9285791.html.plaintext.txt	127	num line compared wt app line pynum
0.35055456.9285791.html.plaintext.txt	128	num abetax numnum num total abeta line jnum
0.35055456.9285791.html.plaintext.txt	129	num compared num line pynum
0.35055456.9285791.html.plaintext.txt	130	moreover dramatic increase total abeta abetanum numnum specie observed line rnum
0.35055456.9285791.html.plaintext.txt	131	preliminary study numsmethionine labeled primary cortical neuronal culture immunoprecipitation abeta conditioned medium revealed substantial increase abeta mutant app line jnum
0.35055456.9285791.html.plaintext.txt	132	num control culture data shown
0.35055456.9285791.html.plaintext.txt	133	vivo result similar obtained cell culture experiment human plasma suggest effect appknumnmnuml fad mutation enhance beta secretase cleavage resulting increased production secretion abeta appvnumi mutation appears influence processing gamma secretase site manner elevates level secreted abetanum numnum
0.35055456.9285791.html.plaintext.txt	134	level various abeta peptide app yac transgenic mouse brain
0.35055456.9285791.html.plaintext.txt	135	brain extract num month old control wild type wt line pynum
0.35055456.9285791.html.plaintext.txt	136	num containing appknumnmnum appvnumi mutation line rnum
0.35055456.9285791.html.plaintext.txt	137	num containing appknumnmnum mutation app yac transgenic mouse num subjected sensitive sandwich elisa detects various abeta peptide shown total abeta abetax numnum
0.35055456.9285791.html.plaintext.txt	138	level expressed pmolg relative control standardized peptide
0.35055456.9285791.html.plaintext.txt	139	abeta principal component parenchymal amyloid deposit ad derived integral membrane glycoprotein app
0.35055456.9285791.html.plaintext.txt	140	several mutation identified app gene co segregate affected individual fad pedigree reviewed num
0.35055456.9285791.html.plaintext.txt	141	although multiple app transgenic mouse generated attempt develop animal model ad reviewed num see also num num molecular mechanism involved altered app metabolism abeta deposition individual fad linked mutation app fully clarified
0.35055456.9285791.html.plaintext.txt	142	present report provides insight theeffects appknumnmnuml appvnumi fad mutation app metabolism abeta production vivo setting mimic condition occurring individual fad mutation
0.35055456.9285791.html.plaintext.txt	143	generated line transgenic mouse contain entire human app gene carried num kbp yac theappknumnmnuml mutation appvnumi mutation mutation together
0.35055456.9285791.html.plaintext.txt	144	mouse mutant human app transcript protein expressed spatial temporal pattern similar endogenous mouse product brain peripheral tissue
0.35055456.9285791.html.plaintext.txt	145	western blot analysis sensitive elisa whole brain homogenate demonstrated mouse expressing appknumnmnuml cell associated c terminal app fragment containing abeta domain abeta peptide elevated concomitant reduction level release alpha secretase cleaved app product
0.35055456.9285791.html.plaintext.txt	146	mouse expressing appvnumi hand accumulated elevated level longer abetanum numnum specie brain
0.35055456.9285791.html.plaintext.txt	147	one additional consideration yac transgenic experiment presence additional gene carried app yac might alter effect fad mutation expressed dosage imbalance
0.35055456.9285791.html.plaintext.txt	148	initial experiment exon trapping num kbp app yac revealed presence five additional exon encode app j
0.35055456.9285791.html.plaintext.txt	149	gearhart unpublished observation
0.35055456.9285791.html.plaintext.txt	150	four thesis exon reveal substantial identity sequence database one trapped exon num nt revealed complete identity bp num num exon num amino acid residue num num human transcription factor gabpa enumtfnum num gene genbank accession
0.35055456.9285791.html.plaintext.txt	151	dnum consistent localization gene chromosome numqnum
0.35055456.9285791.html.plaintext.txt	152	transcription factor contains ets related dna binding domain bind dna cggaaag sequence form heterodimers polypeptide num
0.35055456.9285791.html.plaintext.txt	153	although remains unclear whether entire gabpa gene present num kbp app yac biochemical abnormality observed mutant app yac transgenic mouse likely reflect property unique mutant app polypeptide dosage imbalance gabpa generated wt mutant app yac transgenic mouse express app similar level
0.35055456.9285791.html.plaintext.txt	154	summary result suggest vivo fad mutation influence app processing manner leading increased level highly amyloidogenic peptide abetanum numnum mouse expressing appknumnmnum accumulate increased level abeta peptide mouse expressing appvnumi selectively accumulate elevated level abetanum numnum
0.35055456.9285791.html.plaintext.txt	155	view vitro aggregation immunocytochemical study suggested abetanum numnum highly amyloidogenic deposited early disease process enthusiastic app yac mouse described herein develop amyloid deposit associated lesion described mouse expressing fad linked app transgene num num
0.35055456.9285791.html.plaintext.txt	156	addition yac transgenic mouse allow accurate examination effect fad mutation app processing variety cell type neuron astrocyte glia blood vessel etc
0.35055456.9285791.html.plaintext.txt	157	well alteration neuronal physiology behavior throughout aging
0.35055456.9285791.html.plaintext.txt	158	finally result suggest yac transgenic strategy allow stringent testing role early onset presenilin fad mutation amyloidogenesis examine potential interactive effect different early onset fad gene mutation
0.35055456.9285791.html.plaintext.txt	159	material method yac manipulation
0.35055456.9285791.html.plaintext.txt	160	human app genomic sub library constructed pulsed field gel electrophoresis fractionation isolation num kbp app yac followed digestion saci ligation saci digested lambda phage zapii stratagene
0.35055456.9285791.html.plaintext.txt	161	exon num num app genomic clone isolated screening sub library num bp exon num num num bp exon num product num yielding num
0.35055456.9285791.html.plaintext.txt	162	num kbp genomic clone respectively
0.35055456.9285791.html.plaintext.txt	163	clone converted plasmid restriction map generated
0.35055456.9285791.html.plaintext.txt	164	num kbp hindiii fragment containing exon num num kbp ecori fragment containing exon num subcloned bluescript stratagene
0.35055456.9285791.html.plaintext.txt	165	appknumnmnum appvnumi mutation introduced exon num num genomic subclones respectively pcr mutagenesis
0.35055456.9285791.html.plaintext.txt	166	primary pcr performed internal mutagenic primer num gagatctctgaagtgaatctggatgcagaattccgac num complement appknumnmnum mutation num ggacagtgatcatcatcaccttg num complement appvnumi mutation along external vector primer
0.35055456.9285791.html.plaintext.txt	167	secondary pcr performed external primer alone product subcloned yeast recombination plasmid pnum provided p
0.35055456.9285791.html.plaintext.txt	168	hieter john hopkins medical institution presence mutation confirmed dna sequencing
0.35055456.9285791.html.plaintext.txt	169	acci site upstream exon num genomic clone converted stui site addition linkers
0.35055456.9285791.html.plaintext.txt	170	plasmid containing mutagenized sequence linearized stui cut upstream exon num num introduced wt app yac two step gene replacement yeast described num
0.35055456.9285791.html.plaintext.txt	171	presence mutation determined restriction digestion exon specific pcr product confirmed dna sequencing southern blot analysis
0.35055456.9285791.html.plaintext.txt	172	mutated yac dna purified essentially described num second dimension electrophoresis step num nu sieve low melting point agarose fmc concentrate yac dna num
0.35055456.9285791.html.plaintext.txt	173	cell culture blastocyst injection
0.35055456.9285791.html.plaintext.txt	174	jaenisch whitehead institute rnum kindly provided j
0.35055456.9285791.html.plaintext.txt	175	rossant university toronto e cell maintained standard technique grown mitotically inactivated neor primary embryonic fibroblast presence leukemia inhibitory factor
0.35055456.9285791.html.plaintext.txt	176	transfection num ml isolated yac dna gently mixed num mug lipofectin brl polystyrene tube allowed complex num min room temperature
0.35055456.9285791.html.plaintext.txt	177	lipid dna complex added num num e cell resuspended num ml optimem brl placed num cm bacterial dish incubated num h numoc plated onto num cm tissue culture dish feeder
0.35055456.9285791.html.plaintext.txt	178	gnum num mugml selection initiated following day continued num day
0.35055456.9285791.html.plaintext.txt	179	injection dissociated e cell cnumblnumj blastocyst mating resultant chimera carried essentially described num
0.35055456.9285791.html.plaintext.txt	180	genomic dna isolated e cell mouse tail analyzed pcr southern blot variety probe previously described num
0.35055456.9285791.html.plaintext.txt	181	chideya expert technical assistance g
0.35055456.9285791.html.plaintext.txt	182	thinakaran assistance protein analysis p
0.35055456.9285791.html.plaintext.txt	183	connelly assistance yeast technology h
0.35055456.9285791.html.plaintext.txt	184	willard critical reading manuscript
0.35055456.9285791.html.plaintext.txt	185	work supported national institute health grant agnum nsnum
0.35055456.9285791.html.plaintext.txt	186	recipient javitz neuroscience investigator award nih nsnum leadership excellence alzheimers disease lead award nih agnum
0.35055456.9285791.html.plaintext.txt	187	recipient alzheimers association zenith award
0.35055456.9285791.html.plaintext.txt	188	num precursor alzheimers disease amyloid anum protein resembles cell surface receptor
0.35055456.9285791.html.plaintext.txt	189	num expression beta amyloid protein precursor mrna recognition novel alternatively spliced form quantitation alzheimers disease using pcr
0.35055456.9285791.html.plaintext.txt	190	num novel precursor alzheimers disease amyloid protein show protease inhibitory activity
0.35055456.9285791.html.plaintext.txt	191	num introduction expression num kilobase amyloid precursor protein gene transgenic mouse
0.35055456.9285791.html.plaintext.txt	192	num new anum amyloid mrna contains domain homologous serine proteinase inhibitor
0.35055456.9285791.html.plaintext.txt	193	num protease inhibitor domain encoded amyloid protein precursor mrna associated alzheimers disease
0.35055456.9285791.html.plaintext.txt	194	num cell biology amyloid beta protein precursor mechanism alzheimers disease
0.35055456.9285791.html.plaintext.txt	195	num pathogenetic mutation probable alzheimers disease app gene n terminus beta amyloid
0.35055456.9285791.html.plaintext.txt	196	num mutation codon num amyloid precursor protein gene australian family alzheimers disease
0.35055456.9285791.html.plaintext.txt	197	num early onset alzheimers disease caused mutation codon num beta amyloid precursor protein gene
0.35055456.9285791.html.plaintext.txt	198	num screening mutation open reading frame promoter beta amyloid precursor protein gene familial alzheimers disease identification family appnum val ile
0.35055456.9285791.html.plaintext.txt	199	num segregation missense mutation amyloid precursor protein gene familial alzheimers disease
0.35055456.9285791.html.plaintext.txt	200	num mutation amyloid precursor protein associated hereditary alzheimers disease
0.35055456.9285791.html.plaintext.txt	201	num mi sense mutation val ile exon num amyloid precursor protein gene japanese familial alzheimers disease
0.35055456.9285791.html.plaintext.txt	202	num amyloid precursor protein gene mutation early onset alzheimers disease
0.35055456.9285791.html.plaintext.txt	203	num metabolism swedish amyloid precursor protein variant neuronuma nnuma cell
0.35055456.9285791.html.plaintext.txt	204	num mutation beta amyloid precursor protein familial alzheimers disease increase beta protein production
0.35055456.9285791.html.plaintext.txt	205	num release excess amyloid beta protein mutant amyloid beta protein precursor
0.35055456.9285791.html.plaintext.txt	206	num increased percentage long amyloid beta protein secreted familial amyloid beta protein precursor betaappnum mutant
0.35055456.9285791.html.plaintext.txt	207	num visualization abetanumnum positive abetanum positive senile plaque end specific abeta monoclonal antibody evidence initially deposited abeta specie abetanum numnum
0.35055456.9285791.html.plaintext.txt	208	num seeding one dimensional crystallization amyloid pathogenic mechanism alzheimers disease scrapie cell num num num
0.35055456.9285791.html.plaintext.txt	209	num carboxy terminus beta amyloid protein critical seeding amyloid formation implication pathogenesis alzheimers disease
0.35055456.9285791.html.plaintext.txt	210	num appnum missense mutation affect ratio amyloid beta protein specie abetanum numnum abetanum num familial alzheimers disease brain
0.35055456.9285791.html.plaintext.txt	211	num making model alzheimers disease
0.35055456.9285791.html.plaintext.txt	212	num impaired learning ltp mouse expressing carboxy terminus alzheimer amyloid precursor protein
0.35055456.9285791.html.plaintext.txt	213	num correlative memory deficit abeta elevation amyoid plaque transgenic mouse
0.35055456.9285791.html.plaintext.txt	214	num alzheimer type neuropathology transgenic mouse overexpressing vnumf beta amyloid precursor protein
0.35055456.9285791.html.plaintext.txt	215	num yeast artificial chromosome promise kept pending
0.35055456.9285791.html.plaintext.txt	216	genetic physical mapping
0.35055456.9285791.html.plaintext.txt	217	cold spring harbor laboratory press cold spring harbor ny pp
0.35055456.9285791.html.plaintext.txt	218	num efficient manipulation human adenovirus genome infectious yeast artificial chromosome clone
0.35055456.9285791.html.plaintext.txt	219	num assignment enumtfnum num gene human chromosome numqnum
0.35055456.9285791.html.plaintext.txt	220	num mapping human transcription factor gabpa enumtf num gene chromosome num
0.35055456.9285791.html.plaintext.txt	221	num cdna cloning transcription factor enumtfnum subunit ets notch motif
0.35055456.9285791.html.plaintext.txt	222	num method generation yac transgenic mouse pronuclear microinjection
0.35055456.9285791.html.plaintext.txt	223	num production analysis chimeric mouse
0.35055456.9285791.html.plaintext.txt	224	teratocarcinomas embryonic stem cell practical approach
0.35055456.9285791.html.plaintext.txt	225	num biochemical characterization localization non n methyl d aspartate glutamate receptor rat brain
0.35055456.9285791.html.plaintext.txt	226	correspondence addressed
0.35055456.9285791.html.plaintext.txt	227	tel num num num num fax num num num num email btlpo
0.35055456.9285791.html.plaintext.txt	228	page maintained oup admin
0.35055456.9285791.html.plaintext.txt	229	last updated wed aug num numnumnum bst num
0.35055456.9285791.html.plaintext.txt	230	part oup journal world wide web service
0.35055456.9285791.html.plaintext.txt	231	copyright oxford university press num
0.3514349.9575200.html.plaintext.txt	0	subcellular distribution turnover presenilins transfected cell jimin zhang david e
0.3514349.9575200.html.plaintext.txt	1	kang weiming xia masayasu okochi hiroshi mori dennis j
0.3514349.9575200.html.plaintext.txt	2	department neurology pathology harvard medical school center neurologic disease brigham woman hospital boston massachusetts num department neuroscience university california san diego la jolla california num department molecular biology tokyo institute psychiatry tokyo num japan
0.3514349.9575200.html.plaintext.txt	3	mechanism mutation presenilin num psnum presenilin num psnum result alzheimers disease phenotype unclear
0.3514349.9575200.html.plaintext.txt	4	full length psnum psnum processed stable proteolytic fragment biosynthesis transfected cell
0.3514349.9575200.html.plaintext.txt	5	psnum psnum localized immunocytochemistry endoplasmic reticulum er golgi compartment previous study could differentiate full length presenilin protein fragment
0.3514349.9575200.html.plaintext.txt	6	carried subcellular fractionation cell stably transfected psnum psnum determine localization full length presenilins fragment
0.3514349.9575200.html.plaintext.txt	7	full length psnum psnum principally distributed er fraction whereas n c terminal fragment localized predominantly golgi fraction
0.3514349.9575200.html.plaintext.txt	8	cell expressing psnum mutant lacking exon num enum observed full length molecule present er golgi fraction
0.3514349.9575200.html.plaintext.txt	9	turnover rate considerably slower enum holoprotein apparently due decreased degradation within er
0.3514349.9575200.html.plaintext.txt	10	result suggest full length presenilin protein primarily er resident molecule undergo endoproteolysis within er
0.3514349.9575200.html.plaintext.txt	11	fragment subsequently transported golgi compartment turnover rate much slower full length presenilin er
0.3514349.9575200.html.plaintext.txt	12	alzheimers disease adnum major age related dementing disorder usually occurs sporadically elderly population
0.3514349.9575200.html.plaintext.txt	13	subset case familial ad fad occurs inherited autosomal dominant disease
0.3514349.9575200.html.plaintext.txt	14	mutation three different gene associated familial form ad reviewed ref
0.3514349.9575200.html.plaintext.txt	15	first fad gene amyloid precursor protein app precursor amyloid protein major component senile plaque seen brain ad individual
0.3514349.9575200.html.plaintext.txt	16	gene presenilin num psnum chromosome num num presenilin num psnum chromosome num num num account majority early onset case fad
0.3514349.9575200.html.plaintext.txt	17	psnum psnum functionally homologous c
0.3514349.9575200.html.plaintext.txt	18	elegans sel num molecule num num hydrophobic protein cross membrane num num time num num
0.3514349.9575200.html.plaintext.txt	19	transfected cell psnum psnum holoprotein rapidly turned half life num h num num
0.3514349.9575200.html.plaintext.txt	20	however transfected cell brain tissue stable n ntf c terminal fragment ctf apparently generated endoproteolysis full length presenilin molecule num num num
0.3514349.9575200.html.plaintext.txt	21	immunolocalization study presenilins transfected cell demonstrated predominant endoplasmic reticulum er golgi distribution num num
0.3514349.9575200.html.plaintext.txt	22	localization pattern similar regardless whether antibody generated either n c terminal epitope raising possibility ntfs ctfs remain proximity
0.3514349.9575200.html.plaintext.txt	23	however study distinguish full length presenilin molecule stable fragment
0.3514349.9575200.html.plaintext.txt	24	app also located er golgi direct indirect interaction presenilins may contribute production longer form amyloid peptide num num
0.3514349.9575200.html.plaintext.txt	25	thus knowledge processing trafficking presenilin molecule important understanding pathway production
0.3514349.9575200.html.plaintext.txt	26	role endoproteolysis presenilin maturation function remains defined
0.3514349.9575200.html.plaintext.txt	27	interestingly psnum fad mutation lacking exon num enum result absence conventional endoproteolysis num nevertheless functionally replace egg laying defect resulting c
0.3514349.9575200.html.plaintext.txt	28	date neither subcellular distribution holoprotein fragment compartment endoproteolytic cleavage occurs known
0.3514349.9575200.html.plaintext.txt	29	define distribution full length form stable fragment psnum psnum carried subcellular fractionation stably transfected cell
0.3514349.9575200.html.plaintext.txt	30	result indicate full length psnum psnum located mainly er n c terminal fragment located principally golgi
0.3514349.9575200.html.plaintext.txt	31	turnover rate enum mutant psnum protein slower wild type wt psnum holoprotein
0.3514349.9575200.html.plaintext.txt	32	concomitantly steady state subcellular distribution enum psnum extends er golgi fraction
0.3514349.9575200.html.plaintext.txt	33	finally pulse chase experiment combined subcellular fractionation suggested endoproteolytic cleavage psnum take place er
0.3514349.9575200.html.plaintext.txt	34	psnum psnum stably transfected cell chinese hamster ovary cho cell stably transfected wt mutant mnuml cnumy psnum wt mutant nnumi psnum described previously num num
0.3514349.9575200.html.plaintext.txt	35	cdna encoding wt enum psnum subcloned ecdysone inducible mammalian expression vector pind invitrogen transfected human embryonic kidney num cell previously transfected pvgrxr construct encodes regulatory ecdysone receptor ecrnum invitrogen
0.3514349.9575200.html.plaintext.txt	36	stable cell line selected zeocin gnum resistance
0.3514349.9575200.html.plaintext.txt	37	psnum expression induced overnight treatment num
0.3514349.9575200.html.plaintext.txt	38	antibody psnum polyclonal antibody jnum num raised residue num num num num psnum respectively previously characterized num num
0.3514349.9575200.html.plaintext.txt	39	psnum monoclonal antibody psnnum generated synthetic peptide corresponding residue num num psnum num
0.3514349.9575200.html.plaintext.txt	40	psnum polyclonal antibody num raised glutathione transferase bacterial fusion protein encompassing residue num num psnum
0.3514349.9575200.html.plaintext.txt	41	polyclonal antibody ctnum raised last num residue c terminus app num
0.3514349.9575200.html.plaintext.txt	42	additional polyclonal antibody included calnexin stressgen rat nak atpase upstate biotechnology inc
0.3514349.9575200.html.plaintext.txt	43	lake placid ny plus monoclonal antibody nak atpase america bioresearch co
0.3514349.9575200.html.plaintext.txt	44	pulse chase experiment confluent cho num cell incubated methionine deficient medium num h followed pulse labeling num microciml numsmethionine num min
0.3514349.9575200.html.plaintext.txt	45	cell either lysed immediately chased regular medium num num h
0.3514349.9575200.html.plaintext.txt	46	cell collected fractionated described
0.3514349.9575200.html.plaintext.txt	47	subcellular fractionation cultured cho num cell detached confluent culture grown num cm dish num mm edta ice cold phosphate buffered saline
0.3514349.9575200.html.plaintext.txt	48	cell pelleted resuspended homogenization buffer num mm hepes ph num
0.3514349.9575200.html.plaintext.txt	49	num m sucrose supplemented protease inhibitor mixture
0.3514349.9575200.html.plaintext.txt	50	cell disrupted using num stroke dounce homogenizer followed four passage num gauge needle
0.3514349.9575200.html.plaintext.txt	51	nucleus unbroken cell pelleted centrifugation num x g num min
0.3514349.9575200.html.plaintext.txt	52	pellet resuspended num
0.3514349.9575200.html.plaintext.txt	53	num ml homogenization buffer centrifuged num x g num min
0.3514349.9575200.html.plaintext.txt	54	postnuclear supernatant centrifugation step combined centrifuged numnum x g num h
0.3514349.9575200.html.plaintext.txt	55	vesicle pellet resuspended num
0.3514349.9575200.html.plaintext.txt	56	operation carried num degree c
0.3514349.9575200.html.plaintext.txt	57	cell line analyzed num num time representative experiment shown result
0.3514349.9575200.html.plaintext.txt	58	viscosity gradient medium major determinant sedimentation rate
0.3514349.9575200.html.plaintext.txt	59	addition subcellular organelle osmotically sensitive osmotic activity gradient medium particularly important
0.3514349.9575200.html.plaintext.txt	60	thus although sucrose glycerol ficoll widely used gradient fractionation cellular membrane ideal osmolality viscosity
0.3514349.9575200.html.plaintext.txt	61	optiprep num wv life technology inc
0.3514349.9575200.html.plaintext.txt	62	ready made solution iodixanol numnum num hydroxy num num propanediyl bisacetylamino bisnn bisnumnum dihydroxypropyl numnumnum triiodo numnum benzenecarboxamide
0.3514349.9575200.html.plaintext.txt	63	advantage using iodixanol gradient osmolality viscosity remain relatively constant change density gradient
0.3514349.9575200.html.plaintext.txt	64	mild iso osmotic condition organelle endosomes isolated intact without loss water density gradient increase
0.3514349.9575200.html.plaintext.txt	65	gradient stock solution num iodixanol prepared diluting num
0.3514349.9575200.html.plaintext.txt	66	num m sucrose num mm edta num mm hepes ph num
0.3514349.9575200.html.plaintext.txt	67	linear gradient num num iodixanol formed using gradient maker
0.3514349.9575200.html.plaintext.txt	68	resuspended vesicle preparation loaded top gradient centrifuged beckman swnum rotor numnum x g num h num degree c
0.3514349.9575200.html.plaintext.txt	69	sequential num ml fraction collected bottom gradient
0.3514349.9575200.html.plaintext.txt	70	subcellular marker calnexin galactosyltransferase nak atpase analyzed gradient preparation
0.3514349.9575200.html.plaintext.txt	71	immunoprecipitation western blotting subcellular fraction collected linear iodixanol gradient lysed addition nonidet p num final concentration num
0.3514349.9575200.html.plaintext.txt	72	immunoprecipitations whole cell lysates iodixanol gradient fraction performed described previously num
0.3514349.9575200.html.plaintext.txt	73	resultant immunoprecipitates resuspended laemmli sample buffer separated num num sd polyacrylamide gel electrophoresis transferred either polyvinylidene difluoride supported nitrocellulose membrane
0.3514349.9575200.html.plaintext.txt	74	sample pulse chase experiment transferred membrane following fractionation quantitated directly phosphor imaging
0.3514349.9575200.html.plaintext.txt	75	western blotting carried antibody indicated experiment
0.3514349.9575200.html.plaintext.txt	76	primary antibody visualized either numi conjugated secondary antibody peroxidase conjugated secondary antibody detected super signal enhanced chemiluminescence pierce
0.3514349.9575200.html.plaintext.txt	77	signal quantitated phosphor imaging densitometry respectively
0.3514349.9575200.html.plaintext.txt	78	galactosyltransferase assay numnum galactosyltransferase assay performed iodixanol fraction according method bretz staubli num addition numhgalactose onto oligosaccharide acceptor protein ovomucoid measured
0.3514349.9575200.html.plaintext.txt	79	subcellular fractionation iodixanol gradient cho cell stably transfected psnum wt mnuml cnumy psnum wt nnumi num cell stably transfected psnum wt enum ecdysone inducible system analyzed subcellular fractionation
0.3514349.9575200.html.plaintext.txt	80	subcellular vesicle separated num num continuous iodixanol gradient described material method
0.3514349.9575200.html.plaintext.txt	81	er rich fraction found expected bottom gradient using antibody well characterized er marker protein calnexin num fig
0.3514349.9575200.html.plaintext.txt	82	calnexin reactive er vesicle enriched fraction num num
0.3514349.9575200.html.plaintext.txt	83	golgi containing fraction identified assaying numnum galactosyltransferase trans golgi enzyme num principally found fraction num num fig
0.3514349.9575200.html.plaintext.txt	84	immunoreactivity nak atpase marker plasma membrane found top gradient
0.3514349.9575200.html.plaintext.txt	85	fraction num num although lesser amount immunoreactivity also present mid density region fraction num num shown
0.3514349.9575200.html.plaintext.txt	86	latter reactivity derived molecule transiting golgi
0.3514349.9575200.html.plaintext.txt	87	additional marker cho cell stably expressing wt appnum fractionated analyzed blotting antibody ctnum c terminus app
0.3514349.9575200.html.plaintext.txt	88	expected immature primarily n glycosylated form app appeared er rich fraction fraction num num fig
0.3514349.9575200.html.plaintext.txt	89	numc whereas mature n plus o glycosylated form app appeared golgi rich fraction num num
0.3514349.9575200.html.plaintext.txt	90	data indicate er golgi plasma membrane fraction effectively separated num num iodixanol gradient
0.3514349.9575200.html.plaintext.txt	91	view larger version numk fig
0.3514349.9575200.html.plaintext.txt	92	distribution major subcellular marker app continuous num num iodixanol gradient
0.3514349.9575200.html.plaintext.txt	93	representative result subcellular fractionation cho cell num cell b shown
0.3514349.9575200.html.plaintext.txt	94	distribution calnexin determined immunoblotting
0.3514349.9575200.html.plaintext.txt	95	distribution numnum galactosyltransferase determined enzyme activity assay
0.3514349.9575200.html.plaintext.txt	96	result expressed percentage respective signal fraction sum fraction
0.3514349.9575200.html.plaintext.txt	97	er marker calnexin primarily located fraction num num golgi marker galactosyltransferase distributed mainly fraction num num
0.3514349.9575200.html.plaintext.txt	98	c subcellular distribution app determined cho cell stably transfected appnum
0.3514349.9575200.html.plaintext.txt	99	following fractionation sd polyacrylamide gel electrophoresis sample immunoblotted app c terminal antibody ctnum
0.3514349.9575200.html.plaintext.txt	100	immature app isoforms present er rich fraction num num whereas mature form app appeared primarily golgi rich fraction num num
0.3514349.9575200.html.plaintext.txt	101	subcellular distribution psnum psnum determine distribution psnum performed western blot analysis gradient fraction psnum stably transfected cho cell
0.3514349.9575200.html.plaintext.txt	102	antibody jnum raised n terminus psnum recognized num kda psnum holoprotein derived transgene mainly gradient fraction num num co localized er marker calnexin fig
0.3514349.9575200.html.plaintext.txt	103	contrast major n terminal endoproteolytic fragment num kda consistently localized lighter fraction toward middle gradient principally fraction num num fig
0.3514349.9575200.html.plaintext.txt	104	similarly major c terminal fragment num kda distributed fraction num num fig
0.3514349.9575200.html.plaintext.txt	105	psnum ntf ctf colocalized golgi marker numnum galactosyl transferase
0.3514349.9575200.html.plaintext.txt	106	fractionation stable transfectants expressing psnum missense mutation mnuml cnumy showed significant difference wt psnum subcellular distribution holoprotein n c terminal fragment shown
0.3514349.9575200.html.plaintext.txt	107	view larger version numk fig
0.3514349.9575200.html.plaintext.txt	108	subcellular distribution psnum stably transfected cho cell
0.3514349.9575200.html.plaintext.txt	109	representative experiment fraction immunoblotted either n terminal antibody jnum b c terminal antibody num c d
0.3514349.9575200.html.plaintext.txt	110	signal full length psnum ntf ctf fraction expressed percentage sum fraction b d
0.3514349.9575200.html.plaintext.txt	111	psnum holoprotein found mainly gradient fraction num num co localized er marker calnexin
0.3514349.9575200.html.plaintext.txt	112	num kda major ntf located principally fraction num num
0.3514349.9575200.html.plaintext.txt	113	similarly num kda major ctf distributed fraction num num
0.3514349.9575200.html.plaintext.txt	114	ntf ctf colocalized golgi marker numnum galactosyltransferase respective experiment
0.3514349.9575200.html.plaintext.txt	115	next examined cho cell stably transfected psnum cdna using gradient fractionation blotting psnum n terminal antibody antibody num
0.3514349.9575200.html.plaintext.txt	116	full length psnum molecule detected characteristic num kda band principally er rich fraction num num fig
0.3514349.9575200.html.plaintext.txt	117	num b whereas n terminal fragment localized primarily golgi rich fraction num num
0.3514349.9575200.html.plaintext.txt	118	moreover seen psnum mutation distribution nnumi mutant form psnum identical wt psnum data shown
0.3514349.9575200.html.plaintext.txt	119	therefore subcellular distribution psnum proteolytic fragment similar obtained psnum fragment
0.3514349.9575200.html.plaintext.txt	120	view larger version numk fig
0.3514349.9575200.html.plaintext.txt	121	subcellular distribution psnum
0.3514349.9575200.html.plaintext.txt	122	cho cell expressing wt psnum fractionated iodixanol gradient immunoblotted psnum n terminal antibody num
0.3514349.9575200.html.plaintext.txt	123	signal full length psnum ntf fraction expressed percentage sum fraction b
0.3514349.9575200.html.plaintext.txt	124	similar psnum num kda full length psnum molecule found principally er fraction num num whereas num kda major ntf localized primarily golgi fraction num num
0.3514349.9575200.html.plaintext.txt	125	num cell expressing wt psnum showed pattern distribution holoprotein stable fragment similar seen cho transfected cell although tendency golgi fraction distributed larger number lighter fraction
0.3514349.9575200.html.plaintext.txt	126	however enum mutant protein undergo conventional endoproteolytic cleavage num widely distributed throughout gradient fraction fig
0.3514349.9575200.html.plaintext.txt	127	extension enum psnum lighter golgi fraction result overexpression result seen muristerone reduced cell line match level expression seen wt psnum transfected num cell fig
0.3514349.9575200.html.plaintext.txt	128	expected observed conventional proteolytic fragment enum psnum protein
0.3514349.9575200.html.plaintext.txt	129	furthermore reported num level n terminal fragment derived endogenous psnum decreased enum psnum expression increased higher muristerone induction fig
0.3514349.9575200.html.plaintext.txt	130	distribution ntf wt psnum enum transfected cell line latter without induction identical case latter cell ntf derived endogenous psnum
0.3514349.9575200.html.plaintext.txt	131	therefore subcellular distribution transgene derived psnum fragment altered transfection overexpression
0.3514349.9575200.html.plaintext.txt	132	view larger version numk fig
0.3514349.9575200.html.plaintext.txt	133	subcellular distribution wt enum mutant psnum
0.3514349.9575200.html.plaintext.txt	134	num cell stably expressing wt enum psnum induced overnight num num microm muristerone followed iodixanol fractionation immunoblotting psnum n terminal monoclonal antibody psnnum
0.3514349.9575200.html.plaintext.txt	135	cell induced amount muristerone indicated left
0.3514349.9575200.html.plaintext.txt	136	signal wt enum psnum cell induced num microm num
0.3514349.9575200.html.plaintext.txt	137	num microm muristerone respectively quantitated fraction expressed percentage total signal
0.3514349.9575200.html.plaintext.txt	138	mutant enum holoprotein contrast wt psnum extended er golgi fraction
0.3514349.9575200.html.plaintext.txt	139	note level ntf derived endogenous psnum decreased enum expression increased higher muristerone induction
0.3514349.9575200.html.plaintext.txt	140	enum mutant psnum longer half life reported transfected full length presenilin mainly located er shown short half life n c terminal fragment mainly located golgi shown substantially longer half life num num
0.3514349.9575200.html.plaintext.txt	141	futhermore result showed enum protein extending er golgi rich lighter fraction distinctly different subcellular distribution compared wt psnum holoprotein
0.3514349.9575200.html.plaintext.txt	142	determine whether enum mutant different turnover rate wt enum psnum stably transfected num cell pulse labeled num min chased num num num num num h
0.3514349.9575200.html.plaintext.txt	143	half life wt psnum num h average approximately num min multiple experiment holoprotein num h ntf fig
0.3514349.9575200.html.plaintext.txt	144	hand half life enum consistently twice long wt psnum holoprotein fig
0.3514349.9575200.html.plaintext.txt	145	steady state condition documented experiment described enum protein also present golgi fraction stable proteolytic fragment derived endogenous psnum located
0.3514349.9575200.html.plaintext.txt	146	surprisingly distribution enum mutant psnum substantially altered chase period fig
0.3514349.9575200.html.plaintext.txt	147	num h profile enum protein similar seen earlier time point
0.3514349.9575200.html.plaintext.txt	148	predominantly er fraction whereas virtually labeled psnum wt holoprotein remaining cell fig
0.3514349.9575200.html.plaintext.txt	149	therefore diminished degradation within er appears account large part prolonged half life enum rather shift protein golgi fraction turnover rate may slowed
0.3514349.9575200.html.plaintext.txt	150	view larger version numk fig
0.3514349.9575200.html.plaintext.txt	151	half life wt enum mutant psnum
0.3514349.9575200.html.plaintext.txt	152	overnight induction num microm wt psnum num
0.3514349.9575200.html.plaintext.txt	153	num microm enum muristerone cell pulse labeled chased num num h
0.3514349.9575200.html.plaintext.txt	154	aliquot cell time point lysed immunoprecipitated n terminal antibody jnum
0.3514349.9575200.html.plaintext.txt	155	signal time point chase period shown quantitated expressed percentage time num b
0.3514349.9575200.html.plaintext.txt	156	experiment half life wt psnum enum num num min respectively
0.3514349.9575200.html.plaintext.txt	157	c immunoprecipitation jnum antibody performed fraction iodixanol separation time num num num h chase
0.3514349.9575200.html.plaintext.txt	158	note distribution wt psnum enum holoprotein substantially changed num num h chase
0.3514349.9575200.html.plaintext.txt	159	gradient fraction showed longer half life enum due primarily diminished turnover protein er fraction
0.3514349.9575200.html.plaintext.txt	160	distribution ntf arrowhead psnum wt cell shifted dense lighter fraction chase period top
0.3514349.9575200.html.plaintext.txt	161	ntf derived endogenous psnum enum cell appear num h time point bottom
0.3514349.9575200.html.plaintext.txt	162	closer inspection ntf generated pulse chase period showed time num small amount labeled ntf detected psnum wt cell line fig
0.3514349.9575200.html.plaintext.txt	163	surprisingly time point distribution ntf virtually identical full length protein
0.3514349.9575200.html.plaintext.txt	164	peak signal fraction num num
0.3514349.9575200.html.plaintext.txt	165	num h chase level labeled ntf increased distributed widely extending lighter fraction
0.3514349.9575200.html.plaintext.txt	166	finally num h chase labeled ntf predominantly within golgi enriched fraction similar seen steady state condition
0.3514349.9575200.html.plaintext.txt	167	finding indicated initial cleavage psnum occurred er proteolytic fragment subsequently transported golgi
0.3514349.9575200.html.plaintext.txt	168	similar localization labeled ntf golgi fraction seen enum cell line num h chase time representing fragment derived endogenous psnum fig
0.3514349.9575200.html.plaintext.txt	169	interestingly endogenous ntf enum cell line visible num h time point suggesting delay formation proteolytic specie
0.3514349.9575200.html.plaintext.txt	170	mechanism mutation psnum psnum result early onset ad phenotype unclear
0.3514349.9575200.html.plaintext.txt	171	hypothesized selective increase production release amyloidogenic anum result presenilin mutation key factor pathogenesis fad num num num
0.3514349.9575200.html.plaintext.txt	172	present intracellular compartment presenilin interacts directly indirectly app unknown
0.3514349.9575200.html.plaintext.txt	173	study analyzed subcellular distribution presenilins transfected cell
0.3514349.9575200.html.plaintext.txt	174	result showed psnum psnum similarly distributed holoproteins principally located er stable psnum psnum fragment principally located golgi
0.3514349.9575200.html.plaintext.txt	175	enum psnum mutation result broader distribution protein er golgi rich fraction well prolonged turnover rate due diminished degradation within er
0.3514349.9575200.html.plaintext.txt	176	result also indicate endoproteolysis generate stable n c terminal fragment occurs er
0.3514349.9575200.html.plaintext.txt	177	previous immunolocalization study transfected cell demonstrated psnum psnum located er golgi num num
0.3514349.9575200.html.plaintext.txt	178	study however could distinguish signal derived full length protein versus stable ntfs ctfs
0.3514349.9575200.html.plaintext.txt	179	therefore carried subcellular fractionation cho num cell stably transfected psnum psnum determine localization full length presenilin fragment
0.3514349.9575200.html.plaintext.txt	180	result showed full length psnum psnum distributed dense fraction colocalized er marker calnexin
0.3514349.9575200.html.plaintext.txt	181	stable ntf ctf distributed predominantly lighter fraction colocalized golgi marker galactosyltransferase activity
0.3514349.9575200.html.plaintext.txt	182	gradient fraction er golgi fraction overlapped represent distinct population
0.3514349.9575200.html.plaintext.txt	183	also exclude possibility organelle containing presenilins may co purify gradient fraction
0.3514349.9575200.html.plaintext.txt	184	therefore study determine predominant localization presenilin protein specie compartment
0.3514349.9575200.html.plaintext.txt	185	lesser amount protein location excluded examine nuclear localization presenilins reported recently num
0.3514349.9575200.html.plaintext.txt	186	nonetheless clear subcellular separation full length presenilins stable fragment noteworthy known whether normal physiological function presenilin provided full length molecule proteolytic fragment
0.3514349.9575200.html.plaintext.txt	187	study subcellular distribution two psnum mutation mnuml cnumy nnumi psnum mutation similar respective wt presenilins
0.3514349.9575200.html.plaintext.txt	188	therefore mutation overtly alter presenilin trafficking
0.3514349.9575200.html.plaintext.txt	189	contrast noncleavable enum psnum mutant localized larger number gradient fraction distributed er golgi fraction
0.3514349.9575200.html.plaintext.txt	190	addition shown recently num pulse chase study showed turnover rate enum mutant protein considerably slower wt psnum holoprotein
0.3514349.9575200.html.plaintext.txt	191	initially speculated transport enum golgi compartment stable presenilin fragment located may underlie decrease turnover rate mutant protein specie
0.3514349.9575200.html.plaintext.txt	192	however pulse chase labeling combined subcellular fractionation showed significant pool pulse labeled enum protein remained intact within er time wt psnum holoprotein completely degraded
0.3514349.9575200.html.plaintext.txt	193	result suggests reduced proteolytic degradation enum within er responsible increased half life molecule
0.3514349.9575200.html.plaintext.txt	194	time small fraction undegraded protein together endogenous ntf ctf found golgi compartment
0.3514349.9575200.html.plaintext.txt	195	previous study consistently shown inverse relationship enum expression endogenous ntf level num num suggesting mutant holoprotein competes normal cleavage endogenous psnum
0.3514349.9575200.html.plaintext.txt	196	study increasing expression enum mutant protein muristerone induction similarly led progressively lower level endogenous psnum stable fragment
0.3514349.9575200.html.plaintext.txt	197	interestingly pulse chasefractionation study appearance labeled endogenous fragment delayed
0.3514349.9575200.html.plaintext.txt	198	therefore production ntf proteolysis endogenous psnum affected quantitatively kinetically presence enum mutant protein
0.3514349.9575200.html.plaintext.txt	199	competition likely occur er enum appeared largely degraded compartment
0.3514349.9575200.html.plaintext.txt	200	study also provides evidence constitutive endoproteolysis psnum generate stable ntf ctf occurs er
0.3514349.9575200.html.plaintext.txt	201	pulse chase experiment combined subcellular fractionation showed initial pool labeled ntf albeit low level located predominantly er fraction similar labeled holoprotein
0.3514349.9575200.html.plaintext.txt	202	chase period however amount labeled ntf increased consistent precursor product relationship full length protein specie fragment within er
0.3514349.9575200.html.plaintext.txt	203	importantly ntf seen distribute lighter fraction chase
0.3514349.9575200.html.plaintext.txt	204	num h chase labeled ntf distributed predominantly golgi enriched fraction similar seen steady state
0.3514349.9575200.html.plaintext.txt	205	taken together observation provide compelling evidence constitutive endoproteolysis psnum occurs initially er compartment
0.3514349.9575200.html.plaintext.txt	206	notable exception enum mutation subcellular distribution psnum mnuml cnumy psnum nnumi mutation indistinguishable wt psnum psnum respectively
0.3514349.9575200.html.plaintext.txt	207	since presenilin mutation reported show selective increase anum production num num result suggest perturbation er golgi processing level explain mutant alter anum generation
0.3514349.9575200.html.plaintext.txt	208	like presenilins maturation app exocytic pathway occurs er golgi compartment
0.3514349.9575200.html.plaintext.txt	209	thus colocalization app presenilins subcellular compartment lead possibility interaction two molecule reported transfected cell num num
0.3514349.9575200.html.plaintext.txt	210	using subcellular fractionation recently detected increased level anum er golgi fraction cell expressing mutant presenilins num
0.3514349.9575200.html.plaintext.txt	211	observation suggest understanding molecular interaction app presenilins well protein within cellular compartment important resolving mechanism ad pathogenesis
0.3514349.9575200.html.plaintext.txt	212	victor hsu rick mitchell helpful discussion technical advice dr
0.3514349.9575200.html.plaintext.txt	213	work supported national institute health grant ag num n num e
0.3514349.9575200.html.plaintext.txt	214	ag num ag num d
0.3514349.9575200.html.plaintext.txt	215	grant aid scientific research priority area h
0.3514349.9575200.html.plaintext.txt	216	cost publication article defrayed part payment page charge
0.3514349.9575200.html.plaintext.txt	217	article must therefore hereby marked advertisement accordance num u
0.3514349.9575200.html.plaintext.txt	218	section num solely indicate fact
0.3514349.9575200.html.plaintext.txt	219	correspondence addressed
0.3514349.9575200.html.plaintext.txt	220	neuroscience num university california san diego la jolla ca num num
0.3514349.9575200.html.plaintext.txt	221	num abbreviation used ad alzheimers disease fad familial alzheimers disease psnum presenilin num psnum presenilin num er endoplasmic reticulum app amyloid precursor protein wt wild type enum psnum mutant lacking exon num amyloid peptide ntf n terminal endoproteolytic fragment ctf c terminal endoproteolytic fragment cho chinese hamster ovary
0.3514349.9575200.html.plaintext.txt	222	copyright num american society biochemistry molecular biology inc
0.36325452.16103124.html.plaintext.txt	0	secretase independent mechanism signal transduction amyloid precursor protein matthew r
0.36325452.16103124.html.plaintext.txt	1	department neurology division neuroscience childrens hospital harvard medical school boston massachusetts num
0.36325452.16103124.html.plaintext.txt	2	received publication march num num revised form august num num
0.36325452.16103124.html.plaintext.txt	3	pathogenic autosomal dominant mutation app presenilins lead increased generation fibrillogenic peptide anum form amyloid plaque one hallmark pathogenic lesion alzheimer disease reviewed ref
0.36325452.16103124.html.plaintext.txt	4	moreover neurotoxic vitro vivo num num
0.36325452.16103124.html.plaintext.txt	5	observation led amyloid hypothesis proposes accumulation brain cause neurodegeneration dementia alzheimer disease
0.36325452.16103124.html.plaintext.txt	6	however despite significant effort spent investigating property app biological function reason cleavage remain enigmatic
0.36325452.16103124.html.plaintext.txt	7	evidence app play role cell adhesion axonal transport neurite outgrowth recently signal transduction num num
0.36325452.16103124.html.plaintext.txt	8	suggested app may signal mechanism similar notch receptor intracellular tail released presenilin secretase translocates nucleus activates transcription
0.36325452.16103124.html.plaintext.txt	9	idea supported observation app together adaptor protein fenum could activate transcriptional activity histone acetyltransferase tipnum num
0.36325452.16103124.html.plaintext.txt	10	thus presenilins may mediate regulated intramembrane proteolysis number transmembrane protein release soluble intracellular domain carry signaling function reviewed ref
0.36325452.16103124.html.plaintext.txt	11	adaptor protein fenum contains three protein interaction domain ww domain bind proline rich sequence two c terminal phosphotyrosine binding domain interact tipnum app respectively num num
0.36325452.16103124.html.plaintext.txt	12	fenum app placed within biological pathway caenorhabditis elegans respective mutant similar pharyngeal pumping phenotype num
0.36325452.16103124.html.plaintext.txt	13	expression fenum lead stabilization nuclear translocation aicd may induce apoptosis tipnum num num num
0.36325452.16103124.html.plaintext.txt	14	addition tipnum histone acetyltransferase activity implicated regulation gene expression dna repair num num
0.36325452.16103124.html.plaintext.txt	15	however mechanism underlying ability app regulate tipnum mediated transcription determined
0.36325452.16103124.html.plaintext.txt	16	study provide evidence contrast notch app able activate transcription tipnum independently secretase cleavage recruiting tipnum membrane leading tipnum activation cyclin dependent kinase mediated phosphorylation
0.36325452.16103124.html.plaintext.txt	17	followed nuclear translocation tipnum fenum activation transcription
0.36325452.16103124.html.plaintext.txt	18	view larger version numk figure num
0.36325452.16103124.html.plaintext.txt	19	app signaling require secretase cleavage contrast notch signaling
0.36325452.16103124.html.plaintext.txt	20	wild type wt e p ko cell cotransfected triplicate pfr luciferase prl tk galnum tipnum fenum app psnum plasmid indicated
0.36325452.16103124.html.plaintext.txt	21	approximately num h transfection cell collected dual luciferase reporter assay performed
0.36325452.16103124.html.plaintext.txt	22	b wild type e p ko cell cotransfected triplicate hesnum luciferase prl tk mnotche psnum nicd indicated luciferase assay performed num h post transfection
0.36325452.16103124.html.plaintext.txt	23	c wild type e p ko cell transfected pcdna mock appwt cnumaicd appsw plasmid
0.36325452.16103124.html.plaintext.txt	24	cell harvested num h transfection separated num num tristricine gel western blotted antibody cnum directed app c terminal domain
0.36325452.16103124.html.plaintext.txt	25	transfection plasmid cell transfected using lipo fectamine num invitrogen following manufacturer protocol
0.36325452.16103124.html.plaintext.txt	26	basically cell medium replaced opti mem followed addition mixture opti mem dna lipo fectamine num
0.36325452.16103124.html.plaintext.txt	27	cell incubated num degree c num num h time equivalent volume medium added along appropriate drug treatment
0.36325452.16103124.html.plaintext.txt	28	plasmid used follows pm tipnum galnum tipnum pcmv fenum pcmv myc fenum num num obtained
0.36325452.16103124.html.plaintext.txt	29	sudhof pcmv appnumwt pcdna cnum pcdna cnum myc pcdna ha tipnum pcdna ha tipnumsnumnuma obtained
0.36325452.16103124.html.plaintext.txt	30	khochbin pm galnum tipnumwt generated subcloning hemagglutinin ha tipnum cutting pm ha tipnum vector ecori xbai pm galnum tipnumsnumnuma generated subcloning ha tipnum cutting pm ha tipnum vector ecori xbai prk psnumwt pfr luciferase stratagene prl tk renilla promega hesnum luciferase mnotche pcdna nicd pcdnanum empty vector normalize total dna
0.36325452.16103124.html.plaintext.txt	31	transactivation assay cell plated onto num well plate transfected num num confluent
0.36325452.16103124.html.plaintext.txt	32	three well transfected per treatment
0.36325452.16103124.html.plaintext.txt	33	optimized dna concentration signaling assay num cell num
0.36325452.16103124.html.plaintext.txt	34	num microg pcmv myc fenum num num num
0.36325452.16103124.html.plaintext.txt	35	num microg pcmv appnumwt per well
0.36325452.16103124.html.plaintext.txt	36	pcmv myc fenum num num plasmid used shown previously act similarly full length fenum num hand required lower amount dna allow activation reporter tipnum
0.36325452.16103124.html.plaintext.txt	37	additionally construct myc tag facilitated confirmation equivalent expression western blotting different condition
0.36325452.16103124.html.plaintext.txt	38	approximately num num h transfection cell lysed promega passive lysis buffer
0.36325452.16103124.html.plaintext.txt	39	assay performed dual luciferase kit promega according protocol recommended manufacturer
0.36325452.16103124.html.plaintext.txt	40	luciferase activity read wallac victor model num multilabel counter
0.36325452.16103124.html.plaintext.txt	41	control transfection efficiency activity firefly luciferase reporter driven galnum promoter normalized activity renilla luciferase reporter prl tk
0.36325452.16103124.html.plaintext.txt	42	fold induction determined average three well per treatment normalized average signal reporter alone well
0.36325452.16103124.html.plaintext.txt	43	antibody anti ha antibody obtained sigma
0.36325452.16103124.html.plaintext.txt	44	detect tipnum used antibody nnum kind gift john lough num
0.36325452.16103124.html.plaintext.txt	45	paul greengard generously provided anti fenum antibody num
0.36325452.16103124.html.plaintext.txt	46	used rabbit antibody cnum directed app c terminus
0.36325452.16103124.html.plaintext.txt	47	anti antibody num numenum used immunoprecipitation immunoblotting respectively
0.36325452.16103124.html.plaintext.txt	48	anti lamin bnum antibody obtained zymed laboratory inc
0.36325452.16103124.html.plaintext.txt	49	purchased anti actin antibody oncogene science
0.36325452.16103124.html.plaintext.txt	50	mouse monoclonal antibody numcnum lab vision corp
0.36325452.16103124.html.plaintext.txt	51	secondary antibody purchased jackson immunoresearch laboratory inc
0.36325452.16103124.html.plaintext.txt	52	subcellular fractionation cell collected phosphate buffered saline num confluent pelleted centrifugation num x g num min
0.36325452.16103124.html.plaintext.txt	53	washed buffer num mm hepes koh num
0.36325452.16103124.html.plaintext.txt	54	num mm dithiothreitol num mm edta num mm egta num microm microcystin num mm navonum complete protease inhibitor mixture roche applied science centrifuged num x g num min
0.36325452.16103124.html.plaintext.txt	55	cell swelled num min buffer followed numx dounce homogenization glass pestle
0.36325452.16103124.html.plaintext.txt	56	nucleus pelleted centrifugation num x g num min
0.36325452.16103124.html.plaintext.txt	57	pellet supernatant separated pellet lysed deoxycholate containing radioimmune precipitation assay buffer ripa doc plus phosphatase inhibitor num mm naf num mm nanumpnumonum num microm microcystin num mm navonum complete protease inhibitor mixture saved nuclear fraction
0.36325452.16103124.html.plaintext.txt	58	supernatant combined num
0.36325452.16103124.html.plaintext.txt	59	num m mgclnum num mm edta num mm egta num microm microcystin num mm navonum complete protease inhibitor mixture followed ultracentrifugation numnum x g num h
0.36325452.16103124.html.plaintext.txt	60	pellet resuspended ripa doc phosphatase protease inhibitor saved membrane fraction
0.36325452.16103124.html.plaintext.txt	61	supernatant saved cytoplasmic fraction
0.36325452.16103124.html.plaintext.txt	62	view larger version numk figure num
0.36325452.16103124.html.plaintext.txt	63	secretase inhibitor affect app signaling aicd transcriptional activity
0.36325452.16103124.html.plaintext.txt	64	upper panel b hek num sh synumy cell respectively cotransfected triplicate pfr luciferase prl tk galnum tipnum fenum app cnum myc indicated
0.36325452.16103124.html.plaintext.txt	65	num h secretase inhibitor wpe ii num num inum num nm added
0.36325452.16103124.html.plaintext.txt	66	luciferase assay performed cell lysates num h transfection
0.36325452.16103124.html.plaintext.txt	67	lower panel cell lysates western blotted app antibody cnum actin loading control
0.36325452.16103124.html.plaintext.txt	68	c hek num cell stably expressing appsw hek num sh synumy cell transiently transfected tipnum fenum appwt incubated presence absence control secretase inhibitor wpe ii num num nm
0.36325452.16103124.html.plaintext.txt	69	immunoprecipitated antibody num western blotted antibody numenum
0.36325452.16103124.html.plaintext.txt	70	d hek num cell transfected wild type tipnum tipnumwt tipnumsnumasnuma mutant tipnumsnumnuma together fenum app indicated
0.36325452.16103124.html.plaintext.txt	71	tipnum immunoprecipitated ip anti ha antibody co immunoprecipitated app detected western blotting antibody cnum
0.36325452.16103124.html.plaintext.txt	72	transgenic mouse cortex hippocampus dissected num month old num year old tgnum app transgenic mouse
0.36325452.16103124.html.plaintext.txt	73	used two animal genotype age
0.36325452.16103124.html.plaintext.txt	74	brain sample subjected fractionation described
0.36325452.16103124.html.plaintext.txt	75	briefly brain sample washed phosphate buffered saline swelled buffer num min followed dounce homogenization glass pestle
0.36325452.16103124.html.plaintext.txt	76	nucleus pelleted centrifugation num x g num min
0.36325452.16103124.html.plaintext.txt	77	supernatant combined num
0.36325452.16103124.html.plaintext.txt	78	num volume buffer b ultracentrifuged numnum x g num h
0.36325452.16103124.html.plaintext.txt	79	pellet resuspended ripa doc used membrane fraction western blot analysis
0.36325452.16103124.html.plaintext.txt	80	immunoprecipitation western blotting co immunoprecipitation experiment protein lysates precleared protein g sepharose amersham bioscience num h num degree c followed overnight incubation immunoprecipitating antibody
0.36325452.16103124.html.plaintext.txt	81	next morning fresh protein g sepharose added rocked num degree c num h followed three wash ripa doc anti ha antibody immunoprecipitations phosphate buffered saline antibody num immunoprecipitations
0.36325452.16103124.html.plaintext.txt	82	protein eluted bead boiling numx sample buffer num min
0.36325452.16103124.html.plaintext.txt	83	immunoprecipitationwestern blot experiment hek num sh synumy cell transiently transfected tipnum fenum app numenum appsw expressing hek num stable cell line incubated num num h respectively condition medium
0.36325452.16103124.html.plaintext.txt	84	secretase inhibitor added beginning conditioning final concentration num nm num time icnum value
0.36325452.16103124.html.plaintext.txt	85	transient transfection additional secretase inhibitor added num h num
0.36325452.16103124.html.plaintext.txt	86	num time icnum value compensate turnover inhibitor
0.36325452.16103124.html.plaintext.txt	87	conditioned medium collected spun num rpm num min remove cellular debris
0.36325452.16103124.html.plaintext.txt	88	anti antibody num added conditioned medium rocked overnight num degree c
0.36325452.16103124.html.plaintext.txt	89	next morning protein sepharose amersham bioscience added rocked num degree c num h
0.36325452.16103124.html.plaintext.txt	90	protein sepharose washed three time phosphate buffered saline eluted bead numx sample buffer boiled num min
0.36325452.16103124.html.plaintext.txt	91	experiment app stabilization tipnum cell collected num h post transfection using promega passive lysis buffer
0.36325452.16103124.html.plaintext.txt	92	lysates clarified centrifugation numnum x g num min equivalent cell lysates loaded onto gel western blotting
0.36325452.16103124.html.plaintext.txt	93	immunocytochemistry sh synumy cell plated onto coverslips num well plate num day prior transfection
0.36325452.16103124.html.plaintext.txt	94	cell transfected ha tipnum alone fenum app described incubated num h
0.36325452.16103124.html.plaintext.txt	95	cell fixed num paraformaldehyde num min permeabilized num
0.36325452.16103124.html.plaintext.txt	96	num triton x num num min blocked num donkey serum num h followed overnight incubation anti ha antibody antibody cnum detect tipnum app respectively
0.36325452.16103124.html.plaintext.txt	97	next day used cynum conjugated anti mouse antibody label tipnum cynum conjugated anti rabbit antibody label app
0.36325452.16103124.html.plaintext.txt	98	finally hoechst stain included first wash label nucleus
0.36325452.16103124.html.plaintext.txt	99	image taken zeiss confocal microscope
0.36325452.16103124.html.plaintext.txt	100	view larger version numk figure num
0.36325452.16103124.html.plaintext.txt	101	app signaling independent caspase cleavage regulate neprilysin level
0.36325452.16103124.html.plaintext.txt	102	b hek num cell wild type wt e p ko cell respectively cotransfected pfr luciferase luc prl tk galnum tipnum fenum app indicated
0.36325452.16103124.html.plaintext.txt	103	cell treated num h post transfection secretase inhibitor wpe ii num inum num nm caspase inhibitor benzyloxycarbonyl vad fluoromethyl ketone zvadnum microm
0.36325452.16103124.html.plaintext.txt	104	luciferase assay performed num h transfection
0.36325452.16103124.html.plaintext.txt	105	c whole cell lysates two independent wild type e pbdnum pbdnum two p ko bdnum bdnum cell line probed neprilysin reprobed actin
0.36325452.16103124.html.plaintext.txt	106	d bdnum p ko cell transfected psnum lysates collected num h later western blotted duplicate neprilysin presenilin app c terminal fragment
0.36325452.16103124.html.plaintext.txt	107	e bdnum p ko cell transfected either cnum cnum myc alone tipnum fenum
0.36325452.16103124.html.plaintext.txt	108	num h cell harvested western blotted neprilysin actin cnum myc expression
0.36325452.16103124.html.plaintext.txt	109	cnum expression confirmed darker exposure data shown
0.36325452.16103124.html.plaintext.txt	110	view larger version numk figure num
0.36325452.16103124.html.plaintext.txt	111	cdk phosphorylation tipnum required app dependent transactivation stabilization tipnum
0.36325452.16103124.html.plaintext.txt	112	b luciferase assay performed hek num wild type e cell respectively transfected galnum tipnum tipnumwt galnum tipnumsnumasnuma tipnumsnumnuma together fenum app
0.36325452.16103124.html.plaintext.txt	113	cell treated cdk inhibitor roscovitine rosc
0.36325452.16103124.html.plaintext.txt	114	num microm indicated num h
0.36325452.16103124.html.plaintext.txt	115	c shown phosphorylation tipnum
0.36325452.16103124.html.plaintext.txt	116	hek num cell cotransfected wild type tipnum tipnumwt tipnumsnumasnuma tipnumsnumnuma alone fenum app
0.36325452.16103124.html.plaintext.txt	117	cell harvested num h post transfection equivalent amount lysate protein incubated absence presence calf intestinal alkaline phosphatase cip western blotted anti tipnum antibody nnum
0.36325452.16103124.html.plaintext.txt	118	d app dependent stabilization tipnum requires cdk phosphorylation
0.36325452.16103124.html.plaintext.txt	119	wild type e hek num cell cotransfected wild type tipnum tipnumsnumasnuma fenum app treated roscovitine num microm
0.36325452.16103124.html.plaintext.txt	120	confirmed presenilin deficient cell fail generate detectable level cnum fragment corresponding aicd
0.36325452.16103124.html.plaintext.txt	121	probed lysates either wild type e p ko cell transfected plasmid encoding wild type app appwt cnumaicd appsw
0.36325452.16103124.html.plaintext.txt	122	immunoblot analysis wild type cell expressing appwt appsw antibody raised app c terminus showed band num kda comigrated transfected cnumaicd fig
0.36325452.16103124.html.plaintext.txt	123	however p ko cell expressing appwt appsw show clear num kda band although band appeared p ko cell transfected cnumaicd plasmid
0.36325452.16103124.html.plaintext.txt	124	thus app able activate tipnum mechanism require secretase generation cnumaicd
0.36325452.16103124.html.plaintext.txt	125	confirmed presenilins required notch signaling contrast app signaling require presenilins
0.36325452.16103124.html.plaintext.txt	126	expressed activated notch construct mnotche encodes truncated notch num protein retaining transmembrane domain together notch num responsive hesnum luciferase reporter
0.36325452.16103124.html.plaintext.txt	127	mnotche able drive significant transactivation hesnum reporter wild type cell signaling ability absent p ko cell fig
0.36325452.16103124.html.plaintext.txt	128	numb consistent previous report num num
0.36325452.16103124.html.plaintext.txt	129	expression presenilin p ko cell rescued ability mnotche activate hesnum reporter fig
0.36325452.16103124.html.plaintext.txt	130	show lack notch signaling presenilin deficient cell due solely lack presenilin dependent secretase cleavage mnotche
0.36325452.16103124.html.plaintext.txt	131	illustrating point similar level transactivation obtained upon expression soluble nicd wild type presenilin deficient cell fig
0.36325452.16103124.html.plaintext.txt	132	numb demonstrating cell line similarly competent signal transduction
0.36325452.16103124.html.plaintext.txt	133	result suggest presenilin deficient cell carry signaling requires secretase activity yet cell support app mediated activation tipnum
0.36325452.16103124.html.plaintext.txt	134	thus app may signal alternative mechanism
0.36325452.16103124.html.plaintext.txt	135	secretase independence app signaling confirm surprising secretase independent mode app signaling performed similar assay hek num sh synumy cell
0.36325452.16103124.html.plaintext.txt	136	expected observed significant transactivation upon coexpression fenum app fig
0.36325452.16103124.html.plaintext.txt	137	treatment secretase inhibitor wpe ii num num time icnum value significantly affect app tipnum signaling hek num sh synumy cell fig
0.36325452.16103124.html.plaintext.txt	138	concentration secretase inhibitor greatly decreased production fig
0.36325452.16103124.html.plaintext.txt	139	numc markedly increased accumulation app c terminal fragment fig
0.36325452.16103124.html.plaintext.txt	140	secretase independence app signaling confirmed using another secretase inhibitor wpe iii numc hek num sh synumy cell data shown
0.36325452.16103124.html.plaintext.txt	141	result confirm app nuclear signaling tipnum occur independently secretase cleavage
0.36325452.16103124.html.plaintext.txt	142	view larger version numk figure num
0.36325452.16103124.html.plaintext.txt	143	app recruit tipnum membrane compartment vitro vivo
0.36325452.16103124.html.plaintext.txt	144	hek num cell transfected wild type tipnum tipnumwt alone fenum app num h transfection cell subjected subcellular fractionation nuclear cytoplasmic membrane fraction
0.36325452.16103124.html.plaintext.txt	145	fraction western blotted tipnum showed membrane recruitment coexpression fenum app
0.36325452.16103124.html.plaintext.txt	146	western blotting nuclear protein lamin bnum confirmed lack nuclear contamination membrane fraction
0.36325452.16103124.html.plaintext.txt	147	b similar result observed endogenous tipnum hek num cell stably expressing app
0.36325452.16103124.html.plaintext.txt	148	c cortex hippocampus isolated app transgenic littermate control wild type wt mouse either num month young num year old age
0.36325452.16103124.html.plaintext.txt	149	cortical hippocampal sample fractionated western blotting performed tipnum
0.36325452.16103124.html.plaintext.txt	150	examine role aicd signal transduction pathway replaced app signaling assay cnum construct hek num cell
0.36325452.16103124.html.plaintext.txt	151	cnum essentially signaling ability fig
0.36325452.16103124.html.plaintext.txt	152	numa upper panel contrast signaling competent notch derived nicd fig
0.36325452.16103124.html.plaintext.txt	153	moreover observed cnum dominant negative effect decreased app signaling coexpressed app fig
0.36325452.16103124.html.plaintext.txt	154	immunoblot analysis lysates showed equivalent level app expression fig
0.36325452.16103124.html.plaintext.txt	155	similar result obtained app signaling assay wild type e p ko cell data shown
0.36325452.16103124.html.plaintext.txt	156	result suggest cnumaicd activate transcription tipnum rather act dominant negative protein signaling pathway
0.36325452.16103124.html.plaintext.txt	157	suggested app may able carry signal transduction cleavage caspase cleavage site within cytoplasmic c terminal domain num num
0.36325452.16103124.html.plaintext.txt	158	address possibility used pan caspase inhibitor benzyloxycarbonyl vad fluoromethyl ketone another series luciferase assay hek num cell
0.36325452.16103124.html.plaintext.txt	159	inhibiting caspase activity benzyloxycarbonyl vad fluoromethyl ketone failed significantly affect ability app activate tipnum fig
0.36325452.16103124.html.plaintext.txt	160	notably still effect app signaling secretase caspase inhibitor added together
0.36325452.16103124.html.plaintext.txt	161	similar result observed wild type e p ko cell fig
0.36325452.16103124.html.plaintext.txt	162	thus app retains ability activate tipnum signaling absence cleavage either secretase caspase
0.36325452.16103124.html.plaintext.txt	163	recent study identified degrading enzyme neprilysin potential transcriptional target cnumaicd num
0.36325452.16103124.html.plaintext.txt	164	attempted confirm result using wild type e p ko cell line
0.36325452.16103124.html.plaintext.txt	165	observed significant cell line variability level endogenous neprilysin correlate presenilin genotype fig
0.36325452.16103124.html.plaintext.txt	166	numc indicating variation related presenilin expression
0.36325452.16103124.html.plaintext.txt	167	furthermore attempted elevate neprilysin level p ko cell overexpression psnum cnum cnum myc
0.36325452.16103124.html.plaintext.txt	168	observe reproducible change neprilysin level upon expression plasmid num h transfection fig
0.36325452.16103124.html.plaintext.txt	169	confirmed psnum cnum myc expressed western blotting fig
0.36325452.16103124.html.plaintext.txt	170	moreover confirmed transfected psnum functional rescued accumulation app c terminal fragment observed absence secretase cleavage app fig
0.36325452.16103124.html.plaintext.txt	171	similar result observed hek num cell transfected cnum cnum myc data shown
0.36325452.16103124.html.plaintext.txt	172	result suggest neprilysin may transcriptional target cnumaicd
0.36325452.16103124.html.plaintext.txt	173	complex formation tipnum fenum app shown holo app membrane spanning c terminal fragment rather cnumaicd may mediate signaling investigated whether tipnum form complex holo app
0.36325452.16103124.html.plaintext.txt	174	tipnum co immunoprecipitated holo app fig
0.36325452.16103124.html.plaintext.txt	175	presence holo app suggests tipnum may form complex app membrane compartment rather nucleus suggested previously num
0.36325452.16103124.html.plaintext.txt	176	even longer exposure unable detect significant level app c terminal fragment aicd tipnum immunoprecipitates suggesting tipnum form complex holo app
0.36325452.16103124.html.plaintext.txt	177	coexpression fenum along tipnum app increased complex formation tipnum app fig
0.36325452.16103124.html.plaintext.txt	178	result suggest tipnum form complex holo app presumably membrane support hypothesis app may signal mechanism involves membrane recruitment tipnum rather nuclear translocation aicd
0.36325452.16103124.html.plaintext.txt	179	view larger version numk figure num
0.36325452.16103124.html.plaintext.txt	180	colocalization app tipnum
0.36325452.16103124.html.plaintext.txt	181	sh synumy cell cotransfected tipnum alone c fenum app d f fixed permeabilized num h post transfection
0.36325452.16103124.html.plaintext.txt	182	tipnum visualized antibody ha tag cynum conjugated secondary antibody red app visualized antibody cnum cynum conjugated secondary antibody green
0.36325452.16103124.html.plaintext.txt	183	nucleus labeled hoechst dye
0.36325452.16103124.html.plaintext.txt	184	role cyclin dependent kinase cdk phosphorylation tipnum signaling app activate tipnum pathway require secretase cleavage app considered whether app signaling involves activation kinase cascade
0.36325452.16103124.html.plaintext.txt	185	two cdk site recently identified tipnum serine num num num
0.36325452.16103124.html.plaintext.txt	186	examine role phosphorylation site app tipnum signaling fused galnum dna binding domain tipnum mutant serine num num converted alanine
0.36325452.16103124.html.plaintext.txt	187	assessed activity tipnum mutant luciferase reporter assay transfected hek num cell
0.36325452.16103124.html.plaintext.txt	188	tipnum mutant could activated coexpression fenum app contrast strong transactivation observed wild type tipnum fig
0.36325452.16103124.html.plaintext.txt	189	confirm requirement cdk phosphorylation tipnum app signal transduction tested cdk inhibitor roscovitine
0.36325452.16103124.html.plaintext.txt	190	cdk inhibition roscovitine significantly decreased ability app activate tipnum fig
0.36325452.16103124.html.plaintext.txt	191	similar result observed e cell fig
0.36325452.16103124.html.plaintext.txt	192	thus phosphorylation tipnum serine num num cdks contributes transcriptional signaling
0.36325452.16103124.html.plaintext.txt	193	tipnum phosphorylation mutant able co immunoprecipitate app efficiently wild type tipnum coexpressed fenum fig
0.36325452.16103124.html.plaintext.txt	194	thus inability app activate tipnum mutant unlikely due effect complex formation app tipnum
0.36325452.16103124.html.plaintext.txt	195	stabilization phosphorylated form tipnum app fenum determined whether app facilitates tipnum phosphorylation
0.36325452.16103124.html.plaintext.txt	196	wild type phosphorylation mutant tipnum construct cotransfected fenum app hek num cell fig
0.36325452.16103124.html.plaintext.txt	197	treatment cell lysates calf intestinal alkaline phosphatase led condensation multiple tipnum band single faster migrating form suggesting slower migrating form phosphorylated form tipnum
0.36325452.16103124.html.plaintext.txt	198	tipnum mutant migrated lower apparent molecular mass compared wild type tipnum consistent lack phosphorylation tipnum cdk site
0.36325452.16103124.html.plaintext.txt	199	alkaline phosphatase treatment also led condensation tipnum mutant band single faster migrating form comigrated dephosphorylated wild type tipnum indicating additional phosphorylation site yet identified
0.36325452.16103124.html.plaintext.txt	200	coexpression tipnum fenum app led markedly enhanced level slowest migrating phosphorylated form wild type tipnum fig
0.36325452.16103124.html.plaintext.txt	201	densitometric analysis blot showed num increase slowest migrating band relative fastest migrating form tipnum
0.36325452.16103124.html.plaintext.txt	202	fenum app affect tipnum cdk phosphorylation mutant suggesting act specifically increase phosphorylation cdk site
0.36325452.16103124.html.plaintext.txt	203	coexpression app fenum also led significant phosphorylation tipnum cdk site e cell fig
0.36325452.16103124.html.plaintext.txt	204	confirm phosphorylation event mediated cdks tested cdk inhibitor roscovitine
0.36325452.16103124.html.plaintext.txt	205	increase phosphorylation tipnum mediated fenum app completely blocked cdk inhibitor roscovitine fig
0.36325452.16103124.html.plaintext.txt	206	result indicate app fenum potentiate cdk mediated phosphorylation tipnum thereby activating nuclear signaling
0.36325452.16103124.html.plaintext.txt	207	view larger version numk figure num
0.36325452.16103124.html.plaintext.txt	208	shuttling tipnum nucleus cytoplasm app signaling
0.36325452.16103124.html.plaintext.txt	209	identification two potential nuclear localization sequence nls within tipnum conserved mouse rat human orthologs
0.36325452.16103124.html.plaintext.txt	210	additionally conserved potential nuclear export sequence indicated
0.36325452.16103124.html.plaintext.txt	211	b hek num cell cotransfected pfr luciferase prl tk galnum tipnum fenum app
0.36325452.16103124.html.plaintext.txt	212	cell treated nuclear export inhibitor leptomycin b num nm luciferase assay performed num transfection
0.36325452.16103124.html.plaintext.txt	213	app recruit tipnum membrane compartment determined subcellular localization tipnum fenum app complex performing subcellular fractionation hek num cell expressing tipnum
0.36325452.16103124.html.plaintext.txt	214	substantial portion tipnum present nuclear fraction whether fenum app coexpressed fig
0.36325452.16103124.html.plaintext.txt	215	numa expected based previous study num
0.36325452.16103124.html.plaintext.txt	216	however upon expression fenum app marked redistribution tipnum membrane fraction fig
0.36325452.16103124.html.plaintext.txt	217	nuclear protein lamin bnum present nuclear fraction detectable membrane fraction suggesting membrane associated tipnum due nuclear contamination
0.36325452.16103124.html.plaintext.txt	218	determined whether endogenous tipnum recruited membrane app
0.36325452.16103124.html.plaintext.txt	219	purpose utilized control hek num cell hek num cell stably expressing appwt
0.36325452.16103124.html.plaintext.txt	220	observed overexpressed tipnum endogenous tipnum immunoreactivity nuclear fraction control app expressing cell fig
0.36325452.16103124.html.plaintext.txt	221	however app expressing cell substantial tipnum immunoreactivity membrane fraction observed control cell
0.36325452.16103124.html.plaintext.txt	222	appwt expressing cell showed num fold increase membrane associated tipnum compared control cell overexpress app num fold increase total cellular tipnum
0.36325452.16103124.html.plaintext.txt	223	thus endogenous tipnum recruited membrane app
0.36325452.16103124.html.plaintext.txt	224	lack lamin bnum signal membrane fraction suggests tipnum immunoreactivity membrane fraction due nuclear contamination
0.36325452.16103124.html.plaintext.txt	225	determined whether app recruit tipnum membrane vivo performing subcellular fractionation wild type app transgenic mouse brain
0.36325452.16103124.html.plaintext.txt	226	tipnum level compared membrane fraction cortex hippocampus wild type tgnum app transgenic mouse either num month old prior plaque formation num year old amyloid plaque load high
0.36325452.16103124.html.plaintext.txt	227	significantly tipnum appeared membrane fraction app transgenic sample compared age matched wild type control sample fig
0.36325452.16103124.html.plaintext.txt	228	however tipnum also detected membrane fraction wild type mouse particularly hippocampus suggesting membrane sequestration occurs physiological condition
0.36325452.16103124.html.plaintext.txt	229	purity membrane fraction confirmed absence nuclear protein lamin bnum
0.36325452.16103124.html.plaintext.txt	230	result suggest app recruit tipnum membrane compartment consistent formation tipnum complex transmembrane form app
0.36325452.16103124.html.plaintext.txt	231	colocalization tipnum app effect app tipnum localization also examined confocal immunofluorescence microscopy
0.36325452.16103124.html.plaintext.txt	232	neuroblastoma sh synumy cell transfected ha tipnum alone fig
0.36325452.16103124.html.plaintext.txt	233	num c fenum app d f
0.36325452.16103124.html.plaintext.txt	234	tipnum labeled anti ha antibody app labeled antibody cnum raised app c terminal domain
0.36325452.16103124.html.plaintext.txt	235	nucleus visualized staining hoechst dye
0.36325452.16103124.html.plaintext.txt	236	tipnum expressed alone localized nucleus shown colocalization nuclear hoechst dye fig
0.36325452.16103124.html.plaintext.txt	237	coexpression tipnum fenum app led dramatic change localization tipnum tipnum appearing outside nucleus fig
0.36325452.16103124.html.plaintext.txt	238	moreover substantial colocalization tipnum app cell surface fig
0.36325452.16103124.html.plaintext.txt	239	app excluded nucleus expected fig
0.36325452.16103124.html.plaintext.txt	240	presence non transfected cell labeled indicated specificity tipnum app labeling
0.36325452.16103124.html.plaintext.txt	241	result consistent formation tipnum fenum app complex membrane confirm result subcellular fractionation
0.36325452.16103124.html.plaintext.txt	242	shuttling tipnum nucleus cytoplasm result suggest app recruit tipnum membrane activates phosphorylation complex formation fenum
0.36325452.16103124.html.plaintext.txt	243	investigated whether tipnum contains nuclear localization export sequence could mediate tipnum shuttling nucleus cytoplasm
0.36325452.16103124.html.plaintext.txt	244	psortii program identified two potential nuclear localization sequence within tipnum
0.36325452.16103124.html.plaintext.txt	245	short basic nuclear localization sequence starting amino acid num pgrkrks type num bipartite nuclear localization sequence beginning amino acid num rkgtisffeidgrknks
0.36325452.16103124.html.plaintext.txt	246	nuclear localization sequence completely conserved mouse rat human tipnum protein
0.36325452.16103124.html.plaintext.txt	247	also identified potential nuclear export sequence lttlpvlyl conforms classic lxnum numlivfmxnum numlxli motif completely conserved mouse rat human tipnum protein num
0.36325452.16103124.html.plaintext.txt	248	raise possibility active transport tipnum nucleus may required interaction tipnum app may followed nuclear translocation transcriptional activation
0.36325452.16103124.html.plaintext.txt	249	determine whether nuclear export required tipnum activation used crmnum nuclear export inhibitor leptomycin b galnum tipnum luciferase assay
0.36325452.16103124.html.plaintext.txt	250	treatment leptomycin b greatly suppressed ability app activate tipnum fig
0.36325452.16103124.html.plaintext.txt	251	thus nuclear export tipnum factor required app able activate transcription tipnum
0.36325452.16103124.html.plaintext.txt	252	result support model tipnum actively shuttle cytoplasm nucleus enabling activation app fenum membrane
0.36325452.16103124.html.plaintext.txt	253	view larger version numk figure num
0.36325452.16103124.html.plaintext.txt	254	model app mediated activation tipnum
0.36325452.16103124.html.plaintext.txt	255	app recruit tipnum membrane adaptor protein fenum
0.36325452.16103124.html.plaintext.txt	256	facilitates phosphorylation stabilization tipnum cdks resulting tipnum activation
0.36325452.16103124.html.plaintext.txt	257	followed dissociation complex nuclear translocation tipnum fenum leading transcriptional activation tipnum target gene
0.36325452.16103124.html.plaintext.txt	258	ptb phosphotyrosine binding domain
0.36325452.16103124.html.plaintext.txt	259	model app signaling propose differs canonical notch signaling pathway app signal via activation cytoplasmic protein post translational modification rather providing intracellular domain activate transcription
0.36325452.16103124.html.plaintext.txt	260	difference critical another group num found cnumaicd fragment unable activate transcription contrast transcriptional activity nicd
0.36325452.16103124.html.plaintext.txt	261	moreover result indicate overexpressed cnumaicd act dominant negative protein inhibit app tipnum signaling
0.36325452.16103124.html.plaintext.txt	262	however secretase cleavage appears facilitate signaling e cell presumably release fenum tipnum complex membrane
0.36325452.16103124.html.plaintext.txt	263	one potential secretase independent mechanism dissociation fenum tipnum app membrane could phosphorylation app threonine num shown decrease interaction fenum app num
0.36325452.16103124.html.plaintext.txt	264	interestingly cdknum shown phosphorylate app site num raising possibility cdknum could play dual role activating tipnum releasing complex membrane
0.36325452.16103124.html.plaintext.txt	265	one difference notch app processing app undergoes constitutive ectodomain shedding secretase cleavage whereas notch undergoes ectodomain shedding following ligand binding
0.36325452.16103124.html.plaintext.txt	266	thus difficult understand app signaling could regulated occurs constitutively
0.36325452.16103124.html.plaintext.txt	267	finding indicate one mechanism regulation pathway activity cdks
0.36325452.16103124.html.plaintext.txt	268	particularly intriguing altered activity cdknum already implicated alzheimer disease num num
0.36325452.16103124.html.plaintext.txt	269	furthermore cdknum activator pnum membrane associated suggesting cdknum could specifically phosphorylate tipnum recruited membrane app
0.36325452.16103124.html.plaintext.txt	270	number potential target gene cnumaicd reported recently
0.36325452.16103124.html.plaintext.txt	271	one intriguing potential target degrading enzyme neprilysin reported responsive cnumaicd presenilin deficient cell num
0.36325452.16103124.html.plaintext.txt	272	observe reproducible regulation neprilysin expression psnum cnum
0.36325452.16103124.html.plaintext.txt	273	moreover observed considerable variation neprilysin level e cell line strictly correlate presenilin genotype
0.36325452.16103124.html.plaintext.txt	274	also attempted verify two proposed target gene tipnum kainum manganese super oxide dismutase num num
0.36325452.16103124.html.plaintext.txt	275	hand reporter construct containing promoter two gene responsive tipnum fenum app various combination construct
0.36325452.16103124.html.plaintext.txt	276	another recent study suggested fusion protein citrine cnumaicd increase expression number gene including app bace tipnum glycogen synthase kinase num kainum num
0.36325452.16103124.html.plaintext.txt	277	unable confirm result transfection hek num cell cnum cnum myc could reflect different activity reported citrine fusion protein
0.36325452.16103124.html.plaintext.txt	278	overall able confirm proposed cnumaicd target gene aware time
0.36325452.16103124.html.plaintext.txt	279	work need done delineate app signaling pathway primary importance identification endogenous target gene affected app
0.36325452.16103124.html.plaintext.txt	280	progress area may hindered thus far focus aicd transcriptionally active form
0.36325452.16103124.html.plaintext.txt	281	relevance app signaling alzheimer disease unclear
0.36325452.16103124.html.plaintext.txt	282	however shown many pathogenic mutation presenilins actually decrease notch signaling num num num
0.36325452.16103124.html.plaintext.txt	283	moreover presenilin deficient mouse exhibit neurodegenerative phenotype num
0.36325452.16103124.html.plaintext.txt	284	additionally recent study showed familial alzheimer disease mutation app inhibit signaling app galnum vpnum fusion num
0.36325452.16103124.html.plaintext.txt	285	thus alteration app signaling could potentially play role pathogenesis alzheimer disease
0.36325452.16103124.html.plaintext.txt	286	overall data provide evidence app signaling novel mechanism require secretase cleavage presenilins involves recruitment signaling factor membrane facilitate phosphorylation complex formation
0.36325452.16103124.html.plaintext.txt	287	mechanism would allow signaling regulated multiple way activity cdks shuttling tipnum nucleus cytoplasm possibly secretase activity may modulate activation even though required
0.36325452.16103124.html.plaintext.txt	288	footnote work supported national institute health grant agnum nsnum b
0.36325452.16103124.html.plaintext.txt	289	fellowship national institute health training grant agnum m
0.36325452.16103124.html.plaintext.txt	290	cost publication article defrayed part payment page charge
0.36325452.16103124.html.plaintext.txt	291	article must therefore hereby marked advertisement accordance num u
0.36325452.16103124.html.plaintext.txt	292	section num solely indicate fact
0.36325452.16103124.html.plaintext.txt	293	num correspondence addressed dept
0.36325452.16103124.html.plaintext.txt	294	neurology childrens hospital enders num num longwood ave
0.36325452.16103124.html.plaintext.txt	295	num num num fax num num num e mail bruce
0.36325452.16103124.html.plaintext.txt	296	num abbreviation used app amyloid precursor protein bace beta site app cleaving enzyme appsw app containing swedish mutation appwt wild type app aicd app intracellular domain amyloid peptide hek num human embryonic kidney num ha hemagglutinin nicd notch intracellular domain e embryonic stem p ko presenilin numnum knockout psnum presenilin num cdk cyclin dependent kinase tricine n num hydroxy numnum bishydroxymethylethylglycine ripa doc deoxychelate containing radioimmune precipitation assay buffer
0.36325452.16103124.html.plaintext.txt	297	acknowledgment thank shyan yuan kao providing aicd plasmid changiz geula menglan yuan assistance matthew salanga help confocal microscopy tao lu frank lee helpful discussion
0.37338918.11978763.html.plaintext.txt	0	identification novel family presenilin homologues chris p
0.37338918.11978763.html.plaintext.txt	1	pontingnum mike huttonnum andrew nyborgnum matthew bakernum karen jansennum todd e
0.37338918.11978763.html.plaintext.txt	2	nummrc functional genetics unit university oxford department human anatomy genetics south park road oxford oxnum numqx uk nummayo clinic jacksonville department neuroscience num san pablo road jacksonville fl num usa
0.37338918.11978763.html.plaintext.txt	3	study ps role development ad led appreciation regulate number diverse function cell
0.37338918.11978763.html.plaintext.txt	4	ps shown play role proteolytic processing amyloid s protein precursor app app family member numnum notch notch family member numnum erbbnum num
0.37338918.11978763.html.plaintext.txt	5	case ps appear required permit release cytoplasmic tail protein membrane bound stub generated ectodomain cleavage holoprotein
0.37338918.11978763.html.plaintext.txt	6	significantly inhibition release membrane bound stub protein alters signaling cascade appear mediated translocation cytoplasmic tail nucleus num num
0.37338918.11978763.html.plaintext.txt	7	ps also shown interact wide array different protein implicated ipnum mediated release endoplasmic reticulum er calcium num capacitative calcium entry numnum s catenin signaling num num protein trafficking num
0.37338918.11978763.html.plaintext.txt	8	much work ps focused role processing app num
0.37338918.11978763.html.plaintext.txt	9	ps shown influence final cleavage step release approximately num kda amyloid s protein as app proteolysis referred secretase cleavage
0.37338918.11978763.html.plaintext.txt	10	event generates as membrane stub app turn produced previous hydrolysis app holoprotein membrane bound aspartyl protease referred s secretase
0.37338918.11978763.html.plaintext.txt	11	significantly secretase generates as peptide varying length two specie interest peptide num amino acid assnum num amino acid assnum
0.37338918.11978763.html.plaintext.txt	12	case studied date mutant ps increase relative level assnum production
0.37338918.11978763.html.plaintext.txt	13	longer assnum aggregate rapidly form as previously shown increased ad linked mutation app study implicated ps modulators secretase cleavage also convinced many ad field longer form as critical ad pathogenesis num
0.37338918.11978763.html.plaintext.txt	14	subsequent initial study ad linked p mutation three line evidence emerged support direct role p secretase cleavage app well secretase cleavage regulates release cytoplasmic tail notch erbbnum
0.37338918.11978763.html.plaintext.txt	15	first genetic level ps appear essential cleavage
0.37338918.11978763.html.plaintext.txt	16	psnum knockout markedly inhibits secretase cleavage numnum whereas psnum knockout apparent effect secretase activity num probably owing compensation widely expressed psnum
0.37338918.11978763.html.plaintext.txt	17	however combined psnumpsnum knockout completely abolishes secretase activity numnum
0.37338918.11978763.html.plaintext.txt	18	second biochemical evidence also support identification ps secretase
0.37338918.11978763.html.plaintext.txt	19	ps co fractionate secretase activity high molecular weight complex vitro activity recovered pellet immunoprecipitation antibody psnum num
0.37338918.11978763.html.plaintext.txt	20	addition mutation two absolutely conserved aspartate residue dnum dnum psnum dnum dnum psnum result ps act dominant negative fashion least respect secretase activity numnum
0.37338918.11978763.html.plaintext.txt	21	lead hypothesis ps represent novel class intramembranous cleaving diaspartyl protease hypothesis supported inhibitor study numnum
0.37338918.11978763.html.plaintext.txt	22	third four group able show inhibitor secretase activity bind varying degree specificity psnum psnum num num
0.37338918.11978763.html.plaintext.txt	23	collectively experiment indicate compound including property protease inhibitor bind ps
0.37338918.11978763.html.plaintext.txt	24	moreover given two group specifically designed inhibitor transition state analogue aspartyl protease certainly appears despite lack demonstrable homology known aspartyl protease ps may
0.37338918.11978763.html.plaintext.txt	25	recently primary sequence encompassing one aspartate residue dnum psnum dnum psnum ps proposed similar region type iv prepilin peptidase contain catalytic aspartate residue numnum
0.37338918.11978763.html.plaintext.txt	26	sequence motif similarity common feature spanning membrane several time suggests ps bacterial signal peptidase may distinct member novel class intramembranous protease
0.37338918.11978763.html.plaintext.txt	27	despite local sequence similarity ps type iv prepilin peptidase demonstrably homologous
0.37338918.11978763.html.plaintext.txt	28	order investigate whether ps posse hitherto unappreciated divergent homologues undertook search protein nucleotide sequence database using psi blast num hidden markov model package num
0.37338918.11978763.html.plaintext.txt	29	search revealed family sequence significant similarity presenilins
0.37338918.11978763.html.plaintext.txt	30	observation may assist elucidating molecular cellular function ps
0.37338918.11978763.html.plaintext.txt	31	view larger version numk figure num
0.37338918.11978763.html.plaintext.txt	32	multiple sequence alignment presenilins ps top p homologues pshs represented using chroma httpwww
0.37338918.11978763.html.plaintext.txt	33	ukchroma num consensus
0.37338918.11978763.html.plaintext.txt	34	alignment sequence made using num transmembrane tm model ps
0.37338918.11978763.html.plaintext.txt	35	psnum psnum amino acid substituted individual familial alzheimers disease httpwww
0.37338918.11978763.html.plaintext.txt	36	orgmembersresourcespresmutations shown white red
0.37338918.11978763.html.plaintext.txt	37	amino acid change due non synonymous single nucleotide polymorphism human pshnum pshnum shown white blue amino acid substitution ala pro pshnum prior putative active site residue containing lglgd motif might deleterious function
0.37338918.11978763.html.plaintext.txt	38	aspartic acid thought active site residue shown white magenta indicated
0.37338918.11978763.html.plaintext.txt	39	position seven predicted eight tm segment ps shown correspond seven tm segment pshs
0.37338918.11978763.html.plaintext.txt	40	number parenthesis represent number amino acid excised alignment
0.37338918.11978763.html.plaintext.txt	41	geninfo number amino acid limit sequence shown following alignment
0.37338918.11978763.html.plaintext.txt	42	protein asterisk contain n terminal protease associated pa domain
0.37338918.11978763.html.plaintext.txt	43	protein andor gene name shown followed specie abbreviation af archaeoglobus fulgidus arabidopsis thaliana ce caenorhabditis elegans dm drosophila melanogaster dr danio rerio zebrafish hl helix lucorum mollusc h homo sapiens hsp halobacterium sp
0.37338918.11978763.html.plaintext.txt	44	nrc num sp schizosaccharomyces pombe ta thermoplasma acidophilum tv thermoplasma volcanium xl xenopus laevis
0.37338918.11978763.html.plaintext.txt	45	view larger version numk figure num
0.37338918.11978763.html.plaintext.txt	46	schematic representation predicted transmembrane topology presenilin num human pshnum contains protease associated pa domain
0.37338918.11978763.html.plaintext.txt	47	topology prediction made basis identification signal peptide pa domain pshs num tm model p topology
0.37338918.11978763.html.plaintext.txt	48	pink star represent putative active site aspartic acid residue ps pshs red triangle represent conserved palp motif
0.37338918.11978763.html.plaintext.txt	49	order investigate whether newly identified protein family homologous ps constructed multiple sequence alignment compared global hidden markov model num derived alignment second non redundant database nrdbnum
0.37338918.11978763.html.plaintext.txt	50	result showed presenilins represented highest scoring sequence including plant presenilin arabidopsis thaliana gene product atnumgnum whose sequence similarity family significant enum
0.37338918.11978763.html.plaintext.txt	51	significant sequence similarity demonstrate eukaryotic archaeal protein represent novel family presenilin homologues pshs
0.37338918.11978763.html.plaintext.txt	52	five distinct psh gene evident human genome sequence
0.37338918.11978763.html.plaintext.txt	53	psh gene found fungi saccharomyces cerevisiae archaea archaeoglobus fulgidus
0.37338918.11978763.html.plaintext.txt	54	first time p homologues detected eukaryote plant animal prokaryote
0.37338918.11978763.html.plaintext.txt	55	predicted presence expressed sequence tag est database human psh rt pcr experiment confirm pshs expressed human fig
0.37338918.11978763.html.plaintext.txt	56	pcr product amplified human brain cdna library hnum cdna
0.37338918.11978763.html.plaintext.txt	57	experiment hnum mrna treated dnase remove trace dna contamination prior reverse transcription non reverse transcribed dnase treated rna used control show product originated mrna genomic dna contamination
0.37338918.11978763.html.plaintext.txt	58	thus like pshs intronless pshnum mrna expressed
0.37338918.11978763.html.plaintext.txt	59	full length cdna homologue also amplified hnum cell cdna data shown
0.37338918.11978763.html.plaintext.txt	60	view larger version numk figure num
0.37338918.11978763.html.plaintext.txt	61	rt pcr analysis pshnum num human brain hnum neuroglioma cell
0.37338918.11978763.html.plaintext.txt	62	psnum num transcript expressed brain hnum cell
0.37338918.11978763.html.plaintext.txt	63	non quantitative study appears pshnum likely expressed lower level pshs
0.37338918.11978763.html.plaintext.txt	64	indicates cdna rt indicates hnum mrna treated dnase reverse transcribed brain refers amplification brain cdna library hnum refers rt pcr hnum mrna
0.37338918.11978763.html.plaintext.txt	65	authenticity product verified sequencing
0.37338918.11978763.html.plaintext.txt	66	proximity pshnum mapt gene code microtubule associated protein tau chromosome num suggested might candidate gene variant ftdp num occurs family lack tau pathology obvious mutation tau num num
0.37338918.11978763.html.plaintext.txt	67	sequence analysis therefore performed probands four family frontotemporal dementia ftd similar clinical pathological phenotype tau negative family
0.37338918.11978763.html.plaintext.txt	68	however case ftd family large enough confirm linkage chromosome num
0.37338918.11978763.html.plaintext.txt	69	addition pshnum sequenced control sample hnumhnum hnumhnum mapt genotype identify single nucleotide polymorphism snp linkage disequilibrium haplotype adjacent mapt gene
0.37338918.11978763.html.plaintext.txt	70	analysis demonstrated pshnum highly polymorphic num snp detected nine alter encoded amino acid sequence table num
0.37338918.11978763.html.plaintext.txt	71	nine pshnum snp apparently complete linkage disequilibrium hnumhnum haplotype adjacent mapt gene
0.37338918.11978763.html.plaintext.txt	72	however none snp obviously pathogenic four ftd family since present control individual segregate disease rnumq enumk
0.37338918.11978763.html.plaintext.txt	73	five human psh gene pshnum gene neighbor locus chromosome numqnum linkage bipolar risk num
0.37338918.11978763.html.plaintext.txt	74	pshnum proximal gene mapt gene encoding tau protein chromosome numqnum
0.37338918.11978763.html.plaintext.txt	75	hyperphosphorylated form tau often found brain patient ad mapt mutation associated frontotemporal dementia parkinsonism linked chromosome num ftdp num numnum
0.37338918.11978763.html.plaintext.txt	76	one hand close proximity p homologue gene whose dysfunction intimately associated neurodegenerative condition might coincidental
0.37338918.11978763.html.plaintext.txt	77	hand close proximity num kb gene might significant since sequence analysis revealed multiple nine snp pshnum complete linkage disequilibrium extended hnumhnum haplotype mapt gene num
0.37338918.11978763.html.plaintext.txt	78	hnum haplotype genetic risk factor development sporadic tauopathies progressive supranuclear palsy num cortical basal degeneration num
0.37338918.11978763.html.plaintext.txt	79	addition location pshnum might relevant family described ftdp num lacking tau pathology without obvious mutation mapt gene num num
0.37338918.11978763.html.plaintext.txt	80	sequencing pshnum multiple mapt mutation negative ftd family similar clinical pathological phenotype ftdp num family thus far failed reveal evidence pathogenic mutation
0.37338918.11978763.html.plaintext.txt	81	however none sequenced tau negative ftd family large enough demonstrate linkage chromosome numq thus exclude pshnum candidate gene tau negative ftdp num
0.37338918.11978763.html.plaintext.txt	82	remaining three psh gene chromosome numqnum
0.37338918.11978763.html.plaintext.txt	83	pshs appear widely expressed since represented numerous est diverse tissue cell line
0.37338918.11978763.html.plaintext.txt	84	significantly even though intronless pshnum might predicted non translated pseudogene resulting retrotransposition ancestral psh mrna fact appear expressed least mrna level
0.37338918.11978763.html.plaintext.txt	85	initial non quantitative rt pcr experiment expression pshnum appeared lower pshs
0.37338918.11978763.html.plaintext.txt	86	rigorous analysis relative expression level needed determine relative abundance psh transcript
0.37338918.11978763.html.plaintext.txt	87	identification novel family p homologues likely lead insight p function evolution
0.37338918.11978763.html.plaintext.txt	88	inference ps diaspartyl peptidase function pshs plausible
0.37338918.11978763.html.plaintext.txt	89	however perhaps unlikely pshs cleave known p substrate since psh family represented among archaea eukaryote appear arisen considerably appearance ps as notch erbbnum
0.37338918.11978763.html.plaintext.txt	90	moreover double knockout psnum psnum appears sufficient abolish secretase cleavage app notch numnum
0.37338918.11978763.html.plaintext.txt	91	case additional experiment need conducted determine whether pshs cleave known secretase substrate
0.37338918.11978763.html.plaintext.txt	92	based apparent expression brain unlikely known secretase substrate major substrate pshs
0.37338918.11978763.html.plaintext.txt	93	however shown enzyme family identification wider repertoire pspsh family member may facilitate greater understanding molecular cellular function biomedically important family
0.37338918.11978763.html.plaintext.txt	94	particular given interest developing secretase inhibitor target ps potential therapeutic agent ad num information gathered studying protein family may offer important insight potential catalytic mechanism substrate specificity p psh aid development inhibitor
0.37338918.11978763.html.plaintext.txt	95	member psh sequence family detected searching non redundant nucleotide sequence nt ftpftp
0.37338918.11978763.html.plaintext.txt	96	govpubblastdbnt expressed sequence tag ftpftp
0.37338918.11978763.html.plaintext.txt	97	govpubblastdbest database using blast
0.37338918.11978763.html.plaintext.txt	98	position psh gene human genome determined using blat httpgenome
0.37338918.11978763.html.plaintext.txt	99	educgibinhgblatcommandstart
0.37338918.11978763.html.plaintext.txt	100	signal peptide detected using signalp httpwww
0.37338918.11978763.html.plaintext.txt	101	dkservicessignalp co occurring domain identified using pfam httpwww
0.37338918.11978763.html.plaintext.txt	102	transmembrane topology ps pshs predicted using algorithm tmhmm httpwww
0.37338918.11978763.html.plaintext.txt	103	dkservicestmhmm tmpred httpwww
0.37338918.11978763.html.plaintext.txt	104	rt pcr rna extracted hnum human neuroglioma cell using rneasy rna extraction kit qiagen chatsworth ca according manufacturer instruction
0.37338918.11978763.html.plaintext.txt	105	rna treated dnase using dna free kit ambion austin tx cdna synthesized num microg rna using superscript reverse transcriptase invitrogen carlsbad ca also according manufacturer instruction
0.37338918.11978763.html.plaintext.txt	106	whole brain cdna library purchased invitrogen
0.37338918.11978763.html.plaintext.txt	107	pcr performed taq dna polymerase invitrogen hybaid mb num
0.37338918.11978763.html.plaintext.txt	108	numg thermocycler using touchdown program following cycling parameter num cycle annealing num degree c followed num cycle annealing num degree c
0.37338918.11978763.html.plaintext.txt	109	primer pcr reaction shown table num
0.37338918.11978763.html.plaintext.txt	110	pcr product analyzed num nusieve gel biowhittaker rockland
0.37338918.11978763.html.plaintext.txt	111	pcr primer amplification psh pcr sequence analysis primer designed generate three separate product product num amplified using primer numf numr giving num bp product sequenced numf numr numf numr numf numr
0.37338918.11978763.html.plaintext.txt	112	product num generated using primer numf numr giving num bp product sequenced numf numf numr numr
0.37338918.11978763.html.plaintext.txt	113	product num generated using primer numf numr giving num bp product sequenced numf numf numr numr
0.37338918.11978763.html.plaintext.txt	114	primer sequence shown table num
0.37338918.11978763.html.plaintext.txt	115	reaction contained num ng genomic dna num microl mixture containing num pmol primer num
0.37338918.11978763.html.plaintext.txt	116	num mm dntps num unit taq buffer q solution qiagen california uk
0.37338918.11978763.html.plaintext.txt	117	amplification performed oil free hybaid touchdown thermal cyclers hybaid cambridge uk
0.37338918.11978763.html.plaintext.txt	118	condition num cycle num degree c num num degree c num degree c touchdown annealing num num degree c num final extension num degree c num min
0.37338918.11978763.html.plaintext.txt	119	product purified using qiaquick pcr purification kit qiagen ca
0.37338918.11978763.html.plaintext.txt	120	num ng product sequenced direction using big dye kit perkin elmer
0.37338918.11978763.html.plaintext.txt	121	sequencing performed abinum automated sequencer processed using factura sequence navigator software perkin elmer
0.37338918.11978763.html.plaintext.txt	122	pcr internal sequencing primer
0.37338918.11978763.html.plaintext.txt	123	footnote correspondence addressed tel num num num fax num num num email chris
0.37338918.11978763.html.plaintext.txt	124	num secreted amyloid beta protein similar senile plaque alzheimers disease increased vivo presenilin num num app mutation linked familial alzheimers disease
0.37338918.11978763.html.plaintext.txt	125	num deficiency presenilin num inhibits normal cleavage amyloid precursor protein
0.37338918.11978763.html.plaintext.txt	126	num presenilin num dependent gamma secretase like protease mediates release notch intracellular domain
0.37338918.11978763.html.plaintext.txt	127	num murine notch homologs nnum num undergo presenilin dependent proteolysis
0.37338918.11978763.html.plaintext.txt	128	num secretase cleavage nuclear localization erbb num receptor tyrosine kinase
0.37338918.11978763.html.plaintext.txt	129	num notch signaling outside
0.37338918.11978763.html.plaintext.txt	130	num transcriptionally active complex app fenum histone acetyltransferase tipnum
0.37338918.11978763.html.plaintext.txt	131	num subcellular mechanism presenilin mediated enhancement calcium signaling
0.37338918.11978763.html.plaintext.txt	132	num presenilin mediated modulation capacitative calcium entry
0.37338918.11978763.html.plaintext.txt	133	num capacitative calcium entry deficit elevated luminal calcium content mutant presenilin num knockin mouse
0.37338918.11978763.html.plaintext.txt	134	num destabilization s catenin mutation presenilin num potentiates neuronal apoptosis
0.37338918.11978763.html.plaintext.txt	135	num presenilin num facilitates constitutive turnover beta catenin differential activity alzheimers disease linked psnum mutant beta catenin signaling pathway
0.37338918.11978763.html.plaintext.txt	136	num presenilin num protein component high molecular weight intracellular complex contains beta catenin
0.37338918.11978763.html.plaintext.txt	137	num effect psnum deficiency membrane protein trafficking neuron
0.37338918.11978763.html.plaintext.txt	138	num biochemical detection as isoforms implication pathogenesis diagnosis treatment alzheimers disease
0.37338918.11978763.html.plaintext.txt	139	num presenilin num deficiency cause mild pulmonary phenotype change amyloid precursor protein processing enhances embryonic lethal phenotype presenilin num deficiency
0.37338918.11978763.html.plaintext.txt	140	num presenilins required secretase cleavage s app transmembrane cleavage notch num
0.37338918.11978763.html.plaintext.txt	141	num total inactivation secretase activity presenilin deficient embryonic stem cell
0.37338918.11978763.html.plaintext.txt	142	num presenilin num linked secretase activity detergent solubilized state
0.37338918.11978763.html.plaintext.txt	143	num two transmembrane aspartates presenilin num required presenilin endoproteolysis gamma secretase activity
0.37338918.11978763.html.plaintext.txt	144	num loss function mutation presenilin num interferes amyloid s peptide production notch signaling
0.37338918.11978763.html.plaintext.txt	145	num peptidomimetic probe molecular modeling suggest alzheimers gamma secretase intramembrane cleaving aspartyl protease
0.37338918.11978763.html.plaintext.txt	146	biochemistry num num num
0.37338918.11978763.html.plaintext.txt	147	num secretase evidence multiple proteolytic activity influence membrane positioning substrate generation amyloid beta peptide varying length
0.37338918.11978763.html.plaintext.txt	148	num transition state analogue inhibitor gamma secretase bind directly presenilin num
0.37338918.11978763.html.plaintext.txt	149	num photoactivated secretase inhibitor directed active site covalently label presenilin num
0.37338918.11978763.html.plaintext.txt	150	num presenilin num num molecular target gamma secretase inhibitor
0.37338918.11978763.html.plaintext.txt	151	num aspartyl protease inhibitor pepstatin bind presenilins alzheimers disease
0.37338918.11978763.html.plaintext.txt	152	biochemistry num num num
0.37338918.11978763.html.plaintext.txt	153	num type num prepilin peptidase comprise novel family aspartic acid protease
0.37338918.11978763.html.plaintext.txt	154	num glycine num required presenilin num function conserved bacterial polytopic aspartyl protease
0.37338918.11978763.html.plaintext.txt	155	num improving accuracy psi blast protein database search composition based statistic refinement
0.37338918.11978763.html.plaintext.txt	156	num profile hidden markov model
0.37338918.11978763.html.plaintext.txt	157	bioinformatics num num num
0.37338918.11978763.html.plaintext.txt	158	num hereditary dysphasic disinhibition dementia frontotemporal dementia linked numqnum num
0.37338918.11978763.html.plaintext.txt	159	num mapping disease locus familial rapidly progressive frontotemporal dementia chromosome numqnum num
0.37338918.11978763.html.plaintext.txt	160	num chromosome num hereditary dementia linkage study three non alzheimer family kindred late onset fad
0.37338918.11978763.html.plaintext.txt	161	num first proline palp motif c terminus presenilins obligatory stabilization complex formation gamma secretase activity presenilins
0.37338918.11978763.html.plaintext.txt	162	num pa domain protease associated domain
0.37338918.11978763.html.plaintext.txt	163	num evidence bipolar risk gene chromosome numqnum suggested investigation haplotype sharing allelic association patient faroe island
0.37338918.11978763.html.plaintext.txt	164	num tau mutation frontotemporal dementia
0.37338918.11978763.html.plaintext.txt	165	num molecular genetics chromosome num tauopathies
0.37338918.11978763.html.plaintext.txt	166	num association extended haplotype tau gene progressive supranuclear palsy
0.37338918.11978763.html.plaintext.txt	167	num corticobasal degeneration share tau haplotype association progressive supranuclear palsy
0.37338918.11978763.html.plaintext.txt	168	num clustal w improving sensitivity progressive multiple sequence alignment sequence weighting position specific gap penalty weight matrix choice
0.37662143.11823322.html.plaintext.txt	0	genotype phenotype alzheimers disease clive holmes mrcpsych
0.37662143.11823322.html.plaintext.txt	1	thornhill research unit university southampton moorgreen hospital botley road west end southampton sonum numjb uk
0.37662143.11823322.html.plaintext.txt	2	background patient alzheimers disease show wide variation clinical phenotype
0.37662143.11823322.html.plaintext.txt	3	genetic research largely concerned role mutation common variant risk factor disease
0.37662143.11823322.html.plaintext.txt	4	genetic factor also influence clinical phenotype
0.37662143.11823322.html.plaintext.txt	5	aim examine evidence genetic factor influence clinical expression disease addition influencing risk
0.37662143.11823322.html.plaintext.txt	6	method selective review made key literature
0.37662143.11823322.html.plaintext.txt	7	result mutation three gene coding amyloid precursor protein presenilin num presenilin num common variation num another gene apoe shown lead earlier development disease
0.37662143.11823322.html.plaintext.txt	8	recently genetic association twin study suggested role genetic factor development aspect clinical phenotype notably appearance non cognitive symptom
0.37662143.11823322.html.plaintext.txt	9	conclusion alzheimers disease genetic variation influence number aspect clinical phenotype
0.37662143.11823322.html.plaintext.txt	10	early family twin study indicated number gene important part play development alzheimers disease
0.37662143.11823322.html.plaintext.txt	11	variation gene including rare mutation common polymorphism appears confer increased risk development disease
0.37662143.11823322.html.plaintext.txt	12	however apparent increased risk may largely explained effect genetic variation clinical phenotype alzheimers disease particularly age disease present
0.37662143.11823322.html.plaintext.txt	13	recently proposed genetic variation may also explain feature clinical phenotype including development non cognitive symptom
0.37662143.11823322.html.plaintext.txt	14	clearest evidence genetic contribution aetiology alzheimers disease existence family disease transmitted clear autosomal dominant pattern
0.37662143.11823322.html.plaintext.txt	15	study one large pedigree revealed transmission generation generation single point mutation gene amyloid precursor protein app found chromosome num family member developing early onset alzheimers disease
0.37662143.11823322.html.plaintext.txt	16	study family led discovery point mutation gene later presence mutation two gene encoding presenilin num p num presenilin num p num found chromosome num num respectively
0.37662143.11823322.html.plaintext.txt	17	date num alzheimers disease related mutation discovered app gene num mutation p num gene num mutation p num gene
0.37662143.11823322.html.plaintext.txt	18	significantly research suggests different mutation three gene lead common result increase s anum peptide fragment app form core neuritic plaque found brain people alzheimers disease
0.37662143.11823322.html.plaintext.txt	19	finding immense importance term elucidating biological pathogenesis alzheimers diease important recognise three causal gene may account num num autosomal dominant early onset case around num familial early onset case cruts et al num
0.37662143.11823322.html.plaintext.txt	20	thus given majority case num alzheimers disease occurs age num year clear genetic mutation make small contribution risk developing disease general
0.37662143.11823322.html.plaintext.txt	21	inheritance late onset alzheimers disease complex early onset form
0.37662143.11823322.html.plaintext.txt	22	cross sectional study presence positive family history late onset alzheimers disease consistent risk factor subject late onset form clear autosomal dominant pattern inheritance rare
0.37662143.11823322.html.plaintext.txt	23	twin family study suggest polygenic multifactorial mode inheritance consequence elucidation genetic risk factor late onset alzheimers disease requires different method used early onset disease simple mendelian pattern inheritance
0.37662143.11823322.html.plaintext.txt	24	association study far dominated genetics late onset alzheimers disease
0.37662143.11823322.html.plaintext.txt	25	study look variation frequency allele sample unrelated patient late onset alzheimers disease compared unrelated control subject
0.37662143.11823322.html.plaintext.txt	26	study resulted number candidate gene proposed importance risk factor late onset alzheimers disease include association variation gene encoding low density lipoprotein vldl receptor p num intronic mutation associated early onset alzheimers disease butyrylcholinesterase angiotensin num converting enzyme num antichymotrypsin human leucocyte antigen hla complex num macroglobulin low density lipoprotein like receptor serotonin transporter interleukin num
0.37662143.11823322.html.plaintext.txt	27	typically interest candidate diminished independent replication forthcoming little evidence remains important role genetic variation vldl receptor p num num antichymotrypsin gene development late onset alzheimers disease
0.37662143.11823322.html.plaintext.txt	28	candidate gene still advocate remain hotly disputed
0.37662143.11823322.html.plaintext.txt	29	recently result number linkage study become available
0.37662143.11823322.html.plaintext.txt	30	method used linkage study complex non mendelian disease late onset alzheimers disease le powerful used early onset form
0.37662143.11823322.html.plaintext.txt	31	however study reveal area interest genome might later explored association study
0.37662143.11823322.html.plaintext.txt	32	complete genomic screen series multiplex family affected late onset alzheimers disease revealed five region interest chromosome num num num num num
0.37662143.11823322.html.plaintext.txt	33	excluding effect apoenum locus maximum log likelihood ratio lod score study occurred region located short arm chromosome num pericak vance et al num
0.37662143.11823322.html.plaintext.txt	34	however two subsequent study following similar method blacker et al num wu et al num unable confirm linkage area
0.37662143.11823322.html.plaintext.txt	35	large sibpair study kehoe et al num revealed many possible locus showing linkage late onset alzheimers disease
0.37662143.11823322.html.plaintext.txt	36	include locus chromosome num num num num num num num close apoe num close app gene
0.37662143.11823322.html.plaintext.txt	37	currently main focus attention chromosome num two independent study showing evidence susceptibility locus region ertekin taner et al num myers et al num
0.37662143.11823322.html.plaintext.txt	38	however clear large number locus implicated disagreement study predicted area interest
0.37662143.11823322.html.plaintext.txt	39	finding demonstrate limitation approach also serve emphasise polygenic nature late onset alzheimers disease
0.37662143.11823322.html.plaintext.txt	40	exploration area association study positional candidate approach likely dominate genetics alzheimers disease future
0.37662143.11823322.html.plaintext.txt	41	genetic risk factor advocated role development late onset alzheimers disease least controversial remains increased risk associated possession one copy apoenum allele coding apolipoprotein e apoe variant num
0.37662143.11823322.html.plaintext.txt	42	significantly importance apoenum determined using positional candidate gene approach
0.37662143.11823322.html.plaintext.txt	43	since finding study artiga et al num bullido et al num lambert et al num also suggested association number polymorphism within transcriptional regulatory region apoe gene late onset alzheimers disease independent apoe num status
0.37662143.11823322.html.plaintext.txt	44	based data suggested two independent mechanism risk late onset alzheimers disease modified apoe gene first variation coding region alter functional property apoe second presence promoter variant result quantitative difference apoe expression artiga et al num
0.37662143.11823322.html.plaintext.txt	45	however hypothesis controversial recent study helisalmi et al num zurutuza et al num failed support independence apoe promoter variant development alzheimers disease
0.37662143.11823322.html.plaintext.txt	46	genetic influence clinical phenotype
0.37662143.11823322.html.plaintext.txt	47	age onset family carrying mutation app gene age onset largely within range num num year
0.37662143.11823322.html.plaintext.txt	48	date app mutation carrier reported unaffected beyond age num year
0.37662143.11823322.html.plaintext.txt	49	family carrying mutation p num gene earliest age onset fall largely within range num num year although one family member recently recorded onset num year wisniewski et al num
0.37662143.11823322.html.plaintext.txt	50	mutation largely associated early onset familial alzheimers disease least two mutation alanumval hisnumtyr observed late onset alzheimers disease may non penetrant cruts et al num
0.37662143.11823322.html.plaintext.txt	51	family carrying mutation p num gene age onset largely within range num num year thus show overlap late onset alzheimers disease
0.37662143.11823322.html.plaintext.txt	52	penetrance high may num least two reported case non penetrance age num year bird et al num
0.37662143.11823322.html.plaintext.txt	53	familial influence age onset late onset alzheimers disease may substantial
0.37662143.11823322.html.plaintext.txt	54	thus one study affected sib pair suggests shared familial effect may account num variance tunstall et al num
0.37662143.11823322.html.plaintext.txt	55	indeed study shown late onset disease age onset approximately num year earlier individual carry two copy apoenum allele compared non carrier
0.37662143.11823322.html.plaintext.txt	56	led suggestion apoenum allele risk factor alzheimers disease mainly old age alzheimers disease death competing risk
0.37662143.11823322.html.plaintext.txt	57	factor leading earlier age onset alzheimers disease elderly hence development disease prior death associated alzheimers disease
0.37662143.11823322.html.plaintext.txt	58	evidence confirming hypothesis come large study approximately num individual meyer et al num
0.37662143.11823322.html.plaintext.txt	59	study showed clear decline relative risk developing late onset alzheimers disease subject increasing age clear plateau beyond new case disease reported
0.37662143.11823322.html.plaintext.txt	60	age plateau reached earlier carrier apoenum allele
0.37662143.11823322.html.plaintext.txt	61	thus appears clear apoenum allele predominant effect determining individual develops late onset alzheimers disease meyer et al num
0.37662143.11823322.html.plaintext.txt	62	non cognitive feature genetic risk factor alzheimers disease associated non cognitive symptom one might anticipate subject family history disease increased frequency symptom
0.37662143.11823322.html.plaintext.txt	63	likewise one would expect association known genetic risk factor alzheimers disease including gene app p num p num apoe num allele symptom alzheimers disease
0.37662143.11823322.html.plaintext.txt	64	fact appears little consistent evidence association either positive family history alzheimers disease variation known candidate gene increase frequency non cognitive symptom occurring first time within disease
0.37662143.11823322.html.plaintext.txt	65	thus seems unlikely major genetic risk factor development late onset alzheimers disease substantial role play development non cognitive symptom within late onset disease
0.37662143.11823322.html.plaintext.txt	66	however mean symptom genetic basis since gene may influence phenotypic expression disease without involved directly aetiology
0.37662143.11823322.html.plaintext.txt	67	indeed early study shown evidence association positive family history depressive illness increase frequency depressive symptom occurring first time within alzheimers disease pearlson et al num
0.37662143.11823322.html.plaintext.txt	68	early finding supported sib pair study tunstall et al num showing familial factor role development depressive illness late onset alzheimers disease
0.37662143.11823322.html.plaintext.txt	69	addition small study also suggests role familial factor wide variety non cognitive symptom including agitation aggression psychosis
0.37662143.11823322.html.plaintext.txt	70	direct approach also adopted whereby common genetic polymorphism previously showing association neuropsychiatric condition found associated non cognitive symptom late onset alzheimers disease
0.37662143.11823322.html.plaintext.txt	71	example one study holmes et al num people late onset alzheimers disease found association common polymorphic variation num htnuma num htnumc serotonin receptor gene num tc cysnumser polymorphism respectively previously implicated schizophrenia bipolar affective disorder psychotic symptom alzheimers disease
0.37662143.11823322.html.plaintext.txt	72	association found presence cnum allele presence visual auditory hallucination presence sernum allele visual hallucination
0.37662143.11823322.html.plaintext.txt	73	another study sweet et al num found evidence suggest association psychosis aggression patient alzheimers disease carry common polymorphism dopamine receptor gene drdnum drdnum
0.37662143.11823322.html.plaintext.txt	74	study need replicated suggest common receptor polymorphism may role genesis psychotic non cognitive symptom implicated genetic risk factor late onset alzheimers disease
0.37662143.11823322.html.plaintext.txt	75	cognitive decline study date looked rate decline carrier app p num p num mutation patient late onset alzheimers disease positive family history alzheimers disease show evidence increased rate decline
0.37662143.11823322.html.plaintext.txt	76	majority study also failed show relationship possession apoenum allele increased rate decline
0.37662143.11823322.html.plaintext.txt	77	lack association interesting since implies genetic factor may determine disease start rate degeneration
0.37662143.11823322.html.plaintext.txt	78	clearly caution required interpreting negative finding may association always difficult establish large number confounding factor may influence cognitive deterioration well difficulty use psychometric scale short period
0.37662143.11823322.html.plaintext.txt	79	indeed study craft et al num suggested increased rate cognitive decline apoenum carrier may detectable using long follow period
0.37662143.11823322.html.plaintext.txt	80	duration mean duration illness family p num mutation significantly shorter range num
0.37662143.11823322.html.plaintext.txt	81	num year family p num range num
0.37662143.11823322.html.plaintext.txt	82	num year app mutation range num
0.37662143.11823322.html.plaintext.txt	83	num num year reflecting severity p num associated alzheimers disease
0.37662143.11823322.html.plaintext.txt	84	study late onset alzheimers disease suggest duration illness tends longer people positive family history carrier apoenum allele
0.37662143.11823322.html.plaintext.txt	85	however since shown relationship longer hold true confounding effect age onset taken account
0.37662143.11823322.html.plaintext.txt	86	thus late onset alzheimers disease increased survival directly related earlier age onset influenced number factor exclusively genetic
0.37662143.11823322.html.plaintext.txt	87	clinical implication limitation
0.37662143.11823322.html.plaintext.txt	88	clinical implication number gene implicated risk factor development alzheimers disease
0.37662143.11823322.html.plaintext.txt	89	variation gene appears major effect determining disease develop
0.37662143.11823322.html.plaintext.txt	90	aspect clinical phenotype notably non cognitive symptom also influenced genetic variation
0.37662143.11823322.html.plaintext.txt	91	limitation number risk gene yet identified
0.37662143.11823322.html.plaintext.txt	92	influence unknown gene clinical phenotype yet undetermined
0.37662143.11823322.html.plaintext.txt	93	influence genetic variation non cognitive symptom relatively unexplored
0.37662143.11823322.html.plaintext.txt	94	et al num risk alzheimers disease correlate transcriptional activity apoe gene
0.37662143.11823322.html.plaintext.txt	95	human molecular genetics num num num
0.37662143.11823322.html.plaintext.txt	96	et al num wide range age onset chromosome related familial alzheimers disease
0.37662143.11823322.html.plaintext.txt	97	annals neurology num num num
0.37662143.11823322.html.plaintext.txt	98	et al num alpha num macroglobulin genetically associated alzheimers disease
0.37662143.11823322.html.plaintext.txt	99	et al num polymorphism regulatory region apoe associated risk alzheimers dementia
0.37662143.11823322.html.plaintext.txt	100	et al num accelerated decline apolipoprotein e epsilonnum homozygote alzheimers disease
0.37662143.11823322.html.plaintext.txt	101	et al num estimation genetic contribution presenilin num num mutation population based study presenile alzheimer disease
0.37662143.11823322.html.plaintext.txt	102	human molecular genetics num num num
0.37662143.11823322.html.plaintext.txt	103	et al num linkage plasma s num quantitative locus chromosome num late onset alzheimers disease pedigree
0.37662143.11823322.html.plaintext.txt	104	et al num promoter polymorphism numat apoe gene finnish alzheimers disease patient control individual
0.37662143.11823322.html.plaintext.txt	105	journal neurology num num num
0.37662143.11823322.html.plaintext.txt	106	et al num num htnuma num htnumc receptor polymorphism psychopathology late onset alzheimers disease
0.37662143.11823322.html.plaintext.txt	107	human molecular genetics num num num
0.37662143.11823322.html.plaintext.txt	108	et al num full genome scan late onset alzheimers disease
0.37662143.11823322.html.plaintext.txt	109	human molecular genetics num num num
0.37662143.11823322.html.plaintext.txt	110	et al num pronounced impact thnumenum c mutation compared num mutation neural apoe gene expression risk developing alzheimers disease
0.37662143.11823322.html.plaintext.txt	111	human molecular genetics num num num
0.37662143.11823322.html.plaintext.txt	112	et al num apoe genotype predicts whether one predisposed develop alzheimer disease
0.37662143.11823322.html.plaintext.txt	113	et al num susceptibility locus alzheimers disease chromosome num
0.37662143.11823322.html.plaintext.txt	114	et al num association family history affective disorder depressive syndrome alzheimers disease
0.37662143.11823322.html.plaintext.txt	115	american journal psychiatry num num num
0.37662143.11823322.html.plaintext.txt	116	et al num complete genomic screen late onset familial alzheimer disease
0.37662143.11823322.html.plaintext.txt	117	evidence new locus chromosome num
0.37662143.11823322.html.plaintext.txt	118	et al num dopamine receptor genetic variation psychosis aggression alzheimers disease
0.37662143.11823322.html.plaintext.txt	119	archive neurology num num num
0.37662143.11823322.html.plaintext.txt	120	et al num familial influence variation age onset behavioural phenotype alzheimers disease
0.37662143.11823322.html.plaintext.txt	121	british journal psychiatry num num num
0.37662143.11823322.html.plaintext.txt	122	et al num novel polish presenilin num mutation pnuml associated familial alzheimers disease lead death early age num year
0.37662143.11823322.html.plaintext.txt	123	et al num genetic study chromosome num late onset alzheimer disease
0.37662143.11823322.html.plaintext.txt	124	et al num apoe promoter polymorphism confer independent risk alzheimers disease french population
0.37662143.11823322.html.plaintext.txt	125	european journal human genetics num num num
0.37662143.11823322.html.plaintext.txt	126	received publication may num num
0.37662143.11823322.html.plaintext.txt	127	revision received may num num
0.37662143.11823322.html.plaintext.txt	128	accepted publication may num num
0.37662143.11823322.html.plaintext.txt	129	highlight issue elizabeth walsh bjp num num num
0.37662143.11823322.html.plaintext.txt	130	old age psychiatry alistair burn ian g
0.37812415.15613480.html.plaintext.txt	0	intracellular retention caveolin num presenilin deficient cell douglas r
0.37812415.15613480.html.plaintext.txt	1	lamb anne fernandez magali kitzmann
0.37812415.15613480.html.plaintext.txt	2	department urology northwestern university chicago illinois num johnson johnson pharmaceutical research development titusville new jersey num cell biology unit institut de genetique humaine upr num cnrs num rue de la cardonille montpellier cedex num fnum muscle stem cell facio scapulo humeral dystrophy unit centre de recherche en biochimie macromoleculaire fre num num route de mende num montpellier cedex num france
0.37812415.15613480.html.plaintext.txt	3	received publication september num num revised form december num num
0.37812415.15613480.html.plaintext.txt	4	p dependent proteolytic process involved release cytoplasmic domain increasing range type integral membrane receptor notch num num erbb num num e cadherin num others
0.37812415.15613480.html.plaintext.txt	5	ps addition role secretase catalytic subunit important function subcellular trafficking selected group protein app trk receptor num nicastrin num pen num num
0.37812415.15613480.html.plaintext.txt	6	ps mediate additional physiological function including role calcium homeostasis neurite outgrowth apoptosis synaptic plasticity num
0.37812415.15613480.html.plaintext.txt	7	deleting psnum psnum gene mouse lead early embryonic lethality num role presenilins fully examined double knock mouse
0.37812415.15613480.html.plaintext.txt	8	therefore used cell derived psnum psnum double null termed psnumnum null blastocyst wt control num perform differential proteomic approach
0.37812415.15613480.html.plaintext.txt	9	identified presenilin dependent defect albumin binding reflecting abnormal caveolae dependent pathway
0.37812415.15613480.html.plaintext.txt	10	showed caveolin num mislocalized psnumnum null cell leading abnormal caveolae formation absence caveolinnum lipid raft
0.37812415.15613480.html.plaintext.txt	11	overexpression ps psnumnum null cell sufficient restore normal caveolin localization function
0.37812415.15613480.html.plaintext.txt	12	could detect physical interaction presenilins caveolin num
0.37812415.15613480.html.plaintext.txt	13	result imply presenilins responsible indirect manner caveolin num transport cell surface form caveolae
0.37812415.15613480.html.plaintext.txt	14	two dimensional gel electrophoresis total protein extract wt psnumnum null psnumnum null cell transiently transfected presenilin num cdna blastocyst derived svnum transformed blastocyst derived cell analyzed two dimensional electrophoresis method ofarrell
0.37812415.15613480.html.plaintext.txt	15	ampholine mixture used first dimension electrofocusing gel composed num wv ampholine ph num num num ampholine ph num num
0.37812415.15613480.html.plaintext.txt	16	second dimension performed sd num polyacrylamide gel
0.37812415.15613480.html.plaintext.txt	17	gel stained coomassie blue bsa sequenced maldi tof mass spectrometer carol beach university kentucky
0.37812415.15613480.html.plaintext.txt	18	endocytosis assay blastocyst derived psnumnum null cell wt control grown complete medium num mm glass coverslips
0.37812415.15613480.html.plaintext.txt	19	cell num num confluent medium replaced num ml complete medium containing fitc conjugated albumin sigma final concentration num microgml
0.37812415.15613480.html.plaintext.txt	20	cell incubated num degree c num num min washed pb fixed num
0.37812415.15613480.html.plaintext.txt	21	cell washed num min pb mounted slide
0.37812415.15613480.html.plaintext.txt	22	virtually identical experiment carried fitc conjugated transferrin num microgml sigma
0.37812415.15613480.html.plaintext.txt	23	psnumnum null cell grown num mm tissue culture dish transiently transfected presenilin num presenilin num cdna using lipofectamine plus invitrogen according manufacturer instruction
0.37812415.15613480.html.plaintext.txt	24	transfected cell plated num mm coverslips num well plate num h
0.37812415.15613480.html.plaintext.txt	25	fitc albumin uptake examined transfected cell num h initial transfection
0.37812415.15613480.html.plaintext.txt	26	cell transfected presenilin num presenilin num detected immunostaining anti presenilin num pab oncogene anti presenilin num pab oncogene respectively texas red conjugated secondary antibody jackson immunoresearch
0.37812415.15613480.html.plaintext.txt	27	immunofluorescence microscopy transfected untransfected blastocyst derived psnumnum null cell wt control plated num mm glass coverslips fisher fixed num min pb containing num
0.37812415.15613480.html.plaintext.txt	28	num formaldehyde rinsed pb incubated num min permeabilization buffer pb num
0.37812415.15613480.html.plaintext.txt	29	cell washed pb incubated num min blocking buffer pb num
0.37812415.15613480.html.plaintext.txt	30	num bsa labeled corresponding antibody anti flag mab mnum sigma anti caveolin num pab transduction laboratory anti psnum pab hnum sc biotechnology anti myc mab numenum
0.37812415.15613480.html.plaintext.txt	31	rinsing pb secondary antibody alexa num alexa num donkey anti mouse alexa conjugated donkey anti rabbit molecular probe added period num min
0.37812415.15613480.html.plaintext.txt	32	confocal fluorescence microscope olympus north western university molecular pharmacology biological chemistry prof
0.37812415.15613480.html.plaintext.txt	33	miller laboratory used visualization fitc bsa fitc transferrin fig
0.37812415.15613480.html.plaintext.txt	34	fluorescence microscope leica drmanum institut de genetique humaine used visualization bound secondary antibody fig
0.37812415.15613480.html.plaintext.txt	35	micro injection experiment performed described previously num
0.37812415.15613480.html.plaintext.txt	36	view larger version numk fig
0.37812415.15613480.html.plaintext.txt	37	defect caveolae dependent endocytosis psnumnum null cell
0.37812415.15613480.html.plaintext.txt	38	blastocyst derived wt psnumnum null cell incubated normal medium supplemented fitc albumin left panel fitc transferrin right panel
0.37812415.15613480.html.plaintext.txt	39	num num min num degree c cell rinsed pb formaldehyde fixed visualized fluorescence microscopy
0.37812415.15613480.html.plaintext.txt	40	view larger version numk fig
0.37812415.15613480.html.plaintext.txt	41	p expression restores albumin uptake psnumnum null cell
0.37812415.15613480.html.plaintext.txt	42	total cellular protein extracted psnumnum null cell transiently transfected presenilin num cdna svnum transformed blastocyst derived top blastocyst derived cell bottom separated two dimensional electrophoresis
0.37812415.15613480.html.plaintext.txt	43	migration first dimension ph num ph num illustrated arrow
0.37812415.15613480.html.plaintext.txt	44	localization bsa coomassie stained two dimensional gel psnumnum null cell overexpressing psnum shown circle
0.37812415.15613480.html.plaintext.txt	45	b blastocyst derived psnumnum null cell transiently transfected full length cdna encoding psnum top panel psnum bottom panel
0.37812415.15613480.html.plaintext.txt	46	thirty six hour post transfection cell allowed endocytose fitc albumin num min
0.37812415.15613480.html.plaintext.txt	47	cell rinsed pb formaldehyde fixation immunostaining anti psnum igg top panel anti psnum igg bottom panel
0.37812415.15613480.html.plaintext.txt	48	view larger version numk fig
0.37812415.15613480.html.plaintext.txt	49	presenilin dependent localization caveolin num
0.37812415.15613480.html.plaintext.txt	50	blastocyst derived wt psnumnum null cell formaldehyde fixed permeabilized
0.37812415.15613480.html.plaintext.txt	51	subcellular localization endogenous cavnum ii visualized indirect immunofluorescence
0.37812415.15613480.html.plaintext.txt	52	blastocyst derived wt psnumnum null cell transiently transfected full length cdna encoding gfp cavnum
0.37812415.15613480.html.plaintext.txt	53	gfp cavnum expressing cell visualized fluorescence microscopy formaldehyde fixation iii iv
0.37812415.15613480.html.plaintext.txt	54	b blastocyst derived psnumnum null cell transiently transfected full length cdna encoding flag psnum v vi
0.37812415.15613480.html.plaintext.txt	55	twenty four hour post transfection cell formaldehyde fixed permeabilized immunostained anti flag igg v anti caveolin num igg vi
0.37812415.15613480.html.plaintext.txt	56	psnumnum null cell transiently transfected full length cdna encoding gfp cavnum
0.37812415.15613480.html.plaintext.txt	57	num hour post transfection full length cdna encoding psnum vii viii myc nicd ix x microinjected gfp cavnum positive psnumnum null cell
0.37812415.15613480.html.plaintext.txt	58	sixteen hour post microinjection cell formaldehyde fixed permeabilized immunostained anti psnum igg vii anti myc igg ix
0.37812415.15613480.html.plaintext.txt	59	electron microscopy morphological experiment blastocyst derived psnumnum null cell wt control trypsinized collected centrifugation
0.37812415.15613480.html.plaintext.txt	60	cell pellet fixed phosphate buffer containing num
0.37812415.15613480.html.plaintext.txt	61	num glutaraldehyde overnight num degree c
0.37812415.15613480.html.plaintext.txt	62	cell rinsed phosphate buffer post fixed num osmic acid num h room temperature dehydrated embedded cut onto grid
0.37812415.15613480.html.plaintext.txt	63	thin section num nm leica reichert ultracut e collected different level block counterstained uranyl acetate lead citrate visualization photography hitachi num transmission electron microscope
0.37812415.15613480.html.plaintext.txt	64	em performed centre regional dimagerie cellulaire montpellier france
0.37812415.15613480.html.plaintext.txt	65	isolation caveolin enriched membrane cem immunoblot assay cems prepared detergent extraction cellular protein centrifugation discontinuous sucrose gradient essentially described num
0.37812415.15613480.html.plaintext.txt	66	blastocyst derived psnumnum null cell wt control grown num mm diameter dish num x num cell used prepare cems
0.37812415.15613480.html.plaintext.txt	67	cell washed twice num ml ice cold phosphate buffered saline scraped num ml mbst buffer num mm me num mm nacl num triton x num protease inhibitor mixture roche applied science homogenized loose fitting dounce homogenizer num stroke
0.37812415.15613480.html.plaintext.txt	68	extract adjusted num sucrose addition num ml num sucrose mb lacking triton x num placed bottom ultracentrifuge tube
0.37812415.15613480.html.plaintext.txt	69	discontinuous sucrose gradient formed overlaying solution num ml num sucrose num ml num sucrose mb
0.37812415.15613480.html.plaintext.txt	70	tube centrifuged numnum rpm swnum ti rotor num h num degree c num fraction num ml collected manually top gradient
0.37812415.15613480.html.plaintext.txt	71	determine distribution different protein within gradient num microl fraction precipitated ethanol resuspended num microl numx laemmli buffer subjected sd page num acrylamide gel followed western blot analysis
0.37812415.15613480.html.plaintext.txt	72	primary antibody used follows anti psnum pab hnum sc biotechnology anti cavnum pab nnum sc biotechnology anti adaptin mab transduction laboratory anti bip mab transduction laboratory anti flotillin num mab transduction laboratory
0.37812415.15613480.html.plaintext.txt	73	horseradish peroxidase conjugated anti mouse igg anti rabbit secondary antibody numnum dilution amersham bioscience used visualize bound primary antibody chemiluminescence substrate santa cruz biotechnology
0.37812415.15613480.html.plaintext.txt	74	view larger version numk fig
0.37812415.15613480.html.plaintext.txt	75	bsa differentially boundendocytosed wt psnumnum null cell
0.37812415.15613480.html.plaintext.txt	76	total cellular protein extracted wt psnumnum cell svnum transformed blastocyst derived blastocyst derived cell b separated two dimensional electrophoresis
0.37812415.15613480.html.plaintext.txt	77	migration first dimension ph num ph num illustrated arrow
0.37812415.15613480.html.plaintext.txt	78	localization bsa coomassiestained two dimensional gel wt cell shown circle
0.37812415.15613480.html.plaintext.txt	79	caveolae deficient endothelial cell show defect uptake transport albumin vivo num
0.37812415.15613480.html.plaintext.txt	80	caveolin num null mouse embryonic fibroblast show defect endocytosis albumin transferrin num
0.37812415.15613480.html.plaintext.txt	81	caveolae mediated endocytosis endothelial cell stimulated binding albumin specific albumin binding protein localized caveolae num
0.37812415.15613480.html.plaintext.txt	82	therefore defect endocytosis andor binding albumin observed psnumnum null cell fig
0.37812415.15613480.html.plaintext.txt	83	num could linked abnormal caveolae dependent pathway
0.37812415.15613480.html.plaintext.txt	84	next examined ability wt psnumnum null cell bindendocytose fluorescent tracer fitc albumin
0.37812415.15613480.html.plaintext.txt	85	num show psnumnum null cell left panel failed accumulate fitc albumin even num min continuous incubation contrast wt cell showing cell surface labeling fitc albumin within num min incubation
0.37812415.15613480.html.plaintext.txt	86	ensure lack expression presenilins globally affect ligand bindingendocytosis also examined intracellular uptake second fluorescent tracer fitc transferrin known endocytosed via clathrin coated pit
0.37812415.15613480.html.plaintext.txt	87	num right panel fitc transferrin rapidly endocytosed wt psnumnum null cell
0.37812415.15613480.html.plaintext.txt	88	thus psnumnum null cell show selective defect caveolae mediated ligand binding reminiscent observed caveolin num deficient cell num
0.37812415.15613480.html.plaintext.txt	89	ensure defect caveolae dependent endocytosis observed psnumnum null cell specifically lack p protein examined whether transient expression presenilin cdna sufficient restore albumin binding psnumnum null cell
0.37812415.15613480.html.plaintext.txt	90	numa two dimensional gel profile protein psnumnum null cell re expressing psnum comparable corresponding wt cell see fig
0.37812415.15613480.html.plaintext.txt	91	presence bsa detected coomassie stained two dimensional gel either svnum transformed blastocyst derived psnumnum null cell top blastocyst derived psnumnum null cell bottom overexpressing psnum
0.37812415.15613480.html.plaintext.txt	92	confirmed result restoring efficient fitc albumin uptake blastocyst derived psnumnum null cell expressing either psnum fig
0.37812415.15613480.html.plaintext.txt	93	result show caveolae functionality dependent upon either psnum psnum expression
0.37812415.15613480.html.plaintext.txt	94	phenotype observed psnumnum null cell fig
0.37812415.15613480.html.plaintext.txt	95	num num num reminiscent one observed caveolinnum deficient cell num wondered caveolin num expressed psnumnum null cell
0.37812415.15613480.html.plaintext.txt	96	western blotting able detect caveolin num expression psnumnum null cell
0.37812415.15613480.html.plaintext.txt	97	num decided investigate caveolinnum regulated psnumnum null cell comparison wt cell
0.37812415.15613480.html.plaintext.txt	98	employed following three distinct method address issue
0.37812415.15613480.html.plaintext.txt	99	first explored caveolinnum localization immunofluorescence
0.37812415.15613480.html.plaintext.txt	100	observed caveolae formation em
0.37812415.15613480.html.plaintext.txt	101	finally looked association caveolin num lipid raft sucrose density centrifugation
0.37812415.15613480.html.plaintext.txt	102	order evaluate caveolin num cavnum distribution wt psnumnum null cell performed indirect immunofluorescence experiment fig
0.37812415.15613480.html.plaintext.txt	103	wt cell endogenous caveolin num predominantly localized plasma membrane typical caveolae associated punctated staining fig
0.37812415.15613480.html.plaintext.txt	104	numa whereas psnumnum null cell endogenous caveolin num showed pronounced punctated perinuclear localization fig
0.37812415.15613480.html.plaintext.txt	105	altered localization caveolin num psnumnum null cell also observed forced expression gfp cavnum fig
0.37812415.15613480.html.plaintext.txt	106	numa iv endogenous caveolin num
0.37812415.15613480.html.plaintext.txt	107	num result show intracellular retention caveolin num psnumnum null cell
0.37812415.15613480.html.plaintext.txt	108	evaluate caveolin num membrane localization p dependent examined transient expression presenilin num cdna sufficient induce change caveolin num localization
0.37812415.15613480.html.plaintext.txt	109	numb transient expression flag presenilin num v psnumnum null cell induced redistribution endogenous caveolin num perinuclear localization vi
0.37812415.15613480.html.plaintext.txt	110	micro injection psnum cdna gfp cavnum positive psnumnum null cell fig
0.37812415.15613480.html.plaintext.txt	111	numb vii allowed gfp cavnum relocalized wt cell viii
0.37812415.15613480.html.plaintext.txt	112	contrast noticeable change gfp cavnum localization observed microinjection notch nicd fig
0.37812415.15613480.html.plaintext.txt	113	numb ix construct gfp cavnum positive psnumnum null cell fig
0.37812415.15613480.html.plaintext.txt	114	result show caveolin num mislocalized psnumnum null cell even though psnumnum null mouse phenotype attributable loss notch num function num presenilins involved subcellular localization caveolin num independently notch activity
0.37812415.15613480.html.plaintext.txt	115	expression caveolin num cell lacking caveolae cause de novo formation caveolae whereas ablation mislocalization caveolin num expression cause loss caveolae num num
0.37812415.15613480.html.plaintext.txt	116	wondered psnumnum null cell showing mislocalized caveolin num still able form caveolae
0.37812415.15613480.html.plaintext.txt	117	caveolae well defined organelle forming flask shaped neck plasma membrane easily distinguishable electron microscopy
0.37812415.15613480.html.plaintext.txt	118	presence caveolae psnumnum null cell investigated em
0.37812415.15613480.html.plaintext.txt	119	found marked reduced number caveolae plasma membrane presenilin deficient cell fig
0.37812415.15613480.html.plaintext.txt	120	numb comparison wt cell fig
0.37812415.15613480.html.plaintext.txt	121	addition num psnumnum null cell showed caveolae plasma membrane compared num wt cell
0.37812415.15613480.html.plaintext.txt	122	num data show presenilins involved caveolae formation
0.37812415.15613480.html.plaintext.txt	123	view larger version numk fig
0.37812415.15613480.html.plaintext.txt	124	lack caveolae psnumnum null cell
0.37812415.15613480.html.plaintext.txt	125	transmission electron microscopy wt psnumnum null b cell
0.37812415.15613480.html.plaintext.txt	126	arrow indicate plasma membrane caveolae
0.37812415.15613480.html.plaintext.txt	127	caveolae subset specialized liquid ordered domain referred lipid raft
0.37812415.15613480.html.plaintext.txt	128	caveolae isolated insolubility triton x num sedimentation low density fraction sucrose gradient num
0.37812415.15613480.html.plaintext.txt	129	performed isolation cem wt psnumnum null cell protein see experimental procedure
0.37812415.15613480.html.plaintext.txt	130	shown previously caveolae enriched fraction isolated manner exclude marker caveolae membrane golgi apparatus mitochondrion endoplasmic reticulum num num
0.37812415.15613480.html.plaintext.txt	131	distribution bip adaptin non raft protein localized er trans golgi respectively also examined monitor contamination cem er trans golgi membrane fig
0.37812415.15613480.html.plaintext.txt	132	flotillins described new family protein associated caveolae num
0.37812415.15613480.html.plaintext.txt	133	numa flotillin num expression restricted fraction num num cem implying extraction triton x num yielded good separation lipid raft bip adaptin detected cem fraction
0.37812415.15613480.html.plaintext.txt	134	caveolin num expression restricted cem also found fraction wt cell
0.37812415.15613480.html.plaintext.txt	135	shown previously num num psnum also concentrated raft fraction
0.37812415.15613480.html.plaintext.txt	136	caveolin num expression detected fraction num wt cell fig
0.37812415.15613480.html.plaintext.txt	137	numa psnumnum null cell fig
0.37812415.15613480.html.plaintext.txt	138	psnumnum null cell caveolin num present fraction num high density fraction fraction num num triton x num soluble protein
0.37812415.15613480.html.plaintext.txt	139	result show absence presenilins caveolin num detected low density fraction normally enriched caveolae fraction num num supporting fact caveolae form
0.37812415.15613480.html.plaintext.txt	140	surprisingly flotillin num expression longer associated lipid raft psnumnum null cell implying caveolae also lipid raft may affected deficiency presenilins expression
0.37812415.15613480.html.plaintext.txt	141	view larger version numk fig
0.37812415.15613480.html.plaintext.txt	142	raft dissociation cavnum flotillin num psnumnum null cell
0.37812415.15613480.html.plaintext.txt	143	blastocyst derived wt psnumnum null b cell lysed num triton subjected flotation sucrose density gradient centrifugation
0.37812415.15613480.html.plaintext.txt	144	equal volume precipitated fraction analyzed western blotting antibody bip adaptin ada cavnum psnum flotillin num
0.37812415.15613480.html.plaintext.txt	145	caveolinnum flotillin num mark low buoyant density lipid raft fraction
0.37812415.15613480.html.plaintext.txt	146	non raft protein resident er bip trans golgi ada adaptin recovered heavier fraction
0.37812415.15613480.html.plaintext.txt	147	order determine molecular mechanism responsible caveolin num mislocalization psnumnum null cell tested presenilin num caveolin num able interact one another
0.37812415.15613480.html.plaintext.txt	148	despite co expression caveolin num psnum lipid raft fig
0.37812415.15613480.html.plaintext.txt	149	numa able detect interaction endogenous presenilin num caveolin num immunoprecipitation wt cellsnum either total extract cem fraction
0.37812415.15613480.html.plaintext.txt	150	altogether result show psnum psnum expression required correct localization caveolin num caveolae plasma membrane absence presenilins may affect protein directly implicated caveolin num sorting
0.37812415.15613480.html.plaintext.txt	151	observed intracellular retention caveolin num psnumnum null cell fig
0.37812415.15613480.html.plaintext.txt	152	perinuclear localization caveolin num psnumnum null cell partially co localized adaptin immunofluorescence
0.37812415.15613480.html.plaintext.txt	153	num experiment caveolin num broadly distributed adaptin
0.37812415.15613480.html.plaintext.txt	154	precise localization caveolin num absence presenilins need investigation
0.37812415.15613480.html.plaintext.txt	155	mechanism presenilins chaperone protein allow correct caveolin num localization caveolae formation involve complex caveolin num presenilin independent notch num signaling fig
0.37812415.15613480.html.plaintext.txt	156	flotillin num always target lipid raftcaveolae fraction independent presence caveolin num
0.37812415.15613480.html.plaintext.txt	157	thus absence flotillin num lipid raft fraction psnumnum null cell caveolin num mislocalization implying mechanism presenilins transport raft protein lipid raft global may directly affect common protein involved targeting raft associated protein lipid raft
0.37812415.15613480.html.plaintext.txt	158	lipid raft multifunctional organelle playing important role variety cellular process work pointed important new role presenilins
0.37812415.15613480.html.plaintext.txt	159	neuron form caveolae form lipid raft caveolae type structure
0.37812415.15613480.html.plaintext.txt	160	app found membrane fraction caveolae like property num suggesting caveolae type structure might important manifestation ad
0.37812415.15613480.html.plaintext.txt	161	moreover targeting secretase lipid raft shown regulate site processing app num presenilins found highly enriched caveolin num positive caveolae astrocyte surrounding senile plaque num
0.37812415.15613480.html.plaintext.txt	162	recently secretase complex shown localized lipid raft microdomains post golgi endosomes num
0.37812415.15613480.html.plaintext.txt	163	thus postulate neuron presenilins may implicated trafficking protein flotillin num responsible lipid raft formation
0.37812415.15613480.html.plaintext.txt	164	lipid raft would form best environment secretase activity
0.37812415.15613480.html.plaintext.txt	165	better understanding secretase complex formed transported cell membrane may lead development new pharmacological strategy specifically target cleavage app delay progress ad
0.37812415.15613480.html.plaintext.txt	166	footnote work supported human frontier science program long term fellowship lt numnum m m
0.37812415.15613480.html.plaintext.txt	167	cost publication article defrayed part payment page charge
0.37812415.15613480.html.plaintext.txt	168	article must therefore hereby marked advertisement accordance num u
0.37812415.15613480.html.plaintext.txt	169	section num solely indicate fact
0.37812415.15613480.html.plaintext.txt	170	correspondence addressed crbm frenum num route de mende num montpellier cedex num france
0.37812415.15613480.html.plaintext.txt	171	num num num num num fax num num num num num num e mail magali
0.37812415.15613480.html.plaintext.txt	172	num abbreviation used app amyloid precursor protein ad alzheimers disease p presenilin psnumnum null cell derived psnum psnum double null mouse bsa bovine serum albumin cav caveolin nicd notch num intracellular domain cem caveolin enriched membrane wt wild type pb phosphate buffered saline gfp green fluorescent protein mab monoclonal antibody pab polyclonal antibody fitc fluorescein isothiocyanate bsa bovine serum albumin maldi tof matrix assisted laser desorption ionization time flight me num morpholineethanesulfonic acid er endoplasmic reticulum cavnum caveolin num
0.37812415.15613480.html.plaintext.txt	173	kitzmann unpublished observation
0.37812415.15613480.html.plaintext.txt	174	acknowledgment thank ayuan zhan technical assistance laboratory dr
0.37812415.15613480.html.plaintext.txt	175	thank florence tribillac chantal cazevieille centre regional dimagerie cellulaire montpellier proficiency electron microscopy carol beach university kentucky proficiency protein sequencing
0.38811842.14976159.html.plaintext.txt	0	law mass action applied neurodegenerative disease hypothesis concerning etiology pathogenesis complex disease andrew singleton amanda myers john hardy
0.38811842.14976159.html.plaintext.txt	1	laboratory neurogenetics national institute aging national institute health building num room numcnum mscnum bethesda md num usa
0.38811842.14976159.html.plaintext.txt	2	received january num num revised february num num accepted february num num
0.38811842.14976159.html.plaintext.txt	3	finding well established driven therapeutic research especially allowed development animal model disease well defined therapeutic target num
0.38811842.14976159.html.plaintext.txt	4	example precise pathologic specie protein obscure one debated whether deposit intermediate specie oligomer responsible
0.38811842.14976159.html.plaintext.txt	5	extensively investigated balance recent data favoring smaller intermediate specie toxic entity num however generality fact mutated protein example deposited suggests process pathogenicity related although perhaps separable process deposition
0.38811842.14976159.html.plaintext.txt	6	studying autosomal dominant form disease researcher hope gain insight common sporadic form mechanistic perspective certainly case
0.38811842.14976159.html.plaintext.txt	7	however perhaps surprisingly last num year become clear case many disease least haplotype mendelian pathogenic locus influence disease risk sporadic disease
0.38811842.14976159.html.plaintext.txt	8	review briefly summarise data make prediction concerning etiology pathogenesis neurodegenerative disease
0.38811842.14976159.html.plaintext.txt	9	first though worth noting haplotypic association mean mechanistic perspective absence coding change haplotypic association implies genetic variability either amount expression protein alternate splicing protein contributes disease risk
0.38811842.14976159.html.plaintext.txt	10	alzheimers disease extensive sequencing app gene late onset alzheimers disease failed identify mutation num
0.38811842.14976159.html.plaintext.txt	11	however analysis data sibpairs affected late onset alzheimers disease consistently suggested app locus form disease numnum
0.38811842.14976159.html.plaintext.txt	12	suggests genetic variability app locus contributes disease risk although precise variability identified
0.38811842.14976159.html.plaintext.txt	13	finding consistent longstanding observation individual trisomy num inevitably develop alzheimer pathology fifth decade num however case syndrome caused triplication chromosome num distal app gene develop alzheimers disease num
0.38811842.14976159.html.plaintext.txt	14	thus three copy app gene lead alzheimer pathology fifth decade yet unidentified genetic variability app locus appears contribute disease risk
0.38811842.14976159.html.plaintext.txt	15	frontal temporal dementia tangle disease mutation tau gene cause many case autosomal dominant frontal temporal dementia tau pathology
0.38811842.14976159.html.plaintext.txt	16	many sporadic disease tau pathology occurs usually tangle also pick body argyrophilic grain num
0.38811842.14976159.html.plaintext.txt	17	two genetic haplotype clade caucasian population designated hnum hnum differ intron size promoter sequence wobble base num
0.38811842.14976159.html.plaintext.txt	18	hnum haplotype frequency num caucasian thus hnum homozygote constitute num population
0.38811842.14976159.html.plaintext.txt	19	however individual one three sporadic tau disease progressive supranuclear palsy num corticobasal degeneration num argyrophilic grain disease num although pick disease num guam disease num show robust association hnum homozygosity frequency hnum homozygote num
0.38811842.14976159.html.plaintext.txt	20	data show clearly variability either tau expression tau splicing variability contribute disease risk
0.38811842.14976159.html.plaintext.txt	21	case difficult determine whether control splicing control expression key variable indeed clear many mutation lead mendelian disease altering alternate splicing numnum
0.38811842.14976159.html.plaintext.txt	22	parkinson diseaselewy body dementia mutation synuclein gene cause autosomal dominant parkinson disease synuclein primary component lewy body pathognomic feature parkinson disease num
0.38811842.14976159.html.plaintext.txt	23	genetic variability synuclein promoter contributes risk sporadic parkinson disease numnum associated promoter allele stronger promoter num
0.38811842.14976159.html.plaintext.txt	24	perhaps convincingly triplication whole synuclein locus cause autosomal dominant parkinson diseaselewy body dementia onset age fourth decade num duplication locus lead disease fifth decade num
0.38811842.14976159.html.plaintext.txt	25	thus parkinson disease clear dose relationship synuclein expression disease occurrence normal genetic variability promoter contributing risk typical idiopathic disease multiplication locus causing mendelian disease onset age determined precise dose
0.38811842.14976159.html.plaintext.txt	26	protein study cell line affected individual kindred reveal amount synuclein produced correlate disease
0.38811842.14976159.html.plaintext.txt	27	finding unexpected perhaps
0.38811842.14976159.html.plaintext.txt	28	chemist know power law mass action perhaps surprised u may profound implication determining risk neurodegenerative disease num
0.38811842.14976159.html.plaintext.txt	29	course one therapeutic approach case therefore would aim reduce concentration toxic protein relevant tissue compartment either decreased production increased breakdown
0.38811842.14976159.html.plaintext.txt	30	footnote correspondence addressed
0.38811842.14976159.html.plaintext.txt	31	tel num num fax num num email hardyjatmail
0.38811842.14976159.html.plaintext.txt	32	num coding splice donor site mutation tau cause autosomal dominant dementia ftdp num
0.38811842.14976159.html.plaintext.txt	33	num mutation synuclein gene identified family parkinson disease
0.38811842.14976159.html.plaintext.txt	34	num solved unsolved mystery genetics early onset alzheimers disease
0.38811842.14976159.html.plaintext.txt	35	num role presenilin cofactor gamma secretase complex
0.38811842.14976159.html.plaintext.txt	36	num reconstitution gamma secretase activity
0.38811842.14976159.html.plaintext.txt	37	num genetic classification primary neurodegenerative disease
0.38811842.14976159.html.plaintext.txt	38	num addls protofibrils missing link neurobiol
0.38811842.14976159.html.plaintext.txt	39	num homozygous prion protein genotype predisposes sporadic creutzfeldt jakob disease
0.38811842.14976159.html.plaintext.txt	40	num genetic predisposition iatrogenic creutzfeldt jakob disease
0.38811842.14976159.html.plaintext.txt	41	num sporadic variant creutzfeldt jakob disease associated polymorphism upstream prnp exon num
0.38811842.14976159.html.plaintext.txt	42	num mouse devoid prp resistant scrapie
0.38811842.14976159.html.plaintext.txt	43	num evidence common allelic variation amyloid precursor protein app gene confers susceptibility alzheimers disease
0.38811842.14976159.html.plaintext.txt	44	num genetic variability amyloid beta precursor protein locus may contribute risk late onset alzheimers disease
0.38811842.14976159.html.plaintext.txt	45	num amyloid precursor protein locus late onset alzheimer disease
0.38811842.14976159.html.plaintext.txt	46	num presenile dementia alzheimers disease mongolism
0.38811842.14976159.html.plaintext.txt	47	num molecular mapping alzheimer type dementia down syndrome
0.38811842.14976159.html.plaintext.txt	48	num tau protein pathology neurodegenerative disease
0.38811842.14976159.html.plaintext.txt	49	num association extended haplotype tau gene progressive supranuclear palsy
0.38811842.14976159.html.plaintext.txt	50	num corticobasal degeneration progressive supranuclear palsy share common tau haplotype
0.38811842.14976159.html.plaintext.txt	51	num argyrophilic grain disease sporadic num repeat tauopathy
0.38811842.14976159.html.plaintext.txt	52	num analysis tau haplotype pick disease
0.38811842.14976159.html.plaintext.txt	53	num neurodegenerative disease guam analysis tau
0.38811842.14976159.html.plaintext.txt	54	num missing tau mutation identified
0.38811842.14976159.html.plaintext.txt	55	conum numlinktypedoi crossrefmedline
0.38811842.14976159.html.plaintext.txt	56	num alpha synucleinopathies parkinson disease dementia lewy body multiple system atrophy
0.38811842.14976159.html.plaintext.txt	57	num increased susceptibility sporadic parkinson disease certain combined synucleinapolipoprotein e genotype
0.38811842.14976159.html.plaintext.txt	58	conum xlinktypedoi crossrefmedline
0.38811842.14976159.html.plaintext.txt	59	num synuclein gene haplotype associated parkinson disease
0.38811842.14976159.html.plaintext.txt	60	num functional analysis intra allelic variation nacp repnum synuclein gene
0.38811842.14976159.html.plaintext.txt	61	num synuclein locus triplication cause parkinson disease
0.38811842.14976159.html.plaintext.txt	62	num genomic multiplication alpha synuclein gene three kindred familial lewy body disease
0.38811842.14976159.html.plaintext.txt	63	american society human genetics
0.38811842.14976159.html.plaintext.txt	64	num synuclein implicated parkinson disease present extracellular biological fluid including human plasma
0.38811842.14976159.html.plaintext.txt	65	num functional analysis human promoter polymorphism
0.38811842.14976159.html.plaintext.txt	66	num distortion allelic expression apolipoprotein e alzheimers disease
0.38811842.14976159.html.plaintext.txt	67	num allelic variation human gene expression
0.38811842.14976159.html.plaintext.txt	68	num normal huntington disease hd allele closely linked gene influence age onset hd
0.38811842.14976159.html.plaintext.txt	69	jr num molecular crowding accelerates fibrillization synuclein could increase cytoplasmic protein concentration induce parkinson disease biochemistry num num num
0.3937268.11487570.html.plaintext.txt	0	pathogenic app mutation near secretase cleavage site differentially affect as secretion app c terminal fragment stability chris de jonghe cary esselensnum samir kumar singh katleen craessaertsnum sally serneels frederic checlernum wim annaertnum christine van broeckhoven bart de stroopernum
0.3937268.11487570.html.plaintext.txt	1	laboratory neurogenetics department molecular genetics flanders interuniversity institute biotechnology university antwerp belgium numlaboratory neuronal cell biology department human genetics flanders interuniversity institute biotechnology university leuven belgium numinstitut de pharmacologie moleculaire et cellulaire du centre national de la recherche scientifique valbonne france
0.3937268.11487570.html.plaintext.txt	2	received april num num revised accepted june num num
0.3937268.11487570.html.plaintext.txt	3	presenilin p protein required secretase mediated cleavage app since deletion psnum gene inhibits as generation num
0.3937268.11487570.html.plaintext.txt	4	moreover finding mutagenesis critical aspartate residue dnum dnum psnum cause reduced as secretion accumulation appctfs led hypothesis psnum may exert aspartyl protease activity might identical secretase num
0.3937268.11487570.html.plaintext.txt	5	addition app mutation p interferes secretase activity way production highly amyloidogenic assnum increased num
0.3937268.11487570.html.plaintext.txt	6	consequently leading hypothesis ad etiology amyloid cascade hypothesis num stating increased assnum secretion represents gain misfunction
0.3937268.11487570.html.plaintext.txt	7	however reported recently app vnumm mutation affect assnum rather assnum secretion num
0.3937268.11487570.html.plaintext.txt	8	moreover artifical putative active site dnuma psnum mutant cause accumulation appctfs without concomitant reduction as secretion indicating accumulation appctfs necessarily direct consequence decreased as production num
0.3937268.11487570.html.plaintext.txt	9	recently several novel mutation clustered secretase processing site app identified num num
0.3937268.11487570.html.plaintext.txt	10	compare relative effect secretase cleavage expressed human appnum without clinical mutant tnumi vnumm vnuma inumv vnumi vnuml primary culture cortical neurones analysed full scope app metabolite
0.3937268.11487570.html.plaintext.txt	11	demonstrate mutation lead significantly increased relative assnumassnum concentration level increase inversely correlated age onset ad
0.3937268.11487570.html.plaintext.txt	12	furthermore c terminal app mutation also influenced turnover appctfs resulting accumulation appctfs
0.3937268.11487570.html.plaintext.txt	13	view larger version numk figure num
0.3937268.11487570.html.plaintext.txt	14	effect app c terminal mutation as secretion
0.3937268.11487570.html.plaintext.txt	15	primary neuronal culture transduced recombinant sfv expressing indicated app mutant
0.3937268.11487570.html.plaintext.txt	16	cell metabolically labelled numsmethionine num h culture medium collected
0.3937268.11487570.html.plaintext.txt	17	immunoprecipitation antibody fcanum numnum specifically recognizing assnum fcanum numnum specifically recognizing assnum b performed culture medium
0.3937268.11487570.html.plaintext.txt	18	precipitate separated num num sd nupage detection radioactive band performed using phosphorimaging c
0.3937268.11487570.html.plaintext.txt	19	value expressed relative wild type arbitrarily set equal num represent mean plus minus sem three experiment
0.3937268.11487570.html.plaintext.txt	20	hence assnum numassnum num ratio compared wild type app arbitrarily set equal num mutation ratio increased app mutation
0.3937268.11487570.html.plaintext.txt	21	moreover assnum numassnum num ratio correlate inversely r num
0.3937268.11487570.html.plaintext.txt	22	num mean age onset different mutation httpmolgen www
0.3937268.11487570.html.plaintext.txt	23	view larger version numk figure num
0.3937268.11487570.html.plaintext.txt	24	effect app c terminal mutation assnumassnum ratio
0.3937268.11487570.html.plaintext.txt	25	primary neuronal culture transduced recombinant sfv expressing indicated app mutant
0.3937268.11487570.html.plaintext.txt	26	secretion assnum num assnum num measured described figure num
0.3937268.11487570.html.plaintext.txt	27	mean assnum numassnum num ratio calculated three independent experiment compared wild type arbitrarily set equal num
0.3937268.11487570.html.plaintext.txt	28	b inversely linear relationship assnumassnum ratio mean age onset ad
0.3937268.11487570.html.plaintext.txt	29	mean age onset calculated mutation including data available family httpmolgen www
0.3937268.11487570.html.plaintext.txt	30	also indicated age onset range number patient n
0.3937268.11487570.html.plaintext.txt	31	effect secretion sapp immunoprecipitated secreted app ectodomain conditioned medium neuron transduced sfv expressing wild type mutant app using antibody num
0.3937268.11487570.html.plaintext.txt	32	significant difference level sapp mutant wild type app observed data shown agreement assumption mutation mainly affect secretase processing app
0.3937268.11487570.html.plaintext.txt	33	effect generation appctfs ctfs ctf ctfss remain associated cell s secretase cleavage app immunoprecipitated using antibody bnumnum directed last num amino acid cytoplasmic domain app
0.3937268.11487570.html.plaintext.txt	34	mutation codon num tnumi num vnumi vnuml caused increased level appctfs num
0.3937268.11487570.html.plaintext.txt	35	mutation codon num vnuma vnumm num inumv displayed similar even slightly decreased level appctfs compared wild type app fig
0.3937268.11487570.html.plaintext.txt	36	view larger version numk figure num
0.3937268.11487570.html.plaintext.txt	37	effect c terminal app mutation production appctfs
0.3937268.11487570.html.plaintext.txt	38	primary neuronal culture transduced recombinant sfv expressing indicated app mutation
0.3937268.11487570.html.plaintext.txt	39	cell metabolically labelled numsmethionine num h cell washed lysed
0.3937268.11487570.html.plaintext.txt	40	immunoprecipitation antibody bnumnum numnum app cytoplasmic tail performed cell lysates
0.3937268.11487570.html.plaintext.txt	41	precipitate separated num num sd nupage detection radioactive material performed using phosphorimaging b
0.3937268.11487570.html.plaintext.txt	42	data expressed relative wild type represent mean plus minus sem indicated number n experiment
0.3937268.11487570.html.plaintext.txt	43	investigated whether accumulation appctfs observed tnumi mutation consequence reduced degradation increased production
0.3937268.11487570.html.plaintext.txt	44	therefore pulse chase experiment performed turnover rate wild type mutant ctfs assessed
0.3937268.11487570.html.plaintext.txt	45	appreciated figure numa b turnover rate app holoprotein le identical wild type mutant app
0.3937268.11487570.html.plaintext.txt	46	contrast turnover rate wild type appctfs appinumvctfs faster turnover rate appctfs containing tnumi vnumi mutation fig
0.3937268.11487570.html.plaintext.txt	47	three hour pulse labeling level appctfs clearly decreasing wild type app appctfs continue accumulate tnumi vnumi mutation
0.3937268.11487570.html.plaintext.txt	48	degradation rate inumv mutant appctfs identical wild type
0.3937268.11487570.html.plaintext.txt	49	view larger version numk figure num
0.3937268.11487570.html.plaintext.txt	50	pulse chase analysis wild type mutant full length app
0.3937268.11487570.html.plaintext.txt	51	primary neuronal culture transduced recombinant sfv expressing indicated app mutation
0.3937268.11487570.html.plaintext.txt	52	cell pulse labelled numsmethionine num min followed chase period num num min
0.3937268.11487570.html.plaintext.txt	53	cell extract immunoprecipitated using antibody bnumnum numnum separated using num num sd nupage
0.3937268.11487570.html.plaintext.txt	54	detection radioactive material performed using phosphorimaging
0.3937268.11487570.html.plaintext.txt	55	quantification radioactive band shown app holoprotein b appctfs
0.3937268.11487570.html.plaintext.txt	56	radioactive signal normalized signal obtained app holoprotein time zero
0.3937268.11487570.html.plaintext.txt	57	data representative two independent experiment
0.3937268.11487570.html.plaintext.txt	58	level secretase processing different mutation apparently slightly different effect
0.3937268.11487570.html.plaintext.txt	59	mutation codon num tnumi num vnuma vnumm appear primarily affect num cleavage cause decreased secretion assnum
0.3937268.11487570.html.plaintext.txt	60	mutation codon num inumv num vnumi vnuml predominantly affect num cleavage increase assnum secretion
0.3937268.11487570.html.plaintext.txt	61	hence pathogenic app mutation exert largest effect cleavage site located two three residue n terminal substitution fig
0.3937268.11487570.html.plaintext.txt	62	suggests residue pnum pnum position particular importance exposure scissile bound catalytic site secretase protease
0.3937268.11487570.html.plaintext.txt	63	remarkably drastic decrease assnum secretion observed mutation codon num num clearly accompanied large increase assnum secretion
0.3937268.11487570.html.plaintext.txt	64	however demonstrated previously app tnumi mutation num as isoforms ending residue num num lesser extent num may counterbalance decrease assnum
0.3937268.11487570.html.plaintext.txt	65	overall follows ratio assnum assnum best indicator severity disease patient app mutation
0.3937268.11487570.html.plaintext.txt	66	view larger version numk figure num
0.3937268.11487570.html.plaintext.txt	67	position mutated residue relative cleavage site secretase displayed
0.3937268.11487570.html.plaintext.txt	68	amino acid numbering indicated app holoprotein num num as num num
0.3937268.11487570.html.plaintext.txt	69	arrow residue number indicate effect mutation secretion corresponding as isoform
0.3937268.11487570.html.plaintext.txt	70	b top view spatial model putative helical conformation adapted lichtenthaler et al
0.3937268.11487570.html.plaintext.txt	71	num part transmembrane region app near secretase cleavage site shown
0.3937268.11487570.html.plaintext.txt	72	residue mutated mainly affect num cleavage bold line fully encircled
0.3937268.11487570.html.plaintext.txt	73	residue mutated affect predominantly num cleavage dashed line encircled dash
0.3937268.11487570.html.plaintext.txt	74	note type residue located opposite side helix separated bold dashed line
0.3937268.11487570.html.plaintext.txt	75	unexpectedly app c terminal mutation also influence level appctfs
0.3937268.11487570.html.plaintext.txt	76	tnumi vnumi vnuml mutation cause accumulation appctfs neuron whereas vnuma vnumm inumv mutation significant effect appctf level
0.3937268.11487570.html.plaintext.txt	77	s secretase generated appctfs increase approximately extent
0.3937268.11487570.html.plaintext.txt	78	elevation clearly accompanied increased secretion sapp indicating accumulation appctfs direct result increased s secretase processing app
0.3937268.11487570.html.plaintext.txt	79	increased level appctfs could also result reduced secretase activity num
0.3937268.11487570.html.plaintext.txt	80	could envisaged presence c terminal app mutation reduces secretase activity
0.3937268.11487570.html.plaintext.txt	81	since assnum major as isoform produced specific reduction num cleavage could theoretically explain accumulation appctfs maintaining assnum level pathogenic level
0.3937268.11487570.html.plaintext.txt	82	however app mutation drastically decreased assnum secretion vnuma vnumm display appctf accumulation whereas others vnumi vnuml significantly affect assnum secretion accumulated appctfs
0.3937268.11487570.html.plaintext.txt	83	therefore effect latter mutation appctf metabolism must occur independently secretase cleavage step
0.3937268.11487570.html.plaintext.txt	84	pulse chase data indicated reduced turnover rate mutant ctfs suggesting app mutation affect secretase processing also catabolic pathway degrade fragment
0.3937268.11487570.html.plaintext.txt	85	accumulation appctfs shown swedish london app mutant knumnmnuml vnumi vnumf vnumg num agreement finding
0.3937268.11487570.html.plaintext.txt	86	num proposed appctfss linked signalling transduction pathway
0.3937268.11487570.html.plaintext.txt	87	accumulation appctfss speculated disrupt pathway leading cytoskeletal abnormality neurodegeneration
0.3937268.11487570.html.plaintext.txt	88	however data show accumulation appctfs consistent feature app mutant causing ad
0.3937268.11487570.html.plaintext.txt	89	fact mutation vnumi inumv result similar mean age onset whereas appctfs accumulate former latter
0.3937268.11487570.html.plaintext.txt	90	therefore accumulation appctfs likely le important factor overall pathogenesis disease
0.3937268.11487570.html.plaintext.txt	91	would interest investigate different mutation pathological level brain patient
0.3937268.11487570.html.plaintext.txt	92	unfortunately material yet available patient mutation cause appctf accumulation
0.3937268.11487570.html.plaintext.txt	93	mutation position num num app sequence
0.3937268.11487570.html.plaintext.txt	94	finally propose molecular model integrates observation
0.3937268.11487570.html.plaintext.txt	95	one presumes helical conformation transmembraneous part app num fig
0.3937268.11487570.html.plaintext.txt	96	numb mutation residue num num primarily affect num secretase cleavage located one side helix whereas mutation residue num num predominantly affect num secretase cleavage located opposite side
0.3937268.11487570.html.plaintext.txt	97	noted mutation residue num num leading accumulation appctfs located one side helix whereas mutation residue num num lead accumulation appctfs side fig
0.3937268.11487570.html.plaintext.txt	98	recent unpublished data w
0.3937268.11487570.html.plaintext.txt	99	de strooper demonstrated region app spanning currently investigated clinical mutation involved direct binding app psnum
0.3937268.11487570.html.plaintext.txt	100	speculate therefore investigated clinical mutation cause subtle change binding interaction psnum app therefore mainly affect exposure scissile bond catalytic site secretase abnormal accumulation appctfs observed app mutant could also fit hypothesis since psnum dnuma catalytic site mutant lead accumulation appctfs without concomitant reduction as production num
0.3937268.11487570.html.plaintext.txt	101	primary neuronal culture primary cortical neuron isolated enum embryonic mouse described num
0.3937268.11487570.html.plaintext.txt	102	briefly dissection brain dissociation cell trypsinization cell plated poly lysine coated dish incubated neurobasal medium bnum supplement
0.3937268.11487570.html.plaintext.txt	103	proliferation non neuronal cell prevented adding num microm cytosine arabinoside
0.3937268.11487570.html.plaintext.txt	104	transduction primary neuron recombinant sfv diluted numnum conditioned culture medium added num num day old primary cortical neuron
0.3937268.11487570.html.plaintext.txt	105	num h medium replaced normal culture medium transduction continued num h
0.3937268.11487570.html.plaintext.txt	106	medium replaced methionine free medium containing num microci numsmethionine icn irvine ca
0.3937268.11487570.html.plaintext.txt	107	num h metabolic labelling culture supernatant collected cell washed pb finally lysed dip buffer num mm tris hcl ph num
0.3937268.11487570.html.plaintext.txt	108	num num mm nacl num triton x num num sodium deoxycholate num
0.3937268.11487570.html.plaintext.txt	109	num sd containing protease inhibitor num mm edta num uml trasylol num microgml pepstatin
0.3937268.11487570.html.plaintext.txt	110	pulse chase neuron transduced recombinant sfv described
0.3937268.11487570.html.plaintext.txt	111	neuron pulse labeled num microci numsmethionine num min chased num num num min
0.3937268.11487570.html.plaintext.txt	112	cell extract processed described
0.3937268.11487570.html.plaintext.txt	113	immunoprecipitation sd page antibody directed as numgnum numnum senetek napa ca recognizes total as fcanum numnum specifically recognizes assnum num fcanum numnum specifically recognizes assnum num secreted ectodomain app antibody num numnum num added culture supernatant immune complex recovered protein g sepharose
0.3937268.11487570.html.plaintext.txt	114	antibody bnumnum used precipitate s c terminal fragment app cell extract num
0.3937268.11487570.html.plaintext.txt	115	immunoprecipitated material resolved num num nupage gel novex invitrogen carlsbad ca run me buffer
0.3937268.11487570.html.plaintext.txt	116	intensity radioactive band quantified using phosphoimager molecular dynamic sunnyvale ca imagequant software package
0.3937268.11487570.html.plaintext.txt	117	quantitative data normalized signal obtained corresponding app holoprotein compensate variation expression culture dish different app mutant used
0.3937268.11487570.html.plaintext.txt	118	footnote correspondence addressed
0.3937268.11487570.html.plaintext.txt	119	tel num num num fax num num num email admed
0.3937268.11487570.html.plaintext.txt	120	correspondence addressed
0.3937268.11487570.html.plaintext.txt	121	tel num num num fax num num num email admed
0.3937268.11487570.html.plaintext.txt	122	num mutation amyloid precursor protein gene associated hereditary alzheimer disease
0.3937268.11487570.html.plaintext.txt	123	num early onset alzheimer disease caused mutation codon num s amyloid precursor protein gene
0.3937268.11487570.html.plaintext.txt	124	num pathogenic mutation probable alzheimer disease app gene n terminus s amyloid
0.3937268.11487570.html.plaintext.txt	125	num presenile dementia cerebral haemorrhage linked mutation codon num s amyloid precursor protein gene
0.3937268.11487570.html.plaintext.txt	126	num new pathogenic mutation app gene inumv increase relative proportion assnumnum
0.3937268.11487570.html.plaintext.txt	127	num unusual phenotypic alteration s amyloid precursor protein s app maturation new val num met ssapp num mutation
0.3937268.11487570.html.plaintext.txt	128	num nonfibrillar diffuse amyloid deposition due num secretase site mutation point essential role n truncated assnum
0.3937268.11487570.html.plaintext.txt	129	num early onset alzheimer disease caused new mutation vnuml amyloid precursor protein gene
0.3937268.11487570.html.plaintext.txt	130	num novel leunumpro amyloid precursor protein mutation increase amyloid s numnum peptide level induces apoptosis
0.3937268.11487570.html.plaintext.txt	131	num mutation s amyloid precursor protein familial alzheimer disease increase s protein production
0.3937268.11487570.html.plaintext.txt	132	num release excess amyloid s protein mutant amyloid s protein precursor
0.3937268.11487570.html.plaintext.txt	133	num increased s amyloid release level s amyloid precursor protein app fibroblast cell line family member swedish alzheimer disease app mutation
0.3937268.11487570.html.plaintext.txt	134	num secreted amyloid s protein similar senile plaque alzheimer disease increased vivo presenilin num num app mutation linked familial alzheimer disease
0.3937268.11487570.html.plaintext.txt	135	num mutation associated locus familial alzheimer disease result alternative processing amyloid s protein precursor
0.3937268.11487570.html.plaintext.txt	136	num flemish dutch mutation amyloid s precursor protein different effect amyloid s secretion
0.3937268.11487570.html.plaintext.txt	137	num increased percentage long amyloid s protein secreted familial amyloid s protein precursor ssappnum mutant
0.3937268.11487570.html.plaintext.txt	138	num biochemical evidence long tail form as num numnum amyloid s protein seed molecule cerebral deposit alzheimer disease
0.3937268.11487570.html.plaintext.txt	139	num s secretase cleavage alzheimer amyloid precursor protein transmemebrane aspartic protease bace
0.3937268.11487570.html.plaintext.txt	140	num cell free assay secretase activity
0.3937268.11487570.html.plaintext.txt	141	num novel secretase assay based detection putative c terminal fragment amyloid s precursor protein
0.3937268.11487570.html.plaintext.txt	142	num generation apoptotic intracellular peptide secretase cleavage alzheimer amyloid s precursor protein
0.3937268.11487570.html.plaintext.txt	143	num deficiency presenilin num inhibits normal cleavage amyloid precursor protein
0.3937268.11487570.html.plaintext.txt	144	num two transmembrane aspartates presenilin num required presenilin endoproteolysis secretase activity
0.3937268.11487570.html.plaintext.txt	145	num translating cell biology therapeutic advance alzheimer disease
0.3937268.11487570.html.plaintext.txt	146	num alzheimer disease amyloid cascade hypothesis
0.3937268.11487570.html.plaintext.txt	147	num presenilin num differentially facilitates endoproteolysis s amyloid precursor protein notch
0.3937268.11487570.html.plaintext.txt	148	num characterization new polyclonal antibody specific num num amino acid long amyloid s peptide use examine cell biology presenilins immunohistochemistry sporadic alzheimer disease cerebral amyloid angiopathy case
0.3937268.11487570.html.plaintext.txt	149	num processing s secretase furin member proprotein convertase family
0.3937268.11487570.html.plaintext.txt	150	num secretion ssanum amyloid precursor protein
0.3937268.11487570.html.plaintext.txt	151	identification cleavage site cultured mammalian cell
0.3937268.11487570.html.plaintext.txt	152	num apoe genotype alzheimer disease
0.3937268.11487570.html.plaintext.txt	153	num apoe genotype familial alzheimer disease possible influence age onset appnum valile mutated family
0.3937268.11487570.html.plaintext.txt	154	num mutant presenilins alzheimer disease increase production num residue amyloid s protein transfected cell transgenic mouse
0.3937268.11487570.html.plaintext.txt	155	num increased assnumnum cell line expressing presenilin num mutation
0.3937268.11487570.html.plaintext.txt	156	num evidence assnum plasma level presenilin num mutation carrier allow prediction clinical phenotype
0.3937268.11487570.html.plaintext.txt	157	num apoe genotype modulate age onset family chromosome num encoded alzheimer disease
0.3937268.11487570.html.plaintext.txt	158	num neuronal expression s amyloid precursor protein alzheimer mutation cause intracellular accumulation c terminal fragment containing amyloid s cytoplasmic domain
0.3937268.11487570.html.plaintext.txt	159	num mechanism cleavage specificity alzheimer disease secretase identified phenylalanine scanning mutagenesis transmembrane domain amyloid precursor protein
0.3937268.11487570.html.plaintext.txt	160	num presenilin num control secretase processing amyloid precursor protein pre golgi compartment hippocampal neuron
0.3937268.11487570.html.plaintext.txt	161	num secretory processing alzheimer amyloid ssanum protein precursor increased protein phosphorylation
0.3937268.11487570.html.plaintext.txt	162	num production intracellular amyloid containing fragment hippocampal neuron expressing human amyloid precursor protein protection amyloidogenesis subtle amino acid substitution rodent sequence
0.41595346.15367492.html.plaintext.txt	0	reduced kiaanum mrna expression alzheimers patient new candidate gene product linked disease lluisa de yebranum rosa adroernum nuria de gregorio rocasolanonum rafael blesanum ramon trullasnum nicole mahynum
0.41595346.15367492.html.plaintext.txt	1	numunitat de bioquimica institut dinvestigacions biomediques august pi sunyer idibaps facultat de medicina universitat de barcelona ccasanova num num barcelona spain numunitat de neurobiologia institut dinvestigacions biomediques de barcelona csic institut dinvestigacions biomediques august pi sunyer idibaps crossello num num barcelona spain numservei de neurologia hospital de la santa creu sant pau cst
0.41595346.15367492.html.plaintext.txt	2	claret num num barcelona spain
0.41595346.15367492.html.plaintext.txt	3	received may num num revised july num num accepted september num num
0.41595346.15367492.html.plaintext.txt	4	septohippocampal system play important role memory cognition affected ad patient characterized reduction cholinergic activity significant atrophy medial septum diagonal band broca m dbb correlate grade cognitive memory deficit num
0.41595346.15367492.html.plaintext.txt	5	pathological change arise disease mostly believed driven change gene expression num num aim study disentangle different pattern genetic expression characterize ad medial septum hippocampus
0.41595346.15367492.html.plaintext.txt	6	differential display reverse transcriptase polymerase chain reaction ddrt pcr technique quite unique potential visualize expressed gene eukaryotic cell systematic non biased sequence dependent manner using multiple primer combination num
0.41595346.15367492.html.plaintext.txt	7	thus technique allows searching gene differentially expressed specific disease
0.41595346.15367492.html.plaintext.txt	8	ddrt pcr used laboratory identify new gene involved ad report kiaanum gene differentially expressed human brain several ad patient including one psnum mutation
0.41595346.15367492.html.plaintext.txt	9	differential display analysis gene expression ad total rna extracted hippocampus septum post mortem ad control patient
0.41595346.15367492.html.plaintext.txt	10	autoradiogram show band pattern obtained numpdatp labeled differential display reaction performed duplicate using num aagctttttttttttg num anchored primer h tnumg num aagcttcctctat num random arbitrary primer h apnum
0.41595346.15367492.html.plaintext.txt	11	arrow indicates band corresponding cdna fragment differentially expressed ad patient
0.41595346.15367492.html.plaintext.txt	12	indicates alzheimers patient control
0.41595346.15367492.html.plaintext.txt	13	ad patient alzheimers disease ad patient mutation psnum gene c control
0.41595346.15367492.html.plaintext.txt	14	two brain area analyzed per case hippocampus num septum num
0.41595346.15367492.html.plaintext.txt	15	different lane numbered num num every two lane correspond duplicated sample
0.41595346.15367492.html.plaintext.txt	16	patient e included figure give result similar patient b d
0.41595346.15367492.html.plaintext.txt	17	excising band interest reverse northern dot blot performed gave several positive clone confirmed difference expression fig
0.41595346.15367492.html.plaintext.txt	18	nucleotide sequence representative clone num num identical fig
0.41595346.15367492.html.plaintext.txt	19	confirm difference northern blot analysis performed ad patient fig
0.41595346.15367492.html.plaintext.txt	20	basis known sequence genbank database fragment sequence presented high homology num e num homo sapiens gene product kiaanum
0.41595346.15367492.html.plaintext.txt	21	sequence mrna part human brain cdna library included japanese protein database huge human unidentified gene encoded num
0.41595346.15367492.html.plaintext.txt	22	huge database human large protein aim predict primary structure sequence human large cdna num kb particular cdna clone capable coding large protein num kda num
0.41595346.15367492.html.plaintext.txt	23	kiaanum num bp gene located chromosome num map numqnum qnum region num bp num utr
0.41595346.15367492.html.plaintext.txt	24	view larger version numk figure num
0.41595346.15367492.html.plaintext.txt	25	confirmation differentially expressed cdna
0.41595346.15367492.html.plaintext.txt	26	reverse northern dot blot cdna differential band represented figure num lane num candidate cdna another band showing different intensity ddrt gel control cdna excised reamplified ligated pcr trap cloning vector
0.41595346.15367492.html.plaintext.txt	27	pcr five picked colony cnum cnum cnum cnum cnum blotted onto duplicated filter
0.41595346.15367492.html.plaintext.txt	28	one pair filter hybridized nump labeled cdna control individual
0.41595346.15367492.html.plaintext.txt	29	pair filter hybridized nump labeled cdna ad patient
0.41595346.15367492.html.plaintext.txt	30	cnum cnum clone corresponding candidate cdna present marked difference hybridization control ad mrna probe
0.41595346.15367492.html.plaintext.txt	31	b nucleotide sequence candidate clone cdna fragment
0.41595346.15367492.html.plaintext.txt	32	cdna insert candidate num num clone showing differential expression sequenced
0.41595346.15367492.html.plaintext.txt	33	nucleotide sequence clone identical
0.41595346.15367492.html.plaintext.txt	34	sequence primer used differential gene display analysis underlined hhindiii site num end primer
0.41595346.15367492.html.plaintext.txt	35	c northern blot analysis showing overexpression kiaanum ad patient
0.41595346.15367492.html.plaintext.txt	36	hippocampus septum different patient used two lane pair show hippocampus h septum one patient
0.41595346.15367492.html.plaintext.txt	37	equal amount num microglane total rna septum hippocampus isolated studied brain area run num
0.41595346.15367492.html.plaintext.txt	38	num agarose gel transferred nylon filter
0.41595346.15367492.html.plaintext.txt	39	filter hybridized nump labeled kiaanum cdna fragment identified differential display
0.41595346.15367492.html.plaintext.txt	40	blot also rehybridized s actin probe control
0.41595346.15367492.html.plaintext.txt	41	important consider besides working problem human sample fact human brain thought greatest complexity gene expression region body num obtained clear sharp ddrt gel improving image band compared previously reported study numnum
0.41595346.15367492.html.plaintext.txt	42	identified one cdna expressed septum hippocampus several alzheimers patient including one psnum mutation
0.41595346.15367492.html.plaintext.txt	43	necessary screen num total mrna observe difference ad gene expression transcript could important among total gene potentially associated ad
0.41595346.15367492.html.plaintext.txt	44	differential mrna identified kiaanum
0.41595346.15367492.html.plaintext.txt	45	stage kiaanum mrna directly associated known protein based predicted coding region would translated soluble large protein length num amino acid num molecular weight num kda
0.41595346.15367492.html.plaintext.txt	46	predicted protein present least num homology h
0.41595346.15367492.html.plaintext.txt	47	sapiens aminoacid sequence idnnum ggtr membrane protein protein associated precancerous lesion hepatocellular carcinoma embl bioinformatic harvester
0.41595346.15367492.html.plaintext.txt	48	recent experiment ddrt pcr reported upregulation kiaanum gene product num num case esophageal tumor num
0.41595346.15367492.html.plaintext.txt	49	study predicted kiaa protein indicate multiple domain may participate intricate framework assembly protein complex
0.41595346.15367492.html.plaintext.txt	50	predicted function mainly implied cell communicationsignaling cell structuremotility nucleic acid management num
0.41595346.15367492.html.plaintext.txt	51	would agreement increased kiaanum expression proliferative cell reduction neuronal loss associated neurodegeneration
0.41595346.15367492.html.plaintext.txt	52	true absence kiaanum expression evidenced result may directly involved pathogenesis septohippocampal lesion presented ad
0.41595346.15367492.html.plaintext.txt	53	present study directly conducted determine entire sequence human kiaa protein together biological function help better understand involvement variety disease num
0.41595346.15367492.html.plaintext.txt	54	lack expression kiaanum gene psnum mutation patient could additional factor contributes explain early onset dementia andor early death
0.41595346.15367492.html.plaintext.txt	55	possible genetic association presenilin num kiaanum ad discarded gene map long arm chromosome num numqnum qnum kiaanum numqnum qnum psnum
0.41595346.15367492.html.plaintext.txt	56	ad mutation chromosome result individual wide range age onset num also shown result
0.41595346.15367492.html.plaintext.txt	57	special instability numq chromosome also suggested presentation genetic abnormality leading glioma oligodendrogliomas astrocytomas num ependymomas num
0.41595346.15367492.html.plaintext.txt	58	hand well characterized disease sometimes appear linked genetic mutation locus kiaanum map numqnum qnum
0.41595346.15367492.html.plaintext.txt	59	case type num diabetes num immunoglobulin nephropathy num hereditary prostate cancer num num
0.41595346.15367492.html.plaintext.txt	60	present direct relationship ad established disease except recently recognized association among hyperinsulinemia diabetes ad num insulin degrading enzyme activity s amyloid peptide num num
0.41595346.15367492.html.plaintext.txt	61	therefore knowledge function kiaanum protein future could elucidate possible relationship
0.41595346.15367492.html.plaintext.txt	62	deficiency kiaanum showed male individual though one ad woman included study study necessary disentangle whether link gender
0.41595346.15367492.html.plaintext.txt	63	work needed determine cause lack expression
0.41595346.15367492.html.plaintext.txt	64	among could due mutation kiaanum gene result altered missing mrna upstream effect simply ulterior suppresion mrna production another factor downstream effect
0.41595346.15367492.html.plaintext.txt	65	moment beginning new assay using microchip dna probe specific antibody predicted kiaanum protein new attempt aimed understand difference gene expression found study using ddrt pcr technique
0.41595346.15367492.html.plaintext.txt	66	study incidence kiaanum mrna deficit alzheimers patient wide population sample brain tissue blood give key information better diagnosis disease future
0.41595346.15367492.html.plaintext.txt	67	conclusion found first time strong reduction kiaanum gene expression several ad patient including one psnum mutation
0.41595346.15367492.html.plaintext.txt	68	predicted defective protein present num homology idnnum ggtr sequence
0.41595346.15367492.html.plaintext.txt	69	identification new genetic defect may give new clue explain pathogenesis ad process new starting point design rational diagnostic therapeutic tool
0.41595346.15367492.html.plaintext.txt	70	rna extraction rna extracted num mg studied brain area hippocampus septum using tripure isolation reagent boehringer manheim germany treated dnase genhunter nashville tn usa
0.41595346.15367492.html.plaintext.txt	71	briefly tissue sample sliced homogenized tripure aqueous organic phase separated centrifugation addition chloroform merck darmstadt germany
0.41595346.15367492.html.plaintext.txt	72	aqueous rna solution precipitated isopropyl alcohol scharlau chemie spain rinsed num ethanol resuspended water
0.41595346.15367492.html.plaintext.txt	73	quantification concentration spectrophotometry total rna sample kept frozen num degree c ethanol precipitate
0.41595346.15367492.html.plaintext.txt	74	gene expression analysis used differential display technique ddrt pcr described liang pardee numnum study gene expression
0.41595346.15367492.html.plaintext.txt	75	first strand cdna synthesis pcr amplification labeled numpdatp labeled performed using rna image kit genhunter
0.41595346.15367492.html.plaintext.txt	76	num microg total rna reverse transcribed using anchored oligo dt h tnumv va g c
0.41595346.15367492.html.plaintext.txt	77	aliquot generated cdna corresponding num ng total rna amplified pcr anchored oligo dt used cdna reaction arbitrary primer
0.41595346.15367492.html.plaintext.txt	78	pcr reaction performed always duplicate
0.41595346.15367492.html.plaintext.txt	79	pcr product resolved electrophoresis using num denaturing polyacrylamide gel
0.41595346.15367492.html.plaintext.txt	80	gel dried nummm whatman paper num h vacuum num degree c exposed overnight x omat ar film eastman kodak co
0.41595346.15367492.html.plaintext.txt	81	film put top dried gel marked needle punch order locate gel band identified film film developed
0.41595346.15367492.html.plaintext.txt	82	cdna display showed difference band intensity repeated rna isolation step order ensure result avoid false positive
0.41595346.15367492.html.plaintext.txt	83	cdna band interest corresponding human sample excised gel reamplified pcr set primer pcr condition used mrna display higher concentration dntps ligated pcr trap cloning vector genhunter
0.41595346.15367492.html.plaintext.txt	84	pcr trap vector includes tetracycline dependent positive selection plasmid dna insert thus recombinant plasmid show antibiotic resistance
0.41595346.15367492.html.plaintext.txt	85	ligated plasmid transformed gh competent cell plated lb plate containing num microgml tetracycline
0.41595346.15367492.html.plaintext.txt	86	reverse northern dot blot reverse northern dot blot used verify difference expression cdna fragment identified previously differential display
0.41595346.15367492.html.plaintext.txt	87	tetracycline resistant colony randomly picked plate lysed num microl lysis buffer te buffer ph num
0.41595346.15367492.html.plaintext.txt	88	cloned cdna fragment amplified using primer flanking cloning site vector pcr product individually dot blotted onto duplicate nylon membrane hybond xl amersham pharmacia biotech uk using microfiltration system
0.41595346.15367492.html.plaintext.txt	89	uv crosslinking membrane num h num degree c probed total numpcdna
0.41595346.15367492.html.plaintext.txt	90	probe prepared num microg total rna isolated septum alzheimers patient without band interest septum control present band
0.41595346.15367492.html.plaintext.txt	91	probe labeled numpdctp num cimmol amersham pharmacia biotech
0.41595346.15367492.html.plaintext.txt	92	cdna probe case alzheimers patient control heat denatured used probe duplicate blot
0.41595346.15367492.html.plaintext.txt	93	northern blot cdna overexpression confirmed reverse northern dot blot northern blot performed verify whether selected cdna represent overexpression single mrna
0.41595346.15367492.html.plaintext.txt	94	total rna isolated using tripure isolation reagent boehringer without dnase treatment
0.41595346.15367492.html.plaintext.txt	95	denatured rna num microg total rna brain sample electrophoresed num
0.41595346.15367492.html.plaintext.txt	96	num agarose gel transferred nylon membrane hybond xl amersham pharmacia biotech rna fixed membrane baking num h num degree c
0.41595346.15367492.html.plaintext.txt	97	hybridization nump labeled probe washing condition performed following membrane manufacturer indication
0.41595346.15367492.html.plaintext.txt	98	filter exposed biomax film amersham pharmacia biotech intensifying screen num num h num degree c
0.41595346.15367492.html.plaintext.txt	99	preparation kiaanum s actin probe kiaanum probe used northern blot analysis corresponds fragment num bp obtained pcr amplification positive clone identified reverse northern dot blot
0.41595346.15367492.html.plaintext.txt	100	pcr product directly purified using qiaquick pcr purification kit qiagen previous confirmation size agarose gel
0.41595346.15367492.html.plaintext.txt	101	s actin probe obtained digestion pucnum vector containing num
0.41595346.15367492.html.plaintext.txt	102	num kb pair human s actin insert bamhi site
0.41595346.15367492.html.plaintext.txt	103	digested product electrophoresed agarose purified using qiaquick gel extraction kit qiagen
0.41595346.15367492.html.plaintext.txt	104	probe nump labeled using ready go dna labeling bead amersham pharmacia biotech
0.41595346.15367492.html.plaintext.txt	105	sequencing cdna database search nucleotide alignment cdna sequencing obtained miniprep purification sequencing reaction performed big dye terminator kit abi prism applied byosistems usa
0.41595346.15367492.html.plaintext.txt	106	dna sequencing done using abi prism num fluorescent sequencing instrument serveis cientifico tecnics universitat de barcelona
0.41595346.15367492.html.plaintext.txt	107	database search sequence comparison performed using blast fasta search server national center biotechnology information ncbi european bioinformatics institute ebi respectively
0.41595346.15367492.html.plaintext.txt	108	footnote correspondence addressed
0.41595346.15367492.html.plaintext.txt	109	tel num num fax num num email lluisadeyebraatub
0.41595346.15367492.html.plaintext.txt	110	num cloning gene bearing missense mutation early onset familial alzheimers disease
0.41595346.15367492.html.plaintext.txt	111	num association presenilin num mutation glunumgly complaint memory impairment
0.41595346.15367492.html.plaintext.txt	112	num familial alzheimers disease site mutation influence clinical phenotype
0.41595346.15367492.html.plaintext.txt	113	conum ulinktypedoi crossrefisimedline
0.41595346.15367492.html.plaintext.txt	114	num causative susceptibility gene alzheimers disease review
0.41595346.15367492.html.plaintext.txt	115	num gene dose apolipoprotein e type num allele risk alzheimers disease late onset family
0.41595346.15367492.html.plaintext.txt	116	num central cholinergic system cognition
0.41595346.15367492.html.plaintext.txt	117	num analysis message expression single neuron alzheimers disease brain
0.41595346.15367492.html.plaintext.txt	118	num use cdna microarray search molecular marker involved onset alzheimers disease dementia
0.41595346.15367492.html.plaintext.txt	119	num cdna microarrays high throughput proteomics
0.41595346.15367492.html.plaintext.txt	120	implication search preventive initiative slow clinical progression alzheimers disease dementia
0.41595346.15367492.html.plaintext.txt	121	num differential display eukaryotic messenger rna mean polymerase chain reaction
0.41595346.15367492.html.plaintext.txt	122	num analysis altered gene expression differential display
0.41595346.15367492.html.plaintext.txt	123	num huge database human large protein identified kazusa cdna sequencing project
0.41595346.15367492.html.plaintext.txt	124	num construction characterization human brain cdna library suitable analysis cdna clone encoding relatively large protein
0.41595346.15367492.html.plaintext.txt	125	num overexpression neuronal pentraxin num involved neuronal death evoked low k cerebellar granule cell
0.41595346.15367492.html.plaintext.txt	126	num systematic change gene expression postmortem human brain associated tissue ph terminal medical condition
0.41595346.15367492.html.plaintext.txt	127	num high throughput analysis gene expression human brain
0.41595346.15367492.html.plaintext.txt	128	conum numlinktypedoi crossrefisimedline
0.41595346.15367492.html.plaintext.txt	129	num application differential display brain
0.41595346.15367492.html.plaintext.txt	130	ed differential display method protocol
0.41595346.15367492.html.plaintext.txt	131	num differential display protocol identify differentially expressed mrna potassium deprived cerebellar granule cell
0.41595346.15367492.html.plaintext.txt	132	num characterization cdna clone size fractioned cdna library human brain
0.41595346.15367492.html.plaintext.txt	133	num transcriptional gene expression profile human esophageal squamous cell carcinoma
0.41595346.15367492.html.plaintext.txt	134	num protein protein interaction large protein two hybrid screening using functionally classified library composed long cdna
0.41595346.15367492.html.plaintext.txt	135	num high throughput production recombinant antigen mouse kiaa protein escherichia coli computational allocation possible antigenic region construction expression plasmid glutathione transferase fused antigen vitro recombinant assisted method
0.41595346.15367492.html.plaintext.txt	136	num wide range age onset chromosome num related familial alzheimers disease
0.41595346.15367492.html.plaintext.txt	137	num accumulation chromosomal change human glioma progression
0.41595346.15367492.html.plaintext.txt	138	cytogenetic study num case
0.41595346.15367492.html.plaintext.txt	139	num genetic abnormality detected ependymomas comparative genomic hybridization
0.41595346.15367492.html.plaintext.txt	140	num genomewide scan locus predisposing type num diabetes u
0.41595346.15367492.html.plaintext.txt	141	population diabetes uk warren num repository analysis num pedigree provides independent replication susceptibility locus chromosome numq
0.41595346.15367492.html.plaintext.txt	142	num association single nucleotide polymorphism selectine gene inmunoglobulin nephropathy
0.41595346.15367492.html.plaintext.txt	143	num linkage prostate cancer susceptibility locus chromosome num
0.41595346.15367492.html.plaintext.txt	144	num risk dementia among person diabetes mellitus population based cohort
0.41595346.15367492.html.plaintext.txt	145	num neuron regulate extracellular level amyloid s protein via proteolysis insulin degrading enzyme
0.41595346.15367492.html.plaintext.txt	146	num alzheimers s amyloid peptide compete insulin binding insulin receptor
0.41595346.15367492.html.plaintext.txt	147	num insulin degrading enzyme regulates level insulin amyloid beta protein beta amyloid precursor protein intracellular domain vivo
0.41595346.15367492.html.plaintext.txt	148	num neuropathological staging alzheimer related change
0.41595346.15367492.html.plaintext.txt	149	num application national institute aging nia regan institute neuropathological diagnosis alzheimer disease
0.41595346.15367492.html.plaintext.txt	150	num novel mutation vnuml presenilin num gene family early onset alzheimers disease marked behavioural disturbance
0.41595346.15367492.html.plaintext.txt	151	article abstract free full text pdf version article numnumnum recent ddhnumvnum alert article cited alert correction posted service email article friend similar article journal similar article isi web science similar article pubmed alert new issue journal add personal archive download citation manager request permission google scholar article de yebra l
0.41595346.15367492.html.plaintext.txt	152	pubmed pubmed citation article de yebra l
0.41595346.15367492.html.plaintext.txt	153	online issn num num print issn num num copyright num oxford university press oxford journal oxford university press site map term condition privacy policy frequently asked question oxford university press site oxford university press american national biography bookseller information service childrens fiction poetry childrens reference corporate special sale dictionary dictionary national biography digital reference english language teaching higher education textbook humanity international education unit law medicine music online product oxford english dictionary reference right permission science school book social science short introduction world classic
0.43037122.11266476.html.plaintext.txt	0	notch wnt signaling meet presenilin hub bart de stroopera wim annaerta center human genetics neuronal cell biology laboratory katholieke universiteit leuven flanders interuniversitary institute biotechnology num leuven belgium
0.43037122.11266476.html.plaintext.txt	1	correspondence bart de strooper center human genetics neuronal cell biology laboratory k
0.43037122.11266476.html.plaintext.txt	2	leuven flanders interuniversitary institute biotechnology herestraat num num leuven belgium
0.43037122.11266476.html.plaintext.txt	3	telnum num num faxnum num num e mailbart
0.43037122.11266476.html.plaintext.txt	4	presenilins pssnum part molecular machinery responsible cleaving protein like s amyloid precursor protein app notch plane membrane annaert de strooper num
0.43037122.11266476.html.plaintext.txt	5	mutation psnum one major cause familiar alzheimers disease
0.43037122.11266476.html.plaintext.txt	6	ps also involved regulating wntss catenin signaling pathway exactly remains highly controversial issue full discussion see www
0.43037122.11266476.html.plaintext.txt	7	orgmembersforumsjournalcateninindex
0.43037122.11266476.html.plaintext.txt	8	num provide result tip scale definitively favor concept psnum operates negative regulator wntss catenin signaling pathway
0.43037122.11266476.html.plaintext.txt	9	s catenin neural plakophilin related armadillo protein nprap also called catenin pnum previously known bind large cytoplasmic loop domain psnum see www
0.43037122.11266476.html.plaintext.txt	10	orgmembersforumsjournalcateninindex
0.43037122.11266476.html.plaintext.txt	11	protein characterized repeat armadillo motif num amino acid sequence involved protein protein interaction however function s catenin fairly well established
0.43037122.11266476.html.plaintext.txt	12	one pool s catenin bound cell membrane cell adhesion molecule e cadherin provides link actin cytoskeleton
0.43037122.11266476.html.plaintext.txt	13	second pool located cytoplasm complex axin adenomatous polyposis coli apc glycogen synthase kinase numss gsk numss
0.43037122.11266476.html.plaintext.txt	14	phosphorylation s catenin gsk numss promotes binding s transducing repeat containing protein s trcp f box protein part enumenum ubiquitin ligase complex maniatis num
0.43037122.11266476.html.plaintext.txt	15	upon ubiquitination s catenin becomes rapidly degraded proteasome fig num
0.43037122.11266476.html.plaintext.txt	16	binding soluble ligand wnt membrane receptor frizzled inhibits gsk numss via pathway involving casein kinase protein disheveled
0.43037122.11266476.html.plaintext.txt	17	result accumulation unphosphorylated s catenin cytoplasm subsequent translocation cell nucleus
0.43037122.11266476.html.plaintext.txt	18	s catenin bind member leftcf cell specific transcription factor num family transcriptional regulator activates wnt target gene like cyclin dnum c myc metalloproteases
0.43037122.11266476.html.plaintext.txt	19	thus finely tuned balance three s catenin pool cell membrane cytoplasm nucleus determines final outcome wnt signaling pathway fig num detailed overview see www
0.43037122.11266476.html.plaintext.txt	20	view larger version numk figure num
0.43037122.11266476.html.plaintext.txt	21	presenilin notch wnt signaling pathway
0.43037122.11266476.html.plaintext.txt	22	schematic outline signaling pathway
0.43037122.11266476.html.plaintext.txt	23	horizontal arrow indicate possible negative cross talk
0.43037122.11266476.html.plaintext.txt	24	s cat s catenin s trcp s transducing repeat containing protein apc adenomatous polyposis coli ax axin csl cbfnum suh lagnum dvl disheveled frz frizzled gsk glycogen synthase kinase nicd notch intracellular domain tcf cell specific transcription factor num ub ubiquitin
0.43037122.11266476.html.plaintext.txt	25	however functional relevance p s catenin interaction investigated contradictory result obtained
0.43037122.11266476.html.plaintext.txt	26	psnum appeared either stabilize zhang et al
0.43037122.11266476.html.plaintext.txt	27	num destabilize s catenin kang et al
0.43037122.11266476.html.plaintext.txt	28	remarkably clinical p mutation cause alzheimers disease also affected s catenin stability positively negatively
0.43037122.11266476.html.plaintext.txt	29	given contradictory result remains unclear extent observation contribute understanding disease see www
0.43037122.11266476.html.plaintext.txt	30	orgmembersforumsjournalcateninindex
0.43037122.11266476.html.plaintext.txt	31	attempt avoid methodological confusion soriano et al
0.43037122.11266476.html.plaintext.txt	32	num careful overexpress protein use primary culture large transformed culture psnum knockout fibroblast apply rigorous control use several functional assay make point
0.43037122.11266476.html.plaintext.txt	33	convincingly demonstrate s catenin accumulates cytoplasmic pool leftcf gene transcription becomes activated absence psnum
0.43037122.11266476.html.plaintext.txt	34	conclusion presenilin negative regulator wntss catenin pathway gain considerable support recent vivo study drosophila melanogaster showing accumulation armadillo drosophila homologue s catenin observed p deficient blastoderm embryo noll et al
0.43037122.11266476.html.plaintext.txt	35	genetic screen suppressor armadillo phenotype yielded drosophila p cox et al
0.43037122.11266476.html.plaintext.txt	36	important question psnum affect s catenin stability
0.43037122.11266476.html.plaintext.txt	37	since psnum bind gsk numss tempting speculate provides scaffold phosphorylation s catenin kang et al
0.43037122.11266476.html.plaintext.txt	38	interestingly s catenin interaction site psnum contains consensus sequence phosphorylation gsk numss kirchenbaum et al
0.43037122.11266476.html.plaintext.txt	39	num suggesting interaction regulated interaction s catenin axinapcgsk numss complex
0.43037122.11266476.html.plaintext.txt	40	however data soriano et al
0.43037122.11266476.html.plaintext.txt	41	num appears psnum needed phosphorylation s catenin since phosphorylated s catenin specie accumulate psnum deficient cell
0.43037122.11266476.html.plaintext.txt	42	furthermore presence proteasome inhibitor mgnum fewer ubiquitinated s catenin specie observed psnum deficient cell wild type cell soriano et al
0.43037122.11266476.html.plaintext.txt	43	instead result suggest psnum needed ubiquitination s catenin see noll et al
0.43037122.11266476.html.plaintext.txt	44	num raise intriguing question concerning relationship psnum ubiquitin ligase machinery proteasome fig num
0.43037122.11266476.html.plaintext.txt	45	psnum also involved notch num signaling pathway
0.43037122.11266476.html.plaintext.txt	46	notch num belongs family large type integral membrane receptor involved cell fate decision
0.43037122.11266476.html.plaintext.txt	47	upon ligand binding notch becomes proteolytically processed
0.43037122.11266476.html.plaintext.txt	48	intracellular domain translocates nucleus bind transcription regulator csl family induces expression notch target gene fig num
0.43037122.11266476.html.plaintext.txt	49	psnum function proteolytic complex needed generate intramembranous cleavage notch unlike cleavage app kopan goate num
0.43037122.11266476.html.plaintext.txt	50	embryonic lethal phenotype mouse psnum gene inactivated largely explained deficiency notch signaling system therefore physiological relevance s cateninpsnum connection mammal remained somewhat speculative
0.43037122.11266476.html.plaintext.txt	51	however discussed soriano et al
0.43037122.11266476.html.plaintext.txt	52	num mouse specifically lack expression psnum skin generated zheng h
0.43037122.11266476.html.plaintext.txt	53	mouse develop spectrum skin tumor suggestive increased s catenin activity concept psnum may act repressor pathway adulthood
0.43037122.11266476.html.plaintext.txt	54	inhibitory cross talk notch wnt signaling pathway previously thought occur level notch extracellular domain binding wnt wesley num level notch intracellular domain binding disheveled axelrod et al
0.43037122.11266476.html.plaintext.txt	55	psnum seems provide third level interaction could theoretically occur
0.43037122.11266476.html.plaintext.txt	56	deleting cytoplasmic loop domain psnum annihilates binding s catenin whereas proteolytic cleavage notch app maintained saura et al
0.43037122.11266476.html.plaintext.txt	57	function psnum s catenin turnover thus separated function secretase processing
0.43037122.11266476.html.plaintext.txt	58	many biological question worm caenorhabditis elegans could shed light matter
0.43037122.11266476.html.plaintext.txt	59	num provided evidence protein encoded sel num suppressor notch signaling pathway associate functionally physically sel num worm homologue human p
0.43037122.11266476.html.plaintext.txt	60	selnum related cdcnum family f boxwdnum repeat containing protein
0.43037122.11266476.html.plaintext.txt	61	protein part enum enzyme ubiquitin ligation pathway appear function adapter recruit target protein complex containing enum ubiquitin conjugating enzyme maniatis num
0.43037122.11266476.html.plaintext.txt	62	num mammalian homologues including s trcp identified winston et al
0.43037122.11266476.html.plaintext.txt	63	challenge find whether psnum provides scaffold s trcp member f box protein family ubiquitin ligase substrate like s catenin
0.43037122.11266476.html.plaintext.txt	64	also important establish whether current finding extended protein bind p e
0.43037122.11266476.html.plaintext.txt	65	conclusion psnum involved least two proteolytic machine regulating signal transduction cascade regulated intramembrane proteolysis notch app one hand brown et al
0.43037122.11266476.html.plaintext.txt	66	num regulated protein degradation s catenin wnt signaling pathway noll et al
0.43037122.11266476.html.plaintext.txt	67	num abbreviation used paper s trcp s transducing repeat containing protein apc adenomatous polyposis coli app s amyloid precursor protein gsk glycogen synthase kinase nicd notch intracellular domain p presenilin tcf cell specific transcription factor num
0.43037122.11266476.html.plaintext.txt	68	apologize colleague able cite relevant work editorial constraint
0.43037122.11266476.html.plaintext.txt	69	submitted num january num accepted num january num
0.43037122.11266476.html.plaintext.txt	70	interaction wingless notch signaling pathway mediated dishevelled
0.43037122.11266476.html.plaintext.txt	71	science numnum numabstract
0.43037122.11266476.html.plaintext.txt	72	screen mutation suppress phenotype drosophila armadillo beta catenin homolog
0.43037122.11266476.html.plaintext.txt	73	genetics numnum numabstractfree full text
0.43037122.11266476.html.plaintext.txt	74	presenilin num facilitates constitutive turnover beta catenin differential activity alzheimers disease linked psnum mutant beta catenin signaling pathway
0.43037122.11266476.html.plaintext.txt	75	neurosci numnum numabstractfree full text
0.43037122.11266476.html.plaintext.txt	76	substitution gsk numss phosphorylation site presenilin num separate presenilin function s catenin signaling
0.43037122.11266476.html.plaintext.txt	77	common enzyme connects notch signaling alzheimers disease
0.43037122.11266476.html.plaintext.txt	78	gene dev numnum numfree full text
0.43037122.11266476.html.plaintext.txt	79	ubiquitin ligase complex essential nf kappab wntwingless hedgehog signaling pathway
0.43037122.11266476.html.plaintext.txt	80	gene dev numnum numfree full text
0.43037122.11266476.html.plaintext.txt	81	nonconserved hydrophilic loop domain presenilin p required p endoproteolysis enhanced beta num production mediated familial early onset alzheimers disease linked p variant
0.43037122.11266476.html.plaintext.txt	82	chem numnum numabstractfree full text
0.43037122.11266476.html.plaintext.txt	83	presenilin num negatively regulates s cateninlef signaling independently app notch processing
0.43037122.11266476.html.plaintext.txt	84	numnum numabstractfree full text
0.43037122.11266476.html.plaintext.txt	85	notch wingless regulate expression cuticle patterning gene
0.43037122.11266476.html.plaintext.txt	86	biol numnum numabstractfree full text
0.43037122.11266476.html.plaintext.txt	87	evidence functional physical association caenorhabditis elegans sel num cdcnump related protein sel num presenilin
0.43037122.11266476.html.plaintext.txt	88	usa numnum numabstractfree full text
0.43437973.11884509.html.plaintext.txt	0	notch membrane bound transcription factor raphael kopan
0.43437973.11884509.html.plaintext.txt	1	department molecular biology pharmacology washington university school medicine st louis mo num usa
0.43437973.11884509.html.plaintext.txt	2	poster panel summarizes protein notch signal transduction pathway biochemical function proposed
0.43437973.11884509.html.plaintext.txt	3	panel b outline event occur response ligand binding regulation transcription return basal state
0.43437973.11884509.html.plaintext.txt	4	panel c speculative pathway independent core component presented
0.43437973.11884509.html.plaintext.txt	5	despite associated presenilin complex notch cleaved since extracellular domain somehow block presenilin activity
0.43437973.11884509.html.plaintext.txt	6	ligand binding neuralized add ubiquitin intracellular domain delta trigger endocytosis num kramer num
0.43437973.11884509.html.plaintext.txt	7	ligand endocytosis trigger conformational change notch permit metalloproteases cleave near membrane second site snum extracellular domain trans endocytosed ligand expressing cell num park et al
0.43437973.11884509.html.plaintext.txt	8	event permit presenilin cleave notch third site snum located within transmembrane domain num mumm kopan num
0.43437973.11884509.html.plaintext.txt	9	nicd free translocate nucleus
0.43437973.11884509.html.plaintext.txt	10	cell expressing notch ligand ligand interferes process unknown mechanism interference may relieved neuralized protein target delta degradation kramer num
0.43437973.11884509.html.plaintext.txt	11	nucleus nicd convert csl transcriptional repressor transcriptional activator num num
0.43437973.11884509.html.plaintext.txt	12	current understanding proposes conversion occurs direct protein protein interaction notch intracellular domain skip csl lead smrthdac dissociation reviewed mumm kopan num
0.43437973.11884509.html.plaintext.txt	13	alone sufficient express target gene
0.43437973.11884509.html.plaintext.txt	14	notchcsl recruit histone acetylases hat assist chromatin remodeling mastermindlag num activate additional target
0.43437973.11884509.html.plaintext.txt	15	metabolism nicd nucleus controlled phosphorylation ubiquitination enum ubiquitin ligase sel num gupta rossi et al
0.43437973.11884509.html.plaintext.txt	16	num sudx cornell et al
0.43437973.11884509.html.plaintext.txt	17	nicd degradation reset cell prepares next round notch signaling
0.43437973.11884509.html.plaintext.txt	18	two specific region notch required activity abruptex region notch egf repeat num num dark blue brennan et al
0.43437973.11884509.html.plaintext.txt	19	num region c terminal ank repeat contains pest domain brennan et al
0.43437973.11884509.html.plaintext.txt	20	region previously shown bind dishevelled dsh
0.43437973.11884509.html.plaintext.txt	21	dsh mediator wnt signal downstream frizzled frz receptor huelsken birchmeier num
0.43437973.11884509.html.plaintext.txt	22	drosophila neurogenesis csl dependent notch signal restrict neural competence small number cell within equivalence group kopan turner num
0.43437973.11884509.html.plaintext.txt	23	newly recognized role notch act prevent cell acquiring neural myogenic competence earlier development
0.43437973.11884509.html.plaintext.txt	24	although unclear notch mediates effect many additional protein involved activity requires deltex cytoplasmic ring finger protein ramain et al
0.43437973.11884509.html.plaintext.txt	25	num kinase gsknumss sgg brennan et al
0.43437973.11884509.html.plaintext.txt	26	deltex csl appear antagonistic possibly compete ank domain notch
0.43437973.11884509.html.plaintext.txt	27	cytoplasmic notch activity may require proteolysis numnum however determined yet whether presenilin protease required deltex dependent notch activity
0.43437973.11884509.html.plaintext.txt	28	wnt act block notch either directly via abruptex domain wesley saez num num num likely indirectly stimulating dsh block gsknum circumvent deltexnotch interaction numnum
0.43437973.11884509.html.plaintext.txt	29	interference notchdeltex activity dsh requires dsh binding region notch deletion region abruptex mutation render notch constitutive repressor neural competence num ramain et al
0.43437973.11884509.html.plaintext.txt	30	removal notch wingless restores competence suggesting role wnt acquisition neural myogenic competence antagonize notch
0.43437973.11884509.html.plaintext.txt	31	clear protein facilitating inhibition competence described
0.43437973.11884509.html.plaintext.txt	32	time biochemical mechanism proposed process
0.43437973.11884509.html.plaintext.txt	33	similar wntnotch interaction organism yet discovered casting doubt generality observation
0.43437973.11884509.html.plaintext.txt	34	importance abruptex mutation recognized early name given even realized locus identical notch biochemical explanation complex genetic behavior abruptex mutation still lacking
0.43437973.11884509.html.plaintext.txt	35	recent observation may begin provide answer
0.43437973.11884509.html.plaintext.txt	36	notch signaling cell fate control signal integration development
0.43437973.11884509.html.plaintext.txt	37	notch signaling fringe really glycosyltransferase
0.43437973.11884509.html.plaintext.txt	38	functional analysis notch mutation drosophila
0.43437973.11884509.html.plaintext.txt	39	repression notch required wingless signalling muscle progenitor cell development drosophila
0.43437973.11884509.html.plaintext.txt	40	abruptex mutation notch disrupt establishment proneural cluster drosophila
0.43437973.11884509.html.plaintext.txt	41	drosophila melanogaster suppressor deltex gene regulator notch receptor signaling pathway enum class ubiquitin ligase
0.43437973.11884509.html.plaintext.txt	42	functional interaction sel num f box protein nuclear form activated notchnum receptor
0.43437973.11884509.html.plaintext.txt	43	new aspect wnt signaling pathway higher vertebrate
0.43437973.11884509.html.plaintext.txt	44	regulated intramembrane proteolysis take another twist
0.43437973.11884509.html.plaintext.txt	45	boundary development formation function
0.43437973.11884509.html.plaintext.txt	46	common enzyme connects notch signaling alzheimer disease
0.43437973.11884509.html.plaintext.txt	47	aph numnicastrin essential component secretase regulator notch signalling presenilin localization
0.43437973.11884509.html.plaintext.txt	48	notch pathway democracy aristocracy selection cell fate
0.43437973.11884509.html.plaintext.txt	49	neuralized regulating notch putting away delta
0.43437973.11884509.html.plaintext.txt	50	notchnum receptor cleaved constitutively furin like convertase
0.43437973.11884509.html.plaintext.txt	51	notch mediator cell fate determination hematopoiesis evidence speculation
0.43437973.11884509.html.plaintext.txt	52	transcriptional repression suppressor hairless involves binding hairless dctbp complex drosophila
0.43437973.11884509.html.plaintext.txt	53	notch signaling outside
0.43437973.11884509.html.plaintext.txt	54	notch intracellular domain ubiquitinated negatively regulated mammalian sel num homolog
0.43437973.11884509.html.plaintext.txt	55	ligand endocytosis drive receptor dissociation activation notch pathway
0.43437973.11884509.html.plaintext.txt	56	novel notch allele reveal deltex dependent pathway repressing neural fate
0.43437973.11884509.html.plaintext.txt	57	widespread early requirement novel notch function drosophila embryogenesis
0.43437973.11884509.html.plaintext.txt	58	notch responds differently delta wingless cultured drosophila cell
0.43437973.11884509.html.plaintext.txt	59	sel num inhibitor notch signaling target notch ubiquitin mediated protein degradation
0.43437973.11884509.html.plaintext.txt	60	fringe defining border regulating notch pathway
0.43437973.11884509.html.plaintext.txt	61	nuclear localization cbfnum regulated interaction smrt corepressor complex
0.4394662.14559775.html.plaintext.txt	0	fine mapping catenin gene quantitative trait locus chromosome num late onset alzheimers disease pedigree nilufer ertekin tanernum james ronaldnum hideaki asaharanum linda younkinnum maria hellanum shushant jainnum eugene gnidanum samuel younkinnum daniel fadalenum yasumasa ohyaginum adam singletonnum leah scanlinnum mariza de andradenum ronald petersennum neill graff radfordnum michael huttonnum steven younkinnum
0.4394662.14559775.html.plaintext.txt	1	numdepartment neuroscience mayo clinic jacksonville jacksonville fl usa numdepartment neurology neurological institute graduate school medical science kyushu university fukuoka japan numdepartment health science research division biostatistics mayo clinic rochester rochester mn usa numdepartment neurology mayo clinic rochester rochester mn usa numdepartment neurology mayo clinic jacksonville jacksonville fl usa
0.4394662.14559775.html.plaintext.txt	2	received july num num revised september num num accepted october num num
0.4394662.14559775.html.plaintext.txt	3	several group num num suggested quantitative intermediate phenotype may useful unraveling complex genetics disorder load
0.4394662.14559775.html.plaintext.txt	4	clinical disease state load likely result uncertain complex sequence pathophysiologic event whereas intermediate phenotype may directly related action set gene easily identified
0.4394662.14559775.html.plaintext.txt	5	thus identification gene variant contribute specific intermediate phenotype may tractable way identify least gene contribute disease governed complex genetics
0.4394662.14559775.html.plaintext.txt	6	optimize utility approach important select intermediate phenotype highly heritable close biological link disease question
0.4394662.14559775.html.plaintext.txt	7	study focused level amyloid s protein as specifically assnum quantitative intermediate phenotype load
0.4394662.14559775.html.plaintext.txt	8	as secreted protein num num derived set large precursor protein collectively referred amyloid s protein precursor
0.4394662.14559775.html.plaintext.txt	9	secreted as produced virtually cell readily detected human plasma cerebrospinal fluid
0.4394662.14559775.html.plaintext.txt	10	secreted as forty amino acid assnum small fraction num num two additional amino acid carboxyl terminus assnum num num
0.4394662.14559775.html.plaintext.txt	11	brain patient ad large amount as aggregate deposited senile plaque much form highly insoluble amyloid fibril
0.4394662.14559775.html.plaintext.txt	12	make definite diagnosis ad large number senile plaque neurofibrillary tangle must demonstrated brain autopsy num
0.4394662.14559775.html.plaintext.txt	13	load patient large amount as deposited senile plaque end assnum
0.4394662.14559775.html.plaintext.txt	14	one third case as ending assnum essentially form as deposited one third predominant form one third large amount assnum also deposited num
0.4394662.14559775.html.plaintext.txt	15	worth noting synthetic assnum assnum spontaneously assemble amyloid fibril vitro assnum form amyloid fibril far rapidly assnum numnum
0.4394662.14559775.html.plaintext.txt	16	brain high level app mrna concentration as cerebrospinal fluid num time higher plasma mixed fetal brain culture produce far as type cultured cell numnumnum
0.4394662.14559775.html.plaintext.txt	17	thus likely senile plaque form specifically brain as level higher brain organ
0.4394662.14559775.html.plaintext.txt	18	app presenilin num presenilin num gene many fully penetrant mutation cause early onset familial ad eofad num num
0.4394662.14559775.html.plaintext.txt	19	apart early onset causation specific mutation eofad clinically pathologically indistinguishable load
0.4394662.14559775.html.plaintext.txt	20	others shown eofad mutation increase assnum sometimes increase assnum well numnum num
0.4394662.14559775.html.plaintext.txt	21	importantly observed plasma assnum elevation eofad patient young cognitively normal carrier eofad mutation num
0.4394662.14559775.html.plaintext.txt	22	also observed assnum elevation plasma non demented relative load patient age num num num
0.4394662.14559775.html.plaintext.txt	23	importantly elevation associated apoenum allele variant eofad gene num
0.4394662.14559775.html.plaintext.txt	24	num found longitudinal study unrelated elderly individual subsequently developed ad higher plasma level assnum remained free dementia
0.4394662.14559775.html.plaintext.txt	25	collectively finding show assnum closely linked ad
0.4394662.14559775.html.plaintext.txt	26	investigate heritability plasma as analyzed extended load family found plasma assnum assnum level substantial heritability num
0.4394662.14559775.html.plaintext.txt	27	given finding level plasma assnum likely useful intermediate quantitative phenotype load performed variance component linkage analysis trait group extended load pedigree
0.4394662.14559775.html.plaintext.txt	28	analysis showed significant linkage locus num cm chromosome num num
0.4394662.14559775.html.plaintext.txt	29	linkage region obtained independently study affected load sib pair num
0.4394662.14559775.html.plaintext.txt	30	together two study provide strong evidence novel load locus chromosome num act increase assnum
0.4394662.14559775.html.plaintext.txt	31	sib pair group estimated effect locus equivalent apoe suggesting likely major risk factor load
0.4394662.14559775.html.plaintext.txt	32	third group found linkage downstream region chromosome num focused insulin degrading enzyme ide possible candidate gene region num
0.4394662.14559775.html.plaintext.txt	33	recently fourth group using age onset quantitative phenotype ad parkinson disease pd family found suggestive linkage chromosome num num num cm num
0.4394662.14559775.html.plaintext.txt	34	important advantage variance component approach employed candidate gene identified likely effect assnum evaluated systematically determine much various within gene variant contribute linkage
0.4394662.14559775.html.plaintext.txt	35	study analyzed vrnum variant contribute linkage signal chromosome num
0.4394662.14559775.html.plaintext.txt	36	location function make vrnum strong candidate gene
0.4394662.14559775.html.plaintext.txt	37	located num cm peak previously reported linkage signal vrnum encodes novel catenin catenin recently cloned jannsens et al
0.4394662.14559775.html.plaintext.txt	38	catenins interact closely s catenin play important role intercellular adhesion strong intercellular adhesion depends linkage cadherins actin cytoskeleton via s catenin complex
0.4394662.14559775.html.plaintext.txt	39	catenin closely homologous n catenin neuron specific e catenin expressed tissue
0.4394662.14559775.html.plaintext.txt	40	catenin expressed high level testis heart also expressed human mouse brain num
0.4394662.14559775.html.plaintext.txt	41	catenin overall sequence identity num num e n catenin respectively
0.4394662.14559775.html.plaintext.txt	42	num shown catenin interacts s catenin functionally effective fashion
0.4394662.14559775.html.plaintext.txt	43	make vrnum strong functional candidate s catenin interacts presenilin num num many mutation increase assnum numnumnum cause early onset familial ad num
0.4394662.14559775.html.plaintext.txt	44	num shown loss signalling s catenin pathway lead enhanced neuronal vulnerability as
0.4394662.14559775.html.plaintext.txt	45	addition s catenin presenilin form complex lead stabilization former destabilization complex lead s catenin degradation enhanced neuronal apoptosis
0.4394662.14559775.html.plaintext.txt	46	presenilin mutation shown lead destabilization s catenin presenilin complex degradation s catenin enhanced as production
0.4394662.14559775.html.plaintext.txt	47	given catenins provide link s catenin binding counterpart presenilins actin cytoskeleton possible postulate mutation catenins could lead disruption stability s catenin presenilin complex resulting enhanced neuronal vulnerability cell as increased as production
0.4394662.14559775.html.plaintext.txt	48	dose dependent effect vrnum num snp plasma assnum level extended load family
0.4394662.14559775.html.plaintext.txt	49	box plot depicting median middle part box numth percentile lower limit box numth percentile upper limit box numth percentile lower end line numth percentile upper end line numlogassnum level num num year old family member num load family
0.4394662.14559775.html.plaintext.txt	50	plot depicted separately vrnum num genotype tt red ct green cc blue
0.4394662.14559775.html.plaintext.txt	51	determine snp region vrnum gene show stronger association analyzed num additional snp total num snp analyzed region spanning num
0.4394662.14559775.html.plaintext.txt	52	num kb table num hcvnum hcvnum
0.4394662.14559775.html.plaintext.txt	53	num kb region linkage disequilibrium
0.4394662.14559775.html.plaintext.txt	54	many snp region showed nominally significant association none showed association stronger observed num num table num
0.4394662.14559775.html.plaintext.txt	55	p value association plasma assnum num num year old subject extended load family bounding association vrnum snp plasma assnum bound region vrnum numnum association evaluated total num additional snp spaced either side num num snp
0.4394662.14559775.html.plaintext.txt	56	snp selected several group designed span entire vrnum gene num kb interval well region num vrnum
0.4394662.14559775.html.plaintext.txt	57	known exon vrnum num
0.4394662.14559775.html.plaintext.txt	58	num kb median away closest snp closest snp group meannum
0.4394662.14559775.html.plaintext.txt	59	given extent ld human genome estimated different study anywhere num num kb num num extent one genomic region predictable priori possible miss association signal due variant snp group
0.4394662.14559775.html.plaintext.txt	60	however given size vrnum extent coverage throughout outside gene association signal identify num num vrnum snp well bounded within vrnum snp genotyping design
0.4394662.14559775.html.plaintext.txt	61	three six snp analyzed group linkage disequilibrium significantly associating num snp snp analyzed num combined family fig
0.4394662.14559775.html.plaintext.txt	62	using covariate style regression approach snp analyzed association plasma assnum num num num combined load family table num fig
0.4394662.14559775.html.plaintext.txt	63	view larger version numk figure num
0.4394662.14559775.html.plaintext.txt	64	boundary vrnum numnum association
0.4394662.14559775.html.plaintext.txt	65	marker marker linkage disequilibrium snp analyzed respect num snp
0.4394662.14559775.html.plaintext.txt	66	horizontal line show position num
0.4394662.14559775.html.plaintext.txt	67	b marker phenotype plasma assnum association
0.4394662.14559775.html.plaintext.txt	68	horizontal line show position num
0.4394662.14559775.html.plaintext.txt	69	num num side strongly associating num snp ld flanking snp fell essentially baseline level within large vrnum gene
0.4394662.14559775.html.plaintext.txt	70	num side snp association assnum also decreased baseline level within vrnum gene fig
0.4394662.14559775.html.plaintext.txt	71	num side significance snp association decreased num order magnitude num
0.4394662.14559775.html.plaintext.txt	72	num significantly associated snp nearest snp group hcvnum fig
0.4394662.14559775.html.plaintext.txt	73	association baseline level num side num num kb num margin vrnum
0.4394662.14559775.html.plaintext.txt	74	bounding approach effectively limit region potential association num num side num within vrnum
0.4394662.14559775.html.plaintext.txt	75	thus data provide strong evidence association num num snp plasma assnum due variant vrnum gene
0.4394662.14559775.html.plaintext.txt	76	given total num snp genotyped issue multiple testing raised
0.4394662.14559775.html.plaintext.txt	77	many snp linkage disequilibrium therefore independent one another fig
0.4394662.14559775.html.plaintext.txt	78	therefore simple bonferroni correction assumption num independent test overly conservative study
0.4394662.14559775.html.plaintext.txt	79	nonetheless even bonferroni correction applied num num snp still significant num family pnum
0.4394662.14559775.html.plaintext.txt	80	num num combined family pnum
0.4394662.14559775.html.plaintext.txt	81	association smaller set num family longer significant overly conservative correction pnum num num num respectively nonetheless inclusion analysis lead improved evidence association
0.4394662.14559775.html.plaintext.txt	82	contribution vrnum association linkage num cm next investigated contribution vrnum numnum association linkage previously reported
0.4394662.14559775.html.plaintext.txt	83	initial linkage finding obtained using seven marker covering num cm chromosome num
0.4394662.14559775.html.plaintext.txt	84	analyze entirety chromosome num genotyped num additional marker spanning num cm num load family
0.4394662.14559775.html.plaintext.txt	85	num family combined best two point lod score obtained num num
0.4394662.14559775.html.plaintext.txt	86	peak described multipoint lod score broadened flattened considerably incorporation additional marker maximum multipoint lod score continued num cm fig
0.4394662.14559775.html.plaintext.txt	87	view larger version numk figure num
0.4394662.14559775.html.plaintext.txt	88	effect vrnum snp num multipoint lod score ml load family
0.4394662.14559775.html.plaintext.txt	89	effect vrnum num linkage plasma assnum num load family
0.4394662.14559775.html.plaintext.txt	90	black line linkage gray line linkage conditional upon association vrnum num snp
0.4394662.14559775.html.plaintext.txt	91	multipoint ibds used analysis generated using num marker described text
0.4394662.14559775.html.plaintext.txt	92	reason broader flatter peak fine mapping analysis may several fold
0.4394662.14559775.html.plaintext.txt	93	first utilized mcmc mibd estimation implemented simwalknum package numnum multipoint linkage result presented paper opposed regression based mibd estimation algorithm implemented solar used original paper num see also subject method
0.4394662.14559775.html.plaintext.txt	94	second genotyping additional marker lead information regarding recombination could potentially lead decrease original linkage signal obtained fewer marker
0.4394662.14559775.html.plaintext.txt	95	third utilizing larger number marker increase likelihood map genotyping error despite implementation strict genotype quality control measure
0.4394662.14559775.html.plaintext.txt	96	indeed others also found fine mapping marker lead lowering original lod score obtained lesser number marker numnum
0.4394662.14559775.html.plaintext.txt	97	evaluate extent num num snp functional snp associated tightly linked pair account linkage observed repeated linkage analysis regressing effect vrnum num association including covariate linkage model
0.4394662.14559775.html.plaintext.txt	98	regressing effect snp multipoint linkage signal diminished substantially num combined family fig
0.4394662.14559775.html.plaintext.txt	99	marked diminution lod score indicates substantial proportion linkage signal plasma assnum accounted vrnum num association
0.4394662.14559775.html.plaintext.txt	100	residual linkage signal persisted regressing vrnum num association indicates likely additional variant contribute linkage though residual signal may also due random variation
0.4394662.14559775.html.plaintext.txt	101	diminution maximum multipoint lod score upon inclusion num snp covariate also evident comparison variance component model excludes covariate table numb one includes table numc
0.4394662.14559775.html.plaintext.txt	102	p value major gene effect maximum multipoint locus go num
0.4394662.14559775.html.plaintext.txt	103	trend observed twopoint linkage num snp assessed without including num covariate table numd e
0.4394662.14559775.html.plaintext.txt	104	p value major gene num locus loses significance pnum
0.4394662.14559775.html.plaintext.txt	105	since intronic snp located num
0.4394662.14559775.html.plaintext.txt	106	num kb nearest exon num num unlikely functional effect association assnum presumably occurs ld one several functional vrnum snp
0.4394662.14559775.html.plaintext.txt	107	sequencing vrnum exon reported vrnum transcript num failed identify potentially functional snp could account numnum association
0.4394662.14559775.html.plaintext.txt	108	possible functional snp affect splicing known alternatively spliced exon strong ld numnum
0.4394662.14559775.html.plaintext.txt	109	basic premise studying plasma assnum intermediate phenotype gene variant influence plasma assnum gene variant influence risk load
0.4394662.14559775.html.plaintext.txt	110	result reported useful identify vrnum gene variant influence plasma assnum thereby increasing likelihood vrnum gene one gene num cm region chromosome num variant influence risk load
0.4394662.14559775.html.plaintext.txt	111	important unanswered question well effect snp plasma assnum correlate effect ad phenotype
0.4394662.14559775.html.plaintext.txt	112	unlikely change plasma assnum caused specific genetic variant directly increase risk ad increased risk ad probably produced related effect variant within brain
0.4394662.14559775.html.plaintext.txt	113	thus conceivable perhaps even likely specific variant strong influence plasma assnum may sometimes little influence ad phenotype vice versa
0.4394662.14559775.html.plaintext.txt	114	thoroughly studying several gene elucidating effect entire set functional variant plasma assnum ad phenotype question answered
0.4394662.14559775.html.plaintext.txt	115	may effect two phenotype correlate well variant gene poorly others
0.4394662.14559775.html.plaintext.txt	116	result reported indicate vrnum variant significantly associate plasma assnum account substantial portion linkage signal chromosome num
0.4394662.14559775.html.plaintext.txt	117	additional analysis needed identify entire set functional variant account assnum linkage num cm
0.4394662.14559775.html.plaintext.txt	118	identified important test effect as production vrnum gene function biological experiment well determine whether functional variant modify risk ad
0.4394662.14559775.html.plaintext.txt	119	microsatellite genotyping dna extracted peripheral blood leukocyte using routine method
0.4394662.14559775.html.plaintext.txt	120	genotype microsatellites obtained using abi num num sequencer associated genescangenotyper software package
0.4394662.14559775.html.plaintext.txt	121	single nucleotide polymorphism snp genotyped using taqman chemistry software designing primer probe implemented within abi prism num ht sequence detection system
0.4394662.14559775.html.plaintext.txt	122	pedigree structure phenotypic genotypic information maintained pedsys httpwww
0.4394662.14559775.html.plaintext.txt	123	orgsfbrpublicsoftwarepedsyspedsys
0.4394662.14559775.html.plaintext.txt	124	html num also produced output file analysis performed solar explained
0.4394662.14559775.html.plaintext.txt	125	order location num chromosome num microsatellite marker determined marshfield linkage map
0.4394662.14559775.html.plaintext.txt	126	two marker dnumsnum dnumsnum location marshfield linkage map num placed linkage map according location estimate obtained map o mat program httpcompgen
0.4394662.14559775.html.plaintext.txt	127	two snp found vrnum gene also used marker linkage analysis
0.4394662.14559775.html.plaintext.txt	128	snp numtc numag located num num bp respectively chromosome num genomic map celera database httpwww
0.4394662.14559775.html.plaintext.txt	129	two snp placed linkage map based approximate centimorgan location estimated physical map
0.4394662.14559775.html.plaintext.txt	130	identification genotyping snp vrnum genomic mrna sequence initially obtained national center biotechnology information ncbi web site using genomic contig ntnum afnum
0.4394662.14559775.html.plaintext.txt	131	order identify snp primer designed cover known exon num kb intronic region exon num num
0.4394662.14559775.html.plaintext.txt	132	load case elderly control subject family member extended load pedigree sequenced identify polymorphism
0.4394662.14559775.html.plaintext.txt	133	initial sequencing vrnum exon num kb intronic region identified three snp intronic num kb region num num num
0.4394662.14559775.html.plaintext.txt	134	subsequently many additional snp vrnum flanking gene identified using celera database
0.4394662.14559775.html.plaintext.txt	135	aim cover region using snp group located every num kb group composed num num snp separated num num kb
0.4394662.14559775.html.plaintext.txt	136	total num snp including vrnum num num genotyped throughout vrnum num anxanumpnum num sirtnum flanking gene
0.4394662.14559775.html.plaintext.txt	137	snp within group found strong ld
0.4394662.14559775.html.plaintext.txt	138	snp location obtained celera sequence map
0.4394662.14559775.html.plaintext.txt	139	variance component analysis employed variance component methodology implemented software package solar numnum estimate heritability plasma assnum level perform linkage association analysis detect quantitative trait locus qtls affect variance assnum extended load family
0.4394662.14559775.html.plaintext.txt	140	method described detail elsewhere numnum estimate amount variance quantitative trait due particular genetic locus qnum residual genetic factor gnum individual specific random environmental factor enum based phenotype covariance arbitrary relative pair
0.4394662.14559775.html.plaintext.txt	141	covariance matrix take form
0.4394662.14559775.html.plaintext.txt	142	matrix probability pair individual share genetic material identical descent given chromosomal location estimated genetic marker data num matrix kinship coefficient describing polygenic factor identity matrix describing sporadic environmental factor
0.4394662.14559775.html.plaintext.txt	143	addition effect shared environment hnum variance trait also estimated including household matrix model
0.4394662.14559775.html.plaintext.txt	144	matrix whose ijth element equal num individual j share specified environment num otherwise
0.4394662.14559775.html.plaintext.txt	145	family collection largely composed extended pedigree measured plasma as member family single batch elisa
0.4394662.14559775.html.plaintext.txt	146	rigorously account possible assay batch batch variation may affect variance plasma assnum included household matrix model
0.4394662.14559775.html.plaintext.txt	147	since almost individual family measured one batch household matrix included elementnum individual extended family num otherwise
0.4394662.14559775.html.plaintext.txt	148	realize probably overly conservative
0.4394662.14559775.html.plaintext.txt	149	since shared family household effect employed account potential batch batch variance assay overlap kinship effect num inclusion household matrix almost certainly overcorrects batch batch variance underestimate shared genetic effect
0.4394662.14559775.html.plaintext.txt	150	reason performed heritability linkage analysis without household matrix model
0.4394662.14559775.html.plaintext.txt	151	multipoint result shown figure num num include household matrix
0.4394662.14559775.html.plaintext.txt	152	analysis without household matrix yielded slightly better lod score higher heritabilities general
0.4394662.14559775.html.plaintext.txt	153	scalar qnum gnum hnum enum estimated using maximum likelihood
0.4394662.14559775.html.plaintext.txt	154	heritability estimation compared environmental model qnum gnum fixed zero hnum enum estimated polygenic model gnum hnum enum estimated
0.4394662.14559775.html.plaintext.txt	155	linkage analysis performed comparing polygenic model linkage model qnum also estimated
0.4394662.14559775.html.plaintext.txt	156	difference two lognum likelihood model produce lod score equivalent classical lod score linkage analysis
0.4394662.14559775.html.plaintext.txt	157	incorporated sex age agenum sexage sexagenum covariates heritability estimation
0.4394662.14559775.html.plaintext.txt	158	none covariates significant p num
0.4394662.14559775.html.plaintext.txt	159	num therefore excluded multipoint linkage analysis
0.4394662.14559775.html.plaintext.txt	160	order minimize age dementia related environmental effect plasma assnum level performed analysis num num year age group previous study numnum
0.4394662.14559775.html.plaintext.txt	161	since variance component method based underlying assumption quantitative trait analyzed normal distribution numlogassnum level used phenotype
0.4394662.14559775.html.plaintext.txt	162	extreme outlier plasma as level plus minus num standard deviation beyond mean excluded analysis
0.4394662.14559775.html.plaintext.txt	163	thus numlogassnum phenotype analyzed normal distribution
0.4394662.14559775.html.plaintext.txt	164	plasma as measurement done using well established sandwich elisa system described previously num
0.4394662.14559775.html.plaintext.txt	165	sample measured duplicate
0.4394662.14559775.html.plaintext.txt	166	elisa plate included sample five volunteer
0.4394662.14559775.html.plaintext.txt	167	result five standard sample used normalize value obtained reduce plate plate day day variance
0.4394662.14559775.html.plaintext.txt	168	identity descent probability estimation identity descent ibd probability genotyped marker estimated using pairwise likelihood based estimation method implemented solar num
0.4394662.14559775.html.plaintext.txt	169	ibd estimate used obtain twopoint lod score
0.4394662.14559775.html.plaintext.txt	170	multipoint ibd probability also estimated centimorgan pair adjacent marker using markov chain monte carlo mcmc multipoint ibd estimation approach implemented simwalknum package numnum
0.4394662.14559775.html.plaintext.txt	171	mcmc process run twice default length num replicates second time doubling process length
0.4394662.14559775.html.plaintext.txt	172	multipoint linkage analysis using mibd matrix done using variance component methodology implemented solar
0.4394662.14559775.html.plaintext.txt	173	result using shorter longer run similar
0.4394662.14559775.html.plaintext.txt	174	result latter presented
0.4394662.14559775.html.plaintext.txt	175	given computation time increase marker number two upstream marker yielded evidence linkage datasets two marker dnumsnum dnumsnum omitted mibd estimation
0.4394662.14559775.html.plaintext.txt	176	two major difference mibd estimation utilized previous report linkage chromosome num current study num
0.4394662.14559775.html.plaintext.txt	177	result previous linkage obtained result genotyping seven marker num cm region current study utilizes num marker spread num
0.4394662.14559775.html.plaintext.txt	178	second mibd estimation approach used previous current study different
0.4394662.14559775.html.plaintext.txt	179	mcmc approach implemented simwalknum numnum utilized study different mibd probability estimation algorithm implemented solar approach utilized initial analysis seven chromosome num marker
0.4394662.14559775.html.plaintext.txt	180	num demonstrated significant difference result obtained two method using dataset concluded multipoint mcmc approach yielded accurate mibd probability estimate inter marker locus
0.4394662.14559775.html.plaintext.txt	181	reason utilized mcmc approach study
0.4394662.14559775.html.plaintext.txt	182	test association initially tested association snp plasma assnum num extended load family using regression based covariate approach variance component paradigm implemented computer program solar num
0.4394662.14559775.html.plaintext.txt	183	order control effect linkage included linkage component qnum null alternative model tested
0.4394662.14559775.html.plaintext.txt	184	used multipoint ibd matrix yielded maximum multipoint lod score num cm num extended load family
0.4394662.14559775.html.plaintext.txt	185	multipoint ibd probability matrix estimated simwalk using genetic marker information described
0.4394662.14559775.html.plaintext.txt	186	test effect specific snp genotype used measured genotype approach included copy number snp allele covariate analysis regressed plasma assnum phenotype covariate individual
0.4394662.14559775.html.plaintext.txt	187	measured genotype approach classical test difference trait mean genotype described theoretically previously numnum
0.4394662.14559775.html.plaintext.txt	188	approach also utilized previous association study snp various quantitative trait extended family numnum
0.4394662.14559775.html.plaintext.txt	189	individual xx xy yy snp genotype used covariate take value num num num respectively
0.4394662.14559775.html.plaintext.txt	190	formulation assumes snp additive qtl
0.4394662.14559775.html.plaintext.txt	191	model includes covariate tested model include determine effect quantitative trait interest
0.4394662.14559775.html.plaintext.txt	192	twice difference natural log likelihood two model distributed num distribution num degree freedom
0.4394662.14559775.html.plaintext.txt	193	order test association beyond linkage residual genetic household effect three component included null alternative model
0.4394662.14559775.html.plaintext.txt	194	first tested association snp assnum num load family previously used describe linkage chromosome num num
0.4394662.14559775.html.plaintext.txt	195	order control effect linkage residual genetic effect household effect group estimated effect snp background model included num cm multipoint identity descent matrix well kinship household matrix
0.4394662.14559775.html.plaintext.txt	196	tested snp association assnum second independent set num load family also analyzed combined group num family
0.4394662.14559775.html.plaintext.txt	197	linkage analysis conditional upon association conditional linkage analysis account association functional polymorphism one strong ld linkage locus decrease eliminate linkage signal numnum
0.4394662.14559775.html.plaintext.txt	198	reason performed linkage analysis conditional association strongly associating snp numtc
0.4394662.14559775.html.plaintext.txt	199	performed test estimating proportion variance due linkage background model included snp covariate comparing linkage model excluded covariate
0.4394662.14559775.html.plaintext.txt	200	analysis linkage disequilibrium measured linkage disequilibrium ld snp haplotype group within num extended load family using gold program num
0.4394662.14559775.html.plaintext.txt	201	used expectation maximization algorithm slatkin excoffier num determine various pairwise statistical parameter ld lewontins standardized disequilibrium coefficient d num
0.4394662.14559775.html.plaintext.txt	202	algorithm determines ld founder married in
0.4394662.14559775.html.plaintext.txt	203	ld estimated vrnum num snp snp
0.4394662.14559775.html.plaintext.txt	204	footnote correspondence addressed mayo clinic jacksonville num san pablo road birdsall num jacksonville fl num usa
0.4394662.14559775.html.plaintext.txt	205	tel num num fax num num email younkin
0.4394662.14559775.html.plaintext.txt	206	author wish known opinion first two author regarded joint first author
0.4394662.14559775.html.plaintext.txt	207	num role heredity late onset alzheimer disease vascular dementia
0.4394662.14559775.html.plaintext.txt	208	num heritability alzheimers disease study dementia swedish twin
0.4394662.14559775.html.plaintext.txt	209	num gene dose apolipoprotein e type num allele risk alzheimers disease late onset family
0.4394662.14559775.html.plaintext.txt	210	num effect age sex ethnicity association apolipoprotein e genotype alzheimer disease
0.4394662.14559775.html.plaintext.txt	211	apoe alzheimer disease meta analysis consortium
0.4394662.14559775.html.plaintext.txt	212	num number trait locus late onset alzheimer disease
0.4394662.14559775.html.plaintext.txt	213	num variance component method detecting complex trait locus
0.4394662.14559775.html.plaintext.txt	214	num geneticist approach complex disease
0.4394662.14559775.html.plaintext.txt	215	num sometimes hot sometimes
0.4394662.14559775.html.plaintext.txt	216	num production alzheimer amyloid s protein normal proteolytic processing
0.4394662.14559775.html.plaintext.txt	217	num isolation quantification soluble alzheimers beta peptide biological fluid
0.4394662.14559775.html.plaintext.txt	218	num amyloid beta peptide produced cultured cell normal metabolism
0.4394662.14559775.html.plaintext.txt	219	num cell familial alzheimers disease mutation produce authentic beta peptide
0.4394662.14559775.html.plaintext.txt	220	num characterization beta amyloid peptide human cerebrospinal fluid
0.4394662.14559775.html.plaintext.txt	221	num increased percentage long amyloid beta protein secreted familial amyloid beta protein precursor beta appnum mutant
0.4394662.14559775.html.plaintext.txt	222	num clinical diagnosis alzheimers disease report nincds adrda work group auspex department health human service task force alzheimers disease
0.4394662.14559775.html.plaintext.txt	223	num amyloid beta protein beta alzheimers disease brain
0.4394662.14559775.html.plaintext.txt	224	biochemical immunocytochemical analysis antibody specific form ending betanum beta numnum
0.4394662.14559775.html.plaintext.txt	225	jr num carboxy terminus beta amyloid protein critical seeding amyloid formation implication pathogenesis alzheimers disease
0.4394662.14559775.html.plaintext.txt	226	biochemistry num num num
0.4394662.14559775.html.plaintext.txt	227	num amyloid beta aggregation selective inhibition aggregation mixture amyloid different chain length
0.4394662.14559775.html.plaintext.txt	228	num localization amyloid beta protein messenger rna brain patient alzheimers disease
0.4394662.14559775.html.plaintext.txt	229	num amyloid beta protein gene cdna mrna distribution genetic linkage near alzheimer locus
0.4394662.14559775.html.plaintext.txt	230	num segregation missense mutation amyloid precursor protein gene familial alzheimers disease
0.4394662.14559775.html.plaintext.txt	231	num candidate gene chromosome num familial alzheimers disease locus
0.4394662.14559775.html.plaintext.txt	232	num familial alzheimers disease kindred missense mutation gene chromosome num related alzheimers disease type num gene
0.4394662.14559775.html.plaintext.txt	233	num cloning gene bearing missense mutation early onset familial alzheimers disease
0.4394662.14559775.html.plaintext.txt	234	num familial alzheimers disease linked presenilin num variant elevate abetanum numnum num ratio vitro vivo
0.4394662.14559775.html.plaintext.txt	235	num release excess amyloid beta protein mutant amyloid beta protein precursor
0.4394662.14559775.html.plaintext.txt	236	num mutation beta amyloid precursor protein familial alzheimersdisease increase beta protein production
0.4394662.14559775.html.plaintext.txt	237	num increased amyloid betanumnum brain mouse expressing mutant presenilinnum
0.4394662.14559775.html.plaintext.txt	238	num correlative memory deficit abeta elevation amyloid plaque transgenic mouse
0.4394662.14559775.html.plaintext.txt	239	num secreted amyloid beta protein similar senile plaque alzheimers disease increased vivo presenilin num num app mutation linked familial alzheimers disease
0.4394662.14559775.html.plaintext.txt	240	num role elevated amyloid s protein patient typical late onset alzheimers disease
0.4394662.14559775.html.plaintext.txt	241	num plasma amyloid beta peptide num num incipient alzheimers disease
0.4394662.14559775.html.plaintext.txt	242	conum alinktypedoi crossrefisimedline
0.4394662.14559775.html.plaintext.txt	243	num heritability plasma as level typical late onset alzheimers disease pedigree
0.4394662.14559775.html.plaintext.txt	244	num linkage plasma assnum quantitative locus chromosome num late onset alzheimers disease pedigree
0.4394662.14559775.html.plaintext.txt	245	num susceptibility locus alzheimers disease chromosome num
0.4394662.14559775.html.plaintext.txt	246	num evidence genetic linkage alzheimers disease chromosome numq
0.4394662.14559775.html.plaintext.txt	247	num age onset two common neurodegenerative disease genetically controlled
0.4394662.14559775.html.plaintext.txt	248	num alphat catenin novel tissue specific beta catenin binding protein mediating strong cell cell adhesion
0.4394662.14559775.html.plaintext.txt	249	num destabilization beta catenin mutation presenilin num potentiates neuronal apoptosis
0.4394662.14559775.html.plaintext.txt	250	num pattern linkage disequilibrium human genome
0.4394662.14559775.html.plaintext.txt	251	num high resolution haplotype structure human genome
0.4394662.14559775.html.plaintext.txt	252	num structure haplotype block human genome
0.4394662.14559775.html.plaintext.txt	253	num block limited haplotype diversity revealed high resolution scanning human chromosome num
0.4394662.14559775.html.plaintext.txt	254	num genetic variation numqnum cytokine gene cluster confers susceptibility crohn disease
0.4394662.14559775.html.plaintext.txt	255	num descent graph pedigree analysis application haplotyping location score marker sharing statistic
0.4394662.14559775.html.plaintext.txt	256	num multipoint estimation identity descent probability arbitrary position among marker locus general pedigree
0.4394662.14559775.html.plaintext.txt	257	num inheritance multiple locus familial alzheimer disease
0.4394662.14559775.html.plaintext.txt	258	ed alzheimers disease advance clinical basic research
0.4394662.14559775.html.plaintext.txt	259	john wiley son new york pp
0.4394662.14559775.html.plaintext.txt	260	num fine mapping chromosome numlate onset alzheimer disease locus potential genetic phenotypic heterogeneity
0.4394662.14559775.html.plaintext.txt	261	num pedsys pedigree data management system num
0.4394662.14559775.html.plaintext.txt	262	population genetics laboratory department genetics southwest foundation biomedical research san antonio tx
0.4394662.14559775.html.plaintext.txt	263	num comprehensive human genetic map individual sex specific variation recombination
0.4394662.14559775.html.plaintext.txt	264	num construction multilocus geneticlinkage map human proc
0.4394662.14559775.html.plaintext.txt	265	num multipoint quantitative trait linkage analysis general pedigree
0.4394662.14559775.html.plaintext.txt	266	num solar sequential oligogenic linkage analysis routine
0.4394662.14559775.html.plaintext.txt	267	population genetics laboratory southwest foundation biomedical research san antonio tx num
0.4394662.14559775.html.plaintext.txt	268	num exposure schistosoma mansoni infection rural area brazil
0.4394662.14559775.html.plaintext.txt	269	num extension multivariate normal model pedigree analysis
0.4394662.14559775.html.plaintext.txt	270	num use measured genotype information analysis quantitative phenotype man
0.4394662.14559775.html.plaintext.txt	271	num linkage analysis demonstrates prothrombin gnuma mutation jointly influence plasma prothrombin level risk thrombosis
0.4394662.14559775.html.plaintext.txt	272	num quantitative trait locus human factor xii gene influence plasma factor xii level susceptibility thrombotic disease
0.4394662.14559775.html.plaintext.txt	273	num gold graphical overview linkage disequilibrium
0.4394662.14559775.html.plaintext.txt	274	bioinformatics num num num
0.4394662.14559775.html.plaintext.txt	275	num maximum likelihood estimation molecular haplotype frequency diploid population
0.4394662.14559775.html.plaintext.txt	276	num evolutionary dynamic complex polymorphism
0.44692016.11134059.html.plaintext.txt	0	minireview role presenilins secretase activity michael
0.44692016.11134059.html.plaintext.txt	1	center neurologic disease harvard medical school brigham woman hospital boston massachusetts num ludwig maximilians university munich adolf butenandt institute department biochemistry schillerstrasse num d num muenchen germany
0.44692016.11134059.html.plaintext.txt	2	aphorism basic biological research lay groundwork solving important biomedical problem
0.44692016.11134059.html.plaintext.txt	3	however reverse true well focusing problem human disease lead important new insight intricacy nature
0.44692016.11134059.html.plaintext.txt	4	research alzheimers disease adnum provides case study latter race identify molecular player involved pathogenesis unveiled unexpected fascinating aspect protease biochemistry proteolysis dependent signal transduction
0.44692016.11134059.html.plaintext.txt	5	num num residue amyloid peptide implicated early pathogenic event lead ad peptide carved amyloid precursor protein app secretase fig
0.44692016.11134059.html.plaintext.txt	6	two protease considered important drug target search inhibitor production within pharmaceutical company gone year even though secretase remained unknown recently
0.44692016.11134059.html.plaintext.txt	7	last year secretase identified new membrane tethered member aspartyl protease family num num finding greatly facilitate drug discovery
0.44692016.11134059.html.plaintext.txt	8	secretase prevent formation cleaving middle amyloid domain num shown member adam family disintegrin metalloprotease num num
0.44692016.11134059.html.plaintext.txt	9	time mysterious secretase giving secret well
0.44692016.11134059.html.plaintext.txt	10	genetic study family susceptible autosomal dominant early onset num year ad underscore importance formation disease process num num
0.44692016.11134059.html.plaintext.txt	11	several different missense mutation app gene chromosome num cause familial ad fad mutation found immediately near secretase processing site
0.44692016.11134059.html.plaintext.txt	12	lys asnmet leu double mutation near secretase cleavage site found swedish pedigree lead increased production anum anum num indeed purified secretase cut peptide substrate swedish mutation better peptide based wild type sequence num num num
0.44692016.11134059.html.plaintext.txt	13	several fad causing mutation app near secretase processing site also affect production case mutation alter specificity protease leading increase num residue variant num num
0.44692016.11134059.html.plaintext.txt	14	finding bolstered amyloid hypothesis ad pathogenesis anum particularly prone fibril formation num protein initially deposited neuritic plaque characterize disease num
0.44692016.11134059.html.plaintext.txt	15	gene encoding polytopic presenilin num presenilin num psnum psnum found chromosome num num respectively later identified major locus fad num num mutation presenilins likewise found increase anum production transfected cell line num num transgenic animal num num num human plasma num
0.44692016.11134059.html.plaintext.txt	16	thus presenilins somehow modulate secretase activity
0.44692016.11134059.html.plaintext.txt	17	fact deletion psnum mouse dramatically reduced secretase activity num knockout psnum psnum resulted complete abolition app processing event num num demonstrating presenilins absolutely required proteolysis secretase
0.44692016.11134059.html.plaintext.txt	18	secretase carry unusual proteolysis within middle predicted transmembrane domain substrate cnum generated secretase cnum generated alternative processing secretase fig
0.44692016.11134059.html.plaintext.txt	19	indeed helical conformation secretase cleavage site app explain nearby fad causing mutation specifically increase anum production mutation immediately adjacent amide bond processed give anum num
0.44692016.11134059.html.plaintext.txt	20	phenylalanine scanning study near secretase cleavage site resulting effect anum anum production provided important experimental support idea substrate helical conformation upon initial interaction protease num
0.44692016.11134059.html.plaintext.txt	21	mutagenesis study likewise indicated secretase loose sequence specificity num num
0.44692016.11134059.html.plaintext.txt	22	finding p mutation affect anum generation p knockout prevent production raised question presenilins identical secretase
0.44692016.11134059.html.plaintext.txt	23	presenilins appear bear obvious sequence homology known protease homology spe num caenorhabditis elegans protein apparently involved vesicle transport spermatozoon initially suggested le direct role secretase processing app num
0.44692016.11134059.html.plaintext.txt	24	furthermore overexpression presenilins lead increased secretase activity num
0.44692016.11134059.html.plaintext.txt	25	however presenilins undergo proteolytic processing within hydrophobic region large cytosolic loop transmembrane domain tm num tm num fig
0.44692016.11134059.html.plaintext.txt	26	numb form stable heterodimeric complex num num
0.44692016.11134059.html.plaintext.txt	27	study support eight tm topology presenilins num num although six seven tm topology also suggested num num
0.44692016.11134059.html.plaintext.txt	28	heterodimers produced limited level even upon overexpression holoprotein num num num may found cell surface num
0.44692016.11134059.html.plaintext.txt	29	expression exogenous presenilins lead replacement endogenous presenilin heterodimers corresponding exogenous heterodimers indicating competition limiting cellular factor needed stabilization endoproteolysis num
0.44692016.11134059.html.plaintext.txt	30	fad causing presenilin mutant likewise processed stable heterodimers one exception missense mutation psnum lead aberrant splicing exon num region encodes endoproteolytic cleavage site num num
0.44692016.11134059.html.plaintext.txt	31	psnum enum variant active presenilin like fad causing presenilin mutant cause increased anum production num num
0.44692016.11134059.html.plaintext.txt	32	upon overexpression psnum enum rapidly degraded similar unprocessed wild type presenilins however small portion psnum variant stabilized cell num num form high molecular weight complex like n c terminal fragment num num suggesting interact limiting cellular factor wild type presenilins
0.44692016.11134059.html.plaintext.txt	33	observation consistent idea bioactive form presenilin heterodimer hydrophobic region inhibitory domain
0.44692016.11134059.html.plaintext.txt	34	however several artificial p variant generated biologically activeinactive independent ability undergo endoproteolysis num num
0.44692016.11134059.html.plaintext.txt	35	therefore evidence required finally demonstrate role p endoproteolysis biological pathological function
0.44692016.11134059.html.plaintext.txt	36	given characterization secretase aspartyl protease might catalyze unusual intramembranous proteolysis sequence presenilins inspected found contain two conserved aspartates predicted lie within tm num tm num flanking large cytosolic loop num
0.44692016.11134059.html.plaintext.txt	37	aspartates appear align within membrane secretase cleavage site app fig
0.44692016.11134059.html.plaintext.txt	38	mutation either aspartate alanine completely prevented psnum endoproteolysis asp ala psnum mutant acted dominant negative manner respect secretase processing app
0.44692016.11134059.html.plaintext.txt	39	similar effect app processing observed even conservative mutation glutamate num asparagine num num made indicating crucial identity two residue aspartates suggesting effect likely misfolding
0.44692016.11134059.html.plaintext.txt	40	effect corroborated several laboratory seen psnum psnum num num num num although recent study demonstrated tm num aspartate may le tolerant mutagenesis compared tm num aspartate num
0.44692016.11134059.html.plaintext.txt	41	presenilins also critical processing notch receptor signaling molecule crucial cell fate determination embryogenesis num
0.44692016.11134059.html.plaintext.txt	42	translation er notch processed furin like protease resulting heterodimeric receptor shuttled cell surface fig
0.44692016.11134059.html.plaintext.txt	43	upon interaction cognate ligand ectodomain notch shed metalloprotease apparently identical tumor necrosis factor converting enzyme tace num num
0.44692016.11134059.html.plaintext.txt	44	interestingly metalloproteases tace adam num among identified secretase shed app ectodomain num num
0.44692016.11134059.html.plaintext.txt	45	membrane associated c terminus cut within postulated transmembrane domain release notch intracellular domain nicd translocates nucleus interacts activates csl cbfnum suh lag num family transcription factor num
0.44692016.11134059.html.plaintext.txt	46	nicd formation absolutely required signaling notch receptor knock single point mutation near transmembrane cleavage site notchnum result embryonic lethal phenotype mouse virtually identical observed upon knockout entire notchnum protein num
0.44692016.11134059.html.plaintext.txt	47	parallel app notch processing striking
0.44692016.11134059.html.plaintext.txt	48	cleaved tace also transmembrane region protein processed secretase like protease requires presenilins
0.44692016.11134059.html.plaintext.txt	49	deletion psnum mouse embryonic lethal phenotype similar observed upon knockout notchnum num num psnumpsnum double knockout phenotype even similar num num
0.44692016.11134059.html.plaintext.txt	50	deficiency psnum dramatically reduces nicd formation num complete absence presenilins result total abolition nicd production num num
0.44692016.11134059.html.plaintext.txt	51	treatment cell secretase inhibitor designed transmembrane cleavage site within app likewise block nicd production num nuclear translocation num reduces notch signaling reporter gene num
0.44692016.11134059.html.plaintext.txt	52	moreover two conserved tm aspartates presenilins required cleavage notch tm domain seen secretase inhibitor expression asp mutant psnum psnum result reduction nicd formation translocation signaling num num num num
0.44692016.11134059.html.plaintext.txt	53	thus presenilins catalytic component secretase process app also likely catalytic component related protease clip transmembrane region notch
0.44692016.11134059.html.plaintext.txt	54	advancing understanding secretase role presenilins activity hampered lack isolated enzyme assay
0.44692016.11134059.html.plaintext.txt	55	num reported solubilized secretase assay faithfully reproduces property protease activity observed whole cell
0.44692016.11134059.html.plaintext.txt	56	isolated microsome solubilized detergent secretase activity determined measuring production flag tagged version cnum
0.44692016.11134059.html.plaintext.txt	57	anum anum produced ratio seen living cell numnum peptidomimetics blocked anum anum formation cell likewise inhibited production specie solubilized protease assay
0.44692016.11134059.html.plaintext.txt	58	separation detergent solubilized material size exclusion chromatography secretase activity coeluted two subunit psnum
0.44692016.11134059.html.plaintext.txt	59	remarkably immunoprecipitated psnum heterodimers also produced flag tagged substrate strongly suggesting presenilins part large secretase complex
0.44692016.11134059.html.plaintext.txt	60	direct evidence presenilins catalytic component secretase recently come affinity labeling study using transition state analogue inhibitor targeted active site protease
0.44692016.11134059.html.plaintext.txt	61	num num identified peptidomimetic block secretase activity icnum num
0.44692016.11134059.html.plaintext.txt	62	num nm solubilized protease assay contains hydroxyethyl isostere transition state mimicking moiety found many aspartyl protease inhibitor
0.44692016.11134059.html.plaintext.txt	63	transition state mimicking alcohol directs compound aspartyl protease flanking substructure determine specificity
0.44692016.11134059.html.plaintext.txt	64	photoactivatable version compound bound covalently presenilin subunit exclusively num
0.44692016.11134059.html.plaintext.txt	65	interestingly installation photoreactive group one end inhibitor led labeling n terminal presenilin subunit whereas installation end resulted tagging c terminal subunit
0.44692016.11134059.html.plaintext.txt	66	moreover whereas agent label wild type psnum holoprotein tag psnum enum described processed heterodimers nevertheless active
0.44692016.11134059.html.plaintext.txt	67	num identified peptidomimetic inhibitor containing difluoro alcohol group another type transition state mimicking moiety compound developed starting substrate based inhibitor designed secretase cleavage site app
0.44692016.11134059.html.plaintext.txt	68	conversion one analogue reactive bromoacetamide provided affinity reagent likewise bound covalently specifically psnum subunit cell lysates isolated microsome whole cell
0.44692016.11134059.html.plaintext.txt	69	either psnum subunit labeled could brought antibody subunit coimmunoprecipitation condition demonstrating inhibitor bound heterodimeric psnum
0.44692016.11134059.html.plaintext.txt	70	seiffert colleague num likewise identified presenilin subunit molecular target novel peptidomimetic secretase inhibitor
0.44692016.11134059.html.plaintext.txt	71	inhibitor however resemble known transition state mimic clear whether would expected bind active site protease
0.44692016.11134059.html.plaintext.txt	72	discovery presenilins likely secretase raise number fascinating question respect protease biochemistry well protease evolution
0.44692016.11134059.html.plaintext.txt	73	carry hydrolysis lipid environment transmembrane region likely form pore channel like topography polar residue facing inward allow entry interaction catalytic water
0.44692016.11134059.html.plaintext.txt	74	sequestered active site two dimensional fluidity lipid bilayer substrate probably first interacts binding site outer surface protease subsequent conformational change allowing entry substrate active site within protease interior
0.44692016.11134059.html.plaintext.txt	75	given conformation substrate upon initial interaction protease apparently helix enzyme must mechanism unwinding bending substrate near site cleavage catalytic water protease residue access scissile amide bond
0.44692016.11134059.html.plaintext.txt	76	origin presenilins intramembrane cleaving protease clip num seems likely certain polytopic integral membrane protein acquired catalytic residue essential catalysis rather soluble protease somehow acquired multiple transmembrane domain
0.44692016.11134059.html.plaintext.txt	77	would explain polytopic membrane protease bear little sequence homology soluble protease
0.44692016.11134059.html.plaintext.txt	78	instance snump family protease process membrane bound transcription factor mammal bacteria contains essential hexxh motif consensus sequence number metalloproteases num
0.44692016.11134059.html.plaintext.txt	79	otherwise bear little resemblance metalloproteases
0.44692016.11134059.html.plaintext.txt	80	similarly presenilins require two conserved aspartates proteolytic function otherwise look like typical aspartyl protease
0.44692016.11134059.html.plaintext.txt	81	apparently limited number efficient biochemical solution problem proteolysis mechanism conferred polytopic protease strikingly similar soluble membrane tethered protease
0.44692016.11134059.html.plaintext.txt	82	interestingly presenilins contain motif near one critical aspartates also found bacterial type num prepilin protease family num num polytopic aspartyl protease also eight transmembrane domain require two completely conserved aspartates num
0.44692016.11134059.html.plaintext.txt	83	finding support idea presenilins may indeed polytopic aspartyl protease
0.44692016.11134059.html.plaintext.txt	84	considerable work lie ahead understand presenilins secretase
0.44692016.11134059.html.plaintext.txt	85	clearly top priority identify critical component secretase complex allowing reconstitution activity development purified enzyme assay
0.44692016.11134059.html.plaintext.txt	86	assembly complex active secretase allow focused structural functional study current approach expressing mutant protein whole cell organism
0.44692016.11134059.html.plaintext.txt	87	also understanding num different fad mutation presenilins cause specific increase anum production might shed light deleterious function skewed favor le noxious isoforms
0.44692016.11134059.html.plaintext.txt	88	understanding suggest novel therapeutic approach ad also undergird appreciation working emerging class polytopic membrane protease
0.44692016.11134059.html.plaintext.txt	89	minireview reprinted num minireview compendium available december num
0.44692016.11134059.html.plaintext.txt	90	correspondence may addressed
0.44692016.11134059.html.plaintext.txt	91	correspondence may addressed
0.44692016.11134059.html.plaintext.txt	92	published jbc paper press december num num doi num
0.44692016.11134059.html.plaintext.txt	93	abbreviation used ad alzheimers disease amyloid peptide app amyloid precursor protein fad familial ad p presenilin tm transmembrane domain tace tumor necrosis factor converting enzyme nicd notch intracellular domain er endoplasmic reticulum
0.44692016.11134059.html.plaintext.txt	94	copyright num american society biochemistry molecular biology inc
0.45364788.15322109.html.plaintext.txt	0	sequence length c terminus pen num critical intermolecular interaction function presenilin complex hiroshi hasegawa nobuo sanjo fusheng chen yong jun gu cortney shier agnes petit toshitaka kawarai taiichi katayama stephen d
0.45364788.15322109.html.plaintext.txt	1	mathews gerold schmitt ulms paul e
0.45364788.15322109.html.plaintext.txt	2	fraser peter st george hyslop
0.45364788.15322109.html.plaintext.txt	3	centre research neurodegenerative disease university toronto west toronto ontario mnums numhnum canada new york university medical centernathan kline institute new york new york num department medicine medical biophysics university toronto west toronto ontario mnums numhnum canada department medicine division neurology university health networktoronto western hospital toronto ontario mnums numhnum canada
0.45364788.15322109.html.plaintext.txt	4	received publication june num num revised form august num num
0.45364788.15322109.html.plaintext.txt	5	pen num presenilin enhancer num initially identified genetic screen modifier presenilin homologues caenorhabditis elegans sel num hop num num
0.45364788.15322109.html.plaintext.txt	6	subsequent study confirmed component high molecular weight presenilin complex presence within complex necessary maturation activity num num num
0.45364788.15322109.html.plaintext.txt	7	thus loss pen num activity associated reduced presenilin level num num num reduced presenilin endoproteolysis num num num loss regulated intramembranous proteolytic snum cleavage activity num
0.45364788.15322109.html.plaintext.txt	8	analysis primary amino acid sequence pen num provides clue function
0.45364788.15322109.html.plaintext.txt	9	however protein predicted two hydrophobic transmembrane domain num num
0.45364788.15322109.html.plaintext.txt	10	also series residue hydrophilic c terminus residue num num conserved evolution hypothesize functionally important see fig
0.45364788.15322109.html.plaintext.txt	11	support one three naturally occurring loss function mutant c
0.45364788.15322109.html.plaintext.txt	12	elegans stop codon mutation residue trpnum truncates protein near beginning c terminal hydrophilic loop num see fig
0.45364788.15322109.html.plaintext.txt	13	explore hypothesis investigated functional effect mutation c terminal domain
0.45364788.15322109.html.plaintext.txt	14	data indicate overall length exposed c terminus pen num sequence highly conserved dylsf motif within domain important binding pen num component presenilin complex proper function complex nct maturation presenilin endoproteolysis secretion
0.45364788.15322109.html.plaintext.txt	15	view larger version numk fig
0.45364788.15322109.html.plaintext.txt	16	alignment pen num protein
0.45364788.15322109.html.plaintext.txt	17	transmembrane domain indicated underlining
0.45364788.15322109.html.plaintext.txt	18	arrowhead arrow indicate truncated position series deletion mutant conserved residue among last six residue
0.45364788.15322109.html.plaintext.txt	19	b schematic structure wild type series large deletion mutant
0.45364788.15322109.html.plaintext.txt	20	c mutant dylsf domain
0.45364788.15322109.html.plaintext.txt	21	substituted alanine underlined
0.45364788.15322109.html.plaintext.txt	22	d schematic structure aaa ipg kdas deletion mutant residue num num
0.45364788.15322109.html.plaintext.txt	23	antibody following antibody used study anti pen num antibody gift dr
0.45364788.15322109.html.plaintext.txt	24	thinakaran num anti vnum antibody invitrogen anti psnum n terminal antibody abnum anti myc antibody invitrogen anti app c terminal antibody residue num num appnum sigma anti app n terminal antibody residue num num app chemicon anti app c terminal antibody numenum signet anti aph num num antibody num anti nicastrin antibody sigma anti calnexin antibody transduction laboratory anti gmnum antibody transduction laboratory
0.45364788.15322109.html.plaintext.txt	25	enzyme linked immunosorbent assay study used antibody jrfcanumnum jrfcanumnum jrfatotnum gift dr
0.45364788.15322109.html.plaintext.txt	26	marc mercken johnson johnson pharmaceutical research developmentjanssen pharmaceutica beerse belgium
0.45364788.15322109.html.plaintext.txt	27	immunoprecipitation membrane fraction isolated heknum cell lysed num chapso sigma buffer containing num glycerol
0.45364788.15322109.html.plaintext.txt	28	preclearing protein sepharose cl numb amersham bioscience num h cell lysates incubated appropriate antibody
0.45364788.15322109.html.plaintext.txt	29	immunoprecipitants recovered overnight incubation num degree c protein sepharose cl numb
0.45364788.15322109.html.plaintext.txt	30	bead washed three time num chapso buffer
0.45364788.15322109.html.plaintext.txt	31	cycloheximide treatment stable transfectants empty vector wild type mutant pen num construct incubated presence cycloheximide num microgml num num num h analyzed immunoblotting anti vnum anti pen num antibody
0.45364788.15322109.html.plaintext.txt	32	gradient centrifugation subcellular fractionation membrane fraction isolated heknum cell described previously num applied step gradient consisting num ml num num num num num
0.45364788.15322109.html.plaintext.txt	33	num ml fraction collected analyzed western blotting
0.45364788.15322109.html.plaintext.txt	34	specific marker protein endoplasmic reticulum calnexin golgi gmnum detected using monoclonal antibody
0.45364788.15322109.html.plaintext.txt	35	assay anum anum measured described enzyme linked immunosorbent assay num num using conditioned medium collected pen num knock heknum cell transiently transfected either wild type pen num mutant pen num empty vector control
0.45364788.15322109.html.plaintext.txt	36	value anum anum compared student test
0.45364788.15322109.html.plaintext.txt	37	dylsf mutant represent population related mutant fully independent analyzed mutation involving dylsf domain including deletion mutant single population avoid risk false positive result arising multiple comparison
0.45364788.15322109.html.plaintext.txt	38	aaa ipg delnum num kdas delnum num mutant individually compared wild type pen num represent small number test different hypothesis length c terminus critical
0.45364788.15322109.html.plaintext.txt	39	view larger version numk fig
0.45364788.15322109.html.plaintext.txt	40	expression level component presenilin complex wild type mutant pen num stable transfectant
0.45364788.15322109.html.plaintext.txt	41	lane num mock lane num wild type lane num delnum num lane num delnum num lane num delnum num
0.45364788.15322109.html.plaintext.txt	42	endogenous pen num wild type delnum num pen num transfected cell significantly reduced cell lysates panel num whereas presenilin panel num num aph num panel num app panel num num unchanged
0.45364788.15322109.html.plaintext.txt	43	b binding presenilin panel num num aph num panel num nicastrin panel num delnum num delnum num significantly reduced whereas binding delnum num affected much
0.45364788.15322109.html.plaintext.txt	44	binding psnum endogenous pen num panel num compensates failure binding mutant pen num panel num delnum num delnum num
0.45364788.15322109.html.plaintext.txt	45	explore whether mutant caused destabilization pen num assessed cellular pen num level following cycloheximide blockade protein synthesis heknum cell
0.45364788.15322109.html.plaintext.txt	46	endogenous pen num wild type pen num tagged n terminus delnum num mutant construct equivalent stability half life num num h fig
0.45364788.15322109.html.plaintext.txt	47	contrast delnum num delnum num deletion mutant highly unstable half life approximately num h
0.45364788.15322109.html.plaintext.txt	48	result surprising delnum num delnum num molecule incorporated presenilin complex therefore stabilized
0.45364788.15322109.html.plaintext.txt	49	however also possible protein might intrinsically unstable simply degraded interact component presenilin complex
0.45364788.15322109.html.plaintext.txt	50	exclude possibility transiently expressed vnum tagged wild type mutant pen num peptide psnum psnum double knock e cell stabilizing influence presenilin complex present thereby allowing direct comparison intrinsic stability wild type deletion mutant peptide
0.45364788.15322109.html.plaintext.txt	51	psnumpsnum double knock e cell stability transiently expressed wild type mutant pen num protein equivalently reduced le num h confirming mutant pen num protein intrinsically unstable data shown
0.45364788.15322109.html.plaintext.txt	52	view larger version numk fig
0.45364788.15322109.html.plaintext.txt	53	deletion tagging c terminus accelerate degradation pen num protein
0.45364788.15322109.html.plaintext.txt	54	stable transfectants expressing mock panel num wild type pen num tagged n terminus panel num wild type pen num tagged c terminus panel num delnum num panel num delnum num panel num delnum num panel num treated cycloheximide indicated time num num num num h endogenous exogenous pen num total cell lysates analyzed
0.45364788.15322109.html.plaintext.txt	55	explore whether mutant caused mistrafficking pen num investigated subcellular distribution endogenous exogenous pen num using biochemical fractionation iodixanol gradient
0.45364788.15322109.html.plaintext.txt	56	study revealed endogenous pen num predominantly located intracellular membrane structure especially endoplasmic reticulum colocalizing calnexin golgi network co localizing gmnum fig
0.45364788.15322109.html.plaintext.txt	57	distribution exogenous vnum tagged wild type pen num well delnum num delnum num delnum num mutant essentially identical slightly shifted regard distribution endogenous wild type pen num presence additional vnum tag andor modest overexpression fig
0.45364788.15322109.html.plaintext.txt	58	view larger version numk fig
0.45364788.15322109.html.plaintext.txt	59	deletion c terminus change subcellular distribution
0.45364788.15322109.html.plaintext.txt	60	total cell lysates stable transfectants expressing mock panel num wild type pen num tagged n terminus panel num delnum num panel num delnum num panel num delnum num panel num fractionated iodixanol gradient fractionation lane num num
0.45364788.15322109.html.plaintext.txt	61	gmnum panel num calnexin panel num used marker protein golgi apparatus endoplasmic reticulum respectively
0.45364788.15322109.html.plaintext.txt	62	previous study suggested pen num play role presenilin endoproteolysis nicastrin maturation generation num num num num
0.45364788.15322109.html.plaintext.txt	63	several mutant described even stably overexpressed unable displace endogenous pen num functional complex
0.45364788.15322109.html.plaintext.txt	64	result impossible measure functional property pen num mutant cell expressing endogenous pen num
0.45364788.15322109.html.plaintext.txt	65	circumvent problem created pen num knock cell stable expression pen num sirna
0.45364788.15322109.html.plaintext.txt	66	pen num knock cell endogenous pen num protein moderately clone num severely depleted clone num num num fig
0.45364788.15322109.html.plaintext.txt	67	agreement previously reported study using transient sirna expression pen num num num pen num stable knock cell showed significant accumulation immature glycosylated nicastrin fig
0.45364788.15322109.html.plaintext.txt	68	num panel num full length psnum fig
0.45364788.15322109.html.plaintext.txt	69	pen num knock cell also showed significant reduction amount mature psnum ntf reduction psnum ntf level proportion degree depletion pen num
0.45364788.15322109.html.plaintext.txt	70	expected previous work showing aph num stable initial scaffolding molecule num aph num fig
0.45364788.15322109.html.plaintext.txt	71	num panel num full length app fig
0.45364788.15322109.html.plaintext.txt	72	num panel num affected pen num knockdown
0.45364788.15322109.html.plaintext.txt	73	however secretion significantly reduced compared mock cell fig
0.45364788.15322109.html.plaintext.txt	74	view larger version numk fig
0.45364788.15322109.html.plaintext.txt	75	pen num knock cell fail nct maturation p endoproteolysis secretion resulting accumulation app ctf
0.45364788.15322109.html.plaintext.txt	76	mock clone num num pen num knock cell clone num num num num pen num nct psnum aph num app secretion analyzed panel num num respectively
0.45364788.15322109.html.plaintext.txt	77	ass interaction pen num deletion mutant delnum num delnum num delnum num nicastrin presenilins aph num absence interference endogenous pen num transiently expressed deletion mutant pen num knock cell
0.45364788.15322109.html.plaintext.txt	78	expected initial immunoprecipitation experiment reported delnum num delnum num mutant bound poorly presenilin component even absence endogenous pen num fig
0.45364788.15322109.html.plaintext.txt	79	agreement result reported binding delnum num mutant nicastrin psnum aph num reduced le severely binding delnum num delnum num mutant
0.45364788.15322109.html.plaintext.txt	80	explore sequence specificity apparently important conserved dylsf domain residue num num created deletion mutant delnum num series missense mutation either single residue two residue five residue within num num domain mutated alanine fig
0.45364788.15322109.html.plaintext.txt	81	repeated co immunoprecipitation study
0.45364788.15322109.html.plaintext.txt	82	deletion residue num num missense mutation five residue alanine caused dramatic reduction interaction presenilin num nicastrin aph num fig
0.45364788.15322109.html.plaintext.txt	83	contrast mutation single residue two residue variable generally le severe effect interaction pen num component measured co immunoprecipitation fig
0.45364788.15322109.html.plaintext.txt	84	view larger version numk fig
0.45364788.15322109.html.plaintext.txt	85	binding pen num component severely disturbed delnum num delnum num aaaaa delnum num mutant moderately delnum num delnum num mutant
0.45364788.15322109.html.plaintext.txt	86	using pen num knock cell transiently transfected mock wild type delnum num delnum num delnum num aylsf dalsa eylsf dyaaf aaaaa delnum num aaa ipg delnum numlanes num num num num pulled pen num anti p anti nct anti aph num antibody analyzed
0.45364788.15322109.html.plaintext.txt	87	lane num negative control using normal rabbit serum
0.45364788.15322109.html.plaintext.txt	88	bottom panel show expression level wild type mutant pen num
0.45364788.15322109.html.plaintext.txt	89	wt wild type ip immunoprecipitation
0.45364788.15322109.html.plaintext.txt	90	ass functional property pen num mutant next examined ability rescue presenilin complex formation maturation pen num knock cell
0.45364788.15322109.html.plaintext.txt	91	transient transfection wild type pen num pen num knock cell significantly rescued nicastrin maturation p endoproteolysis secretion fig
0.45364788.15322109.html.plaintext.txt	92	num panel num num num associated slight reduction app ctf fig
0.45364788.15322109.html.plaintext.txt	93	contrast transient expression aaaaa poly substitution residue num num fig
0.45364788.15322109.html.plaintext.txt	94	num deletion mutant bind efficiently presenilin complex component little ability rescue presenilin complex maturation andor secretion fig
0.45364788.15322109.html.plaintext.txt	95	sapp unchanged cell fig
0.45364788.15322109.html.plaintext.txt	96	num panel num indicating mutant altered app maturation trafficking cleavage secretase
0.45364788.15322109.html.plaintext.txt	97	effect robust replicated three independent pen num knockdown cell
0.45364788.15322109.html.plaintext.txt	98	contrast profound loss function effect aaaaa delnum num mutant mutation one two residue dylsf domain caused variable milder reduction nicastrin maturation p endoproteolysis secretion fig
0.45364788.15322109.html.plaintext.txt	99	num lane num num numa lane num num degree reduction commensurate effect mutant interaction presenilin complex component
0.45364788.15322109.html.plaintext.txt	100	instance conservative mutation dylsf eylsf caused modest reduction binding complex maturation secretion fig
0.45364788.15322109.html.plaintext.txt	101	view larger version numk fig
0.45364788.15322109.html.plaintext.txt	102	wild type pen num rescue nct maturation p endoproteolysis secretion aaaaa delnum num mutant
0.45364788.15322109.html.plaintext.txt	103	mock lane num wild type lane num aaaaa lane num delnum num lane num mutant transfected pen num knock cell clone num num num nct psnum pen num app ctf secretion sapp panel top bottom conditioned medium analyzed
0.45364788.15322109.html.plaintext.txt	104	view larger version numk fig
0.45364788.15322109.html.plaintext.txt	105	nct maturation p proteolysis rescued partial substitution mutant dylsf domain aaa ipg mutant delnum num delnum num delnum num aaaaa delnum num delnum num kdas
0.45364788.15322109.html.plaintext.txt	106	nct psnum pen num aph num app panel top bottom analyzed pen num knock cell transiently transfected mock wild type delnum num delnum num delnum num aylsf dalsa eylsf dyaaf aaaaa delnum num aaa ipg kdas delnum numlanes num num num num num
0.45364788.15322109.html.plaintext.txt	107	view larger version numk fig
0.45364788.15322109.html.plaintext.txt	108	secretion fully rescued wild type pen num aaa ipg partially rescued partial substitution mutant dylsf domain
0.45364788.15322109.html.plaintext.txt	109	pen num knock cell transiently transfected mock wild type delnum num delnum num delnum num aylsf dalsa eylsf dyaaf aaaaa delnum num aaa ipg delnum num kdas lane num num num num num
0.45364788.15322109.html.plaintext.txt	110	b secreted condition medium measured enzyme linked immunosorbent assay n num independent replication
0.45364788.15322109.html.plaintext.txt	111	despite fact delnum num mutant bind efficiently presenilin complex component remaining pen num deletion mutation delnum num mutant partially rescued presenilin complex maturation function activity equivalent deletion mutation
0.45364788.15322109.html.plaintext.txt	112	reasoned reduced rescue activity delnum num mutant despite mild reduction binding could occur specific residue num num domain critical pen num activity
0.45364788.15322109.html.plaintext.txt	113	three highly conserved residue domain ile codon num pro codon num gly codon num
0.45364788.15322109.html.plaintext.txt	114	alternate possibility absolute length c terminus critical function pen num deletion deletion altered property
0.45364788.15322109.html.plaintext.txt	115	latter possibility supported prior report exogenous wild type c terminally tagged pen num failed complement loss function allele c
0.45364788.15322109.html.plaintext.txt	116	elegans pen num gene num earlier observation pen num construct tagged c terminal myc epitope unstable fig
0.45364788.15322109.html.plaintext.txt	117	resolve dichotomy made three construct one alanine missense mutation three conserved residue one four residue kdas c terminal addition one deletion two non conserved c terminal residue aaa ipg kdas delnum num respectively fig
0.45364788.15322109.html.plaintext.txt	118	immunoprecipitation experiment following transient expression construct pen num knock heknum cell revealed aaa ipg mutant bound presenilins complex component comparably wild type pen num
0.45364788.15322109.html.plaintext.txt	119	however kdas delnum num mutant moderate reduction binding similar magnitude reduction binding delnum num mutant fig
0.45364788.15322109.html.plaintext.txt	120	num lane num delnum num shown kdas
0.45364788.15322109.html.plaintext.txt	121	would expected binding assay transient expression aaa ipg mutant nearly completely rescued nicastrin maturation p endoproteolysis secretion whereas kdas delnum num mutant minimal effect fig
0.45364788.15322109.html.plaintext.txt	122	num lane num num num numa lane num num num
0.45364788.15322109.html.plaintext.txt	123	data indicate addition sequence size conserved dylsf motif residue num num another critical factor nicastrin maturation p endoproteolysis length c terminus fig
0.45364788.15322109.html.plaintext.txt	124	deletion mutant lesser degree individual missense mutation dylsf domain affect binding pen num presenilin complex result also affect presenilin complex assembly maturation secretase activity equivalent degree
0.45364788.15322109.html.plaintext.txt	125	hand modulation length sequence exposed extreme c terminus pen num le impact pen num binding complex significant affect presenilin complex maturation secretase activity
0.45364788.15322109.html.plaintext.txt	126	interpret finding mean num amino acid sequence dylsf domain important physical binding pen num presenilin complex component num absolute length c terminus important pen num activity within functional presenilin complex
0.45364788.15322109.html.plaintext.txt	127	dylsf domain conserved homology blast database search
0.45364788.15322109.html.plaintext.txt	128	however ylsf sequence match tyrosine based sorting signal yxxlmvif cytoplasmic tail several protein including mu subunit ap adaptor protein complex tgnnum epidermal growth factor receptor mannose num phosphate receptor furin num num
0.45364788.15322109.html.plaintext.txt	129	tyrosine based sorting motif protein responsible targeting protein various organelle num num
0.45364788.15322109.html.plaintext.txt	130	although ylsf motif example work cytoplasm conceivable dylsf domain pen num could also involved targeting pen num nascent presenilin complex may simply binding motif required interaction pen num protein psnum complex
0.45364788.15322109.html.plaintext.txt	131	fact absolute length sequence c terminus pen num critical presenilin complex function affect binding pen num complex suggests c terminus may involved maintaining non sequence based spatial interaction e
0.45364788.15322109.html.plaintext.txt	132	spatial packing component presenilin complex
0.45364788.15322109.html.plaintext.txt	133	similar critical sensitivity length c terminus reported psnum psnum num
0.45364788.15322109.html.plaintext.txt	134	c terminus psnumpsnum pen num oriented cytoplasm additional experiment needed discern whether c terminus two protein fact interact whether directly third protein
0.45364788.15322109.html.plaintext.txt	135	however taken together data raise possibility pen num might function important linkerspacer molecule maintains spatial interaction various presenilin complex component
0.45364788.15322109.html.plaintext.txt	136	footnote work supported grant canadian institute health research howard hughes medical institute canadian genetic disease network scottish rite charitable foundation canada alzheimer society ontario
0.45364788.15322109.html.plaintext.txt	137	cost publication article defrayed part payment page charge
0.45364788.15322109.html.plaintext.txt	138	article must therefore hereby marked advertisement accordance num u
0.45364788.15322109.html.plaintext.txt	139	section num solely indicate fact
0.45364788.15322109.html.plaintext.txt	140	correspondence addressed
0.45364788.15322109.html.plaintext.txt	141	num abbreviation used app amyloid precursor protein p presenilin nct nicastrin amyloid peptide chapso num num cholamidopropyldimethylammonio num hydroxy num propanesulfonic acid
0.45364788.15322109.html.plaintext.txt	142	acknowledgment antibody jrfcanumnum jrfcanumnum jrfatotnum gift dr
0.45364788.15322109.html.plaintext.txt	143	marc mercken johnson johnson pharmaceutical research developmentjanssen pharmaceutica beerse belgium
0.46781272.9013610.html.plaintext.txt	0	phosphorylation subcellular localization membrane orientation alzheimers disease associated presenilins
0.46781272.9013610.html.plaintext.txt	1	received publication may num num revised form october num num
0.46781272.9013610.html.plaintext.txt	2	bart de strooper monique beullens bart contreras lyne levesque katleen craessaerts barbara cordell dieder moechars mathieu bollen paul fraser peter st
0.46781272.9013610.html.plaintext.txt	3	george hyslop fred van leuven
0.46781272.9013610.html.plaintext.txt	4	presenilins num num unglycosylated protein apparent molecular mass num num kda respectively transfected co num chinese hamster ovary cell
0.46781272.9013610.html.plaintext.txt	5	colocalize protein endoplasmic reticulum golgi apparatus transfected untransfected cell
0.46781272.9013610.html.plaintext.txt	6	co num cell low amount intact endogeneous presenilin num migrating num kda detected together relative larger amount presenilin num fragment migrating num num kda
0.46781272.9013610.html.plaintext.txt	7	presenilins strong tendency form aggregate mass num num kda sd polyacrylamide gel electrophoresis partially resolved denatured sd num degree c instead num degree c
0.46781272.9013610.html.plaintext.txt	8	sulfation glycosaminoglycan modification acylation presenilins observed protein posttranslationally phosphorylated serine residue
0.46781272.9013610.html.plaintext.txt	9	mutation ala num glu cys num tyr cause alzheimers disease interfere biosynthesis phosphorylation presenilin num
0.46781272.9013610.html.plaintext.txt	10	finally using low concentration digitonin selectively permeabilize cell membrane endoplasmic reticulum membrane demonstrated two major hydrophilic domain presenilin num oriented cytoplasm
0.46781272.9013610.html.plaintext.txt	11	current investigation document posttranslational modification subcellular localization presenilins indicates postulated interaction amyloid precursor protein metabolism occur early compartment biosynthetic pathway
0.46781272.9013610.html.plaintext.txt	12	alzheimers disease major health problem
0.46781272.9013610.html.plaintext.txt	13	patient suffer progressive dementia caused massive neuronal loss cortical hippocampal area brain num num
0.46781272.9013610.html.plaintext.txt	14	neuropathological sign disease tangle amyloid deposit brain parenchyma amyloid deposit brain vasculature
0.46781272.9013610.html.plaintext.txt	15	cause sporadic form disease still unknown although increased risk associated presence apolipoprotein allele enum num num
0.46781272.9013610.html.plaintext.txt	16	hand familial early onset alzheimers disease caused point mutation amyloid precursor protein gene chromosome num num presenilin num psnumnum gene chromosome num num num frequently presenilin num psnum gene chromosome num num num
0.46781272.9013610.html.plaintext.txt	17	amyloid precursor protein app type integral membrane protein precursor amyloid peptide main component senile plaque num num
0.46781272.9013610.html.plaintext.txt	18	point mutation exon num num app gene cause alteration metabolism app
0.46781272.9013610.html.plaintext.txt	19	result increased production intracellular anum amyloid peptide containing carboxyl terminal app fragment increased secretion potentially neurotoxic anum peptide num num num
0.46781272.9013610.html.plaintext.txt	20	num amino acid residue sequence two presenilins conserved strongly suggests protein involved similar function similar pathogenic role alzheimers disease
0.46781272.9013610.html.plaintext.txt	21	based computer algorithm seven membrane spanning domain defined num num although possibility nine transmembrane domain ruled moment num
0.46781272.9013610.html.plaintext.txt	22	amino terminal domain acidic loop domain located transmembrane domain six seven hydrophilic alternatively spliced num num
0.46781272.9013610.html.plaintext.txt	23	mutation cause familial alzheimers disease found protein hydrophilic loop constitutes hot spot nine different mutation described date num num
0.46781272.9013610.html.plaintext.txt	24	biological function presenilins remains essentially unknown interestingly num carboxyl terminal amino acid residue psnum inhibit apoptosis deathtrap assay num
0.46781272.9013610.html.plaintext.txt	25	based homology caenorhabditis elegans protein role intracellular protein sorting andor intercellular signal transmission proposed well num num
0.46781272.9013610.html.plaintext.txt	26	hypothetical final common pathway pathogenesis genetic sporadic form alzheimers disease postulated based invariable occurrence amyloid deposit neurofibrillar tangle neurodegeneration affected brain
0.46781272.9013610.html.plaintext.txt	27	central question thus mutation presenilin gene cause typical neuropathology
0.46781272.9013610.html.plaintext.txt	28	study indicating increased production amyloidogenic anum num num peptide fibroblast obtained patient presenilin mutation would support amyloid hypothesis postulate abnormal anum amyloid peptide production plaque formation pivotal event pathogenesis disease num num
0.46781272.9013610.html.plaintext.txt	29	however observed increase anum num num peptide production relatively small suggested relationship presenilin mutation app metabolism corroborated experiment showing directly effect presenilin mutation app processing transfected cell brain transgenic animal
0.46781272.9013610.html.plaintext.txt	30	moreover aspect app metabolism production carboxyl terminal app fragment num investigated greater detail
0.46781272.9013610.html.plaintext.txt	31	possibility presenilins interact cytoskeleton exert effect via apoptotic pathway disregarded time num
0.46781272.9013610.html.plaintext.txt	32	addition addressing question basic information needed subcellular localization posttranslational modification membrane orientation presenilins
0.46781272.9013610.html.plaintext.txt	33	used co num cell cho cell express psnum psnum well myc tagged psnum psnum containing mutation cause familial alzheimers disease
0.46781272.9013610.html.plaintext.txt	34	biosynthesis transfected untransfected presenilins studied using immunoblotting metabolical labeling immunoprecipitation assay
0.46781272.9013610.html.plaintext.txt	35	demonstrate transfected presenilins phosphorylated serine residue
0.46781272.9013610.html.plaintext.txt	36	using immunofluorescence microscopy document association presenilin num early compartment biosynthetic pathway demonstrate cytoplasmic orientation two major hydrophilic domain
0.46781272.9013610.html.plaintext.txt	37	cdna coding mouse psnum human psnum psnum psnum containing ala num glu fadnum cys num tyr nihnum mutation described num num
0.46781272.9013610.html.plaintext.txt	38	myc tagged psnum fragment generated pcr using primer num cgggatccattatgacagagttacctgcaccg num num gatcacatgcttggcgccatat num sequence coding myc tag underlined
0.46781272.9013610.html.plaintext.txt	39	fragment used replace naribamhi restriction fragment psnum psgnum
0.46781272.9013610.html.plaintext.txt	40	resulting cdna code psnum myc tag eqkliseedl immediately initiator methionine confirmed cdna sequencing
0.46781272.9013610.html.plaintext.txt	41	plasmid containing cdna furin num num reticulonnsp num num kindly provided dr
0.46781272.9013610.html.plaintext.txt	42	van de ven center human genetics leuven belgium
0.46781272.9013610.html.plaintext.txt	43	polyclonal rabbit antiserum bnum bnum bnum raised peptide pnum ndnrerqehndrrslc amino terminal domain psnum num
0.46781272.9013610.html.plaintext.txt	44	polyclonal rabbit serum bnum bnum raised peptide pnum egdpeaqrrvsknskc situated hydrophilic loop domain psnum
0.46781272.9013610.html.plaintext.txt	45	polyclonal rabbit antiserum num raised residue kdgqliytpftedtec
0.46781272.9013610.html.plaintext.txt	46	antiserum reacts sequence second loop domain psnum psnum
0.46781272.9013610.html.plaintext.txt	47	synthetic peptide pnum pnum manufactured eurogentec liege belgium peptide pnum synthesized solid phase technique purified reverse phase high pressure liquid chromatography laboratory
0.46781272.9013610.html.plaintext.txt	48	num rabbit injected every num week num num num microg peptide complete freunds adjuvant coupled keyhole limpet hemocyanin bovine serum albumin pierce solubilized pb mixed complete freunds adjuvant
0.46781272.9013610.html.plaintext.txt	49	monoclonal antibody mab psnum num reacting peptide rrvsknskynaesteresqdtvaen hydrophilic loop domain psnum mab numenum myc tag num kindly provided dr
0.46781272.9013610.html.plaintext.txt	50	mabs monnum num num monnum num nspreticulon furin described num num
0.46781272.9013610.html.plaintext.txt	51	mabs immunoglobulin binding protein bip calcium pump serca numa iidnum purchased respectively stressgen victoria canada affinity bioreagents neshanic station nj
0.46781272.9013610.html.plaintext.txt	52	cell culture metabolic labeling cell extraction immunoprecipitation
0.46781272.9013610.html.plaintext.txt	53	fibroblast cell line designation agnum coriell institute unaffected individual fadnum lineage cultured dulbeccos modified eagle medium supplemented num fetal bovine serum life technology inc
0.46781272.9013610.html.plaintext.txt	54	cosnum cell cultured described previously dulbeccos modified eagle mediumhams f num num fetal bovine serum num
0.46781272.9013610.html.plaintext.txt	55	cho cell stably transfected appnum kindly provided dr
0.46781272.9013610.html.plaintext.txt	56	greenberg cephalon west chester pa cultured high glucose dulbeccos modified eagle medium life technology inc
0.46781272.9013610.html.plaintext.txt	57	num mm minimal essential medium nonessential amino acid num fetal calf serum num nm methotrexate
0.46781272.9013610.html.plaintext.txt	58	co cell transfected using deaedextran num cho cell transfected using lipofectamine according instruction manufacturer life technology inc
0.46781272.9013610.html.plaintext.txt	59	metabolic labeling done num microci numsmethionine num microci numssulfate num microci numhglucosamine num microci numhpalmitic acid numhmyristic acid num microci numporthophosphateml appropriate culture medium
0.46781272.9013610.html.plaintext.txt	60	radiolabeled precursor amersham
0.46781272.9013610.html.plaintext.txt	61	cellular labeling done num h unless otherwise specified cell extract made described previously num
0.46781272.9013610.html.plaintext.txt	62	analysis phosphorylation postnuclear extract prepared using num
0.46781272.9013610.html.plaintext.txt	63	num vv triton x num tris buffered saline tb containing proteinase inhibitor num unitsml aprotinin num microgml pepstatin tyrosine serinethreonine phosphatase inhibitor num mm sodium orthovanadate num mm edta num mm egta num mm naf
0.46781272.9013610.html.plaintext.txt	64	nucleus pelleted centrifugation numnum rpm num min cooled eppendorf centrifuge
0.46781272.9013610.html.plaintext.txt	65	antiserum added cell extract numnum dilution antibody antigen complex collected incubation immobilized protein g pierce overnight num degree c
0.46781272.9013610.html.plaintext.txt	66	immunoprecipitates washed using tris buffered saline containing num vv triton x num num wv deoxycholate num
0.46781272.9013610.html.plaintext.txt	67	analysis phosphorylation phosphatase inhibitor detailed added buffer
0.46781272.9013610.html.plaintext.txt	68	phorbol myristic acid phorbol dibutyric acid forskolin okadaic acid staurosporin sigma added cell culture last num min metabolic labeling indicated final concentration
0.46781272.9013610.html.plaintext.txt	69	vitro labeling assay immunoprecipitated psnum psnum bound protein g bead incubated purified protein kinase c tris buffered saline presence num
0.46781272.9013610.html.plaintext.txt	70	num mm numpatp num mm mgnum num min num degree c
0.46781272.9013610.html.plaintext.txt	71	precipitate washed analyzed sd page
0.46781272.9013610.html.plaintext.txt	72	gel quantitatively analyzed using phosphorimager molecular dynamic
0.46781272.9013610.html.plaintext.txt	73	immunoblotting experiment cell scraped pb centrifuged num min num rpm solubilized laemmli sample buffer
0.46781272.9013610.html.plaintext.txt	74	blot stained mab numenum myc tag ascites fluid numnum dilution mab psnum num hybridoma supernatant numnum dilution affinity purified goat anti mouse peroxidase conjugated antibody numnumnum bio rad using sensitive ecl system amersham
0.46781272.9013610.html.plaintext.txt	75	immunoprecipitated nump labeled p size fractionated sd page labeled band localized autoradiography
0.46781272.9013610.html.plaintext.txt	76	protein hydrolyzed num n hcl num degree c num min
0.46781272.9013610.html.plaintext.txt	77	hydrolysate supplemented phosphoamino acid standard analyzed two dimensional thin layer electrophoresis ph num
0.46781272.9013610.html.plaintext.txt	78	num respective dimension num
0.46781272.9013610.html.plaintext.txt	79	phosphoserine phosphothreonine phosphotyrosine localized using ninhydrin staining radioactive phosphoamino acid residue visualized autoradiography
0.46781272.9013610.html.plaintext.txt	80	fibroblast grown coverslips coated mouse collagen iv collaborative biomedical product num microgcmnum
0.46781272.9013610.html.plaintext.txt	81	transfected co num cho cell cultured lab tek chamber slide nunc
0.46781272.9013610.html.plaintext.txt	82	cell washed twice pb fixed num formaldehyde pb num min room temperature washed three time pb tb
0.46781272.9013610.html.plaintext.txt	83	cell permeabilized num
0.46781272.9013610.html.plaintext.txt	84	num vv triton x num tb num min num
0.46781272.9013610.html.plaintext.txt	85	num wv saponin num min washed num
0.46781272.9013610.html.plaintext.txt	86	nonspecific binding blocked num
0.46781272.9013610.html.plaintext.txt	87	num cold water fish gelatin num bovine serum albumin num fetal calf serum blocking buffer
0.46781272.9013610.html.plaintext.txt	88	cell probed affinity purified primary antibody num numnum immune serum numnum
0.46781272.9013610.html.plaintext.txt	89	appropriate fitc tritc conjugated anti mouse anti rat anti rabbit antibody sigma used numnum dilution
0.46781272.9013610.html.plaintext.txt	90	preparation viewed nikon diaphot num zeiss axiophot uv microscope
0.46781272.9013610.html.plaintext.txt	91	digitized immunofluorescence image obtained using lsmnum inverted laser scanning confocal microscope zeiss inc
0.46781272.9013610.html.plaintext.txt	92	processed using nih image software
0.46781272.9013610.html.plaintext.txt	93	selective permeabilization plasma membrane obtained incubating fixed cell num mm pipe buffer ph num
0.46781272.9013610.html.plaintext.txt	94	num mm mgclnum num mm edta num microgml digitonin num min num degree c num
0.46781272.9013610.html.plaintext.txt	95	cell washed pb processed
0.46781272.9013610.html.plaintext.txt	96	rat monoclonal antibody kdel sequence num num used demonstrate permeabilization endoplasmic reticulum membrane
0.46781272.9013610.html.plaintext.txt	97	immunocytochemical localization presenilin num endoplasmic reticulum golgi apparatus
0.46781272.9013610.html.plaintext.txt	98	subcellular localization presenilins investigated permeabilized fixed fibroblast using affinity purified polyclonal antibody num raised peptide kdgqliytpftedte conserved sequence second loop domain psnum psnum num num
0.46781272.9013610.html.plaintext.txt	99	fine reticular staining cytoplasm pronounced perinuclear staining observed cell fig
0.46781272.9013610.html.plaintext.txt	100	numa partially colocalized staining obtained mab bip endoplasmic reticulum marker
0.46781272.9013610.html.plaintext.txt	101	preabsorption antibody num peptide antigen resulted loss staining demonstrating specificity observed signal fig
0.46781272.9013610.html.plaintext.txt	102	immunofluorescent staining psnumnum untransfected fibroblast
0.46781272.9013610.html.plaintext.txt	103	fibroblast fixed formaldehyde permeabilized triton x num
0.46781272.9013610.html.plaintext.txt	104	cell incubated affinity purified rabbit antibody num loop num domain psnumnum panel mouse mab bip panel b followed appropriate tritc fitc conjugated secondary antibody
0.46781272.9013610.html.plaintext.txt	105	presenilin staining observed cytoplasm reticular pattern partially colocalizes staining obtained mab endoplasmic reticulum marker bip b
0.46781272.9013610.html.plaintext.txt	106	panel c fibroblast stained antibody num preabsorbed peptide revealed weak background fluorescence
0.46781272.9013610.html.plaintext.txt	107	view larger version image numk gif file
0.46781272.9013610.html.plaintext.txt	108	lacelike network seen co num cell transfected plasmid containing cdna psnum using antiserum bnum peptide ndnrerqehndrrs amino terminal domain psnum antiserum bnum peptide egdpeaqrrvsknsky hydrophilic loop domain psnum fig
0.46781272.9013610.html.plaintext.txt	109	untransfected co num cell remained negative experimental condition used probably low level endogeneous p present cell see
0.46781272.9013610.html.plaintext.txt	110	pattern staining observed monoclonal antibody iidnum num serca numa canum atpase result shown antibody transfected reticulonnsp fig
0.46781272.9013610.html.plaintext.txt	111	protein located endoplasmic reticulum golgi apparatus num
0.46781272.9013610.html.plaintext.txt	112	distribution psnum reticulonnsp remained identical double transfected cell compare panel b fig
0.46781272.9013610.html.plaintext.txt	113	nume transfected furin fig
0.46781272.9013610.html.plaintext.txt	114	numd contrast mainly found golgi apparatus shown previously num num
0.46781272.9013610.html.plaintext.txt	115	similar result obtained cho cell result shown
0.46781272.9013610.html.plaintext.txt	116	immunofluorescent staining psnum transfected co cell
0.46781272.9013610.html.plaintext.txt	117	co num cell double transfected plasmid coding psnum reticulonnsp b single transfected plasmid coding psnum amyloid precursor protein furin c d e
0.46781272.9013610.html.plaintext.txt	118	cell fixed formaldehyde permeabilized saponin
0.46781272.9013610.html.plaintext.txt	119	immunostaining done antiserum bnum amino terminal domain psnum bnum loop domain psnum c mix monoclonal antibody monnum num reticulonnsp b monnum num furin d mab numcnum amyloid precursor protein e followed appropriate tritc conjugated red fitc conjugated green secondary antibody
0.46781272.9013610.html.plaintext.txt	120	notice fine reticular pattern obtained psnum antibody panel c distributes reticulonnsp panel b double transfected cell
0.46781272.9013610.html.plaintext.txt	121	panel e demonstrates amyloid precursor protein located mainly golgi apparatus similar furin panel d
0.46781272.9013610.html.plaintext.txt	122	view larger version image numk gif file
0.46781272.9013610.html.plaintext.txt	123	biosynthesis presenilins
0.46781272.9013610.html.plaintext.txt	124	metabolic labeling untransfected mock transfected co num cho cell using numsmethionine followed immunoprecipitation cell extract using antibody num bnum bnum resolution immunoprecipitates sd page yielded signal fig
0.46781272.9013610.html.plaintext.txt	125	numa lane num prolonged exposure num week nonspecific signal autoradiography result shown
0.46781272.9013610.html.plaintext.txt	126	immunoprecipitation detergent extract co num cell transfected plasmid containing cdna wild type psnum contrast yielded strong specific signal radiolabeled protein migrating apparent molecular mass num kda fig
0.46781272.9013610.html.plaintext.txt	127	diffuse protein band mass num num kda observed variable extent fig
0.46781272.9013610.html.plaintext.txt	128	similar result obtained psnum cdna
0.46781272.9013610.html.plaintext.txt	129	main psnum specie migrated however slightly slowly psnum resulting apparent mass num kda see
0.46781272.9013610.html.plaintext.txt	130	unrelated polyclonal antibody untransfected cell yield band immunoblots co num cell transfected myc tagged psnum stained myc tag specific mab numenum revealed pronounced smearing fig
0.46781272.9013610.html.plaintext.txt	131	result clearly demonstrated num num kda protein smear consisted p protein either associated associated protein
0.46781272.9013610.html.plaintext.txt	132	essential similar pattern observed psnum fadnum ala num glu psnum nihnum cys num tyr expressed fig
0.46781272.9013610.html.plaintext.txt	133	clinical mutation num therefore cause major alteration biosynthesis psnum protein overexpressed co num cell fig
0.46781272.9013610.html.plaintext.txt	134	independent experiment performed cho cell confirmed completely result result shown
0.46781272.9013610.html.plaintext.txt	135	biosynthesis psnum protein co num cell
0.46781272.9013610.html.plaintext.txt	136	panel co num cell transfected construct containing cdna coding wild type psnum psnum wt psnum fadnum ala num glu psnum nihnum cys num tyr expression vector alone psgnum control
0.46781272.9013610.html.plaintext.txt	137	cell metabolically labeled numsmethionine num h
0.46781272.9013610.html.plaintext.txt	138	cell solubilized psnum immunoprecipitated antiserum bnum numnum
0.46781272.9013610.html.plaintext.txt	139	immunoprecipitates resolved num num gradient sd page
0.46781272.9013610.html.plaintext.txt	140	molecular size marker indicated left kda
0.46781272.9013610.html.plaintext.txt	141	panel b western blotting co numcells transfected psnum containing amino terminally inserted myc epitope
0.46781272.9013610.html.plaintext.txt	142	cell extract electophoresed num num gradient acrylamide gel transferred nitrocellulose membrane
0.46781272.9013610.html.plaintext.txt	143	mab numenum myc epitope used detect psnum
0.46781272.9013610.html.plaintext.txt	144	panel c combined immunoprecipitation western blotting psnum untransfected co cell
0.46781272.9013610.html.plaintext.txt	145	detergent extract num x num untransfected co num cell made psnum immunoprecipitated using antiserum bnum n term bnum loop
0.46781272.9013610.html.plaintext.txt	146	num x num co num cell transfected wild type psnum added untransfected cell
0.46781272.9013610.html.plaintext.txt	147	immunoprecipitated material resolved num num gradient sd page transferred nitrocellulose filter
0.46781272.9013610.html.plaintext.txt	148	filter reacted mab psnum num goat anti mouse peroxidase conjugated antibody lane num num indicated psnum num goat anti mouse peroxidase conjugated antibody alone lane num num co
0.46781272.9013610.html.plaintext.txt	149	mobility intact psnum indicated arrow right
0.46781272.9013610.html.plaintext.txt	150	view larger version image numk gif file
0.46781272.9013610.html.plaintext.txt	151	since level endogeneous psnum detectable using classical immunoprecipitation sensitive immunological sandwich type assay developed
0.46781272.9013610.html.plaintext.txt	152	psnum immunoprecipitated detergent extract num x num untransfected co num cell using polyclonal psnum antiserum
0.46781272.9013610.html.plaintext.txt	153	small amount transfected cell num
0.46781272.9013610.html.plaintext.txt	154	num x num added positive control sample
0.46781272.9013610.html.plaintext.txt	155	immunoprecipitates resolved sd page electrophoresis transferred nitrocellulose filter
0.46781272.9013610.html.plaintext.txt	156	immunoprecipitated psnum finally detected mab psnum num raised peptide rrvsknskynaesteresqdtvae loop domain psnum
0.46781272.9013610.html.plaintext.txt	157	weak signal representing intact endogeneous psnum revealed untransfected co num cell fig
0.46781272.9013610.html.plaintext.txt	158	endogeneous psnum migrated mobility num kda transfected psnum best seen experiment using amino terminal domain specific antiserum bnum fig
0.46781272.9013610.html.plaintext.txt	159	since mab psnum num recognizes epitope carboxyl terminally located hydrophilic loop combination antibody expected detect mainly intact psnum fig
0.46781272.9013610.html.plaintext.txt	160	hydrophilic loop specific antiserum bnum contrast relatively pronounced num num kda fragment visualized together intact psnum
0.46781272.9013610.html.plaintext.txt	161	fragment represent likely carboxyl terminal fragment presenilin num
0.46781272.9013610.html.plaintext.txt	162	remarkably observed fragment marginally increased co num cell overexpressing psnum compare lane num lane num fig
0.46781272.9013610.html.plaintext.txt	163	pulse chase experiment transfected cho cell fig
0.46781272.9013610.html.plaintext.txt	164	num c co num cell result shown showed transfected num kda psnum specie half life num h
0.46781272.9013610.html.plaintext.txt	165	fragment seen time point assay either amino terminal bnum hydrophilic loop specific bnum antiserum
0.46781272.9013610.html.plaintext.txt	166	app immunoprecipitated cell extract fig
0.46781272.9013610.html.plaintext.txt	167	numb displayed much faster turnover half life num h indicating relative high expression psnum interfere normal turnover app
0.46781272.9013610.html.plaintext.txt	168	pulse chase metabolic labeling psnum transfected cho cell
0.46781272.9013610.html.plaintext.txt	169	cho cell expressing stably human appnum transfected psnum metabolically labeled numsmethionine num min methionine free medium
0.46781272.9013610.html.plaintext.txt	170	incorporated label chased incubation cell complete medium indicated time
0.46781272.9013610.html.plaintext.txt	171	psnum immunoprecipitated cell extract using bnum n term bnum loop antiserum resolved num num gradient sd page panel
0.46781272.9013610.html.plaintext.txt	172	app consecutively immunoprecipitated cell extract using antibody num num num analyzed num homogeneous sd page
0.46781272.9013610.html.plaintext.txt	173	notice difference turnover transfected presenilin num transfected app
0.46781272.9013610.html.plaintext.txt	174	panel c display quantitative analysis mean plus minus
0.46781272.9013610.html.plaintext.txt	175	three independent pulse chase experiment psnum
0.46781272.9013610.html.plaintext.txt	176	signal quantitated using phosphorimager
0.46781272.9013610.html.plaintext.txt	177	point represent fraction psnum synthesized num min pulse remaining period chase indicated
0.46781272.9013610.html.plaintext.txt	178	result obtained app two experiment also displayed
0.46781272.9013610.html.plaintext.txt	179	view larger version image numk gif file
0.46781272.9013610.html.plaintext.txt	180	posttranslational modification aggregation presenilins
0.46781272.9013610.html.plaintext.txt	181	problem presenilin smear sd page investigated
0.46781272.9013610.html.plaintext.txt	182	enzymatic digestion immunoprecipitated psnum psnum protein glycosidase f num milliunits microl o glycanase num nanounits microl endoglycosidase h num nanounits microl sialidase num nanounits microl combination enzyme affect mobility protein indicating glycosylation psnum psnum occurred result shown
0.46781272.9013610.html.plaintext.txt	183	num milliunits microl heparitinase num
0.46781272.9013610.html.plaintext.txt	184	num milliunits microl chondroitinase ac num milliunits microl chondroitinase abc num milliunits microl also effect mobility protein smear indicating psnum modified glycosaminoglycan chain fig
0.46781272.9013610.html.plaintext.txt	185	negative result independently confirmed metabolic labeling experiment using numhglucosamine numsonum
0.46781272.9013610.html.plaintext.txt	186	radioactive precursor incorporated protein cell extract labeled cell signal obtained transfected psnum immunoprecipitated result shown
0.46781272.9013610.html.plaintext.txt	187	experiment using numhpalmitic numhmyristic acid demonstrated also presenilins incorporate fatty acid
0.46781272.9013610.html.plaintext.txt	188	presenilins modified glycosaminoglycan chain
0.46781272.9013610.html.plaintext.txt	189	psnum immunoprecipitated using serum bnum metabolically labeled co num cell transfected wild type psnum digested heparinase heparitinase chondroitinase abc chondroitinase ac
0.46781272.9013610.html.plaintext.txt	190	digested material resolved num homogeneous sd page
0.46781272.9013610.html.plaintext.txt	191	activity heparinase heparitinase confirmed using proteoglycans immunopurified fibroblast num
0.46781272.9013610.html.plaintext.txt	192	activity chondroitinase abc ac demonstrated using test solution chondroitinesulfate clarified addition enzyme
0.46781272.9013610.html.plaintext.txt	193	molecular size marker indicated left kda
0.46781272.9013610.html.plaintext.txt	194	view larger version image numk gif file
0.46781272.9013610.html.plaintext.txt	195	sonication boiling sample sd num m urea data shown extraction cell presence num mm dithiothreitol resolve aggregate fig
0.46781272.9013610.html.plaintext.txt	196	denaturation immunoprecipitates num degree c instead num degree c reduced aggregate considerably completely fig
0.46781272.9013610.html.plaintext.txt	197	demonstrated aggregate consisted mainly exclusively psnum radiolabeled specie fig
0.46781272.9013610.html.plaintext.txt	198	num also suggested p aggregate least partially produced processing sample electrophoresis
0.46781272.9013610.html.plaintext.txt	199	noticed however even freshly prepared material used heating sample avoided protein smear num num kda region remained visible sd page fig
0.46781272.9013610.html.plaintext.txt	200	presenilin aggregate temperature sensitive
0.46781272.9013610.html.plaintext.txt	201	immunoprecipitated psnum antiserum bnum transfected co cell denatured num min sd mercapthoethanol num degree c lane num num num degree c lane num
0.46781272.9013610.html.plaintext.txt	202	lane num cell extract prepared presence num mm dithiothreitol dtt
0.46781272.9013610.html.plaintext.txt	203	notice decrease num num kda aggregate slightly increased intensity num kda band lane num compared lane num num
0.46781272.9013610.html.plaintext.txt	204	sample resolved num num sd page
0.46781272.9013610.html.plaintext.txt	205	view larger version image numk gif file
0.46781272.9013610.html.plaintext.txt	206	phosphorylation presenilins
0.46781272.9013610.html.plaintext.txt	207	high level serine threonine tyrosine primary amino acid sequence psnum psnum suggested possibility p protein phosphoprotein num num
0.46781272.9013610.html.plaintext.txt	208	numb incorporated nump presenilins
0.46781272.9013610.html.plaintext.txt	209	acid hydrolysis immunoprecipitated nump phosphorylated psnum psnum yielded mainly phosphoserine fig
0.46781272.9013610.html.plaintext.txt	210	longer exposure revealed weak signal phosphothreonine phosphotyrosine never observed
0.46781272.9013610.html.plaintext.txt	211	phosphorylation psnum strongly increased psnum slightly increased treating cell phosphatase inhibitor okadaic acid num nm fig
0.46781272.9013610.html.plaintext.txt	212	okadaic acid inhibits two major class serinethreonine phosphatase num
0.46781272.9013610.html.plaintext.txt	213	protein kinase c inhibitor staurosporin num nm agonist phorbol myristic acid num microm phorbol dibutyric acid num microm protein kinase agonist forskolin num microm effect phosphorylation extent pattern fig
0.46781272.9013610.html.plaintext.txt	214	attempt phosphorylate immunoprecipitated psnum vitro using protein kinase protein kinase c remained also negative result shown
0.46781272.9013610.html.plaintext.txt	215	phosphorylation psnum psnum serine residue
0.46781272.9013610.html.plaintext.txt	216	panel transfected co num cell metabolically labeled using numporthophosphate post nuclear cell extract prepared see material method
0.46781272.9013610.html.plaintext.txt	217	psnum psnum immunoprecipitated antiserum bnum psnum num psnum
0.46781272.9013610.html.plaintext.txt	218	co num cell transfected psgnum labeled extracted immunoprecipitated antibody
0.46781272.9013610.html.plaintext.txt	219	panel b thin layer chromatography hydrolyzed psnum num kda psnum num kda identifying serine phosphorylated residue
0.46781272.9013610.html.plaintext.txt	220	mobility phosphoserine phosphothreonine phosphotyrosine y detected ninhydrin staining indicated dotted line
0.46781272.9013610.html.plaintext.txt	221	view larger version image numk gif file
0.46781272.9013610.html.plaintext.txt	222	analysis psnum psnum phosphorylation
0.46781272.9013610.html.plaintext.txt	223	panel staurosporin num nm okadaic acid num nm added medium transfected co cell num
0.46781272.9013610.html.plaintext.txt	224	num h incubation numporthophosphate
0.46781272.9013610.html.plaintext.txt	225	num min later cell extract made fig
0.46781272.9013610.html.plaintext.txt	226	psnum psnum immunoprecipitated using respectively antiserum bnum num resolved num num gradient gel
0.46781272.9013610.html.plaintext.txt	227	panel b transfected cho cell labeled numporthophosphate p immunoprecipitated using antiserum num psnum wt bnum lane resolved num num gradient gel
0.46781272.9013610.html.plaintext.txt	228	view larger version image numk gif file
0.46781272.9013610.html.plaintext.txt	229	cytoplasmic orientation amino terminal domain hydrophilic loop domain presenilin num
0.46781272.9013610.html.plaintext.txt	230	finally addressed issue whether two major hydrophilic domain presenilin num
0.46781272.9013610.html.plaintext.txt	231	amino terminal domain hydrophilic loop domain num oriented toward cytoplasmic luminal side endoplasmic reticulum
0.46781272.9013610.html.plaintext.txt	232	current model orientation presenilins membrane based theoretical prediction see discussion
0.46781272.9013610.html.plaintext.txt	233	domain candidate region interaction protein orientation determines whether interaction occurs cytoplasmic endoplasmic reticulum protein
0.46781272.9013610.html.plaintext.txt	234	analyze question used low concentration digitonin selectively permeabilize plasma membrane see material method antibody amino terminal domain antiserum bnum myc tag introduced amino terminus mab numenum second loop domain antibody num finally hydrophilic loop domain antiserum bnum psnum
0.46781272.9013610.html.plaintext.txt	235	monitor permeabilization procedure rat monoclonal antibody luminal endoplasmic reticulum retention signal kdel used num num
0.46781272.9013610.html.plaintext.txt	236	antibody amino terminal domain psnum amino terminally inserted myc tag fig
0.46781272.9013610.html.plaintext.txt	237	numa hydrophilic loop fig
0.46781272.9013610.html.plaintext.txt	238	nume reacted psnum digitonin permeabilized cell condition kdel specific monoclonal antibody result labeling fig
0.46781272.9013610.html.plaintext.txt	239	hand antibody second hydrophilic loop domain num reacted psnum saponin fig
0.46781272.9013610.html.plaintext.txt	240	numd digitonin fig
0.46781272.9013610.html.plaintext.txt	241	numc used permeabilize cell suggesting luminal localization domain
0.46781272.9013610.html.plaintext.txt	242	cytoplasmic orientation amino terminal domain hydrophilic loop psnum
0.46781272.9013610.html.plaintext.txt	243	co num cell transfected psnummyc panel b psnum wt panel c f permeabilized using digitonin panel c e saponin panel b d f immunostained anti myc mab numenum panel b polyclonal antibody num second loop domain panel c d polyclonal antibody bnum panel e f rat monoclonal antibody kdel sequence panel f
0.46781272.9013610.html.plaintext.txt	244	psnum immunoreactivity observed redyellow staining kdel immunoreactivity green
0.46781272.9013610.html.plaintext.txt	245	panel b show amino terminus psnum oriented cytoplasmic side endoplasmic reticulum membrane
0.46781272.9013610.html.plaintext.txt	246	cell express psnummyc stain strongly amino terminal domain directed numenum mab digitonin saponin b permeabilized cell
0.46781272.9013610.html.plaintext.txt	247	saponin used untransfected cell stained kdel antibody green since reacts endogenous protein b
0.46781272.9013610.html.plaintext.txt	248	digitonin used staining observed indicating endoplasmic reticulum membrane permeable antibody condition used
0.46781272.9013610.html.plaintext.txt	249	panel c d similar experiment displayed using antiserum num second loop domain
0.46781272.9013610.html.plaintext.txt	250	staining observed saponin used indicating luminal orientation domain panel d
0.46781272.9013610.html.plaintext.txt	251	panel e f demonstrate antiserum bnum hydrophilic loop domain psnum react digitonin e saponin f permeabilized cell indicating cytoplasmic orientation hydrophilic loop
0.46781272.9013610.html.plaintext.txt	252	view larger version image numk gif file
0.46781272.9013610.html.plaintext.txt	253	current investigation provides detailed characterization biosynthesis presenilins overexpressed co num cell cho cell
0.46781272.9013610.html.plaintext.txt	254	result show p protein unglycosylated phosphoprotein apparent molecular mass num num kda sd page
0.46781272.9013610.html.plaintext.txt	255	strong tendency form sd resistant complex apparent molecular mass num num kda
0.46781272.9013610.html.plaintext.txt	256	double immunofluorescence study showed psnum mainly located endoplasmic reticulum golgi apparatus amino terminal domain hydrophilic loop domain oriented cytoplasmic side
0.46781272.9013610.html.plaintext.txt	257	localization transfected psnum endoplasmic reticulum co num cell cho cell simple consequence overexpression protein nonspecific general effect biosynthetic pathway cell
0.46781272.9013610.html.plaintext.txt	258	first endogeneous presenilins located endoplasmic reticulum untransfected cell demonstrated fig
0.46781272.9013610.html.plaintext.txt	259	numa using confocal laser microscopy
0.46781272.9013610.html.plaintext.txt	260	second using identical transfection condition app furin found accumulate golgi apparatus demonstrated num num
0.46781272.9013610.html.plaintext.txt	261	num secretory processing appnum cho cell stably expressing human appnum affected transfection psnum ruling general inhibitory effect protein transport processing
0.46781272.9013610.html.plaintext.txt	262	hand level endogeneous presenilin co num cell apparently low
0.46781272.9013610.html.plaintext.txt	263	combination immunoprecipitation concentrate psnum detergent extract num x num cell followed immunoblotting using mab psnum num allowed u detect endogeneous psnum migrating molecular weight transfected psnum
0.46781272.9013610.html.plaintext.txt	264	disadvantage approach antibody immunoprecipitation step interfere consecutive detection possible p aggregate immunoblotting step fig
0.46781272.9013610.html.plaintext.txt	265	assay also precludes dynamic analysis metabolism presenilins using metabolic labeling pulse chase experiment
0.46781272.9013610.html.plaintext.txt	266	hand allowed u demonstrate presence absence particular antibody epitope psnum fragment
0.46781272.9013610.html.plaintext.txt	267	importantly use hydrophilic loop specific antibody immunoprecipitation step resulted detection relative large amount presumably proteolytic fragment psnum num num kda range fig
0.46781272.9013610.html.plaintext.txt	268	level fragment slightly increased co num cell overexpressed psnum explains readily detected transfection experiment
0.46781272.9013610.html.plaintext.txt	269	proteolytic process involved probably easily saturated even inhibited p overexpression num num
0.46781272.9013610.html.plaintext.txt	270	data therefore allow u speculate exact nature biological significance process
0.46781272.9013610.html.plaintext.txt	271	conclude overexpression study type used suitable study particular aspect presenilin metabolism
0.46781272.9013610.html.plaintext.txt	272	hand clear untransfected cell fig
0.46781272.9013610.html.plaintext.txt	273	num brain tissue vivo num num contain detectable amount intact presenilin
0.46781272.9013610.html.plaintext.txt	274	since endogeneously expressed psnum mobility transfected psnum conclusion transfected psnum psnum subject glycosylation sulfation glycosaminoglycan modification palmitoylation myristoylation also hold apparently true endogeneous protein
0.46781272.9013610.html.plaintext.txt	275	posttranslational modification thereby also excluded contributing formation high molecular mass sd resistant aggregate num num kda sd page electrophoresis
0.46781272.9013610.html.plaintext.txt	276	aggregate observed variable extent experiment noticed others using cell type brain tissue num num num
0.46781272.9013610.html.plaintext.txt	277	since smear detected three different antibody recognizing three different epitope myc directed mab using myc tagged psnum construct aggregate must contain presenilin core protein alone associated unidentified component
0.46781272.9013610.html.plaintext.txt	278	denaturation immunoprecipitates num degree c instead num degree c resulted le aggregate increased amount num kda psnum band fig
0.46781272.9013610.html.plaintext.txt	279	aggregate therefore probably consist mainly oligomers presenilins
0.46781272.9013610.html.plaintext.txt	280	unclear whether property form sd resistant aggregate vitro physiological significance vivo immuno electron microscope observation suggest clustering presenilins also occurs endoplasmic reticulum untransfected cell
0.46781272.9013610.html.plaintext.txt	281	num envisaged pathological condition exacerbated aggregation presenilins could become problem
0.46781272.9013610.html.plaintext.txt	282	context mentioned antibody psnum stain amyloid plaque brain alzheimers disease patient num
0.46781272.9013610.html.plaintext.txt	283	importantly two point mutation causing alzheimers disease studied
0.46781272.9013610.html.plaintext.txt	284	psnum ala num glu fadnum kindred psnum cys num tyr nihnum kindred alter biosynthesis level expression psnum protein co num cell cho cell
0.46781272.9013610.html.plaintext.txt	285	mutation must cause therefore subtle effect
0.46781272.9013610.html.plaintext.txt	286	possibility interfere fragmentation psnum shown recently two mutation num num excluded current data
0.46781272.9013610.html.plaintext.txt	287	analysis brain transgenic mouse expressing psnum ala num glu mutant indicate however least mutation interfere proteolytic processing psnum
0.46781272.9013610.html.plaintext.txt	288	num since p mutation known date act dominant way pathogenesis alzheimers disease gain function likely
0.46781272.9013610.html.plaintext.txt	289	evidence fibroblast derived patient presenilin mutation produce longer form anum amyloid peptide suggests mutation exert effect cellular metabolism trafficking amyloid precursor protein num
0.46781272.9013610.html.plaintext.txt	290	localization psnum early compartment biosynthetic pathway make unlikely presenilin mutation directly influence andor secretase activity since operate late golgi transport vesicle cell surface endosomes num num num
0.46781272.9013610.html.plaintext.txt	291	possibility p mutant influence balance amyloidogenic non amyloidogenic processing app indirect way changing intracellular trafficking explored polarized madin darby canine kidney cell neuron num num num
0.46781272.9013610.html.plaintext.txt	292	study demonstrates furthermore presenilins phosphorylated serine residue
0.46781272.9013610.html.plaintext.txt	293	phosphorylation psnum psnum evident co num cell cho cell phosphorylation psnum le intense variable psnum
0.46781272.9013610.html.plaintext.txt	294	observation okadaic acid enhanced psnum phosphorylation suggests psnum prone phosphatase activity psnum fig
0.46781272.9013610.html.plaintext.txt	295	protein kinase c responsible p phosphorylation since neither stimulation cell phorbol ester purified kinase added immunoprecipitated psnum psnum resulted increased labeling
0.46781272.9013610.html.plaintext.txt	296	therefore unlikely presenilins directly involved regulation app secretion protein kinase c num num
0.46781272.9013610.html.plaintext.txt	297	finally showed hydrophilic nhnum terminal major loop domain psnum exposed cytoplasmic side endoplasmic reticulum membrane
0.46781272.9013610.html.plaintext.txt	298	digitonin low concentration selectively permeabilizes cell membrane endoplasmic reticulum membrane num
0.46781272.9013610.html.plaintext.txt	299	antibody directed toward amino terminal domain psnum fig
0.46781272.9013610.html.plaintext.txt	300	num displayed similar immunofluorescent staining pattern digitonin saponin permeabilized cell
0.46781272.9013610.html.plaintext.txt	301	control experiment antibody luminal epitope
0.46781272.9013610.html.plaintext.txt	302	kdel endoplasmic reticulum retention signal num num showed digitonin permeabilize endoplasmic reticulum membrane
0.46781272.9013610.html.plaintext.txt	303	major hydrophilic loop domain essentially identical result obtained
0.46781272.9013610.html.plaintext.txt	304	conclusion therefore two major hydrophilic domain psnum oriented cytoplasmic side endoplasmic reticulum directs search candidate protein interacting domain toward cytoplasm
0.46781272.9013610.html.plaintext.txt	305	consistent conclusion antibody second loop domain reacted psnum saponin digitonin permeabilization
0.46781272.9013610.html.plaintext.txt	306	confirms luminal localization recognized epitope also validates approach used
0.46781272.9013610.html.plaintext.txt	307	detailed study including electron microscopy enzymatic digestion protection assay required settle definitively orientation presenilins endoplasmic reticulum membrane result clarify already two important issue
0.46781272.9013610.html.plaintext.txt	308	first problem orientation first transmembrane domain psnum determines fact topology following transmembrane domain num
0.46781272.9013610.html.plaintext.txt	309	positive charge difference num carboxyl terminal num amino terminal residue flanking first membrane spanning domain suggests luminal orientation amino terminus num
0.46781272.9013610.html.plaintext.txt	310	however several exception rule known mainly protein amino terminal domain contains num charged amino acid residue num
0.46781272.9013610.html.plaintext.txt	311	psnum domain contains num charged residue would explain cytoplasmic orientation
0.46781272.9013610.html.plaintext.txt	312	second issue pointed others num num num whether two putative hydrophobic stretch p amino acid sequence flanking hydrophilic loop additionally span membrane would make presenilins nine transmembrane domain protein
0.46781272.9013610.html.plaintext.txt	313	data compatible seven transmembrane domain model amino terminal domain hydrophilic loop located cytoplasm fig
0.46781272.9013610.html.plaintext.txt	314	num see also note added proof
0.46781272.9013610.html.plaintext.txt	315	conclusion current study analyzed biosynthesis subcellular localization presenilins provides basis study cell biology possible interaction integral membrane cytoplasmic protein app tau implicated pathogenesis alzheimers disease num
0.46781272.9013610.html.plaintext.txt	316	localization antibody epitope orientation psnum endoplasmic reticulum membrane
0.46781272.9013610.html.plaintext.txt	317	psnum inserted endoplasmic reticulum membrane amino terminal nhnum hydrophilic loop domain cytoplasmic side
0.46781272.9013610.html.plaintext.txt	318	localization peptide used raise different antibody used study topology psnum indicated bar sequence see also material method note added proof
0.46781272.9013610.html.plaintext.txt	319	view larger version image numk gif file
0.46781272.9013610.html.plaintext.txt	320	investigation supported grant fonds voor geneeskundig wetenschappelijk onderzoek fgwo nfwo human frontier science program hfsp action program biotechnology flemish government vlab flemish institute biotechnology vib katholieke universiteit leuven alzheimers society ontario medical research council canada
0.46781272.9013610.html.plaintext.txt	321	cost publication article defrayed part payment page charge
0.46781272.9013610.html.plaintext.txt	322	article must therefore hereby marked advertisement accordance num u
0.46781272.9013610.html.plaintext.txt	323	section num solely indicate fact
0.46781272.9013610.html.plaintext.txt	324	onderzoeksleider national fund scientific research belgium nfwo
0.46781272.9013610.html.plaintext.txt	325	correspondence addressed campus gasthuisberg o n num num leuven belgium
0.46781272.9013610.html.plaintext.txt	326	fax num num num e mail bart
0.46781272.9013610.html.plaintext.txt	327	num abbreviation used psnum presenilin num psnum presenilin num app amyloid precursor protein mab monoclonal antibody pb phosphate buffered saline tb tris buffered saline fitc fluorescein isothiocyanate tritc tetramethylrhodamine isothiocyanate page polyacrylamide gel electrophoresis pipe numnum piperazinediethanesulfonic acid nsp neuroendocrine specific protein
0.46781272.9013610.html.plaintext.txt	328	craessaerts unpublished result
0.46781272.9013610.html.plaintext.txt	329	van leuven unpublished result
0.46781272.9013610.html.plaintext.txt	330	gratefully acknowledge contribution expertise material following scientist b
0.46781272.9013610.html.plaintext.txt	331	schellenberg geriatric research education clinical center seattle wa
0.46781272.9013610.html.plaintext.txt	332	eight transmembrane model hydrophobic region viii loop domain spanning endoplasmic reticulum membrane also compatible data
0.46781272.9013610.html.plaintext.txt	333	would result cytoplasmic orientation carboxyl terminal domain psnum
0.46781272.9013610.html.plaintext.txt	334	num cell num num num medline order article via infotrieve selkoe d
0.46781272.9013610.html.plaintext.txt	335	num num num crossref checler f
0.46781272.9013610.html.plaintext.txt	336	num num num medline order article via infotrieve kosik k
0.46781272.9013610.html.plaintext.txt	337	num num num medline order article via infotrieve haass c
0.46781272.9013610.html.plaintext.txt	338	num num num medline order article via infotrieve strittmatter w
0.46781272.9013610.html.plaintext.txt	339	num num num abstract rebeck g
0.46781272.9013610.html.plaintext.txt	340	num neuron num num num medline order article via infotrieve goate
0.46781272.9013610.html.plaintext.txt	341	num nature num num num crossrefmedline order article via infotrieve rogaev e
0.46781272.9013610.html.plaintext.txt	342	num nature num num num crossrefmedline order article via infotrieve levy lahad e
0.46781272.9013610.html.plaintext.txt	343	num science num num num medline order article via infotrieve li j
0.46781272.9013610.html.plaintext.txt	344	num num num abstract sherrington r
0.46781272.9013610.html.plaintext.txt	345	num nature num num num crossrefmedline order article via infotrieve alzheimers disease collaborative group num nat
0.46781272.9013610.html.plaintext.txt	346	num num num medline order article via infotrieve wasco w
0.46781272.9013610.html.plaintext.txt	347	num num medline order article via infotrieve van broeckhoven c
0.46781272.9013610.html.plaintext.txt	348	num num num medline order article via infotrieve de strooper b
0.46781272.9013610.html.plaintext.txt	349	num num num abstract slunt h
0.46781272.9013610.html.plaintext.txt	350	num science num num num abstract lhernault
0.46781272.9013610.html.plaintext.txt	351	num num num abstract leviatan d
0.46781272.9013610.html.plaintext.txt	352	num nature num num num crossrefmedline order article via infotrieve scheuner d
0.46781272.9013610.html.plaintext.txt	353	num num num medline order article via infotrieve creemers j
0.46781272.9013610.html.plaintext.txt	354	num num num abstractfree full text roebroek
0.46781272.9013610.html.plaintext.txt	355	num num num abstract van de velde h
0.46781272.9013610.html.plaintext.txt	356	num num num abstractfree full text roebroek
0.46781272.9013610.html.plaintext.txt	357	num num num abstractfree full text evan g
0.46781272.9013610.html.plaintext.txt	358	num num num medline order article via infotrieve de strooper b
0.46781272.9013610.html.plaintext.txt	359	num num num abstract cooper j
0.46781272.9013610.html.plaintext.txt	360	num num num medline order article via infotrieve otto j
0.46781272.9013610.html.plaintext.txt	361	num num num abstractfree full text napier r
0.46781272.9013610.html.plaintext.txt	362	num planta num num num munro
0.46781272.9013610.html.plaintext.txt	363	num cell num num num medline order article via infotrieve jorgensen
0.46781272.9013610.html.plaintext.txt	364	num num num medline order article via infotrieve slunt h
0.46781272.9013610.html.plaintext.txt	365	num num num abstractfree full text de strooper b
0.46781272.9013610.html.plaintext.txt	366	num num num abstractfree full text thinakaran g
0.46781272.9013610.html.plaintext.txt	367	num neuron num num num medline order article via infotrieve mercken m
0.46781272.9013610.html.plaintext.txt	368	num num num crossrefmedline order article via infotrieve elder g
0.46781272.9013610.html.plaintext.txt	369	conum p num american society biochemistry molecular biology inc
0.47823864.11983636.html.plaintext.txt	0	genetic host factor dementia down syndrome nicole schupf phd
0.47823864.11983636.html.plaintext.txt	1	laboratory epidemiology new york state institute basic research developmental disability staten island
0.47823864.11983636.html.plaintext.txt	2	center columbia university college physician surgeon new york usa
0.47823864.11983636.html.plaintext.txt	3	correspondence nicole schupf phd new york state institute basic research num forest hill road staten island ny num
0.47823864.11983636.html.plaintext.txt	4	tel num num num num fax num num num num e mail nsnumatcolumbia
0.47823864.11983636.html.plaintext.txt	5	declaration interest grant iirg num num rgnum num num alzheimers association federal grant agnum hdnum pnumagnum fund new york state office mental retardation developmental disability
0.47823864.11983636.html.plaintext.txt	6	presented part blake marsh lecture annual meeting royal college psychiatrist num july num edinburgh
0.47823864.11983636.html.plaintext.txt	7	aim identify factor influence age onset dementia down syndrome
0.47823864.11983636.html.plaintext.txt	8	method study factor influence formation beta amyloid as reviewed including atypical karyotype susceptibility genotype gender oestrogen deficiency individual difference as peptide level
0.47823864.11983636.html.plaintext.txt	9	result apolipoprotein e num allele oestrogen deficiency high level assnum num peptide associated earlier onset dementia atypical karyotype apolipoprotein e num allele associated reduced mortality reduced risk dementia
0.47823864.11983636.html.plaintext.txt	10	conclusion factor influence as level rather overexpression app may account difference age onset dementia down syndrome
0.47823864.11983636.html.plaintext.txt	11	several line evidence suggest deposition as num important initial step pathogenesis alzheimers disease
0.47823864.11983636.html.plaintext.txt	12	assnum num aggregate rapidly deposited earlier alzheimers disease plaque assnum num iwatsubo et al num
0.47823864.11983636.html.plaintext.txt	13	mutation gene app presenilin psnumnum gene associated early onset familial alzheimers disease selective increase assnum num borchelt et al num mann et al num scheuner et al num kosaka et al num younkin num
0.47823864.11983636.html.plaintext.txt	14	brain level assnum num increase early development alzheimers disease strongly correlated cognitive decline cummings cotman num naslund et al num plasma level assnum num higher elderly people subsequently develop alzheimers disease remain free dementia mayeux et al num
0.47823864.11983636.html.plaintext.txt	15	virtually individual down syndrome neuropathological change consistent diagnosis alzheimers disease time reach num year age including deposition as diffuse neuritic plaque wisniewski h
0.47823864.11983636.html.plaintext.txt	16	et al num mann num develop dementia end seventh decade life lai williams num
0.47823864.11983636.html.plaintext.txt	17	despite nearly universal occurrence alzheimers disease pathology middle age wide variation age onset dementia
0.47823864.11983636.html.plaintext.txt	18	prevalence alzheimers disease age num ranged num num zigman et al num
0.47823864.11983636.html.plaintext.txt	19	study shown average age onset dementia num num year range num num year lai williams num prasher krishnan num
0.47823864.11983636.html.plaintext.txt	20	methodological problem may account variation estimated prevalence alzheimers disease down syndrome
0.47823864.11983636.html.plaintext.txt	21	diagnosis alzheimers disease population requires documentation clinically significant decline cognitive adaptive competence previously attained level performance documentation absence condition might cause decline performance aylward et al num
0.47823864.11983636.html.plaintext.txt	22	requirement particularly difficult address adult down syndrome given lifelong intellectual disability
0.47823864.11983636.html.plaintext.txt	23	wide range premorbid level performance associated difference level intellectual disability requires specific criterion clinically significant decline indicative dementia level function beginning developed
0.47823864.11983636.html.plaintext.txt	24	yet consensus set cognitive assessment task diagnostic criterion existing cognitive assessment battery differentiate adult down syndrome dementia early stage
0.47823864.11983636.html.plaintext.txt	25	presently diagnosis alzheimers disease adult down syndrome made clinically relatively late stage disease without systematic cognitive functional testing time
0.47823864.11983636.html.plaintext.txt	26	neuropathological manifestation alzheimers disease down syndrome attributed triplication overexpression gene app located chromosome num rumble et al num increased risk dementia down syndrome may mediated increased substrate cellular production as peptide
0.47823864.11983636.html.plaintext.txt	27	recent neuropathological study shown diffuse plaque prevalent alzheimer type lesion seen individual down syndrome age num associated dementia
0.47823864.11983636.html.plaintext.txt	28	diffuse plaque contain non fibrillar amyloid appear younger age neuritic plaque associated neuronal degeneration appear affect structure function neuron
0.47823864.11983636.html.plaintext.txt	29	contrast increase number neuritic plaque containing substantial amount fibrillised as peptide observed adult down syndrome predominantly num year age associated neuronal degeneration loss function wisniewski
0.47823864.11983636.html.plaintext.txt	30	examination age specific prevalence dementia down syndrome support hypothesis clinical manifestation alzheimers disease down syndrome closely associated development fibrillised plaque lai williams num visser et al num holland et al num lai et al num see fig
0.47823864.11983636.html.plaintext.txt	31	although prevalence study employed varying sampling diagnostic method remarkable agreement across study risk alzheimers disease increase primarily num year age
0.47823864.11983636.html.plaintext.txt	32	addition adult down syndrome develop dementia even reach age presence high density neuritic plaque presumed
0.47823864.11983636.html.plaintext.txt	33	thus triplication gene app may serve increase diffuse plaque adult down syndrome factor distinct app triplication must account individual difference susceptibility formation fibrillised plaque wide range age onset dementia
0.47823864.11983636.html.plaintext.txt	34	central task epidemiology dementia down syndrome identify factor may influence risk alzheimers disease accelerating formation as
0.47823864.11983636.html.plaintext.txt	35	several avenue investigation suggested existing finding review role atypical karyotype b genetic susceptibility factor c gender oestrogen deficiency d individual difference as peptide level
0.47823864.11983636.html.plaintext.txt	36	view larger version numk fig
0.47823864.11983636.html.plaintext.txt	37	num age specific prevalence dementia adult down syndrome
0.47823864.11983636.html.plaintext.txt	38	data lai williams num data visser et al num data lai et al num
0.47823864.11983636.html.plaintext.txt	39	data holland et al num
0.47823864.11983636.html.plaintext.txt	40	polymorphism gene apolipoprotein e apoe associated risk common late onset alzheimers disease onset num year age
0.47823864.11983636.html.plaintext.txt	41	three common variant gene apoe encoded three allele num num num
0.47823864.11983636.html.plaintext.txt	42	numerous cross sectional case control study patient alzheimers disease found significantly likely peer one copy apoe num allele corder et al num mayeux et al num saunders et al num
0.47823864.11983636.html.plaintext.txt	43	apoe num protein may act increasing rate process lead alzheimers disease predisposing greater accumulation as without alzheimers disease rose et al num hyman et al num polvikoski et al num
0.47823864.11983636.html.plaintext.txt	44	presence least common allele apoe num associated delay disease onset even protection investigator corder et al num rose et al num
0.47823864.11983636.html.plaintext.txt	45	apolipoprotein e down syndrome relation apoe genotype risk alzheimers disease down syndrome difficult establish
0.47823864.11983636.html.plaintext.txt	46	study consistently found presence apoe num allele increase longevity reduces risk dementia role num allele controversial hardy et al num royston et al num martin et al num van gool et al num cosgrave et al num lambert et al num schupf et al num prasher et al num schupf et al num sekijima et al num tyrrell et al num lai et al num rubinszstein et al num deb et al num
0.47823864.11983636.html.plaintext.txt	47	small sample size importantly failure consider difference age onset dementia among without num allele may account negative finding
0.47823864.11983636.html.plaintext.txt	48	since effect num allele expressed midlife inclusion sufficient number adult num year age analysis using survival method adjust age year follow important methodological consideration
0.47823864.11983636.html.plaintext.txt	49	group used survival method analysis found presence num allele associated earlier onset dementia greater decline adaptive behaviour schupf et al num
0.47823864.11983636.html.plaintext.txt	50	compared apoe numnum genotype adult down syndrome num allele five time likely develop dementia age num one num allele developed dementia see fig
0.47823864.11983636.html.plaintext.txt	51	among affected individual mean age onset dementia num
0.47823864.11983636.html.plaintext.txt	52	num year num allele num
0.47823864.11983636.html.plaintext.txt	53	num year numnum genotype
0.47823864.11983636.html.plaintext.txt	54	four study found increased frequency num allele adult down syndrome dementia compared down syndrome without dementia martin et al num sekijima et al num rubinsztein et al num deb et al num
0.47823864.11983636.html.plaintext.txt	55	view larger version numk fig
0.47823864.11983636.html.plaintext.txt	56	num cumulative incidence dementia adult down syndrome apolipoprotein e apoe genotype unk unk apoe numnum numnum genotype apoe numnum genotype apoe numnum numnum numnum genotype
0.47823864.11983636.html.plaintext.txt	57	based schupf et al num kind permission lippincott williams wilkins
0.47823864.11983636.html.plaintext.txt	58	result study apoe genotype adult down syndrome mixed
0.47823864.11983636.html.plaintext.txt	59	several study found apoe num allele decreased risk dementia sample size small demonstrate significant effect num allele hardy et al num royston et al num wisniewski
0.47823864.11983636.html.plaintext.txt	60	two case control study adult down syndrome compared allele frequency individual without dementia found significant association apoe genotype alzheimers disease adjust age van gool et al num prasher et al num
0.47823864.11983636.html.plaintext.txt	61	one large study examined num adult down syndrome num num year age used survival analysis examine age onset dementia apoe genotype lai et al num
0.47823864.11983636.html.plaintext.txt	62	cumulative incidence dementia age num num apoe numnum genotype num apoe numnum genotype num num allele
0.47823864.11983636.html.plaintext.txt	63	effect num allele stronger younger age consistent finding study general population effect num allele accelerate onset alzheimers disease corder et al num saunders et al num meyer et al num
0.47823864.11983636.html.plaintext.txt	64	cumulative incidence age num num
0.47823864.11983636.html.plaintext.txt	65	num among num allele num
0.47823864.11983636.html.plaintext.txt	66	num among apoe numnum genotype
0.47823864.11983636.html.plaintext.txt	67	author suggested num effect study may attenuated high rate dementia advanced age
0.47823864.11983636.html.plaintext.txt	68	concluded effect num allele may dependent age study sample
0.47823864.11983636.html.plaintext.txt	69	finding consistent reduced as deposition polvikoski et al num le plaque formation benjamin et al num lippa et al num num allele acceleration as pathology num allele hymen et al num polvikoski et al num
0.47823864.11983636.html.plaintext.txt	70	size num effect relation presence num allele early mortality interaction apoe genotype risk factor dementia down syndrome gender level learning disability remain resolved
0.47823864.11983636.html.plaintext.txt	71	require larger older sample analytic procedure provide better adjustment age potential confounders
0.47823864.11983636.html.plaintext.txt	72	human study data show higher age specific rate alzheimers disease woman compared men bachman et al num approximately half risk alzheimers disease woman received oestrogen replacement therapy barrett conner kritz silverstein num brenner et al num henderson et al num paganini hill henderson num mortel meyer num tang et al num
0.47823864.11983636.html.plaintext.txt	73	finding support hypothesis oestrogen deficiency contributes aetiology alzheimers disease
0.47823864.11983636.html.plaintext.txt	74	contrast randomised controlled clinical trial oestrogen replacement therapy woman moderate severe alzheimers disease failed show cognitive improvement suggesting major effect oestrogen delay onset rather reverse cognitive functional decline henderson et al num mulnard et al num
0.47823864.11983636.html.plaintext.txt	75	gender difference effect oestrogen down syndrome systematically investigated work needed clarify hormonal risk factor may influence onset dementia
0.47823864.11983636.html.plaintext.txt	76	study presented result separately men woman
0.47823864.11983636.html.plaintext.txt	77	study compared woman men found conflicting result different study showing earlier onset raghaven et al num lai et al num later onset farrer et al num schupf et al num difference age onset visser et al num lai williams num gender
0.47823864.11983636.html.plaintext.txt	78	two study employed survival method examine age onset distribution gender adjusting age level learning disability found conflicting result
0.47823864.11983636.html.plaintext.txt	79	colleague found men down syndrome three time likely woman develop alzheimers disease age num see fig
0.47823864.11983636.html.plaintext.txt	80	numa effect gender observed age group num year schupf et al num
0.47823864.11983636.html.plaintext.txt	81	men woman down syndrome show elevation follicle stimulating hormone fsh luteinising hormone puberty indicative primary gonadal dysfunction appear progress age frequent men woman hasen et al num campbell et al num hsiang et al num hestnes et al num
0.47823864.11983636.html.plaintext.txt	82	thus older men may benefit relative preservation oestrogen proposed account lower risk alzheimers disease men general population
0.47823864.11983636.html.plaintext.txt	83	contrast another study found woman down syndrome approximately twice likely develop dementia men lai et al num see fig
0.47823864.11983636.html.plaintext.txt	84	study effect gender seen primarily younger age
0.47823864.11983636.html.plaintext.txt	85	study gender difference largest apoe numnum genotype suggesting high risk associated presence apoe num allele mask gender effect
0.47823864.11983636.html.plaintext.txt	86	basis different result study gender difference clear
0.47823864.11983636.html.plaintext.txt	87	view larger version numk fig
0.47823864.11983636.html.plaintext.txt	88	num cumulative incidence dementia adult down syndrome gender based schupf et al num b based lai et al num kind permission lippincott williams wilkins
0.47823864.11983636.html.plaintext.txt	89	one published study examined influence oestrogen deficiency age onset dementia woman down syndrome cosgrave et al num
0.47823864.11983636.html.plaintext.txt	90	menstrual profile risk dementia num woman down syndrome studied
0.47823864.11983636.html.plaintext.txt	91	twelve woman postmenopausal diagnosed dementia
0.47823864.11983636.html.plaintext.txt	92	significant relationship age menopause age onset dementia subsample rnum
0.47823864.11983636.html.plaintext.txt	93	although sample size small result consistent hypothesis higher endogenous oestrogen level lower risk dementia decreasing as peptide level maintaining cholinergic function critical neuronal population
0.47823864.11983636.html.plaintext.txt	94	association age menopause onset dementia confirmed supporting hormonal data provided oestrogen replacement therapy might prove important intervention delay onset dementia
0.47823864.11983636.html.plaintext.txt	95	view larger version numk fig
0.47823864.11983636.html.plaintext.txt	96	num plasma level assnum num assnum num adult down syndrome without dementia apoe genotype
0.47823864.11983636.html.plaintext.txt	97	schupf et al num permission elsevier science
0.47823864.11983636.html.plaintext.txt	98	limitation reliable valid cognitive assessment battery diagnostic criterion required detect dementia early stage improve study risk factor
0.47823864.11983636.html.plaintext.txt	99	study small sample size controlled potential confounders modifier age gender level intellectual disability
0.47823864.11983636.html.plaintext.txt	100	study used prevalent rather incident case may mask effect risk factor disease onset confounding differential survival
0.47823864.11983636.html.plaintext.txt	101	et al num incidence dementia probable alzheimers disease general population framingham study
0.47823864.11983636.html.plaintext.txt	102	num estrogen replacement therapy cognitive function older woman
0.47823864.11983636.html.plaintext.txt	103	journal american medical association num num num
0.47823864.11983636.html.plaintext.txt	104	et al num protective effect apoe num alzheimers disease
0.47823864.11983636.html.plaintext.txt	105	et al num familial alzheimers disease linked presenilin variant elevate abetal numnum num ratio vitro vivo
0.47823864.11983636.html.plaintext.txt	106	et al num postmenopausal estrogen replacement therapy risk alzheimers disease population based case control study
0.47823864.11983636.html.plaintext.txt	107	american journal epidemiology num num num
0.47823864.11983636.html.plaintext.txt	108	et al num serum gonadotrophin syndrome
0.47823864.11983636.html.plaintext.txt	109	journal medical genetics num num num
0.47823864.11983636.html.plaintext.txt	110	num longevity woman syndrome case study
0.47823864.11983636.html.plaintext.txt	111	mental retardation num num num
0.47823864.11983636.html.plaintext.txt	112	et al num gene dose apolipoprotein e type num allele risk alzheimers disease late onset family
0.47823864.11983636.html.plaintext.txt	113	et al num protective effect apolipoprotein e type num allele late onset alzheimers disease
0.47823864.11983636.html.plaintext.txt	114	et al num lower frequency apolipoprotein enum allele elderly down syndrome population
0.47823864.11983636.html.plaintext.txt	115	biological psychiatry num num num
0.47823864.11983636.html.plaintext.txt	116	et al num age onset dementia age menopause woman down syndrome
0.47823864.11983636.html.plaintext.txt	117	journal intellectual disability research num num num
0.47823864.11983636.html.plaintext.txt	118	num image analysis beta amyloid load alzheimers disease relation dementia severity
0.47823864.11983636.html.plaintext.txt	119	num apoe num influence manifestation alzheimers disease adult down syndrome
0.47823864.11983636.html.plaintext.txt	120	british journal psychiatry num num num
0.47823864.11983636.html.plaintext.txt	121	et al num allelic variability dnumsnum app apoe associated cognitive decline syndrome
0.47823864.11983636.html.plaintext.txt	122	et al num segregation missense mutation amyloid precursor protein gene familial alzheimers disease
0.47823864.11983636.html.plaintext.txt	123	et al num estrogen attenuate corticosterone exacerbates excitotoxicity oxidative injury amyloid beta peptide toxicity hippocampal neuron
0.47823864.11983636.html.plaintext.txt	124	journal neurochemistry num num num
0.47823864.11983636.html.plaintext.txt	125	et al num apoe genotype down syndrome
0.47823864.11983636.html.plaintext.txt	126	num gonadal function trisomy num
0.47823864.11983636.html.plaintext.txt	127	et al num estrogen replacement therapy older woman
0.47823864.11983636.html.plaintext.txt	128	archive neurology num num num
0.47823864.11983636.html.plaintext.txt	129	et al num estrogen alzheimers disease woman randomized double blind placebo controlled trial
0.47823864.11983636.html.plaintext.txt	130	et al num hormonal biochemical disturbance down syndrome
0.47823864.11983636.html.plaintext.txt	131	journal mental deficiency research num num num
0.47823864.11983636.html.plaintext.txt	132	et al num presenilin num polymorphism alzheimers disease
0.47823864.11983636.html.plaintext.txt	133	et al num population based study prevalence presentation dementia adult down syndrome
0.47823864.11983636.html.plaintext.txt	134	british journal psychiatry num num num
0.47823864.11983636.html.plaintext.txt	135	et al num gonadal function patient syndrome
0.47823864.11983636.html.plaintext.txt	136	american journal medical genetics num num num
0.47823864.11983636.html.plaintext.txt	137	et al num quantitative analysis senile plaque alzheimer disease observation log normal size distribution molecular epidemiology difference associated apolipoprotein e genotype trisomy num syndrome
0.47823864.11983636.html.plaintext.txt	138	proceeding national academy science usa num num num
0.47823864.11983636.html.plaintext.txt	139	et al num visualization abnumnum abnum senile plaque end specific ab monoclonal evidence initially deposited specie abnumnum
0.47823864.11983636.html.plaintext.txt	140	et al num amyloid beta protein beta deposition beta numnum precedes beta num syndrome
0.47823864.11983636.html.plaintext.txt	141	annals neurology num num num
0.47823864.11983636.html.plaintext.txt	142	et al num estrogen regulates metabolism alzheimer amyloid beta precursor protein
0.47823864.11983636.html.plaintext.txt	143	journal biological chemistry num num num
0.47823864.11983636.html.plaintext.txt	144	et al num presenilin num polymorphism alzheimers disease
0.47823864.11983636.html.plaintext.txt	145	uk alzheimers disease collaborative group
0.47823864.11983636.html.plaintext.txt	146	et al num beta appnum alzheimer mutation increase percentage plasma amyloid beta protein ending beta numnum
0.47823864.11983636.html.plaintext.txt	147	num prospective study alzheimer disease syndrome
0.47823864.11983636.html.plaintext.txt	148	archive neurology num num num
0.47823864.11983636.html.plaintext.txt	149	et al num apoe genotype gender effect alzheimer disease num adult syndrome
0.47823864.11983636.html.plaintext.txt	150	et al num analysis apoe allele impact down syndrome
0.47823864.11983636.html.plaintext.txt	151	neuroscience letter num num num
0.47823864.11983636.html.plaintext.txt	152	et al num candidate gene chromosome num familial alzheimers disease locus
0.47823864.11983636.html.plaintext.txt	153	et al num apolipoprotein e num alzheimers disease genotype influence pathologic phenotype
0.47823864.11983636.html.plaintext.txt	154	jr et al num amyloid associated protein alpha num antichymotrypsin apolipoprotein e promote assembly alzheimer beta protein filament
0.47823864.11983636.html.plaintext.txt	155	num association alzheimer disease syndrome
0.47823864.11983636.html.plaintext.txt	156	alzheimer disease syndrome relationship ed j
0.47823864.11983636.html.plaintext.txt	157	oxford oxford university press
0.47823864.11983636.html.plaintext.txt	158	et al num predominant deposition amyloid beta numnum plaque case alzheimers disease hereditary cerebral hemorrhage associated mutation amyloid precursor protein gene
0.47823864.11983636.html.plaintext.txt	159	american journal pathology num num num
0.47823864.11983636.html.plaintext.txt	160	et al num apoe genotype australia role early late onset alzheimers disease down syndrome
0.47823864.11983636.html.plaintext.txt	161	et al num apolipoprotein epsilon num allele patient alzheimers disease
0.47823864.11983636.html.plaintext.txt	162	annals neurology num num num
0.47823864.11983636.html.plaintext.txt	163	et al num plasma amyloid beta peptide num num incipient alzheimers disease
0.47823864.11983636.html.plaintext.txt	164	annals neurology num num num
0.47823864.11983636.html.plaintext.txt	165	conum alinktypedoi crossrefmedline
0.47823864.11983636.html.plaintext.txt	166	num apolipoprotein e genotype deposit abetanum abetanum alzheimer disease
0.47823864.11983636.html.plaintext.txt	167	archive neurology num num num
0.47823864.11983636.html.plaintext.txt	168	et al num increased plasma amyloid beta protein num num level syndrome
0.47823864.11983636.html.plaintext.txt	169	neuroscience letter num num num
0.47823864.11983636.html.plaintext.txt	170	et al num apoe genotype predicts whetherone predisposed alzheimers disease
0.47823864.11983636.html.plaintext.txt	171	num lack postmenopausal estrogen therapy risk dementia
0.47823864.11983636.html.plaintext.txt	172	journal neuropsychiatry clinical neuroscience num num num
0.47823864.11983636.html.plaintext.txt	173	num estrogen replacement therapy treatment mild moderate alzheimer disease randomized controlled trial
0.47823864.11983636.html.plaintext.txt	174	alzheimers disease cooperative study
0.47823864.11983636.html.plaintext.txt	175	journal american medical association num num num
0.47823864.11983636.html.plaintext.txt	176	et al num correlation elevated level amyloid b peptide brain cognitive decline
0.47823864.11983636.html.plaintext.txt	177	journal american medical association num num num
0.47823864.11983636.html.plaintext.txt	178	num estrogen deficiency risk alzheimers disease woman
0.47823864.11983636.html.plaintext.txt	179	american journal epidemiology num num num
0.47823864.11983636.html.plaintext.txt	180	et al num ovariectomy num beta estradiol modulate level alzheimers amyloid beta peptide brain
0.47823864.11983636.html.plaintext.txt	181	et al num apolipoprotein e dementia cortical deposition beta amyloid protein
0.47823864.11983636.html.plaintext.txt	182	new england journal medicine num num num
0.47823864.11983636.html.plaintext.txt	183	num age onset duration dementia people syndrome integration num reported case literature
0.47823864.11983636.html.plaintext.txt	184	international journal geriatric psychiatry num num num
0.47823864.11983636.html.plaintext.txt	185	et al num apoe genotype alzheimers disease adult syndrome meta analysis
0.47823864.11983636.html.plaintext.txt	186	american journal mental retardation num num num
0.47823864.11983636.html.plaintext.txt	187	et al num molecular mapping alzheimer type dementia down syndrome
0.47823864.11983636.html.plaintext.txt	188	annals neurology num num num
0.47823864.11983636.html.plaintext.txt	189	et al num gender difference phenotypic expression alzheimers disease down syndrome trisomy num
0.47823864.11983636.html.plaintext.txt	190	et al num clinical application apolipoprotein e genotyping alzheimers disease
0.47823864.11983636.html.plaintext.txt	191	et al num apolipoprotein e epsilon num allele promotes longevity protects patient down syndrome dementia
0.47823864.11983636.html.plaintext.txt	192	et al num apoe genotype risk dementia syndrome
0.47823864.11983636.html.plaintext.txt	193	american journal medical genetics num num num
0.47823864.11983636.html.plaintext.txt	194	conum tlinktypedoi crossrefmedline
0.47823864.11983636.html.plaintext.txt	195	et al num amyloid anum protein precursor down syndrome alzheimers disease
0.47823864.11983636.html.plaintext.txt	196	new england journal medicine num num num
0.47823864.11983636.html.plaintext.txt	197	et al num apolipoprotein e epsilon num allele distribution late onset alzheimers disease amyloid forming disease
0.47823864.11983636.html.plaintext.txt	198	et al num secreted amyloid beta protein similar senile plaque alzheimers disease increased vivo presenilin num num app mutation linked familial alzheimers disease
0.47823864.11983636.html.plaintext.txt	199	et al num onset dementia associated apolipoprotein e num syndrome
0.47823864.11983636.html.plaintext.txt	200	annals neurology num num num
0.47823864.11983636.html.plaintext.txt	201	et al num earlier onset alzheimers disease men syndrome
0.47823864.11983636.html.plaintext.txt	202	et al num elevated plasma amyloid s peptide num onset dementia syndrome
0.47823864.11983636.html.plaintext.txt	203	neuroscience letter num num num
0.47823864.11983636.html.plaintext.txt	204	et al num presenilin num polymorphism alzheimers disease
0.47823864.11983636.html.plaintext.txt	205	et al num prevalence dementia alzheimer type apolipoprotein e phenotype aged patient syndrome
0.47823864.11983636.html.plaintext.txt	206	european neurology num num num
0.47823864.11983636.html.plaintext.txt	207	et al num cloning novel gene bearing missense mutation early familial alzheimers disease
0.47823864.11983636.html.plaintext.txt	208	et al num effect oestrogen menopause risk age onset alzheimers disease
0.47823864.11983636.html.plaintext.txt	209	et al num plasma level amyloid s protein abnum num abnum numnum elevated down syndrome
0.47823864.11983636.html.plaintext.txt	210	annals neurology num num num
0.47823864.11983636.html.plaintext.txt	211	et al num estrogen receptor colocalize low affinity nerve growth factor receptor cholinergic neuron basal forebrain
0.47823864.11983636.html.plaintext.txt	212	proceeding national academy science usa num num num
0.47823864.11983636.html.plaintext.txt	213	et al num protective effect apolipoprotein e enum allele dementia down syndrome
0.47823864.11983636.html.plaintext.txt	214	biological psychiatry num num num
0.47823864.11983636.html.plaintext.txt	215	et al num presenilin num alpha num antichymotrypsin polymorphism syndrome effect presence dementia
0.47823864.11983636.html.plaintext.txt	216	american journal medical genetics num num num
0.47823864.11983636.html.plaintext.txt	217	conum ilinktypedoi crossrefmedline
0.47823864.11983636.html.plaintext.txt	218	num case control study apolipoprotein e genotype alzheimers disease associated down syndrome
0.47823864.11983636.html.plaintext.txt	219	dutch study group down syndrome ageing
0.47823864.11983636.html.plaintext.txt	220	annals neurology num num num
0.47823864.11983636.html.plaintext.txt	221	et al num prospective study prevalence alzheimer type dementia institutionalized individual syndrome
0.47823864.11983636.html.plaintext.txt	222	american journal mental retardation num num num
0.47823864.11983636.html.plaintext.txt	223	num age associated development diffuse thioflavin positive plaque syndrome
0.47823864.11983636.html.plaintext.txt	224	developmental brain dysfunction num num num
0.47823864.11983636.html.plaintext.txt	225	et al num influence apolipoprotein e isotypes alzheimers disease pathology num case down syndrome
0.47823864.11983636.html.plaintext.txt	226	annals neurology num num num
0.47823864.11983636.html.plaintext.txt	227	num genetic association intronic polymorphism presenilin num gene late onset alzheimers disease
0.47823864.11983636.html.plaintext.txt	228	num role beta num alzheimers disease
0.47823864.11983636.html.plaintext.txt	229	journal physiology paris num num num
0.47823864.11983636.html.plaintext.txt	230	et al num epidemiology alzheimer disease intellectual disability result recommendation international conference
0.47823864.11983636.html.plaintext.txt	231	journal intellectual disability research num num num
0.47823864.11983636.html.plaintext.txt	232	received publication january num num
0.47823864.11983636.html.plaintext.txt	233	revision received june num num
0.47823864.11983636.html.plaintext.txt	234	accepted publication june num num
0.48003986.14645205.html.plaintext.txt	0	mutant presenilins specifically elevate level num residue s amyloid peptide vivo evidence augmentation num specific secretase joanna l
0.48003986.14645205.html.plaintext.txt	1	fadalenum jeffrey andersonnum guilian m
0.48003986.14645205.html.plaintext.txt	2	xunum victoria gonzalesnum nancy
0.48003986.14645205.html.plaintext.txt	3	numdepartment pathology numdepartment neuroscience john hopkins university school medicine baltimore md num usa nummayo clinic jacksonville num san pablo road jacksonville fl num usa nummerck research lab san diego num coast boulevard south la jolla ca num usa nummouse cancer genetics program nci frederick cancer research development center frederick md num usa numneurogenetics inc
0.48003986.14645205.html.plaintext.txt	4	num north torrey pine road suite num la jolla ca num usa
0.48003986.14645205.html.plaintext.txt	5	received august num num accepted november num num
0.48003986.14645205.html.plaintext.txt	6	mutation two additional gene presenilin num psnum homolog psnum also cause early onset fad num num
0.48003986.14645205.html.plaintext.txt	7	study vertebrate invertebrate suggest psnum psnum component larger protein complex contains nicastrin aph num pen num num num
0.48003986.14645205.html.plaintext.txt	8	complex either required cofactor secretase activity generates c terminus assnum num numnum numnum num
0.48003986.14645205.html.plaintext.txt	9	deletion psnum psnum lead complete loss secretase activity num
0.48003986.14645205.html.plaintext.txt	10	cell deficient psnum also show abnormality subcellular trafficking integral membrane protein including app numnum
0.48003986.14645205.html.plaintext.txt	11	interaction presenilins app first suggested observation plasma patient mutation psnum higher ratio assnum relative assnum patient sporadic ad num
0.48003986.14645205.html.plaintext.txt	12	subsequent work cell model demonstrated co expression fad mutant psnum app reproduced rise assnum relative assnum seen patient psnum associated ad num num
0.48003986.14645205.html.plaintext.txt	13	shift assnum assnum ratio also found brain transgenic mouse co expressing one several fad psnum mutation mnumv mnuml anume mnuml swedish mutation app numnum num
0.48003986.14645205.html.plaintext.txt	14	similar shift steady state ratio mouse assnum assnum also noted mouse expressing fad variant psnum num psnum num
0.48003986.14645205.html.plaintext.txt	15	transgenic mouse co expressing mutated psnum app developed amyloid pathology much earlier mouse expressing app acceleration amyloid formation directly correlated change assnum assnum ratio numnumnum
0.48003986.14645205.html.plaintext.txt	16	contrast co expression wild type human psnum mutant human app impact rate amyloid formation num
0.48003986.14645205.html.plaintext.txt	17	study dominant negative version psnum chemical inhibitor secretase interpreted evidence psnum may comprise active site secretase complex numnumnum num
0.48003986.14645205.html.plaintext.txt	18	moreover inhibitor coordinately depress assnum assnum production assumed one enzyme complex responsible production peptide numnum
0.48003986.14645205.html.plaintext.txt	19	setting fad mutation psnum might alter ratio as peptide produced app simply shifting specificity secretase favor cleavage residue num num
0.48003986.14645205.html.plaintext.txt	20	scenario mutation increase output assnum accompanied decrease generation assnum
0.48003986.14645205.html.plaintext.txt	21	current work took advantage recent advance elisa methodology examine assnum assnum level several line appswe mouse co expressing either two fad psnum variant anume denum
0.48003986.14645205.html.plaintext.txt	22	psnum variant accelerated rate amyloid deposition differing extent
0.48003986.14645205.html.plaintext.txt	23	quantifying level assnum assnum brain young pre symptomatic animal found co expression either psnumanume psnum denum appswe transgenic mouse specifically increased assnum level without altering assnum
0.48003986.14645205.html.plaintext.txt	24	data defined direct correlation age amyloid onset assnum level
0.48003986.14645205.html.plaintext.txt	25	based work cultured cell model suggesting mutant psnum alters production assnum num num conclude change steady state level peptide transgenic mouse likely due alteration processing app
0.48003986.14645205.html.plaintext.txt	26	suggest fad psnum variant may increase accessibility bacenum cleaved c terminal fragment app s ctfs secretase preferentially cleaves residue num
0.48003986.14645205.html.plaintext.txt	27	immunoblot analysis brain protein separated sd page demonstrated relatively high level appswe expression line fig
0.48003986.14645205.html.plaintext.txt	28	blot probed monoclonal antibody numcnum detects shared epitope n terminal region mouse human app showed transgenic line express num num fold total app non transgenic animal fig
0.48003986.14645205.html.plaintext.txt	29	immunoblots probed monoclonal antibody numenum detects humanized as domain transgene product demonstrated appswe protein level highest brain mouse line cnum num overall expression three line ranked qnum num num cnum num fig
0.48003986.14645205.html.plaintext.txt	30	view larger version numk figure num
0.48003986.14645205.html.plaintext.txt	31	transgene derived appswe expression three mouse line studied
0.48003986.14645205.html.plaintext.txt	32	human as specific antibody numenum used detect transgene derived app brain homogenate line qnum num num cnum num animal
0.48003986.14645205.html.plaintext.txt	33	b antibody numcnum used detect endogenous mouse app amyloid precursor like protein num aplp num num non transgenic control endogenous appaplp num transgene derived human appswe line qnum num num cnum num
0.48003986.14645205.html.plaintext.txt	34	immunoblot analysis consistently revealed highest appswe expression line cnum num lowest line qnum num line num falling two line
0.48003986.14645205.html.plaintext.txt	35	psnum anume psnum denum posse different amyloidogenic potential previous study numnum others numnumnum shown co expression mutant psnum appswe accelerate rate amyloid deposition
0.48003986.14645205.html.plaintext.txt	36	contrast co expression wild type human psnum even high level effect rate amyloid deposition num
0.48003986.14645205.html.plaintext.txt	37	extend work compare effect two fad psnum variant hasten amyloid onset differing degree
0.48003986.14645205.html.plaintext.txt	38	shown previously num transgenic mouse line cnum num develop amyloid deposit well beyond num month age fig
0.48003986.14645205.html.plaintext.txt	39	co expression psnum anume line n num half time cnum numn num mouse developing amyloid deposit num num month fig
0.48003986.14645205.html.plaintext.txt	40	plaque burden cnum numn num mouse worsens age num num month hippocampus cortex show high amyloid burden
0.48003986.14645205.html.plaintext.txt	41	similar acceleration amyloid deposition noted mouse different line psnum anume line inum num crossed cnum num mouse num
0.48003986.14645205.html.plaintext.txt	42	mouse line cnum num crossed mouse expressing exon num deleted variant psnum line num num substantial amyloid deposition visible num month age fig
0.48003986.14645205.html.plaintext.txt	43	psnum anume amyloid burden cnum numpsnum denum mouse increase throughout life fig
0.48003986.14645205.html.plaintext.txt	44	early appearance amyloid deposit observed offspring cnum num mouse mated two different line psnum denum mouse line num shown line o num data shown confirming effect due psnum denum transgene artifact integration site
0.48003986.14645205.html.plaintext.txt	45	view larger version numk figure num
0.48003986.14645205.html.plaintext.txt	46	co expression psnum denum dramatically accelerates amyloid pathology appswe transgenic mouse
0.48003986.14645205.html.plaintext.txt	47	c mouse transgenic appswe line cnum num develop hippocampal amyloid deposit late age shown hirano silver stain
0.48003986.14645205.html.plaintext.txt	48	amyloid plaque absent young middle aged b animal appearing mouse num month age c
0.48003986.14645205.html.plaintext.txt	49	d f co expression psnum anume accelerates appearance amyloid plaque
0.48003986.14645205.html.plaintext.txt	50	deposit first observed line cnum num appswepsnum anume double transgenic mouse num num month age e plaque load worsens age f
0.48003986.14645205.html.plaintext.txt	51	g co expression psnum denum line cnum num appswe mouse hastens appearance pathology
0.48003986.14645205.html.plaintext.txt	52	double transgenic appswepsnum denum mouse substantial number deposit num month age g plaque burden increase progressively time h
0.48003986.14645205.html.plaintext.txt	53	hippocampus shown panel ease comparison plaque also observed superficial layer anterior cortex concurrent hippocampal onset
0.48003986.14645205.html.plaintext.txt	54	measurement as level immunoprecipitation antibody n terminus as followed immunoblotting antibody specific num num terminus demonstrated ratio assnum assnum varied genotype fig
0.48003986.14645205.html.plaintext.txt	55	mouse expressing appswe ratio num num co expressing psnumanume decreased ratio num
0.48003986.14645205.html.plaintext.txt	56	num num co expressing psnumdenum dropped ratio num
0.48003986.14645205.html.plaintext.txt	57	degree change assnum assnum ratio proportional acceleration as deposition across genotype fig
0.48003986.14645205.html.plaintext.txt	58	view larger version numk figure num
0.48003986.14645205.html.plaintext.txt	59	co expressing mutant psnum shift ratio assnum num
0.48003986.14645205.html.plaintext.txt	60	quantitative immunoprecipitation immunoblotting see method used measure assnum num ratio brain mouse co expressing appswe psnumanume psnumdenum
0.48003986.14645205.html.plaintext.txt	61	mouse line cnum num brain contains num num fold assnum assnum
0.48003986.14645205.html.plaintext.txt	62	reported previous work num co expression psnumanume half assnum assnum ratio num
0.48003986.14645205.html.plaintext.txt	63	show expressing psnumdenum cnum num appswe mouse alters as level dramatically assnum becomes dominant specie
0.48003986.14645205.html.plaintext.txt	64	b regression analysis reveals direct correlation age amyloid onset ratio assnum num cnum num transgenic series
0.48003986.14645205.html.plaintext.txt	65	statistical significance determined two tailed student test
0.48003986.14645205.html.plaintext.txt	66	evidence highly pathogenic activity psnum denum seen extended study mouse express lower level appswe
0.48003986.14645205.html.plaintext.txt	67	mouse line qnum num develop amyloid pathology num month age fig
0.48003986.14645205.html.plaintext.txt	68	test whether co expression mutant psnum could induce plaque non depositing line crossed qnum num appswe mouse animal expressing either psnum anume line inum num numnum psnum denum line num numnum
0.48003986.14645205.html.plaintext.txt	69	despite ability accelerate amyloid deposition line cnum num mouse num co expression psnum anume line qnum num produced amyloid pathology brain region num month age fig
0.48003986.14645205.html.plaintext.txt	70	contrast double transgenic offspring qnum numxpsnum denum developed substantial amyloid pathology mid life fig
0.48003986.14645205.html.plaintext.txt	71	deposit probably began num num month time sacrificed num month animal considerable burden diffuse compact plaque throughout hippocampus cortex
0.48003986.14645205.html.plaintext.txt	72	thus psnum denum consistently induces earlier pathology appswe transgenic mouse psnum anume pathogenic enough cause amyloid formation even line appswe animal would otherwise remained free deposit
0.48003986.14645205.html.plaintext.txt	73	view larger version numk figure num
0.48003986.14645205.html.plaintext.txt	74	co expression psnum denum induce plaque formation non depositing line appswe transgenic mouse
0.48003986.14645205.html.plaintext.txt	75	e unlike previously published line appswe transgenic mouse animal line qnum num never develop amyloid deposit even late age
0.48003986.14645205.html.plaintext.txt	76	shown hirano silver stained section hippocampus cortex e num month old animal
0.48003986.14645205.html.plaintext.txt	77	b f co expression psnum anume sufficient induce amyloidosis mouse line qnum num num month age
0.48003986.14645205.html.plaintext.txt	78	c g co expression pathogenic psnum denum lead formation amyloid plaque qnum num mouse num month age
0.48003986.14645205.html.plaintext.txt	79	diffuse dense core deposit found hippocampus c cortex g age
0.48003986.14645205.html.plaintext.txt	80	d h line num mouse appswe psnum denum transgene co injected shown comparison
0.48003986.14645205.html.plaintext.txt	81	animal express slightly higher level appswe line qnum num mouse leading earlier onset pathology qnum numxpsnumdenum
0.48003986.14645205.html.plaintext.txt	82	plaque abundant hippocampus d cortex h line num mouse num month age
0.48003986.14645205.html.plaintext.txt	83	analysis double transgenic mouse created co injecting mohu appswe psnum denum construct confirmed amyloidogenic potential psnum denum variant
0.48003986.14645205.html.plaintext.txt	84	animal line num express level appswe intermediate line cnum num qnum num fig
0.48003986.14645205.html.plaintext.txt	85	num however invariably co express psnumdenum line num mouse develop amyloid deposit far earlier either single transgenic appswe line fig
0.48003986.14645205.html.plaintext.txt	86	occasional deposit found line num mouse young num month age num month animal significant plaque burden cortex hippocampus fig
0.48003986.14645205.html.plaintext.txt	87	thus denum variant appears highly pathogenic mutation profound effect deposition amyloid peptide
0.48003986.14645205.html.plaintext.txt	88	despite highly pathogenic activity expression psnum denum alone mouse sufficient induce amyloid deposit endogenous mouse app shown consistent previous report fad variant psnum transgenic mouse num
0.48003986.14645205.html.plaintext.txt	89	mutant psnum specifically increase steady state level assnum two independent approach demonstrated earlier appearance amyloid mouse co expressing appswe line cnum num psnum anume line n num psnum denum line num associated change ratio assnum assnum favor assnum fig
0.48003986.14645205.html.plaintext.txt	90	study however variance efficiency as peptide captured either immunoprecipitation elisa made difficult distinguish whether assnum level increased expense assnum whether level assnum increased independently assnum remained unchanged
0.48003986.14645205.html.plaintext.txt	91	course study refined elisa approach num developed allowed u address issue
0.48003986.14645205.html.plaintext.txt	92	using refined elisa assay studied level as peptide brain young pre deposit animal double transgenic line described fig
0.48003986.14645205.html.plaintext.txt	93	tissue processed using two step extraction method following sonication num
0.48003986.14645205.html.plaintext.txt	94	num diethylamine dea high speed centrifugation soluble as recovered supernatant pellet re extracted num formic acid fa recover remaining insoluble specie
0.48003986.14645205.html.plaintext.txt	95	two fraction assayed separately data total as calculated addition dea fa fraction value obtained animal
0.48003986.14645205.html.plaintext.txt	96	noted approximately num assnum extracted dea lower variable percentage assnum extracted solvent table num
0.48003986.14645205.html.plaintext.txt	97	sample prepared young pre deposit animal especially case mouse transgenic appswe believe relative insolubility assnum due oligomerization peptide rather inherent difference solubility two peptide dea
0.48003986.14645205.html.plaintext.txt	98	comparison across genotype transgenic series therefore focus total as value rather dea fa soluble fraction accommodate differential solubility two peptide
0.48003986.14645205.html.plaintext.txt	99	view larger version numk figure num
0.48003986.14645205.html.plaintext.txt	100	mutant psnum specifically elevates level assnum proportionately decrease age deposit first appear appswe transgenic mouse
0.48003986.14645205.html.plaintext.txt	101	level assnum num measured brain mouse five distinct genotype noted graph elisa described material method
0.48003986.14645205.html.plaintext.txt	102	value assnum num genotype normalized level cnum num single transgenic mouse value peptide cnum num mouse set num value assnum num genotype related cnum num mouse see table num
0.48003986.14645205.html.plaintext.txt	103	statistical significance among genotype calculated pair wise using two tailed student test pair noted bracket figure
0.48003986.14645205.html.plaintext.txt	104	asterisk denotes significant difference assnum level cnum numxpsnum anume cnum numxpsnum denum p num
0.48003986.14645205.html.plaintext.txt	105	statistical difference assnum level within remaining cnum num pair
0.48003986.14645205.html.plaintext.txt	106	contrast level assnum significantly increased mouse co expressing mutant psnum
0.48003986.14645205.html.plaintext.txt	107	b relationship brain concentration assnum age amyloid onset genotype analyzed
0.48003986.14645205.html.plaintext.txt	108	assnum value normalized level measured cnum num single transgenic animal
0.48003986.14645205.html.plaintext.txt	109	co expression hu psnumdenum induces greatest relative increase assnum largest decrease age amyloid onset
0.48003986.14645205.html.plaintext.txt	110	note onset amyloid lesion line qnum num estimated age plaque appear qnum numxpsnumdenum animal would difficult observe normal mouse lifespan
0.48003986.14645205.html.plaintext.txt	111	c level assnum num brain qnum num appswe mouse crossed psnum mouse measured separate elisa assay
0.48003986.14645205.html.plaintext.txt	112	concentration peptide normalized value measured qnum num single transgenic mouse set num
0.48003986.14645205.html.plaintext.txt	113	cnum num series co expression psnumanume psnumdenum qnum num mouse significantly elevated level assnum without decreasing assnum
0.48003986.14645205.html.plaintext.txt	114	asterisk denotes small significant difference assnum found qnum numxpsnum anume qnum num
0.48003986.14645205.html.plaintext.txt	115	none remaining pair showed significant difference assnum
0.48003986.14645205.html.plaintext.txt	116	normalized fraction brain as extracted dea formic acid two separate series experiment performed
0.48003986.14645205.html.plaintext.txt	117	one series compared assnum assnum level brain cnum num appswe mouse level cnum numxpsnum anume cnum numxpsnum denum appswepsnumdenum line num qnum num mouse fig
0.48003986.14645205.html.plaintext.txt	118	first series value normalized as level cnum num mouse
0.48003986.14645205.html.plaintext.txt	119	graphing relative level peptide animal revealed addition mutant psnum increase concentration assnum without causing proportionate decrease assnum
0.48003986.14645205.html.plaintext.txt	120	case conclusion stronger second series mouse described even cnum num series measurement show compared appswe single transgenic mouse co expression psnumanume caused num increase psnum denum num increase concentration assnum without consistently lowering level assnum
0.48003986.14645205.html.plaintext.txt	121	mouse co expressing psnumdenum variant appswe level assnum exceeded assnum fig
0.48003986.14645205.html.plaintext.txt	122	num hence difficult argue lack change assnum level might due far greater abundance assnum relative assnum
0.48003986.14645205.html.plaintext.txt	123	comparison value age amyloid deposit first appear genotype suggests immediate relationship fig
0.48003986.14645205.html.plaintext.txt	124	age onset cross directly correlate concentration assnum brain
0.48003986.14645205.html.plaintext.txt	125	correlation extends beyond cnum num series
0.48003986.14645205.html.plaintext.txt	126	line num mouse made co injecting appswe psnumdenum vector similar cnum numxpsnum denum mouse peptide level age amyloid onset fig
0.48003986.14645205.html.plaintext.txt	127	end spectrum qnum num single transgenic mouse accumulate even le assnum cnum num single transgenic mouse show sign amyloid pathology age deposit already begun cnum num animal fig
0.48003986.14645205.html.plaintext.txt	128	second elisa experiment measured as level across qnum num appswe series qnum num qnum numxpsnum anume qnum numxpsnum denum
0.48003986.14645205.html.plaintext.txt	129	concentration as value genotype normalized level qnum num single transgenic animal
0.48003986.14645205.html.plaintext.txt	130	found addition mutant psnum specifically elevates assnum level without lowering assnum level fig
0.48003986.14645205.html.plaintext.txt	131	collectively data demonstrate mutant psnum present specific increase assnum without proportionate decrease assnum
0.48003986.14645205.html.plaintext.txt	132	data also demonstrate concentration assnum driving force behind change rate amyloid deposition occur double transgenic mouse
0.48003986.14645205.html.plaintext.txt	133	transgenic mouse expressing psnum denum develop cotton wool plaque fad patient denum mutation associated pathology motor symptom atypical ad
0.48003986.14645205.html.plaintext.txt	134	neuropathological examination several patient carrying mutation revealed large loose cotton wool amyloid aggregate cortex relative absence compact dense core deposit num num
0.48003986.14645205.html.plaintext.txt	135	atypical pathology found psnum denum kindred numnum indeed observed mouse expressing denum transgene
0.48003986.14645205.html.plaintext.txt	136	instead appswepsnum denum double transgenic animal displayed characteristic compact dense cored deposit throughout cortex hippocampus could stained congo red birefringent polarized light fig
0.48003986.14645205.html.plaintext.txt	137	view larger version numk figure num
0.48003986.14645205.html.plaintext.txt	138	congophilic amyloid deposit found mouse co expressing psnum denum appswe
0.48003986.14645205.html.plaintext.txt	139	h mouse expressing denum mutation psnum conjunction mohu appswe develop typical diffuse compact birefringent deposit
0.48003986.14645205.html.plaintext.txt	140	panel show congo red stained plaque bright field c e g polarized light b d f h
0.48003986.14645205.html.plaintext.txt	141	plaque appear qualitatively identical mouse high expressing early onset cnum num low expressing late onset qnum num line
0.48003986.14645205.html.plaintext.txt	142	shown section num month old cnum numxpsnum denum mouse b e f num month old qnum numxpsnum denum mouse c d g h
0.48003986.14645205.html.plaintext.txt	143	congophilic deposit found cortex d hippocampus e h
0.48003986.14645205.html.plaintext.txt	144	amyloid onset determined level assnum previous study numnum others numnumnum demonstrated co expression fad associated psnum variant app transgenic mouse shift ratio assnum assnum shift correlate rapid appearance amyloid deposit
0.48003986.14645205.html.plaintext.txt	145	contrast co expression wild type human psnum impact rate amyloid formation num
0.48003986.14645205.html.plaintext.txt	146	previous study two point comparison one line mouse expressing mutant app mouse mouse expressing one fad psnum variant
0.48003986.14645205.html.plaintext.txt	147	present study first analyze different combination app psnum variant show distinct course amyloid pathology
0.48003986.14645205.html.plaintext.txt	148	data demonstrate age amyloid deposit first appear correlate directly concentration assnum brain
0.48003986.14645205.html.plaintext.txt	149	demonstrated mouse line qnum num animal expressing app even co expressing psnum form amyloid deposit num year lifetime
0.48003986.14645205.html.plaintext.txt	150	co expression psnum anume able dramatically accelerate appearance plaque cnum num appswe transgenic mouse effect strong enough induce plaque num month age lower expressing qnum num appswe mouse
0.48003986.14645205.html.plaintext.txt	151	instead plaque observed mouse line qnum num highly pathogenic psnum denum variant introduced
0.48003986.14645205.html.plaintext.txt	152	quantitative elisa analysis mouse genotype revealed psnum variant altered concentration assnum brain animal expressing either psnum variant contained assnum qnum num single transgenic mouse
0.48003986.14645205.html.plaintext.txt	153	however co expression psnum denum led substantially higher assnum level psnum anume consistent ability induce amyloid formation earlier psnum anume
0.48003986.14645205.html.plaintext.txt	154	study assnum assnum fibrilization vitro demonstrated formation congophilic fibril follows second order kinetics long lag phase nucleation seeding phase followed exponential phase fibril formation extinction substrate numnumnumnum
0.48003986.14645205.html.plaintext.txt	155	since length lag phase proportional concentration as peptide numnumnumnum believe different rate as deposition observed genotype represent change rate nucleation seeding assnum fibril vivo
0.48003986.14645205.html.plaintext.txt	156	congophilic neuritic amyloid pathology mohu appswexpsnumdenum mouse neuropathological study brain fad patient psnum denum mutation reported number case contain senile plaque atypical ad
0.48003986.14645205.html.plaintext.txt	157	unusual case as aggregate described cotton wool deposit lack compact dense core show birefringence stained congo red num num
0.48003986.14645205.html.plaintext.txt	158	however atypical pathology found psnum denum kindred numnum
0.48003986.14645205.html.plaintext.txt	159	indeed mouse carrying psnumdenum mutation recapitulate cotton wool plaque denum fad patient
0.48003986.14645205.html.plaintext.txt	160	instead line appswepsnumdenum mouse examined study develop congophilic neuritic senile plaque fig
0.48003986.14645205.html.plaintext.txt	161	perhaps extreme concentration as needed observe amyloid formation within mouse lifespan artificially drive plaque compact form
0.48003986.14645205.html.plaintext.txt	162	second atypical feature fad caused psnum denum mutation frequent appearance spastic paraparesis numnumnum
0.48003986.14645205.html.plaintext.txt	163	affected patient exhibit abnormal gait hyper reflexive lower extremity
0.48003986.14645205.html.plaintext.txt	164	however kindred carrying psnum denum show motor involvement num
0.48003986.14645205.html.plaintext.txt	165	yet observe evidence diminished motor function line mouse expressing psnum denum either alone conjunction appswe
0.48003986.14645205.html.plaintext.txt	166	incomplete penetrance atypical pathology motor dysfunction psnum denum kindred lack feature transgenic model suggests modifier locus may influence expression phenotype human
0.48003986.14645205.html.plaintext.txt	167	mutant presenilins may recruit new pool substrate secretase pathway elevate production assnum study presenilin biology suggest psnum psnum compete inclusion larger protein complex contains nicastrin aph num pen num num num
0.48003986.14645205.html.plaintext.txt	168	complex required active secretase responsible proteolytic processing app generate c terminus as peptide numnum
0.48003986.14645205.html.plaintext.txt	169	study chemical inhibitor secretase shown cleavage app num site num site coordinately suppressed suggesting single activity responsible cleavage numnumnum num
0.48003986.14645205.html.plaintext.txt	170	setting simplest explanation elevation assnum relative assnum presence mutant psnum simple shift enzyme specificity favor cleavage residue num net change amount total as
0.48003986.14645205.html.plaintext.txt	171	however result indicate expression fad psnum variant specified increase steady state level assnum without altering as num level
0.48003986.14645205.html.plaintext.txt	172	expression mutant psnum thus lead net increase total as
0.48003986.14645205.html.plaintext.txt	173	similar finding reported oyama colleague study mouse transgenic psnum nnumi also show specific increase assnum level num
0.48003986.14645205.html.plaintext.txt	174	experiment cell culture shown co expression fad psnum variant app alters ratio assnum num medium favor assnum num num
0.48003986.14645205.html.plaintext.txt	175	cell culture experiment assumed psnum variant alter production secretion assnum rather altering clearance catabolism
0.48003986.14645205.html.plaintext.txt	176	however cell culture paradigm replicate complex architecture signaling pattern neuron brain
0.48003986.14645205.html.plaintext.txt	177	hippocampal slice culture kamenetz et al
0.48003986.14645205.html.plaintext.txt	178	num recently demonstrated neuronal activity influence secretion as extracellular space
0.48003986.14645205.html.plaintext.txt	179	vivo animal model used study difficult separate change production as change catabolism
0.48003986.14645205.html.plaintext.txt	180	however based cell culture study app processing believe likely increase steady state level assnum measured brain tissue mouse reflects enhanced production assnum rather change stability clearance
0.48003986.14645205.html.plaintext.txt	181	study demonstrating absolute requirement psnum psnum function active secretase numnum consistent interpretation
0.48003986.14645205.html.plaintext.txt	182	recent report indicate psnum required translocation app plasma membrane endosomes secretase cleavage produce extracellular as thought occur num specific mutation psnum alter movement num num
0.48003986.14645205.html.plaintext.txt	183	moreover others demonstrated cell deficient psnum show alteration subcellular trafficking specific membrane protein numnum
0.48003986.14645205.html.plaintext.txt	184	however study cultured cell suggested full length app preferred substrate secretase
0.48003986.14645205.html.plaintext.txt	185	instead appears direct substrate secretase c terminal fragment app generated s secretase
0.48003986.14645205.html.plaintext.txt	186	fragment full length protein accumulate high level secretase inhibited numnumnumnumnum num
0.48003986.14645205.html.plaintext.txt	187	whether effect detected due change app trafficking unclear
0.48003986.14645205.html.plaintext.txt	188	note analysis level sapp s soluble ectodomain app generated bacenum failed detect obvious alteration due co expression mutant psnum supplementaly material fig
0.48003986.14645205.html.plaintext.txt	189	light foregoing data favor notion psnum anume psnum denum differing efficiency place greater amount app ctf substrate contact secretase preferentially cleaves residue num
0.48003986.14645205.html.plaintext.txt	190	mechanism would explain specific elevation assnum level absence change assnum level
0.48003986.14645205.html.plaintext.txt	191	moreover scenario could also explain certain natural experimental variant psnum differentially affect cleavage app ctfs notch another important substrate secretase num
0.48003986.14645205.html.plaintext.txt	192	note psnumnicastrinpen numaph num protein complex responsible delivery substrate secretase proteolysis inhibition psnum complex either genetically pharmacologically would diminish secretase activity manner indistinguishable inhibiting secretase
0.48003986.14645205.html.plaintext.txt	193	thus think possible one effect mutant psnum augment amount substrate presented num specific secretase
0.48003986.14645205.html.plaintext.txt	194	line num companion line num num num num described jankowsky et al
0.48003986.14645205.html.plaintext.txt	195	five line created co injection chimeric mousehuman appswe human psnum denum vector controlled independent mouse prion protein promoter element
0.48003986.14645205.html.plaintext.txt	196	two transgene co integrated co segregate single locus num
0.48003986.14645205.html.plaintext.txt	197	protein expression transgenic appswe line num comparable previously described line num num
0.48003986.14645205.html.plaintext.txt	198	line num mouse deposited jackson laboratory
0.48003986.14645205.html.plaintext.txt	199	animal used study maintained hybrid background back crossing cnumhejxcnumblnumj fnum mouse obtained jackson laboratory bar harbor usa
0.48003986.14645205.html.plaintext.txt	200	offspring genotyped presence transgene pcr amplification genomic dna extracted num cm tail clipping described jankowsky et al
0.48003986.14645205.html.plaintext.txt	201	reaction contained three primer one antisense primer matching sequence within vector also present mouse genomic prp num gtg gat acc ccc tcc ccc agc cta gac c one sense primer specific transgene cdna psnum num cag gtg gtg gag caa gat g app num ccg aga tct ctg aag tga aga tgg atg second sense primer specific genomic prp coding region removed moprp vector num cct ctt tgt gac tat gtg gac tga tgt cgg
0.48003986.14645205.html.plaintext.txt	202	reaction give num bp product endogenous prp gene control dna integrity successful amplification transgene positive sample additional band num bp app num
0.48003986.14645205.html.plaintext.txt	203	animal housed microisolator cage unlimited access food water
0.48003986.14645205.html.plaintext.txt	204	procedure involving animal approved jhu institutional animal care use committee
0.48003986.14645205.html.plaintext.txt	205	as peptide analysis quantitative immunoblot quantitation as level transgenic mouse brain tissue performed described lesuisse et al
0.48003986.14645205.html.plaintext.txt	206	briefly hemibrain sample line cnum num mouse homogenized dounce tissue grinder num vols pb containing num chap num mm pmsf num microgml leupeptin num microgml aprotinin num microm pepstatin
0.48003986.14645205.html.plaintext.txt	207	homogenate mixed num min num degree c centrifuged num h num numg
0.48003986.14645205.html.plaintext.txt	208	supernatant immunoprecipitated monoclonal antibody numdnum specific assnum num recovered peptide separated bicineurea sd page
0.48003986.14645205.html.plaintext.txt	209	protein transferred pvdf membrane blotted numdnum conjugated horseradish peroxidase
0.48003986.14645205.html.plaintext.txt	210	antibody binding visualized ecl reagent exposed film quantified using scanning laser densitometry compare band density sample synthetic as standard run parallel
0.48003986.14645205.html.plaintext.txt	211	statistic performed one way anova least square difference lsd post test using statistica analysis program statsoft tulsa ok usa
0.48003986.14645205.html.plaintext.txt	212	as peptide quantitation elisa frozen mouse hemi brain nnum num per genotype extracted sonication num
0.48003986.14645205.html.plaintext.txt	213	num diethylamine deanum mm nacl concentration num mgml
0.48003986.14645205.html.plaintext.txt	214	centrifugation num numg num h num degree c supernatant removed saved dea extract
0.48003986.14645205.html.plaintext.txt	215	pellet sonicated num formic acid fa diluted water using volume equal original volume dea
0.48003986.14645205.html.plaintext.txt	216	centrifugation num numg num h num degree c supernatant removed saved fa extract
0.48003986.14645205.html.plaintext.txt	217	brain extract measured sandwich elisa described previously numnumnum
0.48003986.14645205.html.plaintext.txt	218	dea extract neutralized adding numnum vol num
0.48003986.14645205.html.plaintext.txt	219	vortexing briefly neutralized sample prepared elisa num num dilution ec buffer num
0.48003986.14645205.html.plaintext.txt	220	num block ace dainipponseiyaku suita osaka japan num
0.48003986.14645205.html.plaintext.txt	221	standard curve used calculate as concentration dea extract also performed ec buffer
0.48003986.14645205.html.plaintext.txt	222	fa extract neutralized prepared elisa diluting num num num m tris phosphate buffer tpb ph num
0.48003986.14645205.html.plaintext.txt	223	standard curve fa extract performed mixture fa tpb
0.48003986.14645205.html.plaintext.txt	224	sample assayed human as specific elisa system us bannum monoclonal antibody mab epitope assnum num capture banum bcnum mabs detection assnum assnum respectively
0.48003986.14645205.html.plaintext.txt	225	final as concentration expressed picomoles per gram tissue calculated original brain weight measurement prior homogenization
0.48003986.14645205.html.plaintext.txt	226	statistic performed one way anova lsd post test using statistica analysis program statsoft tulsa ok usa
0.48003986.14645205.html.plaintext.txt	227	histology mouse euthanized ether inhalation brain removed immersion num paraformaldehydenumxbuffered saline pb
0.48003986.14645205.html.plaintext.txt	228	fixation num h num degree c brain transferred pb dehydrated alcohol series treated cedarwood oil methylsalicylate embedded paraffin sectioning
0.48003986.14645205.html.plaintext.txt	229	hirano silver stain silver impregnation histology performed num microm paraffin embedded section hiranos modification bielschowsky method numnum
0.48003986.14645205.html.plaintext.txt	230	briefly section deparaffinized xylene alcohol tap water placed fresh num silver nitrate solution num min
0.48003986.14645205.html.plaintext.txt	231	washing thoroughly distilled water slide immersed num silver nitrate solution titrated fresh ammonium hydroxide
0.48003986.14645205.html.plaintext.txt	232	num min slide washed ammonia water individually developed num microl developer num ml num formaldehyde num ml distilled water num microl concentrated nitric acid num
0.48003986.14645205.html.plaintext.txt	233	num g citric acid added num ml titrated silver nitrate solution
0.48003986.14645205.html.plaintext.txt	234	slide rinsed tap water fixed num sodium thiosulfate dehydrated alcohol xylene
0.48003986.14645205.html.plaintext.txt	235	congo red stain congo red staining performed according standard technique
0.48003986.14645205.html.plaintext.txt	236	deparaffinized slide num microm brain section counterstained hematoxylin rinsed well immersed congo red solution num g sodium chloride num ml distilled water mixed num g congo red sigma st louis mo usa dissolved num ml num ethanol num min
0.48003986.14645205.html.plaintext.txt	237	without rinsing slide moved aniline blue num
0.48003986.14645205.html.plaintext.txt	238	num g aniline blue num ml glacial acetic acid num ml distilled water dehydrated ethanol xylene
0.48003986.14645205.html.plaintext.txt	239	western blotting western blotting ass transgenic app expression qnum num num cnum num line performed described jankowsky et al
0.48003986.14645205.html.plaintext.txt	240	briefly num num microg brain homogenate probed numcnum numenum antisevnl respectively loaded per lane onto num tris glycine sd page gel invitrogen carlsbad ca usa electrophoresed several hour numxtg sd buffer amresco solon oh usa
0.48003986.14645205.html.plaintext.txt	241	protein transferred overnight num
0.48003986.14645205.html.plaintext.txt	242	num microm optitran nitrocellulose schleicher schuell keene nh usa numxtg buffer amresco
0.48003986.14645205.html.plaintext.txt	243	blot blocked pb containing num non fat dry milk powder incubated num h room temperature either antibody numcnum kind gift drs konrad beyreuther andreas weidemann diluted num num blocking solution antibody numenum signet laboratory dedham ma usa diluted num num blocking solution sevnl num diluted num num blocking solution
0.48003986.14645205.html.plaintext.txt	244	blot washed several time pb containing num
0.48003986.14645205.html.plaintext.txt	245	num tween num incubated either peroxidase conjugated protein sigma st louis mo usa diluted num num blocking solution numenum mixture peroxidase protein diluted num num rabbit anti mouse igg chemicon temecula ca usa diluted num num blocking solution
0.48003986.14645205.html.plaintext.txt	246	washing several time pb num
0.48003986.14645205.html.plaintext.txt	247	num tween num blot developed enhanced chemiluminescence reagent new england nuclear boston ma usa exposed film
0.48003986.14645205.html.plaintext.txt	248	level psnum transgene product mouse used previously described numnumnum
0.48003986.14645205.html.plaintext.txt	249	steady state level human psnum protein various mouse used accumulate similar level numnum
0.48003986.14645205.html.plaintext.txt	250	footnote correspondence addressed department pathology john hopkins university school medicine num ross research building num rutland ave baltimore md num usa
0.48003986.14645205.html.plaintext.txt	251	tel num num fax num num email drboratjhmi
0.48003986.14645205.html.plaintext.txt	252	present addressdivision biology mc num num california institute technology pasadena ca num usa
0.48003986.14645205.html.plaintext.txt	253	num alzheimers disease down syndrome sharing unique cerebrovascular amyloid fibril protein
0.48003986.14645205.html.plaintext.txt	254	num amyloid plaque core protein alzheimer disease syndrome
0.48003986.14645205.html.plaintext.txt	255	num purification ultrastructure chemical analysis alzheimer disease amyloid plaque core protein
0.48003986.14645205.html.plaintext.txt	256	num production alzheimer amyloid s protein normal proteolytic processing
0.48003986.14645205.html.plaintext.txt	257	num amyloid s peptide produced cultured cell normal metabolism
0.48003986.14645205.html.plaintext.txt	258	num beta amyloid num num major component cerebrovascular amyloid deposit implication pathology alzheimer disease
0.48003986.14645205.html.plaintext.txt	259	num mutation s amyloid precursor protein familial alzheimers disease increase s protein production
0.48003986.14645205.html.plaintext.txt	260	num release excess amyloid s protein mutant amyloid s protein precursor
0.48003986.14645205.html.plaintext.txt	261	num mutation associated locus familial alzheimers disease result alternative processing amyloid s protein precursor
0.48003986.14645205.html.plaintext.txt	262	num increased percentage long amyloid s protein secreted familial amyloid s protein precursor ssappnum mutant
0.48003986.14645205.html.plaintext.txt	263	num assembly aggregation property synthetic alzheimers anumss amyloid peptide analog
0.48003986.14645205.html.plaintext.txt	264	num seeding one dimensional crystallization amyloid pathogenic mechanism alzheimers disease scrapie cell num num num
0.48003986.14645205.html.plaintext.txt	265	num visualization assnumnum positive assnum positive senile plaque end specific as monoclonal antibody evidence initially deposited as specie assnum numnum
0.48003986.14645205.html.plaintext.txt	266	num familial alzheimers disease kindred missense mutation gene chromosome num related alzheimers disease type num gene
0.48003986.14645205.html.plaintext.txt	267	num cloning gene bearing missense mutation early onset familial alzheimers disease
0.48003986.14645205.html.plaintext.txt	268	num alzheimers disease associated mutation presenilin num rare variably penetrant
0.48003986.14645205.html.plaintext.txt	269	num evidence level presenilins psnum psnum coordinately regulated competition limiting cellular factor
0.48003986.14645205.html.plaintext.txt	270	num nicastrin modulates presenilin mediated notchglp num signal transduction beta app processing
0.48003986.14645205.html.plaintext.txt	271	num nicastrin required presenilin mediated transmembrane cleavage drosophila
0.48003986.14645205.html.plaintext.txt	272	num presenilin nicastrin regulate determine amyloid beta peptide production via complex formation
0.48003986.14645205.html.plaintext.txt	273	num nicastrin required secretase cleavage drosophila notch receptor
0.48003986.14645205.html.plaintext.txt	274	num mammalian aph num interacts presenilin nicastrin required intramembrane proteolysis app notch
0.48003986.14645205.html.plaintext.txt	275	num drosophila nicastrin essential intramembranous cleavage notch
0.48003986.14645205.html.plaintext.txt	276	num pen num integral component gamma secretase complex required coordinated expression presenilin nicastrin
0.48003986.14645205.html.plaintext.txt	277	num role presenilin cofactor gamma secretase complex
0.48003986.14645205.html.plaintext.txt	278	num pen num aph num coordinately regulate proteolytic processing presenilin num
0.48003986.14645205.html.plaintext.txt	279	num deficiency presenilin num inhibits normal cleavage amyloid precursor protein
0.48003986.14645205.html.plaintext.txt	280	num cell surface presenilin num participates gamma secretase like proteolysis notch
0.48003986.14645205.html.plaintext.txt	281	num presenilin num dependent secretase like protease mediates release notch intracellular domain
0.48003986.14645205.html.plaintext.txt	282	num two transmembrane aspartates presenilin num required presenilin endoproteolysis gamma secretase activity
0.48003986.14645205.html.plaintext.txt	283	num presenilin num differentially facilitates endoproteolysis s amyloid precursor protein notch
0.48003986.14645205.html.plaintext.txt	284	num total inactivation gamma secretase activity presenilin deficient embryonic stem cell
0.48003986.14645205.html.plaintext.txt	285	num presenilins required gamma secretase cleavage beta app transmembrane cleavage notch num
0.48003986.14645205.html.plaintext.txt	286	num presenilin dependent secretase processing s amyloid precursor protein site corresponding snum cleavage notch
0.48003986.14645205.html.plaintext.txt	287	num effect psnum deficiency membrane protein trafficking neuron
0.48003986.14645205.html.plaintext.txt	288	num presenilin num regulates intracellular trafficking cell surface delivery beta amyloid precursor protein
0.48003986.14645205.html.plaintext.txt	289	num secreted amyloid s protein similar senile plaque alzheimers disease increased vivo presenilin num num app mutation linked familial alzheimers disease
0.48003986.14645205.html.plaintext.txt	290	num familial alzheimers disease linked presenilin num variant elevate assnum numnum num ratio vitro vivo
0.48003986.14645205.html.plaintext.txt	291	num mutant presenilins alzheimers disease increase production num residue amyloid s protein transfected cell transgenic mouse
0.48003986.14645205.html.plaintext.txt	292	num presenilin num mutation nnumi linked familial alzheimer disease volga german family increase secretion amyloid s protein ending numnd numrd residue
0.48003986.14645205.html.plaintext.txt	293	num amyloid production deposition mutant amyloid precursor protein presenilin num yeast artificial chromosome transgenic mouse
0.48003986.14645205.html.plaintext.txt	294	num modeling alzheimers disease transgenic mouse effect age presenilin num amyloid biochemistry pathology applondon mouse
0.48003986.14645205.html.plaintext.txt	295	num accumulation proteolytic fragment mutant presenilin num accelerated amyloid deposition co regulated transgenic mouse
0.48003986.14645205.html.plaintext.txt	296	num alzheimer transgenic mouse model come age
0.48003986.14645205.html.plaintext.txt	297	num mutant presenilin num transgenic mouse effect age dependent increase amyloid beta protein num brain
0.48003986.14645205.html.plaintext.txt	298	num accelerated amyloid deposition brain transgenic mouse co expressing mutant presenilin num amyloid precursor protein
0.48003986.14645205.html.plaintext.txt	299	num accelerated alzheimer type phenotype transgenic mouse carrying mutant amyloid precursor protein presenilin num transgene
0.48003986.14645205.html.plaintext.txt	300	num carboxyl terminal fragment alzheimer beta amyloid precursor protein accumulate restricted unpredicted intracellular compartment presenilin num deficient cell
0.48003986.14645205.html.plaintext.txt	301	num transition state analogue inhibitor secretase bind directly presenilin num
0.48003986.14645205.html.plaintext.txt	302	num fad mutation presenilin num amyloid precursor protein decrease efficacy gamma secretase inhibitor evidence direct involvement psnum gamma secretase cleavage complex
0.48003986.14645205.html.plaintext.txt	303	num presenilin num regulates processing beta amyloid precursor protein c terminal fragment generation amyloid beta protein endoplasmic reticulum golgi
0.48003986.14645205.html.plaintext.txt	304	biochemistry num num num
0.48003986.14645205.html.plaintext.txt	305	num vector expressing foreign gene brain heart transgenic mouse
0.48003986.14645205.html.plaintext.txt	306	num mutation alzheimers disease destroying splice acceptor site presenilin num gene
0.48003986.14645205.html.plaintext.txt	307	num co expression multiple transgene mouse cns comparison strategy
0.48003986.14645205.html.plaintext.txt	308	num hyperaccumulation fad linked presenilin num variant vivo
0.48003986.14645205.html.plaintext.txt	309	num hyper expression human apolipoprotein enum astroglia neuron enhance amyloid deposition transgenic mouse
0.48003986.14645205.html.plaintext.txt	310	num age dependent change brain csf plasma amyloid beta protein tgnum transgenic mouse model alzheimers disease
0.48003986.14645205.html.plaintext.txt	311	num variable phenotype alzheimers disease spastic paraparesis
0.48003986.14645205.html.plaintext.txt	312	conum numlinktypedoi crossrefisimedline
0.48003986.14645205.html.plaintext.txt	313	num pathogenic presenilin num deletion cause aberrant abeta num production absence congophilic amyloid plaque
0.48003986.14645205.html.plaintext.txt	314	num variant alzheimers disease wtih spastic paraparaesis unusual plaque due deletion exon num presenilin num
0.48003986.14645205.html.plaintext.txt	315	num identification novel num
0.48003986.14645205.html.plaintext.txt	316	num kb genomic deletion presenilin num gene result exclusion exon num finnish early onset alzheimers disease family alu core sequence stimulated recombination eur
0.48003986.14645205.html.plaintext.txt	317	num case alzheimers disease due deletion exon num presenilin num gene show unusual characteristic beta amyloid pathology known cotton wool plaque
0.48003986.14645205.html.plaintext.txt	318	num increased as numnum plaque depostion early onset familial alzheimers disease brain deletion exon num missense point mutation hnumr p num gene
0.48003986.14645205.html.plaintext.txt	319	jr num carboxy terminus s amyloid protein critical seeding amyloid formation implication pathogenesis alzheimers disease
0.48003986.14645205.html.plaintext.txt	320	biochemistry num num num
0.48003986.14645205.html.plaintext.txt	321	jr num amyloid fibril formation requires chemically discriminating nucleation event study amyloidogenic sequence bacterial protein osmb
0.48003986.14645205.html.plaintext.txt	322	biochemistry num num num
0.48003986.14645205.html.plaintext.txt	323	num variant alzheimers disease spastic paraparesis cotton wool plaque caused p num mutation lead exceptionally high amyloid beta concentration
0.48003986.14645205.html.plaintext.txt	324	conum flinktypedoi crossrefisimedline
0.48003986.14645205.html.plaintext.txt	325	num substrate based difluoro ketone selectively inhibits alzheimers secretase activity
0.48003986.14645205.html.plaintext.txt	326	num photoactivated secretase inhibitor directed active site convalently label presenilin num
0.48003986.14645205.html.plaintext.txt	327	num presenilin num num molecular target gamma secretase inhibitor
0.48003986.14645205.html.plaintext.txt	328	num app processing synaptic function
0.48003986.14645205.html.plaintext.txt	329	num evidence production release amyloid s protein involves endocytic pathway
0.48003986.14645205.html.plaintext.txt	330	num multiple effect aspartate mutant presenilin num processing trafficking amyloid precursor protein
0.48003986.14645205.html.plaintext.txt	331	num presenilin num affect trafficking processing betaapp targeted complex nicastrin plasma membrane
0.48003986.14645205.html.plaintext.txt	332	num role presenilin num regulating delivery amyloid precursor protein cell surface
0.48003986.14645205.html.plaintext.txt	333	num amyloid s protein as alzheimers disease brain
0.48003986.14645205.html.plaintext.txt	334	num comparative study modified bielschowsky bodian thioflavin stain alzheimers neurofibrillary tangle
0.48003986.14645205.html.plaintext.txt	335	num alzheimers neurofibrillary change
0.48003986.14645205.html.plaintext.txt	336	num enhanced amyloidogenic processing s amyloid precursor protein gene targeted mouse bearing swedish familial alzheimers disease mutation humanized as sequence
0.48003986.14645205.html.plaintext.txt	337	num expression ubiquitous cross reactive homologue mouse s amyloid precursor protein app
0.48230362.12966028.html.plaintext.txt	0	intramembrane cleaving aspartic protease disease presenilins signal peptide peptidase homologs bruno martoglionum todd e
0.48230362.12966028.html.plaintext.txt	1	numinstitute biochemistry swiss federal institute technology eth eth hoenggerberg num zurich switzerland numdepartment neuroscience mayo graduate school mayo clinic jacksonville jacksonville fl num usa
0.48230362.12966028.html.plaintext.txt	2	received june num num accepted august num num
0.48230362.12966028.html.plaintext.txt	3	three family protease carry intramembrane proteolysis recognized numnum
0.48230362.12966028.html.plaintext.txt	4	though exact catalytic mechanism remain elusive evidence active site protease could lie within plane lipid bilayer protease within family may utilize conserved catalytic mechanism analogous found classic protease
0.48230362.12966028.html.plaintext.txt	5	first family whose prototypic member human site two protease snump cleaves activates sterol regulatory element binding protein srebps appears group metalloproteases num
0.48230362.12966028.html.plaintext.txt	6	second family rhomboid whose prototypic member drosophila rhomboid num cleaves liberates several egf ligand appears group serine protease num
0.48230362.12966028.html.plaintext.txt	7	third family whose prototypic member presenilins ps involved cleavage amyloid s protein precursor app notch appears group aspartic protease numnum
0.48230362.12966028.html.plaintext.txt	8	collectively protease referred intramembrane cleaving protease clip
0.48230362.12966028.html.plaintext.txt	9	several reason great deal attention focused aspartic clip family
0.48230362.12966028.html.plaintext.txt	10	first prototypic member family human ps therapeutic target alzheimers disease ad
0.48230362.12966028.html.plaintext.txt	11	second new member family signal peptide peptidase spp recently identified shown unequivocally posse proteolytic activity biological function may also make therapeutic target
0.48230362.12966028.html.plaintext.txt	12	herein discus recent advance respect presenilinsignal peptide peptidase family clip
0.48230362.12966028.html.plaintext.txt	13	despite evidence mutation ps altered secretase activity generated as one readily endorsed idea ps secretase
0.48230362.12966028.html.plaintext.txt	14	ps bear homology classic protease thus proposed ps influenced secretase activity indirectly
0.48230362.12966028.html.plaintext.txt	15	past year genetic biochemical evidence emerged demonstrating ps fact secretase
0.48230362.12966028.html.plaintext.txt	16	knockout study psnum psnum demonstrated essential role protein secretase cleavage
0.48230362.12966028.html.plaintext.txt	17	psnum knockout decreased secretase activity num psnum knockout little effect combined psnum psnum knockout abolished secretase activity num num
0.48230362.12966028.html.plaintext.txt	18	biochemical study showed psnum co fractionates secretase activity high molecular weight complex vitro activity could recovered pellet immunoprecipitation antibody psnum num
0.48230362.12966028.html.plaintext.txt	19	significantly mutation conserved aspartate residue dnum dnum psnum dnum dnum psnum present two adjacent transmembrane region produced dominant negative form p inhibited secretase activity cell num
0.48230362.12966028.html.plaintext.txt	20	study together inhibitor study suggested ps might aspartic type protease num
0.48230362.12966028.html.plaintext.txt	21	finally inhibitor secretase activity shown directly target psnum psnum num num
0.48230362.12966028.html.plaintext.txt	22	moreover given two group specifically designed inhibitor transition state analog aspartic protease numnum certainly appears despite lack demonstrable homology known aspartic protease p may
0.48230362.12966028.html.plaintext.txt	23	recent insight component high molecular weight complex contains secretase activity ps offer complete picture secretase
0.48230362.12966028.html.plaintext.txt	24	three additional protein required secretase activity cell
0.48230362.12966028.html.plaintext.txt	25	nicastrin nct aph num num kda type membrane protein originally purified complex num
0.48230362.12966028.html.plaintext.txt	26	two additional protein aph num another integral membrane protein num kda multiple transmembrane region pen num small hairpin like protein num kda initially isolated genetic screen caenorhabditis elegans num
0.48230362.12966028.html.plaintext.txt	27	together p three component appear comprise minimal functional secretase complex num num
0.48230362.12966028.html.plaintext.txt	28	although precise function subunit yet definitively established appears ps catalytic component nct aph num pen num play various role stabilization maturation complex
0.48230362.12966028.html.plaintext.txt	29	also possible accessory protein involved substrate presentation
0.48230362.12966028.html.plaintext.txt	30	biological activity secretase ps extensively reviewed numnum
0.48230362.12966028.html.plaintext.txt	31	although activity ps distinct protease activity e
0.48230362.12966028.html.plaintext.txt	32	stabilization s catenin many
0.48230362.12966028.html.plaintext.txt	33	secretase activity regulates notch app signaling promoting release cytoplasmic tail membrane bound fragment precursor
0.48230362.12966028.html.plaintext.txt	34	clear whether release small peptide as exoplasmic space demonstrable physiologic function
0.48230362.12966028.html.plaintext.txt	35	also clear whether secretase cleavage substrate notch app physiologic function
0.48230362.12966028.html.plaintext.txt	36	possible secretase cleavage certain substrate may simply mechanism breakdown protein
0.48230362.12966028.html.plaintext.txt	37	current list secretase substrate cleavage product putative function listed table num
0.48230362.12966028.html.plaintext.txt	38	role spp cell function poorly understood
0.48230362.12966028.html.plaintext.txt	39	spp substrate identified date represent variety signal peptide viral protein table num num num
0.48230362.12966028.html.plaintext.txt	40	unequivocally demonstrate role spp either degradation signal peptide may otherwise accumulate er membrane activation signaling regulatory molecule
0.48230362.12966028.html.plaintext.txt	41	potential orthologs spp found genome animal plant fungi bacteria numnum
0.48230362.12966028.html.plaintext.txt	42	therefore prime role spp may necessarily clearance membrane signal peptide produced organism basic mechanism may exist fulfil function
0.48230362.12966028.html.plaintext.txt	43	may thus speculate spp analogy clip may promote liberation bioactive peptide protein er membrane
0.48230362.12966028.html.plaintext.txt	44	generation hla e epitope human represents first example spp dependent production bioactive peptide case function reporter
0.48230362.12966028.html.plaintext.txt	45	hla e epitope play key role immune surveillance produced signal sequence antigen presenting mhc class molecule process depends spp num
0.48230362.12966028.html.plaintext.txt	46	epitope eventually presented cell surface cell recognized natural killer nk cell immune system
0.48230362.12966028.html.plaintext.txt	47	presentation signal peptide derived epitope indirect indication probed cell healthy properly synthesized mhc class molecule
0.48230362.12966028.html.plaintext.txt	48	epitope presentation defective otherwise disturbed e
0.48230362.12966028.html.plaintext.txt	49	due virus infection transformation tumor cell impaired cell thought recognized eliminated nk cell num
0.48230362.12966028.html.plaintext.txt	50	spp substrate substrate spectrum spp may restricted classic signal peptide typically short nhnum terminal extension precursor protein
0.48230362.12966028.html.plaintext.txt	51	finding spp exploited hepatitis c virus hcv processing viral core protein implies protease may also catalyse intramembrane cleavage membrane anchored protein similar clip num
0.48230362.12966028.html.plaintext.txt	52	biosynthesis viral protein hcv infected cell immature hcv core protein transiently anchored er membrane via cooh terminal signal peptide like sequence
0.48230362.12966028.html.plaintext.txt	53	intramembrane proteolysis spp promotes final processing core protein release er membrane cytosol
0.48230362.12966028.html.plaintext.txt	54	likewise may speculate protein anchored er membrane signal peptide like sequence may liberated er membrane activated upon cleavage spp
0.48230362.12966028.html.plaintext.txt	55	p psh family member another common feature one typical many clip p spp activity appear require prior cleavage substrate remove ectodomain
0.48230362.12966028.html.plaintext.txt	56	spp substrate first cleaved signal peptidase num whereas p secretase substrate first cleaved shedding protease e
0.48230362.12966028.html.plaintext.txt	57	adam family member s secretase num num
0.48230362.12966028.html.plaintext.txt	58	case studied date initial cleavage essential intramembrane cut occur
0.48230362.12966028.html.plaintext.txt	59	thus substrate specificity p secretase spp may determined much priming cleavage respective substrate sequence
0.48230362.12966028.html.plaintext.txt	60	one striking difference ps spp apparent opposite positioning active site motif containing transmembrane region within plane membrane numnum
0.48230362.12966028.html.plaintext.txt	61	positioning correlate opposite orientation respective substrate
0.48230362.12966028.html.plaintext.txt	62	p substrate type membrane topology cooh terminus facing cytosol whereas spp substrate type ii topology nhnum terminus facing cytosol
0.48230362.12966028.html.plaintext.txt	63	thus appears related protease inversed proteolytic domain evolved cleavage membrane spanning peptide different topology
0.48230362.12966028.html.plaintext.txt	64	despite common feature major difference ps spp
0.48230362.12966028.html.plaintext.txt	65	reconstitution human spp yeast saccharomyces cerevisiae express orthologous signal peptide peptidase suggested human spp require additional protein activity num
0.48230362.12966028.html.plaintext.txt	66	contrast ps appear require least three additional protein partner activity
0.48230362.12966028.html.plaintext.txt	67	ps undergo endoproteolytic activation may depend component together additional protein form active secretase complex
0.48230362.12966028.html.plaintext.txt	68	activation complex formation may provide mean control protease intramembrane cleaving activity regulate substrate delivery andor trafficking intracellular site action
0.48230362.12966028.html.plaintext.txt	69	case spp indication endoproteolysis another activation step
0.48230362.12966028.html.plaintext.txt	70	nevertheless activity almost certainly regulated fashion spp appear randomly attack membrane protein er
0.48230362.12966028.html.plaintext.txt	71	rather protease activity property substrate may account controlled proteolysis spp num
0.48230362.12966028.html.plaintext.txt	72	view larger version numk figure num
0.48230362.12966028.html.plaintext.txt	73	possible model cleavage clip
0.48230362.12966028.html.plaintext.txt	74	several model presented could permit water access active site
0.48230362.12966028.html.plaintext.txt	75	clip may form shallow deep hydrophilic pocket membrane
0.48230362.12966028.html.plaintext.txt	76	would allow access water catalytic residue indicated two star
0.48230362.12966028.html.plaintext.txt	77	pocket may form upon conformational change induced binding substrate
0.48230362.12966028.html.plaintext.txt	78	b two unit clip may act dimer carry cleavage
0.48230362.12966028.html.plaintext.txt	79	case substrate binding one clip unit may induce conformational change formation pore containing merged active site
0.48230362.12966028.html.plaintext.txt	80	footnote correspondence addressed bruno martoglio tel num num fax num num email bruno
0.48230362.12966028.html.plaintext.txt	81	ch u d todd e
0.48230362.12966028.html.plaintext.txt	82	golde tel num num fax num num email tgoldeatmayo
0.48230362.12966028.html.plaintext.txt	83	num physiologic pathologic event mediated intramembranous juxtamembranous proteolysis
0.48230362.12966028.html.plaintext.txt	84	num complementation cloning snump gene encoding putative metalloprotease required intramembrane cleavage srebps
0.48230362.12966028.html.plaintext.txt	85	num drosophila rhomboid num defines family putative intramembrane serine protease
0.48230362.12966028.html.plaintext.txt	86	num two transmembrane aspartates presenilin num required presenilin endoproteolysis gamma secretase activity
0.48230362.12966028.html.plaintext.txt	87	num presenilin num dependent gamma secretase like protease mediates release notch intracellular domain
0.48230362.12966028.html.plaintext.txt	88	num candidate gene chromsome num familial alzheimers disease locus
0.48230362.12966028.html.plaintext.txt	89	num cloning gene bearing missense mutation early onset familial alzheimers disease
0.48230362.12966028.html.plaintext.txt	90	num endoproteolysis presenilin num accumulation processed derivative vivo
0.48230362.12966028.html.plaintext.txt	91	num presenilin num protein component high molecular weight intracellular complex contains beta catenin
0.48230362.12966028.html.plaintext.txt	92	num alzheimers disease gene protein therapy
0.48230362.12966028.html.plaintext.txt	93	num secreted amyloid beta protein similar senile plaque alzheimers disease increased vivo presenilin num num app mutation linked familial alzheimers disease see comment
0.48230362.12966028.html.plaintext.txt	94	num profile soluble amyloid beta protein cultured cell medium
0.48230362.12966028.html.plaintext.txt	95	detection quantification amyloid beta protein variant immunoprecipitation mass spectrometry
0.48230362.12966028.html.plaintext.txt	96	num accelerated alzheimer type phenotype transgenic mouse carrying mutant amyloid precursor protein presenilin num transgene
0.48230362.12966028.html.plaintext.txt	97	num deficiency presenilin num inhibits normal cleavage amyloid precursor protein see comment
0.48230362.12966028.html.plaintext.txt	98	num total inactivation gamma secretase activity presenilin deficient embryonic stem cell
0.48230362.12966028.html.plaintext.txt	99	num presenilin num deficiency cause mild pulmonary phenotype change amyloid precursor protein processing enhances embryonic lethal phenotype presenilin num deficiency
0.48230362.12966028.html.plaintext.txt	100	num presenilins required gamma secretase cleavage beta app transmembrane cleavage notch num
0.48230362.12966028.html.plaintext.txt	101	num presenilin num linked gamma secretase activity detergent solubilized state
0.48230362.12966028.html.plaintext.txt	102	num peptidomimetic probe molecular modeling suggest alzheimers gamma secretase intramembrane cleaving aspartyl protease
0.48230362.12966028.html.plaintext.txt	103	biochemistry num num num
0.48230362.12966028.html.plaintext.txt	104	num transition state analogue inhibitor gamma secretase bind directly presenilin num
0.48230362.12966028.html.plaintext.txt	105	num photoactivated gamma secretase inhibitor directed active site covalently label presenilin num
0.48230362.12966028.html.plaintext.txt	106	num presenilin num num molecular target gamma secretase inhibitor
0.48230362.12966028.html.plaintext.txt	107	num aspartyl protease inhibitor pepstatin bind presenilins alzheimers disease
0.48230362.12966028.html.plaintext.txt	108	biochemistry num num num
0.48230362.12966028.html.plaintext.txt	109	num nicastrin modulates presenilin mediated notchglp num signal transduction betaapp processing
0.48230362.12966028.html.plaintext.txt	110	num aph num pen num required notch pathway signaling gamma secretase cleavage betaapp presenilin protein accumulation
0.48230362.12966028.html.plaintext.txt	111	num reconstitution gamma secretase activity
0.48230362.12966028.html.plaintext.txt	112	num role presenilin cofactor gamma secretase complex
0.48230362.12966028.html.plaintext.txt	113	num gamma secretase membrane protein complex comprised presenilin nicastrin aph num pen num
0.48230362.12966028.html.plaintext.txt	114	num aph num pen num nicastrin presenilin generate active gamma secretase complex
0.48230362.12966028.html.plaintext.txt	115	num identification signal peptide peptidase presenilin type aspartic protease
0.48230362.12966028.html.plaintext.txt	116	num release signal peptide fragment cytosol requires cleavage transmembrane region protease activity specifically blocked novel cysteine protease inhibitor
0.48230362.12966028.html.plaintext.txt	117	num requirement signal peptide peptidase catalyzed intramembrane proteolysis
0.48230362.12966028.html.plaintext.txt	118	num intramembrane proteolysis promotes trafficking hepatitis c virus core protein lipid droplet
0.48230362.12966028.html.plaintext.txt	119	num identification novel family presenilin homologues
0.48230362.12966028.html.plaintext.txt	120	num intramembrane proteolysis signal peptide essential step generation hla e epitope
0.48230362.12966028.html.plaintext.txt	121	num multiple interaction natural killer workshop
0.48230362.12966028.html.plaintext.txt	122	num targeting presenilin type aspartic protease signal peptide peptidase gamma secretase inhibitor
0.48230362.12966028.html.plaintext.txt	123	num evidence tumor necrosis factor alpha converting enzyme involved regulated alpha secretase cleavage alzheimer amyloid protein precursor
0.48230362.12966028.html.plaintext.txt	124	num secretion s amyloid precursor protein cleaved amino terminus s amyloid peptide
0.48230362.12966028.html.plaintext.txt	125	num constitutive regulated alpha secretase cleavage alzheimers amyloid precursor protein disintegrin metalloprotease
0.48230362.12966028.html.plaintext.txt	126	num protein topology presenilin num
0.48230362.12966028.html.plaintext.txt	127	num novel class polytopic protein domain associated putative protease activity
0.48230362.12966028.html.plaintext.txt	128	biochemistry mosc num num num
0.48230362.12966028.html.plaintext.txt	129	num pa domain protease associated domain
0.49538547.12930775.html.plaintext.txt	0	presenilins required formation comma shaped body nephrogenesis pei wangnumnum fred
0.49538547.12930775.html.plaintext.txt	1	pereiranumnumnum duane beasleynum hui zhengnumnumnum
0.49538547.12930775.html.plaintext.txt	2	num huffington center aging baylor college medicine houston tx num usa num department molecular cellular biology baylor college medicine houston tx num usa num department otolaryngology baylor college medicine houston tx num usa num department molecular human genetics baylor college medicine houston tx num usa
0.49538547.12930775.html.plaintext.txt	3	author correspondence e mail huizatbcm
0.49538547.12930775.html.plaintext.txt	4	key word presenilin notch kidney nephrogenesis patterning proximal tubule
0.49538547.12930775.html.plaintext.txt	5	organogenesis highly regulated developmental program involving cell fate decision pattern formation differentiation
0.49538547.12930775.html.plaintext.txt	6	mammal organogenesis initiate body ax established
0.49538547.12930775.html.plaintext.txt	7	kidney organogenesis mouse begin enum involves reciprocal inductive interaction ureteric bud epithelium metanephric mesenchyme
0.49538547.12930775.html.plaintext.txt	8	tip ureteric bud induce nephrogenic mesenchyme form condensate followed pretubular aggregate undergo mesenchyme epithelium transition met progress polarized epithelium renal vesicle comma shaped body saxen num
0.49538547.12930775.html.plaintext.txt	9	morphogenesis patterning epithelial structure lead formation distal proximal tubule glomerulus latter consists podocytes mesangial cell endothelial cell saxen num
0.49538547.12930775.html.plaintext.txt	10	number ductal mesenchymal derived molecule identified loss function study established crucial role nephrogenesis httpgolgi
0.49538547.12930775.html.plaintext.txt	11	relevant study ret expressed tip newly formed branch ureteric bud crucial inductive interaction binding ligand gdnf resides condensing mesenchyme moore et al
0.49538547.12930775.html.plaintext.txt	12	paired box gene paxnum paxnum expressed various mesenchymal derivative ureteric bud epithelium dressler et al
0.49538547.12930775.html.plaintext.txt	13	num rothenpieler dressler num together regulate define nephric lineage bouchard et al
0.49538547.12930775.html.plaintext.txt	14	wntnum documented essential signaling molecule metanephric mesenchyme mesenchymal epithelial cell conversion kispert et al
0.49538547.12930775.html.plaintext.txt	15	wtnum expressed uninduced mesenchyme podocyte precursor cell shaped body mature glomerulus
0.49538547.12930775.html.plaintext.txt	16	required earliest phase kidney formation armstrong et al
0.49538547.12930775.html.plaintext.txt	17	winged helix transcription factor bfnum specifically expressed interstitial stromal mesenchyme shown modulate transition condensed mesenchyme tubular epithelium hatini et al
0.49538547.12930775.html.plaintext.txt	18	notch pathway implicated kidney development
0.49538547.12930775.html.plaintext.txt	19	specifically notchnum notchnum ligand delta likenum dllnum jagnum expressed maturing nephron glomerulus beckers et al
0.49538547.12930775.html.plaintext.txt	20	xenopus pronephros notch signaling proposed involved early determination duct versus tubule fate well controlling tubule patterning mclaughlin et al
0.49538547.12930775.html.plaintext.txt	21	furthermore mouse hypomorphic expression notchnum exhibit kidney glomerulogenesis defect mccright et al
0.49538547.12930775.html.plaintext.txt	22	reported earlier restricted expression human psennum transgene developing brain vertebralspinal column driven human thy num promoter could rescue psennum null patterning defect lethal phenotype qian et al
0.49538547.12930775.html.plaintext.txt	23	bypass early lethality psen null embryo bred transgene onto psennum psennum double knockout background
0.49538547.12930775.html.plaintext.txt	24	showed expression human psennum transgene supported survival psen null embryo perinatal stage
0.49538547.12930775.html.plaintext.txt	25	however loss presenilins resulted profound nephrogenesis defect prior development comma shaped body
0.49538547.12930775.html.plaintext.txt	26	provide evidence presenilins play important role probably notch signaling pathway patterning renal epithelial structure
0.49538547.12930775.html.plaintext.txt	27	view larger version numk fig
0.49538547.12930775.html.plaintext.txt	28	generation morphological biochemical characterization presenilin rescue mouse
0.49538547.12930775.html.plaintext.txt	29	mouse carrying single copy human psennum transgene onto endogenous mouse psennum psennum double knockout psennum psennum psennum presenilin rescue background produced three generation breeding outlined
0.49538547.12930775.html.plaintext.txt	30	b whole mount photograph presenilin rescue embryo mutant along littermates control enum
0.49538547.12930775.html.plaintext.txt	31	c dramatically reduced kidney size presenilin rescue mutant compared littermate control control
0.49538547.12930775.html.plaintext.txt	32	d western blot analysis psennum expression pnum kidney control lane num num presenilin rescue mutant lane num psennum null lane num documenting absence psennum expression presenilin rescue kidney
0.49538547.12930775.html.plaintext.txt	33	lower panel hybridization anti s actin antibody loading control
0.49538547.12930775.html.plaintext.txt	34	embryonic histology embryo dissected fixed num neutral buffered formalin sigma num num hour dehydrated graded alcohol stored num ethanol num degree c
0.49538547.12930775.html.plaintext.txt	35	embryo vacuum embedded paraffin wax sectioned num microm stained hematoxylin eosin
0.49538547.12930775.html.plaintext.txt	36	situ hybridization situ hybridization carried using digoxigenin labeled numsutp labeled antisense riboprobes
0.49538547.12930775.html.plaintext.txt	37	sample fixed num neutral buffered formalin embedded paraffin wax
0.49538547.12930775.html.plaintext.txt	38	section cut num microm radioactive probe num microm nonradioactive probe
0.49538547.12930775.html.plaintext.txt	39	protocol used radioactive situ essentially published qiu et al
0.49538547.12930775.html.plaintext.txt	40	non radioactive situ modified protocol wilkinson employed wilkinson num
0.49538547.12930775.html.plaintext.txt	41	brief section dewaxed dehydrated fixed num paraformaldehyde pfa num minute room temperature
0.49538547.12930775.html.plaintext.txt	42	washing pb section treated proteinase k num microgml num minute refixed pfa washed pb
0.49538547.12930775.html.plaintext.txt	43	sample acetylated num minute washed hybridized num formamide num mm tris hcl ph num
0.49538547.12930775.html.plaintext.txt	44	num num microgml trna numxdenhardts solution num dextran sulfate num mm nacl num mm naponum ph num
0.49538547.12930775.html.plaintext.txt	45	num num mm edta num ng probeslide overnight num degree c humidified chamber
0.49538547.12930775.html.plaintext.txt	46	section washed num minute num
0.49538547.12930775.html.plaintext.txt	47	numxsscnum formamide num degree c followed treatment rnase num minute num degree c washed num minute num
0.49538547.12930775.html.plaintext.txt	48	numxsscnum formamide num degree c
0.49538547.12930775.html.plaintext.txt	49	section blocked blocking solution num mm maleic acid num mm nacl num boehringer blocking agent num hour room temperature incubated alkaline phosphatase conjugated sheep polyclonal antidigoxigenin antibody roche diluted numnum tb buffer overnight num degree c
0.49538547.12930775.html.plaintext.txt	50	washing twice tb alkaline phosphatase activity detected presence nbtbcip roche
0.49538547.12930775.html.plaintext.txt	51	immunohistochemical staining psen null littermate control kidney dissected various developmental stage specified figure legend
0.49538547.12930775.html.plaintext.txt	52	immunohistochemical staining performed frozen laminin num gift d
0.49538547.12930775.html.plaintext.txt	53	abrahamson paraffin fixed section others
0.49538547.12930775.html.plaintext.txt	54	section blocked num goat serum incubated primary antibody num degree c overnight washed pb incubated numnum alexa fluor num alexa fluor num conjugated secondary antibody molecular probe num hour room temperature washed pb mounted glycerolpbs
0.49538547.12930775.html.plaintext.txt	55	digital image obtained zeiss microscope axioskop num
0.49538547.12930775.html.plaintext.txt	56	primary antibody used laminin sigma lnum e cadherin signal transduction cnum wtnum santa cruz scnum cleaved notchnum valnum cell signaling num cleaved caspase num aspnum cell signaling num
0.49538547.12930775.html.plaintext.txt	57	ncam monoclonal antibody developed
0.49538547.12930775.html.plaintext.txt	58	jessell tromanum monoclonal antibody developed p
0.49538547.12930775.html.plaintext.txt	59	brulet obtained developmental study hybridoma bank
0.49538547.12930775.html.plaintext.txt	60	embryonic proliferation apoptosis antibody phosphorylated histone hnum upstate biochemicals used detect mitotic cell wei et al
0.49538547.12930775.html.plaintext.txt	61	tunel assay performed described gavrieli et al
0.49538547.12930775.html.plaintext.txt	62	section stained methyl green identify nucleated cell
0.49538547.12930775.html.plaintext.txt	63	four hundred num cell per section counted proportion mitotic apoptotic cell determined fraction total number nucleated cell four kidneysstagegenotype five sectionskidney counted
0.49538547.12930775.html.plaintext.txt	64	kidney organ culture immunohistochemistry embryonic day num
0.49538547.12930775.html.plaintext.txt	65	num kidney isolated cultured memfnum containing num fetal bovine serum millicell culture plate insert millipore mediumgas interface num day
0.49538547.12930775.html.plaintext.txt	66	kidney fixed num paraformaldehyde num minute num methanol num minute washed pbst phosphate buffered saline num
0.49538547.12930775.html.plaintext.txt	67	stained whole mount anti pan cytokeratin sigma cnum wtnum santa cruz scnum antibody num degree c overnight washed pb incubated numnum alexa fluor num alexa fluor num conjugated secondary antibody molecular probe num hour room temperature washed pb mounted glycerolpbs viewed zeiss confocal microscope lsmnum
0.49538547.12930775.html.plaintext.txt	68	reported earlier expression psennum transgene able rescue somite patterning defect psennum null mouse qian et al
0.49538547.12930775.html.plaintext.txt	69	similarly transgene expression restored somite structure completely absent psen null embryo fig
0.49538547.12930775.html.plaintext.txt	70	presenilin rescue mutant indistinguishable compared littermate control prior enum
0.49538547.12930775.html.plaintext.txt	71	num mutant overtly similar littermates although slightly smaller size difference became dramatic time fig
0.49538547.12930775.html.plaintext.txt	72	mutant could unambiguously identified eye lacked pigmentation phenotype subject separate study
0.49538547.12930775.html.plaintext.txt	73	presenilin rescue mutant died within num hour birth
0.49538547.12930775.html.plaintext.txt	74	examination organ revealed pnum kidney dramatically smaller littermate control fig
0.49538547.12930775.html.plaintext.txt	75	numc suggesting defect kidney development
0.49538547.12930775.html.plaintext.txt	76	western blot analysis showed psennum protein could readily detected control kidney fig
0.49538547.12930775.html.plaintext.txt	77	however detectable psennum psennum psennum rescue mutant fig
0.49538547.12930775.html.plaintext.txt	78	numd lane num suggests defect due loss presenilins mutant kidney herein referred psen null
0.49538547.12930775.html.plaintext.txt	79	histological analysis various stage kidney development revealed enum
0.49538547.12930775.html.plaintext.txt	80	num ureteric bud readily identified surrounded condensed mesenchyme control psen null kidney fig
0.49538547.12930775.html.plaintext.txt	81	result suggests inductive interaction ureteric bud epithelium metanephric mesenchyme proceeded normally absence presenilins
0.49538547.12930775.html.plaintext.txt	82	num kidney development advanced control evidenced appearance pretubular aggregatesrenal vesicle distinguished upon analysis see fig
0.49538547.12930775.html.plaintext.txt	83	num comma shaped body fig
0.49538547.12930775.html.plaintext.txt	84	numc thin arrow arrowhead respectively pretubular aggregatesrenal vesicle fig
0.49538547.12930775.html.plaintext.txt	85	numd thin arrow could found psen null kidney comma shaped body identified
0.49538547.12930775.html.plaintext.txt	86	result indicates presenilins play critical role progression pretubular aggregatesrenal vesicle towards comma shaped body nephrogenesis
0.49538547.12930775.html.plaintext.txt	87	analysis kidney later stage enum
0.49538547.12930775.html.plaintext.txt	88	num pnum support view mature glomerulus could readily detected control fig
0.49538547.12930775.html.plaintext.txt	89	numeg thick arrow completely absent psen null kidney fig
0.49538547.12930775.html.plaintext.txt	90	kidney defect present another psen rescue line num num data shown therefore conclude phenotype result loss presenilin expression rather transgene integration
0.49538547.12930775.html.plaintext.txt	91	view larger version numk fig
0.49538547.12930775.html.plaintext.txt	92	hematoxylin eosin analysis kidney development
0.49538547.12930775.html.plaintext.txt	93	right column presenilin null mutant left column littermate control control
0.49538547.12930775.html.plaintext.txt	94	num ab condensed mesenchyme asterisk surrounding ureteric bud could identified psen null mutant b control
0.49538547.12930775.html.plaintext.txt	95	num cd pretubular aggregate arrow could seen control c mutant d advanced structure comma shaped body arrowhead could detected control psen null kidney
0.49538547.12930775.html.plaintext.txt	96	num ef pnum gh numerous glomerulus formed control eg arrow
0.49538547.12930775.html.plaintext.txt	97	structure absent mutant fh
0.49538547.12930775.html.plaintext.txt	98	view larger version numk fig
0.49538547.12930775.html.plaintext.txt	99	immunohistochemical characterization renal derivative
0.49538547.12930775.html.plaintext.txt	100	double staining anti ncam green anti pan laminin red antibody enum
0.49538547.12930775.html.plaintext.txt	101	ncam positive laminin low negative aggregate asterisk ncam laminin positive renal vesicle thin arrow tubule thick arrow present control psen null mutant
0.49538547.12930775.html.plaintext.txt	102	num section labeled anti laminin num antibody identified polarized renal epithelium psen null mutant b thin arrow
0.49538547.12930775.html.plaintext.txt	103	c double staining anti cytokeratin num cknum red ductal anti e cadherin renal ductal green antibody
0.49538547.12930775.html.plaintext.txt	104	ef magnified view highlighted structure cd respectively
0.49538547.12930775.html.plaintext.txt	105	e cadherin positive cytokeratin num negative renal epithelial derivative could identified either close proximity white arrowhead appear connected ureteric bud terminal thick arrow
0.49538547.12930775.html.plaintext.txt	106	open arrowhead ef indicate site fusion
0.49538547.12930775.html.plaintext.txt	107	scale bar part num microm ab c part d c part e num microm c part ef
0.49538547.12930775.html.plaintext.txt	108	analysis inductive interaction kidney organogenesis involves reciprocal inductive interaction ureteric bud epithelium metanephric mesenchyme performed situ hybridization various ductal mesenchymal marker delineate origin defect
0.49538547.12930775.html.plaintext.txt	109	analysis gdnf bmpnum showed molecule expressed psen null kidney similar littermate control data shown suggesting mesenchymal stem cell preserved
0.49538547.12930775.html.plaintext.txt	110	investigate inductive process analyzed expression paxnum paxnum wntnum
0.49538547.12930775.html.plaintext.txt	111	num comparable level paxnum mesenchymal condensate observed psen null kidney control fig
0.49538547.12930775.html.plaintext.txt	112	numa compare b expression paxnum wntnum undetectable regardless genotype stage shown
0.49538547.12930775.html.plaintext.txt	113	numc part b clearly detectable mesenchymal derivative including aggregate arrow psen null kidney
0.49538547.12930775.html.plaintext.txt	114	however reduced expression gene probably attributed lack differentiation comma shaped body dressler et al
0.49538547.12930775.html.plaintext.txt	115	examination molecule enum
0.49538547.12930775.html.plaintext.txt	116	num development yielded similar result data shown
0.49538547.12930775.html.plaintext.txt	117	view larger version numk fig
0.49538547.12930775.html.plaintext.txt	118	situ hybridization analysis paxnum wntnum b paxnum c ret d expression
0.49538547.12930775.html.plaintext.txt	119	c top panel dark field lower panel corresponding bright field
0.49538547.12930775.html.plaintext.txt	120	num level paxnum comparable control ac psen null mutant bd
0.49538547.12930775.html.plaintext.txt	121	num reduced paxnum expression observed mutant fh compared control eg
0.49538547.12930775.html.plaintext.txt	122	also case wntnum b compare b paxnum c compare b
0.49538547.12930775.html.plaintext.txt	123	arrow indicate aggregate structure positive marker
0.49538547.12930775.html.plaintext.txt	124	num ret positive structure similar control psen null mutant b
0.49538547.12930775.html.plaintext.txt	125	num number ret positive tip reduced mutant d compared control c
0.49538547.12930775.html.plaintext.txt	126	scale bar part num microm c d part ab d part c num microm d part cd
0.49538547.12930775.html.plaintext.txt	127	ret mark tip newly formed ureteric bud branch signaling essential inductive interaction pachnis et al
0.49538547.12930775.html.plaintext.txt	128	num ret expression comparable control mutant fig
0.49538547.12930775.html.plaintext.txt	129	numd compare b indicating primary branching affected loss presenilins stage
0.49538547.12930775.html.plaintext.txt	130	impaired nephrogenesis unambiguously documented stage result suggests ureteric bud signaling primary cause defect
0.49538547.12930775.html.plaintext.txt	131	reduced number ret positive tip mutant enum
0.49538547.12930775.html.plaintext.txt	132	numd compare c d would thus probably result impaired secondary tertiary branching morphogenesis later stage
0.49538547.12930775.html.plaintext.txt	133	exclude possible contribution stromal mesenchyme defect evaluated stromal mesenchyme marker bfnum expression level significantly different mutant control data shown
0.49538547.12930775.html.plaintext.txt	134	therefore combined data suggest loss presenilins disrupt early inductive interaction nephrogenic phenotype psen null kidney probably due defect intrinsic mesenchyme
0.49538547.12930775.html.plaintext.txt	135	analysis mesenchymal epithelial cell conversion presence mesenchymal condensate aggregate absence comma shaped body psen null kidney prompted u examine mesenchyme epithelium transition met
0.49538547.12930775.html.plaintext.txt	136	neuronal cell adhesion molecule ncam highly expressed mesenchymal derivative ureteric bud
0.49538547.12930775.html.plaintext.txt	137	ncam positive structure green readily detected control psen null kidney enum
0.49538547.12930775.html.plaintext.txt	138	majority ncam positive structure also positive pan laminin fig
0.49538547.12930775.html.plaintext.txt	139	numa red found basement membrane ductal renal epithelium cho et al
0.49538547.12930775.html.plaintext.txt	140	data suggest mesenchymal derivative competent epithelization
0.49538547.12930775.html.plaintext.txt	141	proper expression laminin chain shown crucial epithelial polarization ekblom et al
0.49538547.12930775.html.plaintext.txt	142	polarized laminin num positive renal vesicle readily identifiable psen null kidney fig
0.49538547.12930775.html.plaintext.txt	143	epithelial nature mesenchymal derivative confirmed positive staining e cadherin present ductal renal epithelium green negative cytokeratin num ductal epithelium red fig
0.49538547.12930775.html.plaintext.txt	144	result establish notion presenilins required met
0.49538547.12930775.html.plaintext.txt	145	analysis nephron patterning detailed examination ncam positive structure revealed multiple type identified including laminin low irregular aggregate fig
0.49538547.12930775.html.plaintext.txt	146	numa asterisk laminin positive organized renal vesicle lumen fig
0.49538547.12930775.html.plaintext.txt	147	numa thin arrow elongated laminin expressing tubule fig
0.49538547.12930775.html.plaintext.txt	148	numa part d thick arrow suggesting pretubular aggregate progressed renal vesicle tubule psen null mutant kidney
0.49538547.12930775.html.plaintext.txt	149	consistent assessment e cadherin positive renal derivative psen null mutant similar littermate control formed immature tubular structure either close proximity fig
0.49538547.12930775.html.plaintext.txt	150	numc part b arrowhead appear connected duct thick arrow d arrowhead f fig
0.49538547.12930775.html.plaintext.txt	151	characteristic suggest formation distal tubule
0.49538547.12930775.html.plaintext.txt	152	however contrast control advanced tubule adjoining glomerular cleft could recognized fig
0.49538547.12930775.html.plaintext.txt	153	numc part e mutant structure failed undergo differentiation patterning
0.49538547.12930775.html.plaintext.txt	154	investigate possible defect proximal tubule development psen null kidney performed staining lotus tetragonolobus lectin ltl specific marker proximal tubule cho et al
0.49538547.12930775.html.plaintext.txt	155	remarkably although control kidney showed strong staining ltl fig
0.49538547.12930775.html.plaintext.txt	156	numa part ac positive staining could detected ltl mutant fig
0.49538547.12930775.html.plaintext.txt	157	immunostaining wtnum highly expressed podocyte precursor cell shaped body mature glomerulus ryan et al
0.49538547.12930775.html.plaintext.txt	158	num revealed complete absence wtnum expression psen null kidney well fig
0.49538547.12930775.html.plaintext.txt	159	thus presenilins absolutely required formation proximal structure including proximal tubule glomerulus
0.49538547.12930775.html.plaintext.txt	160	view larger version numk fig
0.49538547.12930775.html.plaintext.txt	161	analysis proximal derivative
0.49538547.12930775.html.plaintext.txt	162	lotus tetragonolobus lectin ltl staining revealed complete absence mature proximal tubule psen null mutant bd
0.49538547.12930775.html.plaintext.txt	163	cd magnified view highlighted structure ab respectively
0.49538547.12930775.html.plaintext.txt	164	residual positive d probably result background staining blood vessel
0.49538547.12930775.html.plaintext.txt	165	b double staining anti e cadherin green anti wtnum red antibody documented lack wtnum expressing podocyte precursor psen null kidney b
0.49538547.12930775.html.plaintext.txt	166	c whole mount immunostaining kidney organ culture anti pan cytokeratin green anti wtnum red antibody
0.49538547.12930775.html.plaintext.txt	167	cd magnified view highlighted structure ab respectively revealing connection weak cytokeratin positive truncated renal tubule strong cytokeratin positive ureteric bud terminal psen null kidney culture d
0.49538547.12930775.html.plaintext.txt	168	scale bar part ab num microm part cd b num microm c part ab num microm c part cd num microm
0.49538547.12930775.html.plaintext.txt	169	strengthen vivo finding next studied kidney development organ culture
0.49538547.12930775.html.plaintext.txt	170	control psen null kidney dissected enum
0.49538547.12930775.html.plaintext.txt	171	num embryo cultured num day
0.49538547.12930775.html.plaintext.txt	172	whole mount immunostaining anti pan cytokeratin antibody documented significant branching control psen null kidney three day culture fig
0.49538547.12930775.html.plaintext.txt	173	numc consistent notion presenilins exert effect primary branching morphogenesis
0.49538547.12930775.html.plaintext.txt	174	agreement vivo result psen null kidney devoid wtnum fig
0.49538547.12930775.html.plaintext.txt	175	close examination ureteric bud tip showed psen null culture weak pan cytokeratin positive renal tubule formed least appeared fused ureteric bud strongly positive pan cytokeratin fig
0.49538547.12930775.html.plaintext.txt	176	however compared control fig
0.49538547.12930775.html.plaintext.txt	177	numc part c psen null renal derivative truncated negative wtnum expression fig
0.49538547.12930775.html.plaintext.txt	178	similar result also obtained control kidney culture treated presenilin secretase inhibitor data shown
0.49538547.12930775.html.plaintext.txt	179	vitro organ culture experiment thus lend support essential role presenilins patterning differentiation renal epithelial derivative
0.49538547.12930775.html.plaintext.txt	180	effect proliferation apoptosis nephrogenesis analysis cell undergoing active division anti phosphorylated histone hnum antibody showed cell proliferation profile similar mutant kidney control enum
0.49538547.12930775.html.plaintext.txt	181	double staining anti ncam fig
0.49538547.12930775.html.plaintext.txt	182	numa part cd cytokeratin num antibody shown indicated proliferation rate renal ductal derivative respectively also similar
0.49538547.12930775.html.plaintext.txt	183	however rule possibility minor difference cell proliferation renal structure affected tubule growth patterning presenilin mutant
0.49538547.12930775.html.plaintext.txt	184	finding unexpected much mesenchymal derivative required active cell division already formed psen null kidney
0.49538547.12930775.html.plaintext.txt	185	view larger version numk fig
0.49538547.12930775.html.plaintext.txt	186	cell proliferation apoptosis analysis
0.49538547.12930775.html.plaintext.txt	187	left column littermate control right column presenilin null
0.49538547.12930775.html.plaintext.txt	188	anti phosphorylated histone hnum used stain mitotic cell ab
0.49538547.12930775.html.plaintext.txt	189	double staining anti phosphorylated histone hnum red anti ncam green antibody labeled renal derivative undergoing active division cd
0.49538547.12930775.html.plaintext.txt	190	b tunel assay revealed percentage apoptotic cell arrowhead increased dramatically mutant b compared control
0.49538547.12930775.html.plaintext.txt	191	cd double staining anti cleaved caspase num red anti ncam antibody green showed increased apoptosis ncam positive renal derivative arrow well cortical mesenchyme arrowhead
0.49538547.12930775.html.plaintext.txt	192	yellow dot auto fluorescence blood
0.49538547.12930775.html.plaintext.txt	193	measurement apoptosis using tunel assay revealed enum
0.49538547.12930775.html.plaintext.txt	194	num number apoptotic cell low control psen null kidney appreciable difference could identified data shown
0.49538547.12930775.html.plaintext.txt	195	num number apoptotic cell significantly higher psen null kidney compared control fig
0.49538547.12930775.html.plaintext.txt	196	quantitative analysis showed num
0.49538547.12930775.html.plaintext.txt	197	num cell apoptotic control percentage apoptotic cell reached num
0.49538547.12930775.html.plaintext.txt	198	apoptotic cell widespread majority localized peripherial mesenchyme fig
0.49538547.12930775.html.plaintext.txt	199	enhanced general apoptosis would contribute reduced kidney size psen null mutant
0.49538547.12930775.html.plaintext.txt	200	using co immunostaining detect activated form caspase num ncam fig
0.49538547.12930775.html.plaintext.txt	201	numb part cd able evaluate apoptotic profile renal structure
0.49538547.12930775.html.plaintext.txt	202	similar control pretubular aggregate renal vesicle psen null exhibited caspase num activity
0.49538547.12930775.html.plaintext.txt	203	however high caspase num staining observed ncam positive tubular structure psen null kidney fig
0.49538547.12930775.html.plaintext.txt	204	similar tunel staining cortical mesenchyme also showed higher caspase num activation fig
0.49538547.12930775.html.plaintext.txt	205	overall result suggest defective patterning immature distal tubule absence presenilins lead attenuation nephrogenesis enhanced apoptosis
0.49538547.12930775.html.plaintext.txt	206	analysis notch pathway molecule kidney development impaired notch signal transduction considered leading mechanism somite patterning defect psen null mouse assessed expression notch pathway molecule enum
0.49538547.12930775.html.plaintext.txt	207	first examined cell type exhibiting presenilin secretase activity immunostaining antibody recognizes psen cleaved activated form notchnum notch intracellular domain nicd fig
0.49538547.12930775.html.plaintext.txt	208	co staining anti cytokeratin num antibody cknum marked ductal derivative
0.49538547.12930775.html.plaintext.txt	209	nicd expressed background ureteric bud epithelium control psen null sample fig
0.49538547.12930775.html.plaintext.txt	210	control kidney nicd immunoreactivity could detected pretubular aggregatesrenal vesicle fig
0.49538547.12930775.html.plaintext.txt	211	numaa comma shaped body data shown
0.49538547.12930775.html.plaintext.txt	212	psen null kidney devoid nicd although pretubular aggregate present fig
0.49538547.12930775.html.plaintext.txt	213	notch activation correlated expression downstream target hesrnum heynum mouse genome informatics kokubo et al
0.49538547.12930775.html.plaintext.txt	214	contrast hesrnum expression detected psen null mutant fig
0.49538547.12930775.html.plaintext.txt	215	numbb consistent obligatory role presenilins notch processing signaling
0.49538547.12930775.html.plaintext.txt	216	residual signal probably result staining blood vessel also express hesrnum
0.49538547.12930775.html.plaintext.txt	217	result support idea presenilin mediated nephrogenic signal derived mesenchyme presenilin dependent notch activation signaling mechanism operation
0.49538547.12930775.html.plaintext.txt	218	view larger version numk fig
0.49538547.12930775.html.plaintext.txt	219	notch pathway analysis control left psen null right kidney
0.49538547.12930775.html.plaintext.txt	220	immunohistochemical staining presenilin dependent nicd green expression
0.49538547.12930775.html.plaintext.txt	221	ureteric bud marked cytokeratin num cknum red
0.49538547.12930775.html.plaintext.txt	222	b d situ hybridization analysis notch downstream target hesrnum b notch ligand jagnum c dllnum d
0.49538547.12930775.html.plaintext.txt	223	num except c part cd enum
0.49538547.12930775.html.plaintext.txt	224	thin arrow indicate pretubular aggregatesrenal vesicle arrowhead indicate comma shaped body
0.49538547.12930775.html.plaintext.txt	225	scale bar num microm b num microm b d
0.49538547.12930775.html.plaintext.txt	226	next investigated notch ligand jagnum dllnum expression situ hybridization
0.49538547.12930775.html.plaintext.txt	227	num jagnum expressed condensed mesenchyme fig
0.49538547.12930775.html.plaintext.txt	228	numc part ab asterisk expression turned pretubular aggregate psen null kidney control fig
0.49538547.12930775.html.plaintext.txt	229	numc part ab arrow comma shaped body control kidney fig
0.49538547.12930775.html.plaintext.txt	230	num although jagnum strongly expressed control kidney fig
0.49538547.12930775.html.plaintext.txt	231	numc part c arrowhead expression almost undetectable mutant fig
0.49538547.12930775.html.plaintext.txt	232	loss jagnum caused absence mesenchymal derivative ncam positive pretubular aggregate renal vesicle could readily identified psen null stage fig
0.49538547.12930775.html.plaintext.txt	233	therefore result suggests notch signaling required maintenance jagnum expression kidney organogenesis
0.49538547.12930775.html.plaintext.txt	234	situ hybridization analysis another notch ligand dllnum showed contrast jagnum dllnum expressed condensed mesenchyme pretubular aggregate
0.49538547.12930775.html.plaintext.txt	235	dllnum positive staining could seen comma shaped body control kidney fig
0.49538547.12930775.html.plaintext.txt	236	numd part arrowhead dllnum expression could detected psen null stage nephrogenesis fig
0.49538547.12930775.html.plaintext.txt	237	negative staining could attributed lack dll induction caused defective notch signaling absence comma shaped body psen null mutant kidney
0.49538547.12930775.html.plaintext.txt	238	interesting note dllnum expression seems restricted specific region comma shaped body fig
0.49538547.12930775.html.plaintext.txt	239	numd part arrowhead although fate cell clear
0.49538547.12930775.html.plaintext.txt	240	similar nicd hesrnum notch ligand expressed ureteric bud supporting cell autonomous mechanism presenilin dependent notch signaling within mesenchyme
0.49538547.12930775.html.plaintext.txt	241	progression pretubular aggregate comma shaped body requires conversion patterning mesenchymal cell highly organized polarized epithelium
0.49538547.12930775.html.plaintext.txt	242	analysis cell adhesion molecule extracellular matrix protein ncam e cadherin revealed renal vesicle tubular derivative partially formed psen null kidney
0.49538547.12930775.html.plaintext.txt	243	importantly laminin stained renal structure suggesting developed polarized cell basement membrane
0.49538547.12930775.html.plaintext.txt	244	thus presenilins essential mesenchyme epithelium transition
0.49538547.12930775.html.plaintext.txt	245	however despite formation apparent fusion e cadherin positive distal renal tubule structure bud epithelium mature proximal tubule glomerulus completely absent psen null kidney
0.49538547.12930775.html.plaintext.txt	246	conclusion supported negative binding ltl lack expression wtnum respectively
0.49538547.12930775.html.plaintext.txt	247	data conclude presenilins play indispensable role patterning differentiation renal vesicle leading proximal tubule glomerulus
0.49538547.12930775.html.plaintext.txt	248	contrast inductive interaction met current understanding nephron patterning limited
0.49538547.12930775.html.plaintext.txt	249	candidate regulatory mechanism tubule patterning molecule cadherins differentially regulated various renal epithelial compartment cho et al
0.49538547.12930775.html.plaintext.txt	250	however gene knockout study supported clear function molecule nephron patterning dahl et al
0.49538547.12930775.html.plaintext.txt	251	num dressler num mah et al
0.49538547.12930775.html.plaintext.txt	252	presenilins represent one first example molecule play essential role patterning differentiation renal vesicle derivative
0.49538547.12930775.html.plaintext.txt	253	role presenilins notch signaling nephrogenesis presenilins indispensable processing signaling notch
0.49538547.12930775.html.plaintext.txt	254	activity highly conserved likely account role presenilins somite patterning donoviel et al
0.49538547.12930775.html.plaintext.txt	255	analysis showed presenilin secretase activated form notchnum nicd notch downstream target hesrnum ligand dllnum jagnum expressed mesenchymal derivative expression critically impaired psen null kidney
0.49538547.12930775.html.plaintext.txt	256	thus notch pathway particularly signaling notchnum may underlying mediator presenilin activity kidney development
0.49538547.12930775.html.plaintext.txt	257	noteworthy mouse expressing hypomorphic allele notchnum exhibit kidney glomerulogenesis defect mccright et al
0.49538547.12930775.html.plaintext.txt	258	four mammalian notch protein presenilin substrate vitro saxena et al
0.49538547.12930775.html.plaintext.txt	259	num defective notchnum mediated pathway may also account psen null kidney phenotype
0.49538547.12930775.html.plaintext.txt	260	however presence glomerulus notchnum mutant kidney albeit structurally abnormal indicates notchnum function downstream tubule patterning mccright et al
0.49538547.12930775.html.plaintext.txt	261	although essential role presenilins notch signaling well established regulation affect notch ligand expression subject controversy
0.49538547.12930775.html.plaintext.txt	262	support lateral inhibition model loss notch signaling resulting presenilin deficiency lead ectopic overexpression ligand donoviel et al
0.49538547.12930775.html.plaintext.txt	263	num others suggest presenilin mediated notch signaling necessary proper induction ligand takahashi et al
0.49538547.12930775.html.plaintext.txt	264	difference may caused part variation system study ligand expression seems subjected strict temporal spatial cell type specific regulation
0.49538547.12930775.html.plaintext.txt	265	kidney development detailed examination expression pattern jagnum dllnum yielded interesting finding
0.49538547.12930775.html.plaintext.txt	266	num jagnum expressed condensed mesenchyme expression detected pretubular aggregate renal vesicle
0.49538547.12930775.html.plaintext.txt	267	distinct jagnum staining pattern similar control psen null kidney enum
0.49538547.12930775.html.plaintext.txt	268	num suggesting transition condensed mesenchyme pretubular aggregate depend presenilins
0.49538547.12930775.html.plaintext.txt	269	interestingly although pretubular aggregate renal vesicle still exist psen null mutant enum
0.49538547.12930775.html.plaintext.txt	270	data suggest sustained notch activation necessary maintenance jagnum expression nephrogenesis
0.49538547.12930775.html.plaintext.txt	271	num contrast jagnum dllnum message detected pretubular aggregate
0.49538547.12930775.html.plaintext.txt	272	control kidney dllnum expression seems restricted specific region comma shaped body enum
0.49538547.12930775.html.plaintext.txt	273	although origin cell known spatiotemporally restricted expression pattern may imply functional significance
0.49538547.12930775.html.plaintext.txt	274	indeed somite patterning caudally restricted expression dllnum shown important prefiguring somite identity proper dllnum induction requires presenilin dependent notch signaling takahashi et al
0.49538547.12930775.html.plaintext.txt	275	equally possible however absence dllnum expression could also due physical lack comma shaped body psen null kidney
0.49538547.12930775.html.plaintext.txt	276	besides notch app numerous protein reported substrate presenilin dependent proteolysis lammich et al
0.49538547.12930775.html.plaintext.txt	277	although physiological significance clear impaired processing molecule excluded potential mechanism kidney defect
0.49538547.12930775.html.plaintext.txt	278	processing independent mechanism psennum shown interact s catenin facilitate turnover kang et al
0.49538547.12930775.html.plaintext.txt	279	therefore possible deregulation s catenin pathway psen null may contribute kidney phenotype
0.49538547.12930775.html.plaintext.txt	280	wnt pathway implicated inductive phase kidney development dressler num essentially unaffected psen null
0.49538547.12930775.html.plaintext.txt	281	addition created mouse deletion exon num endogenous psennum essential s catenin interaction
0.49538547.12930775.html.plaintext.txt	282	homozygous exon num deleted mouse crossed onto psennum null background viable exhibit kidney defect h
0.49538547.12930775.html.plaintext.txt	283	observation thus argue potential s catenin involvement psen null kidney
0.49538547.12930775.html.plaintext.txt	284	addition kidney patterning defect psennum psennum double null embryo display abnormality noticeably defect heart looping vascular remodeling donoviel et al
0.49538547.12930775.html.plaintext.txt	285	defect apparently corrected human psennum transgene presumably early expression mesoderm relevant cell derivative
0.49538547.12930775.html.plaintext.txt	286	indeed human thy num promoter shown active endothelial cell gordon et al
0.49538547.12930775.html.plaintext.txt	287	num expression hesrnum although absent developing nephron psen null kidney detected blood vessel
0.49538547.12930775.html.plaintext.txt	288	analysis mechanism leading phenotype currently ongoing
0.49538547.12930775.html.plaintext.txt	289	summary using novel presenilin rescue system identified novel function presenilins nephrogenesis
0.49538547.12930775.html.plaintext.txt	290	specifically presenilins indispensable patterning renal epithelial structure form mature proximal tubule glomerulus
0.49538547.12930775.html.plaintext.txt	291	loss presenilins associated failed progression renal vesicle comma shaped body
0.49538547.12930775.html.plaintext.txt	292	molecular level reveal obligatory role presenilins activation notch signaling maintenance notch ligand jagnum expression mesenchymal derivative kidney development
0.49538547.12930775.html.plaintext.txt	293	acknowledgment probe antibody mainly donated r
0.49538547.12930775.html.plaintext.txt	294	johnson dllnum jagnum hesrnum y
0.49538547.12930775.html.plaintext.txt	295	abrahamson anti laminin num antibody
0.49538547.12930775.html.plaintext.txt	296	lewis provided u presenilin secretase inhibitor
0.49538547.12930775.html.plaintext.txt	297	cheng advice nicd immunostaining sharing result prior publication
0.49538547.12930775.html.plaintext.txt	298	yu expert technical support j
0.49538547.12930775.html.plaintext.txt	299	work supported grant nih nsnum agnum alzheimers association iirg num num
0.49538547.12930775.html.plaintext.txt	300	new scholar ellison medical foundation
0.49538547.12930775.html.plaintext.txt	301	expression wilms tumour gene wtnum developing mammalian embryo
0.49538547.12930775.html.plaintext.txt	302	expression mouse deltanum gene organogenesis fetal development
0.49538547.12930775.html.plaintext.txt	303	nephric lineage specification paxnum paxnum
0.49538547.12930775.html.plaintext.txt	304	differential expression function cadherin num renal epithelium development
0.49538547.12930775.html.plaintext.txt	305	notchnum required coordinate segmentation somite
0.49538547.12930775.html.plaintext.txt	306	genetic dissection cadherin function nephrogenesis
0.49538547.12930775.html.plaintext.txt	307	deficiency presenilin num inhibits normal cleavage amyloid precursor protein
0.49538547.12930775.html.plaintext.txt	308	presenilin num dependent gamma secretase like protease mediates release notch intracellular domain
0.49538547.12930775.html.plaintext.txt	309	mouse lacking presenilin gene exhibitearlyembryonic patterningdefects
0.49538547.12930775.html.plaintext.txt	310	paxnum new murine paired box containing gene expression developing excretory system
0.49538547.12930775.html.plaintext.txt	311	deregulation pax num expression transgenic mouse generates severe kidney abnormality
0.49538547.12930775.html.plaintext.txt	312	tubulogenesis developing mammalian kidney
0.49538547.12930775.html.plaintext.txt	313	transient locally restricted expression laminin chain mrna developing epithelial cell kidney organogenesis
0.49538547.12930775.html.plaintext.txt	314	identification programmed cell death situ via specific labeling nuclear dna fragmentation
0.49538547.12930775.html.plaintext.txt	315	regulation thy num gene expression transgenic mouse
0.49538547.12930775.html.plaintext.txt	316	presenilin num regulates neuronal differentiation neurogenesis
0.49538547.12930775.html.plaintext.txt	317	essential role stromal mesenchyme kidney morphogenesis revealed targeted disruption winged helix transcription factor bf num
0.49538547.12930775.html.plaintext.txt	318	presenilin num deficiency cause mild pulmonary phenotype change amyloid precursor protein processing enhances embryonic lethal phenotype presenilin num deficiency
0.49538547.12930775.html.plaintext.txt	319	presenilin couple paired phosphorylation beta catenin independent axin implication beta catenin activation tumorigenesis
0.49538547.12930775.html.plaintext.txt	320	wnt num mesenchymal signal epithelial transformation metanephric mesenchyme developing kidney
0.49538547.12930775.html.plaintext.txt	321	role laminin chain development epithelial cell polarity
0.49538547.12930775.html.plaintext.txt	322	identification expression novel family bhlh cdna related drosophila hairy enhancer split
0.49538547.12930775.html.plaintext.txt	323	notch signaling essential vascular morphogenesis mouse
0.49538547.12930775.html.plaintext.txt	324	wt num required early kidney development
0.49538547.12930775.html.plaintext.txt	325	presenilin dependent intramembrane proteolysis cdnum lead liberation intracellular domain secretion abeta like peptide
0.49538547.12930775.html.plaintext.txt	326	facilitation lin num mediated signalling sel num caenorhabditis elegans snum alzheimers disease gene
0.49538547.12930775.html.plaintext.txt	327	assessment normal mutant human presenilin function caenorhabditis elegans
0.49538547.12930775.html.plaintext.txt	328	kidney development cadherin num mutant delayed mesenchyme epithelial conversion loss nephron
0.49538547.12930775.html.plaintext.txt	329	presenilin numgamma secretase cleavage release e cadherin intracellular domain regulates disassembly adherens junction
0.49538547.12930775.html.plaintext.txt	330	defect development kidney heart eye vasculature mouse homozygous hypomorphic notchnum mutation
0.49538547.12930775.html.plaintext.txt	331	notch regulates cell fate developing pronephros
0.49538547.12930775.html.plaintext.txt	332	renal neuronal abnormality mouse lacking gdnf
0.49538547.12930775.html.plaintext.txt	333	secretase cleavage nuclear localization erbb num receptor tyrosine kinase
0.49538547.12930775.html.plaintext.txt	334	expression c ret proto oncogene mouse embryogenesis
0.49538547.12930775.html.plaintext.txt	335	paxnum murine paired box gene expressed developing excretory system thyroid gland
0.49538547.12930775.html.plaintext.txt	336	mutant human presenilin num protects presenilin num null mouse embryonic lethality elevates abetanum numnum expression
0.49538547.12930775.html.plaintext.txt	337	spatiotemporal expression pattern chicken ovalbumin upstream promoter transcription factor developing mouse central nervous system evidence role segmental patterning diencephalon
0.49538547.12930775.html.plaintext.txt	338	pax num required mesenchyme epithelium conversion kidney development
0.49538547.12930775.html.plaintext.txt	339	repression pax num wtnum normal kidney development
0.49538547.12930775.html.plaintext.txt	340	cambridge uk cambridge university press
0.49538547.12930775.html.plaintext.txt	341	murine notch homologs nnum num undergo presenilin dependent proteolysis
0.49538547.12930775.html.plaintext.txt	342	defect kidney enteric nervous system mouse lacking tyrosine kinase receptor ret
0.49538547.12930775.html.plaintext.txt	343	cell biology beta amyloid precursor protein presenilin alzheimers disease
0.49538547.12930775.html.plaintext.txt	344	skeletal cns defect presenilin num deficient mouse
0.49538547.12930775.html.plaintext.txt	345	epithelial transformation metanephric mesenchyme developing kidney regulated wnt num
0.49538547.12930775.html.plaintext.txt	346	presenilin required activity nuclear access notch drosophila
0.49538547.12930775.html.plaintext.txt	347	mespnum initiate somite segmentation notch signalling pathway
0.49538547.12930775.html.plaintext.txt	348	phosphorylation histone hnum required proper chromosome condensation segregation
0.49538547.12930775.html.plaintext.txt	349	homolog drosophila notch expressed mammalian development
0.49538547.12930775.html.plaintext.txt	350	notchnum second mammalian notch gene
0.49538547.12930775.html.plaintext.txt	351	whole mount situ hybridization vertebrate embryo
0.49538547.12930775.html.plaintext.txt	352	situ hybridization practical approach ed
0.49538547.12930775.html.plaintext.txt	353	new york oxford university press
0.49538547.12930775.html.plaintext.txt	354	presenilin num required notchnum diinum expression paraxial mesoderm
0.49538547.12930775.html.plaintext.txt	355	aspartate num presenilin num indispensable mouse development production beta amyloid peptide s catenin independent mechanism
0.49538547.12930775.html.plaintext.txt	356	neurogenic phenotype altered notch processing drosophila presenilin mutant
0.49538547.12930775.html.plaintext.txt	357	related article development
0.49538547.12930775.html.plaintext.txt	358	role notch kidney development development num num num
0.49586895.12808018.html.plaintext.txt	0	intramembrane proteolysis presenilin presenilin like protease weiming xia michael
0.49586895.12808018.html.plaintext.txt	1	center neurologic disease brigham woman hospital harvard medical school boston ma num usa e mail wxiaatrics
0.49586895.12808018.html.plaintext.txt	2	edu u d mwolfeatrics
0.49586895.12808018.html.plaintext.txt	3	key word presenilin secretase signal peptide peptidase amyloid alzheimers disease
0.49586895.12808018.html.plaintext.txt	4	production as app involves sequential proteolysis s secretase
0.49586895.12808018.html.plaintext.txt	5	cleavage secretase heterogeneous generates c terminal variation as
0.49586895.12808018.html.plaintext.txt	6	fad mutation p increase assnum level particular p must affect selectivity secretase
0.49586895.12808018.html.plaintext.txt	7	deletion psnum mouse lethal producing major disruption somite segmentation shen et al
0.49586895.12808018.html.plaintext.txt	8	neurogenesis impaired massive neuronal loss observed specific region shen et al
0.49586895.12808018.html.plaintext.txt	9	developmental abnormality embryonic lethality rescued wild type fad mutant psnum davis et al
0.49586895.12808018.html.plaintext.txt	10	num indicates disease causing p mutant least partially functional
0.49586895.12808018.html.plaintext.txt	11	cleavage app secretase cultured psnum knockout neuron markedly inhibited de strooper et al
0.49586895.12808018.html.plaintext.txt	12	num p psnum neuron produce undetectable level secreted as
0.49586895.12808018.html.plaintext.txt	13	clearly demonstrates p required secretase activity as generation
0.49586895.12808018.html.plaintext.txt	14	study inhibitor shown secretase characteristic aspartyl protease shearman et al
0.49586895.12808018.html.plaintext.txt	15	identification two conserved aspartate residue transmembrane tm domain num num p critical secretase activity dnum dnum psnum provided conceptual basis novel hypothesis p aspartyl secretase wolfe et al
0.49586895.12808018.html.plaintext.txt	16	either aspartate residue psnum wolfe et al
0.49586895.12808018.html.plaintext.txt	17	numb psnum kimberly et al
0.49586895.12808018.html.plaintext.txt	18	num mutated secretase activity blocked as level significantly reduced cultured cell
0.49586895.12808018.html.plaintext.txt	19	also observed transgenic mouse overexpressing aspartate dnuma mutant psnum xia et al
0.49586895.12808018.html.plaintext.txt	20	evidence summarized suggests p aspartyl protease entire class p like protease involved intramembrane proteolysis type ii membrane protein
0.49586895.12808018.html.plaintext.txt	21	besides endoproteolysis p form functional ntf ctf association component apparently also critical secretase activity
0.49586895.12808018.html.plaintext.txt	22	investigation p containing high molecular weight hmw complex indicates additional cofactor intimately associate p form active secretase complex
0.49586895.12808018.html.plaintext.txt	23	nicastrin initially identified psnum co immunoprecipitates yu et al
0.49586895.12808018.html.plaintext.txt	24	num bind specifically immobilized transition state analogue secretase inhibitor esler et al
0.49586895.12808018.html.plaintext.txt	25	nicastrin psnum ntf ctf capable binding immobilized secretase inhibitor condition also maintain secretase activity condition disrupting association protein inhibitor also render complex inactive
0.49586895.12808018.html.plaintext.txt	26	common anti psnum antibody anti nicastrin antibody precipitate functional secretase complex esler et al
0.49586895.12808018.html.plaintext.txt	27	although glycosylation nicastrin absolutely required secretase activity herreman et al
0.49586895.12808018.html.plaintext.txt	28	num mainly mature form nicastrin identified hmw secretase complex level nicastrin cell closely correlate p level arawaka et al
0.49586895.12808018.html.plaintext.txt	29	reduction p level lead concomitant reduction nicastrin level downregulation nicastrin expression decrease level stabilized p molecule
0.49586895.12808018.html.plaintext.txt	30	thus reduction amount either protein decrease as generation edbauer et al
0.49586895.12808018.html.plaintext.txt	31	presenilin involved intramembranous processing app also processing signaling notch receptor kopan goate num
0.49586895.12808018.html.plaintext.txt	32	proper notch signaling critical wide variety cell fate determination embryonic development adulthood
0.49586895.12808018.html.plaintext.txt	33	notch type integral membrane protein large extracellular domain single transmembrane domain intracellular domain
0.49586895.12808018.html.plaintext.txt	34	translation receptor proteolyzed trans golgi part maturation heterodimeric cell surface receptor
0.49586895.12808018.html.plaintext.txt	35	notch suffers second proteolysis result ligand activation leading shedding extracellular domain receptor
0.49586895.12808018.html.plaintext.txt	36	remaining membrane bound c terminal stub subsequently cleaved within transmembrane domain release notch intracellular domain translocates nucleus regulates gene expression
0.49586895.12808018.html.plaintext.txt	37	final intramembrane proteolysis mediated multi component secretase complex fortini num
0.49586895.12808018.html.plaintext.txt	38	genetic screening protein cause notch like defect interact presenilin nicastrin orthologues c
0.49586895.12808018.html.plaintext.txt	39	elegans sel num aph num respectively identified two multipass transmembrane protein aph num anterior pharynx defective pen num presenilin enhancer francis et al
0.49586895.12808018.html.plaintext.txt	40	elegans aph num human orthologues predicted contain seven membrane spanning region closely associated sel numps aph numnicastrin c
0.49586895.12808018.html.plaintext.txt	41	aph num apparently facilitates localization aph num cell surface c
0.49586895.12808018.html.plaintext.txt	42	elegans embryo aph num remains er like compartment close nucleus aph num mutant embryo goutte et al
0.49586895.12808018.html.plaintext.txt	43	phenotype aph num mutant embryo similar embryo possessing defective sel num indicating aph num sel num p may act together proper function aph num nicastrin goutte et al
0.49586895.12808018.html.plaintext.txt	44	genetic screening notch pathway component c
0.49586895.12808018.html.plaintext.txt	45	elegans confirmed aph num regulator secretase also revealed additional component pen num francis et al
0.49586895.12808018.html.plaintext.txt	46	pen num two predicted tm domain
0.49586895.12808018.html.plaintext.txt	47	contain known protease motif carry signal peptide
0.49586895.12808018.html.plaintext.txt	48	interestingly chromosomal location chromosome num close apoe gene
0.49586895.12808018.html.plaintext.txt	49	apoenum allele major risk factor associated ad
0.49586895.12808018.html.plaintext.txt	50	inactivation aph num pen num cultured drosophila cell significantly reduces secretase cleavage app notch p ntf ctf level also reduced francis et al
0.49586895.12808018.html.plaintext.txt	51	mammalian cell pen num protein level significantly reduced absence p downregulation nicastrin synthesis similarly cause reduction pen num level
0.49586895.12808018.html.plaintext.txt	52	downregulation pen num synthesis likewise decrease level stabilized p molecule mature nicastrin concomitant reduction secretase activity steiner et al
0.49586895.12808018.html.plaintext.txt	53	reduction aph num level mammalian cell also reduces secretase activity lee et al
0.49586895.12808018.html.plaintext.txt	54	recent study demonstrated aph num pen num nicastrin directly associate p gu et al
0.49586895.12808018.html.plaintext.txt	55	num overexpression four protein enhances secretase activity edbauer et al
0.49586895.12808018.html.plaintext.txt	56	increased level aph num pen num psnum facilitate p heterodimer formation well glycosylation nicastrin edbauer et al
0.49586895.12808018.html.plaintext.txt	57	thus nicastrin aph num pen num regulate one another indispensable secretase activity
0.49586895.12808018.html.plaintext.txt	58	although reconstitution p nicastrin aph num pen num yeast lead p endoproteolysis assaicd production edbauer et al
0.49586895.12808018.html.plaintext.txt	59	num definitive evidence p protease requires vitro reconstitution assay using purified p substrate
0.49586895.12808018.html.plaintext.txt	60	rogaev colleague independently found group p like protein collectively name impas intramembrane protease associated activity imp grigorenko et al
0.49586895.12808018.html.plaintext.txt	61	example impnum identical pshnum encoded gene located chromosome num
0.49586895.12808018.html.plaintext.txt	62	furthermore sequence impnumpshnum identical signal peptide peptidase spp protease involved cleaving signal peptide remnant grigorenko et al
0.49586895.12808018.html.plaintext.txt	63	view larger version numk fig
0.49586895.12808018.html.plaintext.txt	64	signal peptide peptidase presenilin like aspartyl protease
0.49586895.12808018.html.plaintext.txt	65	human spp seven tm domain n terminus facing er lumen c terminus facing cytoplasm
0.49586895.12808018.html.plaintext.txt	66	active site motif yd located center tm domain num corresponding active site motif lgxgd located center adjacent tm domain num
0.49586895.12808018.html.plaintext.txt	67	human p eight tm domain n c terminus facing cytoplasm
0.49586895.12808018.html.plaintext.txt	68	corresponding active motif located center tm domain num num reverse orientation
0.49586895.12808018.html.plaintext.txt	69	p spp involved intramembrane proteolysis type ii substrate respectively
0.49586895.12808018.html.plaintext.txt	70	conserved pall spp palp p motif c terminus also shown
0.49586895.12808018.html.plaintext.txt	71	view larger version numk fig
0.49586895.12808018.html.plaintext.txt	72	type membrane protein substrate p mediated secretase cleavage
0.49586895.12808018.html.plaintext.txt	73	app notch erbb num e cadherin cdnum lrp nectinnum type membrane protein
0.49586895.12808018.html.plaintext.txt	74	app notch cdnum cleaved middle tm domain residue close interface membrane cytoplasm red arrow
0.49586895.12808018.html.plaintext.txt	75	cleavage erbb num occurs several residue membrane cytoplasm boundary cleavage e cadherin occurs right interface
0.49586895.12808018.html.plaintext.txt	76	lrp nectin num undergo proteolysis tm domain release intracellular domain
0.49586895.12808018.html.plaintext.txt	77	ectodomain shedding fl membrane protein blue arrow required subsequent intramembrane proteolysis mediated p
0.49586895.12808018.html.plaintext.txt	78	study spp substrate signal peptide indicate valine residue close interface membrane cytoplasm required cleavage lemberg martoglio num
0.49586895.12808018.html.plaintext.txt	79	although spp cleave signal peptide hormone prolactin human polymorphic mhc class molecule calreticulin viral protein vesicular stomatitis virus g protein vsvg fails cleave signal peptide human cytomegalovirus glycoprotein ulnum rnase
0.49586895.12808018.html.plaintext.txt	80	sequence comparison substrate suggests residue tendency disrupt helix tm domain required spp cleavage
0.49586895.12808018.html.plaintext.txt	81	importantly signal peptidase cleavage pre protein form signal peptide prerequisite spp cleavage consistent requirement ectodomain shedding secretase substrate
0.49586895.12808018.html.plaintext.txt	82	type ii membrane protein thus undergo ectodomain shedding prerequisite secretaseps spp mediated intramembrane proteolysis
0.49586895.12808018.html.plaintext.txt	83	acknowledgment study discussed review supported part alzheimers association nih n num nih ag num m
0.49586895.12808018.html.plaintext.txt	84	level mature glycosylated nicastrin regulated correlate gamma secretase processing amyloid beta precursor protein
0.49586895.12808018.html.plaintext.txt	85	commercially available proteinase inhibitor
0.49586895.12808018.html.plaintext.txt	86	proteolytic enzyme practical approach ed
0.49586895.12808018.html.plaintext.txt	87	oxford university press new york
0.49586895.12808018.html.plaintext.txt	88	familial alzheimers disease linked presenilin num variant elevate assnum numnum num ratio vitro vivo
0.49586895.12808018.html.plaintext.txt	89	proteolytic fragment alzheimers disease associated presenilin num form heterodimers occur num num kda molecular mass complex
0.49586895.12808018.html.plaintext.txt	90	mutant presenilins alzheimers disease increase production num residue amyloid s protein transfected cell transgenic mouse
0.49586895.12808018.html.plaintext.txt	91	alzheimers disease linked psnum variant rescue developmental abnormality psnum deficient embryo
0.49586895.12808018.html.plaintext.txt	92	deficiency presenilin num inhibits normal cleavage amyloid precursor protein
0.49586895.12808018.html.plaintext.txt	93	presenilin num dependent gamma secretase like protease mediates release notch intracellular domain
0.49586895.12808018.html.plaintext.txt	94	protein topology presenilin num
0.49586895.12808018.html.plaintext.txt	95	increased amyloid ssnumnum brain mouse expressing mutant presenilin num
0.49586895.12808018.html.plaintext.txt	96	presenilin nicastrin regulate determine amyloid b peptide production via complex formation
0.49586895.12808018.html.plaintext.txt	97	reconstitution gamma secretase activity
0.49586895.12808018.html.plaintext.txt	98	transition state analogue inhibitor secretase bind directly presenilin num
0.49586895.12808018.html.plaintext.txt	99	activity dependent isolation presenilin secretase complex reveals nicastrin substrate
0.49586895.12808018.html.plaintext.txt	100	aspartyl protease inhibitor pepstatin bind presenilins alzheimers disease
0.49586895.12808018.html.plaintext.txt	101	gamma secretase mediated proteolysis cell surface receptor signalling
0.49586895.12808018.html.plaintext.txt	102	aph num pen num required notch pathway signaling secretase cleavage bapp presenilin protein accumulation
0.49586895.12808018.html.plaintext.txt	103	aph num multipass membrane protein essential notch signaling pathway caenorhabditis elegans embryo
0.49586895.12808018.html.plaintext.txt	104	amyloid s protein as alzheimers disease brain
0.49586895.12808018.html.plaintext.txt	105	novel class polytopic protein domain associated putative protease activity
0.49586895.12808018.html.plaintext.txt	106	biochemistry mosc numnum num
0.49586895.12808018.html.plaintext.txt	107	aph num interacts mature immature form presenilins nicastrin may play role maturation presenilin nicastrin complex
0.49586895.12808018.html.plaintext.txt	108	total inactivation gamma secretase activity presenilin deficient embryonic stem cell
0.49586895.12808018.html.plaintext.txt	109	gamma secretase activity requires presenilin dependent trafficking nicastrin golgi apparatus complex glycosylation
0.49586895.12808018.html.plaintext.txt	110	visualization beta numnum beta num senile plaque end specific beta monoclonal evidence initially deposited specie beta numnum
0.49586895.12808018.html.plaintext.txt	111	nectin num immunoglobulin like receptor involved formation synapsis substrate presenilin secretase like cleavage
0.49586895.12808018.html.plaintext.txt	112	transmembrane aspartates presenilin num num obligatory secretase activity amyloid s protein generation
0.49586895.12808018.html.plaintext.txt	113	complex n linked glycosylated nicastrin associate active gamma secretase undergoes tight cellular regulation
0.49586895.12808018.html.plaintext.txt	114	secretase membrane protein complex comprised presenilin nicastrin aph num pen num
0.49586895.12808018.html.plaintext.txt	115	aph numnicastrin essential component gamma secretase regulator notch signaling presenilin localization
0.49586895.12808018.html.plaintext.txt	116	presenilin dependent intramembrane proteolysis cdnum lead liberation intracellular domain secretion abeta like peptide
0.49586895.12808018.html.plaintext.txt	117	type num prepilin peptidase comprise novel family aspartic acid protease
0.49586895.12808018.html.plaintext.txt	118	presenilin dependent gamma secretase like intramembrane cleavage erbbnum
0.49586895.12808018.html.plaintext.txt	119	mammalian aph num interacts presenilin nicastrin required intramembrane proteolysis app notch
0.49586895.12808018.html.plaintext.txt	120	presenilin num required maturation cell surface accumulation nicastrin
0.49586895.12808018.html.plaintext.txt	121	requirement signal peptide peptidase catalyzed intramembrane proteolysis
0.49586895.12808018.html.plaintext.txt	122	enuma presenilin num alzheimer mutation produce increased assnum deposition severe cerebellar pathology
0.49586895.12808018.html.plaintext.txt	123	familial alzheimers disease locus chromosome num
0.49586895.12808018.html.plaintext.txt	124	additional evidence eight transmembrane domain topology caenorhabditis elegans human presenilins
0.49586895.12808018.html.plaintext.txt	125	photoactivated secretase inhibitor directed active site covalently label presenilin num
0.49586895.12808018.html.plaintext.txt	126	pen num aph num coordinately regulate proteolytic processing presenilin num
0.49586895.12808018.html.plaintext.txt	127	pa domain protease associated domain
0.49586895.12808018.html.plaintext.txt	128	amyloid beta protein beta deposition chromosome num linked alzheimers disease predominance beta numnum
0.49586895.12808018.html.plaintext.txt	129	predominant deposition amyloid ssnumnum plaque case alzheimers disease hereditary cerebral hemorrhage associated muations amyloid precursor protein gene
0.49586895.12808018.html.plaintext.txt	130	presenilin numgamma secretase cleavage release e cadherin intracellular domain regulates disassembly adherens junction
0.49586895.12808018.html.plaintext.txt	131	proteolytic processing low density lipoprotein receptor related protein mediates regulated release intracellular domain
0.49586895.12808018.html.plaintext.txt	132	gamma secretase cleavage nuclear localization erbb num receptor tyrosine kinase
0.49586895.12808018.html.plaintext.txt	133	presenilins mediate dual intramembranous gamma secretase cleavage notch num
0.49586895.12808018.html.plaintext.txt	134	identification novel family presenilin homologues
0.49586895.12808018.html.plaintext.txt	135	mutant human presenilin num protects presenilin num null mouse embryonic lethality elevates abeta num numnum expression
0.49586895.12808018.html.plaintext.txt	136	familial alzheimers disease kindred missense mutation gene chromosome num related alzheimers disease type num gene
0.49586895.12808018.html.plaintext.txt	137	secreted amyloid s protein similar senile plaque alzheimers disease increased vivo presenilin num num app mutation linked familial alzheimers disease
0.49586895.12808018.html.plaintext.txt	138	presenilin num num molecular target gamma secretase inhibitor
0.49586895.12808018.html.plaintext.txt	139	l numnum aspartyl protease transition state mimic potent inhibitor amyloid beta protein precursor gamma secretase activity
0.49586895.12808018.html.plaintext.txt	140	skeletal cns defect presnilin num deficient mouse
0.49586895.12808018.html.plaintext.txt	141	cloning novel gene bearing missense mutation early onset familial alzheimer disease
0.49586895.12808018.html.plaintext.txt	142	loss function mutation presenilin num interferes amyloid s peptide production notch signaling
0.49586895.12808018.html.plaintext.txt	143	glycine num required presenilin num function conserved bacterial polytopic aspartyl protease
0.49586895.12808018.html.plaintext.txt	144	pen num integral component gamma secretase complex required coordinated expression presenilin nicastrin
0.49586895.12808018.html.plaintext.txt	145	role presenilin cofactor gamma secretase complex
0.49586895.12808018.html.plaintext.txt	146	endoprotreolysis presenilin num accumulation processed derivative vivo
0.49586895.12808018.html.plaintext.txt	147	first proline palp motif c terminus presenilins obligatory stabilization complex formation secretase activity presenilins
0.49586895.12808018.html.plaintext.txt	148	complex n glycosylated form nicastrin stabilized selectively bound presenilin fragment
0.49586895.12808018.html.plaintext.txt	149	identification signal peptide peptidase presenilin type aspartic protease
0.49586895.12808018.html.plaintext.txt	150	peptidomimetic probe molecular modeling suggest alzheimers secretase intramembrane cleaving aspartyl protease
0.49586895.12808018.html.plaintext.txt	151	two transmembrane aspartates presenilin num required presenilin endoproteolysis secretase activity
0.49586895.12808018.html.plaintext.txt	152	presenilin num required notch num dnum expression paraxial mesoderm
0.49586895.12808018.html.plaintext.txt	153	enhanced production oligomerization num residue amyloid s protein chinese hamster ovary cell stably expressing mutant presenilins
0.49586895.12808018.html.plaintext.txt	154	loss presenilin num associated enhanced beta catenin signaling skin tumorigenesis
0.49586895.12808018.html.plaintext.txt	155	mature glycosylation trafficking nicastrin modulate binding presenilins
0.49586895.12808018.html.plaintext.txt	156	nicastrin modulates presenilin mediated notchglp num signal transduction beta app processing
0.49586895.12808018.html.plaintext.txt	157	presenilins required gamma secretase cleavage beta app transmembrane cleavage notch num
0.49586895.12808018.html.plaintext.txt	158	intra membrane proteolysis jcs num num num
0.49589044.12668626.html.plaintext.txt	0	two suppressor sel num encode cnumhnum zinc finger protein regulate presenilin transcription caenorhabditis elegans bernard lakowski stefan eimer christine gobel andreas bottcher babett wagler ralf baumeister
0.49589044.12668626.html.plaintext.txt	1	abi department biochemistry laboratory molecular neurogenetics ludwig maximilians universitaet schillerstr
0.49589044.12668626.html.plaintext.txt	2	num d num munich germany present address department neuroscience pasteur institute paris france
0.49589044.12668626.html.plaintext.txt	3	author correspondence e mail ralf
0.49589044.12668626.html.plaintext.txt	4	key word presenilin alzheimers disease genetic suppression transcription regulation
0.49589044.12668626.html.plaintext.txt	5	mutation either human presenilin gene psennum psennum dominant cause early onset alzheimers disease
0.49589044.12668626.html.plaintext.txt	6	result increase ratio num amino acid variant num amino acid variant s amyloid alter total amount presenilin dependent secretase cleavage reviewed selkoe num
0.49589044.12668626.html.plaintext.txt	7	num amino acid variant s amyloid highly insoluble tends aggregate nucleating senile plaque found brain individual alzheimers disease reviewed sisodia st george hyslop num
0.49589044.12668626.html.plaintext.txt	8	presenilin activity also required snum cleavage notch receptor ligand binding struhl adachi num
0.49589044.12668626.html.plaintext.txt	9	like secretase cleavage app cleavage occurs within transmembrane domain release notch intracellular domain nicd
0.49589044.12668626.html.plaintext.txt	10	release nicd essential notch signaling liberated nicd fragment enters nucleus interacts transcription factor csl cbp suppressor hairless lag num de strooper et al
0.49589044.12668626.html.plaintext.txt	11	num additional co activator sel numlag num mastermind doyle et al
0.49589044.12668626.html.plaintext.txt	12	num petcherski kimble num
0.49589044.12668626.html.plaintext.txt	13	elegans genome encodes three presenilin gene sel num hop num spe num homologous human psennum psennum
0.49589044.12668626.html.plaintext.txt	14	spe num divergent member presenilin family appears specific role spermatogenesis arduengo et al
0.49589044.12668626.html.plaintext.txt	15	num lhernault arduengo num
0.49589044.12668626.html.plaintext.txt	16	two presenilins much similar human homologs absolutely essential signaling two c
0.49589044.12668626.html.plaintext.txt	17	elegans notch type receptor lin num glp num levitan greenwald num li greenwald num westlund et al
0.49589044.12668626.html.plaintext.txt	18	absence sel num hop num gene lead completely penetrant lethal phenotype resembles either complete loss glp num complete loss lin num signaling exact phenotype depends double mutant constructed sel num hop num partial maternal effect westlund et al
0.49589044.12668626.html.plaintext.txt	19	mutation hop num obvious phenotype mutation sel num lead egg laying defect egl levitan greenwald num westlund et al
0.49589044.12668626.html.plaintext.txt	20	sel num hop num seem largely overlapping role hop num rescue sel num egl defect expressed sel num promoter li greenwald num westlund et al
0.49589044.12668626.html.plaintext.txt	21	sequence also function presenilins evolutionarily conserved human presenilins psennum psennum also rescue sel num egl defect expressed control appropriate promoter baumeister et al
0.49589044.12668626.html.plaintext.txt	22	order understand biological role presenilins studying sel num gene c
0.49589044.12668626.html.plaintext.txt	23	mutation sel num first identified ability suppress lin num gain function mutation levitan greenwald num
0.49589044.12668626.html.plaintext.txt	24	suggests sel num mutation reduce lin num signaling sel num protein normally facilitates lin num signaling levitan greenwald num
0.49589044.12668626.html.plaintext.txt	25	however mutation sel num completely eliminate lin num signaling presumably owing residual presenilin activity supplied hop num li greenwald num westlund et al
0.49589044.12668626.html.plaintext.txt	26	different level lin num activity required control least five post embryonic signaling event eimer et al
0.49589044.12668626.html.plaintext.txt	27	sel num null mutant two affected varying degree eimer et al
0.49589044.12668626.html.plaintext.txt	28	indicates presenilin activity supplied hop num sufficient lin num signaling event lin num signaling event appear sensitive presenilin dosage others eimer et al
0.49589044.12668626.html.plaintext.txt	29	elucidate function sel num gene one study mutation bypass need sel num
0.49589044.12668626.html.plaintext.txt	30	mutation four gene sel num spr num spr num spr num already shown suppress sel num egg laying defect
0.49589044.12668626.html.plaintext.txt	31	mutation sel num first found screen gene suppress weak lin num loss function mutant hubbard et al
0.49589044.12668626.html.plaintext.txt	32	sel num similar yeast gene cdcnum act enum ubiquitin ligase target intracellular domain lin num glp num protein degradation gupta rossi et al
0.49589044.12668626.html.plaintext.txt	33	sel num mutation also weakly suppress mutation sel num completely bypass need sel num
0.49589044.12668626.html.plaintext.txt	34	screen similar one reported wen et al
0.49589044.12668626.html.plaintext.txt	35	identified four gene strongly suppress egl defect sel num suppressor presenilin described cloning characterization one spr num wen et al
0.49589044.12668626.html.plaintext.txt	36	mutation spr num almost completely bypass need sel num
0.49589044.12668626.html.plaintext.txt	37	biochemical role spr num presently unclear may affect chromatin structure andor transcription wen et al
0.49589044.12668626.html.plaintext.txt	38	paper report result several screen strong suppressor sel num isolation num independent mutation
0.49589044.12668626.html.plaintext.txt	39	mutation lie several complementation group identified wen et al
0.49589044.12668626.html.plaintext.txt	40	well additional gene indicating neither screen reached saturation
0.49589044.12668626.html.plaintext.txt	41	also report cloning characterization two suppressor gene spr num spr num code cnumhnum zinc finger protein similar transcriptional repressor restnrsf
0.49589044.12668626.html.plaintext.txt	42	spr num spr num mutant bypass need sel num upregulating transcription presenilin hop num
0.49589044.12668626.html.plaintext.txt	43	two presenilin suppressor also identified screen spr num spr num encode protein coresthdac complex eimer et al
0.49589044.12668626.html.plaintext.txt	44	numb jarriault greenwald num interacts rest propose spr protein assemble one repressor complex normally repress hop num locus early larval stage
0.49589044.12668626.html.plaintext.txt	45	mutation component complex remove repressor activity leading higher basal level hop num presenilin activity
0.49589044.12668626.html.plaintext.txt	46	lg hop numlgnum dpy numenum ego numomnum unc numenum spr numarnum daf numenum unc numenum unc nummnum unc numenum
0.49589044.12668626.html.plaintext.txt	47	lg v dpy numenum unc numenum
0.49589044.12668626.html.plaintext.txt	48	lg x sel numarnum arnum bynum lgnum dpy numenum spr numarnum lon numenum mndpnum mndpnum
0.49589044.12668626.html.plaintext.txt	49	mutation obtained caenorhabditis genetics center except sel numarnum sel numarnum spr numarnum spr numarnum kindly provided iva greenwald hop numlgnum described wittenburg et al
0.49589044.12668626.html.plaintext.txt	50	num sel numbynum sel numlgnum described eimer et al
0.49589044.12668626.html.plaintext.txt	51	isolation mutant ethylmethanesulfonate em ultra violet lighttetramethylpsoralen uvtmp mutagenesis carried according published procedure anderson num sulston hodgkin num
0.49589044.12668626.html.plaintext.txt	52	mutator screen presented another paper eimer et al
0.49589044.12668626.html.plaintext.txt	53	looked one em numnum haploid genome one uvtmp screen num haploid genome dominant suppressor mutation identify
0.49589044.12668626.html.plaintext.txt	54	screened recessive suppressor mutation similar manner wen et al
0.49589044.12668626.html.plaintext.txt	55	mutant retained spr sel numarnum double mutant displayed essentially wild type egg laying behavior vast majority progeny num become egl
0.49589044.12668626.html.plaintext.txt	56	mutation outcrossed five time phenotypic analysis
0.49589044.12668626.html.plaintext.txt	57	type screen mutagen used number haploid genome screened mutation identified follows
0.49589044.12668626.html.plaintext.txt	58	em numnum bynum bynum bynum bynum bynum bynum bynum bynum bynum bynum
0.49589044.12668626.html.plaintext.txt	59	uvtmp numnum bynum bynum bynum bynum bynum bynum bynum bynum bynum bynum bynum bynum bynum
0.49589044.12668626.html.plaintext.txt	60	mutator generated mutation num bynum bynum
0.49589044.12668626.html.plaintext.txt	61	complementation test complementation test done according standard procedure sulston hodgkin num
0.49589044.12668626.html.plaintext.txt	62	assignment complementation group follows
0.49589044.12668626.html.plaintext.txt	63	spr num arnum bynum bynum bynum bynumbydfnum bynum bynum bynum
0.49589044.12668626.html.plaintext.txt	64	spr num arnum bynum bynum bynum bynum bynum bynum bynum
0.49589044.12668626.html.plaintext.txt	65	spr num bynum bynum bynum bynum bynum bynum
0.49589044.12668626.html.plaintext.txt	66	uncharacterized bynum bynum bynum bynum
0.49589044.12668626.html.plaintext.txt	67	genetic mapping suppressor mutation genetically mapped using standard technique sulston hodgkin num maintaining possible spr mutation homozygous sel numarnum background
0.49589044.12668626.html.plaintext.txt	68	position spr num refined single nucleotide polymorphism snp mapping carried essentially described jakubowski kornfeld num
0.49589044.12668626.html.plaintext.txt	69	transgenic rescue spr num spr num injected strain sel numarnum spr numbynum rescue spr num strain spr numbynum sel numarnum rescue spr num
0.49589044.12668626.html.plaintext.txt	70	looked anti suppressor activity injection mix
0.49589044.12668626.html.plaintext.txt	71	restoration sel num phenotype
0.49589044.12668626.html.plaintext.txt	72	test clone pcr product injected num ng microl num ng microl prfnum rol num num ng microl pbynum ttx numgfp hobert et al
0.49589044.12668626.html.plaintext.txt	73	num co injection marker
0.49589044.12668626.html.plaintext.txt	74	gene structure spr num spr num sequenced two spr num cdna yknumenum yknumcnum kindly provided yuji kohara
0.49589044.12668626.html.plaintext.txt	75	found two cdna similar structure yet yknumcnum additional intron largest exon gene
0.49589044.12668626.html.plaintext.txt	76	however staged northern blot see fig
0.49589044.12668626.html.plaintext.txt	77	numa rt pcr developmental stage single transcript similar length yknumenum could detected data shown
0.49589044.12668626.html.plaintext.txt	78	process sequencing cdna also discovered sequencing error genomic sequence cosmid fnumhnum cnumanum near num end spr num put first atg frame data shown
0.49589044.12668626.html.plaintext.txt	79	error communicated c
0.49589044.12668626.html.plaintext.txt	80	elegans sequencing consortium genomic sequence updated
0.49589044.12668626.html.plaintext.txt	81	determine num end spr num transcript performed pcr random primed cdna library kindly provided bob barstead using slnum slnum forward primer spieth et al
0.49589044.12668626.html.plaintext.txt	82	num gene specific reverse primer rbnum catacttgacggcatcatcgg rbnum catctgcttctcgctcgagaatcg
0.49589044.12668626.html.plaintext.txt	83	found spr num trans spliced slnum slnum
0.49589044.12668626.html.plaintext.txt	84	slnum specific product sequenced found start num numends two sequenced cdna predicted splice acceptor site
0.49589044.12668626.html.plaintext.txt	85	view larger version numk fig
0.49589044.12668626.html.plaintext.txt	86	positional cloning spr num
0.49589044.12668626.html.plaintext.txt	87	three factor mapping spr num mapped interval dpy numenum lon num outside duplication mndpnum see table snum httpdev
0.49589044.12668626.html.plaintext.txt	88	orgsupplemental note spr num previously mapped dpy num unc num close unc num wen et al
0.49589044.12668626.html.plaintext.txt	89	spr num rescued cosmid fnumhnum partially overlapping cosmid cnumanum shown thick bar
0.49589044.12668626.html.plaintext.txt	90	cosmid cnumanum extends right
0.49589044.12668626.html.plaintext.txt	91	orfs fnumhnum named indicated line arrow
0.49589044.12668626.html.plaintext.txt	92	two spr num allele generated uvtmp mutagenesis large rearrangement
0.49589044.12668626.html.plaintext.txt	93	bydfnum deletes num kb cosmid fnumhnum bynum complex rearrangement affect promoter cnumanum
0.49589044.12668626.html.plaintext.txt	94	injecting series restriction fragment subclones pcr product see thick bar fnumhnum minimal rescuing region narrowed num
0.49589044.12668626.html.plaintext.txt	95	num kb fragment using rbnum cagtatacaactacgctctcc rbnum atccaacactcctaagtccg contains cnumanum
0.49589044.12668626.html.plaintext.txt	96	number line rescued indicated right construct
0.49589044.12668626.html.plaintext.txt	97	c northern blot rna nnum sel numarnum num spr num allele sel numarnum background probed spr num cdna
0.49589044.12668626.html.plaintext.txt	98	message detectable strain harboring either two large rearrangement bydfnum spr numbynum
0.49589044.12668626.html.plaintext.txt	99	view larger version numk fig
0.49589044.12668626.html.plaintext.txt	100	expression pattern spr num
0.49589044.12668626.html.plaintext.txt	101	stage specific expression spr num transcript ama num shown control e egg lnum lnum first fourth larval stage adult
0.49589044.12668626.html.plaintext.txt	102	bc spr numegfp promoter fusion expressed broadly throughout animal
0.49589044.12668626.html.plaintext.txt	103	spr num expressed uniformly egg b broadly adult c strong expression pharynx
0.49589044.12668626.html.plaintext.txt	104	de expression gst myc tagged spr num baculovirus construct expressed insect sfnum cell detected fluorescein isothiocyanate coupled goat anti mouse secondary antibody
0.49589044.12668626.html.plaintext.txt	105	d fluorescent e propidium iodide staining cell
0.49589044.12668626.html.plaintext.txt	106	determine structure spr num sequenced nearly full length cdna yknumcnum entirety found matched predicted gene cnumhnum
0.49589044.12668626.html.plaintext.txt	107	num znum except yknumcnum lack first five nucleotide orf last exon start six nucleotide num annotated cnumhnum
0.49589044.12668626.html.plaintext.txt	108	cdna yknumdnum us weak acceptor last exon annotated wormbase httpwww
0.49589044.12668626.html.plaintext.txt	109	org spr num appears alternatively spliced
0.49589044.12668626.html.plaintext.txt	110	two transcript encode identical protein except difference two amino acid region numth numth zinc finger fig
0.49589044.12668626.html.plaintext.txt	111	view larger version numk fig
0.49589044.12668626.html.plaintext.txt	112	genetic position spr num see table snum httpdev
0.49589044.12668626.html.plaintext.txt	113	spr num mapped close right bypnum snp vnumanum
0.49589044.12668626.html.plaintext.txt	114	snumatnum u d
0.49589044.12668626.html.plaintext.txt	115	extent num kb pvuii rescuing fragment shown
0.49589044.12668626.html.plaintext.txt	116	c predicted spr num protein aligned num end cnumgnum
0.49589044.12668626.html.plaintext.txt	117	identical amino acid highlighted black similar amino acid highlighted gray
0.49589044.12668626.html.plaintext.txt	118	num putative cnumhnum zinc finger spr num underlined region could act nuclear localization signal boxed
0.49589044.12668626.html.plaintext.txt	119	two amino acid present alternatively spliced form spr num overlined labeled
0.49589044.12668626.html.plaintext.txt	120	mutation indicated asterisk
0.49589044.12668626.html.plaintext.txt	121	d alignment spr num rest homo sapiens
0.49589044.12668626.html.plaintext.txt	122	identical amino acid highlighted black similar amino acid highlighted gray
0.49589044.12668626.html.plaintext.txt	123	comparison predicted caenorhabditis briggsae gene access unpublished draft genomic sequence caenorhabditis briggsae available welcome trust sanger institute httpwww
0.49589044.12668626.html.plaintext.txt	124	ukprojectscbriggsae genome sequencing center washington university st louis httpgenome
0.49589044.12668626.html.plaintext.txt	125	briggsae preliminary prediction c
0.49589044.12668626.html.plaintext.txt	126	briggsae gene viewed wormbase httpwww
0.49589044.12668626.html.plaintext.txt	127	briggase spr num gene identified possible spr num homolog c
0.49589044.12668626.html.plaintext.txt	128	briggsae contig cnum
0.49589044.12668626.html.plaintext.txt	129	briggsae mixed stage rna qiagen rnaeasy kit according manufacturer instruction qiagen hilden
0.49589044.12668626.html.plaintext.txt	130	determine gene structure performed rt pcr various combination primer
0.49589044.12668626.html.plaintext.txt	131	amplified pcr product using primer rbnum tacttgccacttgtgtccaag rbnum tggtgaacttttcaccagcg reverse transcribed first strand cdna generated primer rbnum
0.49589044.12668626.html.plaintext.txt	132	pcr product sequenced found contain central num region c
0.49589044.12668626.html.plaintext.txt	133	expression construct spr numegfp promoter fusion made cloning egfp spr num atg behind num kb spr num promoter sequence
0.49589044.12668626.html.plaintext.txt	134	construct also contained spr num numutr
0.49589044.12668626.html.plaintext.txt	135	translational fusion construct made inserting egfp rescuing genomic construct either atg n terminal fusion taa stop codon c terminal fusion transgenic line generated construct rescue spr num detectable gfp fluorescence
0.49589044.12668626.html.plaintext.txt	136	baculovirus expression construct made inserting spr num cdna transfer vector pbynum eimer et al
0.49589044.12668626.html.plaintext.txt	137	numb fusing gst myc tag n terminally spr num
0.49589044.12668626.html.plaintext.txt	138	resulting construct co transformed along linearized baculogold dna becton dickinsonpharmingen sfnum cell generate recombinant virus
0.49589044.12668626.html.plaintext.txt	139	rnai feeding subcloned num
0.49589044.12668626.html.plaintext.txt	140	num kb hindiiixhoi fragment cdna yknumanum kindly provided y
0.49589044.12668626.html.plaintext.txt	141	fire cut hindiiixhoi generate cnumgnum
0.49589044.12668626.html.plaintext.txt	142	full length hop num cdna amplified pcr cloned smainoti fragment lnum creating pbynum
0.49589044.12668626.html.plaintext.txt	143	gene transiently inactivated rnai feeding e
0.49589044.12668626.html.plaintext.txt	144	coli strain htnumdenum expressing double stranded rna gene interest timmons et al
0.49589044.12668626.html.plaintext.txt	145	num timmons fire num
0.49589044.12668626.html.plaintext.txt	146	dsrna expression induced described kamath et al
0.49589044.12668626.html.plaintext.txt	147	num worm transferred lnum larva onto seeded plate containing num microgml ampicillin num mm iptg
0.49589044.12668626.html.plaintext.txt	148	num hour parental worm transferred new plate also containing ampicillin iptg
0.49589044.12668626.html.plaintext.txt	149	progeny second rnai plate scored relevant phenotype
0.49589044.12668626.html.plaintext.txt	150	case sel numarnum animal parental worm kept first rnai plate died bag worm phenotype last progeny scored rnai phenotype
0.49589044.12668626.html.plaintext.txt	151	northern blot rna isolated mixed stage plate staged plate prepared rnaeasy kit according manufacturer instruction qiagen hilden
0.49589044.12668626.html.plaintext.txt	152	northern blot num microg total rna per lane denatured num degree c num minute loaded onto num
0.49589044.12668626.html.plaintext.txt	153	gel run overnight separate fragment blotted onto hybond n membrane according sambrook sambrook num
0.49589044.12668626.html.plaintext.txt	154	lnum northern blot num microg total rna used per lane
0.49589044.12668626.html.plaintext.txt	155	probe labeled nump dctp using megaprime labeling kit according manufacturer instruction amersham freiburg germany
0.49589044.12668626.html.plaintext.txt	156	blot hybridized washed according procedure church gilbert num num degree c
0.49589044.12668626.html.plaintext.txt	157	northern blot probed ama num specific probe johnstone barry num loading control
0.49589044.12668626.html.plaintext.txt	158	blot first made blot num microg per lane total rna probed ama num
0.49589044.12668626.html.plaintext.txt	159	used result probing adjust amount rna loaded obtain equal amount mrna per lane
0.49589044.12668626.html.plaintext.txt	160	quantification relative transcript level blot placed storage phosphor screen molecular dynamic several day read storm num scanner molecular dynamic
0.49589044.12668626.html.plaintext.txt	161	intensity band determined using imagequant version num
0.49589044.12668626.html.plaintext.txt	162	num molecular dynamic using user method volume quantitation
0.49589044.12668626.html.plaintext.txt	163	volume adjusted background intensity
0.49589044.12668626.html.plaintext.txt	164	staged northern blot worm synchronized lnum stage alkaline hypochlorite treatment sulston hodgkin num
0.49589044.12668626.html.plaintext.txt	165	synchronized lnum larva spotted onto num cm plate seeded opnum allowed grow num hour num hour num hour num hour num hour lnum lnum lnum lnum young adult stage respectively
0.49589044.12668626.html.plaintext.txt	166	worm inspected visually harvesting confirm worm correct stage
0.49589044.12668626.html.plaintext.txt	167	identified four suppressor presenilin spr gene similar screen described cloning characterization one spr num wen et al
0.49589044.12668626.html.plaintext.txt	168	mapped spr num spr num spr num spr num chromosome v iv x respectively
0.49589044.12668626.html.plaintext.txt	169	complementation analysis spr numarnum spr numarnum kindly provided
0.49589044.12668626.html.plaintext.txt	170	greenwald new york determined bynum bynum allele spr num spr num respectively
0.49589044.12668626.html.plaintext.txt	171	consequently defined new gene spr num reference allele bynum eimer et al
0.49589044.12668626.html.plaintext.txt	172	examined remaining five suppressor mutation found screen see could spr num spr num allele
0.49589044.12668626.html.plaintext.txt	173	none remaining five allele mutation coding region spr num
0.49589044.12668626.html.plaintext.txt	174	however bynum showed close linkage dpy num chromosome v mapped similar region spr num see table snum httpdev
0.49589044.12668626.html.plaintext.txt	175	spr num recently cloned jarriault greenwald num found bynum contains mutation gene eimer et al
0.49589044.12668626.html.plaintext.txt	176	remaining four suppressor mutation pursued detail complementation test define three additional gene data shown
0.49589044.12668626.html.plaintext.txt	177	fact found spr num allele found mutation gene identified wen et al
0.49589044.12668626.html.plaintext.txt	178	num indicates saturation reached either screen
0.49589044.12668626.html.plaintext.txt	179	rest paper report cloning characterization two major complementation group spr num spr num
0.49589044.12668626.html.plaintext.txt	180	spr num spr num potently specifically suppress sel num roughly num sel numarnum adult animal display protruding vulva pvl fig
0.49589044.12668626.html.plaintext.txt	181	num defect strongly correlated presumably caused mi specification lineage eimer et al
0.49589044.12668626.html.plaintext.txt	182	almost sel num animal retain many egg uterus egg laying defective egl phenotype egg hatch develop within mother leading terminal bag worm bag phenotype fig
0.49589044.12668626.html.plaintext.txt	183	egl defect severely limit number progeny generated table num
0.49589044.12668626.html.plaintext.txt	184	mutation spr num completely suppress aspect sel num egg laying defect fig
0.49589044.12668626.html.plaintext.txt	185	sel numarnum spr num double mutant also display nearly wild type brood size table num indicating spr num mutation restore normal egg laying behavior normal fertility
0.49589044.12668626.html.plaintext.txt	186	also respond neurotransmitter stimulate egg laying data shown
0.49589044.12668626.html.plaintext.txt	187	spr num mutation however lead le completely penetrant suppression sel num phenotype allele num spr num sel numarnum animal still become egl fig
0.49589044.12668626.html.plaintext.txt	188	egl phenotype similar sel numarnum except pvl animal seen
0.49589044.12668626.html.plaintext.txt	189	suggests remaining egl animal least part sel num phenotype rescued
0.49589044.12668626.html.plaintext.txt	190	however spr num sel numarnum double mutant animal lay egg display nearly wild type brood size table num
0.49589044.12668626.html.plaintext.txt	191	mutation spr num spr num also suppress sel num allele tested arnum bynum lgnum spr num arnum spr num table num data shown
0.49589044.12668626.html.plaintext.txt	192	mutation spr num spr num obvious phenotype except perhaps slightly reduced brood size table num data shown
0.49589044.12668626.html.plaintext.txt	193	spr num examined clear null mutation bynum also known bydfnum detail
0.49589044.12668626.html.plaintext.txt	194	surprisingly even mutation num kb deletion deletes five gene including spr num upstream downstream neighbor fig
0.49589044.12668626.html.plaintext.txt	195	numb obvious phenotype table num data shown indicating none deleted gene essential
0.49589044.12668626.html.plaintext.txt	196	taken together result show spr num spr num potent specific suppressor sel num able suppress aspect sel num phenotype
0.49589044.12668626.html.plaintext.txt	197	view larger version numk fig
0.49589044.12668626.html.plaintext.txt	198	mutation spr num spr num potently suppress egg laying defect sel num mutant
0.49589044.12668626.html.plaintext.txt	199	percentage animal exhibit protruding vulva pvl black bar egg laying defect egl gray bar die internal hatching bag white bar shown wild type nnum sel num three separate allele spr num spr num sel numarnum background
0.49589044.12668626.html.plaintext.txt	200	number animal examined nnum num arnum num bynum num bynum num bynum num bynum num bynum num bynum num
0.49589044.12668626.html.plaintext.txt	201	brood size spr num spr num mutant
0.49589044.12668626.html.plaintext.txt	202	spr num cnumhnum zinc finger protein genetic mapping placed spr num chromosome x dpy numenum lon numenum close dpy num fig
0.49589044.12668626.html.plaintext.txt	203	dpy numenum roughly num kb deletion left right breakpoints cosmid cnumhnum fnumenum respectively g
0.49589044.12668626.html.plaintext.txt	204	garriga personal communication
0.49589044.12668626.html.plaintext.txt	205	started sequentially injecting sequenced cosmid fnumenum right
0.49589044.12668626.html.plaintext.txt	206	spr num completely rescued cosmid fnumhnum partially overlapping cosmid cnumanum fig
0.49589044.12668626.html.plaintext.txt	207	injected series purified restriction fragment subclones pcr product fnumhnum fig
0.49589044.12668626.html.plaintext.txt	208	injected product containing entirety predicted gene cnumanum
0.49589044.12668626.html.plaintext.txt	209	num produced complete rescue spr num fig
0.49589044.12668626.html.plaintext.txt	210	numb table num data shown
0.49589044.12668626.html.plaintext.txt	211	minimal rescuing fragment narrowed num
0.49589044.12668626.html.plaintext.txt	212	num predicted open reading frame
0.49589044.12668626.html.plaintext.txt	213	spr num encodes novel basic protein predicted pinum
0.49589044.12668626.html.plaintext.txt	214	recognizable domain spr num seven putative cnumhnum zinc finger several region may act nuclear localization signal fig
0.49589044.12668626.html.plaintext.txt	215	spr num allele arnum bynum bynum bynum amino acid stop codon mutation various position protein fig
0.49589044.12668626.html.plaintext.txt	216	bynum mutation single base pair deletion shift frame amino acid num truncates protein num amino acid
0.49589044.12668626.html.plaintext.txt	217	bynum mutation cnumy transition second cysteine sixth zinc finger indicating finger essential spr num function
0.49589044.12668626.html.plaintext.txt	218	bynum deletion numnum base position num fnumhnum position num cnumanum single base pair insertion
0.49589044.12668626.html.plaintext.txt	219	num clearly null spr num function fig
0.49589044.12668626.html.plaintext.txt	220	bynum deletes several gene renamed bydfnum
0.49589044.12668626.html.plaintext.txt	221	combination pcr southern blotting sequencing determined alteration coding sequence bynum
0.49589044.12668626.html.plaintext.txt	222	however bynum complex promoter rearrangement cnumanum
0.49589044.12668626.html.plaintext.txt	223	using northern analysis single transcript detectable bynum bynum bynum bynum bynum lane nearly wild type level although transcript detectable bydfnum bynum fig
0.49589044.12668626.html.plaintext.txt	224	numc indicating bynum also null spr num function
0.49589044.12668626.html.plaintext.txt	225	view larger version numk fig
0.49589044.12668626.html.plaintext.txt	226	determined structure c
0.49589044.12668626.html.plaintext.txt	227	elegans spr num num end c
0.49589044.12668626.html.plaintext.txt	228	black box indicate location predicted cnumhnum zinc finger gray box indicate location sequence might act nuclear localization signal
0.49589044.12668626.html.plaintext.txt	229	region confirmed structure c
0.49589044.12668626.html.plaintext.txt	230	briggsae transcript similar
0.49589044.12668626.html.plaintext.txt	231	also shown region num determined sequence c
0.49589044.12668626.html.plaintext.txt	232	briggsae spr num similar zinc finger num num c
0.49589044.12668626.html.plaintext.txt	233	elegans spr num gene predicted part c
0.49589044.12668626.html.plaintext.txt	234	identical amino acid highlighted black similar amino acid indicated gray
0.49589044.12668626.html.plaintext.txt	235	predicted zinc finger underlined region containing sequence could act nuclear localization signal boxed
0.49589044.12668626.html.plaintext.txt	236	position point mutation shown asterisk
0.49589044.12668626.html.plaintext.txt	237	c alignment zinc finger region spr num rest homo sapiens
0.49589044.12668626.html.plaintext.txt	238	identical amino acid highlighted black similar gray
0.49589044.12668626.html.plaintext.txt	239	gap alignment indicated hyphen gap segment spr num indicated blank space
0.49589044.12668626.html.plaintext.txt	240	spr num broadly expressed nuclearly localized spr num transcript expressed stage different level
0.49589044.12668626.html.plaintext.txt	241	message present high amount egg lnum adult stage weakly expressed lnum lnum lnum stage fig
0.49589044.12668626.html.plaintext.txt	242	determine expression pattern spr num made promoter fusion egfp
0.49589044.12668626.html.plaintext.txt	243	construct broadly expressed embryo larval stage adult fig
0.49589044.12668626.html.plaintext.txt	244	expressed sfnum insect cell using baculovirus expression system spr num localized nucleus fig
0.49589044.12668626.html.plaintext.txt	245	attempt purify spr num insect cell failed
0.49589044.12668626.html.plaintext.txt	246	spr num remained nuclear fraction even dnase treatment high salt extraction data shown
0.49589044.12668626.html.plaintext.txt	247	therefore likely spr num present nuclear subcompartment attached nuclear periphery
0.49589044.12668626.html.plaintext.txt	248	spr num gene evolved rapidly unable identify clear homologs spr num sequence database
0.49589044.12668626.html.plaintext.txt	249	understand better region protein could important function tried identify homologs c
0.49589044.12668626.html.plaintext.txt	250	briggsae closest known relative c
0.49589044.12668626.html.plaintext.txt	251	using rt pcr isolated large fragment transcript determined similar exonintron structure spr num c
0.49589044.12668626.html.plaintext.txt	252	briggsae gene num identical num similar c
0.49589044.12668626.html.plaintext.txt	253	numb similarity confined zinc finger region
0.49589044.12668626.html.plaintext.txt	254	briggsae spr num gene significantly diverged c
0.49589044.12668626.html.plaintext.txt	255	however predicted n terminal region c
0.49589044.12668626.html.plaintext.txt	256	briggsae spr num region similar zinc finger num num c
0.49589044.12668626.html.plaintext.txt	257	spr num similar transcriptional repressor fact spr num weakly conserved c
0.49589044.12668626.html.plaintext.txt	258	briggsae similarity largely confined zinc finger domain suggests region zinc finger little selective pressure zinc finger nuclear localization signal may functional domain protein
0.49589044.12668626.html.plaintext.txt	259	case would expect mutation result amino acid substitution would phenotypic consequence
0.49589044.12668626.html.plaintext.txt	260	consistent one eight spr num allele missense mutation mutation affect conserved cysteine one zinc finger
0.49589044.12668626.html.plaintext.txt	261	spr num contains three pair adjacent zinc finger one lone zinc finger separated non conserved linkers
0.49589044.12668626.html.plaintext.txt	262	therefore analyze zinc finger region protein concatenated sequence zinc finger along short linkers tandem finger searched database similarity
0.49589044.12668626.html.plaintext.txt	263	sequence similar many cnumhnum zinc finger protein similar member rest family transcriptional repressor fig
0.49589044.12668626.html.plaintext.txt	264	suggests spr num may also function transcriptional repressor
0.49589044.12668626.html.plaintext.txt	265	spr num belongs family cnumhnum protein related transcriptional repressor spr num mapped unc num daf num lgi close right single nucleotide polymorphism snp vlnumanum
0.49589044.12668626.html.plaintext.txt	266	snumatnum u d cosmid fnumcnum fig
0.49589044.12668626.html.plaintext.txt	267	near point gene cnumhnum
0.49589044.12668626.html.plaintext.txt	268	num greatest similarity c
0.49589044.12668626.html.plaintext.txt	269	probing spr num allele southern blot yknumbnum cnumhnum
0.49589044.12668626.html.plaintext.txt	270	num cdna could identify clear polymorphism two uvtmp generated spr num allele bynum bynum data shown
0.49589044.12668626.html.plaintext.txt	271	injection either two cosmid overlap cnumhnum fnumgnum cnumbnum gave partial rescue spr num data shown
0.49589044.12668626.html.plaintext.txt	272	cosmid contain num kb pvuii fragment contains entire coding region cnumhnum
0.49589044.12668626.html.plaintext.txt	273	num num kb num sequence well num
0.49589044.12668626.html.plaintext.txt	274	num kb num sequence extending almost next gene upstream fig
0.49589044.12668626.html.plaintext.txt	275	subcloned pvuii fragment fnumgnum pbsiisk cut pvuii found rescue spr num well original cosmid data shown
0.49589044.12668626.html.plaintext.txt	276	spr num code large protein num amino acid fig
0.49589044.12668626.html.plaintext.txt	277	numc containing num cnumhnum zinc finger domain
0.49589044.12668626.html.plaintext.txt	278	one zinc finger labeled znfnum threshold pfam httpwww
0.49589044.12668626.html.plaintext.txt	279	sepfam region highly conserved c
0.49589044.12668626.html.plaintext.txt	280	briggsae data shown indicating may represent functional domain
0.49589044.12668626.html.plaintext.txt	281	possible splice variant also suggested based sequence yknumdnum cdna see material method
0.49589044.12668626.html.plaintext.txt	282	spr num also predicted nuclearly localized contains several nuclear localization signal nls including bipartite nls
0.49589044.12668626.html.plaintext.txt	283	identified mutation three spr num allele fig
0.49589044.12668626.html.plaintext.txt	284	bynum contains num bp deletion num bp insertion position num message
0.49589044.12668626.html.plaintext.txt	285	deletion shift frame amino acid num truncates predicted protein position num fig
0.49589044.12668626.html.plaintext.txt	286	bynum allele qnumstop mutation fig
0.49589044.12668626.html.plaintext.txt	287	southern analysis bynum contains num bp deletion near num end gene data shown
0.49589044.12668626.html.plaintext.txt	288	briggsae data shown distantly related nematode pristionchus pacificus ainum parastrongyloides tricosuri bmnum j
0.49589044.12668626.html.plaintext.txt	289	mccarter personal communication
0.49589044.12668626.html.plaintext.txt	290	spr num also strong similarity enumxnum num cnumgnum
0.49589044.12668626.html.plaintext.txt	291	twenty one first num amino acid identical spr num cnumgnum
0.49589044.12668626.html.plaintext.txt	292	region followed protein highly acidic stretch suggesting region form functional domain fig
0.49589044.12668626.html.plaintext.txt	293	num resemble protein cnumgnum
0.49589044.12668626.html.plaintext.txt	294	num num identical spr num n terminal section znfnum end protein contains zinc finger region except znfnum suggesting spr num cnumgnum
0.49589044.12668626.html.plaintext.txt	295	num may related function fig
0.49589044.12668626.html.plaintext.txt	296	however rna interference feeding kamath et al
0.49589044.12668626.html.plaintext.txt	297	num obvious effect wild type strain nnum influence egl defect sel numarnum sel numarnum data shown
0.49589044.12668626.html.plaintext.txt	298	num also fails produce synthetic effect either spr numbynum sel numarnum spr numbynum background data shown
0.49589044.12668626.html.plaintext.txt	299	result may suggest rnai effect induced bacterial feeding approach however rnai injection purified double stranded rna yknumanum cnumgnum
0.49589044.12668626.html.plaintext.txt	300	num cdna also induced phenotype maeda et al
0.49589044.12668626.html.plaintext.txt	301	interestingly cnumgnum
0.49589044.12668626.html.plaintext.txt	302	num homolog present draft c
0.49589044.12668626.html.plaintext.txt	303	briggsae assembly suggesting cnumgnum
0.49589044.12668626.html.plaintext.txt	304	num may recently diverged ancestral spr num like gene gene low selective pressure lost without phenotypic effect
0.49589044.12668626.html.plaintext.txt	305	spr num also similarity large number zinc finger protein metazoan
0.49589044.12668626.html.plaintext.txt	306	spr num similar member rest family transcriptional repressor fig
0.49589044.12668626.html.plaintext.txt	307	numd also weaker similarity known transcriptional repressor member ctcfccctc binding factor suggesting spr num like spr num may also function transcriptional repressor
0.49589044.12668626.html.plaintext.txt	308	hop num transcription regulated spr num spr num spr num spr num encode cnumhnum zinc finger protein probably nuclearly localized might act transcription factor looked possible target regulated spr num spr num
0.49589044.12668626.html.plaintext.txt	309	therefore probed northern blot prepared mixed stage staged rna spr num spr num mutant several gene involved lin num glp num signaling
0.49589044.12668626.html.plaintext.txt	310	significant difference transcript level seen strain probed lin num glp num lag num apx num sup num data shown
0.49589044.12668626.html.plaintext.txt	311	although probe exhaustively suggested spr num spr num might obvious effect transcription gene involved lin num glp num pathway
0.49589044.12668626.html.plaintext.txt	312	investigated whether spr num spr num might bypass need sel num regulating one presenilin gene spe num hop num
0.49589044.12668626.html.plaintext.txt	313	result mixed stage blot suggested hop num spe num may differentially expressed data shown
0.49589044.12668626.html.plaintext.txt	314	therefore probed staged northern blot
0.49589044.12668626.html.plaintext.txt	315	transcript level three c
0.49589044.12668626.html.plaintext.txt	316	elegans presenilin gene various developmental stage reported previously
0.49589044.12668626.html.plaintext.txt	317	find consistent known role spermatogenesis spe num expressed lnum larval stage hermaphrodite produce sperm fig
0.49589044.12668626.html.plaintext.txt	318	sel num expressed strongly uniformly throughout development fig numbc consistent strong ubiquitous expression sel numegfp promoter fusion baumeister et al
0.49589044.12668626.html.plaintext.txt	319	surprisingly hop num dynamic expression
0.49589044.12668626.html.plaintext.txt	320	strongly expressed adult stage weakly embryo almost undetectable lnum stage fig numac
0.49589044.12668626.html.plaintext.txt	321	hop num expression slowly increase remaining larval stage
0.49589044.12668626.html.plaintext.txt	322	view larger version numk fig
0.49589044.12668626.html.plaintext.txt	323	stage specific expression sel num spe num hop num transcript
0.49589044.12668626.html.plaintext.txt	324	stage specific expression hop num spe num blot ama num equal loading control
0.49589044.12668626.html.plaintext.txt	325	b stage specific expression sel num ama num loading control
0.49589044.12668626.html.plaintext.txt	326	c relative expression various presenilin gene b correction equal loading
0.49589044.12668626.html.plaintext.txt	327	spr num spr num mutant found difference temporal pattern expression sel num spe num see increase hop num expression lnum lnum lnum larval stage stage hop num expression lowest data shown
0.49589044.12668626.html.plaintext.txt	328	egg laying defect sel num animal due developmental defect occurring mid larval stage suppression sel num spr gene could explained stage specific alteration gene expression
0.49589044.12668626.html.plaintext.txt	329	confirm result directly compare different strain prepared northern blot lnum rna nnum sel numarnum several spr strain probed hop num
0.49589044.12668626.html.plaintext.txt	330	expression hop num lowest lnum stage reasoned increased expression stage might easiest detect
0.49589044.12668626.html.plaintext.txt	331	increased amount total rna used num microglane num microglane expression hop num wild type worm near detection level
0.49589044.12668626.html.plaintext.txt	332	tested lnum rna prepared nnum sel numarnum four spr num allele one spr num allele three spr num allele fig
0.49589044.12668626.html.plaintext.txt	333	spr strain tested hop num upregulated
0.49589044.12668626.html.plaintext.txt	334	suggests spr gene may use mechanism bypass requirement sel num
0.49589044.12668626.html.plaintext.txt	335	spr num upregulates hop num expression num fold whereas spr num allele upregulate hop num four num fold fig
0.49589044.12668626.html.plaintext.txt	336	data confirmed separate experiment looked hop num expression lnum stage num seven spr num allele isolated screen num one spr num allele two spr num allele without sel num background
0.49589044.12668626.html.plaintext.txt	337	spr allele hop num strongly expressed control see fig snum snum httpdev
0.49589044.12668626.html.plaintext.txt	338	view larger version numk fig
0.49589044.12668626.html.plaintext.txt	339	mutation spr num spr num de repress expression hop num message lnum stage
0.49589044.12668626.html.plaintext.txt	340	expression hop num message ama num loading control lnum stage nnum wild type sel numarnum four spr num allele bynum bynum bynum bynum one spr num allele bynum three spr num allele bynum bynum bynum
0.49589044.12668626.html.plaintext.txt	341	spr mutant sel numarnum background
0.49589044.12668626.html.plaintext.txt	342	fold expression hop num compared nnum given correction equal loading
0.49589044.12668626.html.plaintext.txt	343	first six lane reproduced permission eimer et al
0.49589044.12668626.html.plaintext.txt	344	preliminary experiment num microglane rna gave qualitatively similar result
0.49589044.12668626.html.plaintext.txt	345	orgsupplemental additional spr num allele
0.49589044.12668626.html.plaintext.txt	346	spr num spr num suppress synthetic lethality hop num sel num double mutant spr gene bypass need sel num upregulating expression hop num spr num spr num mutation suppress synthetic lethal phenotype induced reducing hop num sel num activity
0.49589044.12668626.html.plaintext.txt	347	rnai feeding hop num gene sel numarnum spr numbynum strain spr numbynum sel numarnum strain induces range phenotype seen one induces rnai hop num sel numarnum table num li greenwald num
0.49589044.12668626.html.plaintext.txt	348	animal display lethal phenotype emb lag ste consistent strong reduction lin num andor glp num signaling animal produce progeny egl
0.49589044.12668626.html.plaintext.txt	349	indicates spr num spr num mutation bypass need presenilins per se sel num effect dependent activity hop num
0.49589044.12668626.html.plaintext.txt	350	confirmed result constructing hop num sel num spr num triple mutant strain table num
0.49589044.12668626.html.plaintext.txt	351	similar experiment spr num performed genetic proximity spr num hop num
0.49589044.12668626.html.plaintext.txt	352	find spr num affect phenotype hop num sel num double mutant also shown spr num spr num spr num eimer et al
0.49589044.12668626.html.plaintext.txt	353	numb jarriault greenwald num wen et al
0.49589044.12668626.html.plaintext.txt	354	furthermore num hop numlgnumdpy numenum sel numarnum spr numbynum animal one remaining copy hop num functional sel num gene display egl phenotype table num
0.49589044.12668626.html.plaintext.txt	355	sel numarnum spr numbynum animal never egl see fig
0.49589044.12668626.html.plaintext.txt	356	num indicates sel num spr num background hop num haploinsufficient
0.49589044.12668626.html.plaintext.txt	357	sel num spr num mutant presenilin activity near threshold necessary correct egg laying reducing hop num activity half brings worm threshold
0.49589044.12668626.html.plaintext.txt	358	taken together result consistent spr num spr num suppressing sel num upregulating hop num
0.49589044.12668626.html.plaintext.txt	359	hop num activity required spr num spr num mediated suppression sel num egg laying defect
0.49589044.12668626.html.plaintext.txt	360	hop num haploinsufficient sel num spr num background
0.49589044.12668626.html.plaintext.txt	361	spr gene may function mechanism provide evidence mechanism mutant spr num spr num suppress sel num loss function allele involves de repression hop num transcription stage hop num expression alone suffice
0.49589044.12668626.html.plaintext.txt	362	similarly shown recently spr num spr num protein interact spr num upregulates hop num expression developmental stage mutation spr num spr num eimer et al
0.49589044.12668626.html.plaintext.txt	363	suggests spr num spr num spr num spr num suppress sel num upregulating hop num replacing one presenilin another
0.49589044.12668626.html.plaintext.txt	364	similarly mutation spr num genetically bypass need sel num bypass need sel num hop num wen et al
0.49589044.12668626.html.plaintext.txt	365	although hop num activity required suppression mechanism wen et al
0.49589044.12668626.html.plaintext.txt	366	find evidence hop num transcriptional de repression wen et al
0.49589044.12668626.html.plaintext.txt	367	however stage specific de repression hop num transcription seen would detectable mixed stage northern blot
0.49589044.12668626.html.plaintext.txt	368	thus propose spr num may also bypass need sel num mechanism spr num spr num spr num
0.49589044.12668626.html.plaintext.txt	369	upregulation hop num transcription early larval stage explain suppression sel num spr num spr num mutation spr num spr num clearly de repress transcription hop num early larval stage
0.49589044.12668626.html.plaintext.txt	370	however even suppressor strain absolute hop num transcript level early larval stage still much lower adult stage
0.49589044.12668626.html.plaintext.txt	371	believe stage specific increase hop num expression sufficient explain spr num spr num suppress sel num
0.49589044.12668626.html.plaintext.txt	372	even strong putative null sel num mutant sufficient hop num protein larval stage enable lin num dependent developmental decision occur correctly
0.49589044.12668626.html.plaintext.txt	373	sel num mutant ventral uterineanchor cell decision lateral inhibition vulval precursor sex myoblastcoelomocyte decision affected levitan greenwald num indicating sufficient presenilin activity provided hop num present many cell type
0.49589044.12668626.html.plaintext.txt	374	sel numarnum even cell fate executed correctly vast majority animal sel numarnum executed correctly animal sel num hop num double mutant num animal defective vulval uterine connection cinar et al
0.49589044.12668626.html.plaintext.txt	375	indicates sel num mutant expression hop num almost sufficient wild type cell induction
0.49589044.12668626.html.plaintext.txt	376	therefore likely small increase hop num expression could sufficient compensate completely loss sel num developmental decision
0.49589044.12668626.html.plaintext.txt	377	also reason believe small amount presenilin message may sufficient provide adequate level presenilin activity
0.49589044.12668626.html.plaintext.txt	378	presenilins normally found part high molecular weight complex capell et al
0.49589044.12668626.html.plaintext.txt	379	complex assembled er golgi protein incorporated complex targeted cell membrane rapidly degraded ratovitski et al
0.49589044.12668626.html.plaintext.txt	380	presenilins may required small amount amount component complex limiting assembly edbauer et al
0.49589044.12668626.html.plaintext.txt	381	consequently found cell culture presenilins overproduced thinakaran et al
0.49589044.12668626.html.plaintext.txt	382	furthermore presenilin complex thought enzymatic activity level complex necessary biochemical function may normally vast excess required
0.49589044.12668626.html.plaintext.txt	383	thus even amount complex present cell membrane spr sel num double mutant slightly lower wild type level wild type phenotype double mutant indicates suffices ensure sufficient level lin num signaling
0.49589044.12668626.html.plaintext.txt	384	increased expression hop num early larval stage seen spr num spr num mutant sufficient rescue later larval defect seen sel num mutant several reason believe case
0.49589044.12668626.html.plaintext.txt	385	first cell signaling event lead cell induction correct alignment sex muscle occur prior developmental change cinar et al
0.49589044.12668626.html.plaintext.txt	386	numa presenilin activity presumably required time signaling
0.49589044.12668626.html.plaintext.txt	387	second initial experiment suggested relative expression hop num increased lnum lnum lnum stage spr num spr num mutant
0.49589044.12668626.html.plaintext.txt	388	chose pursue lnum stage thought upregulation hop num expression might obvious stage
0.49589044.12668626.html.plaintext.txt	389	furthermore demonstrated cell culture assembled high molecular weight presenilin complex stable long time period edbauer et al
0.49589044.12668626.html.plaintext.txt	390	finally indication presenilin complex necessary small amount persist num hour c
0.49589044.12668626.html.plaintext.txt	391	elegans see rescue sex myoblastcoelomocyte cell fate decision hop numsel num double mutant maternally provided hop num eimer et al
0.49589044.12668626.html.plaintext.txt	392	thus presenilin protein produced embryo sufficiently stable produced sufficient amount cell fate decision occurring lnum stage
0.49589044.12668626.html.plaintext.txt	393	spr num spr num perform conserved function although spr num spr num clear mammalian homologs may performing similar function known transcriptional repressor
0.49589044.12668626.html.plaintext.txt	394	spr num spr num resemble known transcriptional repressor especially restnrsf renum silencing transcription factorneural restrictive silencing factor different vertebrate
0.49589044.12668626.html.plaintext.txt	395	cnumhnum zinc finger factor rest mediates repression neuronal gene non neuronal cell recruiting co repressor complex sinnum corest humphrey et al
0.49589044.12668626.html.plaintext.txt	396	co repressor complex contain multiple protein including histone deacetylases presumably repress transcription part removing activating acetyl group histone hnum hnum target locus
0.49589044.12668626.html.plaintext.txt	397	possible spr num spr num may also function recruiting conserved co repressor complex hop num locus
0.49589044.12668626.html.plaintext.txt	398	three spr gene spr num spr num spr num encode protein similar component known co repressor eimer et al
0.49589044.12668626.html.plaintext.txt	399	numb jarriault greenwald num wen et al
0.49589044.12668626.html.plaintext.txt	400	spr num member nucleosome assembly protein nap family similar human oncogene set wen et al
0.49589044.12668626.html.plaintext.txt	401	human set purified part inhat inhibitor acetyltransferases co repressor complex help repress transcription binding histone masking acetyltransferase substrate pnumcbp pcaf seo et al
0.49589044.12668626.html.plaintext.txt	402	recently shown upregulation set also inhibits demethylation methylated dna may integrate epigenetic state dna associated histone cervoni et al
0.49589044.12668626.html.plaintext.txt	403	another paper reported identification characterization spr num encodes polyamine oxidase like protein similar known component corest co repressor complex eimer et al
0.49589044.12668626.html.plaintext.txt	404	core corest complex contains six protein hakimi et al
0.49589044.12668626.html.plaintext.txt	405	spr num encodes homolog myb domain containing protein corest eimer et al
0.49589044.12668626.html.plaintext.txt	406	numb jarriault greenwald num additional component corest co repressor complex
0.49589044.12668626.html.plaintext.txt	407	shown spr num spr num interact biochemically vitro vivo eimer et al
0.49589044.12668626.html.plaintext.txt	408	suggests similar complex present c
0.49589044.12668626.html.plaintext.txt	409	elegans function repress hop num transcription
0.49589044.12668626.html.plaintext.txt	410	interestingly corest found associate least two large basic cnumhnum zinc finger protein znfnum rest et al
0.49589044.12668626.html.plaintext.txt	411	num may general co repressor complex recruited different locus different cell type binding different cnumhnum zinc finger protein
0.49589044.12668626.html.plaintext.txt	412	recent work also suggests corest may interact component swi snf complex battaglioli et al
0.49589044.12668626.html.plaintext.txt	413	num may involved silencing chromosomal region lunyak et al
0.49589044.12668626.html.plaintext.txt	414	protein encoded spr gene may form one transcriptional repressor complex thus spr num spr num may recruit one conserved co repressor complex including one similar corest co repressor complex target locus
0.49589044.12668626.html.plaintext.txt	415	propose following model spr gene functioning
0.49589044.12668626.html.plaintext.txt	416	fact loss function mutation either spr num spr num suppress sel num de repress hop num transcription suggest spr num spr num normally recruited hop num locus
0.49589044.12668626.html.plaintext.txt	417	associate co repressor protein similar member inhat corest co repressor complex
0.49589044.12668626.html.plaintext.txt	418	unclear two zinc finger protein co operatively bind co repressor protein zinc finger protein associate different complex
0.49589044.12668626.html.plaintext.txt	419	assembled complex complex probably act basal repressor hop num transcription overridden later developmental stage
0.49589044.12668626.html.plaintext.txt	420	mammalian inhat corest complex purified studied biochemical approach
0.49589044.12668626.html.plaintext.txt	421	however yet little known biological function
0.49589044.12668626.html.plaintext.txt	422	data available spr gene function suggest inhat corest complex studied genetically biochemically c
0.49589044.12668626.html.plaintext.txt	423	elegans genetics may identify additional gene interact complex may help elucidate biological function
0.49589044.12668626.html.plaintext.txt	424	acknowledgment thank gian garriga sophie jarriault iva greenwald jim mccarter sanger institute genome sequencing center washington university st louis communicating unpublished information jean claude labbe advice rna isolation northern analysis jonathan hodgkin iva greenwald strain yuji kohara cdna clone bob barstead cdna library alan coulson cosmid clone
0.49589044.12668626.html.plaintext.txt	425	strain used work provided caenorhabditis genetics center funded national center research resource nih
0.49589044.12668626.html.plaintext.txt	426	work supported embo fellowship b
0.49589044.12668626.html.plaintext.txt	427	grant dfg ec diadem bmbf ngfn r
0.49589044.12668626.html.plaintext.txt	428	footnote supplemental data available online
0.49589044.12668626.html.plaintext.txt	429	incaenorhabditis elegans modern biological analysis organism method cell biology ed
0.49589044.12668626.html.plaintext.txt	430	presenilin protein family member spe num localizes ergolgi derived organelle required proper cytoplasmic partitioning caenorhabditis elegans spermatogenesis
0.49589044.12668626.html.plaintext.txt	431	rest repression neuronal gene requires component hswi
0.49589044.12668626.html.plaintext.txt	432	human presenilin num familial alzheimers disease fad mutant facilitate caenorhabditis elegans notch signalling independently proteolytic processing
0.49589044.12668626.html.plaintext.txt	433	molecular evolutionary framework phylum nematoda
0.49589044.12668626.html.plaintext.txt	434	proteolytic fragment alzheimers disease associated presenilin num form heterodimers occur num num kda molecular mass complex
0.49589044.12668626.html.plaintext.txt	435	oncoprotein settaf numss inhibitor histone acetyltransferase inhibits active demethylation dna integrating dna methylation transcriptional silencing
0.49589044.12668626.html.plaintext.txt	436	sel num presenilin mediates induction caenorhabditis elegans uterine pi cell fate
0.49589044.12668626.html.plaintext.txt	437	deficiency presenilin num inhibits normal cleavage amyloid precursor protein
0.49589044.12668626.html.plaintext.txt	438	presenilin num dependent gamma secretase like protease mediates release notch intracellular domain
0.49589044.12668626.html.plaintext.txt	439	sel num nuclear protein required lin num glp num signaling caenorhabditis elegans
0.49589044.12668626.html.plaintext.txt	440	presenilin nicastrin regulate determine amyloid beta peptide production via complex formation
0.49589044.12668626.html.plaintext.txt	441	caenorhabditis elegans presenilin sel num required mesodermal patterning muscle function
0.49589044.12668626.html.plaintext.txt	442	loss spr num bypass requirement c
0.49589044.12668626.html.plaintext.txt	443	elegans presenilin sel num derepressing hop num
0.49589044.12668626.html.plaintext.txt	444	notch presenilin proteolytic mechanism emerges
0.49589044.12668626.html.plaintext.txt	445	aph num pen num required notch pathway signaling gamma secretase cleavage ssapp presenilin protein accumulation
0.49589044.12668626.html.plaintext.txt	446	mastermind mediates chromatin specific transcription turnover notch enhancer complex
0.49589044.12668626.html.plaintext.txt	447	functional interaction sel num f box protein nuclear form activated notchnum receptor
0.49589044.12668626.html.plaintext.txt	448	core brafnum complex containing histone deacetylase mediates repression neuronal specific gene
0.49589044.12668626.html.plaintext.txt	449	regulation interneuron function c
0.49589044.12668626.html.plaintext.txt	450	elegans thermoregulatory pathway ttx num lim homeobox gene
0.49589044.12668626.html.plaintext.txt	451	sel num negative regulator lin num activity caenorhabditis elegans encodes member cdcnum family protein
0.49589044.12668626.html.plaintext.txt	452	stable histone deacetylase complex distinguished presence sant domain protein corestkiaanum mta lnum
0.49589044.12668626.html.plaintext.txt	453	local high density single nucleotide polymorphism map used clone caenorhabditis elegans cdf num
0.49589044.12668626.html.plaintext.txt	454	suppressor egg laying defective phenotype sel num presenilin mutant implicate corest corepressor complex lin numnotch signaling c
0.49589044.12668626.html.plaintext.txt	455	temporal reiteration precise gene expression pattern nematode development
0.49589044.12668626.html.plaintext.txt	456	effectiveness specific rna mediated interference ingested double stranded rna caenorhabditis elegans
0.49589044.12668626.html.plaintext.txt	457	facilitation lin num mediated signalling sel num caenorhabditis elegans snum alzheimers disease gene
0.49589044.12668626.html.plaintext.txt	458	assessment normal mutant human presenilin function caenorhabditis elegans
0.49589044.12668626.html.plaintext.txt	459	mutation putative sperm membrane protein caenorhabditis elegans prevents sperm differentiation associated meiotic division
0.49589044.12668626.html.plaintext.txt	460	hop num caenorhabditis elegans presenilin appears functionally redundant sel num presenilin facilitate lin num glp num signaling
0.49589044.12668626.html.plaintext.txt	461	presenilin num linked gamma secretase activity detergent solubilized state
0.49589044.12668626.html.plaintext.txt	462	corepressor dependent silencing chromosomal region encoding neuronal gene
0.49589044.12668626.html.plaintext.txt	463	large scale analysis gene function caenorhabditis elegans high throughput rnai
0.49589044.12668626.html.plaintext.txt	464	lag num putative transcriptional activator c
0.49589044.12668626.html.plaintext.txt	465	endoproteolytic processing stabilization wild type mutant presenilin
0.49589044.12668626.html.plaintext.txt	466	molecular cloning laboratory manual
0.49589044.12668626.html.plaintext.txt	467	cold spring harbor ny cold spring harbor laboratory press
0.49589044.12668626.html.plaintext.txt	468	alzheimers disease gene protein therapy
0.49589044.12668626.html.plaintext.txt	469	regulation histone acetylation transcription inhat human cellular complex containing set oncoprotein
0.49589044.12668626.html.plaintext.txt	470	gamma secretase notch as alzheimers disease presenilins fit nat
0.49589044.12668626.html.plaintext.txt	471	proteolytic release nuclear translocation notch num induced presenilin num impaired pathogenic presenilin num mutation
0.49589044.12668626.html.plaintext.txt	472	elegans polycistronic mrna precursor processed trans splicing slnum downstream coding region
0.49589044.12668626.html.plaintext.txt	473	glycine num required presenilin num function conserved bacterial polytopic aspartyl protease
0.49589044.12668626.html.plaintext.txt	474	nuclear access action notch vivo
0.49589044.12668626.html.plaintext.txt	475	inthe nematode caenorhabditis elegans ed
0.49589044.12668626.html.plaintext.txt	476	cold spring harbor ny cold spring harbor laboratory press
0.49589044.12668626.html.plaintext.txt	477	endoproteolysis presenilin num accumulation processed derivative vivo
0.49589044.12668626.html.plaintext.txt	478	stable association presenilin derivative absence presenilin interaction app
0.49589044.12668626.html.plaintext.txt	479	specific interference ingested dsrna
0.49589044.12668626.html.plaintext.txt	480	ingestion bacterially expressed dsrnas produce specific potent genetic interference caenorhabditis elegans
0.49589044.12668626.html.plaintext.txt	481	spr num suppressor egg laying defect caused loss sel num presenilin caenorhabditis elegans member set protein subfamily
0.49589044.12668626.html.plaintext.txt	482	reverse genetic analysis caenorhabditis elegans presenilins reveals redundant unequal role sel num hop num notch pathway signaling
0.49589044.12668626.html.plaintext.txt	483	presenilin required proper morphology function neuron c
0.49589044.12668626.html.plaintext.txt	484	two transmembrane aspartates presenilin num required presenilin endoproteolysis gamma secretase activity
0.49589044.12668626.html.plaintext.txt	485	corest integral component corest human histone deacetylase complex
0.49589044.12668626.html.plaintext.txt	486	presenilin num protein component high molecular weight intracellular complex contains sscatenin
0.49589044.12668626.html.plaintext.txt	487	article summary figure full text pdf supplemental data alert article cited alert correction posted service email article friend similar article journal similar article pubmed alert new issue journal download citation manager google scholar article lakowski b
0.49589044.12668626.html.plaintext.txt	488	article citing article pubmed pubmed citation article lakowski b
0.49919817.11076969.html.plaintext.txt	0	identification ubiquilin novel presenilin interactor increase presenilin protein accumulation alex l
0.49919817.11076969.html.plaintext.txt	1	monteiroa medical biotechnology center department neurology university maryland biotechnology institute baltimore maryland num b institute pathology case western reserve university cleveland ohio num
0.49919817.11076969.html.plaintext.txt	2	monteiro medical biotechnology center room nnum num west lombard street baltimore md num
0.49919817.11076969.html.plaintext.txt	3	telnum num num faxnum num num
0.49919817.11076969.html.plaintext.txt	4	mutation highly homologous presenilin gene encoding presenilin num presenilin num psnum psnum linked early onset alzheimers disease ad
0.49919817.11076969.html.plaintext.txt	5	however apart role early development neither normal function presenilins mechanism mutant protein cause ad well understood
0.49919817.11076969.html.plaintext.txt	6	describe property novel human interactor presenilins named ubiquilin
0.49919817.11076969.html.plaintext.txt	7	yeast two hybrid ynumh interaction glutathione transferase pull experiment colocalization protein expressed vivo together coimmunoprecipitation cell fractionation study provide compelling evidence ubiquilin interacts psnum psnum
0.49919817.11076969.html.plaintext.txt	8	ubiquilin noteworthy since contains multiple ubiquitin related domain typically thought involved targeting protein degradation
0.49919817.11076969.html.plaintext.txt	9	however show ubiquilin promotes presenilin protein accumulation
0.49919817.11076969.html.plaintext.txt	10	pulse labeling experiment indicate ubiquilin facilitates increased presenilin synthesis without substantially changing presenilin protein half life
0.49919817.11076969.html.plaintext.txt	11	immunohistochemistry human brain tissue ubiquilin specific antibody revealed prominent staining neuron
0.49919817.11076969.html.plaintext.txt	12	moreover anti ubiquilin antibody robustly stained neurofibrillary tangle lewy body ad parkinson disease affected brain respectively
0.49919817.11076969.html.plaintext.txt	13	result indicate ubiquilin may important modulator presenilin protein accumulation ubiquilin protein associated neuropathological neurofibrillary tangle lewy body inclusion diseased brain
0.49919817.11076969.html.plaintext.txt	14	key word presenilins alzheimers disease ubiquilin ubiquitin proteasome
0.49919817.11076969.html.plaintext.txt	15	alzheimers disease adnum progressive neurodegenerative disorder characterized impaired memory cognition well altered behavior
0.49919817.11076969.html.plaintext.txt	16	majority ad case late onset appearing people age num
0.49919817.11076969.html.plaintext.txt	17	however small percent num case termed early onset arise unusually young age early third decade life
0.49919817.11076969.html.plaintext.txt	18	molecular genetic analysis linked early onset familial alzheimers disease fad autosomal dominant inheritance mutation three gene s amyloid precursor protein app two homologous gene presenilin num num psnum psnum hardy num price et al
0.49919817.11076969.html.plaintext.txt	19	mechanism mutation three gene cause ad unresolved
0.49919817.11076969.html.plaintext.txt	20	psnum psnum multitransmembrane protein share num sequence identity
0.49919817.11076969.html.plaintext.txt	21	topology presenilins debatable though widely drawn model show protein weave membrane eight time nhnum cooh terminal domain large loop transmembrane domain six seven oriented towards cytoplasm see fig num haass de strooper num
0.49919817.11076969.html.plaintext.txt	22	although protein share extensive sequence identity along entire length nhnum terminal domain second half loop highly divergent suggesting unique region could modulate different function two presenilins
0.49919817.11076969.html.plaintext.txt	23	examination presenilin linked fad mutation mapped far reveals missense mutation identical residue spread throughout polypeptide presenilins suggesting conserved residue important function protein
0.49919817.11076969.html.plaintext.txt	24	view larger version numk figure num
0.49919817.11076969.html.plaintext.txt	25	ubiquilin interacts two different region presenilin protein
0.49919817.11076969.html.plaintext.txt	26	schematic diagram er bound human psnum show eight transmembrane domain nhnum terminus large hydrophilic loop cooh terminus protruding cytoplasm
0.49919817.11076969.html.plaintext.txt	27	psnum believed similar structure
0.49919817.11076969.html.plaintext.txt	28	presenilin loop region loop white cooh terminus striped used ynumh assay
0.49919817.11076969.html.plaintext.txt	29	two psnum mutant used study contained progressively longer cooh terminal deletion psnumc terminated arrowhead psnumlc terminated arrow
0.49919817.11076969.html.plaintext.txt	30	b amino acid sequence psnum psnum cooh terminus loop region used ynumh bait
0.49919817.11076969.html.plaintext.txt	31	c ynumh s galactosidase liquid culture interaction assay ubiquilin prey clone fig num iii construct b without gst psnum cooh terminus psnum c lexa alone nuclear lamin b cenp c bait
0.49919817.11076969.html.plaintext.txt	32	s galactosidase unit normalized cenp c bait weakest interaction
0.49919817.11076969.html.plaintext.txt	33	d s galactosidase interaction assay data near full length ubiquilin prey clone fig num iii construct h without gst repeated bait described c along psnum cooh psnum c terminus psnum loop psnum l psnum loop psnum l bait
0.49919817.11076969.html.plaintext.txt	34	s galactosidase unit normalized cenp c
0.49919817.11076969.html.plaintext.txt	35	study presenilin homologues various specie indicated presenilin gene required proper development
0.49919817.11076969.html.plaintext.txt	36	mutation caenorhabditis elegans presenilin gene sel num produce defect vulva development linked cell signaling defect involving notch based receptor levitan greenwald num haass de strooper num
0.49919817.11076969.html.plaintext.txt	37	disruption drosophila melanogaster presenilin gene result embryonic lethality embryo displaying severe notch like phenotype struhl greenwald num ye et al
0.49919817.11076969.html.plaintext.txt	38	mammalian presenilins also play important role early development disruption mouse psnum gene lead death shortly birth embryo displaying central nervous system defect together abnormal patterning axial skeleton spinal ganglion shen et al
0.49919817.11076969.html.plaintext.txt	39	interestingly psnum mouse rescued human transgene containing fad linked mutation indicating fad mutation affect presenilin function related embryo development davis et al
0.49919817.11076969.html.plaintext.txt	40	contrast disruption mouse psnum gene produce obvious defect psnumpsnum double knock mouse die earlier embryonic day num
0.49919817.11076969.html.plaintext.txt	41	num like psnum mouse display severe misexpression protein involved notch signaling donoviel et al
0.49919817.11076969.html.plaintext.txt	42	result indicate functional redundancy psnum psnum psnum compensate psnum psnum compensate psnum least early mouse development
0.49919817.11076969.html.plaintext.txt	43	human presenilin gene ubiquitously expressed low level
0.49919817.11076969.html.plaintext.txt	44	brain protein highly expressed neuron glia price et al
0.49919817.11076969.html.plaintext.txt	45	knowledge presenilin protein localize cell important understanding function
0.49919817.11076969.html.plaintext.txt	46	however uncertainty exist regarding precise subcellular localization
0.49919817.11076969.html.plaintext.txt	47	neuron endogenous psnum psnum localized er vesicular structure somatodentritic compartment axon price et al
0.49919817.11076969.html.plaintext.txt	48	num haass de strooper num
0.49919817.11076969.html.plaintext.txt	49	overexpressed protein predominantly localize er golgi complex nuclear envelope kovacs et al
0.49919817.11076969.html.plaintext.txt	50	num janicki monteiro num haass de strooper num
0.49919817.11076969.html.plaintext.txt	51	however nonneuronal cell endogenous presenilins localized er golgi complex centrosome centromere cell surface georgakopoulos et al
0.49919817.11076969.html.plaintext.txt	52	num haass de strooper num raina et al
0.49919817.11076969.html.plaintext.txt	53	known extent diverse location reflect true site presenilin function
0.49919817.11076969.html.plaintext.txt	54	presenilin protein linked several cellular function
0.49919817.11076969.html.plaintext.txt	55	interestingly cellular function compromised altered expression p gene containing fad mutation
0.49919817.11076969.html.plaintext.txt	56	presenilin protein shown play important role apoptosis calcium homeostasis cell cycle regulation regulation misfolded protein er cleavage app guo et al
0.49919817.11076969.html.plaintext.txt	57	num janicki monteiro num janicki monteiro num cotman num mattson et al
0.49919817.11076969.html.plaintext.txt	58	num haass de strooper num katayama et al
0.49919817.11076969.html.plaintext.txt	59	clue regarding presenilin function emerging growing list protein presenilin interacts
0.49919817.11076969.html.plaintext.txt	60	previously identified characterized calmyrin newly discovered calcium binding protein preferentially interacts psnum loop modulates presenilin induced cell death stabler et al
0.49919817.11076969.html.plaintext.txt	61	describe novel human presenilin interacting protein named ubiquilin
0.49919817.11076969.html.plaintext.txt	62	describe evidence indicates ubiquilin modulates presenilin protein level associated neuropathological lesion nfts lewy body ad pd affected brain
0.49919817.11076969.html.plaintext.txt	63	ubiquilin cdna protein sequence genbankemblddbj ubiquilin cdna accession number afnum ubiquilin protein accession number aadnum see updated nmnum
0.49919817.11076969.html.plaintext.txt	64	yeast two hybrid experiment yeast two hybrid ynumh procedure utilizes lexatransactivation system performed described previously stabler et al
0.49919817.11076969.html.plaintext.txt	65	psnum cooh terminal num amino acid residue knum inum see fig numa fig b used bait screen human fetal brain cdna library
0.49919817.11076969.html.plaintext.txt	66	num primary yeast transformants num clone selected analysis based growth absence leucine substantial blue color change grown num bromo num chloro num indolyl s d galactopyranoside x gal plate
0.49919817.11076969.html.plaintext.txt	67	false positive subsequently eliminated based interaction negative control bait lexa alone nuclear lamin b cenp c centromere protein
0.49919817.11076969.html.plaintext.txt	68	plasmid dna isolated clone fulfilled requirement dna sequence insert determined compared genbankemblddbj database using blast search program
0.49919817.11076969.html.plaintext.txt	69	two interactors contained overlapping portion num end novel human transcript named ubiquilin
0.49919817.11076969.html.plaintext.txt	70	interaction ubiquilin protein various psnum psnum bait quantified liquid culture assay enzymatic conversion o nitrophenyl s d galactopyranoside onpg o nitrophenol d galactose s galactosidase enzyme encoded ynumh reporter plasmid
0.49919817.11076969.html.plaintext.txt	71	rapid amplification cdna end race num race using strategically designed ubiquilin specific primer performed obtain full length coding sequence ubiquilin
0.49919817.11076969.html.plaintext.txt	72	pcr reaction carried according instruction provided manufacturer using apnum adaptor ligated human adult brain cdna library template advantage cdna polymerase mix clontech laboratory inc
0.49919817.11076969.html.plaintext.txt	73	procedure resulted isolation numnum additional bps num sequence respect longest original ynumh clone
0.49919817.11076969.html.plaintext.txt	74	full length ubiquilin open reading frame orf subsequently obtained sequencing human expressed sequence tag est clone american type culture collection provided extra num bps num sequence including atg start codon kozak consensus sequence upstream frame stop codon
0.49919817.11076969.html.plaintext.txt	75	addition comparison sequence tigr tentative human consensus database returned another independent est sequence thcnum corroborated atg start codon
0.49919817.11076969.html.plaintext.txt	76	radiation hybrid mapping genebridge num radiation hybrid panel research genetics performed two ubiquilin gene specific primer rhnum num gcagcgacaacttttgtctaaccctg num rhnum num caggcaccaaatttggcgcagtag num num indexed human genomic dna template pool
0.49919817.11076969.html.plaintext.txt	77	condition pcr reaction similar num race procedure except longer initial denaturation step used
0.49919817.11076969.html.plaintext.txt	78	positive negative reaction num num respectively num represents ambiguous reaction compiled num num num num num num num num num num vector data submitted whitehead institutemit center genome research website httpcarbon
0.49919817.11076969.html.plaintext.txt	79	edunumcgi bincontigrhmapper
0.49919817.11076969.html.plaintext.txt	80	pl comparison radiation hybrid database
0.49919817.11076969.html.plaintext.txt	81	northern blot analysis cdna hybridization probe nump radiolabeled random primer labeling num ng two ubiquilin cdna restriction fragment x base numnum numnum y base num num shown fig num ii
0.49919817.11076969.html.plaintext.txt	82	probe hybridized different human mrna northern blot human multiple tissue northern blot human brain mtn ii respectively clontech laboratory inc
0.49919817.11076969.html.plaintext.txt	83	hybridization blot washed twice num
0.49919817.11076969.html.plaintext.txt	84	num sd num degree c twice num
0.49919817.11076969.html.plaintext.txt	85	num sd num degree c exposure autoradiography film
0.49919817.11076969.html.plaintext.txt	86	blot subsequently stripped near boiling temperature num
0.49919817.11076969.html.plaintext.txt	87	num sd reprobed radiolabeled human s actin cdna control probe clontech laboratory inc
0.49919817.11076969.html.plaintext.txt	88	band intensity quantified using gelexpert num num
0.49919817.11076969.html.plaintext.txt	89	divided s actin control band intensity lane normalized lowest value
0.49919817.11076969.html.plaintext.txt	90	view larger version numk figure num
0.49919817.11076969.html.plaintext.txt	91	schematic drawing ubiquilin expression construct
0.49919817.11076969.html.plaintext.txt	92	full length ubiquilin polypeptide consists num residue contains nhnum terminal ub domain speckled cooh terminal uba domain striped several regularly spaced asparagine proline asn pro repeat vertical bar
0.49919817.11076969.html.plaintext.txt	93	ii probe used human northern blot
0.49919817.11076969.html.plaintext.txt	94	iii gst fusion construct nnum snum aa b qnum snum aa c qnum mnum aa d qnum snum aa e dnum snum aa f dnum lnum aa g nnum lnum aa h mnum snum aa mnum lnum aa j qnum lnum aa k qnum snum aa l gst alone
0.49919817.11076969.html.plaintext.txt	95	ubiquilin portion construct b isolated original ynumh screen
0.49919817.11076969.html.plaintext.txt	96	bacterially expressed gst fusion b c polypeptide used immunogen anti ubiquilin pab production
0.49919817.11076969.html.plaintext.txt	97	iv mammalian expression construct m full length untagged ubiquilin n nhnum terminal gfp tagged ubiquilin fused residue num ala o cooh terminal myc epitope tagged ubiquilin
0.49919817.11076969.html.plaintext.txt	98	bacterial expression ubiquilin protein express full length nonfusion ubiquilin protein bacteria ncoixhoi cdna fragment containing entire ubiquilin orf subcloned pet numb novagen transformed escherichia coli blnumdenum
0.49919817.11076969.html.plaintext.txt	99	ubiquilin protein expression induced num
0.49919817.11076969.html.plaintext.txt	100	num mm iptg num degree c num num h
0.49919817.11076969.html.plaintext.txt	101	bacteria lysed protein extract separated sd page
0.49919817.11076969.html.plaintext.txt	102	protein transferred onto nitrocellulose filter immunoblotted anti ubiquilin pab
0.49919817.11076969.html.plaintext.txt	103	addition various partial length gst ubiquilin fusion protein constructed expressed purified using gst protein purification procedure described previously janicki monteiro num
0.49919817.11076969.html.plaintext.txt	104	specific subregions ubiquilin expressed depicted fig num iii
0.49919817.11076969.html.plaintext.txt	105	rabbit pab production affinity purification rabbit anti ubiquilin polyclonal antiserum generated purified gst ubiquilin fusion protein b c fig num iii covance research product inc
0.49919817.11076969.html.plaintext.txt	106	affinity purified anti ubiquilin c antibody obtained passing anti c serum first column containing gst alone coupled ch sepharose numb bead num degree c overnight eliminate antibody binding gst mixing flow fraction ubiquilin coupled ch sepharose numb bead num degree c overnight
0.49919817.11076969.html.plaintext.txt	107	extensive washing antibody bound ubiquilin coupled bead eluted dropwise num
0.49919817.11076969.html.plaintext.txt	108	num m sodium chloride solution ph num
0.49919817.11076969.html.plaintext.txt	109	num collected num microl fraction tube containing num microl num m tris hcl ph num
0.49919817.11076969.html.plaintext.txt	110	vitro transcription translation numsmethionine radiolabeled ubiquilin luciferase protein synthesized rabbit reticulocyte lysates vitro transcription translation system promega num degree c num min
0.49919817.11076969.html.plaintext.txt	111	numsmethionine radiolabeled psnum psnum synthesized using system addition canine pancreatic microsomal membrane promega transcription translation
0.49919817.11076969.html.plaintext.txt	112	gst pull binding assay various purified gst ubiquilin fusion protein already bound glutathione agarose bead incubated num
0.49919817.11076969.html.plaintext.txt	113	num microl numsmethionine radiolabeled presenilin protein addition protease inhibitor num
0.49919817.11076969.html.plaintext.txt	114	num bsa num degree c num h rocking
0.49919817.11076969.html.plaintext.txt	115	bead washed several time pull buffer num
0.49919817.11076969.html.plaintext.txt	116	numx pb num mm kcl pull buffer several time pull buffer alone
0.49919817.11076969.html.plaintext.txt	117	supernatant wash discarded whereas bound protein bead mixed sample loading buffer janicki monteiro num separated sd page
0.49919817.11076969.html.plaintext.txt	118	gel stained coomassie blue ensure equal loading gst ubiquilin fusion protein
0.49919817.11076969.html.plaintext.txt	119	gel dried exposed autoradiography film
0.49919817.11076969.html.plaintext.txt	120	mammalian expression fusion construct full length ubiquilin expressed using pgem cmv mammalian expression vector janicki monteiro num see fig num iv
0.49919817.11076969.html.plaintext.txt	121	addition two ubiquilin fusion protein constructed within expression vector
0.49919817.11076969.html.plaintext.txt	122	one green fluorescent protein gfp fused nhnum terminus ubiquilin beginning residue num ala whereas myc epitope tag fused cooh terminus full length ubiquilin
0.49919817.11076969.html.plaintext.txt	123	hela cell culture dna transfection hela cell grown num degree c dme supplemented num fbs transfected plasmid dna using calcium phosphate coprecipitation method
0.49919817.11076969.html.plaintext.txt	124	western blot analysis cell lysed buffer containing protease inhibitor monteiro mical num protein concentration determined bicinchonic acid bca assay
0.49919817.11076969.html.plaintext.txt	125	lysates containing known amount protein mixed sample loading buffer janicki monteiro num either heated num degree c num min num degree c num min separation sd page
0.49919817.11076969.html.plaintext.txt	126	num degree c incubation used detect presenilin protein minimizing tendency aggregate resist entry gel
0.49919817.11076969.html.plaintext.txt	127	gel electrophoresis protein transferred onto nitrocellulose filter immunoblotted according procedure described previously janicki monteiro num
0.49919817.11076969.html.plaintext.txt	128	addition rabbit anti ubiquilin antibody also used following primary antibody goat anti psnum anti psnum anti bip nhnum terminus specific santa cruz biotechnology inc
0.49919817.11076969.html.plaintext.txt	129	rabbit anti psnum nhnum terminus loop specific raised corresponding gst psnum fusion protein janicki monteiro num janicki monteiro num anti ubiquitin dako anti lamin ac mical monteiro num anti calnexin anti calreticulin stressgen mouse anti gfp zymed laboratory anti tubulin sigma aldrich anti lamin b matritect
0.49919817.11076969.html.plaintext.txt	130	binding primary antibody detected numi protein incubation appropriate secondary horseradish peroxidase conjugated antibody new england biolabs inc
0.49919817.11076969.html.plaintext.txt	131	using autoradiography chemiluminescence respectively
0.49919817.11076969.html.plaintext.txt	132	immunoprecipitation cell fractionation study hela cell num h transfection psnum plasmid dna collected immunoprecipitation buffer num mm tris hcl ph num
0.49919817.11076969.html.plaintext.txt	133	num np num num mm edta homogenized gentle stroke dounce homogenizer
0.49919817.11076969.html.plaintext.txt	134	centrifugation pellet discarded protein immunoprecipitated remaining supernatant adding rabbit antiserum preimmune anti psnum nhnum terminus anti psnum loop protein sepharose cl numb bead stabler et al
0.49919817.11076969.html.plaintext.txt	135	bead recovered centrifugation washed num
0.49919817.11076969.html.plaintext.txt	136	boiled sample loading buffer bound protein analyzed sd page immunoblotting
0.49919817.11076969.html.plaintext.txt	137	blot probed primary anti ubiquilin b antibody subsequently detected numi protein
0.49919817.11076969.html.plaintext.txt	138	soluble insoluble triton x num soluble triton x num insoluble protein fraction untransfected psnum transfected hela cell prepared according procedure described previously stabler et al
0.49919817.11076969.html.plaintext.txt	139	equal amount fraction separated sd page electroblot transfer nitrocellulose filter immunoblotted either affinity purified anti ubiquilin c antibody anti psnum nhnum terminus antibody anti lamin ac antibody mical monteiro num
0.49919817.11076969.html.plaintext.txt	140	partitioning endogenous lamin ac protein monitored since cell fractionation behavior known mical monteiro num stabler et al
0.49919817.11076969.html.plaintext.txt	141	cell staining immunofluorescence microscopy procedure used immunofluorescence staining hela cell described previously janicki monteiro num
0.49919817.11076969.html.plaintext.txt	142	indirect immunofluorescent microscopy digital image capture subsequent manipulation merging image done leica dm irb microscope attached powermac computer running signal analytics iplab spectrum software stabler et al
0.49919817.11076969.html.plaintext.txt	143	confocal image captured axiovert num microscope using lsm software zeiss
0.49919817.11076969.html.plaintext.txt	144	primary antibody used rabbit anti ubiquilin b affinity purified anti ubiquilin c goat anti psnum anti psnum nhnum terminus specific santa cruz biotechnology inc
0.49919817.11076969.html.plaintext.txt	145	mouse anti myc mical monteiro num
0.49919817.11076969.html.plaintext.txt	146	human brain immunohistochemistry hippocampus brain tissue six ad case aged num num five control case aged num num fixed methacarn numnumnum chloroformmethanolacetic acid overnight
0.49919817.11076969.html.plaintext.txt	147	locus coreuleus substantia nigra brain tissue three pd case aged num num fixed formalin overnight whereas frontal cortex brain tissue two case diffuse lewy body disease aged num num fixed either formalin methacarn overnight
0.49919817.11076969.html.plaintext.txt	148	sample dehydrated embedded paraffin
0.49919817.11076969.html.plaintext.txt	149	section cut num microm thick mounted onto glass slide
0.49919817.11076969.html.plaintext.txt	150	deparaffinization xylene section hydrated graded ethanol treatment endogenous peroxidase activity eliminated incubation num hydrogen peroxide num min
0.49919817.11076969.html.plaintext.txt	151	nonspecific binding site blocked num normal goat serum tris buffered saline num mm tris hcl num mm nacl ph num
0.49919817.11076969.html.plaintext.txt	152	num num min application either preimmune serum affinity purified anti ubiquilin c antibody anti ubiquilin b antibody
0.49919817.11076969.html.plaintext.txt	153	immunostaining performed using peroxidase anti peroxidase method dab cosubstrate sternberger num
0.49919817.11076969.html.plaintext.txt	154	color image stained slide captured using sony digital photo camera dkc num nikon eclipse enum microscope using adobe photoshop software
0.49919817.11076969.html.plaintext.txt	155	protein accumulation study hela cell transfected expression construct encoding ubiquilin protein num microg plasmid dna psnum protein num microg plasmid dna
0.49919817.11076969.html.plaintext.txt	156	num h transfection cell incubated additional num num h dmefbs medium absence presence proteasome inhibitor num microm synthetic lactacystin num microm mg num calbiochem novabiochemcalbiochem novabiochem
0.49919817.11076969.html.plaintext.txt	157	afterwards cell lysed buffer containing protease inhibitor protein concentration determined
0.49919817.11076969.html.plaintext.txt	158	protein extract totaling num microg loaded per lane separated sd page immunodetected various antibody
0.49919817.11076969.html.plaintext.txt	159	follow experiment hela cell cotransfected constant amount psnum num microg plasmid dna increasing amount either ubiquilin num num num num num microg plasmid dna gfp num num num num num microg plasmid dna expression vector
0.49919817.11076969.html.plaintext.txt	160	pulse chase experiment exponentially growing hela cell maintained flask trypsinized resuspended density num
0.49919817.11076969.html.plaintext.txt	161	num x num cellsml opti mem medium gibco brl
0.49919817.11076969.html.plaintext.txt	162	num ml aliquot cell suspension electroporated mixture either num microg psnum num microg egfp cnum clontech laboratory inc
0.49919817.11076969.html.plaintext.txt	163	expression plasmid dna num microg psnum num microg ubiquilin expression plasmid dna
0.49919817.11076969.html.plaintext.txt	164	aliquot containing dna mixture combined resuspended num ml optimem medium containing num fbs num ml suspension plated num separate well num
0.49919817.11076969.html.plaintext.txt	165	cell incubated num h allow attachment dish medium removed replaced dme containing num fbs
0.49919817.11076969.html.plaintext.txt	166	incubation continued additional num h
0.49919817.11076969.html.plaintext.txt	167	cell starved num min methionine deficient dme containing num dialyzed fbs
0.49919817.11076969.html.plaintext.txt	168	medium removed cell well pulse labeled adding num ml methionine deficient medium containing num microci numsmethionine numnum cimmol amersham pharmacia biotech num h
0.49919817.11076969.html.plaintext.txt	169	labeling cell washed twice dme containing num mm nonradioactive l methionine num dialyzed fbs chased num ml medium num num h
0.49919817.11076969.html.plaintext.txt	170	appropriate time interval cell washed three time ice cold num
0.49919817.11076969.html.plaintext.txt	171	numx pb lysed buffer containing protease inhibitor monteiro mical num
0.49919817.11076969.html.plaintext.txt	172	lysates diluted num fold immunoprecipitation buffer psnum protein immunoprecipitated done addition num microl rabbit anti loop psnum antibody directed gst psnum loop purified protein janicki monteiro num num microl slurry protein sepharose amersham pharmacia biotech
0.49919817.11076969.html.plaintext.txt	173	immunoprecipitated protein attached sepharose bead eluted incubation protein sample loading buffer lacking sd contained num m urea num mm dtt num s mercaptoethanol janicki monteiro num num degree c num min
0.49919817.11076969.html.plaintext.txt	174	entire volume sample separated sd page num
0.49919817.11076969.html.plaintext.txt	175	electrophoresis gel stained coomassie blue impregnated numnum diphenyloxazole dried stabler et al
0.49919817.11076969.html.plaintext.txt	176	radioactivity immunoprecipitated psnum band lane corresponding full length psnum protein quantified using molecular dynamic storm num phosphoimager using imagequant software molecular dynamic
0.49919817.11076969.html.plaintext.txt	177	half life endogenous hela ubiquilin protein estimated pulse labeling mock electroporated hela cell num h num microci numsmethionine followed chase nonradioactive medium num num h
0.49919817.11076969.html.plaintext.txt	178	ubiquilin protein immunoprecipitated using num microl rabbit anti ubiquilin c antibody amount radioactivity incorporated ubiquilin band determined sd page phosphoimage analysis
0.49919817.11076969.html.plaintext.txt	179	identification human ubiquilin novel interactor presenilin protein novel human protein named ubiquilin protein ubiquitin related protein domain interacts presenilins identified yeast two hybrid screen ynumh protein interact psnum cooh terminal sequence fig numa fig b
0.49919817.11076969.html.plaintext.txt	180	two overlapping clone encoding cooh terminal num num residue ubiquilin isolated screen
0.49919817.11076969.html.plaintext.txt	181	clone entire ubiquilin orf num race performed
0.49919817.11076969.html.plaintext.txt	182	yielded numnum bps additional upstream sequence including frame methionine codon located beginning ubiquitin like ub domain
0.49919817.11076969.html.plaintext.txt	183	conceptual translation methionine predicted num amino acid protein
0.49919817.11076969.html.plaintext.txt	184	however methionine unlikely authentic start codon since translation produced protein noticeably smaller seen sd page endogenous ubiquilin detected using pab raised cooh terminal num residue ubiquilin data shown
0.49919817.11076969.html.plaintext.txt	185	subsequent est database search sequencing putative overlapping clone yielded clone longer num end included upstream frame methionine codon corresponding num amino acid protein
0.49919817.11076969.html.plaintext.txt	186	several line evidence indicate methionine codon authentic start methionine ubiquilin
0.49919817.11076969.html.plaintext.txt	187	start methionine contained kozak consensus sequence upstream frame stop codon
0.49919817.11076969.html.plaintext.txt	188	b polypeptide translated start codon matched endogenous ubiquilin protein size num kd hela human cell type
0.49919817.11076969.html.plaintext.txt	189	c mammalian overexpression complete ubiquilin orf see fig num d f vitro transcribed translated ubiquilin rabbit reticulocyte lysates see fig num g human ubiquilin protein synthesized bacteria see fig num h generated num kd protein
0.49919817.11076969.html.plaintext.txt	190	data indicated cloned complete ubiquilin orf protein probably extensively modified mammalian cell since bacterially eukaryotically expressed human ubiquilin protein similar molecular mass separated sd page
0.49919817.11076969.html.plaintext.txt	191	view larger version numk figure num
0.49919817.11076969.html.plaintext.txt	192	ubiquilin mrna protein expression
0.49919817.11076969.html.plaintext.txt	193	human multiple tissue analyzed northern blot probed ubiquilin cdna fragment x fig num ii
0.49919817.11076969.html.plaintext.txt	194	stripping blot reprobed s actin control fragment shown
0.49919817.11076969.html.plaintext.txt	195	b northern blot specific region human brain probed ubiquilin cdna fragment y fig num ii reprobe s actin shown
0.49919817.11076969.html.plaintext.txt	196	c quantification ubiquilin mrna expression level
0.49919817.11076969.html.plaintext.txt	197	relative expression ubiquilin different tissue determined densitometric analysis autoradiograph relating ubiquilin band intensity level s actin hybridization lane
0.49919817.11076969.html.plaintext.txt	198	value presented normalization skeletal muscle spinal cord
0.49919817.11076969.html.plaintext.txt	199	d f characterization anti ubiquilin antibody
0.49919817.11076969.html.plaintext.txt	200	rabbit antibody raised gst ubiquilin fusion protein b c generating anti ubiquilin b anti ubiquilin c antibody respectively
0.49919817.11076969.html.plaintext.txt	201	d anti ubiquilin b antibody used detect overexpressed endogenous ubiquilin ubiquilin transfected mock transfected untransfected endogenous hela cell
0.49919817.11076969.html.plaintext.txt	202	anti ubiquilin b antibody detected num kd doublet band whereas preimmune serum
0.49919817.11076969.html.plaintext.txt	203	e anti ubiquilin c antibody also recognized num kd band untransfected hela lysates varying extent num kd band
0.49919817.11076969.html.plaintext.txt	204	hela cell transfected gfp ubiquilin fig num iv n contain additional num kd reactive band due fusion num kd moiety gfp ubiquilin
0.49919817.11076969.html.plaintext.txt	205	f affinity purified anti ubiquilin c antibody specifically reacts num kd band transfected hela cell lysates
0.49919817.11076969.html.plaintext.txt	206	g full length vitro transcribed translated numsmethionine radiolabeled human ubiquilin polypeptide migrated num kd whereas radiolabeled luciferase migrated num kd
0.49919817.11076969.html.plaintext.txt	207	h uninduced iptg induced lysates bacteria transformed untagged full length human ubiquilin probed anti ubiquilin b antibody
0.49919817.11076969.html.plaintext.txt	208	full length immunoreactive ubiquilin num kd series smaller breakdown product seen induced lysate
0.49919817.11076969.html.plaintext.txt	209	interaction ubiquilin presenilins quantified ynumh s galactosidase liquid culture assay
0.49919817.11076969.html.plaintext.txt	210	partial ubiquilin clone encoding cooh terminal num residue isolated ynumh screen near full length clone encoding residue num num bound psnum cooh terminal bait num fold compared negative control bait fig numc fig d respectively
0.49919817.11076969.html.plaintext.txt	211	however longer ubiquilin clone interacted le strongly psnum cooh terminal bait
0.49919817.11076969.html.plaintext.txt	212	interaction nevertheless still num fold compared negative control bait fig num d
0.49919817.11076969.html.plaintext.txt	213	also tested whether ubiquilin would interact portion loop region presenilins fig numa fig b used another ynumh study stabler et al
0.49919817.11076969.html.plaintext.txt	214	interestingly near full length ubiquilin construct also interacted well psnum psnum loop sequence surprisingly interaction approximately twice strong psnum cooh terminal bait fig num d
0.49919817.11076969.html.plaintext.txt	215	suggested two separate region within presenilin protein could interact ubiquilin
0.49919817.11076969.html.plaintext.txt	216	gene ubiquilin located chromosome numqnum widely expressed northern blot analysis human tissue indicated ubiquilin mrna widely expressed major num
0.49919817.11076969.html.plaintext.txt	217	num kb transcript several smaller differentially expressed minor transcript fig num ii x fig num
0.49919817.11076969.html.plaintext.txt	218	comparison ubiquilin band intensity correction mrna loading s actin control band normalized skeletal muscle value suggested expression num
0.49919817.11076969.html.plaintext.txt	219	num kb transcript highest brain pancreas fig num c
0.49919817.11076969.html.plaintext.txt	220	additional northern blot analysis mrna different subregions human brain revealed slight variation num
0.49919817.11076969.html.plaintext.txt	221	num fold ubiquilin expression num
0.49919817.11076969.html.plaintext.txt	222	num kb transcript predominant specie fig num ii y fig numb fig c
0.49919817.11076969.html.plaintext.txt	223	determined chromosomal location ubiquilin gene using pcr radiation hybrid mapping see material method data shown
0.49919817.11076969.html.plaintext.txt	224	procedure resulted unambiguous assignment ubiquilin nearby two locus chlc
0.49919817.11076969.html.plaintext.txt	225	gatanumcnum located chromosome numqnum close numqnum
0.49919817.11076969.html.plaintext.txt	226	interestingly chromosome region ubiquilin map thought contain susceptibility gene involved late onset ad kehoe et al
0.49919817.11076969.html.plaintext.txt	227	ubiquilin contains ubiquitin related protein domain member highly conserved gene family complete ubiquilin orf consists num residue sequence rich glutamine serine num
0.49919817.11076969.html.plaintext.txt	228	num respectively lacking cysteine fig num
0.49919817.11076969.html.plaintext.txt	229	protein calculated isoelectric point pi num
0.49919817.11076969.html.plaintext.txt	230	num predicted soluble based high hydrophilic profile using macvector num
0.49919817.11076969.html.plaintext.txt	231	num software oxford molecular group data shown
0.49919817.11076969.html.plaintext.txt	232	currently known protein structural motif residing within ubiquilin include nhnum terminal ub domain cooh terminal ubiquitin associated uba domain implicated targeting degradation protein ubiquitin proteasome pathway
0.49919817.11076969.html.plaintext.txt	233	predicted ubiquilin protein also contains numerous regularly spaced asparagine proline asn pro repeat unknown function fig num
0.49919817.11076969.html.plaintext.txt	234	first sequenced apparent mammalian homologue ubiquilin deposited genbankemblddbj database
0.49919817.11076969.html.plaintext.txt	235	however significant homology several full length gene unknown function c
0.49919817.11076969.html.plaintext.txt	236	num gene num identical two related gene arabidopsis thaliana num num identical
0.49919817.11076969.html.plaintext.txt	237	addition protein weak homology saccharomyces cerevisiae dsknum gene num identical suppress karnum defect biggin et al
0.49919817.11076969.html.plaintext.txt	238	karnum essential gene involved duplication yeast microtubule organizing center known spindle pole body
0.49919817.11076969.html.plaintext.txt	239	interestingly ubiquilin homology dsknum primarily confined ub uba domain
0.49919817.11076969.html.plaintext.txt	240	however since ub uba domain present many protein uncertain whether ubiquilin dsknum true orthologs
0.49919817.11076969.html.plaintext.txt	241	view larger version numk figure num
0.49919817.11076969.html.plaintext.txt	242	ubiquilin share significant homology several protein
0.49919817.11076969.html.plaintext.txt	243	inferred amino acid sequence human ubiquilin orf homology several related protein homo sapiens chapnum protein involved binding hspnum like stch protein mu musculus plic num plic num protein involved linking integrins vimentin x
0.49919817.11076969.html.plaintext.txt	244	laevis xdrpnum protein bind cyclin c
0.49919817.11076969.html.plaintext.txt	245	thaliana protein protein unknown function
0.49919817.11076969.html.plaintext.txt	246	cerevisiae dsknum involved spindle pole body duplication
0.49919817.11076969.html.plaintext.txt	247	identical residue darkly shaded whereas similar residue lightly shaded
0.49919817.11076969.html.plaintext.txt	248	homology five sequence shown
0.49919817.11076969.html.plaintext.txt	249	protein contain ub domain square box uba domain rounded box extremely well conserved sequence
0.49919817.11076969.html.plaintext.txt	250	addition central region ub uba domain contain several asparagine proline repeat either regularly spaced apart closed circle located elsewhere throughout protein open circle
0.49919817.11076969.html.plaintext.txt	251	high overall homology protein suggests belong multigene family
0.49919817.11076969.html.plaintext.txt	252	time ubiquilin sequence deposited genbankemblddbj xenopus laevis protein involved inhibiting cyclin protein degradation called xdrpnum num identity ubiquilin submitted funakoshi et al
0.49919817.11076969.html.plaintext.txt	253	since two mu musculus protein thought interlink integrin associated protein vimentin cytoskeleton called plic num plic num num num identical respectively wu et al
0.49919817.11076969.html.plaintext.txt	254	num human chapnum protein renamed ubiquilin num num identical bind hspnum like stch complement dsknum yeast mutant kaye et al
0.49919817.11076969.html.plaintext.txt	255	high degree homology among protein sequence seen aligned macvector num
0.49919817.11076969.html.plaintext.txt	256	num clustalw protein alignment program fig num
0.49919817.11076969.html.plaintext.txt	257	comparison revealed human mouse xenopus sequence closely related one another c
0.49919817.11076969.html.plaintext.txt	258	cerevisiae sequence would expected higher eukaryote
0.49919817.11076969.html.plaintext.txt	259	former group protein shared extensive homology across entire length ubiquilin polypeptide
0.49919817.11076969.html.plaintext.txt	260	four region highest homology include ub uba domain two stretch rich asn pro repeat residue gnum pnum pnum pnum located two ubiquitin related domain
0.49919817.11076969.html.plaintext.txt	261	difference divergent region instructive especially insert residue lnum tnum chapnum conserved plic num missing ubiquilin plic num xdrpnum
0.49919817.11076969.html.plaintext.txt	262	based homology human mouse sequence appears ubiquilin closely related plic num whereas chapnum closely related plic num
0.49919817.11076969.html.plaintext.txt	263	collectively protein likely member related multigene family since least two independent gene known exist human mouse
0.49919817.11076969.html.plaintext.txt	264	evidence ubiquilin protein directly bind psnum psnum gst fusion protein containing uba domain nine cooh terminal residue qhhssisvs ubiquilin necessary sufficient bind numsmethionine radiolabeled psnum psnum gst pull assay fig numa fig b respectively
0.49919817.11076969.html.plaintext.txt	265	interestingly slower migrating form presenilins much tightly bound full length form
0.49919817.11076969.html.plaintext.txt	266	whether slower migrating form ubiquitinated extensively modified merely hydrophobic aggregate known
0.49919817.11076969.html.plaintext.txt	267	expected gst alone fig numa fig b lane l bind either presenilin
0.49919817.11076969.html.plaintext.txt	268	region ubiquilin tested able pull either presenilins indicating binding presenilin ubiquilin mediated sequence spanning uba domain cooh terminal tail
0.49919817.11076969.html.plaintext.txt	269	vitro binding assay result consistent interaction data ubiquilin recovered ynumh screen
0.49919817.11076969.html.plaintext.txt	270	view larger version numk figure num
0.49919817.11076969.html.plaintext.txt	271	ubiquilin bind presenilins vitro
0.49919817.11076969.html.plaintext.txt	272	b gst pull experiment
0.49919817.11076969.html.plaintext.txt	273	full length vitro synthesized nums labeled psnum psnum first lane migrated sd page gel broad band num num kd arrowhead respectively along smear slower migrating form presumably due highly hydrophobic nature protein
0.49919817.11076969.html.plaintext.txt	274	numsps complex especially slower migrating form retained gst ubiquilin construct containing uba domain lane letter correspond construct shown fig num iii lacking domain gst alone
0.49919817.11076969.html.plaintext.txt	275	c immunoprecipitation experiment
0.49919817.11076969.html.plaintext.txt	276	psnum transfected hela cell lysates immunoprecipitated preimmune serum corresponding anti psnum loop antibody anti psnum nhnum terminus antibody
0.49919817.11076969.html.plaintext.txt	277	separation sd page coprecipitating ubiquilin arrowhead detected immunoblotting anti ubiquilin b antibody
0.49919817.11076969.html.plaintext.txt	278	d f cell fractionation experiment
0.49919817.11076969.html.plaintext.txt	279	parallel immunoblots equal portion soluble supernatant insoluble pellet p hela cellular fraction prepared without use detergent presence num triton x num d f anti ubiquilin e anti psnum antibody
0.49919817.11076969.html.plaintext.txt	280	hela cell used cell fractionation d untransfected whereas e f cell transfected full length wild type psnum construct
0.49919817.11076969.html.plaintext.txt	281	relative ratio ubiquilin protein p compared fraction determined densitometric analysis autoradiograph
0.49919817.11076969.html.plaintext.txt	282	analysis indicated transfection presenilin caused num f ubiquilin protein partition pellet fraction absence detergent compared d untransfected cell
0.49919817.11076969.html.plaintext.txt	283	partitioning lamin ac protein cell fractionation untransfected psnum transfected cell monitored anti lamin ac antibody shown d f respectively
0.49919817.11076969.html.plaintext.txt	284	support vitro binding data coimmunoprecipitation cell fractionation experiment psnum endogenous ubiquilin also performed
0.49919817.11076969.html.plaintext.txt	285	psnum transfected hela cell extract immunoprecipitated two different anti psnum specific antibody separated sd page immunoblotted anti ubiquilin b antibody
0.49919817.11076969.html.plaintext.txt	286	ubiquilin protein coimmunoprecipitated anti psnum antibody one raised loop nhnum terminal sequence coimmunoprecipitate preimmune serum used fig num c
0.49919817.11076969.html.plaintext.txt	287	additional verification ubiquilin binding psnum obtained cell fractionation study
0.49919817.11076969.html.plaintext.txt	288	untransfected psnum transfected hela cell fractionated either absence presence triton x num detergent soluble insoluble fraction
0.49919817.11076969.html.plaintext.txt	289	equivalent amount fraction immunoblotted determine amount ubiquilin protein two fraction
0.49919817.11076969.html.plaintext.txt	290	untransfected cell almost ubiquilin protein present soluble fraction independent detergent treatment fig num d lane
0.49919817.11076969.html.plaintext.txt	291	consistent predicted hydrophilic nature ubiquilin protein
0.49919817.11076969.html.plaintext.txt	292	however psnum transfected cell num ubiquilin protein separated pellet fraction absence detergent treatment fig num f lane p
0.49919817.11076969.html.plaintext.txt	293	change solubility likely consequence ubiquilin binding overexpressed membrane bound psnum also fractionated insoluble membrane containing pellet fraction fig num e lane p
0.49919817.11076969.html.plaintext.txt	294	expected integral membrane protein triton x num treatment caused release psnum soluble fraction fig num e lane coincided ubiquilin separating completely soluble fraction fig num f lane
0.49919817.11076969.html.plaintext.txt	295	ubiquilin localizes nucleus cytoplasm determine intracellular distribution ubiquilin used rabbit pab generated two different gst ubiquilin fusion protein see material method
0.49919817.11076969.html.plaintext.txt	296	antiserum detected endogenous overexpressed num kd ubiquilin polypeptide detected preimmune serum fig num d
0.49919817.11076969.html.plaintext.txt	297	although one antiserum reacted unknown protein num kd fig num e reactivity subsequently removed affinity purification antibody fig num f
0.49919817.11076969.html.plaintext.txt	298	immunofluorescence staining ubiquilin within cell performed specific anti ubiquilin antibody
0.49919817.11076969.html.plaintext.txt	299	compared preimmune serum fig numa fig d antibody revealed similar staining pattern fig numb fig e
0.49919817.11076969.html.plaintext.txt	300	indirect immunofluorescence well laser confocal microscopy revealed endogenous intracellular localization ubiquilin hela cell nucleus cytoplasm fig numb fig e fig g
0.49919817.11076969.html.plaintext.txt	301	cell endogenous ubiquilin staining stronger nucleus fig num e arrowhead
0.49919817.11076969.html.plaintext.txt	302	furthermore small subset cell ubiquilin within cytoplasm localized punctate structure fig numb fig e arrow
0.49919817.11076969.html.plaintext.txt	303	frequency structure dramatically increased upon overexpression full length untagged ubiquilin fig numc fig f
0.49919817.11076969.html.plaintext.txt	304	corroborate anti ubiquilin staining pattern performed additional localization study myc gfp tagged ubiquilin protein hela cell fig num iv o n respectively
0.49919817.11076969.html.plaintext.txt	305	overexpressed myc tagged ubiquilin stained anti myc mab exhibited intracellular structure fig num overexpressed wild type ubiquilin fig numc fig f
0.49919817.11076969.html.plaintext.txt	306	finally fluorescent staining pattern reproduced upon overexpression gfp ubiquilin fig num h
0.49919817.11076969.html.plaintext.txt	307	since gfp ubiquilin image fig num h captured live unfixed cell without antibody established anti ubiquilin structure seen previously artifact paraformaldehyde fixation immunofluorescence staining procedure
0.49919817.11076969.html.plaintext.txt	308	view larger version numk figure num
0.49919817.11076969.html.plaintext.txt	309	ubiquilin localizes nucleus cytoplasm
0.49919817.11076969.html.plaintext.txt	310	b d e indirect immunofluorescence microscopy endogenous ubiquilin staining untransfected hela cell c f confocal microscopy hela cell transfected ubiquilin myc tagged ubiquilin
0.49919817.11076969.html.plaintext.txt	311	b preimmune corresponding anti ubiquilin b antibody staining respectively shown
0.49919817.11076969.html.plaintext.txt	312	c overexpressed ubiquilin detected anti ubiquilin b antibody
0.49919817.11076969.html.plaintext.txt	313	d e preimmune corresponding anti ubiquilin c antibody staining respectively shown
0.49919817.11076969.html.plaintext.txt	314	f overexpressed ubiquilin shown detected affinity purified anti ubiquilin c antibody
0.49919817.11076969.html.plaintext.txt	315	anti ubiquilin serum showed specific staining cytoplasm nucleus along cytoplasmic punctate structure subset untransfected cell arrow
0.49919817.11076969.html.plaintext.txt	316	expression level ubiquilin protein within nucleus varied cell containing substantially nuclear protein arrowhead
0.49919817.11076969.html.plaintext.txt	317	transient overexpression wild type ubiquilin caused frequent accumulation ubiquilin intracellular punctate structure
0.49919817.11076969.html.plaintext.txt	318	g endogenous ubiquilin shown detected affinity purified anti ubiquilin c antibody confocal microscopy
0.49919817.11076969.html.plaintext.txt	319	h overexpressed gfp tagged ubiquilin live hela cell seen fluorescence microscopy revealed accumulation fusion protein cytoplasm similar punctate structure
0.49919817.11076969.html.plaintext.txt	320	additional evidence intracellular localization ubiquilin using myc tagged construct stained anti myc mab confocal microscopy shown
0.49919817.11076969.html.plaintext.txt	321	intracellular colocalization presenilin ubiquilin protein overexpressed presenilin protein localized predominantly er ubiquilin protein hela cell found throughout nucleus cytoplasm determined ubiquilin colocalized presenilins latter overexpressed
0.49919817.11076969.html.plaintext.txt	322	indeed dramatic change ubiquilin staining hela cell coexpressing either psnum psnum ubiquilin resulting almost complete colocalization presenilin ubiquilin intracellular staining pattern seen laser confocal immunofluorescence microscopy fig numa fig b
0.49919817.11076969.html.plaintext.txt	323	careful examination colocalized protein revealed ubiquilin staining punctate whereas presenilin staining could traced er like pattern
0.49919817.11076969.html.plaintext.txt	324	particularly striking colocalization ubiquilin irregularly shaped presenilin enriched structure within cytoplasm overexpressing cell
0.49919817.11076969.html.plaintext.txt	325	contrast little colocalization nucleus ubiquilin presenilin staining could found
0.49919817.11076969.html.plaintext.txt	326	view larger version numk figure num
0.49919817.11076969.html.plaintext.txt	327	intracellular colocalization ubiquilin presenilins
0.49919817.11076969.html.plaintext.txt	328	d hela cell cotransfected ubiquilin either wild type psnum b wild type psnum c psnumc deletion mutant d psnumlc deletion mutant costained appropriate goat anti presenilin antibody left image affinity purified rabbit anti ubiquilin c antibody center image
0.49919817.11076969.html.plaintext.txt	329	green fluorescein red rhodamine confocal image row merged shown right yellow indicating colocalization ubiquilin presenilin protein
0.49919817.11076969.html.plaintext.txt	330	since ynumh data suggested ubiquilin interacts loop cooh terminal domain presenilins examined whether removal region psnum would abolish colocalization protein vivo
0.49919817.11076969.html.plaintext.txt	331	ass possibility two psnum construct containing progressively longer cooh terminal deletion made
0.49919817.11076969.html.plaintext.txt	332	first psnumc num amino acid cooh terminal domain deleted fig num arrowhead whereas second psnumlc large hydrophilic loop sequence downstream deleted fig num arrow
0.49919817.11076969.html.plaintext.txt	333	expressed hela cell psnumc still colocalized ubiquilin fig num c presumably since psnum loop region remained could bind ubiquilin suggested strong interaction two ynumh assay fig num d
0.49919817.11076969.html.plaintext.txt	334	however hydrophilic loop region cooh terminus removed psnumlc longer colocalized ubiquilin fig num d suggesting nhnum terminus first six transmembrane domain psnum contain additional ubiquilin binding site
0.49919817.11076969.html.plaintext.txt	335	notable feature overexpression psnumlc accumulation large spherical aggregate failed stain positively ubiquilin
0.49919817.11076969.html.plaintext.txt	336	ubiquilin expression promotes increased accumulation presenilin protein since ubiquilin contains multiple ubiquitin related structural motif investigated whether association presenilin would effect presenilin protein modification andor stability
0.49919817.11076969.html.plaintext.txt	337	treatment mock transfected psnum transfected hela cell proteasome inhibitor lactacystin num microm mg num num microm expected increased overall amount ubiquitinated protein cell fig num lane num num num num num num versus lane num num num respectively
0.49919817.11076969.html.plaintext.txt	338	however condition markedly increase psnum protein level fig num b lane num num
0.49919817.11076969.html.plaintext.txt	339	remarkably coexpression ubiquilin psnum caused substantial num fold increase psnum protein accumulation fig num b lane num num compared overexpression psnum alone fig num b lane num num
0.49919817.11076969.html.plaintext.txt	340	effect independent treatment lactacystin mg num also occurred robustly cell treated proteasome inhibitor
0.49919817.11076969.html.plaintext.txt	341	particularly striking increased accumulation sd page gel full length uncleaved psnum protein fig num b arrowhead higher molecular weight complex psnum form
0.49919817.11076969.html.plaintext.txt	342	increasing amount transfected ubiquilin plasmid dna whereas maintaining constant level transfected psnum plasmid dna revealed dose dependent effect ubiquilin psnum accumulation within cell fig num e lane num num
0.49919817.11076969.html.plaintext.txt	343	effect specific ubiquilin expression since cotransfection increasing amount gfp plasmid dna psnum increase psnum protein accumulation fig num f lane num num
0.49919817.11076969.html.plaintext.txt	344	blot fig num e exposed shorter time fig num f optimally illustrate subtle change psnum protein level
0.49919817.11076969.html.plaintext.txt	345	experiment routinely observed accumulation full length psnum protein endoproteolytic cleaved form protein haass de strooper num
0.49919817.11076969.html.plaintext.txt	346	fact recent report indicated cleavage presenilins essential biological function presenilins namely ability rescue p activity c
0.49919817.11076969.html.plaintext.txt	347	absence detectable endoproteolytic cleaved form psnum clearly illustrated fig num g show antibody specific psnum loop sequence downstream proposed endoproteolytic cleavage site recognized num kd higher psnum specie psnum nhnum terminal specific antibody
0.49919817.11076969.html.plaintext.txt	348	interestingly though ubiquilin caused dose dependent increase presenilin accumulation alter accumulation level various endogenous hela protein lamin b calreticulin calnexin bip tubulin fig num h
0.49919817.11076969.html.plaintext.txt	349	similar experiment repeated psnum indicated ubiquilin also promoted dose dependent increase psnum protein accumulation hela cell data shown
0.49919817.11076969.html.plaintext.txt	350	view larger version numk figure num
0.49919817.11076969.html.plaintext.txt	351	ubiquilin promotes increased psnum protein accumulation
0.49919817.11076969.html.plaintext.txt	352	d hela cell num h transfection ubiquilin num microg expression plasmid lane num num psnum num microg expression plasmid lane num num lane num num either left untreated lane num num num treated num num h proteasome inhibitor num microm synthetic lactacystin lane num num num num microm mg num lane num num num
0.49919817.11076969.html.plaintext.txt	353	equivalent amount protein num microg sample immunoblotted anti ubiquitin b anti psnum nhnum terminus c affinity purified anti ubiquilin c d anti tubulin antibody
0.49919817.11076969.html.plaintext.txt	354	expected anti ubiquitin antibody detected larger molecular weight protein cell treated proteasome inhibitor lane num num num num num num compared untreated cell lane num num num
0.49919817.11076969.html.plaintext.txt	355	significantly psnum protein slower migrating form could seen cell cotransfected ubiquilin lane num num arrowhead compared transfected psnum alone lane num num
0.49919817.11076969.html.plaintext.txt	356	doublet weakly reactive band detected lysates considered nonspecific protein
0.49919817.11076969.html.plaintext.txt	357	anti tubulin blot show equal protein loading sample
0.49919817.11076969.html.plaintext.txt	358	e hela cell transfected psnum alone num microg expression plasmid lane num cotransfected along increasing amount ubiquilin num num num num microg expression plasmid lane num num respectively
0.49919817.11076969.html.plaintext.txt	359	equivalent amount transfected lysates separated num
0.49919817.11076969.html.plaintext.txt	360	num polyacrylamide gel immunoblotted anti psnum nhnum terminus antibody
0.49919817.11076969.html.plaintext.txt	361	f e except increasing amount gfp expression plasmid lane num num instead ubiquilin
0.49919817.11076969.html.plaintext.txt	362	g e protein separated num polyacrylamide gel immunoblotted anti psnum loop antibody
0.49919817.11076969.html.plaintext.txt	363	note absence detectable psnum cleavage product corresponding endoproteolytic psnum cleavage loop
0.49919817.11076969.html.plaintext.txt	364	h blot shown g parallel blot immunoblotted lamin b calreticulin calnexin bip tubulin
0.49919817.11076969.html.plaintext.txt	365	relative level endogenous protein remained relatively unchanged compared psnum level
0.49919817.11076969.html.plaintext.txt	366	ubiquilin facilitates increased psnum expression dramatically alter psnum protein turnover determine ubiquilin induced increase presenilin accumulation due change rate presenilin protein turnover carried pulse chase experiment hela cell psnum protein coexpressed either ubiquilin gfp control
0.49919817.11076969.html.plaintext.txt	367	psnum protein pulse chase lysates immunoprecipitated using anti psnum loop antibody resolved sd page fig num
0.49919817.11076969.html.plaintext.txt	368	phosphoimage analysis immunoprecipitated full length psnum band num kd indicated half life psnum protein approximately similar
0.49919817.11076969.html.plaintext.txt	369	num h coexpressed gfp ubiquilin respectively fig numa fig b
0.49919817.11076969.html.plaintext.txt	370	apart prominent psnum band num kd smear band varying intensity resolved sd page using psnum loop antibody immunoprecipitation
0.49919817.11076969.html.plaintext.txt	371	band appear psnum related especially higher molecular weight specie corresponded similar psnum immunoreactive specie using psnum antibody fig nume fig g janicki monteiro num janicki monteiro num
0.49919817.11076969.html.plaintext.txt	372	phosphoimage analysis smear band num kd marker indicated rate turnover larger psnum complex also similar gfp ubiquilin coexpressing cell data shown
0.49919817.11076969.html.plaintext.txt	373	view larger version numk figure num
0.49919817.11076969.html.plaintext.txt	374	ubiquilin facilitates increased presenilin protein expression substantially change presenilin protein turnover
0.49919817.11076969.html.plaintext.txt	375	hela cell electroporated mixture either psnum gfp expression plasmid num microg psnum num microg pegfp cnum psnum ubiquilin expression plasmid num microg psnum num microg ubiquilin pulse labeled numsmethionine num h chased nonradioactive medium num num h
0.49919817.11076969.html.plaintext.txt	376	appropriate time interval indicated lane cell lysed psnum protein immunoprecipitated using rabbit anti psnum loop antibody
0.49919817.11076969.html.plaintext.txt	377	immunoprecipitated protein separated sd page num
0.49919817.11076969.html.plaintext.txt	378	num gel radioactivity band corresponding full length psnum arrowhead lane determined phosphoimage analysis
0.49919817.11076969.html.plaintext.txt	379	light band probably nonpsnum related protein whose radioactivity changed little chase period experiment therefore useful normalizing protein amount loaded lane
0.49919817.11076969.html.plaintext.txt	380	b graph showing exponential decline pulse labeled psnum protein time
0.49919817.11076969.html.plaintext.txt	381	calculated half life psnum experiment num
0.49919817.11076969.html.plaintext.txt	382	num h coexpressed gfp ubiquilin respectively
0.49919817.11076969.html.plaintext.txt	383	two experiment num
0.49919817.11076969.html.plaintext.txt	384	num fold psnum protein synthesized normalization coexpressed ubiquilin gfp
0.49919817.11076969.html.plaintext.txt	385	c mock electroporated hela cell pulse labeled numsmethionine num h chased nonradioactive medium num num h
0.49919817.11076969.html.plaintext.txt	386	ubiquilin protein immunoprecipitated lysates using rabbit anti ubiquilin c antibody
0.49919817.11076969.html.plaintext.txt	387	radioactivity immunoprecipitated ubiquilin band determined phosphoimage analysis
0.49919817.11076969.html.plaintext.txt	388	analysis revealed small decline radioactivity num reduction num h indicating endogenous ubiquilin hela cell long lived estimated half life num h
0.49919817.11076969.html.plaintext.txt	389	notable difference pulse labeling experiment increased amount immunoprecipitated psnum labeled protein cell overexpressing ubiquilin compared gfp
0.49919817.11076969.html.plaintext.txt	390	despite using similar amount psnum dna electroporation within parallel labeling experiment routinely obtained num
0.49919817.11076969.html.plaintext.txt	391	num fold increase psnum labeled protein psnum coexpressed ubiquilin compared gfp
0.49919817.11076969.html.plaintext.txt	392	effect seen three separate experiment data shown
0.49919817.11076969.html.plaintext.txt	393	overall result suggest ubiquilin induced elevation presenilin accumulation involve substantial change rate presenilin protein turnover instead may facilitate increased psnum protein synthesis
0.49919817.11076969.html.plaintext.txt	394	finally determine rate endogenous ubiquilin protein turnover performed another pulse chase experiment mock transfected hela cell immunoprecipitated endogenous ubiquilin protein using anti ubiquilin c antibody fig num c
0.49919817.11076969.html.plaintext.txt	395	phosphoimage analysis indicated pulse labeled ubiquilin decay exceedingly slowly num num h chase period estimate half life protein num h
0.49919817.11076969.html.plaintext.txt	396	immunohistochemistry human brain tissue section reveals ubiquilin immunoreactivity neuron well within neuropathological lesion neurofibrillary tangle lewy body since neuropathological lesion ad pd found highly immunoreactive ubiquitin antibody investigated whether structure may also contain ubiquilin immunoreactivity
0.49919817.11076969.html.plaintext.txt	397	immunohistochemistry adult human brain section performed anti ubiquilin b anti ubiquilin c antibody
0.49919817.11076969.html.plaintext.txt	398	former raised ubiquilin polypeptide devoid ub domain whereas latter raised ubiquilin polypeptide lacking uba domain well fig num iii b c respectively
0.49919817.11076969.html.plaintext.txt	399	compared preimmune serum showed specific staining fig numa fig c antibody strongly stained neuron little staining glia fig numb fig d fig e
0.49919817.11076969.html.plaintext.txt	400	general anti ubiquilin c antibody stained neuron greater clarity intensity
0.49919817.11076969.html.plaintext.txt	401	cultured cell anti ubiquilin staining neuron nucleus cytoplasm
0.49919817.11076969.html.plaintext.txt	402	addition clear evidence ubiquilin staining within long axonal process fig num d
0.49919817.11076969.html.plaintext.txt	403	interestingly neuron containing neurofibrillary tangle nfts ad affected brain seemed stain intensely compared control neuron fig num e f
0.49919817.11076969.html.plaintext.txt	404	moreover examination ubiquilin staining brain afflicted pd shown diffuse lb disease revealed robust staining lewy body fig num h
0.49919817.11076969.html.plaintext.txt	405	view larger version numk figure num
0.49919817.11076969.html.plaintext.txt	406	anti ubiquilin staining human brain tissue reveals strong staining neuron human brain robust staining nfts lewy body ad pd respectively
0.49919817.11076969.html.plaintext.txt	407	section human brain stained either preimmune anti ubiquilin b anti ubiquilin c antibody
0.49919817.11076969.html.plaintext.txt	408	d consecutive section hippocampus ad afflicted brain stained either c preimmune serum corresponding b anti ubiquilin b d anti ubiquilin c antibody
0.49919817.11076969.html.plaintext.txt	409	e f example strong staining nfts arrow hippocampal section ad afflicted brain anti ubiquilin c antibody
0.49919817.11076969.html.plaintext.txt	410	g anti ubiquilin c antibody staining control nonad human brain showing strong staining neuron
0.49919817.11076969.html.plaintext.txt	411	h cortical human brain section dlbd afflicted brain showing strong anti ubiquilin c staining lewy body arrow
0.49919817.11076969.html.plaintext.txt	412	bar d g h num microm e f num microm
0.49919817.11076969.html.plaintext.txt	413	describe novel human presenilin interacting protein named ubiquilin
0.49919817.11076969.html.plaintext.txt	414	ynumh interaction gst pull experiment coimmunoprecipitation study change cellular fractionation protein colocalization protein expressed vivo provide compelling evidence ubiquilin presenilins interact one another
0.49919817.11076969.html.plaintext.txt	415	ubiquilin important protein contains multiple ubiquitin related domain typically thought involved targeting protein degradation yet ubiquilin promotes increased presenilin protein accumulation
0.49919817.11076969.html.plaintext.txt	416	moreover ubiquilin highly expressed neuron human brain associated nfts lewy body ad pd brain respectively
0.49919817.11076969.html.plaintext.txt	417	promotion presenilin protein accumulation ubiquilin overexpression noteworthy new mean presenilin level may modulated
0.49919817.11076969.html.plaintext.txt	418	conducting pulse chase experiment found ubiquilin induced increase presenilin protein maturation dramatically affect presenilin protein turnover
0.49919817.11076969.html.plaintext.txt	419	net effect time increased presenilin protein synthesis undisturbed turnover rate would eventually lead elevation intracellular pool presenilin protein
0.49919817.11076969.html.plaintext.txt	420	modulation presenilin level ubiquilin may important consequence cellular function presenilins linked various biological process including notch signaling calcium regulation apoptosis cell cycle regulation unfolded protein response well app associated gamma secretase activity see introduction
0.49919817.11076969.html.plaintext.txt	421	interesting determine precise mechanism ubiquilin induces increased presenilin protein synthesis
0.49919817.11076969.html.plaintext.txt	422	ubiquilin could increase presenilin synthesis simply increasing presenilin transcription increasing presenilin translation facilitating correct polypeptide folding maturation intracellular targeting polytopic transmembrane presenilin protein
0.49919817.11076969.html.plaintext.txt	423	based various property especially intrigued possibility ubiquilin may act molecular chaperone
0.49919817.11076969.html.plaintext.txt	424	study xenopus ubiquilin homologue xdrpnum suggested ubiquilin act posttranscriptionally like molecular chaperone prevent degradation vitro translated cyclin protein funakoshi et al
0.49919817.11076969.html.plaintext.txt	425	b chapnum ubiquilin num shown bind stch hspnum like protein kaye et al
0.49919817.11076969.html.plaintext.txt	426	turn many heat shock protein shown function molecular chaperone preventing protein aggregation protein degradation warrick et al
0.49919817.11076969.html.plaintext.txt	427	num krobitsch lindquist num
0.49919817.11076969.html.plaintext.txt	428	c recent evidence linked ubiquilin protein proteasome kleijnen et al
0.49919817.11076969.html.plaintext.txt	429	meanwhile nums regulatory subunit nums proteasome degradation complex ubiquitin tagged protein shown posse protein unfolding activity braun et al
0.49919817.11076969.html.plaintext.txt	430	d indirect evidence ubiquilin may aid presenilin protein folding targeting come observation presenilin construct psnumlc deletion loop cooh terminal ubiquilin interaction site demonstrated ynumh assay lack colocalization ubiquilin within cell frequently accumulated large cytoplasmic aggregate
0.49919817.11076969.html.plaintext.txt	431	contrast presenilin molecule contained ubiquilin interaction site rarely formed large protein aggregate
0.49919817.11076969.html.plaintext.txt	432	connection aggregate accumulation loss ubiquilin interaction may entirely coincidental
0.49919817.11076969.html.plaintext.txt	433	however possibility two interconnected discounted
0.49919817.11076969.html.plaintext.txt	434	finally presenilins protein linked molecular chaperone er involved unfolded protein response katayama et al
0.49919817.11076969.html.plaintext.txt	435	another mechanism ubiquilin might increase presenilin accumulation alter presenilin degradation rate especially ubiquitinated form presenilins
0.49919817.11076969.html.plaintext.txt	436	fact recent report kleijnen et al
0.49919817.11076969.html.plaintext.txt	437	num found evidence overexpression human ubiquilin protein hplic num ubiquilin num hplic num ubiquilin num interfered ubiquitin dependent degradation pnum ikb
0.49919817.11076969.html.plaintext.txt	438	although find significant change turnover rate major num kd psnum polypeptide specie corresponding full length psnum exclude possibility certain ubiquitinated form presenilins may altered turnover rate
0.49919817.11076969.html.plaintext.txt	439	ubiquitinated form presenilins migrated smear sd page gel made quantification turnover rate specie difficult
0.49919817.11076969.html.plaintext.txt	440	important future study determine ubiquilin involved ubiquitin dependent degradation presenilins
0.49919817.11076969.html.plaintext.txt	441	region ubiquilin bind presenilins mapped cooh terminal region containing uba domain highly conserved ubiquilin family member human yeast fig num
0.49919817.11076969.html.plaintext.txt	442	sequence necessary sufficient bind psnum psnum vitro
0.49919817.11076969.html.plaintext.txt	443	uba domain recently recognized motif present one two copy variety protein involved ubiquitinproteasome foldingdegradation pathway uv excision repair phosphorylation hofmann bucher num
0.49919817.11076969.html.plaintext.txt	444	uba domain consists num total residue num appear core residue
0.49919817.11076969.html.plaintext.txt	445	num core residue extremely well conserved suggesting may important determining overall structure domain
0.49919817.11076969.html.plaintext.txt	446	nuclear magnetic resonance structure cooh terminal uba domain human dna repair protein hhrnuma radnum homologue determined
0.49919817.11076969.html.plaintext.txt	447	compact three helix bundle exposed hydrophobic surface predicted involved protein protein interaction dieckmann et al
0.49919817.11076969.html.plaintext.txt	448	strong binding ubiquilin uba domain presenilins may facilitated similar protein protein interaction
0.49919817.11076969.html.plaintext.txt	449	important determine sequence variation uba domain different protein influence binding specificity different target protein
0.49919817.11076969.html.plaintext.txt	450	vitro binding assay indicated ub domain nhnum terminal portion ubiquilin required binding presenilins
0.49919817.11076969.html.plaintext.txt	451	although domain share high homology conserved num amino acid ubiquitin polypeptide unlikely involved covalent linkage lysine residue target protein since lack obligate cooh terminal glycine residue required cleavage conjugation
0.49919817.11076969.html.plaintext.txt	452	another possibility could ub domain modified conjugation either ubiquitin small ubiquitin like protein e
0.49919817.11076969.html.plaintext.txt	453	lysine group group forming ubiquitin conjugate pickart num
0.49919817.11076969.html.plaintext.txt	454	also unlikely occur ubiquilin immunoblots show expected ladder ubiquitin conjugated band
0.49919817.11076969.html.plaintext.txt	455	therefore ub domain may play role function
0.49919817.11076969.html.plaintext.txt	456	example yeast radnum human homologues hhrnuma hhrnumb ub domain involved binding subunit proteasome whereas xdrpnum ub domain necessary binding cyclin
0.49919817.11076969.html.plaintext.txt	457	clearly insight ubiquilins function emerge understanding protein protein interaction role different domain
0.49919817.11076969.html.plaintext.txt	458	using combination immunological gfp tagging approach demonstrated ubiquilin localized nucleus cytoplasm hela cell
0.49919817.11076969.html.plaintext.txt	459	intensity nuclear staining variable nucleus staining brightly
0.49919817.11076969.html.plaintext.txt	460	variability may related cell cycle change cyclin protein ubiquilins homologue xdrpnum shown interact level within nucleus
0.49919817.11076969.html.plaintext.txt	461	cytoplasmic distribution ubiquilin also variable
0.49919817.11076969.html.plaintext.txt	462	untransfected cell endogenous ubiquilin fine punctate appearance hint association network like pattern possibly er
0.49919817.11076969.html.plaintext.txt	463	cell ubiquilin accumulated larger spherical structure throughout cytoplasm whose number size variable
0.49919817.11076969.html.plaintext.txt	464	upon ubiquilin overexpression cell formed even larger numerous ubiquilin containing structure
0.49919817.11076969.html.plaintext.txt	465	confocal microscopy ubiquilin staining pattern colocalized almost perfectly presenilin staining pattern
0.49919817.11076969.html.plaintext.txt	466	considering two presenilin interaction site cooh terminus loop domain face cytoplasm according predicted topology presenilins membrane surprising ubiquilin colocalized er membrane bound presenilin
0.49919817.11076969.html.plaintext.txt	467	still many protein also shown interact two domain presenilins
0.49919817.11076969.html.plaintext.txt	468	clearly understanding dynamic different protein protein interaction provide clue regarding presenilin function
0.49919817.11076969.html.plaintext.txt	469	study mouse plic num plic num suggested involvement linking integrins via integrin associated protein vimentin cytoskeleton wu et al
0.49919817.11076969.html.plaintext.txt	470	observed significant staining ubiquilin cell periphery know way related lack expression particular integrin associated protein integrins hela cell
0.49919817.11076969.html.plaintext.txt	471	nevertheless interesting vimentin presenilins linked one another aggresomes structure involved cellular response misfolded protein johnston et al
0.49919817.11076969.html.plaintext.txt	472	moreover recent evidence indicates aggresomes involved recruitment proteasome hspnum chaperone garcia mata et al
0.49919817.11076969.html.plaintext.txt	473	num circumstantially suggests mechanism ubiquilin could associated protein misfolded protein response
0.49919817.11076969.html.plaintext.txt	474	several line evidence link ubiquitin gene tissue involved ad
0.49919817.11076969.html.plaintext.txt	475	first presenilin protein thought ubiquitinated since treatment proteasome inhibitor cause accumulation large complex migrate sd gel manner consistent modification ubiquitin kim et al
0.49919817.11076969.html.plaintext.txt	476	second well known ubiquitin immunoreactivity strongly associated nfts senile plaque ad hallmark lesion ad pathology mori et al
0.49919817.11076969.html.plaintext.txt	477	strong ubiquilin immunoreactivity associated nfts lewy body intriguing considering lesion known contain misfolded protein
0.49919817.11076969.html.plaintext.txt	478	present result provide clue whether ubiquilin acting causative role end result association misfolded accumulated protein
0.49919817.11076969.html.plaintext.txt	479	plan pursue future
0.49919817.11076969.html.plaintext.txt	480	summary ubiquilin first presenilin interacting protein knowledge found regulate presenilin level cell
0.49919817.11076969.html.plaintext.txt	481	presence multiple ubiquitin related domain suggests ubiquilin may involved regulation presenilin protein level proteasome folding andor degradation pathway
0.49919817.11076969.html.plaintext.txt	482	num abbreviation used paper aa amino acid ad alzheimers disease app s amyloid precursor protein est expressed sequence tag fad familial alzheimers disease gfp green fluorescent protein nft neurofibrillary tangle orf open reading frame pd parkinson disease p presenilin race rapid amplification cdna end ub ubiquitin uba ubiquitin associated ynumh yeast two hybrid
0.49919817.11076969.html.plaintext.txt	483	janicki initiating ynumh screen chung cho help immunoblots fig numg fig h dr
0.49919817.11076969.html.plaintext.txt	484	stabler critical comment manuscript
0.49919817.11076969.html.plaintext.txt	485	work funded part grant national institute aging agnum agnum m
0.49919817.11076969.html.plaintext.txt	486	submitted num february num revised num september num accepted num september num
0.49919817.11076969.html.plaintext.txt	487	yeast ubiquitin like gene involved duplication microtubule organizing center
0.49919817.11076969.html.plaintext.txt	488	mouse lacking presenilin gene exhibit early embryonic patterning defect
0.49919817.11076969.html.plaintext.txt	489	gene dev numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	490	identification xdrpnum xenopus protein related yeast dsknump bind n terminus cyclin inhibits degradation
0.49919817.11076969.html.plaintext.txt	491	j numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	492	characterization dynamic aggresome formation cytosolic gfp chimera
0.49919817.11076969.html.plaintext.txt	493	numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	494	alzheimers presenilin mutation sensitizes neural cell apoptosis induced trophic factor withdrawal amyloid b peptide involvement calcium oxyradicals
0.49919817.11076969.html.plaintext.txt	495	neurosci numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	496	presenilins alzheimers disease proteolysis hold key
0.49919817.11076969.html.plaintext.txt	497	science numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	498	presenilin num deficiency cause mild pulmonary phenotype change amyloid precursor protein processing enhances embryonic lethal phenotype presenilin num deficiency
0.49919817.11076969.html.plaintext.txt	499	usa numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	500	influence endoproteolytic processing familial alzheimers disease presenilin num assnum amyloid peptide formation
0.49919817.11076969.html.plaintext.txt	501	numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	502	increased apoptosis arising increased expression alzheimers disease associated presenilin num mutation nnumi
0.49919817.11076969.html.plaintext.txt	503	cell biol numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	504	presenilin overexpression arrest cell gnum phase cell cycle
0.49919817.11076969.html.plaintext.txt	505	arrest potentiated alzheimers disease psnumnnumi mutant
0.49919817.11076969.html.plaintext.txt	506	pathol numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	507	aggresomes cellular response misfolded protein
0.49919817.11076969.html.plaintext.txt	508	cell biol numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	509	full genome scan late onset alzheimers disease
0.49919817.11076969.html.plaintext.txt	510	genet numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	511	endoproteolytic cleavage proteasomal degradation presenilin num transfected cell
0.49919817.11076969.html.plaintext.txt	512	chem numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	513	aggregation huntingtin yeast varies length polyglutamine expansion expression chaperone protein
0.49919817.11076969.html.plaintext.txt	514	numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	515	presenilin num mutation modulate amplitude kinetics inositol numnumnum trisphosphate mediated calcium signal
0.49919817.11076969.html.plaintext.txt	516	chem numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	517	role sequence unique nuclear intermediate filament targeting assembly human lamin b evidence lack interaction lamin b putative receptor
0.49919817.11076969.html.plaintext.txt	518	cell sci numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	519	ubiquitin detected neurofibrillary tangle senile plaque neurites alzheimer disease brain
0.49919817.11076969.html.plaintext.txt	520	ubiquitin biology cell
0.49919817.11076969.html.plaintext.txt	521	myristoylated calcium binding protein preferentially interacts alzheimers disease presenilin num protein
0.49919817.11076969.html.plaintext.txt	522	numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	523	biological pathological function presenilin num exon num mutation independent defect undergo proteolytic processing
0.49919817.11076969.html.plaintext.txt	524	numnum numabstractfree full text
0.49919817.11076969.html.plaintext.txt	525	numrd ed new york john wiley son inc pp
0.51095337.11136203.html.plaintext.txt	0	genetic risk alzheimers disease advising relative m
0.51095337.11136203.html.plaintext.txt	1	department psychological medicine university wale college medicine cardiff
0.51095337.11136203.html.plaintext.txt	2	institute psychiatry london
0.51095337.11136203.html.plaintext.txt	3	department psychological medicine university wale college medicine cardiff
0.51095337.11136203.html.plaintext.txt	4	liddell department psychological medicine university wale college medicine heath park cardiff cfnum numxn uk
0.51095337.11136203.html.plaintext.txt	5	aim provide information old age psychiatrist wishing advise relative risk developing alzheimers disease
0.51095337.11136203.html.plaintext.txt	6	method selective review key literature genetic epidemiology alzheimers disease
0.51095337.11136203.html.plaintext.txt	7	result currently dna diagnosis attainable num family autosomal dominant alzheimers disease
0.51095337.11136203.html.plaintext.txt	8	first degree relative case risk increased three four fold relative control one third realised average life span
0.51095337.11136203.html.plaintext.txt	9	apolipoprotein e genotyping used predictive test confers minimal diagnostic benefit
0.51095337.11136203.html.plaintext.txt	10	conclusion pedigree familial alzheimers disease referred regional centre medical genetics
0.51095337.11136203.html.plaintext.txt	11	accurate risk prediction possible vast majority pedigree alzheimers disease although possible psychiatrist give rough estimate risk reasonably couched reassuring term
0.51095337.11136203.html.plaintext.txt	12	predictive prenatal testing potentially feasible family fad depend upon availability dna least one affected individual order establish mutation causing disease family
0.51095337.11136203.html.plaintext.txt	13	worth stating genetic counselling highly specialised area strongly recommended psychiatrist involve without appropriate training
0.51095337.11136203.html.plaintext.txt	14	study campion et al num analysed dna num family fad obtained france causative mutation
0.51095337.11136203.html.plaintext.txt	15	probably pathogenic mutation found psennum gene num family mutation within app gene another num mutation psennum psennum app gene remaining num family
0.51095337.11136203.html.plaintext.txt	16	thus individual fad pedigree need informed num chance current state knowledge causative mutation found
0.51095337.11136203.html.plaintext.txt	17	mutation found pedigree strongly suggestive autosomal dominant disorder geneticist may choose go search mutation gene associated similar condition prion protein prp cjd tau frontal temporal dementia example
0.51095337.11136203.html.plaintext.txt	18	yet another factor consider one report apparent non penetrance psennum mutation healthy num year old member fad pedigree rossor et al num
0.51095337.11136203.html.plaintext.txt	19	notwithstanding caveat absence preventive treatment take predictive testing likely low case huntington disease binedell et al num
0.51095337.11136203.html.plaintext.txt	20	faced someone worried risk developing alzheimers disease often worth pointing risk developing alzheimers disease provided live long enough
0.51095337.11136203.html.plaintext.txt	21	large rotterdam study suggests risk age num year developing dementia following num year num
0.51095337.11136203.html.plaintext.txt	22	study num dementia wholly partially attributable alzheimers disease
0.51095337.11136203.html.plaintext.txt	23	large continuing framingham study yield somewhat lower lifetime risk alzheimers disease age num year num
0.51095337.11136203.html.plaintext.txt	24	num men num woman corresponding risk dementia num
0.51095337.11136203.html.plaintext.txt	25	num num respectively seshadri et al num
0.51095337.11136203.html.plaintext.txt	26	many epidemiological study suggest woman increased risk alzheimers disease
0.51095337.11136203.html.plaintext.txt	27	reason clear increased longevity compared men increased survival disease increase intrinsic vulnerability probably play part
0.51095337.11136203.html.plaintext.txt	28	prevalence study tell u dementia double every num year age num year age around num year time rate increase appears slow heeren et al num skoog et al num ritchie kildea num breitner et al num von strauss et al num
0.51095337.11136203.html.plaintext.txt	29	likely slowing due old people living long dementia younger sufferer although also possible survivor late old age relatively resistant developing dementia drachman num
0.51095337.11136203.html.plaintext.txt	30	prevalence data summarised table num
0.51095337.11136203.html.plaintext.txt	31	view table table num prevalence dementia age ritchie kildea num permission
0.51095337.11136203.html.plaintext.txt	32	fact two nearly completely ascertained community based study one japan one netherlands found prevalence dementia centenarian high num japanese num dutch sample asada et al num blansjaar et al num
0.51095337.11136203.html.plaintext.txt	33	asada et al num attributed num dementia alzheimers disease demonstrated num month mortality rate num centenarian dementia whereas none non demented centenarian died
0.51095337.11136203.html.plaintext.txt	34	thus prevalence figure dementia tell u many u risk developing dementia provided live long enough
0.51095337.11136203.html.plaintext.txt	35	obviously simplistic people expect live mid nums much reasonable question chance developing alzheimers disease age num year
0.51095337.11136203.html.plaintext.txt	36	family study alzheimers disease go way towards allowing u answer question relative affected individual
0.51095337.11136203.html.plaintext.txt	37	overall finding study based memory clinic likely centre secondary referral suggest num num probands alzheimers disease history affected first degree relative compared num num control
0.51095337.11136203.html.plaintext.txt	38	translates num num relative patient alzheimers disease history alzheimers disease compared num
0.51095337.11136203.html.plaintext.txt	39	num num first degree relative healthy control
0.51095337.11136203.html.plaintext.txt	40	kaplan meier life table analysis used study infer cumulative risk dementia age num varies num num compared num num control relative
0.51095337.11136203.html.plaintext.txt	41	however pointed breitner owing competing cause death one third theoretical familial predisposition alzheimers disease realised usual life span
0.51095337.11136203.html.plaintext.txt	42	translates actual predicted risk developing alzheimers disease first degree relative probands alzheimers disease num num compared num control breitner et al num breitner num
0.51095337.11136203.html.plaintext.txt	43	latest systematically ascertained twin study heritability alzheimers disease also tend support estimate familial risk derived family study
0.51095337.11136203.html.plaintext.txt	44	probandwise concordance rate num num respectively seen fraternal identical twin bergem et al num
0.51095337.11136203.html.plaintext.txt	45	fraternal twin genetically equivalent ordinary first degree relative observed morbid risk developing alzheimers disease similar estimated first degree relative family study
0.51095337.11136203.html.plaintext.txt	46	study silverman et al num suggested large measure familial component risk relative probands alzheimers disease expended end ninth decade time risk similar control
0.51095337.11136203.html.plaintext.txt	47	number family history study suggested familial factor prominent onset earlier mcguffin et al num
0.51095337.11136203.html.plaintext.txt	48	thus much alzheimers disease late old age may considered familial merely expression one way ageing process manifested survivor late old age
0.51095337.11136203.html.plaintext.txt	49	finding family study used advise relative broadest term
0.51095337.11136203.html.plaintext.txt	50	one little say balance risk first degree relative patient alzheimers disease developed disorder time age num year increased threefold fourfold relative risk control
0.51095337.11136203.html.plaintext.txt	51	would seem translate risk developing alzheimers disease one five one six although improvement risk one two still rather frightening
0.51095337.11136203.html.plaintext.txt	52	order put risk better perspective help allay client anxiety may preferable present risk estimate graphical form done fig
0.51095337.11136203.html.plaintext.txt	53	done client see even num year age greatest risk actual predicted risk num cumulative risk half area curve fx sx age num num probably le num
0.51095337.11136203.html.plaintext.txt	54	experience many tell u reassuring partly worry getting alzheimers disease fifty familial alzheimers disease happens sixtiesseventies thus preventing enjoying retirement
0.51095337.11136203.html.plaintext.txt	55	view larger version numk fig
0.51095337.11136203.html.plaintext.txt	56	num fx represents probability hypothetical relative patient alzheimers disease developing alzheimers disease age x absence competing form mortality
0.51095337.11136203.html.plaintext.txt	57	sx represents actuarial probability surviving age x
0.51095337.11136203.html.plaintext.txt	58	product fx sx represents probability relative surviving age x developing alzheimers disease
0.51095337.11136203.html.plaintext.txt	59	adapted breitner et al num
0.51095337.11136203.html.plaintext.txt	60	case patient alzheimers disease became demented late old age say nums relative probably run num num risk developing dementia anyone else life age num year beyond
0.51095337.11136203.html.plaintext.txt	61	course possible gene confer longevity may also increase risk developing alzheimers disease
0.51095337.11136203.html.plaintext.txt	62	like disorder reflect combined action several gene risk relative drop rapidly degree genetic relatedness fall
0.51095337.11136203.html.plaintext.txt	63	data limited risk second degree relative grand child probably le twice population level heston et al num
0.51095337.11136203.html.plaintext.txt	64	apoe num association alzheimers disease replicated many laboratory around world
0.51095337.11136203.html.plaintext.txt	65	meta analysis summarised data demonstrated association found people european african american american hispanic japanese origin farrer et al num
0.51095337.11136203.html.plaintext.txt	66	exactly apoe num apoenum protein influence pathophysiology alzheimers disease still unknown bearer risk allele appear get alzheimers disease earlier develop heavier amyloid burden
0.51095337.11136203.html.plaintext.txt	67	consensus opinion appears apoe genotype determines rather whether one succumbs alzheimers disease
0.51095337.11136203.html.plaintext.txt	68	example cache county study meyer et al num breitner et al num elderly population almost num found num case alzheimers disease among num apoe num homozygote num among num apoe num heterozygote num among num bearing apoe num allele
0.51095337.11136203.html.plaintext.txt	69	appeared plateau group survival curve beyond new case alzheimers disease seen
0.51095337.11136203.html.plaintext.txt	70	apoe num homozygote new case seen age num year nine individual surviving without alzheimers disease combined total num year
0.51095337.11136203.html.plaintext.txt	71	apoe num heterozygote last onset alzheimers disease num year four long term survivor
0.51095337.11136203.html.plaintext.txt	72	last onset dementia individual without apoe num allele age num year num surviving free dementia combined total num year thereafter
0.51095337.11136203.html.plaintext.txt	73	differential effect apoe genotype age maximum risk alzheimers disease also suggested apoe meta analysis farrer et al num also study asada et al num
0.51095337.11136203.html.plaintext.txt	74	bayesian analysis used seshadri et al num relate apoe genotype lifetime risk developing alzheimers disease
0.51095337.11136203.html.plaintext.txt	75	estimate dementia risk derived framingham study seshadri et al num substituted analysis somewhat lower risk estimate stratified according gender obtained table num
0.51095337.11136203.html.plaintext.txt	76	view table table num remaining lifetime risk age num year developing alzheimers disease according gender apolipoprotein e apoe status
0.51095337.11136203.html.plaintext.txt	77	estimate suggest num apoe num homozygote develop alzheimers disease within lifetime
0.51095337.11136203.html.plaintext.txt	78	prediction agree well general population based study henderson et al num suggested risk developing dementia age num year apoe num homozygote num
0.51095337.11136203.html.plaintext.txt	79	claim made apoe genotyping may aid diagnosing alzheimers disease
0.51095337.11136203.html.plaintext.txt	80	study mayeux et al num suggested patient referred specialised assessment centre alzheimers disease apoe genotyping used combination clinical criterion might improve specificity diagnosis
0.51095337.11136203.html.plaintext.txt	81	data show whereas demonstration one apoe num allele person suspected suffering dementia slightly increase accuracy clinical diagnosis alzheimers disease absence apoe num allele little value either endorsing refuting clinical diagnosis alzheimers disease
0.51095337.11136203.html.plaintext.txt	82	thus even selected group patient presumably high priori chance alzheimers disease apoe genotyping seems confer negligible diagnostic benefit
0.51095337.11136203.html.plaintext.txt	83	family evidence fad indeed familial early onset dementia referred specialist centre uk regional genetics department
0.51095337.11136203.html.plaintext.txt	84	counselling family follow process established huntington disease
0.51095337.11136203.html.plaintext.txt	85	late onset alzheimers disease group agreed role apoe genotyping prediction risk assessment
0.51095337.11136203.html.plaintext.txt	86	late onset alzheimers disease late onset alzheimers disease wide agreement genetic test available genetic testing genetic counselling
0.51095337.11136203.html.plaintext.txt	87	absence test mean relative denied information opportunity discus concern
0.51095337.11136203.html.plaintext.txt	88	asked likely get alzheimers disease relative patient late onset alzheimers disease one answer case alzheimers disease possible advise relative risk broadest term
0.51095337.11136203.html.plaintext.txt	89	extrapolating family history study possible say risk child region one five one six one prepared illustrate mean easy understand graphical form
0.51095337.11136203.html.plaintext.txt	90	believe permissible broad estimate risk imparted consultant doctor specifically trained genetic counselling
0.51095337.11136203.html.plaintext.txt	91	occasionally psychiatrist encounter family several sibling affected late onset alzheimers disease history dementia previous generation
0.51095337.11136203.html.plaintext.txt	92	family almost certainly exhibit high genetic loading reliable data whether extent risk increase number affected relative although study common disorder suggest likely case
0.51095337.11136203.html.plaintext.txt	93	however borne mind number affected relative may well depend factor affecting longevity well degree genetic loading alzheimers disease may advisable possible base discussion risk estimate increased several relative affected late old age
0.51095337.11136203.html.plaintext.txt	94	also preliminary evidence substantially increased risk offspring parent diagnosis alzheimers disease bird et al num
0.51095337.11136203.html.plaintext.txt	95	pedigree relative request information may worth taking detailed family history consulting clinical geneticist
0.51095337.11136203.html.plaintext.txt	96	limitation interest space clarity citation literature selective
0.51095337.11136203.html.plaintext.txt	97	estimate risk instance approximate may need modified light future work
0.51095337.11136203.html.plaintext.txt	98	data relating vascular mixed form dementia available
0.51095337.11136203.html.plaintext.txt	99	num role heredity late onset alzheimers disease vascular dementia
0.51095337.11136203.html.plaintext.txt	100	archive general psychiatry num num num
0.51095337.11136203.html.plaintext.txt	101	num predictive testing huntington disease
0.51095337.11136203.html.plaintext.txt	102	predictor uptake south wale
0.51095337.11136203.html.plaintext.txt	103	clinical genetics num num num
0.51095337.11136203.html.plaintext.txt	104	num conjugal alzheimers disease increased risk offspring annals neurology num num num
0.51095337.11136203.html.plaintext.txt	105	num prevalence dementia centenarian
0.51095337.11136203.html.plaintext.txt	106	international journal geriatric society num num num
0.51095337.11136203.html.plaintext.txt	107	num clinical genetics genetic counselling alzheimers disease
0.51095337.11136203.html.plaintext.txt	108	annals internal medicine num num num
0.51095337.11136203.html.plaintext.txt	109	et al num age dependent expression familial risk alzheimers disease
0.51095337.11136203.html.plaintext.txt	110	american journal epidemiology num num num
0.51095337.11136203.html.plaintext.txt	111	et al num apoe num count predicts age prevalence ad increase decline cache county study
0.51095337.11136203.html.plaintext.txt	112	et al num medical scientific committee alzheimers disease international consensus statement predictive testing
0.51095337.11136203.html.plaintext.txt	113	alzheimers disease associated disorder num num num
0.51095337.11136203.html.plaintext.txt	114	et al num early onset autosomal dominant alzheimers disease prevalence genetic heterogeneity mutation spectrum
0.51095337.11136203.html.plaintext.txt	115	american journal human genetics num num num
0.51095337.11136203.html.plaintext.txt	116	et al num apolipoprotein e survival alzheimers disease patient competing risk death alzheimers disease
0.51095337.11136203.html.plaintext.txt	117	num live long enough demented neurology num num num
0.51095337.11136203.html.plaintext.txt	118	et al num consensus report working group molecular biochemical marker alzheimers disease
0.51095337.11136203.html.plaintext.txt	119	neurobiology aging num num num
0.51095337.11136203.html.plaintext.txt	120	et al num treatment outcome tacrine therapy depends apolipoprotein genotype gender subject alzheimers disease
0.51095337.11136203.html.plaintext.txt	121	et al num american college medical genetics american society human genetics statement use apolipoprotein e testing alzheimers disease
0.51095337.11136203.html.plaintext.txt	122	journal american medical association num num num
0.51095337.11136203.html.plaintext.txt	123	et al num effect age sex ethnicity association apolipoprotein e genotype alzheimers disease meta analysis
0.51095337.11136203.html.plaintext.txt	124	journal american medical association num num num
0.51095337.11136203.html.plaintext.txt	125	et al num apolipoprotein e genotype influence rate cognitive decline alzheimers disease
0.51095337.11136203.html.plaintext.txt	126	et al num prevalence dementia oldest old dutch community
0.51095337.11136203.html.plaintext.txt	127	journal american geriatrics society num num num
0.51095337.11136203.html.plaintext.txt	128	et al num apolipoprotein e allele num dementia cognitive decline population sample
0.51095337.11136203.html.plaintext.txt	129	et al num dementia alzheimer type clinical genetics natural history associated condition
0.51095337.11136203.html.plaintext.txt	130	archive general psychiatry num num num
0.51095337.11136203.html.plaintext.txt	131	et al num apolipoprotein e clinical feature late onset alzheimers disease
0.51095337.11136203.html.plaintext.txt	132	journal neurology neurosurgery psychiatry num num num
0.51095337.11136203.html.plaintext.txt	133	et al num variation dcp encoding ace associated susceptibility alzheimers disease
0.51095337.11136203.html.plaintext.txt	134	et al num apolipoprotein e num allele cognitive decline deterioration everyday performance alzheimers disease
0.51095337.11136203.html.plaintext.txt	135	et al num utility apolipoprotein e genotype diagnosis alzheimers disease
0.51095337.11136203.html.plaintext.txt	136	new england journal medicine num num num
0.51095337.11136203.html.plaintext.txt	137	et al num apoe genotype predicts whether one predisposed develop alzheimers disease
0.51095337.11136203.html.plaintext.txt	138	et al num seminar psychiatric genetics
0.51095337.11136203.html.plaintext.txt	139	et al num incidence risk dementia rotterdam study
0.51095337.11136203.html.plaintext.txt	140	american journal epidemiology num num num
0.51095337.11136203.html.plaintext.txt	141	et al num apolipoprotein enum allele predictor cholinergic deficit treatment outcome alzheimers disease
0.51095337.11136203.html.plaintext.txt	142	proceeding national academy science usa num num num
0.51095337.11136203.html.plaintext.txt	143	num senile dementia age related ageing related evidence meta analysis dementia prevalence oldest old
0.51095337.11136203.html.plaintext.txt	144	et al num incomplete penetrance familial alzheimers disease pedigree novel presenilin gene mutation
0.51095337.11136203.html.plaintext.txt	145	et al num genetic association human longevity apoe ace locus
0.51095337.11136203.html.plaintext.txt	146	num translating cell biology therapeutic advance alzheimers disease
0.51095337.11136203.html.plaintext.txt	147	num apolipoprotein e num allele lifetime risk alzheimers disease physician know know
0.51095337.11136203.html.plaintext.txt	148	archive neurology num num num
0.51095337.11136203.html.plaintext.txt	149	et al num lifetime risk dementia alzheimers disease impact mortality risk estimate framingham study
0.51095337.11136203.html.plaintext.txt	150	et al num pattern risk first degree relative patient alzheimers disease
0.51095337.11136203.html.plaintext.txt	151	archive general psychiatry num num num
0.51095337.11136203.html.plaintext.txt	152	et al num population based study dementia num year old
0.51095337.11136203.html.plaintext.txt	153	new england journal medicine num num num
0.51095337.11136203.html.plaintext.txt	154	et al num absence apolipoprotein num allele associated aggressive form alzheimers disease
0.51095337.11136203.html.plaintext.txt	155	annals neurology num num num
0.51095337.11136203.html.plaintext.txt	156	et al num apolipoprotein e high avidity binding s amyloid increased frequency type num allele late onset familial alzheimers disease
0.51095337.11136203.html.plaintext.txt	157	proceeding national academy science usa num num num
0.51095337.11136203.html.plaintext.txt	158	num uk alzheimers disease genetics consortium
0.51095337.11136203.html.plaintext.txt	159	international journal geriatric psychiatry num num num
0.51095337.11136203.html.plaintext.txt	160	conum vlinktypedoicrossrefmedline
0.51095337.11136203.html.plaintext.txt	161	et al num ageing occurrence dementia finding population based cohort large sample nonagenarian
0.51095337.11136203.html.plaintext.txt	162	archive neurology num num num
0.51095337.11136203.html.plaintext.txt	163	received publication february num num
0.51095337.11136203.html.plaintext.txt	164	revision received june num num
0.51095337.11136203.html.plaintext.txt	165	accepted publication june num num
0.5120089.12944419.html.plaintext.txt	0	reporter amyloid precursor protein secretase activity drosophila ming guonum elizabeth j
0.5120089.12944419.html.plaintext.txt	1	numdepartment neurology brain research institute david geffen school medicine university california los angeles num usa numdivision biology mcnum num california institute technology pasadena ca num usa numdepartment biological chemistry howard hughes medical institute university california los angeles ca num usa
0.5120089.12944419.html.plaintext.txt	2	received june num num accepted august num num
0.5120089.12944419.html.plaintext.txt	3	view larger version numk figure num
0.5120089.12944419.html.plaintext.txt	4	fly eye based reporter secretase activity
0.5120089.12944419.html.plaintext.txt	5	schematic illustration app cleavage site
0.5120089.12944419.html.plaintext.txt	6	sequential action s secretase cleaves app extracellular domain ecd secretase cleaves app within transmembrane domain tmd generates as
0.5120089.12944419.html.plaintext.txt	7	b schematic illustrating secretase reporter
0.5120089.12944419.html.plaintext.txt	8	reporter contains two component chimeric protein app galnum substrate uas grim construct output
0.5120089.12944419.html.plaintext.txt	9	app galnum specifically expressed eye
0.5120089.12944419.html.plaintext.txt	10	absence secretase mediated app cleavage left panel cell death observed vivo
0.5120089.12944419.html.plaintext.txt	11	presence secretase right panel unleashed app fragment galnum translocated nucleus activate grim dependent cell death
0.5120089.12944419.html.plaintext.txt	12	c f scanning electron micrographs adult fly eye various genotype
0.5120089.12944419.html.plaintext.txt	13	genotype follows c gmr app galnum d uas grim e gmr app galnum uas grim f gmr pnum gmr app galnum uas grim
0.5120089.12944419.html.plaintext.txt	14	expression gmr app galnum c uas grim d isolation resulted fly wildtype appearing eye
0.5120089.12944419.html.plaintext.txt	15	contrast expression gmr app galnum uas grim reporter result adult fly small eye e indicative retinal cell death
0.5120089.12944419.html.plaintext.txt	16	retinal cell death present reporter fly eliminated eye size restored normal coexpression caspase inhibitor baculovirus pnum f
0.5120089.12944419.html.plaintext.txt	17	secretase activity resides large multi protein complex num exact molecular weight composition still elucidated reviewed numnum
0.5120089.12944419.html.plaintext.txt	18	recent observation indicate activity four protein presenilin nicastrin aph num pen num necessary secretase activity reviewed num
0.5120089.12944419.html.plaintext.txt	19	human genome encodes two presenilins presenilin num psnum presenilin num psnum
0.5120089.12944419.html.plaintext.txt	20	presenilins bind app probably provide active catalytic core secretase act intimate cofactor reviewed numnumnum num
0.5120089.12944419.html.plaintext.txt	21	mutation psnum psnum associated majority familial ad case num
0.5120089.12944419.html.plaintext.txt	22	nicastrin transmembrane glycoprotein isolated via ability bind psnum num promote notch signaling c
0.5120089.12944419.html.plaintext.txt	23	aph num polytopic membrane protein originally identified regulator notch signaling c
0.5120089.12944419.html.plaintext.txt	24	elegans numnum bind presenilins nicastrin num num
0.5120089.12944419.html.plaintext.txt	25	pen num small protein span membrane twice also first identified regulator notch signaling c
0.5120089.12944419.html.plaintext.txt	26	four protein coexpressed
0.5120089.12944419.html.plaintext.txt	27	cerevisiae lack endogenous secretase activity sufficient create active secretase complex num reviewed num
0.5120089.12944419.html.plaintext.txt	28	finding suggests four protein minimal core component secretase although exclude possibility factor yeast may also contribute formation active secretase complex
0.5120089.12944419.html.plaintext.txt	29	four protein regulate stability maturation tissue culture num num
0.5120089.12944419.html.plaintext.txt	30	regulation occurs unknown
0.5120089.12944419.html.plaintext.txt	31	also unknown signaling pathway regulate secretase activity modifying assembly activity protein
0.5120089.12944419.html.plaintext.txt	32	drosophila secretase four known component functionally conserved
0.5120089.12944419.html.plaintext.txt	33	drosophila endogenous secretase activity app notch num mechanism action formation high molecular weight complex presenilin also conserved num
0.5120089.12944419.html.plaintext.txt	34	drosophila single homolog presenilin psn num num nicastrin nct num num aph num pen num num
0.5120089.12944419.html.plaintext.txt	35	loss psn nct function drosophila result notch like phenotype num num
0.5120089.12944419.html.plaintext.txt	36	removing aph num pen num drosophila schneider num snum culture cell via rna interference rnai suppresses cleavage app notch num
0.5120089.12944419.html.plaintext.txt	37	together observation indicate mechanism app cleavage occurs fly well pathway activity regulated conserved mammal
0.5120089.12944419.html.plaintext.txt	38	gene regulate cleavage app isolated successfully several approach
0.5120089.12944419.html.plaintext.txt	39	positional cloning familial ad gene resulted identification psnum psnum
0.5120089.12944419.html.plaintext.txt	40	biochemical purification psnum associated protein led identification nicastrin reviewed num num
0.5120089.12944419.html.plaintext.txt	41	function based vivo genetic screen conducted model system c
0.5120089.12944419.html.plaintext.txt	42	elegans drosophila phenotype suggestive alteration secretase activity provide important complementary strategy identifying new gene regulating secretase
0.5120089.12944419.html.plaintext.txt	43	elegans mutant notch like presenilin like developmental defect identified secretase regulator aph num nicastrin num aph num pen num numnum
0.5120089.12944419.html.plaintext.txt	44	advantage vivo genetic approach rely direct physical binding existing protein presenilins thus limited low affinity abundance important interacting component
0.5120089.12944419.html.plaintext.txt	45	addition potential identify component regulatory pathway secretase activity may bind presenilin
0.5120089.12944419.html.plaintext.txt	46	describe reporter allows determination endogenous level secretase activity easy visualize nonessential neuronal tissue adult fly eye
0.5120089.12944419.html.plaintext.txt	47	reporter designed identify change cleavage app
0.5120089.12944419.html.plaintext.txt	48	contrast previous c
0.5120089.12944419.html.plaintext.txt	49	elegans drosophila based screen used presenilin notch mutant phenotype development surrogate marker num num
0.5120089.12944419.html.plaintext.txt	50	addition describe result screen utilizing fly identified small region second chromosome containing one gene whose product may promote app secretase activity
0.5120089.12944419.html.plaintext.txt	51	fly expressing gmr app galnum alone wildtype appearing eye fig
0.5120089.12944419.html.plaintext.txt	52	numc fly carrying uas grim fig
0.5120089.12944419.html.plaintext.txt	53	contrast fly expressing gmr app galnum uas grim referred hereafter reporter fly small eye fig
0.5120089.12944419.html.plaintext.txt	54	importantly reporter small eye phenotype completely suppressed reporter fly also expressed gmr control potent cell death caspase inhibitor baculovirus pnum num fig
0.5120089.12944419.html.plaintext.txt	55	numf drosophila cell death caspase inhibitor diapnum num data shown
0.5120089.12944419.html.plaintext.txt	56	observation indicate reporter small eye phenotype strictly due grim induced caspase dependent cell death result developmental defect activation signal transduction pathway cleaved app galnum reporter protein
0.5120089.12944419.html.plaintext.txt	57	secretase reporter fly act useful genetic background carry screen secretase regulator see
0.5120089.12944419.html.plaintext.txt	58	screen genetic chemical generates false positive
0.5120089.12944419.html.plaintext.txt	59	mutation act modifier interesting project hand
0.5120089.12944419.html.plaintext.txt	60	case source modifier include mutation affect efficiency gmr galnum dependent transcriptional activation efficacy grim dependent cell death signaling
0.5120089.12944419.html.plaintext.txt	61	intended use gmr galnum uas grim eliminate false positive
0.5120089.12944419.html.plaintext.txt	62	however since gmr galnum uas grim fly lethal chose utilize two strain fly act reporter false positive
0.5120089.12944419.html.plaintext.txt	63	first strain gmr grim express grim directly gmr control small eye fig
0.5120089.12944419.html.plaintext.txt	64	second strain gmr galnum uas grim greaper num
0.5120089.12944419.html.plaintext.txt	65	chimeric protein greaper n terminus grim c terminus second cell death activator reaper rpr num
0.5120089.12944419.html.plaintext.txt	66	gmr galnum uas grpr fly also small eye phenotype due induction caspase dependent cell death num fig
0.5120089.12944419.html.plaintext.txt	67	true modifier secretase activity alter eye size reporter fly false positive reporter fly
0.5120089.12944419.html.plaintext.txt	68	false positive hand modify eye size similarly presence reporter false positive reporter
0.5120089.12944419.html.plaintext.txt	69	example latter reduction level glass encodes transcription factor drive gmr dependent expression num result suppression small eye phenotype reporter fly well false positive reporter data shown
0.5120089.12944419.html.plaintext.txt	70	view larger version numk figure num
0.5120089.12944419.html.plaintext.txt	71	secretase reporter fly sensitive level psn
0.5120089.12944419.html.plaintext.txt	72	scanning electron micrographs various genotype shown
0.5120089.12944419.html.plaintext.txt	73	genotype follows gmr app galnum uas grim b gmr app galnum uas grim psncnum c gmr app galnum uas grim gmr psndn d gmr grim e gmr grim psncnum f gmr grim gmr psndn g gmr galnum uas grpr h gmr galnum uas grpr psncnum gmr galnum uas grpr gmr psndn
0.5120089.12944419.html.plaintext.txt	74	identical figure nume cross figure num num set parallel
0.5120089.12944419.html.plaintext.txt	75	decreasing psn level suppress gmr app galnum uas grim dependent small eye phenotype b c cf
0.5120089.12944419.html.plaintext.txt	76	small eye phenotype associated gmr grim e f cf
0.5120089.12944419.html.plaintext.txt	77	d gmr galnum uas grpr h cf
0.5120089.12944419.html.plaintext.txt	78	activity reporter depends presenilin nicastrin aph num presenilin nicastrin aph num required secretase dependent cleavage app mammal drosophila reviewed numnum
0.5120089.12944419.html.plaintext.txt	79	thus important prediction eye phenotype reporter fly false positive reporter fly gmr grim gmr galnum uas grpr sensitive level psn nct aph num
0.5120089.12944419.html.plaintext.txt	80	used two approach decrease psn level first made reporter fly heterozygous psn null mutation psncnum num thereby decreasing psn genetic dose num second generated expressed dominant negative version drosophila psn gmr control gmr psndn fly see material method detail
0.5120089.12944419.html.plaintext.txt	81	heterozygous fly psncnum gmr psndn alone wild type appearing eye data shown
0.5120089.12944419.html.plaintext.txt	82	contrast decreasing psn level suppressed small eye phenotype reporter fig
0.5120089.12944419.html.plaintext.txt	83	small eye phenotype associated gmr grim fig
0.5120089.12944419.html.plaintext.txt	84	d gmr galnum uas grpr fig
0.5120089.12944419.html.plaintext.txt	85	result similar series experiment showed reporter eye phenotype also sensitive level second component secretase complex nct fig
0.5120089.12944419.html.plaintext.txt	86	used two approach reduce level nct
0.5120089.12944419.html.plaintext.txt	87	first made reporter fly heterozygous nct null allele nct jnum num thereby decreasing nct genetic dose num
0.5120089.12944419.html.plaintext.txt	88	second generated fly expressed nct rna interference construct gmr control gmr rnai nct fly see material method detail introduced reporter background
0.5120089.12944419.html.plaintext.txt	89	heterozygous fly nctjnum gmr rnai nct isolation wild type appearing eye data shown
0.5120089.12944419.html.plaintext.txt	90	however led strong suppression reporter dependent small eye phenotype fig
0.5120089.12944419.html.plaintext.txt	91	psn reduction nct dose effect eye size false positive reporter fly gmr grim fig
0.5120089.12944419.html.plaintext.txt	92	d gmr galnum uas grpr fig
0.5120089.12944419.html.plaintext.txt	93	view larger version numk figure num
0.5120089.12944419.html.plaintext.txt	94	secretase reporter fly sensitive level nct
0.5120089.12944419.html.plaintext.txt	95	scanning electron micrographs various genotype shown
0.5120089.12944419.html.plaintext.txt	96	genotype follows gmr app galnum uas grim b gmr app galnum uas grim nctjnum c gmr app galnum uas grim gmr rnai nct d gmr grim e gmr grim nctjnum f gmr grim gmr rnai nct g gmr galnum uas grpr h gmr galnum uas grpr nctjnum gmr galnum uas grpr gmr rnai nct
0.5120089.12944419.html.plaintext.txt	97	identical figure nume numa d identical figure numd g identical figure numg cross figure num num set parallel
0.5120089.12944419.html.plaintext.txt	98	decreasing nct level suppresses gmr app galnum uas grim dependent small eye phenotype b c cf
0.5120089.12944419.html.plaintext.txt	99	small eye phenotype associated gmr grim e f cf
0.5120089.12944419.html.plaintext.txt	100	d gmr galnum uasgrpr h cf
0.5120089.12944419.html.plaintext.txt	101	aph num third conserved protein required secretase activity
0.5120089.12944419.html.plaintext.txt	102	mutation drosophila aph num available
0.5120089.12944419.html.plaintext.txt	103	therefore determine loss aph num function suppressed reporter small eye phenotype generated fly expressed aph num rnai construct gmr control gmr rnai aph num fly
0.5120089.12944419.html.plaintext.txt	104	fly wild type appearance data shown
0.5120089.12944419.html.plaintext.txt	105	acted strong suppressor small eye phenotype reporter fig
0.5120089.12944419.html.plaintext.txt	106	numb false positive reporter gmr grim fig
0.5120089.12944419.html.plaintext.txt	107	numd gmr galnum uas grpr fig
0.5120089.12944419.html.plaintext.txt	108	thus secretase reporter fly eye phenotype sensitive small change roughly num fold level three known component regulator secretase complex psn nct aph num
0.5120089.12944419.html.plaintext.txt	109	observation argue gmr app galnumuas grim fly function reporter endogenous secretase activity constitute sensitized background screen secretase regulator component
0.5120089.12944419.html.plaintext.txt	110	view larger version numk figure num
0.5120089.12944419.html.plaintext.txt	111	secretase reporter fly sensitive level aph num
0.5120089.12944419.html.plaintext.txt	112	scanning electron micrographs various genotype shown
0.5120089.12944419.html.plaintext.txt	113	genotype follows gmr app galnum uas grim b gmr app galnum uas grim gmr rnai aph num c gmr grim d gmr grim gmr rnai aph num e gmr galnum uas grpr f gmr galnum uas grpr gmr rnai aph num
0.5120089.12944419.html.plaintext.txt	114	decreasing aph num level suppress gmr app galnum uas grim dependent small eye phenotype b cf
0.5120089.12944419.html.plaintext.txt	115	small eye phenotype associated gmr grim d cf
0.5120089.12944419.html.plaintext.txt	116	c gmr galnum uas grpr f cf
0.5120089.12944419.html.plaintext.txt	117	numcnum num region contains potential regulator secretase activity carried genetic screen suppressor app secretase activity drosophila
0.5120089.12944419.html.plaintext.txt	118	screened second chromosome using publicly available deficiency kit contains num stock total delete num chromosome make two fifth drosophila genome
0.5120089.12944419.html.plaintext.txt	119	heterozygous deletion bearing fly crossed reporter fly progeny bearing deletion reporter identified
0.5120089.12944419.html.plaintext.txt	120	scored suppression compared fly carrying reporter alone
0.5120089.12944419.html.plaintext.txt	121	several region contained strong suppressor activity identified table num
0.5120089.12944419.html.plaintext.txt	122	one numa numf defined dfnumrnum contains pen num gene numcnum num encodes fourth component mammalian drosophila secretase complex
0.5120089.12944419.html.plaintext.txt	123	second strong suppressor region identified numanum cnum defined deficiency dfnumlnum fig
0.5120089.12944419.html.plaintext.txt	124	region contains aph num numanum
0.5120089.12944419.html.plaintext.txt	125	dfnumlnum numanum bnum also remove aph num
0.5120089.12944419.html.plaintext.txt	126	deficiency acted reporter suppressor much weaker one dfnumlnum fig
0.5120089.12944419.html.plaintext.txt	127	suggested region deleted dfnumlnum contains additional secretase suppressor locus
0.5120089.12944419.html.plaintext.txt	128	used smaller deficiency region map suppressor activity
0.5120089.12944419.html.plaintext.txt	129	dfnumlnum numcnum dnum dfnumlnum numdnum numenum dfnumlnum numcnum numenum suppress reporter phenotype
0.5120089.12944419.html.plaintext.txt	130	however dfnumlnum deletes numcnum enum overlap dfnumlnum acted strong reporter suppressor fig
0.5120089.12944419.html.plaintext.txt	131	dfnumlnum suppress small eye phenotype two false positive reporter line gmr grim gmr galnum uas grpr fig
0.5120089.12944419.html.plaintext.txt	132	together observation place suppressor numcnum num region
0.5120089.12944419.html.plaintext.txt	133	based current annotation berkeley drosophila genome project bdgp region span roughly num kb contains num num annotated gene
0.5120089.12944419.html.plaintext.txt	134	numcnum num region contains potential regulator secretase activity
0.5120089.12944419.html.plaintext.txt	135	schematic drawing chromosomal region numa e left arm second chromosome numl solid black bar
0.5120089.12944419.html.plaintext.txt	136	deficiency utilized cross indicated left
0.5120089.12944419.html.plaintext.txt	137	region deleted indicted gap bar
0.5120089.12944419.html.plaintext.txt	138	location aph num indicated asterisk
0.5120089.12944419.html.plaintext.txt	139	strength reporter suppression deficiency indicated right strongest see also c
0.5120089.12944419.html.plaintext.txt	140	boundary numcnum num region identified containing suppressor indicated dashed vertical line
0.5120089.12944419.html.plaintext.txt	141	b e representative scanning electron micrographs fly eye different genotype
0.5120089.12944419.html.plaintext.txt	142	dfnumlnum result strong suppression gmr app galnum uas grim small eye phenotype c cf
0.5120089.12944419.html.plaintext.txt	143	dfnumlnum much smaller deficiency deletes aph num result weaker suppression d
0.5120089.12944419.html.plaintext.txt	144	dfnumlnum include aph num also result suppression gmr app galnum uas grim small eye phenotype e
0.5120089.12944419.html.plaintext.txt	145	dfnumlnum suppress gmr grim g cf
0.5120089.12944419.html.plaintext.txt	146	f gmr galnum uas grpr cf
0.5120089.12944419.html.plaintext.txt	147	together observation consistent hypothesis numcnum num region contains gene promotes secretase activity
0.5120089.12944419.html.plaintext.txt	148	observation consistent hypothesis region contains gene promote secretase activity
0.5120089.12944419.html.plaintext.txt	149	however exclude possibility modifier function instead regulate fate aicd galnum appended see also discussion
0.5120089.12944419.html.plaintext.txt	150	possibility uninteresting
0.5120089.12944419.html.plaintext.txt	151	aicd shown interact number protein evidence suggests participate multiple cell biological process reviewed numnum
0.5120089.12944419.html.plaintext.txt	152	responsible modifier gene identified cell culture based assay using rnai interference follow aicd processing fate absence gene num distinguish possibility
0.5120089.12944419.html.plaintext.txt	153	described generation fly function living reporter app secretase activity
0.5120089.12944419.html.plaintext.txt	154	fly secretase dependent cleavage app tethered transcription factor protease substrate expressed specifically developing eye lead transcriptional activation cell death activator grim
0.5120089.12944419.html.plaintext.txt	155	thus level endogenous secretase activity read function grim dependent cell death manifest fly decreased eye size
0.5120089.12944419.html.plaintext.txt	156	drosophila eye particularly useful screening system regulator secretase activity since cell population dominated neuron eye dispensable viability fertility
0.5120089.12944419.html.plaintext.txt	157	importantly reporter small eye phenotype easily quantifiable regulated dose dependent manner modest change roughly num fold level psn nct aph num encode known component secretase containing complex
0.5120089.12944419.html.plaintext.txt	158	thus fly constitute sensitized background carry genetic screen regulator secretase activity
0.5120089.12944419.html.plaintext.txt	159	important point surprising modest change level secretase component num fold reduction associated heterozygosity alter reporter eye phenotype effect secretase dependent developmental process eye notch signaling
0.5120089.12944419.html.plaintext.txt	160	reporter specifically designed sensitive able report level secretase activity within normal physiologic range
0.5120089.12944419.html.plaintext.txt	161	thus reporter fly engineered display dominant eye phenotype response wild type level secretase activity
0.5120089.12944419.html.plaintext.txt	162	brought several different way
0.5120089.12944419.html.plaintext.txt	163	reporter protein contains n terminal signal sequence removed cotranslationally generating protein n terminus s secretase cleaved app
0.5120089.12944419.html.plaintext.txt	164	therefore contrast endogenous substrate reporter protein require s secretase cleavage order become suitable substrate secretase
0.5120089.12944419.html.plaintext.txt	165	extent prior cleavage event rate limiting reporter become preferred substrate
0.5120089.12944419.html.plaintext.txt	166	addition reporter fly app galnum expressed high level probably much higher endogenous secretase substrate notch
0.5120089.12944419.html.plaintext.txt	167	therefore likely reporter protein becomes molar basis dominant substrate
0.5120089.12944419.html.plaintext.txt	168	finally output reporter cell death eye requires galnum dependent transcriptional activation uas grim element
0.5120089.12944419.html.plaintext.txt	169	five optimized galnum binding site present construct num thereby conferring significant level transcription dependent amplification
0.5120089.12944419.html.plaintext.txt	170	sensitized background modest change level secretase activity brought change level component would expected result modification eye phenotype
0.5120089.12944419.html.plaintext.txt	171	contrast engineered situation heterozygosity almost gene fly genome including psn nct aph num result observable phenotype normal development residual num gene activity sufficient mediate normal signaling within cell
0.5120089.12944419.html.plaintext.txt	172	word endogenous cellular signaling pathway notch normally buffered phenotypic variability response modest change activity gene required notch processing reviewed num
0.5120089.12944419.html.plaintext.txt	173	secretase reporter fly designed identify factor regulate secretase cleavage
0.5120089.12944419.html.plaintext.txt	174	however important note several sort interesting modifier may identified
0.5120089.12944419.html.plaintext.txt	175	include factor influence stability subcellular localization app galnum aicd secretase component
0.5120089.12944419.html.plaintext.txt	176	could also include factor regulate proteolysis reporter outside secretase target site
0.5120089.12944419.html.plaintext.txt	177	particular regulator recently identified cleavage c terminal cleavage site also regulated psn num num may also detected
0.5120089.12944419.html.plaintext.txt	178	many factor would potential relevance understanding alzheimers disease mechanism
0.5120089.12944419.html.plaintext.txt	179	reporter several advantage conducting genome wide genetic screen
0.5120089.12944419.html.plaintext.txt	180	first small eye phenotype reporter fly act readout endogenous physiological level secretase
0.5120089.12944419.html.plaintext.txt	181	stand contrast situation many eye based dominant modifier screen sensitized background result hyperactivation signaling pathway num
0.5120089.12944419.html.plaintext.txt	182	thus modification reporter small eye phenotype genetic manipulation chemical compound directly reflects modification endogenous physiologically relevant level secretase activity
0.5120089.12944419.html.plaintext.txt	183	second reporter allows u conduct screen focused specifically identifying gene regulate cleavage app
0.5120089.12944419.html.plaintext.txt	184	make assumption role psn secretase function thus constitutes unbiased approach identifying factor regulating app processing
0.5120089.12944419.html.plaintext.txt	185	stand contrast screen focused identifying gene use notch psn loss function phenotype development surrogate marker
0.5120089.12944419.html.plaintext.txt	186	third sensitivity reporter allows u conduct fnum dominant modifier screen
0.5120089.12944419.html.plaintext.txt	187	since large number fly screened short period time fnum first generation set stage genome wide search mutation affecting secretase
0.5120089.12944419.html.plaintext.txt	188	moreover disruption one copy almost gene fly genome lead fly viable fertile
0.5120089.12944419.html.plaintext.txt	189	thus function gene tested even though homozygous deletion gene might lethal earlier development
0.5120089.12944419.html.plaintext.txt	190	finally reporter fly also useful exploring role candidate gene secretase regulation
0.5120089.12944419.html.plaintext.txt	191	particular fact level specific gene eye reporter fly selectively decreased using gmr rnai construct illustrated nct aph num provides rapid method test candidate secretase regulator neural tissue vivo
0.5120089.12944419.html.plaintext.txt	192	residue dnum drosophila psn corresponds one two evolutionarily conserved aspartate residue located putative transmembrane domain num num num
0.5120089.12944419.html.plaintext.txt	193	mutation either conserved residue alanine mammalian psnum creates protein dominant negative activity num
0.5120089.12944419.html.plaintext.txt	194	generated dominant negative version drosophila psn psn dnuma psn cdna ldnum obtained research genetics using stratagene quikchange site directed mutagenesis kit
0.5120089.12944419.html.plaintext.txt	195	psn dnuma introduced gmr vector generating gmr psn dnuma
0.5120089.12944419.html.plaintext.txt	196	gmr driven nct aph num rnai construct generated following strategy result transcription sense antisense strand transgene expressed gmr control num
0.5120089.12944419.html.plaintext.txt	197	similar strategy developed drive double stranded rna production uas control num
0.5120089.12944419.html.plaintext.txt	198	fragment drosophila nct coding region residue num num aph num coding region amino acid residue num num introduced two gmr promoter sequence oriented opposite direction vector pcasper generating gmr rnai nct gmr rnai aph num respectively
0.5120089.12944419.html.plaintext.txt	199	ensure rnai effect specific transgene question transgenic fly containing gmr rnai nct suppresses small eye phenotype gmr app galnum uas grim reporter crossed fly small eye due expression gmr grim gmr reaper rpr gmr hid numnum
0.5120089.12944419.html.plaintext.txt	200	small eye phenotype fly suppressed data shown
0.5120089.12944419.html.plaintext.txt	201	transformants generated using standard microinjection num procedure num num h wnum embryo
0.5120089.12944419.html.plaintext.txt	202	multiple transgenic line obtained microinjections
0.5120089.12944419.html.plaintext.txt	203	experiment least four different insertion line tested
0.5120089.12944419.html.plaintext.txt	204	fly strain genetics drosophila strain raised standard cornmeal yeast agar medium num degree c except gmr galnum uas greaper stock raised room temperature num degree c
0.5120089.12944419.html.plaintext.txt	205	allele used study follows psncnum psncnum struhl num nctjnum nctjnum nctanum fortini num gmr greaper num nambu gmr pnum num gmr diapnum num
0.5120089.12944419.html.plaintext.txt	206	fly carrying one copy gmr app galnum one copy uas grim chromosome generated meiotic recombination
0.5120089.12944419.html.plaintext.txt	207	resulting gmr app galnum uas grim chromosome balanced cyo
0.5120089.12944419.html.plaintext.txt	208	gmr app galnum uas grim fly crossed different genetic background appropriate progeny compared progeny gmr app galnum uas grim outcrossed wnum background stock gmr driven transgene introduced
0.5120089.12944419.html.plaintext.txt	209	similar cross carried two false positive reporter gmr grim gmr galnum uas grpr
0.5120089.12944419.html.plaintext.txt	210	cross carried num degree c except involving gmr galnum uas grpr carried room temperature num degree c
0.5120089.12944419.html.plaintext.txt	211	group stock deficiency kit together delete one piece time large fraction second chromosome obtained bloomington stock center
0.5120089.12944419.html.plaintext.txt	212	line crossed reporter fly
0.5120089.12944419.html.plaintext.txt	213	reporter progeny carrying one copy deficiency chromosome examined suppression reporter small eye phenotype
0.5120089.12944419.html.plaintext.txt	214	deficiency tested positive assay characterized similar cross false positive reporter strain gmr grim gmr galnum uas grpr
0.5120089.12944419.html.plaintext.txt	215	scanning electron microscopy sample fly dehydrated ethanol series incubated overnight hexamethyldisilazane sigma air dried prior analyzed using hitachi scanning electron microscopy
0.5120089.12944419.html.plaintext.txt	216	others fly quickly frozen num degree c mounted analyzed directly
0.5120089.12944419.html.plaintext.txt	217	method preparation gave identical result
0.5120089.12944419.html.plaintext.txt	218	footnote correspondence addressed
0.5120089.12944419.html.plaintext.txt	219	tel num num fax num num email mingflyatucla
0.5120089.12944419.html.plaintext.txt	220	num secretase notch ab alzheimers disease presenilins fit nat
0.5120089.12944419.html.plaintext.txt	221	num alzheimers disease gene protein therapy
0.5120089.12944419.html.plaintext.txt	222	num molecular genetics alzheimers disease
0.5120089.12944419.html.plaintext.txt	223	num new frontier alzheimers disease genetics
0.5120089.12944419.html.plaintext.txt	224	num secretase mediated proteolysis cell surface receptor signaling
0.5120089.12944419.html.plaintext.txt	225	num notch signaling cell fate control signal integration development
0.5120089.12944419.html.plaintext.txt	226	num presenilin num linked secretase activity detergent solubilized state
0.5120089.12944419.html.plaintext.txt	227	num cell biological perspective alzheimers disease
0.5120089.12944419.html.plaintext.txt	228	num aph num pen num nicastrin presenilin generate active secretase complex
0.5120089.12944419.html.plaintext.txt	229	num presenilin secretase structure meet function
0.5120089.12944419.html.plaintext.txt	230	num multiple paradox presenilins
0.5120089.12944419.html.plaintext.txt	231	num intramembrane protease mixing oil water
0.5120089.12944419.html.plaintext.txt	232	num alzheimer disease secretase complex story gxgd type presenilin protease
0.5120089.12944419.html.plaintext.txt	233	num nicastrin modulates presenilin mediated notchglp num signal transduction ssapp processing
0.5120089.12944419.html.plaintext.txt	234	num aph num encodes novel extracellular protein required glp num mediated signaling
0.5120089.12944419.html.plaintext.txt	235	development num num num
0.5120089.12944419.html.plaintext.txt	236	num aph num multipass membrane protein essential notch signaling pathway caenorhabditis elegans embryo
0.5120089.12944419.html.plaintext.txt	237	num aph num pen num required notch pathway signaling secretase cleavage ssapp presenilin protein accumulation
0.5120089.12944419.html.plaintext.txt	238	num mammalian aph num interacts presenilin nicastrin required intramembrane proteolysis amyloid s precursor protein notch
0.5120089.12944419.html.plaintext.txt	239	num aph num interacts mature immature form presenilins nicastrin may play role maturation presenilin nicastrin complex
0.5120089.12944419.html.plaintext.txt	240	num role presenilin cofactor secretase complex
0.5120089.12944419.html.plaintext.txt	241	num reconstitution secretase activity
0.5120089.12944419.html.plaintext.txt	242	num secretase membrane protein complex comprised presenilin nicastrin aph num pen num
0.5120089.12944419.html.plaintext.txt	243	num different cofactor activity secretase assembly evidence nicastrin aph num subcomplex
0.5120089.12944419.html.plaintext.txt	244	num pen num aph num coordinately regulate proteolytic processing presenilin num
0.5120089.12944419.html.plaintext.txt	245	num pen num integral component secretase complex required coordinated expression presenilin nicastrin
0.5120089.12944419.html.plaintext.txt	246	num transgenic drosophila expressing human amyloid precursor protein show secretase activity blistered wing phenotype
0.5120089.12944419.html.plaintext.txt	247	num mechanism secretase activity high molecular weight complex formation presenilins conserved drosophila melanogaster mammal
0.5120089.12944419.html.plaintext.txt	248	num characterization drosophila presenilin colocalization notch development
0.5120089.12944419.html.plaintext.txt	249	num cloning characterization drosophila presenilin homologue
0.5120089.12944419.html.plaintext.txt	250	neuroreport numnum num num
0.5120089.12944419.html.plaintext.txt	251	num isolation characterization drosophila presenilin homolog
0.5120089.12944419.html.plaintext.txt	252	num nicastrin required presenilin mediated transmembrane cleavage drosophila
0.5120089.12944419.html.plaintext.txt	253	num nicastrin required secretase cleavage drosophila notch receptor
0.5120089.12944419.html.plaintext.txt	254	num drosophila nicastrin essential intramembranous cleavage notch
0.5120089.12944419.html.plaintext.txt	255	num presenilin required activity nuclear access notch drosophila
0.5120089.12944419.html.plaintext.txt	256	num neurogenic phenotype altered notch processing drosophila presenilin mutant
0.5120089.12944419.html.plaintext.txt	257	num drosophila presenilin required neuronal differentiation affect notch subcellular localization signaling
0.5120089.12944419.html.plaintext.txt	258	num expression baculovirus pnum prevents cell death drosophila
0.5120089.12944419.html.plaintext.txt	259	development num num num
0.5120089.12944419.html.plaintext.txt	260	num grim novel cell death gene drosophila
0.5120089.12944419.html.plaintext.txt	261	num cloning method identify caspase regulator yeast identification drosophila iapnum inhibitor drosophila caspase dcp num
0.5120089.12944419.html.plaintext.txt	262	num nuclear access action notch vivo
0.5120089.12944419.html.plaintext.txt	263	num indirect evidence delta dependent intracellular processing notch drosophila embryo
0.5120089.12944419.html.plaintext.txt	264	num sensitive quantitative assay measuring cleavage presenilin substrate
0.5120089.12944419.html.plaintext.txt	265	num drosophila homologs baculovirus inhibitor apoptosis protein function block cell death
0.5120089.12944419.html.plaintext.txt	266	num rhg motif drosophila reaper grim important distinct cell death inducing ability
0.5120089.12944419.html.plaintext.txt	267	num genetic control programmed cell death drosophila
0.5120089.12944419.html.plaintext.txt	268	num glass gene encodes zinc finger protein required drosophila photoreceptor cell
0.5120089.12944419.html.plaintext.txt	269	num s amyloid precursor protein app alzheimers disease tail wag dog traffic num num num
0.5120089.12944419.html.plaintext.txt	270	num targeted gene expression mean altering cell fate generating dominant phenotype
0.5120089.12944419.html.plaintext.txt	271	num genotype phenotype protein chaperone evolvability
0.5120089.12944419.html.plaintext.txt	272	num novel epsilon cleavage within transmembrane domain alzheimer amyloid precursor protein demonstrates homology notch processing
0.5120089.12944419.html.plaintext.txt	273	biochemistry num num num
0.5120089.12944419.html.plaintext.txt	274	num presenilin dependent secretase processing s amyloid precursor protein site corresponding snum cleavage notch
0.5120089.12944419.html.plaintext.txt	275	num characterization presenilin mediated amyloid precursor protein carboxyl terminal fragment
0.5120089.12944419.html.plaintext.txt	276	evidence distinct mechanism involved secretase processing app notchnum transmembrane domain
0.5120089.12944419.html.plaintext.txt	277	num distinct intramembrane cleavage s amyloid precursor protein family resembling secretase like cleavage notch
0.5120089.12944419.html.plaintext.txt	278	num fly eye view biology
0.5120089.12944419.html.plaintext.txt	279	num precursor alzheimers disease amyloid anum protein resembles cell surface receptor
0.5120089.12944419.html.plaintext.txt	280	num primary structure saccharomyces cerevisiae galnum gene
0.5120089.12944419.html.plaintext.txt	281	num two transmembrane aspartates presenilin num required presenilin endoproteolysis secretase activity
0.5120089.12944419.html.plaintext.txt	282	num drosophila bruce potently suppress rpr grim dependent hid dependent cell death
0.5120089.12944419.html.plaintext.txt	283	num rnai triggered symmetrically transcribed transgene drosophila melanogaster
0.5120089.12944419.html.plaintext.txt	284	num drosophila caspase dronc cleaves following glutamate aspartate regulated diapnum hid grim
0.5120089.12944419.html.plaintext.txt	285	num genetic transformation drosophila transposable element vector
0.5120089.12944419.html.plaintext.txt	286	article abstract free full text pdf version article numnumnum recent ddgnumvnum alert article cited alert correction posted service email article friend similar article journal similar article isi web science similar article pubmed alert new issue journal add personal archive download citation manager search citing article isi web science num request permission google scholar article guo m
0.5120089.12944419.html.plaintext.txt	287	pubmed pubmed citation article guo m
0.5120089.12944419.html.plaintext.txt	288	online issn num num print issn num num copyright num oxford university press oxford journal oxford university press site map term condition privacy policy frequently asked question oxford university press site oxford university press american national biography bookseller information service childrens fiction poetry childrens reference corporate special sale dictionary dictionary national biography digital reference english language teaching higher education textbook humanity international education unit law medicine music online product oxford english dictionary reference right permission science school book social science short introduction world classic
0.5472486.15123653.html.plaintext.txt	0	notch oncoproteins depend secretasepresenilin activity processing function indranil da colleen craig yasuhiro funahashi kwang mook jung tae wan kim richard byers andrew p
0.5472486.15123653.html.plaintext.txt	1	department pathology obstetricsgynecology columbia university college physician surgeon new york new york num dana farber cancer institute boston massachusetts num department pathology brigham woman hospital harvard medical school boston massachusetts num
0.5472486.15123653.html.plaintext.txt	2	received publication august num num revised form may num num
0.5472486.15123653.html.plaintext.txt	3	vertebrate full length notch protein part family four receptor notchnum num five ligand include member jagged delta family
0.5472486.15123653.html.plaintext.txt	4	notch receptor extracellular ec domain consisting largely multiple epidermal growth factor like repeat within binding site ligand
0.5472486.15123653.html.plaintext.txt	5	notch receptor also cytoplasmic region containing ram domain seven ankyrin repeat c terminal pest domain
0.5472486.15123653.html.plaintext.txt	6	newly synthesized notch receptor processed initially trans golgi furin like convertase generating ligand binding ectodomain transmembrane signaling domain remain associated transport plasma membrane num num
0.5472486.15123653.html.plaintext.txt	7	ligand binding ectodomain induces several successive proteolytic cleavage event transmembrane subunit result release intracellular domain cell membrane
0.5472486.15123653.html.plaintext.txt	8	initial cleavage adam disintegrin metalloprotease type metalloproteases occurs external transmembrane tm domain num num serf facilitate additional cleavage secretasespresenilins within tm domain num
0.5472486.15123653.html.plaintext.txt	9	mammalian presenilins p num p num polytopic membrane protein appear function aspartyl protease within high molecular mass multiprotein complex also includes protein nicastrin aph num pen num num num
0.5472486.15123653.html.plaintext.txt	10	presenilins provide active site secretase proteolytic activity num
0.5472486.15123653.html.plaintext.txt	11	presenilin mediated cleavage involved activation four mammalian notch receptor num num case notchnum occurs several site within tm domain num
0.5472486.15123653.html.plaintext.txt	12	notchnum cleavage prevented addition secretase inhibitor mutation within critical aspartate residue presenilin num num
0.5472486.15123653.html.plaintext.txt	13	delta num induced signaling notchnum also reduced cell deficient presenilins cell treated secretase inhibitor num num
0.5472486.15123653.html.plaintext.txt	14	presenilins recently recognized multiple substrate addition notch including amyloid precursor protein erbbnum n e cadherins cdnum num num
0.5472486.15123653.html.plaintext.txt	15	presenilins necessary ectodomain shedding cleavage subsequent nuclear translocation intracellular domain polypeptide num num num num
0.5472486.15123653.html.plaintext.txt	16	case notch presenilin mediated cleavage allows notch intracellular domain ic gain access nucleus bind transcription factor cbfnumcsl
0.5472486.15123653.html.plaintext.txt	17	binding event convert csl transcriptional repressor transcriptional activator leading expression target gene num
0.5472486.15123653.html.plaintext.txt	18	notch signaling normally activated interaction notch receptor ligand expressed adjacent cell
0.5472486.15123653.html.plaintext.txt	19	truncated form notch containing deletion spanning ec domain bypass need ligand binding signal constitutively
0.5472486.15123653.html.plaintext.txt	20	two notch deletion involving mouse notchnum human notchnum initially named tan num translocation associated notch homolog num originally identified oncogene
0.5472486.15123653.html.plaintext.txt	21	int num oncogene refer notchnumint num arises retroviral integration mouse mammary tumor virus notchnum locus cause murine mammary tumor num num
0.5472486.15123653.html.plaintext.txt	22	case viral integration result production truncated transcript encodes tm ic domain notchnum see fig
0.5472486.15123653.html.plaintext.txt	23	similar fashion tan num oncogene associated generated truncation human notchnum caused recurrent num num chromosomal translocation involving notchnum gene cell receptor gene num
0.5472486.15123653.html.plaintext.txt	24	breakpoints identified date occur within intron prior exon encoding numth epidermal growth factor repeat result fusion num end notchnum cell receptor promoterenhancer element
0.5472486.15123653.html.plaintext.txt	25	fusion gene drive expression multiple truncated mrna encode series n terminally truncated tan num polypeptide ranging size slightly larger slightly smaller normal notchnum transmembrane subunit num
0.5472486.15123653.html.plaintext.txt	26	precise structure origin polypeptide defined
0.5472486.15123653.html.plaintext.txt	27	view larger version numk fig
0.5472486.15123653.html.plaintext.txt	28	model notch processing signaling
0.5472486.15123653.html.plaintext.txt	29	ligand binding full length notch may induce structural change allow tumor necrosis factor alpha converting enzyme tace presenilin cleavage release notchic membrane
0.5472486.15123653.html.plaintext.txt	30	notchnumint num lack ectodomain inserted membrane traffic cell surface cleaved readily presenilins
0.5472486.15123653.html.plaintext.txt	31	blockade presenilin mediated activity inhibit signal induction notchnumint num fl notch
0.5472486.15123653.html.plaintext.txt	32	tan num polypeptide demonstrate partial dependence presenilins
0.5472486.15123653.html.plaintext.txt	33	like notchnumint num tan num polypeptide inserted membrane depend proteolytic cleavage presenilins mtan num tan num polypeptide however may localized cell surface targeted nucleus presenilin independent manner ctan num
0.5472486.15123653.html.plaintext.txt	34	understand mechanism action activity notch engineered notch protein constitutively active studied
0.5472486.15123653.html.plaintext.txt	35	engineered notch protein include form either consisting ic ic linked tm domain small portion ec domain leader peptide notche
0.5472486.15123653.html.plaintext.txt	36	form active variety assay oncogenic num num notche depends presenilin activity num num
0.5472486.15123653.html.plaintext.txt	37	instance pharmacologic inhibition presenilin suppresses growth notchnume induced alls alls induced notchnum ic domain nnumic num
0.5472486.15123653.html.plaintext.txt	38	study asked whether notchnumint num tan num oncogenic form notch protein require presenilins proper processing signaling function activity
0.5472486.15123653.html.plaintext.txt	39	based known site truncation within notchnum notchnum gene oncogenic conversion tan num notchnumint num predicted encode protein including tm domain lacking signal peptide
0.5472486.15123653.html.plaintext.txt	40	thus unclear whether oncoproteins would insert membrane require presenilin activity activation
0.5472486.15123653.html.plaintext.txt	41	result show notchnumint num tan num targeted membrane subject presenilin mediated proteolytic processing
0.5472486.15123653.html.plaintext.txt	42	notchnumint num requires presenilin activity csl mediated signaling biological activity endothelial cell
0.5472486.15123653.html.plaintext.txt	43	tan num however demonstrates partial dependence presenilin activity
0.5472486.15123653.html.plaintext.txt	44	although blockade presenilin function alters tan num processing affect growth cell apparently tan num polypeptide bypass requirement presenilin processing nuclear access
0.5472486.15123653.html.plaintext.txt	45	finding oncogenic form notch depend presenilin activity function suggests potential avenue therapeutic intervention
0.5472486.15123653.html.plaintext.txt	46	luciferase reporter assay transient transfections performed calcium phosphate precipitation
0.5472486.15123653.html.plaintext.txt	47	assessment activated notch signaling hela cell cell plated num h prior transfection num well plate num
0.5472486.15123653.html.plaintext.txt	48	cell transfected triplicate num ng pqncnnumic ha num ng plncnotchnumint num ha combination num ng csl luciferase reporter pganum num num ng plnclacz control transfection efficiency
0.5472486.15123653.html.plaintext.txt	49	activated notch signaling mefs wild type p numnum assessed plating cell num h prior transfection num well plate num x num cellswell
0.5472486.15123653.html.plaintext.txt	50	mefs transfected triplicate num microg pqncnnumic ha num microg plncnotchnumint num ha combination num ng pganum num num ng plnclacz
0.5472486.15123653.html.plaintext.txt	51	determine ligand induced notch signaling coculture assay performed using hela num derived bosc cell
0.5472486.15123653.html.plaintext.txt	52	hela cell plated num day earlier num cm plate num
0.5472486.15123653.html.plaintext.txt	53	num x num transfected num
0.5472486.15123653.html.plaintext.txt	54	num microg pbos notchnum pbos notchnum num microg pganum num num microg plnc lacz
0.5472486.15123653.html.plaintext.txt	55	bosc cell plated num day prior num cm plate num x num transfected either num microg phytc jaggednum phytc delta num phytc delta num phytc x empty vector
0.5472486.15123653.html.plaintext.txt	56	one day transfection cell cocultured triplicate helabosc numnum num well plate num h
0.5472486.15123653.html.plaintext.txt	57	case culture treated plus minus cpde num h prior harvest cell
0.5472486.15123653.html.plaintext.txt	58	cell harvested luciferase activity determined num day post transfection using enhanced luciferase assay kit pharmingen galactosidase activity determined using galacto light plus kit pe biosystems
0.5472486.15123653.html.plaintext.txt	59	assay performed berthold dual injection luminometer
0.5472486.15123653.html.plaintext.txt	60	reporter activation normalized transfection efficiency
0.5472486.15123653.html.plaintext.txt	61	fold reduction cpde calculated ratio normalized reporter activity untreated cell cpde treated cell
0.5472486.15123653.html.plaintext.txt	62	biotinylation assay membrane expression tan num notchnumint num nnumic ha determined performing surface biotinylation experiment
0.5472486.15123653.html.plaintext.txt	63	notchnumint num nnumic transiently transfected hela cell lipofectamine num according manufacturer instruction invitrogen
0.5472486.15123653.html.plaintext.txt	64	suptnum cell expressing tan num transfected hela cell treated plus minus cpde num h prior harvest
0.5472486.15123653.html.plaintext.txt	65	suptnum cell transfected hela cell washed phosphate buffered saline labeled ez link sulfo nh biotin pierce num min num degree c
0.5472486.15123653.html.plaintext.txt	66	biotin quenched phosphate buffered saline glycine cell washed phosphate buffered saline
0.5472486.15123653.html.plaintext.txt	67	cell cultured num cm plate lysed tent buffer clearing lysates small aliquot saved load num ng whole cell lysate
0.5472486.15123653.html.plaintext.txt	68	remainder lysate used purify surface protein incubating immunopure immobilized streptavidin bead pierce overnight num degree c
0.5472486.15123653.html.plaintext.txt	69	streptavidin precipitated protein whole cell lysates treated phosphatase new england biolabs separated sd page transferred polyvinylidene difluoride membrane probed antibody tc detect tan num num corbnum num detect notchnumint num num numcanum detect ha tagged nnumic anti glycogen synthetase kinase num transduction laboratory anti tubulin sigma anti num integrin num provided eugene marcantonio columbia university p num loop p num loop antibody detect presenilins num num respectively num
0.5472486.15123653.html.plaintext.txt	70	protein visualized ecl amersham bioscience
0.5472486.15123653.html.plaintext.txt	71	analysis notchnumint num expression num cell num cell maintained dulbeccos modified eagle medium supplemented num fetal bovine serum penicillinstreptomycin
0.5472486.15123653.html.plaintext.txt	72	stable cell line dwt dasp maintained dulbeccos modified eagle medium supplemented num fetal bovine serum penicillinstreptomycin presence num microgml zeocin invitrogen
0.5472486.15123653.html.plaintext.txt	73	transient transfection cell transfected num mm dish num microg plncint num ha notchnume plasmid using superfect transfection reagent according manufacturer instruction qiagen
0.5472486.15123653.html.plaintext.txt	74	culture treated cpde l numnum calbiochem aebsf roche applied science pepstatin roche applied science menumso num h prior harvest cell
0.5472486.15123653.html.plaintext.txt	75	num h post transfection cell lysed using buffer ip num mm tris hcl ph num
0.5472486.15123653.html.plaintext.txt	76	num num mm nacl num triton x num num
0.5472486.15123653.html.plaintext.txt	77	num nonidet p num num mm edta supplemented protease inhibitor mixture tablet roche applied science
0.5472486.15123653.html.plaintext.txt	78	protein quantification sd page western blot analysis carried described previously num
0.5472486.15123653.html.plaintext.txt	79	primary anti ha antibody ha num covance used dilution numnumnum anti cleaved notchnum valnum antibody cell signaling used dilution numnumnum anti tubulin sigma used numnumnum
0.5472486.15123653.html.plaintext.txt	80	culture human umbilical vein endothelial cell huvec huvec isolated human umbilical vein method described previously num
0.5472486.15123653.html.plaintext.txt	81	huvec grown egmnum kit bio whittaker san diego containing vascular endothelial growth factor basic fibroblast growth factor epidermal growth factor insulin num fetal bovine serum type collagen coated num cm dish harvested num confluence trypsin
0.5472486.15123653.html.plaintext.txt	82	num x num cell huvec passage num seeded type collagen coated num well plate day adenoviral infection
0.5472486.15123653.html.plaintext.txt	83	adenoviral infection ad lacz ad notchnumint num virus num performed multiplicity infection num incubated num degree c num h occasional swirling plate
0.5472486.15123653.html.plaintext.txt	84	infected cell harvested day infection experiment
0.5472486.15123653.html.plaintext.txt	85	sprouting assay making collagen gel ice cold solution porcine type collagen nitta gelatin tokyo japan mixed num x rpmi num medium neutralization buffer ratio numnumnum
0.5472486.15123653.html.plaintext.txt	86	aliquot collagen gel num microl added num well plate allowed gel least num h num degree c
0.5472486.15123653.html.plaintext.txt	87	adenoviral infection huvec harvested plated num
0.5472486.15123653.html.plaintext.txt	88	num x num cellswell onto top collagen gel num well plate num
0.5472486.15123653.html.plaintext.txt	89	huvec became nearly confluent num h plating
0.5472486.15123653.html.plaintext.txt	90	seeding medium changed every num day next num week
0.5472486.15123653.html.plaintext.txt	91	treatment cpde started day num continued num week
0.5472486.15123653.html.plaintext.txt	92	sprouting observed photograph taken num week olympus digital camera mounted microscope
0.5472486.15123653.html.plaintext.txt	93	quantification number sprout five fieldseach well selected randomly sprouting counted microscopy blind manner two investigator
0.5472486.15123653.html.plaintext.txt	94	cell cycle analysis suptnum cell seeded num x numml dulbeccos modified eagle medium containing num fetal calf serum indicated concentration cpde carrier alone menumso
0.5472486.15123653.html.plaintext.txt	95	cell split every num day fresh medium drug maintain cell density num
0.5472486.15123653.html.plaintext.txt	96	day num cell harvested fixed num etoh stained propidium iodide analyzed flow cytometry dna content
0.5472486.15123653.html.plaintext.txt	97	cell cycle fraction determined using multicycle software
0.5472486.15123653.html.plaintext.txt	98	immunostaining suptnum cell jurkat cell grown dulbeccos modified eagle medium num fetal calf serum plus minus num microm cpde num h washed twice phosphate buffered saline fixed num min num buffered formalin centrifuged numnum x g num min
0.5472486.15123653.html.plaintext.txt	99	cell pellet dehydrated embedded paraffin sectioned num microm
0.5472486.15123653.html.plaintext.txt	100	dewaxing graded ethanol section subjected antigen retrieval heating num
0.5472486.15123653.html.plaintext.txt	101	south san francisco ca steam pressure cooker decloaking chamber biocare medical walnut creek ca according manufacturer instruction
0.5472486.15123653.html.plaintext.txt	102	wash distilled water slide pretreated peroxidase block dako usa carpinteria ca num min followed goat serum numnum num mm tris cl ph num
0.5472486.15123653.html.plaintext.txt	103	section incubated rabbit anti notchnumic tc numnumnum num num mm tris cl ph num
0.5472486.15123653.html.plaintext.txt	104	num containing num goat serum followed goat anti rabbit horseradish peroxidase conjugated antibody envision detection kit dako
0.5472486.15123653.html.plaintext.txt	105	washing immunoperoxidase staining developed using diaminobenzidine chromogen dako followed enhancing solution zymed laboratory inc
0.5472486.15123653.html.plaintext.txt	106	spectral imaging section stained anti notchnumic tc antibody subjected analysis using cri nuance spectral imaging system cri cambridge ma
0.5472486.15123653.html.plaintext.txt	107	briefly conventional bright field image xnum magnification captured sequentially num nm wavelength interval num nm blue num nm red resultant image cube concatenated stack image wavelength interval per pixel analyzed using cri nuance software
0.5472486.15123653.html.plaintext.txt	108	diaminobenzidine spectral profile applied across image cube determine intensity diaminobenzidine staining per pixel staining intensity converted composite false color image
0.5472486.15123653.html.plaintext.txt	109	wanted establish secretasepresenilin activity general requirement ligand induced notch signaling wanted determine whether notch family protein addition notchnum depend secretasepresenilin
0.5472486.15123653.html.plaintext.txt	110	address issue used pharmacological inhibitor secretase cpde num conjunction vitro cocultivation assay ligand receptor expressed independently two different cell type cocultured
0.5472486.15123653.html.plaintext.txt	111	cpde shown bind p num p num cell membrane num
0.5472486.15123653.html.plaintext.txt	112	additionally cpde block cleavage event release notchnume cell surface num also block growth cell transformed membrane tethered notchnume num
0.5472486.15123653.html.plaintext.txt	113	ligand mediated signaling notchnum notchnum assessed via reporter construct encoding six csl binding site transfected notch expressing cell ass notch activation
0.5472486.15123653.html.plaintext.txt	114	csl mediated signaling observed notchnum notchnum jaggednum fig
0.5472486.15123653.html.plaintext.txt	115	numa also delta num delta num data shown
0.5472486.15123653.html.plaintext.txt	116	jaggednum stimulated notchnum activity num fold control stimulated notchnum activity num fold control
0.5472486.15123653.html.plaintext.txt	117	cpde added vitro coculture assay num h prior harvest cell csl reporter activity reduced notchnum notchnum via different ligand tested fig
0.5472486.15123653.html.plaintext.txt	118	cpde caused num fold inhibition jaggednum induced signaling num fold inhibition delta num induced signaling notchnum notchnum
0.5472486.15123653.html.plaintext.txt	119	additionally delta num induced signaling reduced num fold num fold notchnum notchnum respectively
0.5472486.15123653.html.plaintext.txt	120	thus attenuation signaling secretasepresenilin inhibitor demonstrates requirement secretasepresenilin activity notchnum notchnum signaling whether via ligand jaggednum delta num delta num
0.5472486.15123653.html.plaintext.txt	121	view larger version numk fig
0.5472486.15123653.html.plaintext.txt	122	ligand induced signaling notchnum notchnum receptor requires presenilin activity
0.5472486.15123653.html.plaintext.txt	123	jaggednum expressing cell cocultured cell expressing csl luciferase reporter either notchnum notchnum
0.5472486.15123653.html.plaintext.txt	124	cell treated presence absence num nm cpde num h prior lysis
0.5472486.15123653.html.plaintext.txt	125	graph show normalized value luciferase reporter activation relative control cocultures ligand
0.5472486.15123653.html.plaintext.txt	126	value represent mean fold induction obtained least three experiment
0.5472486.15123653.html.plaintext.txt	127	b experiment similar performed examine effect cpde notch signaling indicated ligand
0.5472486.15123653.html.plaintext.txt	128	data represented fold reduction notchnum notchnum signaling cpde
0.5472486.15123653.html.plaintext.txt	129	presenilin activity necessary notchnumint num signaling test dependence notchnumint num presenilin activity relied expression construct drive expression polypeptide observed mouse mammary tumor caused proviral insertion
0.5472486.15123653.html.plaintext.txt	130	notchnumint num translation initiated construct internal notchnum start codon resulting synthesis polypeptide includes num amino acid ec domain tm domain ic domain notchnum signal peptide absent polypeptide
0.5472486.15123653.html.plaintext.txt	131	second construct encoding ic domain notch nnumic signal presenilin independent fashion used negative control
0.5472486.15123653.html.plaintext.txt	132	transient expression either notchnumint num nnumic led robust induction csl mediated reporter activity hela cell ref
0.5472486.15123653.html.plaintext.txt	133	determined whether blocking secretasepresenilin activity would affect reporter activity induced constitutively active notch protein
0.5472486.15123653.html.plaintext.txt	134	notchnumint num nnumic expressed independently hela cell mefs presence absence cpde
0.5472486.15123653.html.plaintext.txt	135	cell line cpde attenuated activity notchnumint num num
0.5472486.15123653.html.plaintext.txt	136	contrast cpde inhibit nnumic induced activity fig
0.5472486.15123653.html.plaintext.txt	137	furthermore notchnumint num activity mef line deficient p num p num almost completely abrogated compared activity wild type mefs fig
0.5472486.15123653.html.plaintext.txt	138	level nnumic signaling similar wild type p numnum mefs
0.5472486.15123653.html.plaintext.txt	139	result indicate presenilins necessary notchnumint num induced csl signaling consistent intramembrane cleavage presenilin tm domain notchnumint num
0.5472486.15123653.html.plaintext.txt	140	nnumic encode tm domain therefore dependent presenilin cleavage subsequent nuclear translocation
0.5472486.15123653.html.plaintext.txt	141	view larger version numk fig
0.5472486.15123653.html.plaintext.txt	142	csl mediated signaling notchnumint num dependent presenilin activity
0.5472486.15123653.html.plaintext.txt	143	notchnumint num ha nnumic ha transfected hela cell mefs b together csl reporter
0.5472486.15123653.html.plaintext.txt	144	cell treated presence absence num nm cpde num h prior harvest
0.5472486.15123653.html.plaintext.txt	145	graph depict fold reduction notchnumint num nnumic signaling cpde treatment
0.5472486.15123653.html.plaintext.txt	146	c notchnumint num ha nnumic ha transfected native mefs mefs deficient p num p num psnumnum
0.5472486.15123653.html.plaintext.txt	147	cell treated cpde assayed
0.5472486.15123653.html.plaintext.txt	148	normalized value reporter activity relative cell transfected control plasmid
0.5472486.15123653.html.plaintext.txt	149	blockade presenilin activity alters protein expression pattern notchnumint num tan num noted previously membrane tethered form truncated notchnum notche accumulate presence presenilin inhibitor num raising possibility presenilin blockade would also stabilize notchnumint num tan num polypeptide
0.5472486.15123653.html.plaintext.txt	150	transient expression notchnumint num transfected num cell led appearance multiple closely spaced notchnum isoforms phosphorylated differentially num
0.5472486.15123653.html.plaintext.txt	151	treatment two different presenilin inhibitor cpde l numnum shifted protein band pattern toward higher molecular mass fig
0.5472486.15123653.html.plaintext.txt	152	drug treatment decrease level lowest molecular mass band increase level two higher molecular mass band became pronounced increasing drug concentration
0.5472486.15123653.html.plaintext.txt	153	regulation higher molecular mass notchnumint num protein likely attributed accumulation unprocessed larger form notchnumint num would arise protein cleaved tm domain presenilin
0.5472486.15123653.html.plaintext.txt	154	consistent result similar shift notchnumint num protein observed num cell stably coexpressing dominant negative form presenilin dnuma psnum dnuma psnum num relative num cell stably coexpressing wild type form presenilins fig
0.5472486.15123653.html.plaintext.txt	155	demonstrate inhibitory effect cpde l numnum specific secretase activity experiment performed two unrelated protease inhibitor aebsf pepstatin affect secretasepresenilin cleavage indicated concentration
0.5472486.15123653.html.plaintext.txt	156	use nonspecific inhibitor relatively high concentration num microm alter processing notchnumint num fig
0.5472486.15123653.html.plaintext.txt	157	numf observed cpde fig
0.5472486.15123653.html.plaintext.txt	158	view larger version numk fig
0.5472486.15123653.html.plaintext.txt	159	notchnumint num tan num polypeptide processed secretasepresenilin
0.5472486.15123653.html.plaintext.txt	160	b notchnumintnum ha transfected num cell incubated presence indicated concentration cpde lnumnum b num h
0.5472486.15123653.html.plaintext.txt	161	detergent lysates analyzed western blot ha num
0.5472486.15123653.html.plaintext.txt	162	c stable num cell coexpressing either wild type p num p num wt loss function variant p num p num dnuma p num dnuma p num respectively dasp transfected notchnumintnum ha lysed analyzed western blot ha num
0.5472486.15123653.html.plaintext.txt	163	c arrow denote lower molecular mass specie notchnumint num decrease secretase inhibited bracket denote higher molecular mass protein regulated
0.5472486.15123653.html.plaintext.txt	164	d suptnum cell incubated without num nm cpde num h
0.5472486.15123653.html.plaintext.txt	165	detergent lysates analyzed western blot anti notchnumic antibody tc
0.5472486.15123653.html.plaintext.txt	166	protein specie increase bracket decrease arrow cpde treatment denoted
0.5472486.15123653.html.plaintext.txt	167	e notchnumintnumha transfected f notchnume transfected num cell incubated presence cpde aebsf pepstatin pep num microm vehicle menumso dmso alone
0.5472486.15123653.html.plaintext.txt	168	lysates analyzed western blot ha num e anticleaved notchnum valnum f
0.5472486.15123653.html.plaintext.txt	169	lower panel blot probed tubulin control sample loading
0.5472486.15123653.html.plaintext.txt	170	effect secretasepresenilin inhibitor processing tan num polypeptide examined human lymphoblastic cell line suptnum carry two copy numnum normal notchnum gene num
0.5472486.15123653.html.plaintext.txt	171	multiple truncated notchnum mrna specie observed suptnum cell initiate cryptic promoter lying near chromosomal breakpoint num
0.5472486.15123653.html.plaintext.txt	172	transcript give rise series polypeptide ranging size num num kda fig
0.5472486.15123653.html.plaintext.txt	173	numd polypeptide detected two different anti notchnumic antibody num
0.5472486.15123653.html.plaintext.txt	174	polypeptide likely arise part cryptic translational start site num
0.5472486.15123653.html.plaintext.txt	175	treatment cpde altered expression pattern tan num polypeptide increasing level prominent broad band num kda decreasing level band slightly lower molecular mass fig
0.5472486.15123653.html.plaintext.txt	176	numd suggesting precursorproduct relationship
0.5472486.15123653.html.plaintext.txt	177	normally cleavage might occur spontaneously presence secretasepresenilin inhibitor conversion prevented
0.5472486.15123653.html.plaintext.txt	178	thus tan num notchnumint num polypeptide accumulate secretasepresenilin cleavage inhibited
0.5472486.15123653.html.plaintext.txt	179	notchnumint num tan num targeted membrane presenilin mediated cleavage within tm domain notch thought occur predominantly cell surface within plasma membrane num num num
0.5472486.15123653.html.plaintext.txt	180	notchnumint num tan num derived polypeptide substrate presenilin blockage presenilin activity would thus expected increase level notchnumint num tan num polypeptide cell surface
0.5472486.15123653.html.plaintext.txt	181	determine localization notchnumint num tan num presenilins used cell surface biotinylation followed streptavidin affinity purification immunoblotting
0.5472486.15123653.html.plaintext.txt	182	transiently expressing hela cell notchnumint num protein expressed cell surface whole cell lysate fig
0.5472486.15123653.html.plaintext.txt	183	numa whereas nnumic localizes nucleus biotinylated
0.5472486.15123653.html.plaintext.txt	184	examine tan num polypeptide suptnum cell biotinylated
0.5472486.15123653.html.plaintext.txt	185	western analysis performed using antibody specifically recognizes intracellular domain notchnum revealed minor tan num polypeptide precipitated streptavidin agarose fig
0.5472486.15123653.html.plaintext.txt	186	control nonspecific labeling intracellular protein sample probed antibody intracellular protein glycogen synthetase kinase num
0.5472486.15123653.html.plaintext.txt	187	expected glycogen synthetase kinase num detected biotin streptavidin precipitated sample indicating cytoplasmic protein biotinylated fig
0.5472486.15123653.html.plaintext.txt	188	view larger version numk fig
0.5472486.15123653.html.plaintext.txt	189	notchnumint num tan num expressed cell membrane accumulate secretase inhibition
0.5472486.15123653.html.plaintext.txt	190	hela cell transfected either notchnumint num ha nnumic ha
0.5472486.15123653.html.plaintext.txt	191	transfected hela cell suptnum cell b incubated without cpde num h treated membrane impermeable biotin label cell surface protein
0.5472486.15123653.html.plaintext.txt	192	detergent lysates made biotinylated protein captured streptavidin agarose bead
0.5472486.15123653.html.plaintext.txt	193	protein bound bead mem whole cell lysates cl analyzed western blot indicated protein
0.5472486.15123653.html.plaintext.txt	194	antibody num integrin used control demonstrating cpde nonspecifically affect membrane protein level
0.5472486.15123653.html.plaintext.txt	195	antibody glycogen synthetase kinase num gsk num used cytosolic protein control
0.5472486.15123653.html.plaintext.txt	196	normal notch polypeptide associate presenilin early secretory pathway within golgiendoplasmic reticulum move cell surface num
0.5472486.15123653.html.plaintext.txt	197	found hela cell express p num p num whereas suptnum cell express p num fig
0.5472486.15123653.html.plaintext.txt	198	num b data shown
0.5472486.15123653.html.plaintext.txt	199	cell line presenilins present cell surface based susceptibility biotinylation fig
0.5472486.15123653.html.plaintext.txt	200	cleavage notch oncoproteins presenilins occurs cell surface one may expect inhibition secretasepresenilin activity would alter membrane bound form protein preventing cleavage
0.5472486.15123653.html.plaintext.txt	201	analysis performed treating cell cpde examine effect membrane expression truncated notch protein
0.5472486.15123653.html.plaintext.txt	202	cell surface expression level notchnumint num protein transfected hela cell increased noticeably cpde treatment fig
0.5472486.15123653.html.plaintext.txt	203	similarly cpde treatment suptnum cell led dramatic increase level specific tan num polypeptide cell surface fig
0.5472486.15123653.html.plaintext.txt	204	cpde nonspecifically alter expression cell surface protein num integrin level membrane similar cpde treatment
0.5472486.15123653.html.plaintext.txt	205	thus presenilin inhibition cause cell surface accumulation notchnumint num tan num polypeptide presumably represent presenilin substrate
0.5472486.15123653.html.plaintext.txt	206	differential biological effect notch oncoproteins observed secretase inhibition next asked whether inhibition secretasepresenilin activity would abrogate biological activity notchnumint num protein vitro angiogenesis assay tan num protein growth inhibition assay suptnum cell
0.5472486.15123653.html.plaintext.txt	207	recent study indicate notch signaling involved endothelial cell development angiogenesis num num num
0.5472486.15123653.html.plaintext.txt	208	several vitro assay developed demonstrate role notch signaling angiogenesis
0.5472486.15123653.html.plaintext.txt	209	num three dimensional collagen gel bioassay expression notchnumint num huvec induces endothelial cell sprout fig
0.5472486.15123653.html.plaintext.txt	210	result help define potential role notchnum signaling angiogenesis
0.5472486.15123653.html.plaintext.txt	211	treatment presenilin inhibitor cpde caused dramatic decrease huvec sprouting fig
0.5472486.15123653.html.plaintext.txt	212	numb indicating notchnumint num activity dependent presenilin mediated cleavage
0.5472486.15123653.html.plaintext.txt	213	specificity cpde activity membrane bound notch apparent also used endothelial tube formation culture assay notchnumint num nnumic inhibited endothelial tube formation cpde relieved block tube formation caused notchnumint num nnumic data shown
0.5472486.15123653.html.plaintext.txt	214	view larger version numk fig
0.5472486.15123653.html.plaintext.txt	215	secretase inhibition prevents ad notchnumintnum induced sprouting huvec cultured collagen gel
0.5472486.15123653.html.plaintext.txt	216	b morphology adenovirus infected huvec
0.5472486.15123653.html.plaintext.txt	217	ad lacz infected huvec b ad notchnumintnum infected huvec
0.5472486.15123653.html.plaintext.txt	218	ad lacz infected huvec made confluent monolayer whereas ad notchnumintnum infected huvec made sprout beneath monolayer
0.5472486.15123653.html.plaintext.txt	219	arrow show branched sprouting ad notchnumintnum infected huvec
0.5472486.15123653.html.plaintext.txt	220	photograph taken xnum
0.5472486.15123653.html.plaintext.txt	221	c effect cpde treatment number ad notchnumintnum induced sprout huvec
0.5472486.15123653.html.plaintext.txt	222	number sprout determined described experimental procedure
0.5472486.15123653.html.plaintext.txt	223	experiment performed triplicate
0.5472486.15123653.html.plaintext.txt	224	constitutive notchnum signaling induces appearance cell lymphoblastic neoplasm num num require sustained notchnum signaling growth survival num
0.5472486.15123653.html.plaintext.txt	225	murine cell line transformed notchnume require presenilin cleavage nuclear access treatment cpde led growth arrest apoptosis cell num
0.5472486.15123653.html.plaintext.txt	226	similarly dominant negative inhibitor cslnnumic nuclear complex cause gnum cell cycle arrest apoptosis suptnum cell num indicating nuclear notchnum also needed growth survival human cell
0.5472486.15123653.html.plaintext.txt	227	despite requirement treatment suptnum cell num day num microm cpde effect growth assessed cell number shown cell cycle analysis fig
0.5472486.15123653.html.plaintext.txt	228	view larger version numk fig
0.5472486.15123653.html.plaintext.txt	229	growth sup tnum cell unaffected secretase inhibition
0.5472486.15123653.html.plaintext.txt	230	suptnum cell cultured num day indicated dos cpde drug carrier menumso stained propidium iodide analyzed cell cycle fraction described experimental procedure
0.5472486.15123653.html.plaintext.txt	231	observation together western blot data shown fig
0.5472486.15123653.html.plaintext.txt	232	numc suggest partial requirement secretasepresenilin activity tan num polypeptide enter nucleus
0.5472486.15123653.html.plaintext.txt	233	study extent nuclear access tan num polypeptide secretasepresenilin dependent suptnum cell treated cpde carrier immunostained antibody specific c terminal portion intracellular domain notchnum anti tc fig
0.5472486.15123653.html.plaintext.txt	234	nuclear cytoplasmic staining observed absence drug fig
0.5472486.15123653.html.plaintext.txt	235	numa nuclear staining decreased preferentially treatment cpde fig
0.5472486.15123653.html.plaintext.txt	236	documented analysis anti notchnumic tc staining control treated suptnum cell spectral imager confirmed substantial redistribution tan num polypeptide nucleus cytoplasm cell treated cpde fig
0.5472486.15123653.html.plaintext.txt	237	contrast distribution intensity anti notchnumic tc staining unchanged cpde treated jurkat cell control cell leukemia cell line express normal notchnum polypeptide modest level fig
0.5472486.15123653.html.plaintext.txt	238	data consistent existence two pool tan num polypeptide major pool dependent secretasepresenilin nuclear access minor pool access nucleus secretasepresenilin independent fashion see fig
0.5472486.15123653.html.plaintext.txt	239	support existence latter type tan num polypeptide seen western blot fig
0.5472486.15123653.html.plaintext.txt	240	numc one tan num polypeptide slightly smaller size membrane associated presenilin sensitive polypeptide unaffected drug treatment
0.5472486.15123653.html.plaintext.txt	241	polypeptide also fails appear cell surface fig
0.5472486.15123653.html.plaintext.txt	242	numb presumably lack tm domain thus would expected require secretasepresenilin activity processing nuclear access
0.5472486.15123653.html.plaintext.txt	243	tan num polypeptide may generate sufficient constitutive notch activity maintain growth suptnum cell presence secretasepresenilin blockade
0.5472486.15123653.html.plaintext.txt	244	view larger version numk fig
0.5472486.15123653.html.plaintext.txt	245	effect secretase inhibition nuclear localization tan num polypeptide suptnum cell
0.5472486.15123653.html.plaintext.txt	246	num microm section paraffin embedded suptnum cell treated num h menumso c num microm cpde b d stained antibody specific intracellular domain notchnum anti tc
0.5472486.15123653.html.plaintext.txt	247	b show representative conventional light microscopic image cell stained using immunoperoxidase method produce brown stain c d show composite false color spectral image
0.5472486.15123653.html.plaintext.txt	248	arrow b denote redistribution notch staining cytoplasm e f
0.5472486.15123653.html.plaintext.txt	249	jurkat cell sectioned immunostained notchnum culturing absence e presence num microm cpde f
0.5472486.15123653.html.plaintext.txt	250	membrane targeting notchnumint num tan num presenilins notch interact early secretory pathway within golgiendoplasmic reticulum num even notch construct devoid ec domain num num
0.5472486.15123653.html.plaintext.txt	251	perhaps association promotes membrane insertion truncated notch polypeptide lacking signal peptide retaining tm domain
0.5472486.15123653.html.plaintext.txt	252	insertion truncated notch would competent transport cell surface part complex containing presenilin
0.5472486.15123653.html.plaintext.txt	253	consistent coimmunoprecipitation experiment showing notch protein targeted membrane associated presenilin num
0.5472486.15123653.html.plaintext.txt	254	presenilins expressed membrane biologically active complex nicastrin num num membrane tethered notch also observed complex nicastrin num
0.5472486.15123653.html.plaintext.txt	255	thus possible affinity notch presenilin andor nicastrin mediates localization notch oncoproteins cell surface
0.5472486.15123653.html.plaintext.txt	256	idea presenilins assist cell surface targeting notch supported study role presenilins trafficking amyloid precursor protein app num num
0.5472486.15123653.html.plaintext.txt	257	aberrant processing amyloid precursor protein presenilin associated alzheimers disease
0.5472486.15123653.html.plaintext.txt	258	addition role presenilins also necessary trafficking amyloid precursor protein trans golgi endoplasmic reticulum num cell surface endosomes num
0.5472486.15123653.html.plaintext.txt	259	additionally presenilins required proper maturation trafficking nicastrin cell membrane num num
0.5472486.15123653.html.plaintext.txt	260	presenilins may serve similar function trafficking notch
0.5472486.15123653.html.plaintext.txt	261	function would independent proteolytic activity mutation critical aspartate residue abrogate proteolytic activity presenilin without affecting trafficking notch cell surface num
0.5472486.15123653.html.plaintext.txt	262	differential effect presenilin inhibitor biological activity mediated tan num notchnumint num although notchnumint num tan num polypeptide exhibit altered proteolytic processing accumulate cell surface presenilin activity blocked secretasepresenilin inhibition yield different effect biological activity oncoproteins
0.5472486.15123653.html.plaintext.txt	263	biological activity notchnumint num examined bioassay established detect endothelial sprouting huvec
0.5472486.15123653.html.plaintext.txt	264	notchnumint num induced strong sprouting response assay demonstrating role notchnum signaling initial process angiogenesis effect almost completely inhibited secretasepresenilin inhibitor
0.5472486.15123653.html.plaintext.txt	265	study suggest blockade presenilin activity may mean inhibiting notch mediated angiogenesis could useful tool regulating tumor associated angiogenesis
0.5472486.15123653.html.plaintext.txt	266	biological activity tan num studied growth assay suptnum cell two truncated normal notchnum gene
0.5472486.15123653.html.plaintext.txt	267	suptnum cell contain increased level nuclear notchnum required persistent notchnum signaling growth based effect dominant negative inhibitor nnumiccsl function num
0.5472486.15123653.html.plaintext.txt	268	however suptnum cell growth unaffected cpde despite evidence altered tan num processing accumulation tan num polypeptide cell surface
0.5472486.15123653.html.plaintext.txt	269	unresponsiveness suptnum cell may result expression tan num polypeptide dependent presenilin mediated proteolysis nuclear access
0.5472486.15123653.html.plaintext.txt	270	specifically smallest tan num polypeptide detected suptnum whole cell lysates unaltered cpde fig
0.5472486.15123653.html.plaintext.txt	271	polypeptide may arise cryptic translational start site downstream region encoding extracellular domain
0.5472486.15123653.html.plaintext.txt	272	aberrant initiation codon demonstrated within tm domain murine notchnum num feline notchnum num
0.5472486.15123653.html.plaintext.txt	273	whether site purely pathophysiologic utilized normal circumstance unknown
0.5472486.15123653.html.plaintext.txt	274	hypothesize tan num polypeptide access nucleus presenilin independent fashion accounting refractoriness suptnum cell presenilin blockade
0.5472486.15123653.html.plaintext.txt	275	model notchnumint num tan num cleavage presenilins study consistent current model notch processing activation num num illustrated fig
0.5472486.15123653.html.plaintext.txt	276	model propose notch receptor normally inhibited proteolytic processing conformational constraint imposed ec domain
0.5472486.15123653.html.plaintext.txt	277	ligand binding may induce structural change allow proteolytic cleavage tace tumor necrosis alpha converting enzyme metalloproteases consequent shedding ec domain
0.5472486.15123653.html.plaintext.txt	278	enables subsequent proteolysis mediated presenilins
0.5472486.15123653.html.plaintext.txt	279	gain function mutation notch could either act independently presenilin function presenilin mediated cleavage
0.5472486.15123653.html.plaintext.txt	280	study indicate presenilin dependent independent form tan num oncoproteins
0.5472486.15123653.html.plaintext.txt	281	still controversial whether presenilins recognize specific consensus sequence within notch required cleavage
0.5472486.15123653.html.plaintext.txt	282	four notch receptor cleaved presenilin conserved valine within tm domain mutation valine residue within notchnum notchnum greatly reduces efficiency cleavage num
0.5472486.15123653.html.plaintext.txt	283	however notch cleavage also observed another site within tm domain n terminal conserved valine num
0.5472486.15123653.html.plaintext.txt	284	additionally study drosophila show size notch ec domain critical whether presenilin cleave shorter ec domain efficient cleavage num
0.5472486.15123653.html.plaintext.txt	285	lack cleavage site specificity also observed substrate suggests presenilins may serve general role facilitating cleavage particular single pas tm protein short ec domain
0.5472486.15123653.html.plaintext.txt	286	notch oncoproteins cancer n terminal truncation within notch protein lead oncogenic gain function phenotype
0.5472486.15123653.html.plaintext.txt	287	truncation observed human alls chromosomal translocation notchnum alls mouse cat proviral insertion notchnum num notchnum num respectively murine mammary tumor proviral insertion notchnum num num
0.5472486.15123653.html.plaintext.txt	288	interestingly various human tumor cell line exhibit regulation rna specie encoding truncated form notchnum also transforming potential num
0.5472486.15123653.html.plaintext.txt	289	study one might predict regulation presenilin mediated proteolysis subsequent activation notch oncoproteins dependent upon whether protein encodes tm domain
0.5472486.15123653.html.plaintext.txt	290	tumor driven notch oncoproteins containing tm domain secretasepresenilin inhibitor may effective therapy
0.5472486.15123653.html.plaintext.txt	291	notchnumint num oncoprotein potent mammary oncogene dependent presenilin signal activation function
0.5472486.15123653.html.plaintext.txt	292	addition ligand dependent signaling full length notch receptor may also important neoplasm
0.5472486.15123653.html.plaintext.txt	293	example ligand dependent activation full length notch receptor contributes growth hodgkin anaplastic large cell lymphoma cell line num
0.5472486.15123653.html.plaintext.txt	294	many neoplasm express one notch receptor reliable mean measuring notch activation mediated low level nuclear notch readily available
0.5472486.15123653.html.plaintext.txt	295	presenilin inhibitor may generally useful tool evaluating role notch signaling various neoplasm
0.5472486.15123653.html.plaintext.txt	296	footnote work supported public health service grant hl num nhlbi national institute health
0.5472486.15123653.html.plaintext.txt	297	cost publication article defrayed part payment page charge
0.5472486.15123653.html.plaintext.txt	298	article must therefore hereby marked advertisement accordance num u
0.5472486.15123653.html.plaintext.txt	299	section num solely indicate fact
0.5472486.15123653.html.plaintext.txt	300	correspondence addressed columbia university college physician surgeon num num num w
0.5472486.15123653.html.plaintext.txt	301	num abbreviation used cell acute lymphoblastic leukemia cpde compound e ec domain extracellular domain ha hemagglutinin huvec human umbilical vein endothelial cell ic domain intracellular domain mef mouse embryo fibroblast menumso dimethyl sulfoxide nnumic notchnum ic domain p presenilin tm domain transmembrane domain
0.5472486.15123653.html.plaintext.txt	302	funahashi manuscript preparation
0.5472486.15123653.html.plaintext.txt	303	acknowledgment thank gina finan kimara glaser kirschenbaum technical assistance
0.5697466.15003956.html.plaintext.txt	0	meta analysis association cathepsin d alanumval gene polymorphism risk alzheimer disease huge gene disease association review christos ntaisnum anastasia polycarpounum john p
0.5697466.15003956.html.plaintext.txt	1	num clinical molecular epidemiology unit department hygiene epidemiology university ioannina school medicine ioannina greece
0.5697466.15003956.html.plaintext.txt	2	num biomedical research institute foundation research technology hellas ioannina greece
0.5697466.15003956.html.plaintext.txt	3	num institute clinical research health policy study department medicine tuft new england medical center tuft university school medicine boston ma
0.5697466.15003956.html.plaintext.txt	4	received publication august num num accepted publication october num num
0.5697466.15003956.html.plaintext.txt	5	alzheimer disease cathepsin d ctsd epidemiology genetics meta analysis polymorphism genetics
0.5697466.15003956.html.plaintext.txt	6	abbreviation abbreviation ci confidence interval odds ratio
0.5697466.15003956.html.plaintext.txt	7	molecular epidemiologic study presented seemingly contradictory result concerning potential role ctsd polymorphism alzheimer disease num num
0.5697466.15003956.html.plaintext.txt	8	also controversy whether polymorphism may interact apolipoprotein e num allele apoenum best known genetic determinant sporadic alzhei mer disease num
0.5697466.15003956.html.plaintext.txt	9	single study may underpowered detect interaction even overall effect
0.5697466.15003956.html.plaintext.txt	10	given amount accumulated data deemed important perform quantitative synthesis evidence using rigorous method
0.5697466.15003956.html.plaintext.txt	11	thus conducted comprehensive meta analysis available study relating ctsd polymorphism risk alzheimer disease
0.5697466.15003956.html.plaintext.txt	12	case control study eligible determined distribution ctsd genotype alzheimer disease case regardless age onset concurrent control group dementia free subject using molecular method genotyping
0.5697466.15003956.html.plaintext.txt	13	case alzheimer disease eligible regardless whether family history alzhei mer disease
0.5697466.15003956.html.plaintext.txt	14	however excluded family based study pedigree several affected case per family analysis based linkage consideration
0.5697466.15003956.html.plaintext.txt	15	data extraction two investigator independently extracted data reached consensus item
0.5697466.15003956.html.plaintext.txt	16	following information sought report author journal year publication country origin selection characteristic alzheimer disease case control demographic ethnic group study population eligible genotyped case control number case control ctsd genotype
0.5697466.15003956.html.plaintext.txt	17	study including subject different ethnic group data extracted separately ethnicity whenever possible
0.5697466.15003956.html.plaintext.txt	18	furthermore examined whether matching used whether specific mention blinding personnel performed genotyping clinical status subject whether genotyping method validated
0.5697466.15003956.html.plaintext.txt	19	meta analysis primary analysis compared alzheimer disease case control contrast versus c allele
0.5697466.15003956.html.plaintext.txt	20	analysis aim detect overall difference
0.5697466.15003956.html.plaintext.txt	21	also examined contrast extreme homozygote tt versus cc
0.5697466.15003956.html.plaintext.txt	22	finally examined contrast tt versus ct cc contrast ct tt versus cc
0.5697466.15003956.html.plaintext.txt	23	contrast correspond recessive dominant effect respectively allele
0.5697466.15003956.html.plaintext.txt	24	odds ratio used metric choice
0.5697466.15003956.html.plaintext.txt	25	genetic contrast estimated study heterogeneity across eligible comparison using chi square based q statistic num
0.5697466.15003956.html.plaintext.txt	26	heterogeneity considered significant p num
0.5697466.15003956.html.plaintext.txt	27	data combined using fixed effect mantel haenszel random effect dersimonian laird model num
0.5697466.15003956.html.plaintext.txt	28	random effect incorporate estimate study variance tend provide wider confidence interval result constituent study differ among
0.5697466.15003956.html.plaintext.txt	29	absence study heterogeneity two method provide identical result
0.5697466.15003956.html.plaintext.txt	30	random effect appropriate heterogeneity present num
0.5697466.15003956.html.plaintext.txt	31	also performed cumulative meta analysis num recursive cumulative meta analysis num num evaluate whether summary odds ratio versus c contrast changed time data accumulated whether strength association changed first hypothesis generating study excluded calculation num
0.5697466.15003956.html.plaintext.txt	32	inverted funnel plot begg mazumdar publication bias diagnostic nonparametric correlation coefficient num evaluated whether magnitude observed association related variance study whether large study gave different result compared smaller one num
0.5697466.15003956.html.plaintext.txt	33	finally evaluated whether summary result different analysis limited study intensive effort exclude alzheimer disease control clearly performed neuropsychological testing control
0.5697466.15003956.html.plaintext.txt	34	previous investigation alluded possibility allele may interact apoenum allele conferring susceptibility alzheimer disease num num
0.5697466.15003956.html.plaintext.txt	35	thus also evaluated effect allele carriage risk alzheimer disease separately apoenum positive apoenum negative subject
0.5697466.15003956.html.plaintext.txt	36	moreover evaluated genetic effect conferred presence apoenum separately subject carrying allele carrying allele
0.5697466.15003956.html.plaintext.txt	37	odds ratio combined fixed random effect model described
0.5697466.15003956.html.plaintext.txt	38	data reported communicated primary investigator obtain information whenever possible
0.5697466.15003956.html.plaintext.txt	39	analysis performed spss num
0.5697466.15003956.html.plaintext.txt	40	chicago illinois meta analyst joseph lau boston massachusetts software
0.5697466.15003956.html.plaintext.txt	41	whenever num value num x num table added num
0.5697466.15003956.html.plaintext.txt	42	num four cell odds ratio could calculated
0.5697466.15003956.html.plaintext.txt	43	characteristic study included meta analysis specific matching age described five study num num num
0.5697466.15003956.html.plaintext.txt	44	one study also matched sex num
0.5697466.15003956.html.plaintext.txt	45	one study num specifically mentioned blinding personnel performed genotyping
0.5697466.15003956.html.plaintext.txt	46	appropriate molecular method genotyping used
0.5697466.15003956.html.plaintext.txt	47	study used polymerase chain reaction two study num num also used dynamic allele specific hybridization
0.5697466.15003956.html.plaintext.txt	48	meta analysis database eligible study summarized table num included total numnum case alzheimer disease numnum control numnum numnum respectively genotype data
0.5697466.15003956.html.plaintext.txt	49	allele highly represented among control american descent overall prevalence num
0.5697466.15003956.html.plaintext.txt	50	num percent num percent confidence interval ci num
0.5697466.15003956.html.plaintext.txt	51	num control european num
0.5697466.15003956.html.plaintext.txt	52	significant heterogeneity prevalence rate allele even across control subject european descent rate num
0.5697466.15003956.html.plaintext.txt	53	num percent among hispanic american num
0.5697466.15003956.html.plaintext.txt	54	num percent spain lower rate northern european country num
0.5697466.15003956.html.plaintext.txt	55	num percent united kingdom num
0.5697466.15003956.html.plaintext.txt	56	num percent germany lowest prevalence rate num
0.5697466.15003956.html.plaintext.txt	57	num percent polish population
0.5697466.15003956.html.plaintext.txt	58	overall prevalence tt homozygosity num
0.5697466.15003956.html.plaintext.txt	59	num percent control subject american european asian descent respectively
0.5697466.15003956.html.plaintext.txt	60	respective prevalence rate ct heterozygosity num
0.5697466.15003956.html.plaintext.txt	61	num percent respective rate cc homozygosity num
0.5697466.15003956.html.plaintext.txt	62	distribution genotype control group consistent hardy weinberg equilibrium study
0.5697466.15003956.html.plaintext.txt	63	distribution ctsd allele among alzheimer disease case control included study overall effect trend suggesting allele may confer increased susceptibility alzheimer disease figure num
0.5697466.15003956.html.plaintext.txt	64	shown table num summary odds ratio num
0.5697466.15003956.html.plaintext.txt	65	num significant heterogeneity among num study comparison p num
0.5697466.15003956.html.plaintext.txt	66	found evidence association tt genotype risk alzheimer disease relative cc genotype
0.5697466.15003956.html.plaintext.txt	67	significant study heterogeneity
0.5697466.15003956.html.plaintext.txt	68	evidence association alzhei mer disease discerned also recessive model examined effect trend association seen dominant model random effect num
0.5697466.15003956.html.plaintext.txt	69	study heterogeneity recessive model contrast significant heterogeneity p num
0.5697466.15003956.html.plaintext.txt	70	num still seen dominant model contrast
0.5697466.15003956.html.plaintext.txt	71	subgroup analysis study case control european descent yielded similar result num comparison numnum allele num
0.5697466.15003956.html.plaintext.txt	72	view larger version numk figure num
0.5697466.15003956.html.plaintext.txt	73	meta analysis effect allele versus c allele risk alzheimer disease
0.5697466.15003956.html.plaintext.txt	74	comparison presented name first author year publication
0.5697466.15003956.html.plaintext.txt	75	h signifies hispanic subject j signifies japanese subject
0.5697466.15003956.html.plaintext.txt	76	comparison point estimate odds ratio accompanying num confidence interval ci shown
0.5697466.15003956.html.plaintext.txt	77	represents summary random effect estimate comparison along respective num confidence interval
0.5697466.15003956.html.plaintext.txt	78	value num denote increased risk alzheimer disease allele
0.5697466.15003956.html.plaintext.txt	79	summary odds ratio various contrast bias diagnostics cumulative meta analysis recursive cumulative meta analysis magnitude summary odds ratio stable time changed considerably per year apparent dissipation postulated effect random effect summary v
0.5697466.15003956.html.plaintext.txt	80	excluding first hypothesis generating study num found summary odds ratio became num
0.5697466.15003956.html.plaintext.txt	81	num significant study heterogeneity p num
0.5697466.15003956.html.plaintext.txt	82	num evidence association even comparison homozygote tt v
0.5697466.15003956.html.plaintext.txt	83	num study heterogeneity
0.5697466.15003956.html.plaintext.txt	84	relation effect size variance study suggesting larger study agreed result smaller study
0.5697466.15003956.html.plaintext.txt	85	analysis limited study intensive effort exclude alzheimer disease control yielded similar result num comparison numnum allele num
0.5697466.15003956.html.plaintext.txt	86	interaction apoe genotype nine study num num num num num num obtained data ctsd apoe genotype
0.5697466.15003956.html.plaintext.txt	87	one study num separating male female subject num comparison became available
0.5697466.15003956.html.plaintext.txt	88	nine comparative study tended gave slightly inflated effect allele compared full meta analysis num comparison summary random effect num
0.5697466.15003956.html.plaintext.txt	89	num complete meta analysis thus inference cautious
0.5697466.15003956.html.plaintext.txt	90	among carrier high risk apoenum allele allele carrier random effect odds ratio num
0.5697466.15003956.html.plaintext.txt	91	num alzheimer disease compared subject carrying allele
0.5697466.15003956.html.plaintext.txt	92	among subject carrying apoenum allele respective odds ratio num
0.5697466.15003956.html.plaintext.txt	93	significant study heterogeneity apoenum positive group p num
0.5697466.15003956.html.plaintext.txt	94	two effect size overlapped widely
0.5697466.15003956.html.plaintext.txt	95	among carrier allele presence apoenum increased risk alzheimer disease num
0.5697466.15003956.html.plaintext.txt	96	num study heterogeneity
0.5697466.15003956.html.plaintext.txt	97	among subject without allele presence apoenum increased risk alzheimer disease num
0.5697466.15003956.html.plaintext.txt	98	num significant study heterogeneity p num
0.5697466.15003956.html.plaintext.txt	99	two estimate overlapped widely individual study overall typically odds ratio larger group allele carrier figure num
0.5697466.15003956.html.plaintext.txt	100	meta analysis finding may interpreted postulated biologic context ctsd polymorphism
0.5697466.15003956.html.plaintext.txt	101	cathepsin d intracellular acid protease beta secretase activity vitro num num cleave amyloid precursor protein tau protein generate fragment intact microtubule binding domain num might play role pathogenesis paired helical filament
0.5697466.15003956.html.plaintext.txt	102	one study shown ctsd polymorphism associated increased secretion altered intracellular maturation procathepsin d num
0.5697466.15003956.html.plaintext.txt	103	noted clear whether ctsd polymorphism functional consequence mature form enzyme
0.5697466.15003956.html.plaintext.txt	104	although exclude biologic effect ctsd polymorphism finding accordance result recent full genome scan showing significant linkage alzheimer disease short arm chromosome num region ctsd gene located num num
0.5697466.15003956.html.plaintext.txt	105	attention given design individual study
0.5697466.15003956.html.plaintext.txt	106	result meta analysis may affected methodological problem potential bias design constituent study
0.5697466.15003956.html.plaintext.txt	107	nondifferential misclassification error may dilute strength observed association
0.5697466.15003956.html.plaintext.txt	108	alzheimer disease case generally selected according appropriate criterion
0.5697466.15003956.html.plaintext.txt	109	however young control subject may developed alzheimer disease older age
0.5697466.15003956.html.plaintext.txt	110	choice appropriate age window assessing postulated genetic risk factor alzheimer disease difficult
0.5697466.15003956.html.plaintext.txt	111	study younger subject may suitable identifying risk factor result early onset alzhei mer disease
0.5697466.15003956.html.plaintext.txt	112	conversely selection younger subject may le appropriate influence postulated genetic risk factor important late onset alzhei mer disease
0.5697466.15003956.html.plaintext.txt	113	subgroup effect effect modification e
0.5697466.15003956.html.plaintext.txt	114	differential effect genetic polymorphism early v
0.5697466.15003956.html.plaintext.txt	115	late onset alzheimer disease case familial v
0.5697466.15003956.html.plaintext.txt	116	sporadic disease complex interaction gene may also need considered num
0.5697466.15003956.html.plaintext.txt	117	analysis addressed interaction apoenum major known genetic determinant alzhei mer disease
0.5697466.15003956.html.plaintext.txt	118	interaction genetic environmental factor studied
0.5697466.15003956.html.plaintext.txt	119	trend stronger effect apoenum presence allele carriage interesting light data suggesting carriage may affect general intelligence num
0.5697466.15003956.html.plaintext.txt	120	however subgroup interaction analysis interpreted cautiously since difference subgroup may occur chance num validation would require study even larger sample size several thousand included meta analysis
0.5697466.15003956.html.plaintext.txt	121	finally population stratification may theoretically affected result constituent study meta analysis num since documented frequency allele varied considerably among different ethnic group even among different ethnic group european descent
0.5697466.15003956.html.plaintext.txt	122	however study strictly ethnically defined population stratification effect unlikely considerable magnitude
0.5697466.15003956.html.plaintext.txt	123	increasing prevalence alzheimer disease worldwide crucial identify genetic risk factor neurodegenerative disease
0.5697466.15003956.html.plaintext.txt	124	thus list identified polymorphism may influence risk alzheimer disease continuously expanding num num reported association candidate gene date remain nonreplicated least controversial subsequent investigation
0.5697466.15003956.html.plaintext.txt	125	early small genetic association study may come spurious finding num num num
0.5697466.15003956.html.plaintext.txt	126	even genetic association replicated usually major public health impact would lead screening recommendation num
0.5697466.15003956.html.plaintext.txt	127	nevertheless knowledge could improve understanding pathogenesis complex disease alzheimer disease
0.5697466.15003956.html.plaintext.txt	128	acknowledgment author thank jonathan
0.5697466.15003956.html.plaintext.txt	129	prince patrizia mecocci anthony j
0.5697466.15003956.html.plaintext.txt	130	brooke providing additional data study
0.5697466.15003956.html.plaintext.txt	131	note correspondence dr
0.5697466.15003956.html.plaintext.txt	132	ioannidis department hygiene epidemiology university ioannina school medicine ioannina num greece e mail jioannidatcc
0.6103489.15220354.html.plaintext.txt	0	functional implication presenilin dimerization reconstitution secretase activity assembly catalytic site dimer interface two catalytically inactive presenilins sara cervantes carlos
0.6103489.15220354.html.plaintext.txt	1	saura esther pomares roser gonzalez duarte gemma marfany
0.6103489.15220354.html.plaintext.txt	2	departament de genetica facultat de biologia universitat de barcelona avda
0.6103489.15220354.html.plaintext.txt	3	diagonal num e num barcelona spain center neurologic disease brigham woman hospital harvard medical school boston massachusetts num
0.6103489.15220354.html.plaintext.txt	4	received publication april num num revised form june num num
0.6103489.15220354.html.plaintext.txt	5	widely accepted psnum psnum catalytic component secretase complex appears aspartyl protease whose activity resides interface two presenilin fragment n terminal ntf c terminal ctf fragment num num
0.6103489.15220354.html.plaintext.txt	6	ntf ctf presenilin moiety probably produced autocatalytic presenilinase activity stable p holoprotein num num
0.6103489.15220354.html.plaintext.txt	7	ntf ctf heterodimerize numnum stoichiometry within secretase complex num num complex also contains nicastrin aph num pen num yet undetermined stoichiometry num num num
0.6103489.15220354.html.plaintext.txt	8	new view secretase complex put forward group others providing evidence functional secretase core contains two presenilin molecule num num num presenilin fad mutant may produce subtle alteration presenilin dimerization hence alter secretase tertiary quaternary structure num
0.6103489.15220354.html.plaintext.txt	9	report demonstrate hydrophobic transmembrane region presenilin contribute interaction within dimer alteration dimer related catalytic site affecting hlnum domain impair secretase function
0.6103489.15220354.html.plaintext.txt	10	addition reconstituting secretase activity two catalytically inactive presenilin aspartic mutant demonstrate functional diaspartyl catalytic group formed interface ntf ctf moiety two different presenilin molecule
0.6103489.15220354.html.plaintext.txt	11	generate construct expressed slnum cell frame fusion containing ha n terminal tagged drosophila presenilin h psn pact num pact psn subcloned expression vector pactppa kindly provided dr
0.6103489.15220354.html.plaintext.txt	12	vaquero drive expression ha psn drosophila actin numc expression cassette
0.6103489.15220354.html.plaintext.txt	13	expression construct bearing n terminal c myc tagged psn forward strand oligonucleotide num catggaggaacaaaagctgatttctgaagaagacttgg num complementary reverse strand oligonucleotide num aattccaagtcttcttcagaaatcagcttttgttcctc num coding c myc epitope annealed cloned ncoi ecori site pasnum num psn
0.6103489.15220354.html.plaintext.txt	14	entire c myc psn fusion subcloned pactppa expression vector
0.6103489.15220354.html.plaintext.txt	15	aspartic mutant psns obtained site directed mutagenesis using psn template described elsewhere num
0.6103489.15220354.html.plaintext.txt	16	frame substitution hlnum amino acid num num hlnum amino acid num num two step cloning strategy used
0.6103489.15220354.html.plaintext.txt	17	resulting psn cdna containing n terminal ha tag hlnum region tmi cloned pactppa expression plasmid generate pactppa ha psnhlnum num
0.6103489.15220354.html.plaintext.txt	18	pactppa expression plasmid containing two psn expression cassette obtained subcloning sali fragment containing actin numc expression cassette driving expression c myc tagged psn unique bstznumi site plasmid pactppa ha psn
0.6103489.15220354.html.plaintext.txt	19	cleavage reporter assay drosophila necn necn gvnum construct pbluescript sk obtained substituting num bp aatii fragment oggnum num
0.6103489.15220354.html.plaintext.txt	20	num kb aatii fragment containing galnumvpnum nnum
0.6103489.15220354.html.plaintext.txt	21	plasmid oggnum nnum kindly provided dr
0.6103489.15220354.html.plaintext.txt	22	struhl tested vivo drosophila num
0.6103489.15220354.html.plaintext.txt	23	necn gvnum fusion subcloned kpniecorv site pactppa
0.6103489.15220354.html.plaintext.txt	24	cnum galnumvpnum construct pcdnanum
0.6103489.15220354.html.plaintext.txt	25	pcmv luciferase plasmid stratagene hspnummp numxgnum gal construct gift dr
0.6103489.15220354.html.plaintext.txt	26	vaquero used reporter
0.6103489.15220354.html.plaintext.txt	27	assessment production scnum construct encoding human cnum secretase substrate signal peptide rat preproenkephalin cdna cloned pacnum
0.6103489.15220354.html.plaintext.txt	28	numvnum kindly provided dr
0.6103489.15220354.html.plaintext.txt	29	integrity conserved reading frame dna construct confirmed sequencing perkinelmer life science big dye num
0.6103489.15220354.html.plaintext.txt	30	num using num num dna analyzer
0.6103489.15220354.html.plaintext.txt	31	split ubiquitin assay yeast strain lnum cotransformed corresponding nub cub derived construct num using standard lithium acetate procedure
0.6103489.15220354.html.plaintext.txt	32	transformants selected growth sd trp leu supplemented num mm num aminotriazole num
0.6103489.15220354.html.plaintext.txt	33	necessary proteinprotein interaction quantified assessment galactosidase activity reporter gene liquid culture using o nitrophenyl p d galactopyranoside substrate following standard procedure
0.6103489.15220354.html.plaintext.txt	34	cell culture transfection drosophila schneiders num cell line slnum cell maintained drosophila schneiders insect medium sigma supplemented num fetal bovine serum penicillinstreptomycin invitrogen num degree c
0.6103489.15220354.html.plaintext.txt	35	transient transfections performed num microg dna cellfectin invitrogen num mm plate num well plate following manufacturer instruction
0.6103489.15220354.html.plaintext.txt	36	cell harvested num h post transfection
0.6103489.15220354.html.plaintext.txt	37	stable transfections corresponding pactppa expression plasmid cotransfected pcohygro kindly provided dr
0.6103489.15220354.html.plaintext.txt	38	two day post transfection cell selected num microg microl hygromycin invitrogen num week stable cell line expanded
0.6103489.15220354.html.plaintext.txt	39	cycloheximide treatment performed follows num x num cell cell line seeded num mm plate allowed attach plate surface
0.6103489.15220354.html.plaintext.txt	40	subsequently medium removed replaced fresh medium supplemented num microgml cycloheximide
0.6103489.15220354.html.plaintext.txt	41	cell num mm plate harvested specified time point washed cold phosphate buffered saline frozen num degree c analysis
0.6103489.15220354.html.plaintext.txt	42	rna interference experiment dsrna corresponding num num utrs drosophila presenilin gene obtained vitro transcription pbluescript sk num num bp num num bp psn utr sequence previously cloned
0.6103489.15220354.html.plaintext.txt	43	dsrna specifically targeted disrupt endogenous presenilin expression without affecting exogenous presenilin since num num utrs latter provided expression vector
0.6103489.15220354.html.plaintext.txt	44	briefly transcription tnum tnum promoter yielded forward reverse single stranded rna respectively
0.6103489.15220354.html.plaintext.txt	45	two complementary rna strand annealed heating num min num degree c subsequent incubation num min num degree c obtain num bp num utr num utr dsrna
0.6103489.15220354.html.plaintext.txt	46	either num num microg dsrna co transfected specified dna construct num microg dnadsrna mixture cellfectin described
0.6103489.15220354.html.plaintext.txt	47	cell harvested num h post transfection allow protein turnover rna interference residual endogenous presenilin
0.6103489.15220354.html.plaintext.txt	48	protein extraction immunoblotting stable transiently transfected cell harvested washed cold phosphate buffered saline centrifugation num x g num min
0.6103489.15220354.html.plaintext.txt	49	ha psn detection total protein extracted num microl num mm plate transiently transfected cell num microl num cmnum flask num mm plate stably transfected cell lysis buffer num mm tris hcl ph num
0.6103489.15220354.html.plaintext.txt	50	num num mm nacl num mm edta num nonidet p num num
0.6103489.15220354.html.plaintext.txt	51	num triton x num num mm phenylmethylsulfonyl fluoride protease inhibitor mixture sonicated num ice using branson sonicator num
0.6103489.15220354.html.plaintext.txt	52	insoluble protein cell debris removed centrifugation numnum rpm num min num degree c
0.6103489.15220354.html.plaintext.txt	53	protein quantified using bio rad dc protein assay
0.6103489.15220354.html.plaintext.txt	54	immunoblotting num microg protein extract loaded onto num m urea sd page transferred polyvinylidene difluoride membrane immunodetected monoclonal antibody ha
0.6103489.15220354.html.plaintext.txt	55	c myc psn analysis cell membrane extracted num
0.6103489.15220354.html.plaintext.txt	56	num dodecyl maltoside buffer follows
0.6103489.15220354.html.plaintext.txt	57	cell resuspended volume homogenization buffer num mm hepes ph num
0.6103489.15220354.html.plaintext.txt	58	num num mm edta num mm sucrose num brij num num mm phenylmethylsulfonyl fluoride protease inhibitor indicated subjected mechanical lysis polytron homogenizer
0.6103489.15220354.html.plaintext.txt	59	presenilin enriched membrane fraction obtained subsequent centrifugation numnum x g num min num degree c
0.6103489.15220354.html.plaintext.txt	60	psn solubilized membrane pellet num num microl buffer ii num mm sodium citrate ph num
0.6103489.15220354.html.plaintext.txt	61	num num mm edta num glycerol num mm phenylmethylsulfonyl fluoride protease inhibitor num num min ice
0.6103489.15220354.html.plaintext.txt	62	subsequently total protein concentration quantified using bio rad dc protein assay clarifying spin num microg protein subjected electrophoresis
0.6103489.15220354.html.plaintext.txt	63	c myc psn immunodetected monoclonal anti myc antibody numenum santa cruz biotechnology inc
0.6103489.15220354.html.plaintext.txt	64	detection app ctfs protein extract prepared drosophila schneider slnum cell lysis ice radioimmune precipitation buffer num mm tris hcl ph num
0.6103489.15220354.html.plaintext.txt	65	num num mm nacl num mm edta num triton x num num sodium deoxycholate num
0.6103489.15220354.html.plaintext.txt	66	num sd supplemented protease inhibitor sigma
0.6103489.15220354.html.plaintext.txt	67	lysates sonicated protein concentration determined using bca protein assay kit pierce
0.6103489.15220354.html.plaintext.txt	68	protein extract num microg mixed numx sd sample buffer resolved num num trisglycine gel invitrogen
0.6103489.15220354.html.plaintext.txt	69	immunoblot analysis protein transferred polyvinylidene difluoride membrane incubated num min blocking buffer num nonfat milk num
0.6103489.15220354.html.plaintext.txt	70	num bovine serum albumin phosphate buffered saline ph num
0.6103489.15220354.html.plaintext.txt	71	num followed incubation primary polyclonal antiserum specific c terminal residue num num app saeko numnumnum num
0.6103489.15220354.html.plaintext.txt	72	app ctfs detected ecl plus chemiluminescence kit perkinelmer life science
0.6103489.15220354.html.plaintext.txt	73	density band quantified using nih image software normalized tubulin sigma
0.6103489.15220354.html.plaintext.txt	74	data represent average plus minus
0.6103489.15220354.html.plaintext.txt	75	three independent experiment
0.6103489.15220354.html.plaintext.txt	76	cleavage cnum snum cleavage necn substrate co expression cnum galnumvpnum necn galnumvpnum fusion protein substrate secretase together hspnummp numxgnum gal reporter construct hereafter referred hspnum uas gal allowed quantification presenilin mediated cleavage
0.6103489.15220354.html.plaintext.txt	77	stably transfected cell expressing presenilin construct transiently transfected num
0.6103489.15220354.html.plaintext.txt	78	num microg cnum galnumvpnum num ng hspnum uas gal num ng cytomegalovirusluciferase control plasmid num microg dsrna
0.6103489.15220354.html.plaintext.txt	79	analysis nicd production cell transfected num ng necn galnumvpnum num
0.6103489.15220354.html.plaintext.txt	80	num microg hspnum uas gal num ng pcmv luciferase control plasmid num microg dsrna
0.6103489.15220354.html.plaintext.txt	81	transfections performed num well plate amount transfected dnarna kept num microg
0.6103489.15220354.html.plaintext.txt	82	seventy two hour post transfection cell harvested washed cold phosphate buffered saline lysed quantify galactosidase luciferase activity galactosidase reporter gene assay chemiluminescent roche applied science luciferase assay system invitrogen respectively following manufacturer instruction
0.6103489.15220354.html.plaintext.txt	83	elisa slnum cell stably expressing wild type mutant p variant transiently transfected cdna encoding c terminal num amino acid app scnum andor dsrna using cellfectin invitrogen following manufacturer instruction
0.6103489.15220354.html.plaintext.txt	84	cell incubated num h allow inactivation endogenous psn expression old medium replaced fresh medium additional num h
0.6103489.15220354.html.plaintext.txt	85	culture medium collected ice centrifuged numnum x g num min
0.6103489.15220354.html.plaintext.txt	86	supernatant collected coded used elisa analysis
0.6103489.15220354.html.plaintext.txt	87	anum anum level determined numgnumnumb numfnumnumb sandwich elisa previously described num num
0.6103489.15220354.html.plaintext.txt	88	value normalized cellular protein represent average three independent transfections analyzed duplicate
0.6103489.15220354.html.plaintext.txt	89	combination tested result interaction assay depicted fig
0.6103489.15220354.html.plaintext.txt	90	specificity interaction confirmed absence growth yeast co transformed either psn ntf cub prota lexa vpnum psn ctf cub prota lexa vpnum another yeast er transmembrane protein algnum nubg shown ref
0.6103489.15220354.html.plaintext.txt	91	main conclusion interaction assay transmembrane domain indeed play important role ntfntf ctfctf ntfctf dimerization particularly transmembranes num num ntf num num ctf
0.6103489.15220354.html.plaintext.txt	92	view larger version numk fig
0.6103489.15220354.html.plaintext.txt	93	contribution presenilin transmembrane domain ntfctf ntfntf ctfctf dimerization assayed yeast split ubiquitin system
0.6103489.15220354.html.plaintext.txt	94	presenilin domain tested different combination frame fusion construct either nub cub lexa vpnum indicated
0.6103489.15220354.html.plaintext.txt	95	interaction detected selective growth medium lacking histidine
0.6103489.15220354.html.plaintext.txt	96	dissection transmembrane domain contribution ntfctf interaction
0.6103489.15220354.html.plaintext.txt	97	b dissection transmembrane domain contribution ntfntf interaction
0.6103489.15220354.html.plaintext.txt	98	c dissection transmembrane domain contribution ctfctf interaction
0.6103489.15220354.html.plaintext.txt	99	d effect substitution hlnum hlnum ntfntf dimerization assessed quantification activation lacz reporter gene using o nitrophenyl p d galactopyranoside substrate
0.6103489.15220354.html.plaintext.txt	100	asterisk indicates statistical significance u mann whitney test p num
0.6103489.15220354.html.plaintext.txt	101	previous work proposed hlnum played important role dimer formation probably conformation presenilin secretase complex due homomeric proteinprotein interaction mediated domain
0.6103489.15220354.html.plaintext.txt	102	support num num mutation psnum psnum cluster num amino acid loop fad mutation analyzed altered hlnumhlnum dimerization num
0.6103489.15220354.html.plaintext.txt	103	nonetheless result depicted fig
0.6103489.15220354.html.plaintext.txt	104	num b suggested region comprising n terminus tmi hlnum tmii domain required ntfntf ntfctf interaction given deletion affect strength ntfntf ntfctf interaction compared wild type fragment assessed semiquantitatively growth selective medium
0.6103489.15220354.html.plaintext.txt	105	address role hlnum ntfntf homodimerization undertook new series experiment analyze whether ntfntf interaction dimerization would altered hlnum loop sequence substituted another connecting loop topology relative position transmembrane domain still maintained
0.6103489.15220354.html.plaintext.txt	106	end generated ntf variant named ntfnum num hlnum amino acid num num psn replaced hlnum shorter er facing connecting loop peptide psn amino acid num num psn
0.6103489.15220354.html.plaintext.txt	107	frame substitution alter number transmembranes connecting loop general ntf topology preserved
0.6103489.15220354.html.plaintext.txt	108	directly test ntfntf interaction membrane resorted split ubiquitin system previously shown allowed presenilin properly anchored membrane
0.6103489.15220354.html.plaintext.txt	109	interaction different combination wild type ntf ntfnum num assessed quantification lacz reporter activity fig
0.6103489.15220354.html.plaintext.txt	110	according result replacement hlnum increase strength ntfntf interaction thus confirming contribution domain formation stability dimer indicating hlnum may modulatory role ntfntf interaction thus presenilin dimerization
0.6103489.15220354.html.plaintext.txt	111	contrast none hydrophilic domain ctf domain seemed determinant structural interaction since could deleted without affecting ctfctf ntfctf interaction fig
0.6103489.15220354.html.plaintext.txt	112	expression metabolism hlnum presenilin mutant observation pointing modulatory role hlnum formation presenilin dimer prompted u investigate contribution er facing loop presenilinase secretase activity vivo
0.6103489.15220354.html.plaintext.txt	113	ntfnum num variant engineered new psn mutant hlnum substituted hlnum
0.6103489.15220354.html.plaintext.txt	114	recombinant psn named psnhlnum num
0.6103489.15220354.html.plaintext.txt	115	already mentioned frame substitution hlnum alter number tm connecting loop resulting psn fig
0.6103489.15220354.html.plaintext.txt	116	using drosophila slnum cell homologous expression system stably transfected overexpressed several construct bearing either wild type mutant n terminal ha tagged psns wtpsn psnhlnum num assessed expression processing western blot analysis protein lysates fig
0.6103489.15220354.html.plaintext.txt	117	addition ha tag n terminus psn alter presenilinase processing wtpsn endoproteolytically cleaved transient stable transfectants
0.6103489.15220354.html.plaintext.txt	118	contrast psnhlnum num generate corresponding ntf fragment behaved like null presenilin mutant catalytic aspartic acid residue fig
0.6103489.15220354.html.plaintext.txt	119	numb thus demonstrating hlnum essential psn endoproteolysis
0.6103489.15220354.html.plaintext.txt	120	view larger version numk fig
0.6103489.15220354.html.plaintext.txt	121	expression metabolism psnhlnum num variant
0.6103489.15220354.html.plaintext.txt	122	scheme showing predicted dimer structure psnhlnum num psn mutant hlnum substituted hlnum note presenilinase cleavage depicted since autoproteolytic processing variant completely abolished
0.6103489.15220354.html.plaintext.txt	123	b western blot total protein extract num microg transiently left stably right transfected slnum cell immunodetected anti ha monoclonal antibody
0.6103489.15220354.html.plaintext.txt	124	c western blot total protein extract num microg stably transfected cell expressed either wtpsn psndnuma psnhlnum num variant treated cycloheximide block total protein synthesis indicated period time immunodetected anti ha
0.6103489.15220354.html.plaintext.txt	125	tested subcellular localization protein stability psnhlnum num mutant
0.6103489.15220354.html.plaintext.txt	126	immunofluorescent analysis transfected slnum cell revealed similar subcellular distribution mainly er compartment wtpsn psnhlnum num psndnuma mutant data shown
0.6103489.15220354.html.plaintext.txt	127	ass presenilin stability total protein synthesis inhibited cycloheximide treatment cell harvested different time
0.6103489.15220354.html.plaintext.txt	128	immunodetection lysates stably transfected cell using anti ha antibody showed psnhlnum num holoprotein stable time wtpsn holoprotein fig
0.6103489.15220354.html.plaintext.txt	129	numc since substantial amount psnhlnum num still detected num h treatment
0.6103489.15220354.html.plaintext.txt	130	observation indicates contrast wtpsn proportion psnhlnum num holoprotein pool stabilized similarly reported mutant presenilin holoproteins num num
0.6103489.15220354.html.plaintext.txt	131	hlnum domain psn required secretase activity determine effect secretase activity due alteration psn hlnum domain next examined ability psnhlnum num mutant mediate cleavage human app derived substrate cnum fused galnumvpnum cnum gvp generate aicd respectively
0.6103489.15220354.html.plaintext.txt	132	previous control experiment slnum cell stably transfected either wtpsn positive control psn single psndnuma psndnuma double psndnumadnuma aspartic mutant negative control confirmed expression exogenous tagged psn variant
0.6103489.15220354.html.plaintext.txt	133	analyzed production aicd performing quantitative assay based galactosidase reporter system activated substrate cleavage num
0.6103489.15220354.html.plaintext.txt	134	chose assay secretase activity using reporter based assay since widely used monitor signaling pathway mediated cleavage drosophila highly sensitive easily quantified
0.6103489.15220354.html.plaintext.txt	135	besides substrate similar assay successfully used recently characterize secretase activity psnum variant num num
0.6103489.15220354.html.plaintext.txt	136	control assay using empty vector stably transfected cell showed detectable level galactosidase activity thus indicating endogenous presenilin secretase activity
0.6103489.15220354.html.plaintext.txt	137	avoid background endogenous presenilin designed performed rnai experiment dsrna num bp corresponding fused num num utr sequence drosophila psn gene
0.6103489.15220354.html.plaintext.txt	138	dsrna co transfected along assay construct order specifically knock endogenous psn without altering level tagged exogenous psn expression confirmed western blot analysis data shown
0.6103489.15220354.html.plaintext.txt	139	treatment dsrna targeting endogenous presenilin produced significant decrease galactosidase activity stably vector transfected cell whereas galactosidase activity stably wtpsn transfected cell remained unaltered data shown
0.6103489.15220354.html.plaintext.txt	140	ass whether num utr num utr dsrna reduced cleavage site cnum substrate endogenous presenilin therefore decreased production slnum cell transiently transfected scnum construct encoding cnum substrate num along dsrna
0.6103489.15220354.html.plaintext.txt	141	forty eight hour post transfection medium replaced quantify de novo produced peptide rnai treatment
0.6103489.15220354.html.plaintext.txt	142	production anum anum peptide clearly reduced dsrna treatment fig
0.6103489.15220354.html.plaintext.txt	143	numa left indicating efficient disruption endogenous presenilin activity
0.6103489.15220354.html.plaintext.txt	144	interestingly dsrna treatment alter production anum peptide relative total thus anumnum ratio remained unaffected dsrna treated cell fig
0.6103489.15220354.html.plaintext.txt	145	decrease endogenous presenilin activity measured production correlated accumulation ctf stub generated secretase cleavage fig
0.6103489.15220354.html.plaintext.txt	146	result confirmed efficiency dsrna interference thus experiment performed dsrna treated cell
0.6103489.15220354.html.plaintext.txt	147	view larger version numk fig
0.6103489.15220354.html.plaintext.txt	148	substitution hlnum impairs aicd nicd production
0.6103489.15220354.html.plaintext.txt	149	control assay slnum cell dsrna targeting num num utrs psn showed reduction endogenous psn activity measured following
0.6103489.15220354.html.plaintext.txt	150	anumnum production analyzed sandwich elisa slnum cell transiently transfected scnum construct left ratio production anum total altered dsrna treatment right b secretase cleavage excess scnum substrate cleaved secretase produced ctf stub
0.6103489.15220354.html.plaintext.txt	151	c slnum cell stably expressing indicated psn variant transiently transfected cnum galnumvpnum construct along dsrna n num three independent experiment
0.6103489.15220354.html.plaintext.txt	152	d anumnum production quantified sandwich elisa slnum cell stably transfected indicated psn variant transiently transfected scnum construct along dsrna n num independent transfections
0.6103489.15220354.html.plaintext.txt	153	e western blot protein lysates cell analyzed d immunodetected antibody specific c terminus app amino acid num num
0.6103489.15220354.html.plaintext.txt	154	f slnum cell stably expressing indicated psn variant transiently transfected necn galnumvpnum construct along dsrna n num two independent experiment
0.6103489.15220354.html.plaintext.txt	155	statistical significance according u mann whitney test follows p num
0.6103489.15220354.html.plaintext.txt	156	ass activity psnhlnum num mutant analyzed production aicd cleavage nicd snum cleavage cleavage ha psnhlnum num stably transfected cell using aforementioned quantitative reporter based strategy
0.6103489.15220354.html.plaintext.txt	157	several timing control cell harvested num h post transfection allow efficient rna interference endogenous presenilin protein turnover
0.6103489.15220354.html.plaintext.txt	158	galactosidase activity measured aicd production cleavage obtained mutant stably transfected cell compared wtpsn considered num
0.6103489.15220354.html.plaintext.txt	159	remarkably secretase activity psnhlnum num stable cell line assessed cnum gvp substrate completely abolished yielding value similar tmvii aspartic mutant presenilin psndnuma fig
0.6103489.15220354.html.plaintext.txt	160	result showed hlnum appears essential cleavage app consequently aicd production
0.6103489.15220354.html.plaintext.txt	161	next tested whether psnhlnum num mutant cleaved app derived substrate produce anum anum peptide cleavage
0.6103489.15220354.html.plaintext.txt	162	stable cell line expressing different presenilin variant transiently transfected scnum construct production cell medium subsequently analyzed
0.6103489.15220354.html.plaintext.txt	163	numd expression psnhlnum num mutant resulted significant num fold decrease production
0.6103489.15220354.html.plaintext.txt	164	impairment secretase activity correlated accumulation ctf stub fig
0.6103489.15220354.html.plaintext.txt	165	result demonstrate hlnum psn required cleavage app
0.6103489.15220354.html.plaintext.txt	166	examined ability psnhlnum num cleave notch substrate snum site using reporter based strategy
0.6103489.15220354.html.plaintext.txt	167	drosophila notch derived substrate lacking extracellular domain necn fused transcription factor galnumvpnum necn gvp co transfected aforementioned reporter construct slnum cell
0.6103489.15220354.html.plaintext.txt	168	galactosidase activity significantly decreased psnhlnum num mutant psndnuma mutant compared wtpsn fig
0.6103489.15220354.html.plaintext.txt	169	altogether result confirmed indeed hlnum domain play modulating role presenilin dimerization showed substitution hlnum another connecting domain resulted complete loss secretase function concerning presenilinase activity cleavage app well snum cleavage notch without affecting psn stability
0.6103489.15220354.html.plaintext.txt	170	view larger version numk fig
0.6103489.15220354.html.plaintext.txt	171	aspnum aspnum different psn holoproteins constitute active catalytic center
0.6103489.15220354.html.plaintext.txt	172	scheme psn dimer model depicting tm vi vii potential functional diaspartyl group black box acting arrow potential substrate
0.6103489.15220354.html.plaintext.txt	173	diaspartyl group formed two tmvi num aspartic residue left two tmvii num aspartic residue second scheme left aspartic residuesof ntf ctf psn monomer second scheme right aspartic residue ntf ctf different psn monomer right
0.6103489.15220354.html.plaintext.txt	174	numbering according human psnum
0.6103489.15220354.html.plaintext.txt	175	b protein lysates slnum cell stably expressing indicated psn variant immunodetected anti ha left anti c myc right
0.6103489.15220354.html.plaintext.txt	176	c slnum cell stably expressing indicated psn variant transiently transfected cnum galnumvpnum construct galactosidase luciferase reporter plasmid dsrna n num four independent experiment
0.6103489.15220354.html.plaintext.txt	177	d production quantified sandwich elisa slnum cell stably transfected psn variant indicated transiently transfected scnum construct along dsrna n num independent transfections normalized protein concentration
0.6103489.15220354.html.plaintext.txt	178	last lane indicates endogenous activity end cell untreated dsrna
0.6103489.15220354.html.plaintext.txt	179	e anum total differ wtpsn reconstituted secretase activity ha psndnumamyc psndnuma endogenous psn
0.6103489.15220354.html.plaintext.txt	180	f western blot protein lysates cell analyzed d immunodetected antibody specific c terminus app amino acid num num relative quantification
0.6103489.15220354.html.plaintext.txt	181	g slnum cell stably expressing indicated psn variant transiently transfected necn galnumvpnum construct two reporter plasmid along dsrna n num replicates two independent experiment
0.6103489.15220354.html.plaintext.txt	182	statistical significance according u mann whitney test follows p num
0.6103489.15220354.html.plaintext.txt	183	designed experimental approach based genetic complementation two different aspartic mutant ass whether tmvi aspartic residue aspnum drosophila psnaspnum human psnum one monomer formed functional diaspartyl group tmvii aspartic residue aspnum drosophila psnaspnum human psnum
0.6103489.15220354.html.plaintext.txt	184	case able reconstitute secretase activity two catalytically inactive aspartic mutant thus providing evidence presenilins function dimer vivo least two aspartic residue required
0.6103489.15220354.html.plaintext.txt	185	knowledge possibility formally tested
0.6103489.15220354.html.plaintext.txt	186	constructed double cassette expression plasmid stably co express two presenilin mutant ha psndnuma c myc psndnuma slnum cell
0.6103489.15220354.html.plaintext.txt	187	ass secretase activity analyzed production aicd nicd using corresponding substrate
0.6103489.15220354.html.plaintext.txt	188	cell stably expressing psn mutant predicted formation three different complex inactive homodimers containing mutation thus containing either two num two num aspartic residue ha psndnumaha psndnuma myc psndnumamyc psndnuma respectively heterodimeric complex one aspartic num one aspartic num ha psndnumamyc psndnuma numnumnum ratio
0.6103489.15220354.html.plaintext.txt	189	functional catalytic site formed two mutant monomer would expect presenilin heterodimer psndnumapsndnuma would produce one presenilin dependent cleavage product aicd nicd anumnum
0.6103489.15220354.html.plaintext.txt	190	first analyzed expression level different presenilin mutant stably transfected slnum cell
0.6103489.15220354.html.plaintext.txt	191	western blot analysis cell lysates showed high level expression ha tagged fig
0.6103489.15220354.html.plaintext.txt	192	numb left myc tagged presenilins fig
0.6103489.15220354.html.plaintext.txt	193	numb right even co expressed
0.6103489.15220354.html.plaintext.txt	194	contrast cell co expressing ha wtpsn c myc wtpsn presenilinase activity detected ha psndnuma c myc psndnuma mutant co expressed fig
0.6103489.15220354.html.plaintext.txt	195	thus presenilinase activity reconstituted mutant presenilin holoproteins could assemble dimer core secretase complex cell
0.6103489.15220354.html.plaintext.txt	196	evaluate production aicd generated cleavage activity stable cell line co transfected cnum gvp substrate corresponding reporter construct
0.6103489.15220354.html.plaintext.txt	197	interestingly observed contrast galactosidase activity single double aspartic dnuma dnuma mutant co expression single mutant presenilins resulted significantly higher secretase activity fig
0.6103489.15220354.html.plaintext.txt	198	numc amounting num wild type presenilin value
0.6103489.15220354.html.plaintext.txt	199	result show co expression two mutant psndnuma psndnuma restores aicd production providing strong evidence active catalytic site formed ntf ctf aspartics different presenilins within complex
0.6103489.15220354.html.plaintext.txt	200	similarly production anumnum cnum substrate determined
0.6103489.15220354.html.plaintext.txt	201	contrast abolition anum anum production cell expressing one single either psndnuma psndnuma double psndnumadnuma aspartic mutant coexpression two psn mutant restored production anum anum level endogenous psn cell untreated dsrna fig
0.6103489.15220354.html.plaintext.txt	202	numd around num num achieved overexpression wtpsn
0.6103489.15220354.html.plaintext.txt	203	furthermore anumnum ratio cell expressing combination aspartic mutant similar wtpsn fig
0.6103489.15220354.html.plaintext.txt	204	rescue secretase activity due co expression two aspartic mutant confirmed significant reduction ctfs level cell compared cell expressing mutant psndnuma psndnuma alone fig
0.6103489.15220354.html.plaintext.txt	205	note statistical significance decrease ctf level co expressing two mutant lane num compared single double mutant expressed lane num num statistically different among
0.6103489.15220354.html.plaintext.txt	206	ass snum cleavage performed similar series experiment necn gvp substrate
0.6103489.15220354.html.plaintext.txt	207	remarkably contrast app derived cnum substrate co expression psndnuma psndnuma mutant restore nicd production fig
0.6103489.15220354.html.plaintext.txt	208	fact null value obtained comparable single psndnuma mutant
0.6103489.15220354.html.plaintext.txt	209	taken together result indicate functional diaspartyl group formed ntf ctf two different presenilins restore secretase activity least mediate cleavage cnum also diaspartyl group may display substrate specificity since able discriminate two substrate cnum necn
0.6103489.15220354.html.plaintext.txt	210	evidence presenilin dimerization first gathered yeast two hybrid assay mostly assessed ability hydrophilic domain large presenilin fragment selfassociate num num
0.6103489.15220354.html.plaintext.txt	211	nonetheless exhaustive analysis situ interaction performed membrane anchored presenilin domain study contribution hydrophobic transmembranes dimerization missing
0.6103489.15220354.html.plaintext.txt	212	split ubiquitin system num allowed u design test assaying different combination tm region grouped even number order preserve general presenilin topology cytosoliclumen direction domain
0.6103489.15220354.html.plaintext.txt	213	result show presenilin transmembrane domain relevant interaction within ntfntf ctfctf ntfctf dimer either assembly stabilization therefore maintenance tertiary quaternary presenilin structure
0.6103489.15220354.html.plaintext.txt	214	context fact hydrophobic domain evolutionarily conserved presenilin region fad mutation mainly concentrated transmembrane domain indicate even conservative change may cause subtle disturbance dimerization final quaternary structure reflected shift substrate cleavage site
0.6103489.15220354.html.plaintext.txt	215	previous result group showed hlnum domain hydrophilic loop connecting tmi tmii two ntfs interacted involved ntfntf homodimerization num
0.6103489.15220354.html.plaintext.txt	216	addition largest er facing loop highly evolutionarily conserved hlnum domain presenilin hydrophilic region cluster highest number fad mutation
0.6103489.15220354.html.plaintext.txt	217	remarkably fad mutation analyzed altered formation hlnum hlnum complex num
0.6103489.15220354.html.plaintext.txt	218	substitution domain increased ntfntf interaction thus indicating requirement interaction may rather play modulatory role dimerization mean achieve correct presenilin tertiary quaternary structure
0.6103489.15220354.html.plaintext.txt	219	therefore focused domain ass contribution presenilin structure function
0.6103489.15220354.html.plaintext.txt	220	interestingly substitution hlnum another er hydrophilic connecting loop hlnum presumably generates topologically equivalent presenilin protein totally inhibited presenilinase activity
0.6103489.15220354.html.plaintext.txt	221	addition production aicd nicd completely absent cell expressing psn variant
0.6103489.15220354.html.plaintext.txt	222	abrogation presenilinase secretase activity due increased presenilin instability since psnhlnum num mutant holoprotein still detected num h cycloheximide treatment thus proving much stable wtpsn holoprotein
0.6103489.15220354.html.plaintext.txt	223	although rule possibility inhibition secretase activity psn mutant secondary effect lack presenilin endoproteolysis favor explanation since presenilinase secretase activity necessarily correlate num num
0.6103489.15220354.html.plaintext.txt	224	another presenilin variant lacking hlnum analyzed
0.6103489.15220354.html.plaintext.txt	225	tmnum num psnum mutant deletion comprising tmi hlnum tmii region able generate peptide num although maturation trafficking secretase complex component highly altered
0.6103489.15220354.html.plaintext.txt	226	similar effect psnhlnum num mutant could assumed
0.6103489.15220354.html.plaintext.txt	227	however deem unlikely since presenilin transmembrane region integrally maintained psnhlnum num tmnum num mutant mediate interaction within secretase complex num num
0.6103489.15220354.html.plaintext.txt	228	recently suggested presenilin endoproteolysis regulatory event cause cleavage induced conformational change presenilin becomes activated enzyme num
0.6103489.15220354.html.plaintext.txt	229	according report presenilinase cleavage would retrieve loop encoded exon num would otherwise occupy presenilin substrate binding site
0.6103489.15220354.html.plaintext.txt	230	case surmise tmnum num mutant adopted conformation relieved exon num peptide binding pocket whereas conformation psnhlnum num variant allowed neither endoproteolysis processing retrieval exon num peptide hence secretase activity might severely compromised
0.6103489.15220354.html.plaintext.txt	231	one prediction presenilin dimer secretase core formation one catalytic diaspartyl group
0.6103489.15220354.html.plaintext.txt	232	addressed whether diaspartyl combination functional
0.6103489.15220354.html.plaintext.txt	233	result showed reconstitution active secretase two different presenilin aspartic mutant co expressed functional diaspartyl group formed tmvi aspnum aspartic residue aspnum human psnum one psn monomer tmvii dnum aspartic residue aspnum human psnum fig
0.6103489.15220354.html.plaintext.txt	234	diaspartyl group cleave cnum app derived substrate site also produced anum anum peptide ratio wtpsn thus suggesting similar diaspartyl combination responsible app cleavage vivo
0.6103489.15220354.html.plaintext.txt	235	remarkably fact experimental condition catalytic group generate nicd snum cleavage support idea different requirement met app notch cleavage agreement previous report num num num num
0.6103489.15220354.html.plaintext.txt	236	addition result suggest presenilinase activity requires formation diaspartyl group ntf ctf monomer
0.6103489.15220354.html.plaintext.txt	237	according result endoproteolytic processing longer requirement presenilin activation co expressing two presenilin aspartic mutant
0.6103489.15220354.html.plaintext.txt	238	presenilin aspartic mutant might adopt slightly different conformation would need retrieve exon num binding substrate site num
0.6103489.15220354.html.plaintext.txt	239	ruled possible concern reconstitution secretase activity experimental condition following ground discarded domain swapping two mutant presenilin molecule first event already ruled presenilins several author previous report num num num moreover case presenilin domain swapping completely prevented since expressed mutant endoproteolytically cleaved ntf ctf fragment ii even considering residual endogenous presenilin dependent independent secretase activity rnai treatment fact presenilin mutant might equally effective replacing residual activity fact individual mutant abrogated secretase activity measured loss aicd nicd production fig
0.6103489.15220354.html.plaintext.txt	240	num c d g whereas experimental condition co expression two mutant restored num num wild type activity accordance heterodimer psndnumapsndnuma representing one half dimer population indicated genetic complementation two mutant occurred functional diaspartyl group assembled trans finally iii reconstituted secretase activity cleaved app derived substrate whereas activity notch derived one completely impaired
0.6103489.15220354.html.plaintext.txt	241	presenilin independent activity account app processing notch cleavage activity detected mutant control obviously case
0.6103489.15220354.html.plaintext.txt	242	hence fact secretase activity restored co expression two aspartic mutant presenilins within cell activity discriminates two substrate contrast wild type endogenous presenilin make complementation two presenilin mutant highest likely explanation restoration secretase activity
0.6103489.15220354.html.plaintext.txt	243	concluded reconstituted presenilin catalytic function due bona fide formation diaspartyl group trans interface two mutant presenilins providing one different aspartic residue
0.6103489.15220354.html.plaintext.txt	244	result also completely consistent provide feasible explanation recent report rescue presenilinase secretase activity cnum substrate co expression inactive c terminally truncated presenilin mutant wild type ctf mutant aspartic ctf p deficient cell num
0.6103489.15220354.html.plaintext.txt	245	based result propose model catalytic diaspartyl group responsible cleaving substrate partially overlap within presenilin secretase complex
0.6103489.15220354.html.plaintext.txt	246	thus aspnumaspnum group formed trans interface two presenilin monomer would cleave cnum substrate whereas aspnumaspnum group ci ntf ctf moiety molecule would process necn substrate fig
0.6103489.15220354.html.plaintext.txt	247	experimental approach two aspartic mutant allow test second possibility
0.6103489.15220354.html.plaintext.txt	248	hypothesis consistent divergent transmembrane sequence substrate according model would cleaved different diaspartyl combination
0.6103489.15220354.html.plaintext.txt	249	noted observation presented fully compatible recently proposed model secretase may contain separated docking catalytic site num num num num
0.6103489.15220354.html.plaintext.txt	250	scenario also compatible observation
0.6103489.15220354.html.plaintext.txt	251	one conformation ha psndnumamyc psndnuma heterodimer hinders access catalytic site necn substrate cnum
0.6103489.15220354.html.plaintext.txt	252	context conformation mutant slightly different wild type protein mutation catalytic site could alter turn accessibility binding site allowing access cnum still hampering necn substrate
0.6103489.15220354.html.plaintext.txt	253	second alternative might mutant presenilins addressed cellular compartment different wild type allowing access app derived substrate precluding notch substrate
0.6103489.15220354.html.plaintext.txt	254	another alternative recognition andor cleavage necn substrate requires least three aspartic residue presenilin dimer similar suggested num
0.6103489.15220354.html.plaintext.txt	255	finally author proposed different isoforms p num p num aph numal aph numas aph numb assemble different secretase complex provide substrate specificity num
0.6103489.15220354.html.plaintext.txt	256	apply model component secretase complex encoded single copy gene drosophila num
0.6103489.15220354.html.plaintext.txt	257	notwithstanding irrespective number composition secretase complex substrate reached catalytic center may cleaved specific diaspartyl group could differ different substrate
0.6103489.15220354.html.plaintext.txt	258	view larger version numk fig
0.6103489.15220354.html.plaintext.txt	259	hypothetical model cnum necn presenilin secretase cleavage
0.6103489.15220354.html.plaintext.txt	260	diaspartyl group formed one aspartic acid num one aspartic acid num black two presenilin molecule cleaves cnum substrate site whereas necn substrate b cleaved diaspartyl group black formed ntf ctf monomer
0.6103489.15220354.html.plaintext.txt	261	numbering according human psnum
0.6103489.15220354.html.plaintext.txt	262	presenilins belong emerging family unusual diaspartyl protease clip num num whose characteristic include complex structural topology ability carry regulated intramembraneous proteolysis substrate num
0.6103489.15220354.html.plaintext.txt	263	remarkably another member signal peptide peptidase recently reported form homodimer labeled inhibitor directed active site secretase num
0.6103489.15220354.html.plaintext.txt	264	finding two aspartyl clip signal peptide peptidase presenilins function dimer recognized active site inhibitor suggests dimerization may general requirement function regulation family protease provides new insight regulated intramembraneous proteolysis may take place
0.6103489.15220354.html.plaintext.txt	265	sum main conclusion reconstituted secretase activity co expression two distinct catalytically inactive aspartic presenilin mutant provided evidence presenilin function dimer within secretase complex functional diaspartyl group formed interface dimer
0.6103489.15220354.html.plaintext.txt	266	disturbance presenilin dimerization compromise even abrogates presenilinase secretase activity
0.6103489.15220354.html.plaintext.txt	267	footnote study funded ministerio de ciencia y tecnologia grant pmnum num r
0.6103489.15220354.html.plaintext.txt	268	new investigator research grant alzheimers association c
0.6103489.15220354.html.plaintext.txt	269	cost publication article defrayed part payment page charge
0.6103489.15220354.html.plaintext.txt	270	article must therefore hereby marked advertisement accordance num u
0.6103489.15220354.html.plaintext.txt	271	section num solely indicate fact
0.6103489.15220354.html.plaintext.txt	272	present address ucsf diabetes center parnassus campus san francisco ca num
0.6103489.15220354.html.plaintext.txt	273	present address institut de neurociencies universitat autogravenoma de barcelona bellaterra barcelona num spain
0.6103489.15220354.html.plaintext.txt	274	correspondence addressed
0.6103489.15220354.html.plaintext.txt	275	num num fax num num e mail gmarfanyatub
0.6103489.15220354.html.plaintext.txt	276	num abbreviation used p presenilins psn drosophila presenilins wtpsn wild type psn fad familiar autosomal dominant alzheimers disease tm transmembrane ctf c terminal fragment ntf n terminal fragment aicd app intracellular domain nicd notch intracellular domain ha hemagglutinin dsrna double stranded rna utr untranslated region er endoplasmic reticulum elisa enzyme linked immunosorbent assay app amyloid precursor protein
0.6103489.15220354.html.plaintext.txt	277	acknowledgment grateful neus abella technical support jennifer strahle weiming xia elisa assay peptide
0.6103489.15220354.html.plaintext.txt	278	dori huertas consejo superior de investigaciones cientificas csic barcelona spain gift plasmid pcohygro dr
0.6103489.15220354.html.plaintext.txt	279	alejandro vaquero csic gift plasmid construct pactppa pactppa galnumbd hspnummp numxgnum gal dr
0.6103489.15220354.html.plaintext.txt	280	gary struhl columbia university new york gift oggnum nnum construct dr
0.6103489.15220354.html.plaintext.txt	281	johan lundkvist karolinska institute stockholm sweden gift cnum galnumvpnum construct dr
0.6103489.15220354.html.plaintext.txt	282	taisuke tomita university tokyo gift scnum construct dr
0.6103489.15220354.html.plaintext.txt	283	mikio shoji saeko antibody
0.6103489.15220354.html.plaintext.txt	284	thank serveis cientifico tecnics de la universitat de barcelona use num num dna analyzer robin rycroft revising english
0.62542415.8817335.html.plaintext.txt	0	alzheimers disease associated mutation presenilin num rare variably penetrant alzheimers disease associated mutation presenilin num rare variably penetrant r
0.62542415.8817335.html.plaintext.txt	1	numcentre research neurodegenerative disease department medicine university toronto department medicine division neurology toronto hospital toronto ontario mnums numanum canada numkarolinska institute department clinical neuroscience geriatric medicine novum kfc num num huddinge sweden numdepartment neurology psychiatry university florence viale morgagni num florence italy numlaboratoire de genetique moleculaire chu rouen num rouen france numdepartment medical molecular genetics university toronto research institute hospital sick child num university avenue toronto ontario canada numdepartment neurology hopital de la salpetriere inserm unum num paris france numsurrey place centre department obstetrics gynaecology dept
0.62542415.8817335.html.plaintext.txt	2	physiology university toronto toronto ontario mnums numanum canada numinserm unum chateau de longchamp num paris france numdepartment neurology university udine udine italy
0.62542415.8817335.html.plaintext.txt	3	received february num num revised accepted april num num
0.62542415.8817335.html.plaintext.txt	4	missense mutation presenilin num p num gene chromosome num sought direct nucleotide sequence analysis open reading frame num pedigree familial alzheimers disease fad
0.62542415.8817335.html.plaintext.txt	5	majority pedigree p num beta amyloid precursor protein betaapp gene mutation excluded
0.62542415.8817335.html.plaintext.txt	6	additional p num pathogenic mutation detected four silent nucleotide substitution alternative splicing nucleotide num num glunum observed
0.62542415.8817335.html.plaintext.txt	7	analysis additional member pedigree known segregate metnumval mutation p num revealed age onset symptom highly variable range num num year
0.62542415.8817335.html.plaintext.txt	8	variability attributable difference apoe genotype
0.62542415.8817335.html.plaintext.txt	9	result suggest contrast mutation p num mutation p num relatively rare cause fad ii genetic environmental factor modify ad phenotype associated p num mutation iii still fad susceptibility gene remain identified
0.62542415.8817335.html.plaintext.txt	10	missense mutation associated early onsetalzheimers disease ad discovered two related gene termed presenilin chromosome num num presenilin ii chromosome num num num
0.62542415.8817335.html.plaintext.txt	11	analysis number large data set revealed missense mutation presenilin p num gene frequent cause early onset familial alzheimers disease fad accounting perhaps much num case early onset fad num num num num
0.62542415.8817335.html.plaintext.txt	12	order determine frequency mutation presenilin ii p num gene undertook survey mutation open reading frame orf p num gene num pedigree fad
0.62542415.8817335.html.plaintext.txt	13	disease family characterized occurrence ad consistent ninds adrda criterion least three closely related subject often one generation
0.62542415.8817335.html.plaintext.txt	14	pedigree age onset range num num year num mean age onset num year num mean age onset num year num insufficient reliable data age onset overlapped observed pedigree known p num mutation onset num num year
0.62542415.8817335.html.plaintext.txt	15	determine penetrance p num mutation also examined several additional member flonum pedigree previously described metnumval missense mutation p num gene num
0.62542415.8817335.html.plaintext.txt	16	data suggest missense mutation p num gene rare cause ad missense mutation may subject modifying action gene environmental influence
0.62542415.8817335.html.plaintext.txt	17	fibroblast transformed lymphoblast peripheral blood sample obtained least one affected member num kindred multiple num family member affected fad ascertained familial alzheimers disease registry university toronto clinic university florence massachusetts alzheimers disease research centre karolinska institute stockholm sweden french university hospital national inserm network france indiana university alzheimers disease dna bank nia sponsored repository coriell institute
0.62542415.8817335.html.plaintext.txt	18	diagnosis ad affected member used ninds adrda criterion similar cerad criterion
0.62542415.8817335.html.plaintext.txt	19	mutation p num beta amyloid precursor protein betaapp gene previously excluded majority pedigree sequencing reverse transcriptase polymerase chain reaction rt pcr product corresponding p num gene genomic pcr product corresponding exon num num betaapp
0.62542415.8817335.html.plaintext.txt	20	analysis nucleotide sequence rt pcr product corresponding orf p num num fad pedigree failed uncover additional mutation beyond two initial mutation asnnumile mutation three related kindred volga german origin metnumval mutation flonum pedigree italian origin previously reported data set num
0.62542415.8817335.html.plaintext.txt	21	specific screening asnnumile metnumval mutation supplemental set genomic dna sample affected probands num swedish fad pedigree also failed identify instance either mutation
0.62542415.8817335.html.plaintext.txt	22	however although pathogenic nucleotide sequence difference observed four silent nucleotide substitution detected c num bpcodon num c num bpcodon num c num bpcodon num g num bpcodon num sequence numbering accession
0.62542415.8817335.html.plaintext.txt	23	substitution occurred third nucleotide position codon would therefore predicted cause change amino acid sequence
0.62542415.8817335.html.plaintext.txt	24	fifth sequence variant variable presence nucleotide num num encoding glunum residuewas found transcript tissue
0.62542415.8817335.html.plaintext.txt	25	transcript without nucleotide num num reflects use alternate splice donor sequence approximately equal abundance brain fibroblast leukocyte
0.62542415.8817335.html.plaintext.txt	26	investigation p num gene several newly ascertained member flonum pedigree segregating metnumval mutation p num identified additional carrier mutation subject iii num table num
0.62542415.8817335.html.plaintext.txt	27	surprisingly subject aged num year evidence cognitive memory impairment serial follow several year age num year noted become mildly demented profoundly demented mini mental status examination score numnum clinical feature sustain diagnosis probable ad ninds adrda criterion
0.62542415.8817335.html.plaintext.txt	28	review clinical data additional member extended pedigree also uncovered two subject direct lineage family either historical evidence late onset ad subject num affected grandfather iii num died num year dementia currently clinical feature consistent probable ad using ninds adrda criterion subject iii num onset num year
0.62542415.8817335.html.plaintext.txt	29	others previously reported genotype apolipoprotein e gene modulate age onset alzheimers disease subject valnumile mutation betaapp num num
0.62542415.8817335.html.plaintext.txt	30	however flonum family metnumval mutation p num apoe genotype correlate age onset table num
0.62542415.8817335.html.plaintext.txt	31	thus elderly symptomatic subject iii num onset num year apoe genotype epsilonnumepsilonnum three affected carrier metnumval mutation developed symptom younger age onset num num year
0.62542415.8817335.html.plaintext.txt	32	moreover affected carrier iv num apoe genotype epsilonnumepsilonnum developed symptom age num year similar affected sibling iv num apoe genotype epsilonnumepsilonnum onset num year table num fig
0.62542415.8817335.html.plaintext.txt	33	sample size small draw reliable conclusion presence absence interaction apoe genotype asnnumile mutation table num
0.62542415.8817335.html.plaintext.txt	34	abbreviated pedigree diagram flonum
0.62542415.8817335.html.plaintext.txt	35	small type face roman numeral pedigree location subject
0.62542415.8817335.html.plaintext.txt	36	solid symbol ad affected subject hatched symbol risk subject open symbol risk
0.62542415.8817335.html.plaintext.txt	37	known age onset age death denoted arabic numeral
0.62542415.8817335.html.plaintext.txt	38	exception subject iii num whose genotype p num apoe unknown biological sample available affected subject carried p num metnumval mutation
0.62542415.8817335.html.plaintext.txt	39	although large cadre fad pedigree reported represent unbiased survey paucity missense mutation p num gene amongst fad pedigree data set suggests contrast mutation orf p num mutation orf gene rare cause fad least caucasian population
0.62542415.8817335.html.plaintext.txt	40	confidently exclude mutation intronic sequence associated rna splice site indeed one mutation affect splicing exon num p num found fad affected subject
0.62542415.8817335.html.plaintext.txt	41	however num utr num utr sequence searched pathogenic mutation exclude formal possibility mutation might exist sequence pedigree
0.62542415.8817335.html.plaintext.txt	42	nevertheless two corollary conclusion p num orf mutation rare
0.62542415.8817335.html.plaintext.txt	43	first unless phenotype uniquely associated least enriched subject p num mutant found screening program mutation orf p num likely low yield
0.62542415.8817335.html.plaintext.txt	44	second importantly yet unidentified fad susceptibility locus must exist
0.62542415.8817335.html.plaintext.txt	45	table num age onset relative genotype apoe p num gene subject
0.62542415.8817335.html.plaintext.txt	46	age symptom onset current age p num mutation carrier displayed along subject apoe genotype
0.62542415.8817335.html.plaintext.txt	47	conclusion drawn data age symptom onset subject p num mutation generally older num num year observed p num mutation num num year highly variable even amongst affected member pedigree
0.62542415.8817335.html.plaintext.txt	48	contrast sharply experience p num mutation age onset generally quite similar amongst affected member family often amongst member different family mutation num num num num
0.62542415.8817335.html.plaintext.txt	49	date subject ad flonum pedigree inherited metnumval mutation unlikely late onset case represent phenocopies andor represents polymorphism linkage disequilibrium nearby pathogenic mutation
0.62542415.8817335.html.plaintext.txt	50	consequently parsimonious explanation single cause disease metnumval mutation phenotype modified genetic environmental factor
0.62542415.8817335.html.plaintext.txt	51	limited number subject asnnumile mutation data set prevents rigorous conclusion interaction apoe genotype mutation
0.62542415.8817335.html.plaintext.txt	52	however analysis larger data set
0.62542415.8817335.html.plaintext.txt	53	schellenberg also reveals obvious interaction genotype apoe p num asnnumile manuscript preparation
0.62542415.8817335.html.plaintext.txt	54	absence close correlation apoe genotype age symptom onset subject p num mutation two implication
0.62542415.8817335.html.plaintext.txt	55	first view parallel observation showing apparent interaction apoe genotype mutation p num num num num together structural amino acid sequence similarity p num p num protein num num likely functional effect p num p num mutation similar either remote functional effect apoe epsilonnum allele affect biochemical pathway leading ad different influenced apoe epsilonnum
0.62542415.8817335.html.plaintext.txt	56	second variation age onset p num mutation carrier argues modifying environmental genetic factor e
0.62542415.8817335.html.plaintext.txt	57	polymorphism within presenilin gene difference gene must exist
0.62542415.8817335.html.plaintext.txt	58	nature factor remains determined
0.62542415.8817335.html.plaintext.txt	59	however modifying factor identified might exploitable therapeutic tool
0.62542415.8817335.html.plaintext.txt	60	subject familially clustered alzheimers disease defined occurrence least three first second degree relative ad recruited patient referred investigation dementia university toronto university florence massachusetts alzheimers disease research centre huddinge hospital karolinska institute french university hospital
0.62542415.8817335.html.plaintext.txt	61	subject provided informed consent using institutionally approved protocol
0.62542415.8817335.html.plaintext.txt	62	diagnosis ad made affected pedigree member direct clinical examination standard laboratory procedure met exceeded stringency nincds adrda criterion num num
0.62542415.8817335.html.plaintext.txt	63	evidence ad deceased family member ascertained investigation medical family record previously described num
0.62542415.8817335.html.plaintext.txt	64	additional fad pedigree sample obtained cornell institute camden nj n num indiana university alzheimers disease dna bank indianapolis n num
0.62542415.8817335.html.plaintext.txt	65	mutation sought orf p num gene numnum pedigree exon num num betaapp gene numnum pedigree using method previously described num num num
0.62542415.8817335.html.plaintext.txt	66	p num gene orf investigated north american italian pedigree isolating complimentary dna fragment amplification using rt pcr oligonucleotide primer sequence reaction condition previously described num
0.62542415.8817335.html.plaintext.txt	67	french family rt pcr performed using primer fnum num caggaaacagctatgaccgagctgaccctcaaatacgg fnum num tgtaaaacgacggccagtgagatcatacacagagatgg recover codon num num primer fnum num caggaaacagctatgacctcaagtacctcccagagtgg fnum num tgtaaaacgacggccagtagcctgtggcacaccatgtc recover codon num num
0.62542415.8817335.html.plaintext.txt	68	nucleotide sequence rt pcr product affected pedigree member determined using fluorescent dye terminator dye primer cycle sequencing
0.62542415.8817335.html.plaintext.txt	69	mutation detected analysis resultant chromatogram heterozygous nucleotidesubstitutions using direct inspection factura ver num
0.62542415.8817335.html.plaintext.txt	70	num sequence navigator ver num
0.62542415.8817335.html.plaintext.txt	71	numbnum software package abi foster city ca
0.62542415.8817335.html.plaintext.txt	72	presence c substitution base pair num p num cdna sequence give rise metnumval mutation assessed genomic dna previously described num
0.62542415.8817335.html.plaintext.txt	73	num familial alzheimers disease kindred missense mutation novel gene chromosome num related alzheimers disease type num gene
0.62542415.8817335.html.plaintext.txt	74	num familial alzheimers disease locus chromosome num
0.62542415.8817335.html.plaintext.txt	75	num molecular genetic analysis familial early onset alzheimers disease linked chromosome numqnum
0.62542415.8817335.html.plaintext.txt	76	num mutation presenilin num gene family early onsetalzheimers disease
0.62542415.8817335.html.plaintext.txt	77	num alzheimers disease collaborative group num structure presenilin gene identification six mutation early onset ad pedigree
0.62542415.8817335.html.plaintext.txt	78	num alzheimers disease possible gene interaction
0.62542415.8817335.html.plaintext.txt	79	num apoe genotype familial alzheimers disease possible influence age onset appnumval ile mutated family
0.62542415.8817335.html.plaintext.txt	80	num apoe genotype modulate age onset family chromosome num encoded alzheimers disease
0.62542415.8817335.html.plaintext.txt	81	num french alzheimers disease collaborative study group num apolipoprotein e genotype affect age onset patient chromosome num encoded alzheimers disease
0.62542415.8817335.html.plaintext.txt	82	num clinical diagnosis alzheimer disease report nincds adrda work group auspex department health human service task force alzheimer disease
0.62542415.8817335.html.plaintext.txt	83	num diagnosis alzheimer disease
0.62542415.8817335.html.plaintext.txt	84	num genetic evidence novel familial alzheimer disease gene chromosome num
0.62542415.8817335.html.plaintext.txt	85	num molecular prospective phenotypic characterization pedigree familial alzheimer disease missense mutation codon num beta amyloid precursor protein app gene
0.62542415.8817335.html.plaintext.txt	86	num pathogenic mutation probable alzheimers disease app gene n terminus beta amyloid
0.62542415.8817335.html.plaintext.txt	87	num association apoliprotein e allele epsilonnum late onset familial sporadic alzheimer disease
0.62542415.8817335.html.plaintext.txt	88	num association alzheimer disease apolipoprotein gene chr num due linkage disequilibrium ann
0.62542415.8817335.html.plaintext.txt	89	correspondence addressed page maintained oup admin
0.62542415.8817335.html.plaintext.txt	90	last updated thu oct num numnumnum gmt num
0.62542415.8817335.html.plaintext.txt	91	part oup journal world wide web service
0.62542415.8817335.html.plaintext.txt	92	copyright oxford university press num
